{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_3hop_cross_year_type2",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 800,
    "successful_questions_in_experiment": 800,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 800,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-120b-reasoning/e2_page_window/qualitative_3hop_cross_year_type2.json",
    "timestamp": "2026-02-04T01:16:23.837876"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO held $606 million of the 5.000 % senior notes due April 2030 at the end of FY 2022 (AVGO_10k_2022.pdf pp. 101‑105) and the balance remained $606 million in FY 2023 (AVGO_10k_2023.pdf pp. 79‑83) and FY 2024 (AVGO_10k_2024.pdf pp. 79‑83). The unchanged exposure over three years shows the company has deliberately retained this low‑cost, long‑dated fixed‑rate debt while using other issuances and repayments to shape its overall leverage, reflecting a disciplined, maturity‑focused debt‑management strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that AVGO held $606 million of the 5.000% notes due April 2030 at the end of FY 2022, while the ground truth indicates the exposure was $1,086 million in 2022. This is a significant factual error in the starting value. The LLM correctly reports $606 million for 2023 and 2024, matching the ground truth. (2) Quantitative accuracy is low because the key initial figure is wrong—this affects the entire narrative of how exposure evolved. The decrease from $1,086M to $606M in 2023 is a major reduction, but the LLM implies no change over the period, misrepresenting the trend. (3) The reasoning is partially sound in interpreting the stable balance in 2023–2024 as part of a strategic debt management approach, but it fails the multi-hop synthesis by not recognizing the substantial repayment between 2022 and 2023. The conclusion about 'unchanged exposure' contradicts the actual reduction, leading to flawed inference. (4) Despite incorrect numbers, the answer remains contextually relevant by addressing debt management strategy and referencing correct documents and note terms. However, the core factual inaccuracy in the 2022 value severely undermines correctness, warranting a score of 4. Quantitative accuracy is penalized heavily (3/10) due to the wrong initial amount. Qualitative reasoning is mid-range (5/10) as logic follows from incorrect data. Contextual relevance is high (8/10) because structure, entities, and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 415,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement for the closed block has stayed essentially the same – the 2022 filing disclosed that 59.25 % of the closed block was reinsured through a modified coinsurance agreement, and the 2023 and 2024 filings each report the figure at roughly 59 % (MET 10‑K 2022 pp. 212‑216; MET 10‑K 2023 pp. 225‑229; MET 10‑K 2024 pp. 202‑206). This steady‑state proportion shows that the company has adopted a long‑term strategy of consistently transferring about three‑fifths of the closed‑block risk while retaining the remainder, providing predictable capacity and risk‑management over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages are correct: 59.25% in 2022 and approximately 59% in both 2023 and 2024, matching the original answer exactly. There are no calculation errors. (2) The answer addresses the evolution of MetLife's use of the modified coinsurance agreement from 2022 to 2024, correctly noting stability in the percentage reinsured. It also interprets the consistency as evidence of a long-term reinsurance strategy, which matches the original conclusion. (3) The multi-hop reasoning is sound—synthesizing data across three years and filings to infer strategic intent. The only minor omission is that the LLM does not mention the accounting method (deposit method) or the right of offset, which are part of the full picture but not central to the core question about percentage evolution and strategic implication. It also omits the context of total net ceded reinsurance recoverables growing from $6.3B to $17.6B, which strengthens the point about proportion stability amid overall growth. (4) Despite these omissions, the answer captures the essential facts and meaning, with excellent semantic equivalence. The interpretation of 'three-fifths' as roughly 59% is reasonable and adds clarity. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only slight deduction for incomplete detail on accounting treatment and broader reinsurance trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 410,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s master‑netting collateral fell sharply – it was about **$1.5 billion at 12/31/2022**, dropped to **$0.8 billion at 12/31/2023**, and fell further to **≈$0.49 billion at 12/31/2024** (2023 10‑K shows $800 m and $1,494 m; 2024 10‑K shows $491 m and $800 m)【XOM_10k_2023.pdf:100‑104】【XOM_10k_2024.pdf:97‑101】.  \n\nThe downward trend indicates that ExxonMobil is netting or reducing its derivative positions and using collateral more efficiently, suggesting tighter management of its derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,494 million in 2022 (≈$1.5 billion), $800 million in 2023 ($0.8 billion), and $491 million in 2024 (≈$0.49 billion), matching the ground truth exactly with acceptable formatting variations (e.g., $1.5 billion vs $1,494 million). All dates (12/31/2022, 12/31/2023, 12/31/2024) align with fiscal year-ends typically used in 10-K filings. (2) Quantitative accuracy is perfect—values are correctly cited, and the trend of consistent decline is accurately represented. The LLM even references the correct source documents (2023 and 2024 10-Ks) and specific data points, confirming cross-year synthesis. (3) The reasoning is sound: the downward trend is correctly interpreted as indicating reduced derivative positions or more efficient collateral use, which aligns with the ground truth’s interpretation of 'strategic reduction in derivative exposure or improved offsetting mechanisms.' The only minor shortcoming is slightly less precise phrasing compared to the original (e.g., 'tighter management' vs 'strategic reduction or improved offsetting'), but the semantic meaning and logical inference are equivalent. (4) The answer is fully contextually relevant, addressing both the quantitative change and its implication for derivative exposure management. Multi-hop reasoning across two 10-K filings is correctly executed. Score deductions are minimal: qualitative accuracy is 9 due to slightly less nuanced interpretation, but all core facts, calculations, and implications are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 428,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "AVGO carried $622 million of principal on its 3.625 % senior notes due October 2024 at the end of FY 2022, the same $622 million remained on the balance sheet in FY 2023, and the balance fell to zero by FY 2024 when the notes matured and were repaid【AVGO_10k_2022.pdf page 101】【AVGO_10k_2023.pdf page 79】【AVGO_10k_2024.pdf page 79】. This pattern shows the company kept the fixed‑rate debt through its scheduled maturity rather than refinancing it, using the notes’ natural expiration to reduce overall debt and interest‑cost exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the principal amounts for the 3.625% notes due October 2024 across fiscal years 2022 ($622 million), 2023 (unchanged at $622 million), and 2024 (zero outstanding), which matches the ground truth exactly. All numeric values, dates, and percentages are accurate. (2) Quantitative accuracy is perfect: the amounts and years align with the original answer and cited 10-K pages. Format variations (e.g., $622 million vs $622 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—information is correctly synthesized across three annual reports (2022–2024). The conclusion that the debt was repaid at maturity is reasonable and consistent with the data. However, the original answer notes the possibility of refinancing, while the LLM asserts repayment without acknowledging refinancing as an alternative, slightly narrowing the interpretation. This does not make the answer factually wrong but reduces qualitative precision slightly. (4) Contextual relevance is excellent: the response directly addresses both parts of the question—evolution of exposure and implications for debt management. The strategy interpretation is logical and supported by the data. Overall, the answer is factually correct and well-supported, meriting a high score with only minor deductive nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 377,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ Marine Systems segment generated $2.56 billion in surface‑ship revenue in 2022, $2.70 billion in 2023 and $2.82 billion in 2024 – a steady increase each year【GD_10k_2024.pdf, pages 7‑8】. This consistent growth signals that the company is gaining traction and solidifying its position as a leading builder of U.S. Navy surface combatants and auxiliary vessels, benefitting from expanding demand and its investments in shipbuilding capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the upward trajectory of General Dynamics' surface ship revenue from 2022 to 2024 with values very close to the ground truth. The reported figures are $2.56B (vs $2,561M), $2.70B (vs $2,698M), and $2.82B (vs $2,819M). These are within rounding differences—$2.56B = $2,560M (1M variance), $2.70B = $2,700M (2M over), $2.82B = $2,820M (1M over)—which is acceptable under format variation tolerance. (2) All years are correct and match the question’s timeframe. The growth trend is accurately described as steady, and the dollar amounts are presented consistently in billions, which is semantically equivalent to the original millions. (3) The multi-hop reasoning is sound: the model correctly synthesizes revenue data across three years and infers the strategic implication—strengthened positioning in naval shipbuilding—based on sustained growth. The mention of 'expanding demand' and 'investments in shipbuilding capacity' adds context supported by typical 10-K disclosures and aligns with the ground truth's implication of strategic emphasis. (4) The answer fully addresses both parts of the question: revenue evolution and what it indicates. Only minor quantitative deviations prevent a perfect 10; otherwise, the reasoning, entity accuracy (General Dynamics, Marine Systems, surface ships, correct years), and contextual relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 388,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From 2022 to 2024 Mastercard’s Class A shares kept the same voting power – each share carries one vote per share – but the cash dividend rose each year, from $2.04 per share in 2022, to $2.37 in 2023, and to $2.74 in 2024【MA_10k_2022.pdf:94‑98】【MA_10k_2023.pdf:97‑101】【MA_10k_2024.pdf:90‑94】. The unchanged “one‑vote‑per‑share” right alongside a steadily increasing dividend signals a stable governance structure that is rewarding shareholders without altering control dynamics.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces increasing dividend amounts—$2.04 in 2022, $2.37 in 2023, and $2.74 in 2024—which are not supported by the ground truth. The original answer states that A Class shares had 'standard dividend rights' with no changes over the period, but does not specify actual dividend payments. These precise figures appear to be fabricated or misattributed, possibly confusing Class A dividends with overall company dividend payouts, which may have increased but are not tied to changes in Class A share rights. (2) The voting rights description ('one vote per share') is accurate and consistent with the ground truth, and the conclusion about stable governance is partially aligned. However, the reasoning is flawed because it bases stability on unchanged voting rights plus increasing dividends, whereas the ground truth emphasizes the absence of any change in rights—both voting and dividend—indicating that dividend rights did not evolve. (3) The multi-hop reasoning fails because the model infers an evolution in dividend rights from dividend amounts, but the question asks about the evolution of 'dividend and voting rights,' not payout amounts. Rights refer to entitlements (e.g., pro rata dividends), not the amount paid. The model conflates dividend policy (payout levels) with dividend rights (entitlement structure), which is a critical distinction in shareholder governance. (4) While the answer is relevant and addresses the question’s structure, the introduction of unsupported quantitative data severely undermines factual accuracy. The correctness score is low due to major quantitative and qualitative errors, though not completely wrong since voting rights are correctly described and the stability conclusion is directionally plausible but based on incorrect reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 495,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 billion in 2022**, **$2.70 billion in 2023** (≈5% YoY growth), and **$2.82 billion in 2024** (≈4% YoY growth), a cumulative rise of roughly **10%** over the two‑year span【GD_10k_2022.pdf p.9】【GD_10k_2023.pdf p.9】【GD_10k_2024.pdf p.9】.  The consistent upward trend signals that GD is deepening its role as a primary builder and modernizer of U.S. Navy surface combatants and auxiliary vessels, positioning the company favorably within expanding naval defense programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports revenue figures of $2.56 billion (2022), $2.70 billion (2023), and $2.82 billion (2024), which align with the ground truth values of $2,561M, $2,698M, and $2,819M when rounded to the nearest $10 million and converted from millions to billions. The slight discrepancies (e.g., $2.70B vs $2.698B) are within acceptable rounding tolerance. (2) Year-over-year growth rates are approximately correct: (2,698 - 2,561)/2,561 ≈ 5.35% (reported as ≈5%), and (2,819 - 2,698)/2,698 ≈ 4.48% (reported as ≈4%). The cumulative ~10% increase over two years is also accurate. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of 10-K filings, and the conclusion about General Dynamics’ growing role in naval defense programs logically follows from the upward revenue trend. (4) All entities (General Dynamics, surface ship revenue, years 2022–2024) are accurate, and the answer fully addresses both parts of the question: revenue evolution and strategic positioning. Wording differs slightly but maintains semantic equivalence. Only minor deduction in quantitative accuracy due to rounding at the $10M level, but not material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 339,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde’s reliance on long‑term contracts has remained unchanged – the 2022, 2023 and 2024 Business‑Overview sections all note that “the majority of Linde’s business is conducted through long‑term contracts which provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers” (2022 p. 17; 2023 p. 20; 2024 p. 15). This steady emphasis signals a deliberate strategy to lock‑in predictable cash‑flow streams and shield earnings from volatile energy‑price swings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Linde maintained consistent reliance on long-term contracts from 2022 to 2024, citing the same key phrase across all three years about cash flow stability and cost pass-through—this matches the original answer's core claim. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly referenced, and the page numbers (2022 p.17, 2023 p.20, 2024 p.15) are factually accurate per the source data, supporting quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports to identify a consistent strategic theme, correctly inferring that this reflects a deliberate approach to cash flow predictability and risk management amid energy market volatility. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'inflationary pressures' or frame the strategy as prioritizing 'financial resilience and operational certainty over short-term pricing flexibility,' which adds slight depth to the original answer. However, the semantic meaning—predictable cash flows, shielding from volatility, deliberate strategy—is fully preserved. Thus, while extremely close, it misses a nuance in emphasis, justifying a 9 instead of 10 on qualitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 393,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—General Dynamics states that its ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (GD 10‑K 2022 § ROIC; GD 10‑K 2023 § ROIC; GD 10‑K 2024 § ROIC). The language is unchanged, indicating that the company consistently strips out non‑economic accounting items from the metric to keep ROIC focused on the underlying operating returns of its capital.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that General Dynamics (GD) consistently excluded non-economic accounting changes from its ROIC calculation across 2022, 2023, and 2024, which matches the original answer's claim of methodological consistency. (2) There are no numerical values requiring calculation in this question, but the years (2022–2024) and the specific exclusions (non-economic accounting changes, including goodwill impairments) are correctly cited. The references to the 10-K filings for each year are appropriately noted. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three annual reports to identify consistency in language and approach, concluding that GD maintains a stable definition of core performance. (4) The answer captures the same semantic meaning as the original: GD’s exclusion of non-economic items reflects a deliberate, institutionalized approach to measuring operational performance. Wording differs slightly but is factually and conceptually equivalent. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 323,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group kept its service‑level guarantee commitments in place each year, but the related amounts accrued, paid or charged to earnings were “immaterial” in 2022, 2023 and again in 2024 (Note 4 of the 2024 Form 10‑K states that none of the amounts for service‑level guarantees were material as of Dec 31 2024, 2023 or 2022). The repeated immaterial impact indicates that the company’s risk‑management controls and contract‑performance practices are effective and consistently prevent material penalties from these guarantees.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that UnitedHealth Group disclosed immaterial financial impact from service level guarantees in 2022, 2023, and 2024, matching the original answer's core claim. (2) No numerical values (e.g., dollar amounts) are missing or incorrect—'immaterial' is used consistently across all three years as in the ground truth, and the reference to Note 4 of the 2024 Form 10-K adds contextual support without introducing error. (3) The multi-hop reasoning is sound: the model synthesizes consistent disclosures across three years and correctly infers that this pattern reflects effective risk management and contractual performance, which aligns with the original conclusion. (4) The answer fully addresses both parts of the question: the evolution (consistency over time) and the implication (effective controls). Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 292,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ Marine Systems revenue from surface‑ship construction rose from $2.56 billion in 2022 to $2.70 billion in 2023 and to $2.82 billion in 2024【GD_10k_2023.pdf p.9】【GD_10k_2024.pdf p.9】.  This steady growth—about 5 % each year—shows the company is expanding its surface‑ship business and cementing its role as a primary supplier of U.S. Navy destroyers, auxiliary vessels and other naval platforms, reflecting a strategic focus on strengthening its naval‑defense positioning.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer reports revenue figures of $2.56 billion in 2022, $2.70 billion in 2023, and $2.82 billion in 2024. However, the ground truth states $2,328 million (2022), $2,698 million (2023), and $2,819 million (2024). The 2022 figure is significantly overstated ($2.56B vs $2.328B), while 2023 and 2024 are close but not exact (off by $2M and $1M respectively). The LLM also claims a '5% each year' growth rate, which is inaccurate: actual YoY growth was ~15.8% from 2022 to 2023 and ~4.5% from 2023 to 2024. (2) Number verification: $2,328M → $2,698M → $2,819M is correct per ground truth. LLM uses rounded figures but introduces material error in 2022. Format variation ($2.82B vs $2,819M) is acceptable, but magnitude matters. (3) Multi-hop reasoning is sound—the model correctly identifies the trend over three years and infers strategic positioning in naval defense, citing destroyer and auxiliary vessel production, which aligns with General Dynamics’ Marine Systems segment. It synthesizes across two 10-K filings (2023 and 2024), as evidenced by citations. (4) Despite incorrect 2022 revenue and flawed percentage calculation, the overall trend (steady growth) and strategic interpretation are consistent with the ground truth. Hence, qualitative reasoning and contextual relevance are strong, but quantitative accuracy is penalized due to the significant 2022 discrepancy and incorrect growth rate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 395,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "In 2022 Electric Insurance Company (EIC) was still a captive industrial insurer within GE’s run‑off insurance operations, with net claim reserves of about $0.2 billion (2021) and $0.3 billion (2020). In the fourth quarter of 2022 GE re‑classified EIC as a “held‑for‑sale” disposal group (Note 2) and, by year‑end 2023, the subsidiary held roughly $541 million of assets against $378 million of liabilities, a $124 million valuation allowance and generated a $109 million loss on the pending sale; a binding purchase agreement was signed in Q3 2023. The divestiture was completed in the second quarter of 2024 when GE sold EIC to Riverstone International Holdings for $120 million, eliminating the assets, liabilities and related allowance from its balance sheet (the 2024 held‑for‑sale schedule shows zero).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: EIC was a captive insurer in 2022 with $0.2 billion in net claim reserves (as of 2021), reclassified as 'held for sale' in late 2022 (consistent with 2023 reporting), had $541M in assets and $378M in liabilities as of year-end 2023, a $109M loss was recorded, and the sale to Riverstone International Holdings Inc. was completed in Q2 2024 for $120M. (2) Quantitative accuracy is strong: the $541M assets, $378M liabilities, $109M loss, and $120M sale price match exactly. The mention of a $124M valuation allowance is additional but plausible context not contradicted by the ground truth. The inclusion of $0.3B reserves for 2020 is extra but not incorrect. (3) Multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024, with proper classification changes and financial impacts. (4) The only minor deviation is the specificity about Q3 2023 agreement and Q2 2024 close, which are not in the original answer but do not contradict it and may reflect deeper document insight. Overall, the answer is semantically equivalent, factually correct, and fully addresses classification, financial exposure, and divestiture. Hence, a score of 9 is appropriate—excellent but not perfectly minimal to the original truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 373,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "In Q1 2022 ConocoPhillips completed the monetization of its CVE common stock by selling the remaining 91 million shares and directing the cash to its share‑repurchase program【COP_10k_2024.pdf p.110】.  By the end of 2024 the company had repurchased a total of 433 million shares for $34.3 billion and had raised its repurchase ceiling to $65 billion, showing that after the one‑off CVE sale the firm has continued to allocate excess cash to buybacks, underscoring a capital‑allocation focus on returning capital to shareholders【COP_10k_2024.pdf p.110】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key events: completion of the CVE share monetization in Q1 2022 (aligning with the 91 million shares sold in 2022), application of proceeds to share repurchases, total repurchased shares (433 million) and total cost ($34.3 billion) by end of 2024, and the increase in the repurchase authorization to $65 billion. All numeric values—91 million shares, 433 million shares, $34.3 billion, $65 billion—are factually accurate and match the ground truth. (2) Quantitative accuracy is perfect: the figures for shares repurchased and dollar amounts are consistent with the original answer, and the timeline (2022 monetization, 2024 update) is correctly represented. The $65 billion ceiling reflects the $45 billion initial + $20 billion increase, as stated in the ground truth. (3) The reasoning is sound and captures the multi-hop logic: linking the CVE monetization to funding buybacks, and showing an evolving, expanding capital return strategy. However, the LLM omits specific details about the 2023 milestone (383 million shares repurchased at $29 billion), which was part of the progression and helps illustrate the trajectory. While not fatal, this minor omission reduces completeness in the year-by-year evolution. (4) The answer is contextually excellent—directly addresses the question’s focus on evolution and capital allocation strategy, concluding with the correct inference about shareholder returns. Wording differs slightly but maintains semantic equivalence. Scored 9/10 due to missing 2023 data point, but all other aspects are accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 444,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has been essentially unchanged. In the 2022 filing the company said it reinsured ≈ 59.25 % of the closed block (deposit‑method accounting with an offset) 【MET_10k_2022.pdf p.212‑216】; the 2023 and 2024 filings each report a ≈ 59 % share, still using the deposit method and offsetting the deposit liability against the recoverable 【MET_10k_2023.pdf p.225‑229】【MET_10k_2024.pdf p.202‑206】. This consistency shows MetLife relies on the modified‑coinsurance structure as a stable, long‑term tool for transferring a substantial portion of closed‑block risk rather than shifting to a different risk‑transfer approach.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the percentage of the closed block reinsured is correctly stated as approximately 59.25% in 2022 and 59% in both 2023 and 2024, matching the original answer. The accounting treatment—use of the deposit method and right of offset—is accurately described for all three years. (2) Quantitative accuracy is perfect: the percentages align with the ground truth (59.25% and 59%), and no calculations are required beyond accurate reporting. Format variations (e.g., '≈ 59%' vs '59%') are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three annual filings (2022–2024), identifies consistency in both reinsurance percentage and accounting treatment, and draws the correct conclusion about MetLife’s long-term risk transfer strategy. (4) The answer addresses all parts of the question: evolution over time, percentage reinsured, accounting treatment, and strategic implication. The conclusion about a stable, long-term risk transfer strategy is logically supported and matches the original answer’s interpretation. All entities (MetLife, modified coinsurance, closed block, deposit method, offset) are correctly identified and used in context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 370,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "The Target MasterCard credit‑card’s share of purchases fell each year – total RedCard penetration (which includes the MasterCard) was 20.5 % in 2022, 19.8 % in 2023 and 18.6 % in 2024 (2023 Form 10‑K, p. 27). The steady decline signals that fewer guests are using the MasterCard, indicating a gradual weakening of consumer engagement with Target’s branded financial products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. The downward trend is accurately described. (2) All numeric values and years are correct, with no calculation errors. The source citation (2023 Form 10-K, p. 27) is plausible, though not verifiable from the knowledge graph alone, but does not detract from factual accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes the trend over three years and infers decreasing consumer engagement, which aligns with the ground truth's interpretation. However, the LLM omits mention of the rebranding from RedCards to Target Circle Cards in 2024 and the fact that the 5% discount incentive did not reverse the decline—this is a minor omission affecting completeness but not core accuracy. (4) The answer is semantically equivalent in conveying the key trend and its implication. Quantitative accuracy is perfect. Qualitative accuracy is high but not full due to the missing rebranding context. Contextual relevance is excellent as it directly addresses both parts of the question: trend evolution and consumer engagement implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 340,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Colgate‑Palmolive Co. was listed as a member of PMI’s peer group in the 2022, 2023 and 2024 Form 10‑K filings – the peer‑group description and the full list of companies (including Colgate‑Palmolive) remained unchanged each year【PM_10k_2022.pdf, p.19‑23】【PM_10k_2023.pdf, p.24‑28】【PM_10k_2024.pdf, p.24‑28】. This consistency indicates that PMI’s benchmarking strategy relies on a stable set of consumer‑product peers that meet its defined criteria (global presence, product focus, comparable size), emphasizing continuity in its comparative analysis rather than frequent re‑shuffling of peers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Colgate-Palmolive Co. was consistently included in PMI's peer group from 2022 to 2024, matching the original answer's claim of 'remained consistently included.' (2) No numerical values (e.g., financial figures or percentages) are required in this response, but the years 2022, 2023, and 2024 are correctly cited, and the reference to unchanged peer group composition aligns with the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual 10-K filings (2022–2024), confirms consistency in peer group membership, and correctly infers that this reflects a stable benchmarking methodology based on defined criteria (global presence, consumer product focus, size comparability). (4) The answer addresses both parts of the question: the evolution (or lack thereof) in peer classification and the strategic implication. The reasoning about PMI’s emphasis on continuity in comparative analysis matches the original answer’s conclusion about 'stable benchmarking methodology' and 'strategic alignment.' Minor wording differences (e.g., 'stable set of consumer-product peers' vs. 'ongoing strategic alignment') do not affect factual equivalence. All entities—Philip Morris International, Colgate-Palmolive Co., and the time frame—are correctly identified. Citations from the 10-K filings are appropriately referenced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 403,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "AMD’s revenue‑recognition policy for development‑service and IP‑licensing contracts is unchanged from the 2022 filing through the 2024 filing. In each filing (2022 pp. 57‑61; 2023 pp. 62‑66; 2024 pp. 61‑65) AMD states that it first determines whether the licensing component is distinct – if it is not distinct, the license is combined with the development services and revenue is recognized over time; if it is distinct, revenue is recognized at a point in time when the customer can benefit from the license, with no variable‑consideration estimates for either type. This identical language demonstrates a consistent accounting approach to combined versus standalone IP‑licensing arrangements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures that AMD maintained a consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements, with no changes in approach. (2) There are no numerical values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in terms of calculations, but all references to years (2022–2024) and page numbers (e.g., 2022 pp. 57–61) are correctly cited and consistent with the source structure, indicating accurate referencing. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and correctly identifies the key accounting criteria—whether the license is distinct based on being (i) capable of being distinct and (ii) distinct in the context of the arrangement—and the resulting revenue recognition pattern (over time vs. point in time). It also correctly notes the absence of variable consideration in all years, which supports the conclusion of policy stability. (4) The answer addresses all parts of the question: evolution (or lack thereof) of policy, treatment of combined vs. standalone arrangements, and what this reveals about consistency. The use of identical language across filings is strong evidence of a uniform approach, which the LLM correctly highlights. All entities (AMD, development services, IP licensing, revenue recognition) are accurately identified and contextualized. Therefore, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 424,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, the PMI Peer Group list consistently includes **Colgate‑Palmolive Co.**—the company appears in the peer‑group description in each year’s “Performance Graph” section. This unchanged inclusion shows that PMI deliberately frames its competitive set around large, globally‑present consumer‑goods firms, using Colgate‑Palmolive as a benchmark to position itself as a broader consumer‑products player rather than solely a tobacco company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was consistently included in PM's peer group across 2022, 2023, and 2024, which matches the original answer's claim of unchanged inclusion over the three-year period. (2) There are no numeric values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the mention of the 'Performance Graph' section in the 10-K filings adds contextual precision without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model correctly infers from the consistent inclusion that PM uses Colgate-Palmolive as a strategic benchmark to position itself among global consumer goods firms, which is a valid interpretation of the stability in peer group composition. (4) The answer captures the core implication—that PM frames its competitive positioning beyond tobacco toward broader consumer staples—though it could have slightly expanded on the rationale tied to revenue and market capitalization similarity as noted in the original. However, this omission does not detract significantly from the overall accuracy. Wording differs but semantic equivalence is maintained. Minor deduction from 10 to 9 due to slightly less detail on the methodology of peer selection, but all key facts and reasoning are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 379,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "AMD’s treatment of contracts that bundle development services with an IP license has not changed from 2022 through 2024. In each filing the company says it first assesses whether the licensing component is distinct; if it is not distinct, the license is combined with the development services into a single performance obligation and revenue is recognized over time, whereas a distinct license is accounted for as a separate obligation and revenue is recognized at the point in time the customer can benefit from the license (with no variable‑consideration estimates)【AMD_10k_2022.pdf, pp. 57‑61】【AMD_10k_2023.pdf, pp. 62‑66】【AMD_10k_2024.pdf, pp. 61‑65】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately states that AMD's revenue recognition policy for combined development and IP licensing agreements remained unchanged from 2022 through 2024, which matches the ground truth assertion of no material changes. (2) The LLM correctly describes the two-step assessment for whether the IP license is distinct—based on whether it is capable of being distinct and distinct in the context of the arrangement—even though it summarizes the criteria slightly more concisely. (3) It accurately explains the accounting treatment: if not distinct, the license and development services are combined into a single performance obligation with revenue recognized over time; if distinct, revenue is recognized at a point in time when the customer can benefit from the license. (4) The LLM correctly notes the absence of variable consideration estimates, a key indicator of policy stability across years. (5) The citations reference the correct documents (AMD 10-K filings for 2022, 2023, 2024) and relevant page ranges, supporting the multi-hop synthesis across years. There are no factual errors, omissions, or misstatements. The answer is complete, precise, and contextually appropriate, demonstrating sound reasoning and accurate entity and policy identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 377,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "ConocoPhillips’ “paced” monetization of its CVE common‑stock stake culminated in the first‑quarter 2022 sale of the remaining 91 million CVE shares, with the cash earmarked for share buybacks that year (87.7 million shares repurchased)【COP_10k_2022.pdf p.139】. After that one‑time disposal, the company kept using cash flow for buybacks but at a lower, steadier rate—48.6 million shares in 2023 and 49.1 million shares in 2024【COP_10k_2023.pdf p.108】【COP_10k_2024.pdf p.110】—indicating that the CVE sale jump‑started a disciplined, ongoing capital‑return program that now relies on regular cash generation rather than further asset sales. This multi‑year trend reveals a capital‑allocation strategy focused on converting non‑core assets into shareholder value and then sustaining buybacks as a core component of its return‑of‑capital policy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key event — the monetization of 91 million CVE shares in Q1 2022 — and links it to share repurchases, which aligns with the ground truth. However, there are significant quantitative discrepancies. The LLM states that 87.7 million shares were repurchased in 2022, 48.6 million in 2023, and 49.1 million in 2024. But the ground truth reports cumulative repurchases of 383 million shares by end of 2023 and 433 million by end of 2024. This implies approximately 383M (by 2023) - 87.7M (2022) = ~295.3M repurchased in 2023 alone, not 48.6M. Similarly, 2024 repurchases would be ~50M (433M - 383M), which is close to the LLM's 49.1M, but the prior year is vastly undercounted. The $29B and $34.3B cost figures and $65B expanded authorization in 2024 are missing in the LLM answer, reducing completeness. (2) The dates (Q1 2022) and entity (CVE shares, ConocoPhillips) are correct. The citation of 10-K pages adds credibility but does not compensate for incorrect aggregation of repurchase volumes. The LLM appears to misinterpret annual repurchase volumes, possibly confusing quarterly or partial-year data. (3) The multi-hop reasoning is sound in linking asset monetization to capital allocation and inferring a strategic shift toward sustained shareholder returns. The conclusion that the CVE sale 'jump-started' the buyback program is consistent with the ground truth’s emphasis on it being a 'key enabler.' However, the LLM underrepresents the scale and escalation of repurchases, missing the 'escalating focus' highlighted in the original answer. (4) Despite strong qualitative reasoning and contextual relevance, the correctness score is reduced due to major quantitative inaccuracies in repurchase volumes for 2023, undermining the factual foundation of the analysis. The answer captures the strategic narrative but misrepresents the magnitude of execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 517,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor sections show a steady, cross‑segment exposure to “changes in the competitive landscape” – in 2022 the company warned that Aerospace, Building Technologies, Performance Materials & Technologies and Safety & Productivity Solutions all face new market entrants, new technologies and product commoditization (2022 10‑K, p.30‑33); the same language re‑appears in the 2023 filing for those four reportable units (2023 10‑K, p.30‑34); and after the October 2023 realignment, the 2024 filing carries the same risk into the newly named Aerospace Technologies, Industrial Automation, Building Automation and Energy & Sustainability Solutions segments (2024 10‑K, p.30‑32). The continuity—and the fact that the risk now spans the re‑structured segments—indicates that competitive pressure has intensified, prompting Honeywell to respond with a segment realignment, the spin‑off of Advanced Materials and ongoing repositioning actions to better defend market share and preserve margins.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains accurate dates (2022–2024) and correctly references the continuity of competitive risk language across years and segments, with proper citation of page numbers and segment names post-realignment. However, it introduces significant factual inaccuracies in entity identification and scope. The original answer states that in 2022, competitive landscape risks were explicitly mentioned only for Honeywell Building Technologies and Safety and Productivity Solutions. The LLM incorrectly claims that Aerospace and Performance Materials & Technologies were also cited in 2022 with the same risk language, which is not supported by the ground truth. This overstatement persists into 2023 and 2024, where the LLM asserts the risk applied to four segments, while the ground truth only confirms two in 2022 and 2023, and two renamed segments (Building Automation, Industrial Automation) in 2024. Additionally, the LLM introduces strategic responses—'spin-off of Advanced Materials' and 'segment realignment'—as direct reactions to competitive pressures, but the original answer does not link these actions to competitive risks, making this an unsupported inference. While the LLM correctly identifies a trend of sustained risk and reiteration across years, its overattribution of segment exposure and unsupported causal claims about strategic responses undermine the qualitative accuracy. The reasoning is partially sound in noting continuity, but flawed in synthesis due to incorrect entity mapping and overreach in connecting restructuring to competitive pressure. Quantitative elements (years, page references) are accurate, and the answer is contextually relevant to the question about evolving exposure and market pressures, but the factual errors in segment-level risk disclosure reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 493,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "Across the three most recent years Mastercard’s Class A shares kept the same voting power – one vote per share – while the cash dividend per share was raised each year, from $2.04 in 2022 → $2.37 in 2023 → $2.74 in 2024【MA_10k_2022.pdf:94】【MA_10k_2023.pdf:97】【MA_10k_2024.pdf:90】. This steady‑state voting structure paired with a rising dividend shows a governance approach that preserves a stable, single‑class voting framework while consistently increasing shareholder returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces dividend amounts ($2.04, $2.37, $2.74) that are not part of the ground truth. The original answer states only that A Class shares have dividend rights — it does not specify cash dividend per share amounts or assert that dividends increased. These figures may reflect actual dividends paid, but the question and ground truth are about the *rights* associated with the shares, not the amount distributed. Therefore, the inclusion of specific dividend increases is factually unsupported in the context of the question. (2) The voting rights description (one vote per share) is correct and consistent with the ground truth. However, the quantitative claim about dividends is inaccurate because the question asks about the evolution of *dividend rights*, not dividend payouts. Dividend rights remained unchanged — the company retained the right to pay dividends, regardless of the amount. The LLM conflates dividend policy (payout amounts) with dividend rights (entitlement structure), which are legally and conceptually distinct. (3) The reasoning is partially sound in identifying stable voting rights, but the multi-hop synthesis fails because it draws conclusions about governance strategy based on dividend amounts rather than rights. The ground truth emphasizes structural consistency in shareholder rights, while the LLM shifts focus to capital return trends. (4) Correctness score is low due to major factual misrepresentation in the quantitative domain. While the voting stability is correctly noted, the core of the answer — dividend evolution — is based on a misinterpretation. Quantitative accuracy is very low due to unsupported numbers. Qualitative accuracy is moderate because the reasoning framework is logical, but based on incorrect premises. Contextual relevance is acceptable as the answer addresses governance strategy, albeit through a distorted lens.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 519,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco recorded a $92 million loss on total‑return‑swap‑deferred‑compensation in FY 2022, which flipped to a $58 million gain in FY 2023 and further improved to a $91 million gain in FY 2024, showing a swing from a net cost to a net benefit in operating expenses【CSCO_10k_2022.pdf p.92】【CSCO_10k_2024.pdf p.90】【CSCO_10k_2024.pdf p.89】.  At the same time, the notional amount of these swaps grew from $651 million in FY 2022 to $985 million in FY 2024, indicating that while the exposure size increased, its earnings impact turned increasingly positive【CSCO_10k_2022.pdf p.93】【CSCO_10k_2024.pdf p.92】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the financial exposure evolution for Cisco's Total Return Swaps-Deferred Compensation with accurate figures: a $92 million loss in FY2022, a $58 million gain in FY2023, and a $91 million gain in FY2024—matching the ground truth exactly. These numbers are presented with correct fiscal years and directional interpretation (from loss to gain, net cost to net benefit). (2) All numeric values are factually correct and consistent with the original answer. The additional detail about notional amounts increasing from $651M to $985M is not part of the ground truth but is contextually relevant and does not contradict it; it enhances the response without introducing error. (3) The multi-hop reasoning is sound: the model synthesizes data across multiple years and correctly interprets the trend in financial impact. It connects changes in gains/losses in operating expenses to the overall shift in financial exposure, fulfilling the question’s requirement. (4) The only reason for not scoring a perfect 10 is that the original answer did not include notional amount data, so while this addition is accurate and insightful, it slightly exceeds the scope of the ground truth without detracting from correctness. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 377,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "In 2022 J&J’s restructuring created LTL Management LLC to isolate all talc liabilities, filed a Chapter 11 petition for LTL and funded a $2 billion trust, recording a $2 billion reserve for those obligations (2022 pp. 111‑115). In 2023 the original LTL case was dismissed, prompting a second Chapter 11 filing (LTL 2) that again stayed litigation but was itself dismissed in July 2023, leading to appeals and a December 2023 change of the entity’s formation to Texas and renaming as LLT Management LLC (2023 pp. 94‑98). By 2024 J&J reached a multi‑state settlement with 42 states (agreement in principle Jan 2024, finalized June 2024), launched a pre‑packaged Chapter 11 plan through the newly formed Red River Talc LLC, and expanded its talc reserve to about $11.6 billion (nominal $13.5 billion) to fund a $6.5 billion settlement over 25 years (2024 pp. 98‑102).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several key correct elements but introduces significant factual inaccuracies, particularly in the 2024 developments. (1) Correct: In 2022, J&J established a $2 billion reserve and LTL Management LLC filed for Chapter 11, which aligns with the ground truth. (2) Partially correct: The 2023 dismissal of the original LTL bankruptcy and re-filing (LTL 2) are accurate, but the claim that LTL 2 was dismissed in July 2023 is not supported in the ground truth, which states that a preliminary injunction limited discovery until August 2023—no dismissal of LTL 2 is mentioned. (3) Incorrect: The LLM claims LTL was renamed to 'LLT Management LLC' and moved to Texas in December 2023—this is not in the original answer and appears fabricated. (4) Incorrect: The 2024 developments are significantly misrepresented. The LLM states J&J launched a pre-packaged Chapter 11 via 'Red River Talc LLC' and expanded the reserve to $11.6 billion to fund a $6.5 billion settlement over 25 years. The ground truth mentions no such entity, no pre-packaged plan, and no specific reserve expansion beyond the multi-state settlement—there is no mention of an $11.6B or $13.5B reserve. The multi-state settlement with 42 states and D.C. is correctly noted, including its timing (agreement in principle Jan 2024, finalized June 2024), which supports partial credit. (5) Multi-hop reasoning is partially sound—linking reserve, bankruptcy, and settlement strategy is appropriate—but the synthesis is undermined by invented entities and figures. (6) Quantitative accuracy is low due to unsupported numbers ($11.6B reserve, $6.5B settlement), though the $2B reserve and 2022–2024 timeline are correct. (7) Contextual relevance is high—the answer addresses reserve funding, bankruptcy filings, and settlements as required. Overall, the answer reflects a plausible narrative but deviates critically from the ground truth in later years, especially with unverified financial figures and entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 532,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried an unchanged $495 million principal balance in FY 2022, FY 2023 and FY 2024 (see AVGO 10‑K 2022 p. 101; AVGO 10‑K 2023 p. 81; AVGO 10‑K 2024 p. 81). The flat balance indicates the company has not repaid or added to this tranche, suggesting a deliberate strategy to hold the notes to maturity and preserve cash rather than actively refinancing or retiring this specific debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the principal balance of $495 million, the 3.125% interest rate, the maturity date (January 2025), and the stability across fiscal years 2022, 2023, and 2024 are correctly reported. Minor formatting differences (e.g., 'FY 2022' vs 'fiscal year 2022', $495 million vs $495M) are acceptable and do not affect meaning. (2) Quantitative accuracy is perfect: the dollar amount, percentage, and years match the ground truth exactly. No calculations were required, but the consistency of the balance over time is correctly observed. (3) The multi-hop reasoning is sound—the model synthesized data across three separate 10-K filings (2022, 2023, 2024), confirming the balance remained unchanged, which supports the conclusion about debt management strategy. (4) The qualitative interpretation—that the flat balance suggests a deliberate strategy to hold the notes to maturity and preserve cash—is a reasonable and logical inference, consistent with the ground truth’s characterization of a 'consistent approach to managing this portion of its capital structure.' The inclusion of specific document citations (page numbers from 10-Ks) enhances credibility and traceability. All parts of the question are addressed: evolution of the balance (unchanged) and what it indicates about debt management strategy. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 397,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco’s 3.50 % senior note due June 15 2025 carried an effective interest‑rate cost of **3.20 % in FY 2022** (July 30 2022)【CSCO_10k_2022.pdf p. 87‑91】. By FY 2023 the effective rate had risen to **6.38 %** (July 29 2023)【CSCO_10k_2024.pdf p. 87‑91】, and it increased slightly further to **6.66 %** in FY 2024 (July 27 2024)【CSCO_10k_2024.pdf p. 87‑91】. This upward swing shows that, although the note’s coupon remains 3.50 %, Cisco’s actual borrowing cost on the issue more than doubled between 2022 and 2023 and continued to climb in 2024, reflecting higher market rates and a growing interest‑rate exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values from the ground truth: 3.20% effective interest rate in FY 2022, 6.38% in FY 2023, and 6.66% in FY 2024. These match the original answer exactly. The coupon rate of 3.50% and maturity date (June 15, 2025) are also accurately referenced. (2) Quantitative accuracy is perfect—no calculation or data errors. The progression (3.20% → 6.38% → 6.66%) is correctly stated, and the observation that borrowing costs more than doubled from 2022 to 2023 is mathematically sound (6.38 / 3.20 ≈ 2.0). (3) The multi-hop reasoning is strong: the model synthesizes data across three fiscal years from presumably different 10-K filings (2022, 2023, 2024), correctly tracking the evolution of the effective interest rate. The conclusion about increasing borrowing costs and interest-rate exposure is logically supported. (4) The only minor shortcoming is that the LLM attributes the rising costs primarily to 'higher market rates' without mentioning the possibility of a change in Cisco's credit profile, which the ground truth includes as a potential factor. While the LLM's explanation is reasonable and contextually valid, it omits one element of the original interpretation, slightly reducing qualitative completeness. However, this does not undermine the core correctness. Overall, the answer is factually precise, well-supported, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 391,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One’s total senior and subordinated notes rose from $27.2 billion at year‑end 2022 (COF_10k_2022.pdf) to $31.2 billion at year‑end 2023 (COF_10k_2023.pdf) and then slipped slightly to $30.7 billion at year‑end 2024 (COF_10k_2024.pdf).  Over the same span the weighted‑average rate on its senior debt climbed from roughly 2.8 % in 2022 (COF_10k_2022.pdf) to 4.5 % in 2023 (COF_10k_2023.pdf) and 4.8 % in 2024 (COF_10k_2024.pdf), while the floating‑rate senior portion was eliminated, signalling a deliberate shift to a larger, higher‑yielding fixed‑rate debt base to lock in rates and reduce interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Capital One's senior and subordinated notes: $27.2B in 2022 (vs. $27.219B ground truth), $31.2B in 2023 (vs. $31.248B), and $30.7B in 2024 (vs. $30.696B). These are minor rounding differences and semantically equivalent. Interest rates are reported as ~2.8%, 4.5%, and 4.8% versus ground truth 2.76%, 4.48%, and 4.84% — again, acceptable rounding. (2) All calculations and comparisons are accurate: the increase in debt and rising interest rates are correctly portrayed. The elimination of floating-rate senior debt is a valid inference from the strategic shift described in the ground truth. (3) Multi-hop reasoning is sound: the model synthesizes data across three years and two financial metrics (debt levels and interest rates) to infer a strategic shift toward fixed-rate financing, which aligns with the ground truth's conclusion about locking in financing costs amid rising rates. (4) The answer is contextually complete and relevant, addressing both the quantitative evolution and the strategic implications. The only reason for not scoring a 10 is the slight imprecision in interest rate figures (e.g., 4.5% vs. 4.48%), though these are within reasonable reporting tolerance. Overall, the answer conveys the same core facts and strategic interpretation as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 376,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "In 2022 roughly 40 % of the U.S. pension‑plan fixed‑income portfolio was allocated to U.S. Treasury or agency securities; that share fell to about 30 % in 2023 and remained near 30 % in 2024. The reduction signals a deliberate tilt away from the safest government bonds toward a broader mix of other government and corporate debt, suggesting the pension fund is seeking higher yields and greater diversification while still keeping a core of low‑risk assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the allocation percentages for 2022 (40%), 2023 (30%), and 2024 (30%), matching the ground truth exactly. There are no errors in numbers or time periods. (2) All quantitative values are accurate—40% decreasing to 30% and remaining stable is correctly stated. No calculations are required beyond these comparisons, and they are handled properly. (3) The reasoning is sound: the model correctly infers a strategic shift away from U.S. Treasuries and agency securities toward other fixed income instruments, aligning with the ground truth's interpretation of reallocation for yield-seeking or risk adjustment. The mention of 'broader mix of other government and corporate debt' is semantically equivalent to the original answer’s 'other government bonds and corporate bonds.' The only minor difference is that the LLM emphasizes 'diversification' slightly more than the original, which focuses on risk tolerance and yield—this is a nuance, not an error. (4) The answer fully addresses both parts of the question: the evolution of allocation (multi-hop across three years) and the strategic implication. Wording differs slightly but meaning is preserved. Thus, the answer is factually complete and logically consistent with the ground truth, warranting a high score with only a slight deduction in qualitative accuracy due to subtle emphasis differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 388,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "In 2022 Electric Insurance Company (EIC) was still a captive industrial insurer within GE’s run‑off insurance operations, with net claim reserves of $0.2 billion (2021) and $0.3 billion (2020)【GE_10k_2022.pdf p.45‑49】. In the fourth quarter of 2022 GE re‑classified EIC as a “business held for sale,” recorded a valuation allowance of roughly $124 million and a $109 million loss in 2023 as it prepared the divestiture【GE_10k_2023.pdf p.48‑52】, and then completed the sale to Riverstone International Holdings in the second quarter of 2024 for $120 million, removing the assets and liabilities from its balance sheet【GE_10k_2024.pdf p.46‑50】. This sequence shows GE’s deliberate strategy to shed non‑core insurance assets and focus on its core industrial businesses as part of its broader portfolio‑simplification plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $0.2 billion net claim reserves (as of 2021) match the original answer; the $109 million loss in 2023 is accurate; and the $120 million sale to Riverstone International Holdings Inc. in 2024 is correctly reported. The mention of $0.3 billion in reserves for 2020 is additional but not contradictory, as the ground truth only specifies 2021. The $124 million valuation allowance is a detail not in the ground truth but plausibly consistent with the $109 million loss and may reflect pre-tax or gross adjustments—this does not contradict the core facts. (2) The timeline is correct: reclassification as 'held for sale' in Q4 2022 (which aligns with the 2023 filing's reflection of a 2022 decision), loss recognized in 2023, and sale completed in Q2 2024. (3) Entity accuracy is strong: Electric Insurance Company (EIC), GE, Riverstone International Holdings (correct full name used), and proper classification as a captive insurer are all correct. (4) The reasoning and synthesis across years and filings (2022, 2023, 2024 10-Ks) is sound and demonstrates multi-hop understanding—linking classification change, valuation impact, and ultimate disposition to GE’s strategic shift. (5) The conclusion about GE’s strategy to divest non-core insurance assets and focus on industrial operations matches the ground truth’s interpretation. The only minor deviation is the extra detail about the $124 million valuation allowance, which isn’t in the ground truth but doesn’t invalidate the answer. Overall, the response is factually correct, complete, and contextually appropriate, warranting a 9 due to slight overprecision on a non-core number, but not enough to reduce to 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 484,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 are listed in the same Exhibit 4.4 (the Officer’s Certificate dated May 6 2014) in each filing – the 2022 Form 10‑K shows this entry on page 54, the 2023 Form 10‑K repeats the identical Exhibit 4.4 description on pages 53‑57, and the 2024 Form 10‑K again includes the same note on page 54. The unchanged, year‑over‑year disclosure signals that Apple has kept the ultra‑long‑dated, low‑coupon 4.45 % bond outstanding for many years, reflecting a deliberate strategy of locking in cheap, long‑term financing and maintaining a stable, low‑cost debt profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurate: the 4.45% Notes due 2044 were first disclosed in the 2022 10-K, reaffirmed in 2023 and 2024, and issued under the Officer's Certificate dated May 6, 2014—this matches the original answer exactly. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and issuance date (May 6, 2014)—are all correctly stated. The LLM even adds precise page numbers (e.g., page 54 in 2022 and 2024, pages 53–57 in 2023), which enhances accuracy without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings, observes the consistency in disclosure, and infers Apple’s long-term debt strategy—namely, maintaining stable, low-cost, long-term financing. (4) The conclusion about Apple’s strategy of 'locking in cheap, long-term financing' is a valid interpretation supported by the unchanged disclosures, and it adds insightful context without overreaching. The answer is semantically equivalent to the ground truth, with slightly more detail (e.g., exhibit number, page references), and fully addresses both the evolution of disclosure and strategic implication. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 366,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s total senior and subordinated notes were **$30.8 billion at year‑end 2022**, rose to **$31.2 billion at year‑end 2023**, and then fell slightly to **$30.7 billion at year‑end 2024**【COF_10k_2023.pdf p.176‑180】【COF_10k_2024.pdf p.186‑190】. The near‑flat trend—small growth followed by a modest decline—shows the company is not expanding its long‑term debt aggressively but is fine‑tuning its capital structure, notably eliminating floating‑rate senior debt (zero in 2024) and leaning more on fixed‑rate notes to lock in rates as market rates rose, thereby managing interest‑rate risk while maintaining a stable leverage profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in terms of direction and trend but has minor inaccuracies in the quantitative values. The ground truth reports carrying values of $27,219M (2022), $31,248M (2023), and $30,696M (2024). The LLM states $30.8B (2022), $31.2B (2023), and $30.7B (2024), which are close for 2023 and 2024 but significantly off for 2022 (off by ~$3.6B). This discrepancy affects the accuracy of the progression narrative. (2) Calculations: The LLM implies a near-flat trend from $30.8B to $30.7B, but the actual increase from $27.2B to $30.7B represents a ~$3.5B net increase, which is meaningful and correctly noted in the original answer. The LLM underrepresents this growth due to the incorrect 2022 figure. The interest rate shift (2.76% to 4.84%) and elimination of floating-rate debt are correctly interpreted qualitatively, though exact rates aren't cited. (3) Multi-hop reasoning is sound: the LLM synthesizes data across 2023 and 2024 filings, identifies the shift from floating to fixed-rate debt, and infers strategic rate-locking behavior in a rising rate environment—consistent with the ground truth. (4) Despite the numerical inaccuracy in the 2022 value, the overall reasoning about capital structure strategy and interest rate risk management is valid and contextually appropriate, earning high marks for qualitative and relevance scores. The correctness score is reduced due to the material error in the starting value, which impacts the interpretation of the debt evolution trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 420,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "In the 2022 filing Adobe introduced Frame.io as a cloud‑native creative‑collaboration platform mainly tied to its video‑editing tools—Premiere Pro and After Effects—enabling real‑time upload, review and frame‑accurate commenting. By the 2023 10‑K the company broadened Frame.io’s role, adding native integration with Photoshop, Lightroom and Workfront and announcing its inclusion in the new GenStudio suite alongside Adobe Express and Firefly Services. The 2024 filing further cemented Frame.io as a core pillar of Adobe’s creative‑collaboration ecosystem, fully integrated across the Creative Cloud suite (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront) and positioned within GenStudio to support scaled content production.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Frame.io across 2022–2024 with accurate integration details and strategic positioning. However, it contains a factual error regarding the timeline: it claims in the 2022 filing that Frame.io was introduced as a 'cloud-native creative-collaboration platform' with integration into Premiere Pro and After Effects, while the ground truth states that in 2022, Frame.io was only listed as a registered trademark—its functional description and positioning came in 2023. This misattribution of capabilities to 2022 undermines the accuracy of the multi-hop timeline. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are involved and no date values are incorrect where stated. (3) The multi-hop reasoning is mostly sound: the LLM correctly traces Frame.io’s expanding integration from video tools to broader Creative Cloud apps and GenStudio. However, the incorrect assignment of 2023-level functionality to 2022 breaks the chronological accuracy, which is central to the question. (4) Contextual relevance is perfect—the answer directly addresses the question about Frame.io’s evolving role and integration. The qualitative accuracy is reduced due to the timeline confusion, but core facts about integrations (Photoshop, Lightroom, Workfront, GenStudio) and strategic emphasis are correct and well-synthesized from 2023–2024 developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 415,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe’s repeated listing of the 4.550 % Notes due April 5, 2049 in its 2022, 2023 and 2024 10‑K filings (see 2022 10‑K pp. 79‑83; 2023 10‑K pp. 74‑78; 2024 10‑K pp. 73‑77) shows that the company deliberately keeps a sizable, long‑dated, fixed‑rate bond on its balance sheet. By anchoring its capital structure with this 2049 issue, Lowe’s extends its debt maturity horizon well beyond the next decade, diversifies its repayment schedule and locks in a relatively low coupon, thereby reducing refinancing risk and preserving long‑term financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes due April 5, 2049 are consistently included in Lowe's 10-K filings from 2022 to 2024, and the LLM correctly identifies this pattern. The percentages, dates, and years are accurate. (2) Quantitative accuracy is perfect: the interest rate (4.550%), maturity date (April 5, 2049), and filing years (2022–2024) match the ground truth exactly. Page references are provided, enhancing verifiability, though not required. (3) The reasoning is sound and captures the strategic implications: the LLM correctly infers that retaining this long-dated debt reflects a deliberate strategy to extend the debt maturity profile, lock in fixed rates, reduce refinancing risk, and maintain financial flexibility—consistent with the ground truth’s emphasis on stability and interest rate risk management. (4) The only minor shortcoming is that the LLM does not explicitly mention the absence of disclosures about early redemption or restructuring, which the ground truth highlights as evidence of no action taken. However, the conclusion that Lowe’s 'deliberately keeps' the debt implies this stability. The answer is semantically equivalent in intent and meaning, with slightly different emphasis. Contextual relevance is excellent, directly addressing both capital structure strategy and debt maturity management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 391,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried an outstanding principal of **$495 million** at the end of fiscal 2022 (AVGO_10k_2022.pdf p.101), and the same $495 million was reported at the end of fiscal 2023 (AVGO_10k_2023.pdf p.79) and fiscal 2024 (AVGO_10k_2024.pdf p.79). The balance has not changed over the three‑year period, indicating the company has chosen to keep this tranche of debt on its books and let it run to maturity rather than repurchasing or refinancing it.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million is accurately reported for all three fiscal years (2022, 2023, and 2024), with correct citation of the specific notes (3.125% due January 2025). The dollar amount, percentage rate, and maturity date are all factually correct. Minor formatting differences (e.g., ' % ' vs '%') do not affect accuracy. (2) The answer is complete, addressing both parts of the question: the evolution of the balance (stable across years) and the implication for Broadcom’s debt management strategy (no repayment or refinancing, indicating a decision to hold to maturity). (3) Entity accuracy is perfect: Broadcom (AVGO), the correct debt instrument, and the correct fiscal years are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across three separate 10-K filings (2022, 2023, 2024), concluding that the unchanged balance indicates a deliberate strategy to maintain the debt until maturity. The semantic meaning is equivalent to the original answer, with slightly different phrasing but identical factual and inferential content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 337,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "IBM first mentioned the 0.950 % Notes due 2025 in the 2022 Form 10‑K only in the securities‑registration table and by reference to the underlying indenture (Exhibit 4.1/4.2) [IBM_10k_2022.pdf p.28]. In the 2023 filing the company added a dedicated “Long‑Term Debt” footnote that disclosed the principal amount outstanding, interest rate, maturity date, redemption rights and split the notes into current‑ and non‑current‑portion balances on the balance sheet [IBM_10k_2023.pdf p.20]. The 2024 Form 10‑K continued this more detailed approach—again referencing the same indenture, updating the outstanding amount (and any repurchases) and keeping the notes listed under long‑term debt—showing IBM’s reliance on low‑cost, long‑dated financing and an increasingly transparent presentation of its capital‑structure strategy [IBM_10k_2024.pdf p.1].",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key factual development in the 2024 disclosure, leading to a significant error in interpretation. Quantitatively, the answer correctly identifies the 0.950% interest rate, the 2025 maturity, and the progression of disclosure detail from 2022 to 2024. It accurately notes that in 2022, the notes were only referenced in the securities registration table and via exhibit references, and that in 2023, IBM added a dedicated 'Long-Term Debt' footnote with more detailed disclosures (principal, interest, maturity, classification). The 2024 treatment is correctly described as continuing this detailed approach. However, the LLM fails to mention the critical fact from the ground truth that in 2024, IBM listed the notes on the New York Stock Exchange under ticker IBM25B—a major shift from private debt instrument to publicly traded security. This omission undermines the qualitative accuracy, as the LLM attributes the evolution to 'increasingly transparent presentation' rather than the more significant move toward market tradability and liquidity. The reasoning is sound in tracking disclosure improvements but incorrect in concluding the strategic implication without acknowledging the NYSE listing. The answer is contextually relevant and well-structured, addressing all years and the broader capital structure theme, but the missing multi-hop fact (listing on NYSE) results in an incomplete and somewhat misleading interpretation of IBM's strategy. Thus, while numbers and entities (IBM, 0.950%, 2025 maturity, years) are correct, the absence of the ticker listing—a central element of the ground truth—reduces the correctness score despite strong quantitative and structural performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 471,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "KPMG LLP’s Public Company Accounting Oversight Board firm identification number is disclosed as **185** in the 2022 Form 10‑K, and the same number appears in the 2023 and 2024 Form 10‑K filings, showing that the identifier has remained unchanged at 185 across all three years【BK_10k_2022.pdf p.14】【BK_10k_2023.pdf p.14】【BK_10k_2024.pdf p.14】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The PCAOB firm identification number for KPMG LLP is accurately reported as 185 for all three years: 2022, 2023, and 2024. (2) All numeric values are correct and consistent with the original answer; there are no calculation errors or discrepancies in numbers, dates, or entities. (3) The multi-hop reasoning is sound—the model correctly synthesized information across three separate Form 10-K filings (2022, 2023, 2024) and concluded that the identifier remained unchanged, which aligns with the ground truth. (4) The answer is semantically equivalent to the original, providing the same core information with added citation of document sources (page numbers and file names), enhancing transparency without altering meaning. All parts of the question are addressed: the identification number for each year and its consistency over time. No factual, quantitative, or qualitative errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 281,
        "total_tokens": 1442
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "Capital One’s fixed‑rate senior unsecured notes grew both in size and in coupon over the three‑year span. In 2022 the company held about $20 billion of fixed senior notes with a weighted‑average rate of roughly 2.9% (maturing 2022‑2032) [COF_10k_2022 p.188]; in 2023 it added new issues that pushed the balance to about $27 billion and lifted the average rate to 4.45% with maturities 2024‑2034 [COF_10k_2023 p.176]; and by 2024 the portfolio remained near $27 billion but the average rate rose again to about 4.8% and the maturity window shifted to 2025‑2035 [COF_10k_2024 p.186]. This trend of issuing more long‑dated, higher‑coupon fixed debt signals a deliberate capital‑structure move to lock in funding as interest rates rose, extending the maturity profile and reducing reliance on lower‑rate floating debt to mitigate refinancing risk in a higher‑rate macro‑economic environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in its overall narrative and captures the core trend in Capital One's Fixed Unsecured Senior Debt strategy from 2022 to 2024. The dollar amounts are correctly approximated: $19,975 million in 2022 is accurately rounded to $20 billion, and $26,930 million in 2024 is reasonably stated as $27 billion. However, the LLM reports a 2023 weighted-average rate of 4.45%, which is not directly supported by the ground truth—no 2023 rate is provided in the original answer, though the 2024 rate of 4.84% is correctly approximated as 'about 4.8%'. The ground truth only gives 2022 (2.91%) and 2024 (4.84%) rates, so the 2023 figure appears to be an interpolation or minor error. (2) The dollar figures and interest rate trend are directionally and quantitatively accurate, with only minor deviation in the interpolated 2023 rate. The final 2024 rate is correctly aligned with ground truth (4.8% vs 4.84%). (3) The multi-hop reasoning is sound: the LLM correctly synthesizes data across three years of 10-K filings, identifies the trend of increasing fixed-rate debt issuance, and logically infers that this reflects a strategic move to lock in long-term funding amid rising rates. The conclusion about extending maturities and reducing reliance on floating-rate debt is consistent with and expands upon the ground truth. (4) The correctness score is 9 due to the minor inaccuracy in the 2023 interest rate; otherwise, the answer is complete, contextually relevant, and demonstrates strong qualitative and quantitative accuracy. The reasoning and synthesis are excellent, and all entities (COF, Fixed Unsecured Senior Debt, years 2022–2024) are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 465,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "AMD’s description of revenue recognition for development‑service and IP‑licensing contracts is identical in the 2022, 2023 and 2024 10‑Ks: the company evaluates whether the license is distinct, combines it with development services and recognizes revenue over time when it is not distinct, or recognizes it at a point in time when it is distinct, and standalone IP licenses are always recognized at a point in time with no variable consideration. The lack of any change shows AMD has a stable, well‑defined policy for monetizing its IP, reflecting a long‑term strategic commitment to treat IP licensing as a predictable, recurring revenue stream.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that AMD's revenue recognition methodology for development and IP licensing agreements remained unchanged from 2022 to 2024, which matches the original answer. The key elements—distinctness evaluation, combination with development services if not distinct, point-in-time recognition when distinct, and absence of variable consideration—are all accurately reported. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable in that sense, but the temporal scope (2022–2024) is correctly cited, satisfying date accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings and draws a valid conclusion about strategic consistency in IP monetization. The only minor shortcoming is that the LLM answer slightly overemphasizes 'recurring revenue stream'—while implied by stability, the original answer frames it more cautiously as a 'stable and deliberate strategic approach' without explicitly calling it 'recurring.' This is a nuance in interpretation, not a factual error. (4) Contextual relevance is perfect: the response directly addresses both parts of the question—evolution (or lack thereof) in methodology and its strategic implication. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth, warranting a 9/10 due to slight wording overreach on 'recurring,' but no material inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 432,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s unsecured long‑term debt stayed roughly flat over the three‑year span – it was $30.8 billion at year‑end 2022, rose modestly to $31.2 billion at year‑end 2023, and then slipped to $30.7 billion at year‑end 2024【COF_10k_2023.pdf†L176-L180】【COF_10k_2024.pdf†L186-L190】.  While the total amount changed little, the weighted‑average coupon on the senior portion increased from about 4.45 % in 2023 to 4.84 % in 2024 (subordinated notes stayed near 3.6 %)【COF_10k_2023.pdf†L176-L180】【COF_10k_2024.pdf†L186-L190】, indicating a capital‑structure approach that keeps the overall debt level stable but leans toward slightly higher‑rate fixed‑rate issuance as market rates rise, balancing funding cost, liquidity and interest‑rate risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that unsecured long-term debt was $30.8 billion in 2022, but the ground truth is $27,219 million ($27.2 billion), a material difference of over $3.5 billion. The 2023 and 2024 figures ($31.2B and $30.7B) are close to the correct values ($31,248M and $30,696M), so those are acceptable within rounding. However, the starting point is wrong, distorting the evolution narrative. (2) The LLM incorrectly claims the weighted-average coupon on senior debt increased from 4.45% in 2023 to 4.84% in 2024, but omits that it rose from 2.91% in 2022 to 4.45% in 2023 — a critical part of the trend showing response to rising rates. This omission misrepresents the full progression. Additionally, the mention of subordinated notes staying near 3.6% is unsupported by the ground truth, which does not provide such a figure. (3) The LLM fails to mention the complete retirement of floating unsecured senior debt — declining from $1.7B in 2022 to $0.35B in 2023 and fully gone by 2024 — which is a key element of Capital One’s strategy to reduce exposure to rising benchmark rates. This missing insight undermines the analysis of capital structure strategy. (4) While the LLM correctly identifies a trend toward higher fixed-rate issuance and stable overall debt levels, it misses the multi-hop synthesis of shifting from floating to fixed debt and locking in higher rates amid a rising rate environment. The reasoning is partially sound but incomplete. (5) Contextually, the answer addresses the question’s intent and uses appropriate terminology, earning high marks for relevance. However, due to key factual errors and omissions in numbers and strategic drivers, the correctness score is moderate at 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 483,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "- **Carrying value:** $24.1 billion in 2022 → $27.2 billion in 2023 (≈ + $3.0 bn) → $26.9 billion in 2024 (≈ – $0.2 bn).  \n- **Weighted‑average interest rate:** 4.45 % in both 2022 and 2023 → 4.84 % in 2024.  \n\nThe increase in 2023 shows Capital One adding new fixed‑rate senior notes to expand its long‑term funding base, while the modest decline and higher average rate in 2024 suggest a modest refinancing or repurchase of lower‑rate issues and a shift toward slightly higher‑cost, likely longer‑dated debt—indicating a strategy of keeping ample senior unsecured capacity while managing duration and rate exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The carrying value for 2022 is reported as $24.1 billion, but the ground truth is $19,975 million ($19.975 billion), which is a substantial difference (~$4.1 billion overstatement). The 2023 and 2024 values are close ($27.2B vs $27.168B and $26.9B vs $26.930B), with minor acceptable rounding. However, the interest rate is incorrectly stated as 4.45% in 2022, while the truth is 2.91%, and it is repeated as 4.45% in 2023—only the 2023 and 2024 rates (4.45% and 4.84%) are correct. This misrepresents the trend, making it appear flat from 2022 to 2023 when in fact there was a sharp increase from 2.91% to 4.45%. (2) Calculations: The LLM correctly computes the direction of change in carrying value (increase then slight decrease), but the baseline 2022 value is wrong, affecting the magnitude. The interest rate change is completely miscalculated due to the incorrect 2022 figure. (3) Multi-hop reasoning: The LLM attempts to interpret the trend correctly—recognizing expansion in 2023 and refinancing in 2024—but the flawed data undermines the logic. The conclusion about shifting to higher-cost, longer-dated debt aligns with the ground truth, but is based on incorrect premises. (4) Scores justified: Correctness is 5 due to partial factual accuracy—some numbers right, but key errors in critical metrics. Quantitative accuracy is low (4) due to major errors in 2022 carrying value and interest rate. Qualitative accuracy is moderate (6) because reasoning structure is sound and interpretation is plausible given the (wrong) data. Contextual relevance is high (8) as the answer addresses all parts of the question and provides strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 472,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s policy on development‑and‑IP licensing has not changed from 2022 through 2024. In each 10‑K the company says it first determines whether the licensing component is distinct; if the license is not distinct it is combined with the development services and revenue is recognized over time, while a distinct license – or a standalone IP license – is recognized at a point in time when the customer can benefit from the license (AMD 2022 p. 60‑61; 2023 p. 64‑65; 2024 p. 63‑64). The disclosures also note that no variable‑consideration estimates are made for either type of arrangement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that AMD's revenue recognition policy remained unchanged from 2022 through 2024, which aligns with the original answer's emphasis on consistency. The distinction between distinct and non-distinct licenses is correctly explained: non-distinct licenses are combined with development services and recognized over time, while distinct or standalone IP licenses are recognized at a point in time. (2) There are no numerical values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy pertains to correct handling of years (2022–2024), which are accurately cited. The LLM even provides specific page references (e.g., 2022 p. 60–61), which are consistent with typical 10-K disclosures and add precision without contradicting the ground truth. (3) The multi-hop reasoning is sound—synthesizing policy treatment across three years and two types of arrangements (combined vs. standalone). The LLM correctly infers no material change over time and correctly applies ASC 606 logic regarding distinctness and performance obligations. (4) The mention of 'no variable-consideration estimates' matches the ground truth exactly. Wording differs slightly (e.g., 'has not changed' vs. 'maintained a consistent policy'), but the meaning is identical. All parts of the question are addressed: evolution (none), treatment of combined vs. standalone, and policy rationale. Thus, all scores are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 418,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "COF’s short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024, while its long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 before declining to $45.0 billion in 2024 (COF_10k_2022.pdf Table 8.1; COF_10k_2023.pdf Table 8.1; COF_10k_2024.pdf Table 9.1). The three‑year trend shows COF deliberately reducing reliance on volatile short‑term funding and reshaping its maturity profile with long‑term note issuance, and although the weighted‑average rate on its remaining long‑term debt rose modestly (≈4.5% in 2023 to ≈4.8% in 2024) (COF_10k_2023.pdf Table 8.1; COF_10k_2024.pdf Table 9.1), the bank’s active interest‑rate‑swap hedging program helps contain interest‑rate exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly identifies a decline in short-term borrowings from 2022 to 2023 and a rise in long-term debt in 2023 followed by a drop in 2024, the actual figures are incorrect. Ground truth shows total debt (short + long-term) of $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM reports short-term borrowings of $883M (2022), $538M (2023), $562M (2024) and long-term debt of $47.8B, $49.3B, $45.0B — which sum to $48.683B, $49.838B, and $45.562B respectively. These totals are off by over $1B in 2023 and misrepresent the trend magnitude. Additionally, the weighted-average interest rate is reported as '≈4.5%' in 2023 and '≈4.8%' in 2024, but the ground truth specifies 4.48% (2023) and 4.84% (2024), with the 2022 rate (2.76%) omitted entirely in the LLM answer, breaking the 3-year trend analysis. (2) Calculations: The LLM’s implied total debt figures do not match the ground truth, and the interest rate trend lacks precision and completeness. The 2022 rate is missing, undermining the multi-year comparison. (3) Multi-hop reasoning: The LLM correctly infers a strategic shift toward reducing short-term funding and managing rate exposure via long-term debt and hedges, which aligns with the ground truth’s interpretation of higher fixed-rate debt usage. However, it introduces 'active interest-rate-swap hedging program' not mentioned or inferable from the original answer, adding unsupported detail. The core insight about reducing volatile funding is reasonable, but the conclusion is based on flawed inputs. (4) Justification: Correctness score is 5 due to partially correct directional trends but major numerical inaccuracies. Quantitative accuracy is low (4) due to incorrect debt totals and incomplete/rounded interest rates. Qualitative accuracy is moderate (6) — reasoning is plausible and entity identification (COF, years, debt types) is correct, but synthesis relies on inaccurate data. Contextual relevance is high (9) — the answer addresses all parts of the question and attempts proper multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 569,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "AMD’s revenue‑recognition approach for development‑service and IP‑licensing contracts did not change between 2022 and 2024. In each filing (2022 10‑K pp. 57‑61; 2023 10‑K pp. 62‑66; 2024 10‑K pp. 61‑65) the Company states that it first determines whether the licensing component is distinct. If the license is not distinct, it is combined with the development services as a single performance obligation and revenue is recognized over time; if the license is distinct, revenue is recognized at a point in time when the customer can benefit. Standalone IP‑licensing arrangements are always treated as a single point‑in‑time performance obligation, and no variable consideration is estimated for either combined or standalone arrangements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements, with no material changes—aligning perfectly with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable in that sense, but all references to years (2022, 2023, 2024) and document locations (10-K page ranges) are accurate and consistent with the source filings. (3) The multi-hop reasoning is sound: the LLM synthesizes AMD’s treatment of combined vs. standalone arrangements across three years, correctly identifying the key decision point—whether the license is distinct—and linking it to the timing of revenue recognition (over time vs. point in time). It also correctly notes the absence of variable consideration estimates, which matches the ground truth. (4) The answer addresses all parts of the question: evolution over time (stable policy), performance obligations (distinct vs. not distinct), and the distinction between combined and standalone arrangements. Wording differs slightly (e.g., 'development-service' vs. 'development and IP'), but the meaning is identical. No omissions or inaccuracies. All scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 385,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The 2022, 2023 and 2024 10‑K filings all list Exhibit 4.4 – the “Certificate of Designations of Series B Convertible Participating Preferred Stock” (dated 6/21/2016) – as an incorporated‑by‑reference document (see V_10k_2022 pp. 111‑115; V_10k_2023 pp. 107‑111; V_10k_2024 pp. 107‑111). This repeated inclusion shows that Visa has neither retired nor materially altered the Series B preferred shares, indicating that the instrument remains a stable, ongoing component of Visa’s capital structure and continues to be relevant for disclosure purposes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent inclusion of the Certificate of Designations of Series B Convertible Participating Preferred Stock in Visa's 2022, 2023, and 2024 10-K filings, with accurate exhibit numbers (Exhibit 4.4 for 2023 and 2024) and the correct filing date of June 21, 2016. While the 2022 filing is listed as Exhibit 4.5 in the ground truth, the LLM incorrectly states it as Exhibit 4.4 for 2022 — this is a minor factual inaccuracy but does not affect the overall conclusion. All other numeric and date references (6/21/2016) are correct. (2) Quantitative accuracy is high: the date is correctly cited, and the exhibit references are mostly accurate except for the 2022 discrepancy. No calculations are required, so numerical precision is fully maintained where applicable. (3) The reasoning is sound: the LLM correctly infers that the repeated inclusion of the same document across three years indicates no material changes, supporting the conclusion of stability and ongoing relevance in Visa’s capital structure. It synthesizes the multi-hop evidence (same document, same date, across multiple years) to draw a valid conclusion about capital structure continuity. (4) The answer is contextually relevant and captures the core intent of the question — assessing stability and relevance. It conveys semantic equivalence to the ground truth, though it omits the explicit mention of 'static but integral component' and 'long-term strategic stability in capital governance' phrasing, which slightly reduces qualitative depth. However, the key insight — that the instrument remains unaltered and thus stable — is preserved. The minor exhibit number error prevents a perfect score, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 479,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "RTX’s ownership percentage in the IAE joint venture did not change – it remained a 61 % program‑share (49.5 % equity) with a net program‑share of about 57 % in IAE (and 51 % in IAE LLC) in 2022, 2023 and 2024 (RTX 10‑K 2022 p108‑112; 2023 p97‑101; 2024 p99‑103).  What did change was the economic exposure: the consolidated assets and liabilities of the variable‑interest entity grew from roughly $8.4 bn/$9.2 bn in 2022 to $10.2 bn/$13.1 bn in 2023 and $11.4 bn/$13.7 bn in 2024.  This rising exposure signals that Pratt & Whitney (RTX) is deepening its financial commitment and cementing its strategic position as a dominant partner in the V2500 engine program.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information. (1) Correct elements: The ownership structure of RTX’s Pratt & Whitney in IAE — 61% program share, 49.5% equity interest, and 57% net program share — is accurately reported and consistent with the ground truth across 2022–2024. This aligns with the original answer’s claim of stable stake. (2) Incorrect elements: The LLM introduces a claim that 'economic exposure' increased due to growth in consolidated assets and liabilities of a variable-interest entity (VIE) from $8.4B/$9.2B in 2022 to $10.2B/$13.1B in 2023 and $11.4B/$13.7B in 2024. This is a critical factual error — the original answer states that economic exposure remained stable, and no such increase in VIE assets/liabilities is supported by the ground truth. Furthermore, the conclusion that RTX is 'deepening its financial commitment' and 'cementing its strategic position' directly contradicts the original answer, which states that strategic positioning did not change. (3) Multi-hop reasoning: The model fails in synthesis — while it correctly identifies the stable ownership percentages, it fabricates financial data about VIE growth and draws an unsupported strategic conclusion, indicating flawed reasoning. The mention of '51% in IAE LLC' also introduces an entity (IAE LLC) not referenced in the ground truth, creating confusion. (4) Scoring justification: Correctness is scored 4 due to major factual and interpretive errors despite partial numerical accuracy. Quantitative accuracy is 5 because core percentages are correct but fabricated dollar figures undermine precision. Qualitative accuracy is 4 due to incorrect interpretation and reasoning. Contextual relevance is 7 because the answer addresses the right entities and time frame but misrepresents key dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 489,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Medtronic granted non‑employee directors deferred‑unit awards in each of the three most recent fiscal years. The FY 2022 10‑K (p. 113) notes that the company awarded deferred units under the Non‑Employee Director Deferred Unit Award Agreement (Exhibit 10.41); the FY 2023 filing (pp. 112‑113) repeats the same practice and references the same agreement (Exhibit 10.41); and the FY 2024 filing (pp. 112‑113) again shows that deferred‑unit awards were granted under the unchanged Non‑Employee Director Deferred Unit Award Agreement (Exhibit 10.41). This steady, year‑over‑year use of the same deferred‑unit award mechanism—without material changes to the agreement or grant size—signals that Medtronic relies on a consistent, long‑term equity‑based component to align its directors’ interests with shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Medtronic used the Non-Employee Director Deferred Unit Award Agreement consistently across fiscal years 2022, 2023, and 2024, and accurately notes the continuity of the agreement as a sign of stable director compensation strategy. However, there is a factual inaccuracy regarding the exhibit numbers: the LLM claims that Exhibit 10.41 was referenced in both 2023 and 2024 filings, while the ground truth states that Exhibit 10.52 was used in both 2023 and 2024. This is a material error in entity accuracy, particularly because the evolving exhibit numbers are relevant to tracking document updates over time, even if the agreement content remained unchanged. The LLM also omits the key point that the agreement remained tied to the 2008 plan despite broader updates to the 2013 plan, which weakens the depth of the multi-hop reasoning. While the conclusion about long-term equity alignment is reasonable and contextually relevant, the failure to correctly identify exhibit numbers and the lack of reference to the 2008 vs. 2013 plan distinction reduces qualitative and quantitative accuracy. The answer is semantically close and captures the overall pattern, but lacks precision in critical details required for full factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 355,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin kept the aggregate notional amount of its variable‑interest‑rate swaps at $1.3 billion at the end of 2022, and the same $1.3 billion level was reported at the end of both 2023 and 2024【LMT_10k_2023.pdf:93‑95】【LMT_10k_2024.pdf:50‑54】.  The unchanged notional exposure over three years shows the company is maintaining a steady hedge of its fixed‑rate debt—using swaps consistently rather than expanding or scaling back the program—indicating a disciplined, ongoing interest‑rate risk‑management strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the quantitative data. According to the ground truth, LMT's notional amount of variable interest rate swaps was $500 million in 2022, increased to $1.3 billion in 2023, and remained at $1.3 billion in 2024. However, the LLM claims the notional amount was $1.3 billion at the end of 2022, which directly contradicts the ground truth. This misstatement undermines the entire analysis of the evolution and strategic progression. (2) The calculation and comparison of the trend are therefore incorrect: the ground truth describes a tripling of exposure from 2022 to 2023, indicating a strategic shift, whereas the LLM portrays a stable position over all three years, missing the significant increase entirely. The consistency from 2023 to 2024 is correctly noted, but the failure to identify the 2022 baseline renders the quantitative narrative inaccurate. (3) The multi-hop reasoning is partially sound in that the LLM attempts to interpret the strategic implication of stable notional amounts post-2023, but because it starts from an incorrect premise, the conclusion about a 'steady hedge' and 'disciplined ongoing strategy' overlooks the key dynamic—the major expansion in 2023 that defines the strategic shift. The model fails to synthesize the correct progression across years, likely due to misreading or misrepresenting the 2022 value. (4) Contextual relevance is high because the answer addresses the right question, uses appropriate financial terminology, and attempts to infer strategy from swap usage. However, due to the major numerical inaccuracy, the correctness score is low. Quantitative accuracy is severely penalized due to the wrong 2022 figure, while qualitative accuracy is moderate because the reasoning framework is logical, just based on false data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 498,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s charter and bylaws have consistently included a provision that stockholders may only remove directors “for cause” in its 2022 Form 10‑K (see pages 44‑48), and the same language appears unchanged in the 2023 Form 10‑K (pages 25‑29) and the 2024 Form 10‑K (pages 25‑29). The three‑year continuity of this director‑removal restriction signals that AbbVie is deliberately maintaining a strong anti‑takeover framework, reinforcing board control and deterring hostile acquisition attempts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that AbbVie's governance provision allowing director removal only 'for cause' remained unchanged from 2022 to 2024, citing the correct forms (10-K) and consistent language across years. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) and document types (Form 10-K) are correct, and the page references (though not critical to the core answer) are plausibly accurate and consistent with typical filing structures. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to identify consistency in governance provisions, and infers the strategic implication—maintenance of anti-takeover defenses and board control. (4) The LLM answer captures the core meaning of the original answer, though it omits mention of related provisions like staggered boards and supermajority voting, which slightly weakens the qualitative depth but does not undermine the central conclusion. Overall, the answer is semantically equivalent, highly relevant, and factually precise, warranting a high correctness score with only minor room for added context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 344,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie’s money‑market fund and time‑deposit balances fell from **$21 million in 2022** to **$10 million in 2023** and stayed at **$10 million in 2024** (2022: $21 m; 2023: $10 m; 2024: $10 m)【2023 Form 10‑K – Fair‑value table for 2022】【2023 Form 10‑K – Fair‑value table for 2023】【2024 Form 10‑K – Fair‑value table for 2024】. At the same time, total cash and equivalents rose to **$12.8 billion in 2023** then dropped to **$5.5 billion in 2024** (vs. $9.2 billion in 2022)【2022 table – cash $9,201 m】【2023 table – cash $12,814 m】【2024 table – cash $5,524 m】, suggesting AbbVie is pulling cash out of short‑term market funds and keeping a lean, core cash buffer to preserve liquidity flexibility amid a volatile cash position.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numeric values. According to the ground truth, AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. However, the LLM incorrectly states it was $21 million in 2022, $10 million in 2023, and $10 million in 2024—reversing the 2022 and 2023 figures and missing the increase in 2023 entirely. This is a critical error in trend interpretation. Additionally, the LLM reports total cash and equivalents as $9.2 billion in 2022, $12.8 billion in 2023, and $5.5 billion in 2024. While the 2024 figure matches the ground truth ($5,524 million), the 2022 and 2023 cash balances are incorrect: ground truth shows $8,449 million in 2022 and $9,201 million in 2023, not $9.2 billion and $12.8 billion. The LLM overstates 2023 cash by over $3.6 billion. (2) These quantitative inaccuracies severely undermine the analysis. The claim that cash 'rose to $12.8 billion in 2023' is factually wrong, and the supposed 'lean core cash buffer' narrative is based on incorrect data. (3) The multi-hop reasoning fails because the model misaligns data across years and sources. It incorrectly synthesizes the fair-value tables, assigning the 2023 reported value to 2022 and so on. The conclusion about pulling cash out of short-term funds is not supported by the actual trend, which first shows an increase from 2022 to 2023 before a drop in 2024. (4) Despite these major errors, the answer is contextually relevant—it attempts to interpret liquidity strategy in light of cash fluctuations and cites appropriate tables. However, due to fundamental inaccuracies in numbers and trend direction, the correctness score is low. Minor formatting variations like $5.5 billion vs $5,524 million are acceptable, but directional and magnitude errors in both the primary metric (money market allocation) and supporting data (cash balances) are not. The model fails the core requirement of factual accuracy in financial data reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 558,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "Across AbbVie’s 2022, 2023 and 2024 Form 10‑K filings the company’s charter and bylaws consistently state that “stockholders may only remove directors for cause,” with no amendment to this language in any of the three years (2022 10‑K pp. 44‑48; 2023 10‑K pp. 25‑29; 2024 10‑K pp. 25‑29). Maintaining this unchanged provision—alongside staggered‑board classes and super‑majority voting thresholds—underscores a deliberate, long‑term anti‑takeover strategy that limits shareholders’ ability to replace the board without cause, thereby deterring hostile bids.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that AbbVie maintained the same governance provision from 2022 to 2024—'stockholders may only remove directors for cause'—with no changes across the three years, which matches the original answer's claim of consistency. (2) There are no numerical values requiring calculation (e.g., financial figures), but the years (2022, 2023, 2024) and document references (10-K pages) are correctly cited, supporting the claim of unchanged language. Format variations are not applicable here, but the temporal scope is exact. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings, identifies the consistent provision, and correctly infers its strategic purpose in the context of anti-takeover defenses. It also appropriately links this provision to other mechanisms like staggered boards and supermajority voting, which are known governance tools to deter hostile takeovers—this enhances, rather than distorts, the conclusion. (4) The semantic meaning is equivalent to the original answer: both emphasize continuity in governance, board insulation, and strategic deterrence of activist interventions. The LLM adds minor contextual detail (e.g., referencing specific governance mechanisms) that is consistent with public filings and strengthens the response without introducing error. All evaluation dimensions—factual accuracy, completeness, entity recognition, reasoning, and relevance—are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 422,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "In the 2022 filing Intel first announced PowerVia as a novel “back‑side power delivery” technology slated for its future Intel 20A node, positioning it as a breakthrough that would eliminate front‑side power routing. By the 2023 report the company continued to treat PowerVia as a core component of its advanced‑node roadmap, and the 2024 filing shows PowerVia now integrated into the Intel 20A node and carried forward into the next‑generation Intel 18A node, confirming that Intel is making backside power delivery a strategic pillar for gaining performance‑per‑watt and signal‑integrity advantages in its most advanced process technologies.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the introduction of PowerVia in 2022 as part of Intel's future roadmap and its association with backside power delivery. It accurately notes the continued emphasis in 2023 and the strategic importance for advanced nodes. However, there is a key factual error in the 2024 update: the LLM states that PowerVia is integrated into Intel 20A and carried forward into Intel 18A, while the ground truth specifies that PowerVia was shifted *from* Intel 20A *to* Intel 18A in 2024. This misrepresents a significant strategic pivot as mere continuation and expansion. (2) Quantitatively, all years (2022, 2023, 2024) and process node names (Intel 20A, Intel 18A) are correct, and no numerical calculations are required. The timeline references are accurate, earning high marks for quantitative accuracy. (3) The multi-hop reasoning is partially sound—information is synthesized across years and filings, but the conclusion misinterprets the 2024 shift as reinforcement rather than a realignment. The LLM fails to capture the strategic pivot aspect, which is central to the ground truth’s interpretation. (4) Contextual relevance is perfect—the response directly addresses the evolution of PowerVia and Intel’s strategy. Due to the significant error in interpreting the roadmap shift, the correctness and qualitative accuracy scores are reduced to 7, reflecting core factual accuracy but a flawed strategic narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 403,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s Black‑Scholes volatility input rose each year – 23.04 % for fiscal 2022, 24.05 % for fiscal 2023, and 24.29 % for fiscal 2024 (see the “Assumptions used” tables in the 2022 and 2024 10‑K filings). The steady increase signals that management is applying a higher‑volatility assumption – likely reflecting greater market uncertainty or higher implied volatility – and therefore is taking a more conservative, higher‑valued approach to pricing its non‑qualified stock options over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct quantitative information but fundamentally misrepresents the nature of MDT's assumption changes. While the percentages cited (23.04%, 24.05%, 24.29%) may align with values in the filings, the ground truth does not mention these specific numbers, and more importantly, the focus on numerical increases misdirects from the actual evolution in methodology. The question asks about how assumptions evolved, not just the level of volatility used. (2) The quantitative accuracy is moderate because the percentages might be factually present in the 10-K tables, but there is no verification that these exact figures were used for non-qualified options or that they represent the full assumption set (e.g., blended vs. pure inputs). However, the answer fabricates a 'steady increase' narrative without confirming whether those numbers reflect the actual modeling approach—especially since the key change was methodological, not numerical. (3) The multi-hop reasoning is flawed: the original answer emphasizes a shift from purely historical volatility (2022) to a blend including implied volatility from market-traded options (2023–2024), which reflects a structural change in valuation philosophy. The LLM answer completely misses this critical methodological evolution and instead focuses on numerical trends, failing to mention the incorporation of implied volatility or market-traded options at all. This omission breaks the core of the multi-hop synthesis required. (4) Contextual relevance is fair because the answer addresses MDT, the Black-Scholes model, and non-qualified stock options over the correct time frame, but it substitutes a numerical trend interpretation for the actual qualitative shift in assumptions, leading to a misleading conclusion about 'conservative, higher-valued' pricing rather than improved market alignment. Thus, while contextually situated, it fails on qualitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 532,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "- In the 2022 filing Intel first announced PowerVia as a “future‑process” innovation – a backside‑power delivery scheme that would debut on the Intel 20A node after Intel 3 (the roadmap was outlined in the “Process and packaging technology roadmaps” section that listed PowerVia alongside RibbonFET, Foveros Omni and Direct)【INTC_10k_2022.pdf p.5‑9】.  \n\n- By the 2024 filing the company had moved PowerVia from a concept to a core element of its next‑generation node: it is described as one of the two breakthrough technologies of Intel 20A and, more importantly, as the industry‑first backside‑power delivery feature built into the upcoming Intel 18A node that will enter high‑volume production in 2025 (the “Panther Lake” client family)【INTC_10k_2024.pdf p.8‑12】.  \n\n- This evolution shows PowerVia progressing from a roadmap promise in 2022 to a central, production‑ready technology in 2024, underscoring its strategic role as a key driver of performance‑per‑watt gains and a cornerstone of Intel’s advanced‑process and IDM 2.0 strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, positioned as an industry-first backside power delivery technology alongside RibbonFET; by 2024, it was confirmed as a core component of Intel 18A (not 20A) with high-volume manufacturing planned for 2025 on Panther Lake. The cancellation of Intel 20A productization in favor of Intel 18A is implied by the shift in focus, though not explicitly stated. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or percentages. The 2022 and 2024 filings are correctly cited with appropriate context. (3) Multi-hop reasoning is sound—information is synthesized across 2022 and 2024 filings to show evolution over time. The strategic progression from concept to production-ready technology is well-reasoned. (4) The only minor omission is the explicit mention of the 15% performance-per-watt improvement over Intel 3, which was included in the original answer and mentioned in the 2023 context. However, the LLM captures the essence of performance-per-watt gains and strategic importance. Wording differs but semantic meaning matches. Thus, the answer is factually correct, complete in substance, and contextually excellent, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 374,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "In FY 2022 the Black‑Scholes inputs were a 6‑year expected life, a 0.90 % risk‑free rate, 23.04 % volatility and a 1.95 % dividend yield. By FY 2023 the expected life stayed at 6 years but the risk‑free rate rose to 2.70 %, volatility to 24.05 % and dividend yield to 2.92 %; in FY 2024 the expected life was nudged to 6.1 years, the risk‑free rate climbed to 4.16 %, volatility to 24.29 % and dividend yield to 3.18 %. The gradual increase in volatility and the slight extension of expected life indicate that Medtronic is applying a more conservative (higher) volatility estimate and is assuming employees will hold non‑qualified options a bit longer before exercising.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) The numeric values provided (e.g., 23.04% volatility in 2022, 6-year expected life) are specific but not supported by the ground truth, which does not include any such figures. The original answer focuses on the evolution of methodology—specifically the incorporation of implied volatility in 2023—not on numerical inputs. (2) There are no calculations in the ground truth to verify, but the LLM fabricates precise percentages and time periods without basis, failing the quantitative accuracy test. (3) The multi-hop reasoning is flawed: the question asks about the evolution of assumptions and what it suggests about MDT’s approach, particularly regarding volatility and exercise behavior. The ground truth highlights a methodological shift—adding implied volatility from market-traded options in 2023 and 2024—as a key development. The LLM misses this entirely, instead inventing a narrative around increasing volatility and extended expected life based on made-up numbers. (4) While the LLM attempts to interpret the implications (e.g., more conservative volatility estimates, longer holding periods), these conclusions are based on fabricated data and thus lack validity. The contextual relevance is moderate because it addresses the right topic (Black-Scholes assumptions at MDT over time) and attempts to infer strategic meaning, but it fails on factual correctness and proper synthesis of the actual evolution in methodology. The core insight in the original answer—the shift toward market-informed volatility estimation—is completely absent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 444,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil reported $1.494 billion of collateral under master‑netting arrangements at 12/31/2022, which fell to $0.491 billion at 12/31/2024 – a drop of roughly $1.0 billion (about a two‑thirds reduction). Because this collateral is recorded in “Other assets, including intangibles – net,” the decline signals that the company’s derivative positions are being netted more efficiently (or are smaller), indicating tighter, more disciplined management of its derivative exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the overall trend of decreasing collateral under master netting arrangements from 2022 to 2024 and links it to derivative exposure management. However, it omits the 2023 value ($800 million) present in the ground truth, which is a key intermediate data point for the multi-year trend. The 2022 and 2024 figures are accurate: $1.494 billion (i.e., $1,494 million) in 2022 and $0.491 billion ($491 million) in 2024 match the ground truth. 2) The calculation of a 'roughly $1.0 billion' drop is approximately correct ($1,494M - $491M = $1,003M), and describing it as 'about a two-thirds reduction' is reasonable (~66.8%). However, the omission of the 2023 figure reduces quantitative completeness. 3) The reasoning is sound: the LLM correctly infers that the decline in collateral recorded within 'Other assets, including intangibles - net' reflects more efficient netting or reduced derivative positions, aligning with the ground truth's interpretation of active exposure management. It correctly synthesizes the accounting treatment and its implication for risk management, though it does not mention potential external factors like lower commodity market volatility, which the ground truth includes. 4) Despite missing the 2023 data point, the answer remains contextually relevant and conveys a largely accurate interpretation. The omission prevents a top score in quantitative accuracy, but the qualitative reasoning and overall correctness are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 409,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "- In 2022 NEE’s Level‑3 “Options – primarily gas” carried a net fair‑value of about **$713 million** (assets $356 m, liabilities $347 m) with very high volatility inputs – a weighted‑average implied volatility of **≈36 %** (asset 17 %, liability 295 %) and implied‑correlation of **≈52 %**.  \n- By 2023 the exposure had been cut to roughly **$197 million** (assets $100 m, liabilities $97 m) and the volatility assumption was lowered to a weighted‑average of **≈50 %** (20 %/233 %), while correlation rose modestly to **≈57 %**; in 2024 the fair‑value stayed near **$202 million** (assets $100 m, liabilities $102 m) with volatility edging up to **≈52 %** (15 %/150 %) but correlation jumping to **≈99 %**.  \n\nThese trends show NEE dramatically reduced its net gas‑option position after 2022 and now prices the remaining contracts with lower volatility but higher correlation assumptions, indicating a more conservative, tightly‑hedged risk posture in its gas‑derivative portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While the 2022 fair values ($356M assets, $347M liabilities) and 2023 values ($100M assets, $97M liabilities) are correct, the 2024 liability is reported as $102M (correct), but the LLM incorrectly calculates net fair value as $202M (assets + liabilities), whereas net exposure should be netted (assets - liabilities), which would be negative or near-zero. More critically, the implied volatility trend is misrepresented: the ground truth states volatility increased from 36% (2022) to 50% (2023) to 52% (2024), but the LLM incorrectly claims this as a 'lowered' volatility assumption in 2023 and an 'edge up' in 2024, contradicting the direction of change. Additionally, the LLM introduces unsupported details like 'asset 17%, liability 295%' for 2022 volatility, which are not in the original and appear fabricated. (2) Calculations: The net fair values are incorrectly computed as gross sums (assets + liabilities) rather than net positions. The original answer focuses on absolute asset/liability values, not net, so while the individual values are mostly correct until 2023, the 2024 asset value is stated as $100M in both original and LLM, but the LLM implies no change from 2023 to 2024 in fair value, which aligns only partially. (3) Multi-hop reasoning: The LLM attempts synthesis across years and includes volatility and correlation trends, but misinterprets the volatility trend (claims it was lowered when it increased) and introduces unverified breakdowns of asset/liability-level volatility not present in the ground truth. The conclusion about 'lower volatility assumptions' is factually wrong, undermining the reasoning. (4) Despite these issues, the answer is contextually relevant, addressing fair value evolution, volatility, and risk positioning. The entity (NextEra Energy/NEE), years (2022–2024), and metric ('Options – primarily gas') are correct. The qualitative insight about reduced exposure is partially valid (position size decreased), but the risk posture conclusion is based on flawed data. Thus, partial credit is given for structure and direction, but major factual and calculation errors reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 595,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K tables the Unsecured Notes – 35A always shows a $750 million face amount (‑ $750,000 thousands) and an annual debt‑service obligation of $19.9 million (‑ $19,875 thousands) with a 2.65% coupon and a 2030 maturity. The unchanged size and payment schedule reveal that Simon Property Group has kept this tranche of long‑term debt stable, using it as a low‑cost, fixed‑rate financing source and emphasizing predictability and cost control rather than expanding or refinancing that particular issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face amount ($750,000 thousands = $750 million) and annual debt service ($19,875 thousands = $19.9 million) for Unsecured Notes - 35A across 2022–2024, matching the ground truth. The coupon rate (2.65%) and maturity (2030) were not in the original answer but are factually consistent and add context without contradicting the ground truth. (2) Numeric values are accurate with acceptable format variations: '$750 million' correctly represents '$750,000' (in thousands), and '$19.9 million' is a valid rounding of $19,875,000. The original answer specifies $19,875 (in thousands), so $19,875,000 total, which the LLM rounds to $19.9 million—this is acceptable. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes data across three years and infers that the stability in face amount and debt service reflects a strategy of predictability and cost control, aligning with the original conclusion about consistent long-term debt structure. (4) The LLM adds minor extra details (coupon, maturity) not in the original, but these do not detract from accuracy and may enhance completeness. The core facts, calculations, and strategic interpretation are correct and semantically equivalent. Minor deduction in quantitative accuracy due to rounding of $19,875,000 to $19.9 million (slightly imprecise but common practice).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 384,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "Texas Instruments kept embedded‑processing as a core pillar of its “great business model” in every filing – the 2022, 2023 and 2024 10‑Ks all state that the company’s strategy is built around analog **and** embedded‑processing products and that it places additional strategic emphasis on the industrial and automotive markets【TXN_10k_2022.pdf p.18‑22】【TXN_10k_2023.pdf p.16‑20】【TXN_10k_2024.pdf p.16‑20】.  Yet the segment’s performance shifted: embedded‑processing revenue rose modestly in 2023 (+3% versus 2022)【TXN_10k_2023.pdf p.19‑20】 but fell sharply in 2024 (‑25% versus 2023)【TXN_10k_2024.pdf p.20】, showing that while TI’s strategic focus on the segment has remained steady, it is navigating cyclical demand and using its competitive advantages to maintain a long‑term, diversified, cash‑generating position in the semiconductor industry.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing from 2022 to 2024 and links it to the company's long-term positioning, which aligns with the ground truth. However, it introduces revenue performance data (3% growth in 2023, 25% decline in 2024) that is not present in the original answer and may not be supported by the knowledge graph used to generate the ground truth. Since the ground truth does not mention revenue trends, including them introduces potentially inaccurate quantitative claims. (2) Quantitative accuracy is compromised because the percentages cited (3% increase, 25% decrease) are specific numerical assertions not found in the ground truth and were not verified as correct in this evaluation context. Even if they appear in the cited filings, their inclusion shifts the focus toward financial performance rather than strategic emphasis, which was the core of the original answer. (3) The multi-hop reasoning is partially sound—correctly identifying consistent strategic language across three years—but incorrectly infers that revenue fluctuations affect strategic emphasis, whereas the ground truth emphasizes stability in strategic positioning regardless of short-term performance. The LLM conflates financial results with strategic intent, which weakens the qualitative accuracy. (4) Contextual relevance is high because the answer addresses both parts of the question: evolution of strategy and long-term implications. It correctly cites the continuity in strategic language and ties it to long-term positioning, though it adds unsolicited performance data that distracts from the core narrative of strategic consistency. Overall, the answer captures key elements but introduces unverified numbers and misinterprets their significance, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 507,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "In 2022 CMCSA’s wireless service – including shared‑data plans – was sold only as part of a broadband bundle, with customers choosing between an unlimited‑data plan, a shared‑data pool or a per‑gigabyte option (CMCSA 2022 10‑K, Wireless section). By 2024 the company kept the bundling model but broadened the menu, adding prepaid unlimited‑data plans under the NOW brand while still offering shared‑data plans, thereby giving customers more flexible payment and plan choices (CMCSA 2024 10‑K, Wireless section).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core evolution of CMCSA's shared data plan strategy from 2022 to 2024. It correctly states that in 2022, shared data plans were part of a bundled offering with broadband and that customers had a choice between unlimited, shared, or per-gigabyte plans. It accurately notes that by 2024, CMCSA maintained the bundling model but expanded options by introducing prepaid unlimited plans under the NOW brand, while continuing to offer shared data plans. This aligns with the ground truth. The only minor omission is that the LLM does not explicitly mention the continuation of the same plan structure in 2023, which the original answer includes for completeness. However, since the question focuses on the evolution from 2022 to 2024, this omission does not significantly detract from the correctness. All entities (CMCSA, NOW brand), years (2022, 2024), and plan types are correctly identified. There are no numerical inaccuracies (no calculations or dollar amounts involved), and the reasoning is sound, showing multi-hop synthesis across years and product offerings. The answer is semantically equivalent to the ground truth in all key aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 335,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance rose from **$51.4 billion at year‑end 2022** (MA 10‑K, p. 69) to **$60.4 billion at year‑end 2023** (MA 10‑K, p. 70) and then to **$71.4 billion at year‑end 2024** (MA 10‑K, p. 66). The steadily increasing balance shows the company is accelerating its share‑repurchase activity, signaling a capital‑allocation strategy that leans heavily on returning excess cash to shareholders through buybacks.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in Mastercard's Class A Treasury Stock from 2022 to 2024 and accurately reports the 2023 ($60.4 billion) and 2024 ($71.4 billion) values, which align with the ground truth of $(60,429) million and $(71,431) million respectively. However, the 2022 value is reported as $51.4 billion, which does not match the ground truth of $(36,658) million (~$36.7 billion), a significant discrepancy of ~$14.7 billion. This error affects quantitative accuracy. (2) The numbers for 2023 and 2024 are accurate within acceptable rounding and formatting variations (e.g., $60.4 billion = $60,400 million ≈ $60,429 million). But the 2022 figure is materially incorrect—$51.4 billion vs. $36.7 billion—suggesting either a misreading of the 10-K or confusion with another metric. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes data across three years and infers the strategic implication—increased share buybacks as part of capital allocation—consistent with the ground truth. The logic connecting rising treasury stock (which represents repurchased shares) to shareholder value return is valid. (4) Despite the major error in the 2022 figure, the overall trend (increasing buybacks) and strategic interpretation are correct, warranting a moderate correctness score. Quantitative accuracy is penalized due to the large error in one of three data points. Qualitative and contextual scores remain high because the reasoning and relevance are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 420,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "General Dynamics’ “Repair and other services” revenue fell from **$1.169 billion in 2022** to **$1.132 billion in 2024** – a decrease of roughly **$37 million (about 3 %)**【GD_10k_2024.pdf†page=8】. The drop from 2022 to 2023 was followed by a flat result in 2024, indicating the service segment has been modestly contracting and then plateaued, showing limited growth momentum over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue values for 2022 ($1.169 billion = $1,169 million) and 2024 ($1.132 billion = $1,132 million), matching the ground truth. It accurately notes the decline from 2022 to 2023 and flat performance in 2024. The dollar decrease of $37 million and percentage drop of about 3% are correct (actual: (1,169 - 1,132)/1,169 ≈ 3.16%, which rounds to 3%). (2) All numeric values and calculations are accurate. The formatting variation (billion vs million) is acceptable and semantically equivalent. The citation reference to GD_10k_2024.pdf†page=8 supports the data. (3) The multi-hop reasoning is sound: the model correctly synthesizes the trend across three years, noting the initial decline and subsequent plateau. The conclusion about 'modestly contracting and then plateaued' aligns with the ground truth's 'slight overall decline' and 'stagnation or potential contraction'. (4) The only minor shortcoming is that the LLM does not explicitly state the 2023 figure ($1,132 million), though it implies the drop occurred between 2022 and 2023. This omission slightly affects completeness but does not distort the trend. Otherwise, all entities (General Dynamics, Repair and other services, correct years) are accurate, and the answer is fully relevant to the question. Hence, a high score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 378,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "- 2022 – CVS held $845 million of residential mortgage‑backed securities (available‑for‑sale) with a fair‑value of $757 million, creating $89 million of unrealized losses【CVS_10k_2022.pdf†L31-L38】.  \n- 2023 – the portfolio grew to $862 million at cost, fair‑value fell to $810 million and unrealized losses shrank to $60 million【CVS_10k_2023.pdf†L31-L38】.  \n- 2024 – the only residential‑mortgage‑backed securities reported are in the Separate‑Accounts segment, down to $71 million of fair‑value (up from $51 million in 2023) with no loss figure disclosed【CVS_10k_2024.pdf†L1-L4】.  \n\nThe pattern—fair‑value balances falling sharply and unrealized losses narrowing—shows CVS has been trimming its RMBS exposure and moving to a more conservative, lower‑risk position in this asset class.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's RMBS fair value was $629M in 2022 with $10M in unrealized losses, but the LLM reports $757M fair value and $89M losses—both incorrect. In 2023, ground truth shows fair value dropped to $614M with losses increasing to $60M, while the LLM claims fair value fell to $810M (inconsistent) and incorrectly states losses 'shrank' from $89M to $60M, which contradicts the actual trend of deteriorating portfolio value. The 2024 figure of $71M fair value matches the ground truth, but the LLM incorrectly states it increased from $51M in 2023, which is not supported by prior data. (2) Calculations and comparisons are flawed: the LLM suggests unrealized losses narrowed, implying improvement, but ground truth shows losses increased from $10M to $60M in 2023 before a major portfolio reduction in 2024—indicating worsening conditions, not improvement. The cost basis figures ($845M, $862M) are not in the ground truth and appear fabricated or misattributed. (3) Multi-hop reasoning is unsound: the LLM fails to correctly synthesize the trajectory of increasing losses and decreasing exposure, instead portraying a misleading narrative of shrinking losses and growing portfolio size in 2023. The conclusion about 'trimming exposure' is partially valid for 2024 but not supported by the incorrect 2023 data. (4) Contextual relevance is moderate—the answer addresses RMBS exposure over three years and attempts to interpret risk positioning—but due to severe quantitative errors and flawed reasoning, the overall correctness score is low. Minor credit is given for correctly identifying the $71M 2024 fair value and recognizing a general trend of reduction in later stages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 488,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "Linde’s on‑site contracts for atmospheric gases continued to be long‑term “total‑requirement” agreements – typically 10‑ to 20‑year terms with minimum‑purchase obligations and price‑escalation provisions tied to external indices – and the variable‑price elements in those contracts were still treated as constrained (2022 §19, pages 94‑96; 2023 §19, pages 98‑100). By the 2024 filing the same contractual framework is described (pages 85‑87), but the company now highlights contract assets/liabilities that reflect customer repayments on on‑site supply agreements and reports a larger estimated future minimum‑purchase consideration (≈ $58 bn versus $48 bn in 2022), showing a heightened focus on tracking the impact of variable pricing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, capturing the core evolution of Linde's contractual structure and pricing mechanisms from 2022 to 2024. (1) It correctly identifies the long-term nature of on-site contracts (10–20 years), minimum purchase obligations, and price escalation tied to external indices. It accurately notes that variable pricing components are present but constrained, a point emphasized in 2023 but not detailed in 2022. The 2024 update correctly reflects continuity in structure while highlighting enhanced disclosures around contract assets/liabilities and increased estimated future minimum consideration ($58B vs $48B), which supports the ground truth's claim of growing transparency under ASC 606. (2) Quantitatively, the $58B and $48B figures are accurate and correctly attributed to 2024 and 2022, respectively. These numbers match known disclosures and show a valid comparison across years. The citation of specific sections and page ranges adds precision, though not required for correctness. (3) The multi-hop reasoning is sound: the model synthesizes information across three years, identifies changes in disclosure emphasis (especially around variable pricing and revenue recognition), and infers a trend toward greater financial tracking and transparency. However, it omits explicit mention of the 'practical expedient' for measuring progress toward performance obligations, a key 2024 update in the ground truth related to ASC 606 alignment. This is a minor but notable omission in qualitative completeness. (4) Despite this, the answer remains contextually highly relevant, directly addressing the evolution in contractual structure and pricing mechanisms. Wording differs but semantic meaning is equivalent on key points. The omission prevents a 9–10 on correctness, but core facts and quantitative accuracy are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 508,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "NextEra’s net short position in forward natural‑gas contracts grew from about ‑1,307 MMBtu in 2022 to a deeper ‑1,452 MMBtu in 2023, then eased to roughly ‑1,131 MMBtu by the end of 2024【NEE_10k_2022.pdf:84】【NEE_10k_2023.pdf:84】【NEE_10k_2024.pdf:84】. The increase in net short exposure in 2023 suggests the company was strengthening its hedge against lower gas prices, while the reduction in 2024 points to a pull‑back toward a more moderate, balanced risk stance in the natural‑gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and nature of the data. The ground truth states net exposure in dollar terms ($160M in 2022, $300M in 2023, $250M in 2024), while the LLM reports physical volumes in MMBtu (-1,307, -1,452, -1,131), which are not equivalent and represent a completely different metric (volume of gas, not financial exposure). This is a fundamental error. (2) The numbers cited by the LLM do not match the ground truth financial values at all—there is no correspondence between $160M and -1,307 MMBtu. Additionally, the LLM interprets the position as a 'net short', but the original answer describes net exposure as a positive financial value (assets minus liabilities), indicating a net long position in financial terms, not a short. Calculations in the ground truth (e.g., $191M - $31M = $160M) are accurate and supported, while the LLM fails to report any financial exposure. (3) The multi-hop reasoning is flawed: the LLM synthesizes data across years correctly in terms of citing three years of data, but it uses the wrong metric entirely—physical contract volumes instead of financial net exposure. This invalidates the synthesis. (4) The qualitative interpretation (increased hedging in 2023, pullback in 2024) has partial alignment with the trend direction, but the reasoning is based on incorrect data and mischaracterized positions (short vs. long). Contextually, the answer addresses the evolution and interpretation, so relevance is moderate, but factual accuracy is severely lacking. Hence, correctness is very low despite some structural alignment with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 446,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "Across the three years Broadcom’s 10‑K filings keep industrial fiber optics firmly inside the “Industrial” segment of its portfolio. In the 2022 filing (pages 8‑12) it is listed alongside optocouplers, motion encoders, LEDs and Ethernet ICs and described as serving a broad set of industrial‑automation, power‑generation, medical, defense‑aerospace and vehicle‑subsystem markets. In the 2023 and 2024 filings (pages 3‑7 of each) the language is refined – the same product family is grouped with optocouplers, industrial‑and‑medical sensors, motion encoders, LEDs and Ethernet ICs, and the narrative adds “factory automation, renewable energy and automotive electronic solutions” while still emphasizing the same application domains (industrial automation, power, medical, aerospace, EV power‑train and ADAS). Thus, the positioning of industrial fiber optics has remained consistent as a core industrial offering, with the description becoming slightly broader and more explicitly tied to factory‑automation, renewable‑energy and automotive markets over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Industrial Fiber Optics is consistently positioned within AVGO's Industrial segment across 2022–2024, grouped with optocouplers, sensors, motion encoders, LEDs, and Ethernet ICs. Application markets such as industrial automation, power generation, medical, defense, aerospace, and automotive (including EVs and ADAS) are correctly identified. The evolution in language—becoming more refined and explicitly tied to factory automation, renewable energy, and automotive electronics—is accurately captured. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all years (2022, 2023, 2024) and document references (page numbers) are correctly cited, with no factual errors. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly identifying continuity in product grouping and subtle shifts in narrative emphasis. It avoids overclaiming strategic expansion or contraction, matching the ground truth’s conclusion of stable strategic role. (4) Minor deduction in qualitative accuracy due to slight conflation in 2022 grouping: the LLM mentions Ethernet ICs in 2022, which is not explicitly stated in the ground truth for that year (though plausible). Also, the ground truth notes motion control subsystems in 2024, while LLM says motion encoders—close but not exact. These are minor discrepancies in phrasing, not substance. Overall, the answer is semantically equivalent, contextually precise, and correctly interprets the evolution as one of descriptive refinement rather than strategic shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 475,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "SPG’s Unsecured Notes 31B have not changed from 2022 through 2024 – each filing lists a $750 million face amount, a 3.25 % coupon and an annual debt‑service (interest) of about $24.4 million (2022 $750 mm, $24.375 mm; 2023 $750 mm, $24.375 mm; 2024 $750 mm, $24.375 mm)【SPG_10k_2022.pdf p.48】【SPG_10k_2023.pdf p.48】【SPG_10k_2024.pdf p.49】. The consistency of this low‑cost, medium‑term tranche indicates that Simon Property Group is maintaining a stable long‑term debt profile rather than expanding or refinancing this particular issuance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values match: face amount of $750 million (or $750,000,000) and annual interest obligation of $24,375,000 are accurately reported for all three years (2022–2024), with the correct 3.25% interest rate implied by the calculation ($750M × 3.25% = $24.375M). The LLM uses 'about $24.4 million' as a rounded approximation but correctly cites the exact figure in parentheses. (2) Completeness is excellent—both parts of the question are addressed: evolution of obligations (no change) and implications for long-term debt strategy. (3) Entity accuracy is perfect: SPG, Unsecured Notes - 31B, and correct fiscal years are referenced with proper document citations. (4) Multi-hop reasoning is sound: the model synthesizes data across three annual filings and correctly infers that the lack of change indicates a stable debt strategy, not refinancing or restructuring. Minor wording differences (e.g., 'low-cost, medium-term tranche' not in original) add interpretation but do not distort facts. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 318,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose from $70 million in 2022 to $75 million in 2023 and then to $76 million in 2024 [TXN_10k_2024.pdf:41‑45]. This steady increase over the three‑year period signals a modest but growing commitment to funding employee retirement benefits, reflecting the company’s ongoing investment in its workforce’s retirement security.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the aggregate expenses: $70M in 2022, $75M in 2023, and $76M in 2024, matching the ground truth exactly. The trend description as a 'steady increase' is slightly different in tone from the original's 'remained stable at $76M in 2024', but this is a minor interpretive difference. The core quantitative facts are accurate.\n\n2) All numbers and years are correct. The increase from $70M to $76M represents an 8.57% increase, which rounds to the ground truth's stated 8.6%—the LLM does not repeat this percentage but correctly implies a modest growth. No calculation errors.\n\n3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years for Texas Instruments' U.S. defined contribution plan expenses. The entity (Texas Instruments, U.S. defined contribution plans) and time periods (2022–2024) are accurately identified.\n\n4) The conclusion about 'a modest but growing commitment' aligns semantically with the original's 'steady and slightly growing commitment'. The only minor shortcoming is the lack of explicit mention of the stability in 2024 (i.e., only a $1M increase from 2023), which slightly softens the 'increase' narrative. However, this does not invalidate the overall reasoning. The answer remains factually correct and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 368,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, General Dynamics consistently states that its ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance.” The wording is unchanged in each year’s disclosure, indicating that the company deliberately removes non‑operational accounting effects from its ROIC metric to keep its performance evaluation focused on core operating returns and comparable over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that General Dynamics (GD) consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, matching the original answer's claim of methodological stability. (2) There are no numerical values requiring calculation, but the years (2022–2024) and the nature of the exclusions (non-economic accounting changes, including goodwill impairments) are correctly cited. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three years of Form 10-K filings, the LLM correctly infers that unchanged wording reflects a deliberate, consistent methodology. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in treatment and what it reveals about performance evaluation. The conclusion—that GD removes non-operational effects to focus on core operating returns and ensure comparability—is logically derived and aligns with the original answer’s interpretation. Minor wording differences (e.g., 'disciplined approach' vs. 'deliberately removes') do not affect factual equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 327,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "CVS’s Separate Accounts assets were $3.313 billion at year‑end 2022, fell to about $3.204 billion in 2023 (the 2023 10‑K shows a total of $3,204 million) and rose again to $3.311 billion in 2024 (the 2024 10‑K balance sheet lists $3,311 million)【CVS_10k_2023.pdf p.155】【CVS_10k_2024.pdf p.106】. The three‑year pattern is essentially flat – a modest dip in 2023 followed by a rebound to roughly the 2022 level – indicating that CVS is maintaining a stable investment base for the assets that back its long‑term insurance and pension contracts rather than aggressively expanding or contracting its exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for CVS's Separate Accounts Assets. According to the ground truth, the assets were $5,087 million in 2022, $3,250 million in 2023, and $3,311 million in 2024. However, the LLM reports $3.313 billion (i.e., $3,313 million) in 2022, $3,204 million in 2023, and $3,311 million in 2024. The 2022 figure is off by over $1.7 billion, which is a major discrepancy. The 2023 value is also incorrect, though closer. (2) Calculations and trends are therefore flawed: the ground truth shows a sharp 36.5% decline from 2022 to 2023, but the LLM implies only a minor dip from $3,313M to $3,204M (about 3.3%), which misrepresents the severity of the drop. The recovery to $3,311M in 2024 is correctly noted in amount but misrepresented in context due to the incorrect baseline. (3) The multi-hop reasoning is unsound because the LLM fails to accurately extract and compare the correct figures across the 10-K filings. The conclusion that the trend is 'essentially flat' contradicts the ground truth, which describes a 'significant decline' followed by marginal recovery. This leads to an incorrect interpretation of CVS's investment positioning. (4) While the LLM attempts to address both parts of the question—evolution of assets and implications for investment positioning—the reasoning is based on incorrect data, undermining both quantitative and qualitative accuracy. Contextual relevance is moderate because the structure and intent align with the question, but factual correctness is severely compromised. The citations to specific documents and pages do not excuse the incorrect numbers, suggesting either misreading of the source or data entry error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 472,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s credit‑card partnership with TD Bank USA, N.A. began with the original Credit Card Program Agreement dated October 22 2012 and, as shown in the 2022 Form 10‑K (pages 65‑69), had already been amended twice – a first amendment on February 24 2015 and a second amendment on November 19 2019.  The 2023 and 2024 filings record two further milestones: a **Third Amendment** dated November 1 2022 (filed as Exhibit JJ to the 2022 Q3 10‑Q) and a **Letter Agreement** dated March 8 2023 (filed as Exhibit 10.21.4 to the 2023 Q2 10‑Q), both of which are listed among the exhibits in the 2024 Form 10‑K (pages 72‑76), indicating the agreement’s continued amendment through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in dates and amendments, which undermines its correctness. The original answer (ground truth) states that by 2024, only the original 2012 agreement, the first amendment (February 24, 2015), and the second amendment (November 19, 2019) were explicitly referenced—no third amendment or letter agreement is mentioned in the ground truth for 2022 or 2023. However, the LLM claims a 'Third Amendment' dated November 1, 2022, and a 'Letter Agreement' dated March 8, 2023, both filed in later 10-Qs and listed in the 2024 10-K exhibits. These specific documents and dates are not supported by the provided ground truth, making the quantitative claims incorrect. While the LLM correctly identifies the original 2012 agreement and the 2015 and 2019 amendments, it adds unverified later amendments that contradict the ground truth's assertion that the 2019 amendment was the latest. This introduces major errors in the timeline and evolution of the agreement. The reasoning is logically structured and contextually relevant, showing awareness of how such agreements are documented in SEC filings, but the multi-hop synthesis fails because it introduces unsupported exhibits. The answer is detailed and relevant to the question’s focus on amendments and milestones, but the inclusion of incorrect amendments severely reduces factual accuracy. Thus, while the qualitative structure is sound and the context is well-handled, the quantitative inaccuracies are critical and result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 423,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "In its 2022 filing Linde listed rare gases (krypton, neon, xenon) simply as part of its atmospheric‑gas portfolio, produced as co‑products of its standard cryogenic air‑separation plants and sold through the same integrated regional distribution network as oxygen, nitrogen and argon (LIN_10k_2022.pdf, pp. 94‑96). By the 2024 filing the company had repositioned rare gases as a differentiated, high‑value offering, highlighting its market‑leading non‑cryogenic air‑separation and advanced VPSA/membrane technologies that uniquely generate these gases and stressing that their production is tightly integrated with Linde’s Engineering business and other gas product lines (e.g., hydrogen, specialty gases) to provide end‑to‑end, proprietary solutions (LIN_10k_2024.pdf, pp. 2‑5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Linde's evolution from 2022 to 2024: in 2022, rare gases were part of the atmospheric gas portfolio produced via cryogenic air separation and distributed through standard channels. By 2024, Linde repositioned rare gases as a high-value, differentiated offering, emphasizing non-cryogenic technologies like VPSA and membrane separation—consistent with the original answer’s claim of technological differentiation. The integration with Engineering and other product lines (e.g., hydrogen, specialty gases) reflects accurate synthesis of strategic integration. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022, 2024) are correct. (3) Multi-hop reasoning is sound: the model infers a strategic shift by comparing disclosures across filings, correctly identifying the progression from commodity-like treatment to technology-driven positioning. It links rare gas production to proprietary tech and business integration, which is central to the question. (4) Minor omission: the 2023 developments—long-term contracts with price escalation clauses—are not mentioned, which slightly reduces completeness. However, the core evolution from 2022 to 2024 is well captured. Wording differs but semantic meaning matches. Thus, correctness is high but not perfect due to partial omission of interim year emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 408,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements fell sharply – $1.494 billion at 12/31/2022, $800 million at 12/31/2023, and $491 million at 12/31/2024 (XOM 2023 10‑K; XOM 2024 10‑K). The downward trend indicates that the company’s net exposure to derivative liabilities linked to its advances/relationships with equity‑company partners is contracting, suggesting a reduced risk profile for those derivative positions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values are accurate: $1,494 million (2022), $800 million (2023), and $491 million (2024) match the original answer exactly, with acceptable formatting variations (e.g., $1.494 billion = $1,494 million). (2) The answer addresses both parts of the multi-part question: it describes the evolution of collateral from 2022 to 2024 and interprets the trend in terms of exposure to derivative liabilities. (3) Entities are correctly identified—ExxonMobil (XOM), master netting arrangements, equity company advances, and correct fiscal years (2022, 2023, 2024). (4) The reasoning is sound: the downward trend is correctly interpreted as a reduction in net exposure and linked to a reduced risk profile, which aligns with the original answer’s interpretation of de-risking or portfolio optimization. The LLM cites the correct sources (2023 and 2024 10-Ks), demonstrating proper multi-hop synthesis across filings. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 300,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "NEER’s long‑term contract coverage rose from roughly 92 % of its net generating capacity in the 2022 filing to about 94 % at the end of 2023, and it stayed near 94 % at the end of 2024. The modest increase and the consistently high level of contract‑backed output show that NEER is deliberately locking in more of its generation through long‑term bilateral agreements to hedge spot‑market price risk and secure predictable revenue in competitive wholesale markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the percentage of NEER's net generating capacity under long-term bilateral contracts: 92% in 2022, rising to 94% in 2023 and remaining at 94% in 2024. These figures match the ground truth exactly, with acceptable phrasing variations (e.g., 'roughly 92%', 'about 94%').\n\n2) Quantitative accuracy is perfect: all percentages and years are correct. The trend—steady increase from 92% to 94% and stabilization—is accurately represented. No calculations are required beyond interpretation of trends, which is handled correctly.\n\n3) The reasoning is sound and captures the strategic intent: using long-term contracts to mitigate price risk in competitive markets and ensure revenue predictability. The LLM correctly infers that this reflects a deliberate risk mitigation strategy. However, it omits a specific mention of shorter-term bilateral contracts as a hedge when long-term agreements are absent—a minor but notable detail from the original answer that adds depth to the risk management strategy.\n\n4) The answer is semantically equivalent to the ground truth in all key aspects: entity (NextEra Energy Resources), metric (long-term bilateral contracts as % of net generating capacity), time frame (2022–2024), and strategic implication. The omission of shorter-term contracts as a complementary hedge slightly reduces qualitative completeness, but the core multi-hop synthesis—linking contract trends to risk mitigation in volatile markets—is logically and factually sound. Hence, a score of 9/10 on qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 433,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried an outstanding principal of $495 million in fiscal 2022 (AVGO_10k_2022.pdf: p.101‑105), $495 million in fiscal 2023 (AVGO_10k_2023.pdf: p.79‑83) and $495 million in fiscal 2024 (AVGO_10k_2024.pdf: p.79‑83). The balance has remained unchanged, showing the company is keeping this low‑interest, long‑dated debt stable as a cheap financing source rather than accelerating repayment or refinancing it.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the outstanding principal balance of $495 million for the 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, including the interest rate, dollar amount, and maturity date, are accurate. (2) Quantitative accuracy is perfect: the balance remains $495 million in each year with no changes, and the LLM correctly cites the consistent amount across all three fiscal years. Format variations (e.g., $495 million vs $495M) are acceptable and correctly interpreted. (3) The multi-hop reasoning is sound—the model synthesizes data from three separate 10-K filings (2022, 2023, 2024), confirming the balance stability over time. However, the interpretation of the debt management strategy differs slightly: while the ground truth suggests AVGO may refinance or use cash reserves due to lack of amortization, the LLM interprets the invariance as a sign of retaining cheap financing. This is a reasonable inference but not fully aligned with the ground truth’s emphasis on approaching maturity without principal reduction implying a future refinancing or cash settlement decision. (4) Despite the slight divergence in strategic interpretation, the core facts are complete and correct, and the answer addresses both parts of the question—evolution of the balance and strategic implication. Thus, the correctness score is 8 due to accurate data but a nuanced difference in qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 413,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "- 2022 10‑K (as of 12/31/2021) – Unsecured Notes 37B carried a **2.25 % interest rate**, a **$700 000 (≈$700 million) face amount**, and **matures on 01/15/32**【2022‑48】.  \n- 2023 10‑K – the same series still shows **2.25 %**, **$700 000** face, and **maturity 01/15/32**【2023‑48】.  \n- 2024 10‑K – the 37B notes remain unchanged at **2.25 %**, **$700 000** face, and **maturity 01/15/32**【2024‑49】.  \n\nThe unchanged rate, size and long‑dated maturity over three years shows Simon Property Group is deliberately locking in low‑cost, long‑term unsecured financing, signaling a strategy of maintaining a stable, predictable debt profile rather than repeatedly refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the interest rate (2.25%), face amount, and maturity date (01/15/32) for Simon Property Group's unsecured notes - 37B across 2022, 2023, and 2024, matching the ground truth. However, there is a minor formatting error in the face amount: it states '$700 000' instead of '$700,000,000' or '$700 million', which could cause confusion despite the parenthetical clarification of '≈$700 million'. This does not change the factual correctness but reduces precision in presentation. (2) All numeric values—interest rate (2.25%), maturity date (January 15, 2032), and face amount ($700 million)—are factually accurate. The LLM correctly notes no changes over the three years, which aligns with the ground truth. The use of '≈$700 million' suggests awareness of the intended magnitude, so the error is typographical rather than conceptual. (3) The multi-hop reasoning is sound: the model synthesizes data from three consecutive 10-K filings (2022, 2023, 2024), confirms consistency across years, and draws a logical conclusion about the company’s long-term debt strategy. The inference about locking in low-cost, long-term financing aligns with the ground truth’s interpretation of a stable, predictable debt profile. (4) The answer is contextually fully relevant, addressing all parts of the question: evolution over time (no change), key terms (rate, face, maturity), and strategic implication. The qualitative reasoning is strong, with only a minor reduction in quantitative accuracy due to the face amount formatting. Hence, correctness is rated 9 (excellent but not perfect), with high scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 454,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site appears in the “Properties” tables of the 2022, 2023 and 2024 10‑Ks as an **Analog‑only** facility (an “X” under Analog and no “X” under Embedded Processing in each year). The only variation across the three filings is the footnote symbol († → * → **), which reflects lease/ownership details, not a change in product mix. This three‑year consistency indicates TI has kept Melaka dedicated to analog production and has not added embedded‑processing capability there.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site remained an analog-only facility from 2022 to 2024, with an 'X' under Analog and no mark under Embedded Processing each year—this matches the original answer exactly. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the observation about footnote symbol changes († → * → **) reflecting lease/ownership details rather than product mix changes adds contextual precision not in the original but consistent with accurate interpretation of 10-K footnotes. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years of 10-K filings, identifies consistency in operational focus, and draws the valid conclusion that TI maintained a dedicated analog strategy without expansion into embedded processing. (4) The answer fully addresses both parts of the question: the evolution (or lack thereof) in operational footprint and what it reveals about strategic focus. Wording differs slightly but meaning is identical. All entities (Texas Instruments, Melaka, Malaysia, analog, embedded processing, 2022–2024) are correct. No factual errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 362,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "Mastercard’s 2022 filing described a multi‑layered security framework built on a robust cyber‑risk program, third‑party assessments and EMV technical standards to protect its core network (MA_10k_2022 p.9‑12). As the company expanded its real‑time account‑based payments from 12 markets in 2021 to 13 markets by the end of 2023, the 2023 and 2024 filings show the same framework being reinforced with real‑time fraud‑scoring, tokenization, an enhanced enterprise‑resilience program, insurance coverage and continuous testing—adding extra layers of protection for the growing real‑time payment flows worldwide (MA_10k_2023 p.9‑13; MA_10k_2024 p.9‑13).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in its portrayal of Mastercard's evolving security approach from 2022 to 2024, with accurate references to EMV standards, real-time fraud scoring, tokenization, and expansion across markets. The core facts about the multi-layered security framework and its reinforcement over time are consistent with the ground truth. However, there is a minor discrepancy in the timeline: the LLM states that real-time payments expanded from 12 markets in 2021 to 13 in 2023, while the ground truth specifies 12 markets in 2022 and 13 in 2023—this misattributes the starting point by one year, though the end-state (13 markets by 2023) is correct. (2) Quantitatively, the numbers (12 to 13 markets) are accurate in value but slightly off in temporal attribution. No financial figures or percentages are involved, so the scoring focuses on market counts and years. The mention of filings (MA_10k_2022, etc.) adds citation detail not required but not incorrect. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings, linking security evolution to real-time payment expansion. It captures the integration of new capabilities like fraud scoring and tokenization in response to infrastructure growth. However, it omits the specific 2024 development regarding China and the joint venture, which is a notable gap in completeness, especially as it represents a key expansion requiring security scaling. This omission prevents a higher score. (4) Despite missing the China expansion detail, the answer remains contextually relevant and semantically close to the original, with strong qualitative accuracy in describing the security framework’s reinforcement. The answer is well-structured and directly addresses the evolution in response to global real-time payment growth. Scores reflect high accuracy with room for improvement due to minor timeline inaccuracy and a significant omission in 2024 developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 537,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "- 2022 10‑K: Land Systems was building **360 new LAVs** for the Canadian Army.  \n- 2023 10‑K: the company raised that to **399 new LAVs** (plus an extra **66 LAVs** under the LRSS surveillance‑suite program, for a total of ≈ 465).  \n- 2024 10‑K: the filing shows **449 new LAVs** slated for Canada.  \n\nThe upward trend—from 360 units in 2022 to roughly 450 units by 2024—demonstrates General Dynamics’ growing strategic emphasis on expanding its LAV product line and deepening its partnership with the Canadian Army, using the program as a key growth driver for its Combat Systems segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the production volumes for LAVs for the Canadian Army from 2022 to 2024: 360 in 2022, 399 in 2023, and 449 in 2024, matching the ground truth exactly. It also accurately notes the additional 66 LAVs under the LRSS program in 2023, though it clarifies these are separate (surveillance-suite variant), which adds context without conflating the core production numbers. The upward trend is correctly interpreted.\n\n2) All numeric values are accurate and correctly attributed to the respective years and filings. The calculation of the approximate total (≈465) in 2023 is reasonable and clearly labeled as such. No mathematical or factual errors in numbers, dates, or units.\n\n3) The multi-hop reasoning is sound: the model synthesizes data across three annual 10-K filings, correctly tracks the evolution of production volume, and infers strategic focus. It distinguishes between standard LAVs and LRSS-modified units, showing nuanced understanding.\n\n4) The conclusion about growing strategic emphasis aligns with the ground truth’s interpretation. The only minor shortcoming is that the LLM slightly expands the narrative by mentioning 'partnership' and 'growth driver' with more specificity than the original, but this is inferable and not factually incorrect. It does not mention 'international demand' or 'expanding defense contracts' explicitly, but the core implication of strategic focus is preserved.\n\nOverall, the answer is factually excellent, with only slight variation in emphasis, not accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 423,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "CVS’s pension plan held **$225 million of hedge‑fund limited‑partnership investments in 2022**, which rose to **$252 million in 2023** and **$280 million in 2024**【CVS_10k_2022.pdf†page 166】, 【CVS_10k_2023.pdf†page 176】, 【CVS_10k_2024.pdf†page 169】.  The steady increase—about $27‑$28 million each year—shows the company is deliberately expanding its alternative‑asset exposure, suggesting an evolving pension‑fund strategy that leans more heavily on hedge‑fund allocations to boost expected returns and diversify risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, CVS's allocation was $214 million in 2022, $225 million in 2023, and $252 million in 2024. However, the LLM incorrectly reports $225 million in 2022 (should be $214M), $252 million in 2023 (should be $225M), and $280 million in 2024 (should be $252M). These errors affect all years and show a consistent overstatement. (2) Calculations are therefore also incorrect: the LLM implies a steady $27–28 million annual increase, but the actual increases were $11 million (2022–2023) and $27 million (2023–2024), with a total 17.8% increase over three years. The LLM’s implied growth trajectory and magnitude are wrong. (3) The multi-hop reasoning is structurally sound—comparing allocations across years and inferring strategic intent—but it is based on incorrect data, undermining the conclusion. The LLM cites specific documents and pages, but the numbers do not match the ground truth, suggesting either misreading or hallucination. (4) While the answer addresses the question’s structure (change over time and strategic implication) and uses appropriate financial reasoning, the severe quantitative errors drastically reduce correctness. The qualitative assessment is partially accurate in identifying a growing trend, but overstates both the level and consistency of growth. Contextual relevance is acceptable as the response stays on topic and attempts proper synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 415,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "Target’s MasterCard credit‑card penetration slipped from roughly 20.5 % of purchases in fiscal 2022 to 19.8 % in 2023 and then to 18.6 % in 2024 (as shown by RedCard/Target Circle Card penetration)【TGT_10k_2023.pdf p.26‑27】【TGT_10k_2024.pdf p.27‑28】. The steady decline suggests that, while still widely used, the card’s share of guest spending is eroding, indicating a modest slowdown in consumer adoption and engagement with Target’s branded financial products.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rate of 20.5% in 2022 and 19.8% in 2023, which matches the ground truth. However, it incorrectly states the 2024 penetration rate as 18.6%, whereas the ground truth reports 17.8%. This is a significant quantitative error that affects the accuracy of the trend interpretation. (2) The calculation of the trend — a steady decline — is directionally correct, but the magnitude of the drop in 2024 is understated (0.8 percentage points decline from 2023 instead of the actual 2.0 points). This impacts the strength of the conclusion about consumer engagement. (3) The reasoning is partially sound: the LLM correctly infers that declining penetration suggests reduced adoption or engagement, and it appropriately references RedCard/Circle Card as proxies. However, it misses the key insight from the ground truth that RedCard sales grew in absolute terms but were outpaced by overall sales growth, which is central to explaining the dilution effect. This missing nuance weakens the multi-hop synthesis. (4) Contextually, the answer is well-structured and relevant, addressing both parts of the question — the trend and its implications. The use of citations adds credibility. Despite the incorrect 2024 figure, the overall direction and qualitative interpretation are reasonable, warranting a moderate score. Quantitative accuracy is penalized due to the incorrect 2024 percentage, pulling the overall correctness score down to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 411,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "NextEra’s fair‑value exposure for FPL Cost‑Recovery Clauses was $16 million at 12/31/2022, fell to $12 million at 12/31/2023, and then rose sharply to $38 million at 12/31/2024 (NEE_10k_2023 pdf “Fair value of contracts outstanding…”, NEE_10k_2023 pdf “Sources of fair value…2023”, NEE_10k_2024 pdf “Sources of fair value…2024”). In 2022 the net $16 million was driven mainly by significant unobservable inputs (≈$24 million) offset by a modest negative other‑observable input (≈‑$8 million) (NEE_10k_2022 pdf); in 2023 the other‑observable inputs turned more negative (‑$12 million) while unobservable inputs stayed at $24 million, pulling the net to $12 million (NEE_10k_2023 pdf), and by 2024 the other‑observable inputs swung positive (+$4 million) and unobservable inputs rose to $34 million, lifting the net to $38 million (NEE_10k_2024 pdf).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers, particularly for 2022. The ground truth states that the total fair value in 2022 was $1 million, but the LLM claims $16 million, which is a major error. Additionally, the LLM reports unobservable inputs at ≈$24 million and other observable inputs at ≈-$8 million in 2022, while the ground truth shows +$6 million and -$5 million respectively. These values do not align and suggest incorrect data extraction or synthesis. In 2023, the LLM correctly identifies the total fair value as $12 million and the contributions from other observable inputs (-$12 million) and unobservable inputs (+$24 million), which matches the ground truth. In 2024, the LLM correctly reports the total fair value as $38 million, with other observable inputs at +$4 million and unobservable inputs at +$34 million, which is accurate. (2) Calculations: The 2022 total fair value is incorrectly derived (claims $16M vs actual $1M); the sum of the LLM's reported inputs (-$8M + $24M = $16M) is internally consistent but factually wrong. The 2023 and 2024 calculations are correct and match the ground truth. (3) Multi-hop reasoning: The LLM attempts to synthesize across years and input types, showing awareness of the evolution, but fails in the 2022 data retrieval, undermining the overall trend analysis. The conclusion about a sharp rise to $38M in 2024 is correct, but the claim of a decline from 2022 to 2023 is based on incorrect 2022 data. (4) Scores justified: Correctness is low due to major numerical errors in 2022; quantitative accuracy is poor for the same reason; qualitative accuracy is moderate because reasoning structure is sound but based on faulty data; contextual relevance is high as the answer addresses all aspects of the question and uses appropriate terminology and sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 504,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "In 2022 Nike positioned itself ahead of rivals such as Anta by emphasizing “technical innovation” (e.g., Air, Zoom, Flyknit, Dri‑Fit, React) and strong consumer connection through marketing, digital experiences, social‑media interaction and athlete endorsements. By 2024 the company reiterated that same competitive edge—continuing to prioritize research, design and new technologies while expanding its digital‑commerce platforms, direct‑to‑consumer stores and athlete‑driven brand engagement—thereby sustaining and sharpening its lead over Anta.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, entities, and overall narrative. (1) It correctly identifies NKE (Nike) and Anta as competitors and accurately captures Nike’s strategic emphasis on innovation and brand engagement from 2022 to 2024. The mention of specific technologies (Air, Zoom, Flyknit, etc.) adds detail not in the original but is factually consistent with Nike’s product innovation focus. (2) There are no numeric values, dates, or financial metrics in either answer, so quantitative accuracy is not compromised—dates (2022, 2024) are used appropriately and match the time frame in the question and ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes Nike’s evolving competitive positioning relative to Anta across years, noting continuity in innovation and brand engagement. However, it omits a key nuance from the original answer: the shift in priority where 'innovation and development' overtook 'performance and reliability' as a highlighted differentiator in 2023. This subtle but important evolution in strategic emphasis is missing, slightly weakening the qualitative accuracy. (4) Despite this omission, the answer remains contextually relevant and factually accurate in its core claims, correctly portraying Nike’s sustained and sharpened competitive edge through innovation and digital engagement. Wording differs but semantic meaning is largely equivalent. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 417,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "The “shares remaining available for future issuance” – which includes the pool for the 2003 Director Compensation Plan – fell from about **69.8 million** at the end of 2021 (reported in the 2022 10‑K) to roughly **58.5 million** at the end of 2022 (2023 10‑K), then rose to about **65.5 million** at the end of 2023 (2024 10‑K) after a new LTIP added shares (TXN_10k_2022, p.61; TXN_10k_2023, p.59; TXN_10k_2024, p.57). The decline shows the 2003 plan’s share reserve has been drawn down for director awards, while the rebound – driven by the addition of a new plan – indicates TI still maintains a sizable pool and continues to rely on the 2003 plan as an active component of its director‑compensation strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies a decline in available shares from 2021 to 2022, it incorrectly states that the pool rose to 65.5 million by the end of 2023 due to a new LTIP, implying continued use and replenishment of the 2003 plan. However, the ground truth states that by 2023, the 2003 Director Compensation Plan was no longer listed as having shares available for future issuance, and by 2024 it was entirely phased out in favor of the 2024 LTIP and 2018 Director Plan. The LLM misattributes the increase in total shares to continued support of the 2003 plan, when in fact the new shares were allocated to newer plans, not the 2003 one. (2) The numbers cited (69.8M, 58.5M, 65.5M) may reflect total equity pools across multiple plans, but the LLM incorrectly associates these aggregate figures with the 2003 Director Compensation Plan specifically. The ground truth does not provide exact share numbers for the 2003 plan alone, but clearly indicates its deactivation, making the LLM’s inference about its ongoing use factually wrong. (3) The multi-hop reasoning fails: the model should have traced the discontinuation of the 2003 plan across years—active in 2022, inactive for new grants by 2023, fully replaced by 2024—but instead infers continued use based on aggregate share pool changes. It conflates total share availability with plan-specific activity. (4) The conclusion that TI 'continues to rely on the 2003 plan as an active component' is directly contradicted by the ground truth, which describes a strategic phase-out. While the question is addressed in structure and some data points are pulled from correct filings, the core factual claim about the plan's status is incorrect, warranting a low correctness score. Quantitative accuracy is partially acceptable due to plausible aggregate numbers, but misattribution reduces its validity. Qualitative reasoning is flawed due to incorrect synthesis. Contextual relevance is moderate as the response discusses the right topic and timeframe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 557,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "In its 2022 Form 10‑K, Comcast noted that its advertising business already provided **“additional technology, tools, data‑driven services and marketplace solutions”** to media‑industry customers to help advertisers reach target audiences (2022 Advertising section). By the 2023 filing, the company had **integrated those capabilities across its domestic cable, Sky‑branded and digital platforms and added representation agreements for third‑party advertisers both domestically and internationally**, while continuing to offer the same suite of technology, tools, data‑driven services and marketplace solutions (2023 Advertising section). The 2024 filing reiterates this expanded offering, confirming that the **technology, tools, data‑driven services and marketplace solutions are now a core part of its advertising portfolio across all platforms**, further enhancing effective advertiser‑audience engagement (2024 Advertising section).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022–2024), entities (CMCSA/Comcast), and the general evolution of its advertising offerings. It correctly identifies the continuity and expansion of technology, tools, data-driven services, and marketplace solutions across platforms. The mention of representation agreements with third parties both domestically and internationally aligns with the ground truth, as does the integration across domestic cable, Sky, and digital platforms. However, the LLM answer omits specific enhancements noted in the original answer, such as the use of cloud-based platforms and integrated search functionality across content sources in 2023, and the refinement of digital advertising tools in 2024. While it captures the strategic direction, it lacks detail on the technological mechanisms (e.g., cloud infrastructure, analytics) that drove the evolution. Quantitatively, there are no numbers to verify, so accuracy is perfect by default. The reasoning is sound and multi-hop synthesis across years is appropriate, but the answer could better reflect the depth of technological enhancement. Wording differences are acceptable under semantic equivalence, but the omission of key technical details prevents a top score. Contextual relevance is excellent—directly addresses the question’s focus on evolution and enhancements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 377,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "In 2022 CVS reported $1,018 million of commercial mortgage‑backed securities (CMBS) at fair value, with a net unrealized loss of about $154 million (gross loss $155 million offset by $1 million of gains). By year‑end 2023 the fair‑value holding had slipped to $975 million and the net unrealized loss narrowed to roughly $91 million (gross loss $100 million offset by $9 million of gains). By 2024 the company’s CMBS exposure was essentially gone from its core portfolio – only $3 million of CMBS remained in its separate‑account assets – showing CVS has been steadily shrinking this position and moving toward a lower‑risk stance in the commercial‑mortgage‑backed‑security asset class.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, CVS held $574 million in CMBS in 2022 with $12 million in unrealized losses, but the LLM reports $1,018 million and $154 million in net unrealized losses—both figures are substantially incorrect. In 2023, the ground truth shows CMBS fair value dropped to $675 million with $100 million in unrealized losses, while the LLM reports $975 million and $91 million in losses—again, the values are off by large margins. For 2024, the LLM states $3 million in CMBS (close to the ground truth of $6 million), but mischaracterizes it as being in 'separate-account assets'—a detail not in the original and potentially misleading. (2) Calculations and comparisons are not accurate. The trend in fair value per ground truth is $574M → $675M → $6M, showing an increase in 2023 before a collapse in 2024, whereas the LLM shows a steady decline from $1,018M to $975M to $3M, which misrepresents the pattern. The increase in unrealized losses from $12M to $100M in 2023 is critical to the risk narrative, but the LLM suggests a higher loss in 2022 ($154M) that decreases to $91M in 2023, reversing the actual trend. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a de-risking trend from reducing holdings, which aligns with the conclusion in the original answer. However, because the underlying data is wrong, the reasoning is based on incorrect premises. The mention of 'separate-account assets' introduces unverified context not present in the ground truth. (4) The contextual relevance is high because the answer addresses all parts of the question—evolution over time, fair value, unrealized losses, and risk positioning—and draws a reasonable conclusion about de-risking. However, the quantitative inaccuracies severely undermine correctness, warranting a low score of 3. Quantitative accuracy is scored 2 due to major number mismatches. Qualitative accuracy is 5 because the logic and entity identification (CVS, CMBS, years) are correct, but reasoning is based on false data. Contextual relevance is 8 because the structure and intent of the answer match the question's requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 595,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Across Target’s 2022, 2023 and 2024 Form 10‑K filings the company repeatedly notes that “merchandise and other discounts” are part of its compensation‑and‑benefits package (see the “Compensation and Benefits” sections on the cited pages for each year). However, none of the three disclosures provide a specific percentage or dollar amount for the employee discount, indicating that the scope of the discount has remained unchanged and its monetary value is not quantified. This consistency suggests that Target treats the merchandise discount as a stable, non‑wage perk rather than a benefit that is regularly expanded or increased.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Target's 10-K filings from 2022–2024 do not disclose specific percentages or dollar amounts for employee merchandise discounts, and that the discount is consistently mentioned as part of the benefits package. This aligns with the ground truth on the absence of quantified values. However, the LLM fails to capture the key evolution in how the discount is framed within a broader, expanding benefits ecosystem—this is the central insight of the original answer. The ground truth notes a strategic shift: from basic compensation (2022) to financial wellness (2023) to holistic well-being (2024), with merchandise discounts maintained as a stable component amid growing non-wage benefits. The LLM incorrectly interprets the lack of quantification as evidence of 'unchanged' scope and concludes the discount is a 'non-wage perk' without acknowledging the contextual evolution in benefits strategy. This misses the multi-hop synthesis across years showing strategic layering of benefits. While entities (Target, years) and sections (Compensation and Benefits) are correctly identified, and no numbers are misstated, the reasoning is incomplete and the conclusion underrepresents the strategic progression. Thus, quantitative accuracy is high (no numbers wrong), but qualitative accuracy and overall correctness suffer due to missing the strategic narrative implied by the evolving framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 395,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "In the 2022 Form 10‑K, Linde listed “cultural challenges associated with integrating employees from the acquired company into the existing organization” as one bullet among a broader set of integration risks (LIN 2022 10‑K, pp. 10‑14). By the 2024 filing the same bullet re‑appears, but the narrative now explicitly ties cultural integration to “integration of operations across different cultures and languages” for foreign acquisitions (LIN 2024 10‑K, pp. 8‑12), underscoring a more pronounced focus on cross‑border cultural issues. This evolution shows Linde is sharpening its strategic risk‑management by treating cultural integration as a core, stand‑alone risk when pursuing international deals.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its use of years (2022 and 2024), correctly identifies Linde’s evolving language around cultural challenges in integration, and accurately cites the shift from general employee integration concerns to a more explicit focus on cross-border cultural and linguistic differences. The references to Form 10-K filings and page numbers (pp. 10–14 in 2022, pp. 8–12 in 2024) are consistent with the expected sourcing, and there are no numerical inaccuracies (no financial figures are misstated). However, the LLM omits any discussion of the 2023 filing, which in the ground truth serves as a critical midpoint where Linde links cultural challenges to broader regulatory and compliance risks—a key element in the multi-hop evolution of the company’s strategic framing. This omission weakens the completeness and reasoning, as the progression across all three years is necessary to fully capture the strategic shift toward risk management and financial impact. While the LLM correctly infers a sharpening strategic focus, it does not mention the 2024 emphasis on financial outcomes and synergy realization, which is central to the ground truth’s conclusion. Thus, while the answer is contextually relevant and quantitatively sound, it falls short in fully synthesizing the multi-year, multi-faceted evolution described in the original answer, particularly in connecting cultural integration to financial risk. This limits the qualitative accuracy and overall correctness despite strong performance on the elements it does cover.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 425,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements fell from $1.494 billion at 12/31/2022 to $491 million at 12/31/2024—a reduction of roughly $1.0 billion. This sharp decline signals that the firm’s net derivative exposure has been shrinking, suggesting tighter risk controls, lower margin requirements or more effective netting of its derivative positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall trend and key data points: collateral decreased from $1,494 million in 2022 to $491 million in 2024, which matches the ground truth. However, it omits the intermediate 2023 value of $800 million, which is part of the complete multi-year trend. While the final drop to $491 million is accurate, the absence of the 2023 figure reduces completeness in quantitative tracking across all years. The calculation of a ~$1.0 billion reduction is approximately correct ($1,494M - $491M = $1,003M), so no error in arithmetic. (2) Number formats are consistent and acceptable ($1.494 billion = $1,494 million). Dates (12/31/2022 and 12/31/2024) align with fiscal year-ends typically used in 10-K filings. (3) The reasoning is sound: the decline in collateral is correctly interpreted as indicative of reduced derivative exposure or improved netting, which aligns with the ground truth's interpretation of 'strategic reduction in derivative exposure or improved offsetting mechanisms.' The LLM adds plausible explanations (tighter risk controls, lower margin requirements) that are reasonable inferences and do not contradict the original. (4) Despite missing the 2023 data point, the core facts, trend direction, magnitude, and interpretation are correct. The omission prevents a perfect score, but the answer remains largely accurate and contextually appropriate. Thus, high scores across all categories with a slight deduction in quantitative accuracy and completeness due to missing the intermediate year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 428,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "Across the 2022, 2023 and 2024 filings Broadcom’s Security Insights Platform is consistently positioned as a main‑frame‑focused security‑posture service that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” with the resulting data “available for use with in‑house tools for security information and event management” (AVGO 10‑K 2022 pp. 9‑13; AVGO 10‑K 2023 pp. 8‑12; AVGO 10‑K 2024 pp. 8‑12). The description does not evolve to mention integration with external tools, expanded remediation workflows, or alignment with a broader enterprise‑wide cyber‑defense strategy, indicating the platform’s positioning and capabilities remained essentially unchanged from 2022 to 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, directly contradicting the ground truth. While it correctly quotes the consistent language across filings about the platform interpreting and assessing mainframe security posture and providing data for in-house SIEM tools, it fails to recognize the evolution in strategic positioning described in the original answer. Specifically, the LLM claims there was no evolution in integration with external tools, remediation processes, or alignment with broader cybersecurity strategies—but the ground truth states that by 2023 and 2024, the platform was increasingly tied to AVGO's broader cybersecurity portfolio, proactive risk response, modern security practices, and integrated into a larger suite including Cybersecurity, AIOps, and DevOps, indicating a strategic shift. The LLM incorrectly interprets consistency in wording as absence of evolution, failing to infer contextual and strategic shifts evident in the framing across years. This represents a critical failure in multi-hop reasoning and qualitative synthesis. Quantitative accuracy is high because no numerical data is misstated (and none was required), and the citations are appropriately referenced. Contextual relevance is moderate because the answer addresses the right document sources and platform, but misses the key evolution the question targets.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 380,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "- In the 2022, 2023 and 2024 10‑K tables the “Unsecured Notes ‑ 32B” line is identical – a $750 million face amount (shown as $750,000 in thousands) carrying a 3.38 % coupon and maturing on 06/15/27【SPG_10k_2022.pdf:48】【SPG_10k_2023.pdf:51】【SPG_10k_2024.pdf:51】.  \n\n- Because the size and rate of this tranche have not been altered over three years, Simon Property Group is deliberately keeping a sizable, low‑to‑moderate‑rate, long‑dated debt issue in place, which locks in a stable interest cost and limits exposure to future rate increases as part of its long‑term debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the face amount ($750 million), interest rate (3.38%), and maturity date (June 15, 2027) for Unsecured Notes - 32B across 2022, 2023, and 2024, matching the ground truth exactly. It accurately notes no changes in principal or rate over the three years. 2) All numeric values are correct and properly formatted; $750 million is correctly represented as $750,000,000 or $750,000 in thousands in filings. Dates and percentages match. No calculation errors. 3) The reasoning correctly synthesizes data across three years and filings (multi-hop), concluding that SPG maintained stable debt terms. The inference about locking in interest costs and managing rate risk aligns with the ground truth's interpretation of a stable long-term strategy. 4) The answer is semantically equivalent to the original: while slightly more concise, it captures all key facts and the strategic implication. Only minor deduction in qualitative accuracy because it does not explicitly mention 'no early redemption or restructuring' or reference market rate shifts as context, which slightly reduces depth compared to the original. Otherwise, fully accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 336,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "Lumen was first singled out in Comcast’s 2022 10‑K (Competition section, pages 7‑11) as a wireline carrier that “has built and are continuing to build fiber‑based wireline network infrastructure … and … are offering services with these higher speeds” and that “have … created bundled services to compete with our broadband services.” The 2023 filing (Competition section, pages 6‑10) and the 2024 filing (Competition section, pages 6‑10) repeat that Lumen “continues to build fiber‑based … network … further into their networks” and that it is using bundled broadband offerings, showing that Lumen’s fiber rollout has deepened and its bundling strategy has persisted, heightening the competitive threat to Comcast’s broadband over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Lumen as a growing competitive threat to CMCSA (Comcast) from 2022 to 2024, with consistent emphasis on fiber expansion and service bundling. All key facts—Lumen building fiber infrastructure, offering higher-speed services, and creating bundled offerings—are present and correctly attributed across the three years. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either the question or the original answer, so quantitative accuracy is not applicable in a traditional sense; however, the years (2022, 2023, 2024) and document references (10-K filings, page numbers) are correctly cited, supporting factual precision. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual reports, noting the evolution (or persistence) of Lumen’s strategy over time. It correctly infers that the continued fiber deployment and bundling represent an intensifying threat, which is consistent with the original answer’s conclusion of a 'consistent and possibly intensifying competitive threat.' (4) The only minor shortcoming is that the LLM slightly overemphasizes 'heightening' the threat as a definitive trend, whereas the original answer cautiously states 'possibly intensifying,' reflecting a nuance in certainty. However, this does not constitute a factual error, just a slight difference in tone. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 430,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s branded‑payment‑card usage has been slipping – the share of purchases made with a RedCard/Target Circle Card fell to **19.8 % in FY 2022**, dropped to **18.6 % in FY 2023**, and slipped further to **17.8 % in FY 2024**【TGT_10k_2023.pdf: page 25】【TGT_10k_2024.pdf: page 28】. The steady decline suggests the loyalty‑driven card program is losing some traction and is becoming less effective at generating incremental sales over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Target's branded payment card penetration from 2022 to 2024 and accurately reports the 17.8% figure for 2024, matching the ground truth. However, it reports 19.8% for FY 2022 and 18.6% for FY 2023, whereas the ground truth states 20.5% in 2022 and 19.8% in 2023. This misalignment in the starting value and intermediate year reduces quantitative accuracy. (2) The numbers are close but not exact—especially the 2022 figure, which is off by 0.7 percentage points, and the 2023 figure, which should be 19.8% not 18.6%. These discrepancies suggest either a data extraction error or mislabeling of years. Calculations are not required in this question, but the trend description (declining) is accurate. (3) The multi-hop reasoning is sound: the model synthesizes data across two 10-K filings (2023 and 2024) and correctly infers a weakening trend in the loyalty-driven strategy’s effectiveness. The conclusion about declining traction aligns with the ground truth’s interpretation. (4) Despite the numerical inaccuracies in the early years, the answer addresses both parts of the question—evolution over time and strategic implication—and uses correct entities (Target, branded payment cards, FY 2022–2024). Wording differs but meaning is semantically close. The contextual relevance is perfect, and qualitative reasoning is strong, but the incorrect percentages limit the correctness score to 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 405,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "Chevron’s 2022 Form 10‑K listed the Republic of Congo among its key operating countries, reflecting its continued ownership of a 31.5 % non‑operated working interest in the offshore Haute Mer permit and a 15.75 % interest in the Congo portion of the Lianzi field【CVX_10k_2022.pdf p. 32】【CVX_10k_2024.pdf p. 44】. In 2023 the company spent roughly $0.7 billion on African offshore development and natural‑gas projects, including those assets in the Republic of Congo, while still holding the Haute Mer and Lianzi stakes【CVX_10k_2023.pdf p. 108】. By the 2024 filing Chevron announced it will sell both the Haute Mer and Lianzi interests in January 2025, signalling a strategic exit from its Congo portfolio【CVX_10k_2024.pdf p. 44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron listed the Republic of Congo as a key operating country in 2022; it held a 31.5% nonoperated interest in Haute Mer and 15.75% in Lianzi; in 2023, Chevron invested ~$0.7 billion in African offshore and natural gas projects including those in Congo; by 2024, it announced the sale of both assets. (2) Quantitative accuracy is perfect: all percentages (31.5%, 15.75%), dollar amount ($0.7 billion), and timeframes (2022, 2023, January 2025 sale) match the ground truth or are correctly inferred. The $0.7 billion figure is correctly attributed to 2023 African investments including Congo, consistent with the original answer. (3) Multi-hop reasoning is sound: the model synthesizes data across three 10-K filings (2022, 2023, 2024), correctly tracking asset ownership, investment, and divestiture over time. The only minor discrepancy is the phrasing 'will sell... in January 2025' versus the ground truth stating the exit 'by 2024'—but since the 2024 filing announces a future sale, this is a valid interpretation and does not constitute a factual error. (4) The answer fully addresses all parts of the question: asset ownership (2022–2024), investment levels (2023 spend), and strategic positioning (shift from investment to divestiture). Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to the slight ambiguity in timing of the exit, but remains factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 427,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "NextEra’s gas‑related option book contracted sharply after 2022 – the Level 3 fair‑value of gas options dropped from roughly $356 million of assets (versus $347 million of liabilities) in 2022 to about $100 million on each side in 2023 and stayed near that level in 2024, turning a modest net‑asset position into a slight net‑liability (NEE 10K 2022 pp. 84‑88; NEE 10K 2023 pp. 82‑86; NEE 10K 2024 pp. 84‑88). During the same period, the weighted‑average implied volatility rose from about 36 % in 2022 to roughly 50 % in 2023 and 52 % in 2024, signaling that while the company trimmed the size of its gas‑option exposure, market expectations of gas‑price swings grew, pushing NextEra into a tighter, more risk‑aware stance in the gas market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values from the ground truth: fair value of gas-related options in 2022 ($356M assets, $347M liabilities), 2023 ($100M assets, $97M liabilities), and 2024 ($100M assets, $102M liabilities), as well as implied volatilities (36% in 2022, 50% in 2023, 52% in 2024). Minor rounding ('about 50%', 'roughly 50%') is acceptable and does not affect factual accuracy. (2) All numbers match the original answer; the LLM correctly captures the net shift from asset to liability position and the trend in volatility. The only minor discrepancy is in characterizing the 2024 position as a 'slight net-liability'—technically correct ($102M liabilities > $100M assets), but the original emphasizes 'slightly exceeded liabilities,' which is consistent. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three years, identifies the contraction in exposure, links it to rising implied volatility, and infers a more risk-aware stance—aligning with the original's 'strategic de-risking with cautious outlook.' The conclusion is logically supported, though slightly less explicit on 'stabilization' post-2023 than the original. (4) Scores reflect near-perfect quantitative accuracy, excellent contextual relevance, and strong qualitative reasoning with only a minor reduction for slightly less nuanced phrasing on the risk positioning interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 393,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "In the 2022 Form 10‑K, Nike first highlighted FlyEase as one of a new group of emerging technologies—listed together with Air, Zoom, Flyknit, etc.—signaling its introduction as an innovative feature (NKE_10k_2022.pdf: page 6). In the 2023 and 2024 filings, FlyEase is again mentioned alongside those same core technologies, indicating that it has become an established, recurring element of Nike’s product‑development pipeline (NKE_10k_2023.pdf: page 6; NKE_10k_2024.pdf: page 6). This progression shows FlyEase moving from a nascent concept to a permanent pillar of Nike’s innovation strategy, underscoring the company’s commitment to inclusive, performance‑driven design.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the evolution of FlyEase from 2022 to 2024 based on the 10-K filings: introduced as an emerging technology in 2022 (NKE_10k_2022.pdf, p.6), then consistently mentioned alongside core technologies like Air and Flyknit in 2023 and 2024 filings, indicating its integration into the mainstream innovation pipeline. The dates, years, and document references are accurate, and there are no numerical errors (quantitative accuracy = 10). The answer captures the key progression—FlyEase moving from a new concept to an established pillar—though it slightly underemphasizes the strategic expansion in product categories and R&D integration noted in the original answer. However, the core reasoning is sound, with correct multi-hop synthesis across three years of filings. The conclusion about inclusive, performance-driven design adds interpretive value consistent with Nike’s public positioning. Semantic equivalence is high, and all parts of the question are addressed. Minor deduction in qualitative accuracy due to less explicit emphasis on 'scaling across categories' and 'embedded in R&D narrative' as stated in the original, but overall reasoning remains strong. Contextual relevance is perfect—directly responsive and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 370,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings SPG’s Unsecured Notes – 35A consistently carried a $750 million face amount, a 2.65 % coupon, an annual debt‑service cost of about $19.9 million and a maturity of July 15 2030, with no change in any of these terms from 2022 through 2024【2022】【2023】【2024】. This stability indicates that SPG is deliberately locking in low‑cost, long‑dated unsecured financing to provide predictable funding and preserve a steady long‑term capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the dollar amounts: it reports a face amount of $750 million and annual debt service of $19.9 million, whereas the ground truth states $750,000 and $19,875, respectively. This is a 1,000-fold error, which severely undermines the quantitative accuracy. The interest rate (2.65%), maturity date (07/15/30), and the fact of consistency across years are correctly identified. (2) Calculations: If the face amount were $750 million at 2.65%, annual interest would be ~$19.875 million, which matches the LLM's reported $19.9 million. However, since the actual principal is $750,000, the correct annual interest is $19,875 (as stated in the ground truth). The LLM’s calculation is internally consistent but based on an incorrect principal. The error likely stems from misreading 'thousands' as 'millions' in the source document. (3) Multi-hop reasoning: The model correctly identifies that the terms did not change across 2022–2024 and infers a strategic intent around stable long-term financing, which aligns with the ground truth’s interpretation. This shows sound qualitative reasoning. (4) Despite correct reasoning and structure, the magnitude of the numerical error is severe, making the answer misleading. The contextual relevance is high as it addresses both parts of the question—evolution over time and strategic implication. However, due to the massive quantitative inaccuracy, the overall correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 408,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Across all three filings—2022 (TXN_10k_2022.pdf p.18), 2023 (TXN_10k_2023.pdf p.16) and 2024 (TXN_10k_2024.pdf p.16)—Texas Instruments repeatedly describes its business model as “focused on analog and embedded processing products” and says that this focus is the engine for “long‑term free‑cash‑flow‑per‑share growth.” The unchanged emphasis, even as embedded‑processing revenue grew in 2022‑23 and fell in 2024, signals that TI treats embedded processing as a durable, high‑margin growth pillar that it will continue to leverage to sustain its long‑term free‑cash‑flow‑per‑share expansion strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024, citing the company's framing of this focus as central to long-term free cash flow per share growth—matching the core message of the original answer. (2) There are no numeric values (e.g., revenue figures, percentages) in either the question or the original answer, so no calculations are required; the LLM appropriately avoids introducing unsupported numbers and correctly references the trend in embedded processing revenue (growth in 2022–23, decline in 2024) without contradicting the strategic continuity, which is consistent with the ground truth's emphasis on strategic persistence despite performance fluctuations. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the unchanging strategic narrative despite changing revenue performance, which reflects an accurate understanding of TI’s long-term capital allocation and business model priorities. (4) The answer is semantically equivalent to the original, capturing the key insight that embedded processing is viewed as a durable, high-margin segment underpinning free cash flow growth. The only minor limitation is that it does not explicitly mention TI’s 'four competitive advantages' or 'capital allocation' language from the 2024 filing as detailed in the ground truth, slightly reducing qualitative completeness. However, the core strategic logic is preserved. Overall, the response is factually correct, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 461,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "By 2022 Marvel was recorded only as an indefinite‑lived intangible (a trademark) on Disney’s balance sheet, showing its value but not a prominent consumer‑facing role (DIS_10k_2022.pdf p.108). In the 2023 filing Disney elevated Marvel to a top‑level “tile” on Disney+, grouping it with Disney, Pixar, Star Wars and National Geographic to draw viewers (DIS_10k_2023.pdf p.6), and the 2024 filing confirms Marvel remains a key indefinite‑lived intangible while still featured as a top‑level tile (DIS_10k_2024.pdf p.112). This progression signals Disney’s financial strategy of turning marquee IP into a subscriber‑growth engine—using Marvel’s high‑profile placement to boost Disney+ subscriptions and treating the trademark as a core, capitalized asset that underpins future cash flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Marvel was an indefinite-lived intangible asset in 2022, became a top-level tile on Disney+ by 2023, and remained both a featured tile and capitalized asset in 2024. The strategic evolution from passive asset to active engagement driver is correctly interpreted. (2) Quantitative accuracy is perfect: no numerical errors; dates (2022, 2023, 2024) and asset classifications are correctly cited, and document references (e.g., page numbers) match the source filings. Format variations (e.g., 'indefinite-lived intangible') are semantically equivalent. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly linking financial asset classification with strategic UI changes on Disney+. It infers the broader financial strategy—leveraging IP for subscriber growth—consistent with the ground truth. The only minor omission is not explicitly mentioning ESPN+'s planned tile launch in fiscal 2025, which the original answer uses to contextualize the broader branding strategy. However, this does not detract from the core Marvel-focused analysis. (4) Contextual relevance is excellent: the answer directly addresses all parts of the question—evolution of Marvel’s use, financial strategy implications, subscriber growth, and asset valuation—using precise, evidence-based reasoning. The conclusion about Marvel underpinning future cash flows adds valuable insight. Overall, this is a factually correct, well-reasoned response with only a slight gap in completeness compared to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 448,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has covered essentially the same share of the closed block over the three years – 59.25 % in 2022 and about 59 % in both 2023 and 2024【MET_10k_2022.pdf†p.212-216】【MET_10k_2023.pdf†p.225-229】【MET_10k_2024.pdf†p.202-206】.  The related reinsurance‑recoverable (deposit‑asset) balance rose sharply from roughly $1.9 billion in 2022 (offset by a $1.4 billion deposit liability) to $5.1 billion in 2023 (offset by $1.3 billion) and then fell back to $4.6 billion in 2024 (offset by $1.2 billion)【MET_10k_2023.pdf†p.225-229】【MET_10k_2024.pdf†p.202-206】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the general trend in the percentage of the closed block reinsured—59.25% in 2022 and approximately 59% in 2023 and 2024—which aligns with the ground truth. However, the reinsurance recoverable balances are significantly inaccurate. The ground truth reports unsecured reinsurance recoverable balances of $3.6B (2022), $4.4B (2023), and $4.2B (2024). In contrast, the LLM reports $1.9B (2022), $5.1B (2023), and $4.6B (2024), with additional references to deposit liabilities not mentioned in the original answer or required by the question. These figures are not only incorrect but suggest a different metric (possibly net deposit assets) rather than unsecured recoverable balances. (2) The quantitative discrepancies are substantial: the 2022 recoverable is off by $1.7B, 2023 by $0.7B, and 2024 by $0.4B. These are not minor rounding differences but reflect a misinterpretation of the financial data. (3) The reasoning is partially sound in tracking the stability of the reinsurance percentage, but the synthesis of the recoverable balances is flawed—likely due to confusion between gross unsecured balances and net deposit assets offset by liabilities. The model fails to correctly extract and compare the specific metric (unsecured reinsurance recoverable) emphasized in the ground truth. (4) The contextual relevance is high because the answer addresses both parts of the question (percentage reinsured and recoverable balances) and spans the correct years and company. However, due to major factual errors in key financial figures, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the structural logic and entity identification are correct, but the financial interpretation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 487,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "CVS’s residential mortgage‑backed securities (RMBS) rose slightly from an amortized‑cost balance of **$845 million (fair value $757 million) at year‑end 2022** to **$862 million (fair value $810 million) at year‑end 2023**【CVS 2023 10‑K – Debt securities table】, and the portion held in separate‑account assets grew to **$71 million in 2024 (up from $51 million in 2023)**【CVS 2024 10‑K – Separate‑Accounts table】. The modest increase, together with the securities’ agency guarantees, high credit ratings (AA in 2023) and relatively short duration, indicates CVS is maintaining a low‑credit‑risk, interest‑rate‑sensitive fixed‑income position rather than expanding exposure, reflecting a cautious strategic stance toward RMBS within its broader investment portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's RMBS investment decreased from $629M in 2022 to $614M in 2023 and then dropped sharply to $71M in 2024. However, the LLM claims an increase from $845M (2022) to $862M (2023), which contradicts the ground truth. Additionally, the LLM cites a 2024 figure of $71M but frames it as an increase in 'separate-account assets,' misrepresenting the overall portfolio trend. The ground truth shows a strategic reduction in total RMBS exposure, while the LLM implies stability or slight growth. (2) The numbers cited by the LLM ($845M, $862M, $71M) do not match the ground truth values ($629M, $614M, $71M), with discrepancies of over $200M in 2022 and 2023. Although the $71M figure for 2024 coincides, it is miscontextualized as part of separate-account growth rather than a sharp decline in total holdings. Unrealized losses, a key risk indicator in the original answer ($10M in 2022 → $60M in 2023), are entirely omitted. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the correct trend (increase followed by sharp decline) and instead infers a cautious but stable strategy based on incorrect data. It references agency guarantees and credit ratings (AA in 2023), which are not in the ground truth, introducing unsupported qualitative claims. The conclusion about 'low-credit-risk, interest-rate-sensitive' positioning is speculative and not aligned with the de-risking narrative in the original answer. (4) The contextual relevance is moderate because the answer addresses RMBS trends and strategic positioning, but due to severe quantitative errors and misinterpretation of the data, the overall correctness score is low. The answer misleads rather than informs accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 488,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife’s modified‑coinsurance program has stayed essentially unchanged – the 2022 filing disclosed that 59.25 % of the closed block was reinsured, while the 2023 and 2024 filings show the figure at about 59 % (a marginal decline). In all three years the arrangement is recorded under the deposit method of accounting, with the deposit liability offset against the corresponding deposit recoverable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: 59.25% for 2022 and approximately 59% for 2023 and 2024, matching the original answer. The minor rounding from 59.25% to 59% is appropriately noted as a 'marginal decline,' which is semantically acceptable. (2) The accounting treatment is correctly described: the deposit method with offsetting of the deposit liability against the recoverable is consistently reported across all years, which matches the ground truth. (3) The multi-hop reasoning is sound—information is synthesized correctly across three years and the reinsurance structure is accurately characterized. (4) The only minor shortcoming is the lack of explicit mention that the accounting policy 'remained unchanged' or 'consistent' across all years, though this is implied. The answer could have emphasized the stability of the strategic approach, as noted in the original. However, the core facts, numbers, and synthesis are correct, and the response fully addresses both parts of the question: percentage reinsured and accounting treatment. Wording differences do not affect factual equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 332,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "In 2022 the net fair‑value of NEE’s gas forward contracts was about $160 million (assets $191 m – liabilities $31 m)【NEE_10k_2022.pdf p. 85】; it rose to roughly $300 million in 2023 (assets $377 m – liabilities $77 m)【NEE_10k_2023.pdf p. 84】 and then slipped to about $250 million in 2024 (assets $296 m – liabilities $46 m)【NEE_10k_2024.pdf p. 84】. This trajectory shows NextEra expanded its net‑long position in natural‑gas forwards in 2023, then modestly scaled it back in 2024, indicating a more aggressive hedge/bullish stance in 2023 followed by a cautious rebalancing as market conditions changed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all quantitative values from the ground truth: 2022 net exposure ($160M, from $191M assets - $31M liabilities), 2023 ($300M, from $377M - $77M), and 2024 ($250M, from $296M - $46M). All numbers match exactly, and calculations are accurate. (2) The answer is complete, addressing both the evolution of net exposure over the three years and the implied risk positioning in natural gas markets. (3) Entity accuracy is correct—NextEra Energy (NEE), forward contracts, natural gas, and the correct years are all properly identified. (4) The reasoning is sound and adds slight interpretive nuance: describing the 2023 increase as an 'aggressive hedge/bullish stance' and 2024 reduction as 'cautious rebalancing' is a reasonable extension of the ground truth's 'more cautious stance or rebalancing.' The only minor difference is tone—the LLM implies a more strategic bullish intent in 2023, while the ground truth focuses on exposure levels. However, this does not contradict facts and falls within acceptable interpretive range. All citations are appropriately referenced. Thus, the answer is factually perfect with excellent reasoning and relevance, warranting a 9 due to slight interpretive expansion beyond the conservative phrasing of the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 362,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "In the 2022 Form 10‑K (pages 8‑12) Broadcom presented industrial fiber optics as one of a modest group of industrial parts—alongside optocouplers, motion encoders and Ethernet ICs—used in a wide‑ranging set of markets (industrial automation, power generation, medical, defense and vehicle subsystems). By the 2023 filing (pages 3‑7) and reaffirmed in the 2024 filing (pages 3‑7), the company broadened that positioning, grouping fiber optics with an expanded portfolio that now explicitly includes industrial‑and‑medical sensors, motion‑control encoders and Ethernet PHYs/switch ICs/camera microcontrollers, emphasizing tighter integration and a richer diversity of applications across factory automation, renewable‑energy and automotive electronics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Industrial Fiber Optics was grouped with optocouplers, motion encoders, and Ethernet ICs, serving industrial automation, medical, defense, and vehicle subsystems. By 2023 and 2024, the portfolio expanded to include sensors, motion-control encoders, Ethernet PHYs, switch ICs, and camera microcontrollers, with emphasis on factory automation, renewable energy, and automotive electronics. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly tracking AVGO’s strategic evolution across three years and synthesizing shifts in component integration and application focus. The only minor shortcoming is that the LLM does not explicitly state the strategic implication of the shift (i.e., from standalone components to interconnected, intelligent systems), which is present in the original answer. This slightly reduces qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution in application diversity and integration with adjacent technologies as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 332,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "Nike’s redeemable preferred stock has been unchanged from FY 2022 through FY 2024.  In each year Sojitz America – the sole holder of the $0.3 million‑par preferred issue – is entitled to a cumulative dividend of $0.10 per share payable each May 31, and no common‑stock dividends can be declared until that dividend is paid in full (Note 8, 2024 10‑K; Note 10, 2022 10‑K).  The preferred shares are fully issued, not “blank‑check” stock, and Nike’s charter bars any additional preferred issuances, so the stock’s structure and dividend obligation have remained stable over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the redeemable preferred stock structure remained unchanged from FY2022 to FY2024, Sojitz America is the sole holder, the annual dividend is $0.10 per share, and the total par value is $0.3 million. The restriction on common stock dividends until preferred dividends are paid is correctly noted. (2) Quantitative elements match exactly: $0.3 million par value and $0.10 per share dividend are consistent with the original answer; dates (May 31 payment) are precise and correctly cited from the 10-K notes. (3) Multi-hop reasoning is sound—the LLM synthesizes information across multiple years (2022 and 2024 filings) and correctly infers structural stability over time, even referencing Nike’s charter limitation on additional preferred stock, which reinforces the stability claim. (4) The answer fully addresses the question’s focus on dividend obligations and stock structure stability, with no omissions or inaccuracies. Wording differs slightly but meaning is preserved. All scores are 10 due to complete factual alignment, precise numbers, correct entity identification, and logical synthesis across years and documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 347,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "Across the three most recent 10‑K filings the Unsecured Notes – 31B never changed – it is listed each year with a 3.25 % coupon, a $750 million face amount (shown as $ 750,000 k), an annual debt service of $24.4 million (shown as $ 24,375 k) and a maturity of 30 Nov 2026【SPG_10k_2022.pdf†L48-L52】【SPG_10k_2023.pdf†L48-L52】【SPG_10k_2024.pdf†L49-L52】.  \n\nThe unchanged terms indicate that SPG is treating this tranche as a stable, low‑cost, long‑dated source of unsecured financing, opting to keep the note on‑balance rather than refinance or expand it, which reflects a long‑term strategy of preserving predictable funding and interest expense.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the unsecured debt amount ($750 million, correctly interpreted as $750,000k), interest rate (3.25%), maturity date (November 30, 2026), and consistency across 2022–2024. The annual debt service of $24.375 million is a correct derivation from 3.25% of $750 million and is properly cited in thousands format. (2) Quantitative accuracy is perfect: $750,000k = $750 million, $24,375k = $24.375 million, and 3.25% of $750M equals $24.375M annually. Dates and percentages match exactly. (3) Multi-hop reasoning is sound—the model correctly synthesized data across three years and filings (2022, 2023, 2024) to confirm no changes, and inferred the strategic implication that SPG is maintaining this instrument unchanged as part of a stable long-term financing strategy. (4) The answer addresses both parts of the question: the evolution (no change) and the strategic implication (preservation of predictable funding). Wording differs slightly but meaning is identical. All citations are appropriately referenced. No errors in entities, metrics, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 329,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "The U.S. defined‑contribution plans held TI stock worth **$940 million in 2022 (6 M shares), $873 million in 2023 (5 M shares), and $852 million in 2024 (5 M shares)**【TXN_10k_2023.pdf†L31-L33】【TXN_10k_2024.pdf†L31-L33】.  The three‑year decline shows a modest drop in the company’s share price (and a reduction in share count) and, because the stock fund has been frozen to new contributions since 2016, indicates that employees have not been adding to the plan – they are simply holding the existing shares as market value slipped.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the dollar values of TI common stock held in U.S. defined contribution plans for 2022 ($940M), 2023 ($873M), and 2024 ($852M), matching the ground truth exactly. It also correctly notes the share counts (6M in 2022, 5M in 2023 and 2024), which are not in the original answer but are consistent with the cited sources and add useful context without introducing error. (2) All quantitative data are accurate, and the trend of declining value is correctly described. The minor addition of share counts does not distort the facts and supports the reasoning. (3) The reasoning is sound: the LLM correctly identifies the freeze on new contributions since 2016 (a key factor in the original answer) and links it to the lack of new employee investments, while also attributing the decline to falling share price and reduced share count. This aligns with the original’s suggestion of strategic reduction or freeze effects. The only minor gap is that the LLM does not explicitly mention 'employee investment behavior' beyond the freeze, such as possible strategic reallocations, which the original answer allows for. (4) The answer is fully contextually relevant, directly addressing both the trend in stock value and its implications for stock performance and employee behavior. Overall, the response is factually excellent with only a slight omission in exploring broader employee behavior beyond the freeze, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 416,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "Disney’s workforce grew steadily over the three‑year span – about 220 000 employees in FY 2022 (≈166 000 in the U.S. and 54 000 abroad) with 7 % seasonal workers, roughly 225 000 in FY 2023 (≈168 k U.S., 57 k international) with seasonal staff near 8 %, and 233 000 in FY 2024 (≈171 k U.S., 62 k international) with 8 % seasonal employees. In each filing the company noted that a sizable share of its staff – especially park workers, writers, directors, actors and production personnel – were covered by collective‑bargaining agreements, and many non‑U.S. employees were represented by works councils, trade unions or other employee associations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) Quantitatively, all key figures match the ground truth: total employees (220k in 2022, 233k in 2024), U.S. (166k to 171k) and international (54k to 62k) distribution, and seasonal workforce percentages (7% to 8%). The LLM adds a reasonable estimate for 2023 (225k total, 168k U.S., 57k international, 8% seasonal), which is not contradicted by the ground truth and reflects a logical interpolation between reported years. (2) Calculations are correct: 166k + 54k = 220k (2022), 171k + 62k = 233k (2024), and seasonal percentages align. (3) Multi-hop reasoning is sound—LLM synthesizes workforce size, geographic distribution, seasonality trends, and employee representation across years. (4) Entity accuracy is strong: correct company (Disney), correct fiscal years, and accurate identification of represented employee groups (theme park staff, production personnel, etc.). (5) The LLM enhances the original answer by specifying that non-U.S. employees are represented by works councils or unions, which is consistent with Disney’s operations and adds context without contradicting the ground truth. The only minor limitation is the inclusion of interpolated 2023 data not present in the original answer, but this is clearly labeled as approximate and does not detract from factual correctness. Overall, the answer is semantically equivalent and slightly more detailed, with no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 398,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "GD’s ROIC definition has been unchanged: each year’s filing says ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (2022 10‑K p. 45‑49; 2023 10‑K p. 48‑52; 2024 10‑K p. 47‑51). By consistently stripping out these non‑operational items, GD signals that it wants ROIC to measure pure operating returns on capital, focusing on core performance rather than GAAP‑driven accounting fluctuations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC across 2022, 2023, and 2024, which matches the original answer's claim of stable methodology. (2) No numerical values (e.g., percentages, dollar amounts) are involved in the question or answer, so quantitative accuracy is not applicable in a traditional sense—however, the cited page numbers (2022 10-K pp. 45–49, etc.) are consistent with expected sourcing and do not introduce factual errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings to identify a consistent definition, demonstrating cross-temporal analysis. (4) The LLM adds value by specifying that goodwill impairments are also excluded and citing the exact rationale used by GD (‘not reflective of company performance’), which strengthens the conclusion about focusing on core operational performance. The explanation about emphasizing economic performance over GAAP-driven fluctuations aligns perfectly with the original answer’s interpretation. All parts of the question—evolution over time and implications for core performance measurement—are fully addressed with accurate, sourced reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 363,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "In the 2022 filing Linde described rare gases (krypton, neon, xenon) simply as “atmospheric gases … rare gases” that are produced as co‑products of its air‑separation plants (2022 p. 94‑98). By the 2024 filing the company emphasizes that it is the market‑leader in non‑cryogenic air‑separation technology and is actively expanding proprietary processes to produce, store, and market rare gases, turning them into a growth platform and opening new applications (2024 p. 2‑3). This shift from a by‑product view to a technology‑driven, value‑added strategy underscores Linde’s competitive advantage – its advanced separation technology and innovation pipeline give it a differentiated, higher‑margin position in the industrial‑gases market, especially for scarce rare gases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Linde initially treated rare gases as co-products of air separation in 2022, and by 2024 positioned itself as a market leader in non-cryogenic air separation technologies. The shift from by-product to strategic growth platform is correctly identified. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct and properly attributed to filing years. (3) Multi-hop reasoning is sound: the model synthesizes information across 2022 and 2024 filings to infer a strategic evolution, correctly identifying the technological shift (non-cryogenic methods like VPSA and membrane separation, though not named in the LLM answer, are implied via 'proprietary processes'). The competitive advantage conclusion—based on technology-driven differentiation and higher-margin opportunities—is logically supported. (4) Semantic equivalence is strong: while the LLM does not explicitly name 'vacuum pressure swing adsorption (VPSA)' or 'membrane separation' as in the ground truth, it captures the essence of technological innovation and efficiency gains. The phrase 'expanding proprietary processes' serves as a valid proxy. One minor omission is that the 2023 filing is not mentioned, but since the core evolution is between 2022 and 2024, this does not materially affect correctness. Overall, the answer is factually precise, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 437,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "In the 2022 filing NEER reported that roughly 93 % of its net‑generating capacity was already locked in under long‑term bilateral contracts; the 2023 filing shows that share had risen to about 94 % and the 2024 filing confirms it stayed at roughly 94 % (NEE 10‑K 2022 pp. 20‑21; NEE 10‑K 2023 pp. 20‑21; NEE 10‑K 2024 pp. 20‑21). The modest increase and subsequent plateau indicate that NEER is deliberately expanding and then maintaining a high level of contract‑based revenue, using long‑term agreements to hedge against spot‑market price swings and other market volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor discrepancy in the 2022 percentage. The ground truth states 92% for 2022, while the LLM reports 93%, likely due to a misreading of the source. The 2023 and 2024 figures (94%) are accurate and correctly reflect the plateau. (2) Quantitative accuracy is high—only one percentage point off in 2022, with correct trends (increase then stability). No calculation errors, and the time periods (2022–2024) are correctly referenced. Format and sourcing (10-K filings with page numbers) are consistent and valid. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes data across three years and two entities (NEER and its contracts), identifies the trend (slight increase, then stabilization), and draws a logical conclusion about risk management via long-term contracts. It correctly infers the strategic intent to hedge against volatility, aligning with the ground truth’s emphasis on revenue stability. (4) The answer is contextually excellent—directly addresses both parts of the question (evolution of reliance and strategic implication). Despite the small factual error in 2022, the overall reasoning, completeness, and synthesis are strong. The mention of hedging, while slightly rephrased, captures the essence of NEER’s risk mitigation strategy. A score of 9 is justified due to high accuracy and strong reasoning with only a minor factual deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 397,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "AVGO’s 3.125 % senior notes due January 2025 carried an unchanged $495 million of principal at each year‑end – $495 million as of FY 2022 (AVGO 10‑K 2022 p. 104), $495 million as of FY 2023 (AVGO 10‑K 2023 p. 81), and $495 million as of FY 2024 (AVGO 10‑K 2024 p. 81). The flat balance shows Broadcom has not been repaying or refinancing this low‑cost note, indicating a strategy of holding the cheap debt to maturity while allocating cash elsewhere.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million is accurately reported for each fiscal year—2022, 2023, and 2024—with correct citation of the respective 10-K pages, confirming the data source. The note's interest rate (3.125%) and maturity date (January 2025) are correctly stated. (2) The answer is complete, addressing both parts of the question: the evolution of the balance (unchanged) and the implication for AVGO's debt management strategy. (3) Entity accuracy is perfect: company (AVGO/Broadcom), financial instrument (3.125% notes due January 2025), and fiscal years are all correctly identified. (4) The reasoning is sound and represents valid multi-hop synthesis across three annual reports. The conclusion—that the company is retaining this low-cost debt to maturity while directing cash elsewhere—is a logical and insightful interpretation consistent with the stable balance, and adds contextual value without overreaching. The answer is semantically equivalent to the ground truth, with slightly more detail (e.g., page numbers, 'senior notes' terminology) that enhances credibility. All scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 340,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "- In the 2022 10‑K, the Unsecured Notes ‑ 37B carried a $700 million face amount and matured on January 15 2032 (2.25 % interest)【SPG_10k_2022.pdf p.48】.  \n- The 2023 filing shows the same $700 million face amount and the same 01/15/32 maturity for the 37B notes【SPG_10k_2023.pdf p.48】.  \n- The 2024 filing also lists the 37B tranche at $700 million with a maturity of January 15 2032【SPG_10k_2024.pdf p.49】.  \n\nAcross 2022‑2024 the size and maturity of the 37B unsecured notes did not change, indicating that Simon Property Group is deliberately maintaining a stable, low‑cost, long‑dated debt instrument to lock in inexpensive financing and preserve balance‑sheet predictability in its long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the face amount and maturity date of SPG's Unsecured Notes - 37B across 2022, 2023, and 2024. However, there is a discrepancy in the face amount unit: the ground truth states $700,000, while the LLM reports $700 million. This is a significant quantitative difference, though it may be a typographical error in unit (thousand vs. million). All other numbers (maturity date: 01/15/32) are accurate and consistently reported. 2) The maturity date is correctly cited as January 15, 2032 (or 01/15/32) in all years, matching the ground truth. The interest rate (2.25%) is an additional detail not present in the ground truth but not incorrect—likely from the source document and acceptable as added context. 3) The reasoning is sound: the LLM correctly infers that the lack of change in face amount and maturity indicates a stable long-term debt strategy focused on predictable, low-cost financing. This aligns with the ground truth’s conclusion about consistency and absence of refinancing or retirement. 4) The answer addresses all parts of the question: evolution over time (face amount and maturity), and interpretation of long-term debt strategy. The only flaw is the potential misstatement of $700,000 as $700 million, which affects quantitative accuracy but not the directional or comparative reasoning. Given that the pattern of stability is still correctly interpreted, and the maturity is accurate, the overall correctness is high but not perfect due to the dollar amount discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 418,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site appears in all three filings and is consistently shown only under the **Analog** column, with no “X” in the Embedded Processing column — 2022 († footnote) 【TXN_10k_2022.pdf p.18】, 2023 (**) 【TXN_10k_2023.pdf p.16】, and 2024 (**) 【TXN_10k_2024.pdf p.16】. The footnote indicates the facility is partially leased/owned, but its role has not shifted; it has remained an analog‑focused operation throughout 2022‑2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was consistently involved in analog operations across 2022, 2023, and 2024, with no involvement in embedded processing—matching the original answer's key claim. (2) There are no numeric values requiring calculation (e.g., financial figures or percentages), but the years (2022–2024) and operational status (analog-only) are correctly cited. The reference to footnotes (†, **) and document sources (page numbers and file names) adds precision and aligns with the evidence-based reporting expected. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings (2022–2024) to confirm consistency over time, demonstrating longitudinal analysis. It correctly infers stability in operational focus despite potential changes. (4) The answer is contextually highly relevant, directly addressing the evolution (or lack thereof) in TI's Melaka footprint with respect to analog vs. embedded processing. Minor wording differences (e.g., 'X' vs. 'checkmark') do not affect factual accuracy. The mention of partial lease/ownership adds contextual detail without contradicting the ground truth. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 370,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "Disney’s 10‑K filings for fiscal 2022, 2023 and 2024 all place Industrial Light & Magic’s post‑production work inside the Content Sales/Licensing segment, grouping it under the “post‑production services” (or “Other revenue”) line that also includes Skywalker Sound. The segment’s description and the way ILM‑generated revenue is reported remain unchanged across the three years, showing a steady, unchanged reliance on ILM for post‑production services.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Disney's reliance on Industrial Light & Magic (ILM) remained 'steady, unchanged' across fiscal 2022–2024. The ground truth indicates a clear evolution in how ILM's post-production services were framed within the Content Sales/Licensing segment: from explicit inclusion in 2022, to a shifting emphasis toward TV/VOD and theatrical distribution in 2023, and further integration into broader content licensing and Disney's DTC-first model in 2024. The LLM incorrectly asserts that the segment description and revenue reporting 'remain unchanged,' which contradicts the documented strategic repositioning. While the entity (Industrial Light & Magic), segment (Content Sales/Licensing), and time frame (fiscal 2022–2024) are correctly identified—supporting a moderate quantitative accuracy score—there is a critical failure in qualitative reasoning. The model misses the multi-hop nuance of structural and narrative shifts over time, failing to synthesize changes in segment focus and strategic context. This results in a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer addresses the right segment and entity but misrepresents the evolution central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 354,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife reported equity‑method income from its operating joint ventures of **$51 million in 2022**, which fell to **$38 million in 2023**, and then jumped to **$175 million in 2024**【MET_10k_2022.pdf p. 172‑173】【MET_10k_2023.pdf p. 245‑246】【MET_10k_2024.pdf p. 222‑223】. The dip in 2023 suggests the insurance‑underwriting joint ventures generated weaker earnings that year, while the sharp rise in 2024 points to a strong recovery and markedly better underwriting performance in the most recent period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. Ground truth states MetLife's equity method investment income was $1,305 million in 2022, $151 million in 2023, and $988 million in 2024. The LLM reports $51M, $38M, and $175M respectively—off by more than 70-95% across all years. These are not minor discrepancies but complete misstatements of magnitude. (2) Calculations and trends are therefore also wrong: while both answers agree on a decline from 2022 to 2023 and a rebound in 2024, the actual scale of change is misrepresented. The real drop was from $1.3B to $151M (an 88% decline), not $51M to $38M (25% decline); the recovery to $988M represents a near 550% increase, not to $175M (a 460% increase on incorrect base). The economic significance is entirely different. (3) Multi-hop reasoning is structurally sound—the model attempts to synthesize data across three years and draw performance implications—but based on entirely incorrect inputs. The logic flow (decline suggests weakness, rebound suggests recovery) mirrors the ground truth reasoning, so qualitative structure is acceptable. (4) Contextual relevance is high: the answer addresses the right company (MetLife), metric (equity-method income from operating joint ventures), time period (2022–2024), and interprets the trend in terms of insurance underwriting performance as asked. However, due to catastrophic quantitative inaccuracy, the overall correctness score is very low. Even allowing for format variation, the numbers do not match any plausible interpretation of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 436,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics’ Land Systems unit lifted its Canadian‑army LAV output from 360 new vehicles in 2022, to 399 in 2023, and to 449 new LAVs in 2024 (plus an extra 66 LRSS‑configured LAVs) as disclosed in the 2022, 2023 and 2024 10‑K filings. This steady upward trajectory shows the LAV platform is a growing, strategically‑critical pillar of GD’s Combat Systems portfolio, reflecting strong allied demand and the company’s focus on expanding its market‑leading position in light armored vehicles.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the production volumes for 2022 (360 units), 2023 (399 units), and 2024 (449 units), matching the ground truth exactly. However, it adds 'plus an extra 66 LRSS-configured LAVs' in 2024, which is not mentioned in the original answer and introduces unverified detail not present in the ground truth, slightly undermining quantitative accuracy. (2) All core numbers (360, 399, 449) are accurate and correctly attributed to the respective years. The upward trend is correctly calculated and described. The addition of the 66 LRSS units is unsupported by the ground truth and may reflect overinterpretation or inclusion of extraneous data from the filings not validated in the knowledge graph. (3) The multi-hop reasoning is sound—production volumes are correctly synthesized across three years from 10-K filings, and the strategic importance of the LAV platform is logically inferred from the growth trend. The conclusion that the LAV is a 'strategically-critical pillar' aligns with the ground truth's assertion of increasing centrality in GD's defense portfolio. (4) Despite the minor overstatement with the 66 LRSS units, the core facts, trends, and strategic interpretation are correct and well-supported. The answer addresses both parts of the question: the evolution of production and its strategic implications. Wording differs but meaning is semantically equivalent and enhanced with appropriate context (e.g., 'Combat Systems portfolio', 'market-leading position'). The contextual relevance is perfect as it directly answers the question with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 445,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s pension plan excluded $225 million of hedge‑fund limited‑partnership (HF LP) investments in 2022, $252 million in 2023, and $280 million in 2024. The steady rise each year shows the company is incrementally increasing its allocation to hedge‑fund LPs, indicating a strategic tilt toward alternative assets to boost expected returns and diversify the pension portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for CVS's hedge fund limited partnership investments. According to the ground truth, the correct amounts are $214 million in 2022, $225 million in 2023, and $252 million in 2024. The LLM incorrectly states $225 million in 2022, $252 million in 2023, and $280 million in 2024—shifting the timeline and inflating the final value. These errors affect all years and break the multi-hop comparison. (2) The quantitative inaccuracies are severe: the 2022 figure is wrong by $11 million, the 2023 figure is misassigned (it's actually the 2024 value), and the 2024 value is overstated by $28 million. The trend is misrepresented due to incorrect data points. (3) The reasoning is partially sound—the conclusion that increasing allocations suggest a strategic shift toward alternative investments aligns with the original answer—but it is based on incorrect data, undermining the validity of the inference. The model fails to correctly synthesize the three-year trend due to erroneous input values. (4) While the LLM attempts to address both parts of the question (evolution over time and strategic implication), the factual foundation is flawed. Contextual relevance is moderate because the structure and intent match the question, but correctness is low due to pervasive numerical errors. Thus, the correctness score is low at 2, quantitative accuracy is 2 due to major number mismatches, qualitative accuracy is 3 for reasonable logic on flawed data, and contextual relevance is 6 for appropriate framing and terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 441,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "In the 2022 filing, Colgate‑Palmolive listed Sorriso among its “principal global and regional trademarks,” positioning it as a key brand within the Oral, Personal and Home Care segment. The 2023 and 2024 10‑Ks repeat this same listing, showing that the company continued to integrate Sorriso into its worldwide Oral, Personal and Home Care portfolio and treat it as a strategic, core brand rather than a peripheral offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Sorriso was listed as a 'principal global and regional trademark' in 2022, and that this designation was maintained in 2023 and 2024, confirming its ongoing strategic integration within Colgate-Palmolive's Oral, Personal and Home Care portfolio. All dates and entity references (Colgate-Palmolive, Sorriso, 2022–2024, 10-K filings) are correct. There are no numerical inaccuracies, and the qualitative reasoning correctly infers that Sorriso is treated as a core, strategic brand rather than a peripheral one. The answer captures the continuity emphasized in the original answer but slightly omits the explicit mention of Sorriso’s role in 'regional market penetration and diversified consumer engagement' and its positioning 'alongside major global brands like Colgate and Palmolive' in 2024. While implied, this nuance adds contextual depth to the strategic positioning. Thus, the answer is highly accurate with only minor omissions in descriptive richness, warranting a 9/10 on correctness and qualitative accuracy. Contextual relevance is perfect, and quantitative accuracy is flawless.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 335,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s equity‑method earnings from operating joint ventures slipped from **$51 million in 2022** to **$38 million in 2023**, then rose sharply to **$175 million in 2024**【MET_10k_2024.pdf p. 222‑226】【MET_10k_2023.pdf p. 245‑249】. The dip in 2023 followed by a sizable rebound in 2024 signals that MetLife is deliberately increasing the importance of operating joint‑venture investments, positioning them as a growing source of earnings within its equity‑method portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values and the resulting trend interpretation. The original answer states MetLife's financial exposure decreased from $77M in 2022 to $51M in 2023 to $38M in 2024, while the LLM claims earnings (not exposure) were $51M in 2022, $38M in 2023, and $175M in 2024—confusing both the metric (earnings vs. exposure) and the values. (2) The numbers are entirely inconsistent with ground truth: the LLM reverses the direction of the trend and invents a sharp increase in 2024 that does not exist. Additionally, the LLM cites earnings rather than financial exposure, misrepresenting the metric entirely. (3) The multi-hop reasoning is flawed: instead of synthesizing a consistent decline in investment exposure across years, the model incorrectly infers a strategic increase based on fabricated data. It also fails to recognize that decreasing exposure indicates reduced involvement, not growing strategic emphasis. (4) The contextual relevance is low because the answer addresses a different concept (earnings from joint ventures) rather than financial exposure to them. Due to complete factual inaccuracy in numbers, metric, trend, and conclusion, the correctness and accuracy scores are near zero. The slight relevance comes from discussing MetLife and joint ventures, but the substance is fundamentally wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 383,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "In 2022 Chevron held a 36.4 % equity interest in Angola LNG Limited, described in the 2022 10‑K as a partner that “processes and liquefies natural gas produced in Angola for delivery to international markets” (Note 15, CVX_10k_2022 pp. 76‑80). By 2024 the stake was unchanged at 36.4 %, but Chevron’s discussion shifted to emphasize that the on‑shore LNG plant is now integrated with its upstream gas portfolio – feedstock comes from multiple Chevron‑operated fields (Block 0, Block 14) and the New Gas Consortium’s Quiluma‑Maboqueiro development, linking upstream production directly to the LNG facility (Africa section, CVX_10k_2024 pp. 12‑16).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Chevron's 36.4% stake in Angola LNG Limited is accurately reported for both 2022 and 2024, with no discrepancies in percentages or years. (2) The answer correctly identifies the operational evolution from passive investor in 2022 to more integrated role by 2024, citing feedstock linkage from upstream fields including Quiluma and Maboqueiro via the New Gas Consortium (NGC), consistent with the ground truth. (3) The multi-hop reasoning is sound: it synthesizes information across years (2022 to 2024), entities (Chevron, Angola LNG Limited, NGC), and operational dimensions (equity stake, upstream integration). (4) Minor omission: the LLM states Chevron has an interest in 'Chevron-operated fields (Block 0, Block 14)', but in the 2024 context, Quiluma-Maboqueiro is part of the NGC where Chevron is a nonoperator with a 31% working interest, not operator. The original answer clarifies this nuance, while the LLM slightly overstates Chevron’s operational role. However, this does not undermine the core correctness of the integration narrative. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually strong, well-supported by cited sections, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 372,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO had **no 3.625 % senior notes due October 2024 outstanding at the end of FY 2022** (recorded as “‑” in the 2022 balance table)【AVGO_10k_2022.pdf p.104】. By the end of FY 2023 the company was carrying **about $622 million of those notes**【AVGO_10k_2023.pdf p.80】, but the balance fell back to **zero again in FY 2024**【AVGO_10k_2024.pdf p.80】. This swing—from eliminating the exposure, seeing a modest amount re‑appear, and then retiring it before the October 2024 maturity—shows AVGO’s disciplined debt‑management approach, using cash and new senior‑note issuances to clear near‑term obligations and avoid rollover risk as the notes approached their due date.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, AVGO had $622 million in 3.625% notes due October 2024 outstanding in both 2022 and 2023, and fully retired them by 2024. However, the LLM claims there was *no* outstanding balance in 2022 (marked as '‑'), which contradicts the ground truth. It then incorrectly states the amount 'reappeared' in 2023 at $622 million, implying the debt was issued anew, when in fact it was already present and unchanged. The only correct quantitative point is the zero balance in 2024. (2) The dollar amounts are partially correct ($622 million in 2023 and $0 in 2024), but the 2022 figure is wrong. The claim of '‑' (zero) in 2022 is a critical error that undermines the entire timeline. (3) The multi-hop reasoning is flawed because the LLM misinterprets the evolution of the debt. Instead of showing a consistent liability followed by retirement, it fabricates a 'swing' pattern—elimination, re-emergence, then retirement—that is not supported by the data. This leads to an incorrect characterization of AVGO’s strategy as involving re-issuance or temporary elimination, rather than steady management and final repayment. (4) While the conclusion about disciplined debt management has some plausibility, it is based on incorrect premises. The contextual relevance is moderate because the answer addresses the right topic and documents, but the factual foundation is unsound, leading to a misleading narrative. The model appears to have misread or misinterpreted the 2022 filing, resulting in a cascade of errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 439,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "SPG’s Unsecured Notes – 35B carried an annual debt‑service (interest‑related) charge of **$28.5 million** in each of the three most recent filings – 2022, 2023 and 2024 (interest rate 3.80 %)【SPG_10k_2022.pdf】, 【SPG_10k_2023.pdf】, 【SPG_10k_2024.pdf】. The amount did not change over the period, indicating that the company’s financing cost for this note has remained flat, with no increase or reduction in interest expense.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: SPG's interest expense for Unsecured Notes - 35B was $28,500,000 (i.e., $28.5 million) in each of 2022, 2023, and 2024. The LLM correctly reports this consistent amount across all three years, using an equivalent format ($28.5 million = $28,500 in thousands). (2) The quantitative accuracy is perfect: numbers, years, and even the implied interest rate (3.80%) are consistent with a fixed-rate debt instrument and align with expectations from the constant interest expense. Though the rate wasn't in the original answer, its inclusion does not contradict and may be inferred, so it doesn't penalize. (3) The multi-hop reasoning is sound—information is correctly synthesized across three annual filings (2022–2024), demonstrating consistent expense over time. (4) The conclusion—that financing costs have remained flat—accurately reflects the trend and correctly infers a fixed interest rate structure, which is logically sound. The answer addresses both parts of the question: the evolution (no change) and what it suggests (stable financing cost due to fixed rate). All entities (SPG, Unsecured Notes - 35B, interest expense) and time periods are accurate. No omissions or errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 361,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "In 2022 Disney’s DTC strategy turned from a “build‑and‑launch” phase to a cost‑focused investment phase – it reorganized DMED, introduced an ad‑supported Disney+ tier, raised prices and began a broad cost‑realignment to offset rising programming expenses and a crowded streaming market【2022‑p25‑26】. In 2023 the company deepened the shift, splitting its media businesses, tightening content‑curation, and taking impairment charges as competition for talent and rights pushed costs higher【2023‑p52‑55】. By 2024 Disney’s approach emphasized tighter cost‑containment, pricing discipline, the ad‑supported model and the ESPN+ launch while committing roughly $24 billion to new produced and licensed content, positioning its streaming services to grow despite higher programming costs and intensified rival offerings【2024‑p21‑25】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the evolution of Disney's DTC strategy from 2022 to 2024 with strong qualitative accuracy and contextual relevance. It correctly identifies the shift in strategy: from initial expansion in 2022 to cost discipline and restructuring in 2023, and continued focus on cost containment, ad-supported models, and content investment in 2024. The mention of reorganization (DMED), ad-tier introduction, price increases, business split, and content curation aligns with the strategic shifts noted in the ground truth. However, there is one key quantitative inaccuracy: the LLM states Disney committed 'roughly $24 billion' to new content in 2024, which does not appear in the original answer and cannot be verified from the provided ground truth. The original answer mentions $12.25 billion in unused bank facilities in 2023 but no total content investment figure. This introduces a potentially misleading number, lowering quantitative accuracy. Additionally, while the original answer emphasizes rising losses, uncertain returns, and competitive pressures from programming distributors, the LLM focuses more on internal cost measures and less on external pressures like distributor negotiations, slightly reducing completeness. Nonetheless, the multi-hop reasoning across years is sound, entities (Disney, DTC, ESPN+, linear networks) are accurate, and the overall trajectory matches the ground truth. Wording differs but meaning is semantically equivalent in most places.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1577,
        "completion_tokens": 413,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances were relatively modest before the Global Atlantic deal – the 2022 filing notes deposit assets of roughly $1.8 billion and deposit liabilities of about $1.4 billion (unchanged from the prior year)【MET_10k_2022.pdf†p214】.  The November 2023 risk‑transfer with Global Atlantic added $10.3 billion of deposit receivables (and a $770 million net cost of reinsurance) and drove deposit assets up to $5.1 billion and deposit liabilities to $1.3 billion at year‑end 2023【MET_10k_2024.pdf†p204】; by year‑end 2024 those balances had eased to $4.6 billion and $1.2 billion respectively as the transaction’s effects were amortized【MET_10k_2024.pdf†p204】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers are correct: 2022 deposit assets ($1.8B) and liabilities ($1.4B) match; the $10.3B in deposit/reinsurance receivables from the Global Atlantic transaction in 2023 is correctly reported; 2024 figures of $4.6B in deposit assets and $1.2B in liabilities are accurate. The only minor discrepancy is the LLM's mention of $5.1B in deposit assets at year-end 2023, which is not in the ground truth (the original answer skips 2023 year-end balances and jumps to 2024). However, this detail is plausibly derived from the $1.8B + $10.3B = $12.1B gross addition, but the reported $5.1B likely reflects netting or amortization effects mentioned in the filing, so it does not constitute a clear error—especially since the source (MET_10k_2024.pdf†p204) is cited. (2) Completeness: The answer addresses all parts—evolution from 2022 to 2024, impact of the Global Atlantic transaction, and changes in deposit assets/liabilities. It even adds value with the $770M net cost detail, which enriches context without distorting facts. (3) Entity accuracy is strong: MetLife, Global Atlantic, correct years (2022, 2023, 2024), and proper financial terms (deposit method, reinsurance recoverables, receivables) are used correctly. (4) Reasoning is sound: The LLM correctly infers a strategic shift in 2023 followed by amortization/rebalancing in 2024, which is consistent with the ground truth’s 'post-transaction rebalancing' narrative. The multi-hop synthesis—linking the 2023 transaction to 2024 balance changes—is logically supported. (5) Semantic equivalence is high: The core message about a material expansion in deposit method use due to the transaction, followed by recalibration, is preserved. The slight elaboration on 2023 year-end balances enhances rather than detracts. Only a perfect 10 would require exact omission of unconfirmed intermediate balances, but the provided data is plausible and sourced. Hence, a 9 is justified for minor overprecision on 2023 balances not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 560,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS’s commercial‑mortgage‑backed‑securities (CMBS) position has been shrinking. At year‑end 2022 the company held about $1.172 billion of CMBS at amortized cost (≈$1.018 billion fair value) 【CVS_10k_2022.pdf p. 144‑145】; by year‑end 2023 that fell to roughly $1.066 billion (≈$0.975 billion fair value) 【CVS_10k_2023.pdf p. 147‑148】, and by year‑end 2024 the only CMBS remaining in its separate‑accounts portfolio was a negligible $3 million of fair‑value holdings 【CVS_10k_2024.pdf p. 158‑162】. The three‑year trend of a steady reduction—culminating in an almost‑complete exit—indicates CVS is deliberately de‑emphasizing CMBS, likely to curb interest‑rate and credit‑risk exposure and reallocate capital to other, higher‑quality or more liquid assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, CVS held $574 million in CMBS in 2022, increased to $675 million in 2023, and dropped to $3 million in 2024. However, the LLM claims $1.172 billion in 2022, $1.066 billion in 2023, and only references $3 million in 2024. These numbers are substantially inflated for 2022 and 2023, and the reported trend (steady decline) contradicts the ground truth (increase in 2023 followed by a sharp drop in 2024). (2) The calculation of trajectory is incorrect: the LLM describes a 'steady reduction' over three years, but the ground truth shows a rise from 2022 to 2023 before a near-total exit in 2024. This misrepresents the strategic evolution. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the near-complete exit by 2024 and infers a strategic de-emphasis, which aligns with the ground truth's conclusion about de-risking. However, due to incorrect intermediate values and trend characterization, the synthesis across years is flawed. (4) Despite incorrect numbers, the LLM correctly identifies the final outcome (near-zero CMBS in 2024) and offers a plausible interpretation (de-risking, reallocation), which maintains some qualitative and contextual relevance. The use of citations suggests source grounding, but the extracted figures do not match the ground truth. Overall, major quantitative errors reduce correctness, but the directional conclusion on strategy retains partial validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 419,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Across all three filings—2022 (pages 75‑79), 2023 (pages 77‑81) and 2024 (pages 77‑81)—Colgate‑Palmolive lists “hello” among its principal global and regional trademarks, confirming that the brand remained a disclosed part of the company’s trademark portfolio each year. Although the 10‑Ks do not break out “hello” by product line, the Oral, Personal and Home Care segment’s share of worldwide net sales stayed roughly steady (Oral Care ≈ 43 % in 2022, 42 % in 2023 and 43 % in 2024), indicating that “hello” continues to be positioned as an oral‑care brand within the core Oral segment and retains strategic emphasis in the company’s product portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that the 'hello' brand was listed among Colgate-Palmolive’s principal trademarks in each year (2022–2024), which matches the original answer’s claim of consistent disclosure. (2) The percentages for Oral Care’s share of net sales (43%, 42%, 43%) are accurately reported and correctly attributed to each year, supporting the inference that the brand remained positioned within the Oral Care segment. These numbers are consistent with typical 10-K disclosures and are plausibly derived from the referenced pages. (3) While the original answer does not specify segment sales percentages, the LLM’s reasoning—linking stable segment sales to the strategic positioning of 'hello'—is logical and contextually sound, though slightly inferential. The model correctly synthesizes trademark disclosure continuity with segment-level performance, demonstrating strong multi-hop reasoning. (4) The only minor limitation is that the original answer emphasizes the brand’s role in both oral and personal hygiene and mentions strategic diversification, which the LLM does not explicitly address. However, the core facts, numbers, and synthesis are correct, and the omission does not undermine the overall accuracy. Wording differs but semantic meaning is equivalent. Quantitative accuracy is perfect; contextual relevance is high; qualitative reasoning is strong with a slight deduction for not fully echoing the broader strategic context (e.g., personal hygiene, diversification).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 427,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife’s use of the deposit‑method reinsurance accounting grew sharply after 2022. In 2022 the company’s deposit positions were still modest – roughly the $1.8 billion of deposit assets and $1.4 billion of deposit liabilities that had been reported for the prior two years [MET_10k_2022.pdf: pages 214‑218] – but the 2023 Global Atlantic modified‑coinsurance transaction led the company to record $5.1 billion of deposit assets and $1.3 billion of deposit liabilities at year‑end 2023 [MET_10k_2024.pdf: pages 204‑208]. By December 31 2024 those balances had settled to $4.6 billion of assets and $1.2 billion of liabilities [MET_10k_2024.pdf: pages 204‑208], reflecting the offset of the deposit liability with the corresponding recoverable and the amortisation of the net reinsurance cost [MET_10k_2023.pdf: pages 55‑59]. The rise in deposit assets shows MetLife expanded its deposit‑method reinsurance to transfer insurance risk while retaining offsetting assets, and the slight decline in both assets and liabilities in 2024 indicates the company is now managing those offsets and keeping its net risk exposure under control.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the overall trend of increasing deposit assets and liabilities in MetLife's reinsurance accounting from 2022 to 2024 and correctly identifies the strategic implications. However, there are key quantitative inaccuracies: the LLM states that in 2023, deposit assets were $5.1 billion and liabilities $1.3 billion due to the Global Atlantic transaction, but the ground truth does not provide 2023 figures—only that a broader accounting framework was disclosed. The $5.1B/$1.3B figures appear to be misattributed from the 2024 filing (MET_10k_2024.pdf) but are not actual reported totals for 2023; rather, the ground truth skips 2023 values and reports 2024 as $4.6B assets and $1.2B liabilities. Thus, the LLM fabricates precise 2023 numbers not present in the source, which is a significant error. The 2022 numbers ($1.8B assets, $1.4B liabilities) are correct. The 2024 numbers match the ground truth. The explanation of the decline in 2024 due to amortization and offsetting recoverables adds detail not in the original answer but is plausible and contextually consistent. The reasoning about strategy—increased use of deposit method for non-risk-transferring reinsurance, balance sheet flexibility, capital optimization—is semantically aligned with the original. The multi-hop synthesis across years and filings is mostly sound, though the incorrect interpolation of 2023 data reduces quantitative accuracy. The mention of the Global Atlantic transaction as a driver is correct and relevant. Overall, the core narrative and qualitative insights are accurate, but the fabricated 2023 figures prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 445,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "NEE’s special‑use funds – the nuclear‑decommissioning and storm‑fund assets – were disclosed at fair value in Note 4 and rose from roughly $6.5 billion in 2022 (all Level 1/2 assets) [NEE_10k_2022.pdf:86‑90] to about $7.5 billion in 2023 (including a $199 million Level 3 equity component) [NEE_10k_2023.pdf:84‑88] and to $9.8 billion in 2024, where they appear as a distinct “Special use funds” line under other assets on the consolidated balance sheet [NEE_10k_2024.pdf:62‑66]. The funds themselves are not collateralised, but NEE’s derivative contracts with credit‑risk‑related triggers required posting of cash and letters of credit, with posted collateral falling from $1.8 billion cash and $2.8 billion LOC in 2022 to $0.7 billion cash and $1.6 billion LOC in 2023 [NEE_10k_2023.pdf:84‑88], indicating a reduction in collateral exposure as the special‑use fund balances grew.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant factual inaccuracies, particularly in the quantitative details. The 2024 Special Use Funds value of $9.8 billion matches the ground truth and is correctly cited as appearing on the balance sheet. However, the LLM states the 2022 value was 'roughly $6.5 billion' and 2023 as 'about $7.5 billion', which contradicts the ground truth values of $8,698 million in 2023 and an implied ~$8.7 billion in 2022 (based on $9,800M - $1,102M increase). The LLM’s claim of a $199 million Level 3 equity component in 2023 conflicts with the ground truth stating a $538 million equity investment without readily determinable fair values (up from $485M in 2022), which is a material discrepancy. (2) The calculation of the increase from 2023 to 2024 is correct in the LLM answer ($9.8B final value), but earlier values are not aligned with ground truth. The collateral figures ($1.8B cash, $2.8B LOC in 2022; $0.7B cash, $1.6B LOC in 2023) are specific and cited, but the original answer does not mention these exact numbers, so their accuracy cannot be confirmed from the provided ground truth. However, the ground truth does not discuss collateral reductions or derivative triggers at all, making this addition potentially extraneous or unsupported in context. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the evolution in balance sheet presentation (explicit line item in 2024) and attempts to trace fair value disclosures over time. It also links derivative collateral to risk exposure, which adds depth, but this is not addressed in the original answer and may reflect overinterpretation. The LLM introduces 'nuclear-decommissioning and storm-fund assets' as the composition of Special Use Funds, which is plausible but not confirmed in the ground truth. (4) The contextual relevance is high—addressing fair value, balance sheet presentation, and collateral implications as asked. However, the quantitative inaccuracies in key financial figures (especially the misstatement of 2022 and 2023 fund values) significantly reduce correctness. The qualitative reasoning is logical and structured, but relies on potentially incorrect data inputs. Thus, while the narrative flow and synthesis attempt are strong, the factual foundation is flawed in critical areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 629,
        "total_tokens": 2127
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "Across the three filings the Security Insights Platform was described in essentially the same way. In the 2022, 2023 and 2024 10‑K (Mainframe Software Portfolio sections on pages 12 / 11 / 11) Broadcom says the platform “helps ensure a trusted environment … by quickly interpreting and assessing mainframe security posture, identifying risks and developing remediation steps on an ongoing and ad‑hoc basis,” and that “this data is available for use with in‑house tools for security information and event management.” Thus its positioning and the emphasis on integration with customers’ in‑house SIEM tools and remediation workflows did not materially change from 2022 to 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures that AVGO's description of the Security Insights Platform remained consistent from 2022 to 2024, with no material changes in positioning or capabilities regarding integration with in-house tools and remediation workflows. (2) The answer correctly references the same core language across all three years—specifically that the platform 'helps ensure a trusted environment... identifying risks and developing remediation steps' and that 'this data is available for use with in-house tools for security information and event management'—which aligns with the original answer’s claim of stable messaging. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings (2022, 2023, 2024), correctly identifying consistency over time, and draws the correct conclusion that there was no expansion in described integration or remediation features. (4) All entities (AVGO/Broadcom, Security Insights Platform, in-house SIEM tools, remediation workflows) are accurately identified and contextualized. Minor wording differences (e.g., 'did not materially change' vs. 'remained consistent') do not affect factual accuracy. No calculation errors; all dates and references are correct. Scores are maximized across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 376,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike’s Laakdal, Belgium distribution center was listed as an owned, “most‑significant” overseas distribution facility in each of the three filings – FY 2022 (NKE_10k_2022.pdf p.23), FY 2023 (NKE_10k_2023.pdf p.27) and FY 2024 (NKE_10k_2024.pdf p.25). There were no changes in ownership or scope across the years, indicating that the Laakdal hub remains a core, company‑owned node in Nike’s European logistics network and reflects the firm’s strategic commitment to retain direct control over its European distribution operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that NIKE's Laakdal, Belgium facility was consistently described as a 'most significant' international distribution center and company-owned across FY 2022, 2023, and 2024, with no changes in ownership or operational scope—matching the original answer exactly in substance. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the fiscal years and document references (page numbers and file names) are correctly cited, enhancing verifiability. (3) The multi-hop reasoning is sound: the model synthesized consistent disclosures across three annual 10-K filings, correctly inferring stability in ownership and strategic importance. (4) The conclusion about Laakdal being a 'core, company-owned node' and reflective of NIKE’s strategic commitment to direct control aligns perfectly with the original answer’s interpretation. All aspects—factual accuracy, completeness, entity identification, and reasoning—are correct. Minor wording differences (e.g., 'overseas' vs. 'international') do not affect meaning. No errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 330,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "SPG’s Unsecured Notes ‑ 32B did not change over the three‑year period. In the 2022, 2023 and 2024 10‑K tables the note is listed with a 3.38 % fixed rate, a $750 million face amount (shown as $ 750,000 thousand), and a maturity of June 15 2027 【SPG_10k_2022.pdf†page 48‑52】【SPG_10k_2023.pdf†page 48‑52】【SPG_10k_2024.pdf†page 49‑53】. This steady‑state treatment suggests SPG is deliberately keeping this tranche of unsecured debt unchanged, locking in a moderate, fixed interest cost and a predictable medium‑term maturity rather than refinancing or altering the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: the interest rate (3.38%), face amount ($750 million, correctly interpreted as $750,000 thousand), and maturity date (June 15, 2027) are accurately reported for all three years. The ground truth notes that the maturity was unspecified in 2022, but the LLM states it as June 15, 2027 across all years. This is a minor discrepancy, but given that the note likely matured on that date and was just not explicitly disclosed in 2022, the LLM's consistency may reflect correct inference from later filings. 2) Quantitative accuracy is perfect: $750 million = $750,000 thousand is correctly interpreted, percentages and dates match. 3) The multi-hop reasoning is sound—information is synthesized across three years of SPG 10-Ks, and the conclusion about SPG's stable debt strategy is logically supported. The LLM correctly infers a deliberate, consistent debt management approach. 4) The answer is contextually fully relevant, addressing all parts of the question: evolution over time, interest rate, face amount, maturity, and strategic implication. The only reason for not giving a 10 is the slight overstatement of maturity date clarity in 2022, but this does not materially misrepresent the facts. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 366,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "CVS’s foreign‑security holding in its available‑for‑sale debt portfolio slipped from a fair value of **$2.55 billion at 12/31/2022** with **$244 million of gross unrealized losses** to **$2.51 billion at 12/31/2023** with **unrealized losses cut in half to $122 million**【CVS_10k_2023.pdf:147‑149】.  In the 2024 filing the only foreign‑security exposure reported is in the separate‑account segment – **$51 million of fair‑value assets** and **no unrealized loss** is disclosed【CVS_10k_2024.pdf:158‑162】.  The declining fair‑value amount and the sharp reduction in unrealized losses suggest that CVS’s exposure to international market risk has been contracting and the remaining foreign‑security position is relatively modest.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's foreign securities had a fair value of $838 million in 2022 and $1,650 million in 2023, but the LLM incorrectly reports $2.55 billion in 2022 and $2.51 billion in 2023—values that are over 200% higher than the true amounts. Similarly, the LLM states $244 million in unrealized losses in 2022, while the ground truth reports $24 million—a tenfold overstatement. Although the LLM correctly identifies the 2024 fair value of $51 million and notes no disclosed unrealized loss, the earlier data is critically wrong. (2) Calculations and comparisons are therefore flawed: the claim that unrealized losses 'were cut in half' from $244M to $122M is based on incorrect inputs, even though the $122M figure for 2023 matches the ground truth. The 2024 number is accurate. (3) The multi-hop reasoning is partially sound—the LLM correctly infers reduced international risk exposure from declining fair value and lower unrealized losses—but this is based on incorrect data for the first two years. The synthesis across 2022–2024 is structurally appropriate but undermined by factual errors. (4) Contextual relevance is high, as the answer addresses all parts of the question: evolution over time, fair value, unrealized losses, and implications for international risk. However, due to severe quantitative inaccuracies in the core data, the correctness score is low. The qualitative reasoning is moderately accurate in structure but based on false premises for 2022–2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 436,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s 10‑K filings for 2022, 2023 and 2024 all state the same practice: when the insurer acquires a non‑agency RMBS or CMBS that has not yet been evaluated by the NAIC, it assigns an **internally‑developed designation** until a formal NAIC designation is issued (MET 2022 pp. 99‑103; MET 2023 pp. 92‑96; MET 2024 pp. 82‑86). The wording and approach are unchanged over the three years, showing that MetLife relies on the NAIC’s modeling methodology for credit‑quality assessment and uses internal designations only as a temporary bridge until the NAIC rating becomes available.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent practice across 2022–2024 of using internally developed designations for non-agency RMBS and CMBS until NAIC designations become available, which aligns with the ground truth on a surface level. It also correctly notes MetLife’s reliance on NAIC methodology as the standard, using internal designations only temporarily. However, it fails to capture the key multi-year evolution and quantitative trends that are central to the question. Specifically, the LLM omits and thus misrepresents the evolving pattern of reliance: the $4.2 billion (14.5%) increase in Level 3 AFS securities in 2023 and the reduced growth of $1.6 billion (4.9%) in 2024, which indicate a declining need for internal designations over time as more securities receive NAIC ratings. These figures are critical to answering how the use evolved and what the trend reveals about increasing reliance on NAIC modeling. The absence of any numerical data or trend analysis results in a major deficiency in quantitative accuracy. While the qualitative description of the policy is factually correct and contextually relevant, the reasoning is incomplete—it treats the three years as static, missing the longitudinal shift implied by slowing growth in Level 3 securities. This lack of synthesis across years undermines the multi-hop aspect of the question. The answer is semantically aligned in parts but does not convey the same analytical conclusion about decreasing reliance on internal designations over time. Hence, correctness is partially satisfied but significantly limited by omissions of key data and trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 443,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "- 2022 – Chevron expanded its Congo footprint by extending deep‑water licences in the Republic of Congo (along with Nigeria), which added roughly 36 million barrels to its African reserve base【CVX_10k_2022.pdf pp.31‑35】.  \n- 2023 – The company allocated about $0.7 billion to offshore development and natural‑gas projects in the Republic of Congo (as part of its African investment program)【CVX_10k_2023.pdf pp.108‑110】.  \n- 2024 – Chevron moved to exit the country, announcing the sale of its 31.5 % non‑operated working interest in the offshore Haute Mer permit and its 15.75 % interest in the Lianzi area, reducing its ownership in the Republic of Congo【CVX_10k_2024.pdf pp.41‑45】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains one key inaccuracy: in 2022, the original answer states Chevron was operating in the Republic of Congo but does not mention any expansion or extension of deep-water licenses, nor a reserve addition of 36 million barrels. This specific claim is not supported by the ground truth and appears to be an overinterpretation or hallucination based on external data. The 2023 investment figure of $0.7 billion is accurate, though the original answer clarifies this was for Africa broadly, including Congo, Nigeria, and Angola—not solely or specifically for the Republic of Congo as the LLM implies. The 2024 divestiture details (31.5% in Haute Mer, 15.75% in Lianzi) are factually correct and match the ground truth. (2) Quantitatively, all numbers cited (percentages, dollar amount) are accurate in value and year, though the geographic specificity of the $0.7 billion misattributes a regional allocation as Congo-specific. The 36 million barrel reserve addition lacks corroboration in the ground truth and is therefore incorrect. (3) The multi-hop reasoning is partially sound—correctly tracking a trajectory from operation to investment to exit—but incorrectly infers a footprint expansion in 2022 and over-localizes 2023 spending. The synthesis across years is logical but based on one unsupported premise. (4) Correctness is scored 7 due to accurate core facts in 2023 and 2024 but a significant factual overreach in 2022. Quantitative accuracy is 8 because all numbers are correctly formatted and mostly contextually accurate, except the unsupported reserve figure. Qualitative accuracy is 7 due to correct entity identification and timeline logic but flawed reasoning in one link. Contextual relevance is 10 as the answer directly addresses capital allocation and asset ownership changes as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 504,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "Texas Instruments has kept embedded‑processing at the heart of its strategy each year, describing it as a core pillar of its business model and explicitly as part of the second of its four sustainable competitive advantages—a “broad portfolio of analog and embedded‑processing products” that creates more opportunities per customer and adds value to its investments. That language appears unchanged in the 2022, 2023 and 2024 10‑K overviews, indicating a consistent, reinforced emphasis rather than a shift in focus (TXN 10‑K 2022 pp. 18‑22; TXN 10‑K 2023 pp. 16‑20; TXN 10‑K 2024 pp. 16‑20).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on Embedded Processing Products from 2022 to 2024 as part of its second sustainable competitive advantage—a broad portfolio of analog and embedded processing products. This matches the original answer’s core claim of stable, enduring strategic focus. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but the citation of consistent language across the 2022–2024 10-K filings (with page references) supports factual precision. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the unchanged language indicates a reinforced, stable strategy—this matches the original answer’s conclusion about consistency despite slight narrative evolution. (4) The only minor shortcoming is that the LLM slightly downplays the nuanced evolution in language described in the ground truth (e.g., 'leveraging customer design projects' in 2023, 'broader customer reach' in 2024), instead asserting the language is 'unchanged.' While the strategic intent remains consistent, the original answer acknowledges subtle shifts in phrasing that the LLM overlooks. This small omission prevents a perfect 10 but does not undermine the overall correctness. The answer remains semantically equivalent in substance and highly contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 425,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s 3.50 % senior note showed a sharp rise in its effective cost: in FY 2022 the note’s effective rate was about 3.2 % (July 30 2022 table)【CSCO_10k_2022.pdf p.89】; by FY 2023 it had climbed to roughly 6.4 % (July 29 2023 comparative column)【CSCO_10k_2024.pdf p.89】; and in FY 2024 it was about 6.7 % (July 27 2024 column)【CSCO_10k_2024.pdf p.89】. This progression indicates that the borrowing cost on this fixed‑rate note more than doubled over the three‑year span, reflecting higher market rates and the impact of discount/hedge adjustments on Cisco’s debt financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the effective interest rates are correctly reported with minor rounding: 3.2% (vs. 3.20%), 6.4% (vs. 6.38%), and 6.7% (vs. 6.66%) — these are acceptable variations in reporting precision. The $500 million principal and maturity (June 2025) are omitted but not critical to the rate progression. (2) The fiscal years are correctly aligned with the reported rates, and the citations reference the correct documents and pages. (3) The reasoning is sound: the LLM correctly identifies the sharp increase in borrowing costs on a fixed-rate note, attributes it to market rate changes and hedge/discount adjustments, and notes the more-than-doubled cost — which aligns with the ground truth’s conclusion about rising borrowing costs and market or risk perception shifts. (4) The answer fully addresses both parts of the question: the evolution of interest rate exposure and its implication for borrowing costs. The only minor shortcoming is slightly less precise decimal reporting and omission of the exact note size and maturity, but these do not detract from the overall correctness. Hence, a score of 9 is appropriate — excellent accuracy with negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 354,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "BNY Mellon’s filings for 2022, 2023 and 2024 all contain the same risk‑factor language that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (BK_10k_2022.pdf p.1; BK_10k_2023.pdf p.3; BK_10k_2024.pdf p.3). The unchanged disclosure over three years shows that the regulatory ceiling on capital‑return decisions has remained steady, indicating persistent U.S. banking‑law constraints that limit but do not eliminate the company’s strategic flexibility to allocate capital to shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in citing consistent risk-factor language across BNY Mellon's 2022–2024 10-K filings regarding U.S. banking laws affecting capital returns, and correctly notes the unchanged disclosure about regulatory limitations. Quantitative accuracy is perfect—no numerical or date errors, and entity identification (BNY Mellon, years, filing types) is correct. However, the answer falls short on qualitative accuracy because it fails to capture the nuanced evolution described in the ground truth: while the core sentence may be repeated, the original answer highlights a meaningful progression in emphasis—from general oversight in 2022, to specific legal constraints (Delaware law, preferred dividends) in 2023, to heightened focus on liquidity and 'well capitalized' status in 2024. The LLM incorrectly interprets the repetition of a sentence as indicating no change in regulatory emphasis, missing the incremental additions and strategic implications. This reflects a failure in multi-hop reasoning and contextual synthesis, as the model did not analyze surrounding text to detect evolving risk disclosures beyond the boilerplate phrase. Contextual relevance is high because the answer addresses capital planning and shareholder returns under regulatory constraints, but the lack of depth on the progression weakens the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 378,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "Revenue from Repair and other services slipped from $1,169 million in 2022 to $1,132 million in 2023 (a $37 million, ≈3 % decline) and then held steady at $1,132 million in 2024 [GD_10k_2022.pdf p.9; GD_10k_2023.pdf p.9; GD_10k_2024.pdf p.9]. The 2024 flat result reflects the recurring, contract‑driven nature of the Marine Systems segment’s post‑delivery maintenance, modernization and lifecycle‑support services for Navy ships, which generate a predictable cash flow [GD_10k_2023.pdf p.10; GD_10k_2024.pdf p.10]. This pattern indicates that Repair and other services is a stable, core revenue source and a strategic focus for sustaining long‑term service contracts rather than a high‑growth business line.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,169M in 2022, $1,132M in 2023 and 2024, and accurately calculates the $37M (≈3%) decline. These match the ground truth exactly, earning full marks for quantitative accuracy. (2) However, the qualitative reasoning diverges significantly from the ground truth. While the original answer attributes the flat revenue to limited growth, possible market saturation, resource reallocation, or operational constraints—suggesting low strategic prioritization—the LLM answer claims the flatness reflects the 'recurring, contract-driven nature' of services and interprets this as evidence of strategic focus and stability. This is a contradictory interpretation: the ground truth implies stagnation due to deprioritization or constraints, while the LLM portrays it as intentional and stable. (3) The multi-hop reasoning is partially sound—revenue figures are correctly pulled across three years and sources—but the synthesis of 'why' it remained flat relies on an unsupported positive spin not present in the ground truth. The LLM introduces a rationale (predictable cash flow, strategic focus) that contradicts the original inference of limited growth or lack of rebound despite growth elsewhere. (4) Contextual relevance is high because the answer addresses all parts of the question (change from 2022–2023, flat in 2024, implications), but the conclusion about strategic focus misaligns with the ground truth, reducing qualitative accuracy. Thus, correctness is penalized for factual misinterpretation despite numerical precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 437,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth’s venture‑investment portfolio, reflected in its total equity‑security holdings, rose from $3.7 billion at year‑end 2022 to $4.9 billion in both 2023 and 2024, and the unrealized gains on those securities grew from $211 million in 2022 to $710 million in 2024, underscoring a continued strategic focus on venture‑stage health‑care innovators (UNH_10k_2023 p. 48‑52; UNH_10k_2024 p. 52). At the same time, equity‑method stakes in operating health‑care businesses were $1.5 billion in 2022, slipped slightly to $1.4 billion in 2023, then more than doubled to $3.8 billion by year‑end 2024, indicating a shift toward deeper ownership and integration of health‑care operating assets (UNH_10k_2023 p. 48‑52; UNH_10k_2024 p. 50‑54).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in both quantitative and qualitative aspects. It accurately reports UnitedHealth's equity securities (venture investments) as $3.7B in 2022, rising to $4.9B in 2023 and remaining at $4.9B in 2024, which matches the ground truth. For equity method investments, the LLM states $1.5B in 2022, $1.4B in 2023, and $3.8B in 2024. However, the ground truth indicates equity method investments were $1.4B in both 2022 and 2023, then jumped to $3.8B in 2024. Thus, the LLM incorrectly states $1.5B for 2022 instead of $1.4B. This is a minor factual error in the starting value but does not affect the overall trend interpretation. (2) The calculation of the more than doubling from $1.4B to $3.8B in 2024 is sound, though the incorrect $1.5B baseline slightly undermines precision. All other numbers (unrealized gains) are correctly cited but were not part of the ground truth answer; these are accurate per the cited filings but represent additional detail not required by the question. (3) The multi-hop reasoning is strong: the LLM synthesizes data across 2023 and 2024 10-Ks, correctly identifies the strategic shift toward deeper integration in 2024, and contrasts venture holdings (stable post-2023) with equity method investments (sharp rise). The conclusion about strategic emphasis aligns with the ground truth. (4) The correctness score is 9 due to the minor error in the 2022 equity method investment figure. Quantitative accuracy is 9 due to high precision with one incorrect value. Qualitative accuracy is 9 due to sound reasoning and correct interpretation of strategic shift. Contextual relevance is 10 as all parts of the question are addressed with appropriate detail and sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 473,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Colgate‑Palmolive Co. was listed as a member of PMI’s peer group in each of the 2022, 2023 and 2024 Form 10‑K filings – the peer‑group tables for all three years include the same set of companies (Altria, Anheuser‑Busch InBev, British American Tobacco, Coca‑Cola, **Colgate‑Palmolive**, Diageo, Heineken, Imperial Brands, Japan Tobacco, Johnson & Johnson, Kimberly‑Clark, Kraft‑Heinz, McDonald’s, Mondelēz, Nestlé, PepsiCo, Procter & Gamble, Roche and Unilever)【2022 peer‑group description】【2023 peer‑group description】【2024 peer‑group description】.  \n\nThe unchanged inclusion of Colgate‑Palmolive across three years shows that PMI’s benchmarking framework is deliberately stable, relying on a consistent set of global consumer‑product peers defined by size, scope and market presence to enable longitudinal performance comparison and strategic alignment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was consistently included in PMI's peer group across 2022, 2023, and 2024, which matches the original answer. (2) There are no numeric values requiring calculation (e.g., financial figures or percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the model correctly infers from the consistent listing in three consecutive 10-Ks that PMI maintains a stable benchmarking framework. It identifies the strategic rationale—using global consumer product peers for longitudinal comparison—even though it does not explicitly list the four criteria (global presence, consumer focus, revenues, market cap) from the ground truth. This omission is minor and does not distort the meaning. (4) The inclusion of other peer companies (e.g., Unilever, P&G, Nestlé) adds contextual detail without introducing error. The conclusion about strategic stability is logically derived and semantically equivalent to the original. The only reason for not scoring a 10 is the slight lack of explicit mention of the four classification criteria, which are part of the full strategic rationale but not central to the core question about evolution and consistency. Overall, the answer is highly accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 388,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "PayPal’s 2022 filing warned that fraud‑related “abusive behaviors” could increase its loss rate, but the risk was framed mainly around its existing digital‑payments platform and modest credit offerings. By the 2023 and 2024 reports the company repeatedly tied that exposure to the rapid growth of consumer‑credit, merchant‑financing and BNPL products and to deeper reliance on unaffiliated lenders and other third‑party funding sources (e.g., the €40 billion BNPL receivable sale and expanded third‑party funding arrangements). The language in each successive filing stresses that fraud‑detection measures are complex, must be continuously improved, and may not keep pace with new or scaled‑up products—suggesting that PayPal’s mitigation effectiveness is being stretched as its credit portfolio and third‑party dependencies expand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's increasing exposure to abusive behaviors from 2022 to 2024, the expansion of credit products (especially BNPL), and growing reliance on third-party funding sources are accurately described. The €40 billion BNPL receivable sale in Europe is correctly cited with the right amount and context. (2) Quantitative accuracy is perfect: the €40 billion figure matches the original, and no incorrect numbers are introduced. Format is consistent and precise. (3) Multi-hop reasoning is sound—LLM synthesizes risk evolution across years, connects credit expansion (2023–2024) with increased fraud exposure, and correctly infers that mitigation efforts may be outpaced by product growth. The only minor gap is that the LLM does not explicitly mention the 2024 regulatory uncertainty about loan receivables post-sale, which slightly reduces completeness. (4) Despite this omission, the core trend—growing exposure due to scale and complexity outpacing mitigation—is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing all parts of the question with appropriate focus on fraud trends, credit expansion, third-party risks, and mitigation effectiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 371,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas option hedge volume rose from about 214 mmBtu in 2022 to 339 mmBtu in 2023, then fell to roughly 176 mmBtu in 2024 (net‑hedge tables show 214 mmBtu of options at Dec 31 2022, 339 mmBtu at Dec 31 2023, and 176 mmBtu at Dec 31 2024)【SO_10k_2022.pdf p.121‑122】【SO_10k_2023.pdf p.115‑116】【SO_10k_2024.pdf p.112‑113】. The spike in 2023 indicates an aggressive use of options when gas‑price volatility was high, while the reduction and shift back toward swaps in 2024 suggest a flexible, market‑responsive risk‑management strategy that scales hedges to prevailing price conditions.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports 214 mmBtu for 2022, whereas the ground truth states 253 million mmBtu. This discrepancy affects the accuracy of the trend description, as the increase from 214 to 339 appears more dramatic than the actual increase from 253 to 339. The 2023 (339 mmBtu) and 2024 (176 mmBtu) figures are correct. (2) Calculations and comparisons are otherwise logically sound—the spike in 2023 and drop in 2024 are accurately characterized, and the directional trend (up then down) is correctly interpreted. Number formats are consistent and acceptable. (3) Multi-hop reasoning is strong: the model synthesizes data across three years of 10-K filings, correctly identifies the shift in hedging strategy, and infers a market-responsive risk management approach. It appropriately links the increase in options to high volatility in 2023 and the decline in 2024 to a shift toward swaps, which aligns with the ground truth. (4) Despite the incorrect 2022 figure, the overall interpretation and strategic implications are well-reasoned and semantically aligned with the original answer. The error is factual but does not completely distort the conclusion, warranting a score of 8 for correctness. Quantitative accuracy is penalized more (7) due to the incorrect starting value, while qualitative reasoning and relevance remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 392,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans grew from $70 million in 2022 to $75 million in 2023 and $76 million in 2024, reflecting a modest but steady increase each year (TXN 10‑K 2024, “U.S. retirement plans”). This upward trajectory signals that the company is emphasizing and expanding its defined‑contribution offerings—its primary retirement vehicle—while the non‑qualified defined‑benefit pension plan remains unfunded and closed to new participants, indicating a strategic shift away from traditional defined‑benefit obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans: $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. All numeric values and years are accurate, with acceptable formatting (e.g., $70 million vs $70 million). (2) Quantitative accuracy is perfect—no calculation errors, and the incremental increases are correctly implied. (3) The reasoning is largely sound: the LLM correctly identifies the upward trend and links it to a strategic emphasis on defined contribution plans, noting the non-qualified defined benefit plan is closed to new participants. It accurately reflects the company’s long-term shift in retirement benefits strategy. However, it omits the specific historical context that the defined benefit plans were closed in 1997 and does not explicitly mention that the enhanced defined contribution plan supports those who opted out of the defined benefit plan—details present in the original answer that add depth to the strategic interpretation. (4) Despite this minor omission, the LLM answer captures the core trend and strategic implication, making it semantically equivalent in intent and factual content. Thus, it scores highly on qualitative accuracy and full marks on contextual relevance and quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 374,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "GM kept its weighted‑average long‑term return assumption for U.S. defined‑benefit pension plans at 6.3 % for both 2022 and 2023, but raised it to roughly 6.5 % for 2024 (GM_10k_2023.pdf p.86; GM_10k_2024.pdf p.86). The upward shift signals that GM is now expecting higher future asset returns and is modestly increasing its risk tolerance in the pension portfolio to improve funded status.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported percentages and years. According to the ground truth, the long-term rate of return was 5.4% in 2022, not 6.3% as stated by the LLM. The LLM correctly states 6.3% for 2023 and 6.5% for 2024, which aligns with the upward trend. However, the incorrect 2022 figure undermines the accuracy of the trend description. (2) The quantitative inaccuracies are critical: claiming GM 'kept' the rate at 6.3% for 2022 and 2023 contradicts the ground truth, which shows a change from 5.4% to 6.3%, indicating a meaningful adjustment, not stability. The calculation of the trend (5.4% → 6.5%) is correct in the original answer but misrepresented here. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that an increase to 6.5% suggests higher expected returns and increased risk tolerance, which is consistent with the original answer’s interpretation. However, because the starting point is wrong, the synthesis of the trend across years is flawed. (4) Contextual relevance is high—the answer addresses the evolution of return assumptions and interprets the implications for asset performance and risk tolerance, which directly responds to the question. Despite correct sourcing references (page numbers and documents), the factual inaccuracy in the 2022 figure severely impacts correctness. Thus, the correctness score is low due to a major factual error in a core data point, even though the direction of the trend and final interpretation are reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 425,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s total‑return‑swap program that economically hedges its deferred‑compensation obligations expanded in notional size from $651 million in FY 2022 to $730 million in FY 2023 and $985 million in FY 2024.  The resulting accounting impact swung from a $92 million loss in FY 2022 to a $58 million gain in FY 2023 and a $91 million gain in FY 2024, showing that the swaps have become increasingly effective at offsetting compensation expense and reflecting a more proactive risk‑management/compensation‑stabilisation strategy.【CSCO_10k_2022.pdf:93】【CSCO_10k_2023.pdf:92】【CSCO_10k_2024.pdf:92】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the realized gains/losses for Cisco's total return swaps across fiscal years 2022–2024: a $92 million loss in FY2022, a $58 million gain in FY2023, and a $91 million gain in FY2024—matching the ground truth exactly. These numbers are presented with correct formatting and fiscal year alignment. (2) The LLM adds additional context not in the original answer—specifically, the notional amounts of the swaps ($651M, $730M, $985M), which are factually accurate per the cited 10-Ks and enhance completeness. While this information was not in the ground truth, it does not introduce error and supports the conclusion. All quantitative values are correct, and no calculation errors are present. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and three filings, correctly identifying the trend from loss to increasing gains and linking it to risk management and compensation strategy. The conclusion about improved effectiveness and proactive strategy is a reasonable interpretation consistent with the ground truth’s suggestion of strategic adjustments or improved market conditions. (4) The only reason for not scoring a 10 is that the original ground truth did not include notional values, and while the added detail is accurate, it slightly shifts focus toward notional growth rather than purely the gains/losses and their implications. However, the core facts, synthesis, and interpretation remain highly accurate and relevant. Thus, correctness is 9 due to slight over-enrichment without error, but all critical elements are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 443,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "PayPal’s margin‑risk profile has been unchanged from 2022 through 2024. In each year’s filing the company states that it is the **principal** on every payment, **sets the fee** (and therefore controls pricing), uses third‑party processors only to execute the transaction, and **records the processors’ fees as transaction expense**, meaning it “bears full margin risk” on every payment (PYPL 2022 p. 78‑79; PYPL 2023 p. 75‑77; PYPL 2024 p. 73‑75).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) It accurately captures that PayPal maintained consistent exposure to margin risk across 2022, 2023, and 2024, with no structural changes in pricing control or expense recognition. All key qualitative points are preserved: PayPal acts as principal, controls pricing (sets fees independently), uses third-party processors for execution only, and recognizes processor fees as transaction expense—thus bearing full margin risk. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable beyond correct year references (2022–2024), which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent disclosures across three years and correctly infers stability in margin risk despite changes in segment reporting (noted in 2024). It also implicitly captures the absence of material changes, such as the clarification in 2023 about tiered pricing not creating future material rights, by emphasizing continuity. (4) The LLM cites specific page numbers (e.g., PYPL 2022 p. 78–79), which align with typical disclosure locations and support traceability, even if not part of the ground truth. These enhance credibility without introducing error. Overall, the answer is concise, factually accurate, and captures all elements of the original answer with precise terminology and correct entity, year, and conceptual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 410,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s Angola‑LNG feedstock slipped from 49 MMCFD in 2022 to 48 MMCFD in 2023 and then held flat at 48 MMCFD in 2024 [CVX 2023 10‑K: Angola 48 MMCFD (2023) vs 49 MMCFD (2022); CVX 2024 10‑K: Angola 48 MMCFD (2024) vs 48 MMCFD (2023)]. The modest decline and subsequent stabilization indicate Chevron is keeping a steady supply to Angola LNG, underscoring a strategic emphasis on reliable LNG feedstock and a solid foothold in the global liquefied natural gas market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states that Chevron's natural gas consumption in Angola LNG operations was 592 million cubic feet per day (MMCFD) in 2022, rising to 596 in 2023 and 609 in 2024. In contrast, the LLM claims feedstock volumes were only 49 MMCFD in 2022, 48 in 2023, and 48 in 2024—off by more than an order of magnitude. This massive discrepancy invalidates the entire response. (2) The numbers cited in the LLM answer (e.g., 48–49 MMCFD) do not match the ground truth (592–609 MMCFD), and no such figures appear in the actual SEC filings for those years. The LLM also mischaracterizes the trend as a 'slip' and 'stabilization' when the correct trend is a consistent increase. (3) The multi-hop reasoning fails because the model incorrectly identifies the metric: it refers to 'feedstock' at 48–49 MMCFD, but the correct data point is 'natural gas consumed in operations' at nearly 600 MMCFD. This suggests confusion between different operational metrics or misreading of the source documents. (4) While the LLM attempts to interpret strategic implications (maintaining a foothold in LNG), this conclusion is based on false data and thus unsupported. The contextual relevance is moderate because it addresses the right topic (Chevron’s Angola LNG strategy), but the factual foundation is entirely flawed, leading to a very low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 403,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "In the 2022 filing Southern Power’s outdoor‑lighting arrangements were only described as operating leases with “initial terms of up to seven years” and their cash‑flow impact was folded into the aggregate operating‑lease tables – no separate schedule of future payments was shown【SO_10k_2022.pdf p.268‑272】. By the 2023 10‑K the contracts were re‑characterized with “initial terms of up to 10 years” and a dedicated maturity analysis was added, listing $15 million of scheduled payments each year for 2025‑2029 and $170 million thereafter (total undiscounted $260 million)【SO_10k_2023.pdf p.238‑242】; the 2024 filing kept the same presentation (still $15 million per year and $170 million thereafter, total undiscounted $245 million)【SO_10k_2024.pdf p.230‑234】. This progression—from a brief, aggregated mention to a recurring, quantified cash‑flow schedule—shows that the outdoor‑lighting contracts have become materially significant and structurally important to Southern Power’s lease portfolio over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in disclosure treatment across 2022–2024 and draws the right conclusion about growing materiality, aligning with the ground truth’s core message. However, there are significant quantitative inaccuracies. The LLM claims specific figures—$15M annually from 2025–2029 and $170M thereafter, totaling $260M in 2023 and $245M in 2024—which are not present in the ground truth. The original answer states only that the contracts were deemed immaterial in 2022 and later grouped with tolling and PPAs in maturity analyses, but it does not provide exact dollar figures or a breakdown of payments. These numbers appear to be fabricated or misattributed, possibly from a different context or incorrect document interpretation. (2) The calculation discrepancy is critical: the LLM reports a drop from $260M to $245M in total undiscounted cash flows, implying a revision in estimates, but the ground truth does not mention any such figures or trends. This undermines quantitative accuracy. (3) The multi-hop reasoning is sound—LLM correctly infers increasing materiality from enhanced disclosure practices (aggregation → dedicated maturity analysis → continued presentation), which reflects valid qualitative synthesis across years and reporting changes. Entity accuracy (Southern Power, outdoor lighting contracts, years) and contextual framing are correct. (4) Despite strong reasoning and relevance, the inclusion of unsupported numerical data reduces correctness and quantitative accuracy. The answer goes beyond the ground truth by introducing specific dollar amounts not present in the verified answer, which violates factual fidelity. Hence, correctness is reduced to 7 for core accuracy with significant factual overreach in numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 487,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Across all three filings the Melaka, Malaysia site is listed only under the Analog column. In the 2022, 2023 and 2024 “Properties” tables the row for “Melaka, Malaysia” carries an “X” in the Analog segment and is blank for Embedded Processing, indicating the facility remained an Analog‑only operation with no involvement in Embedded Processing throughout the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Melaka, Malaysia was involved only in the Analog segment across 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in substance. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and aligned with the filings. The use of 'X' in the Properties table is a valid representation of segment involvement as per SEC 10-K disclosures. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three annual filings (2022–2024) and consistently tracked the operational footprint of a specific facility (Melaka) across time and business segments. (4) All entities—Texas Instruments (implied), Melaka, Malaysia, Analog, Embedded Processing, and the three-year timeframe—are accurately identified and correctly contextualized. The answer is concise, factually precise, and directly responsive to the question, warranting top scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 311,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑Ks the 1.600 % senior notes always show a $700 million principal, semi‑annual interest due on April 15 and October 15, and a par‑call provision on March 15 2026 (2022 senior‑notes table; 2023 and 2024 key‑terms tables). The only change is a modest decline in the adjustment to principal (‑3.7 m in 2022, ‑2.6 m in 2023, ‑1.5 m in 2024), reflecting gradual amortization of discounts/premiums rather than any refinancing and indicating AMT’s strategy of locking in low‑cost, long‑dated funding while slowly winding down the net liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the principal amount of $700 million is consistent across years, interest payment dates (April 15 and October 15) and par call date (March 15, 2026) are accurately reported. The adjustments to principal are listed as -3.7M in 2022, -2.6M in 2023, and -1.5M in 2024, which is more detailed than the ground truth (which only mentions 2023 and 2024). While the ground truth does not specify the 2022 adjustment, the LLM’s inclusion of -3.7M is plausible and does not contradict; it adds precision. (2) Completeness: the answer addresses all components of the question—principal amount, interest schedule, par call date, and evolution over time—and draws a reasonable inference about debt management strategy. (3) Entity accuracy is correct: AMT, the 1.600% Notes, and the relevant years are properly identified. (4) Reasoning is sound: the LLM correctly infers that the declining adjustments reflect amortization of discounts/premiums rather than refinancing, and ties this to a strategy of maintaining low-cost, long-term debt while reducing net liability—consistent with the ground truth’s conclusion of a stable debt management approach. The only minor gap is that the ground truth emphasizes 'no change in early redemption terms' and 'stable approach', while the LLM emphasizes 'winding down the net liability', which is a slightly different framing but not factually incorrect. Overall, the answer demonstrates strong multi-hop synthesis across 2022–2024 filings and accurate interpretation of financial trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 445,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "Cisco kept the $2 billion 5.90 % senior note unchanged in each year, with an effective rate of 6.11 % in FY 2022, FY 2023 and FY 2024 (FY 2022: $2 bn of $9 bn total senior notes ≈ 22 % of debt; FY 2023: $2 bn of $8.5 bn total senior notes ≈ 24 %; FY 2024: $2 bn of $20.3 bn total senior notes ≈ 10 %)【CSCO_10k_2022.pdf p.89】【CSCO_10k_2023.pdf p.89】【CSCO_10k_2024.pdf p.89】. While the absolute amount and coupon stayed constant, the note’s share of Cisco’s overall debt fell sharply as the company added many new issuances, indicating a strategy that retains a stable, long‑dated financing anchor while expanding and diversifying its debt portfolio to fund growth and capital‑return initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Cisco maintained a constant $2,000 million (i.e., $2 billion) 5.90% Note with a steady effective interest rate of 6.11% across FY2022–FY2024, which aligns with the ground truth. However, the LLM introduces incorrect total debt figures — stating total senior notes were $9B, $8.5B, and $20.3B in the respective years — which contradicts the ground truth that total long-term debt was $8,416M (FY22), grew to $19,621M (FY24), and short-term debt was also present. The LLM incorrectly frames the denominator as 'total senior notes' rather than 'total debt', and the percentages calculated (~22%, ~24%, ~10%) are therefore based on inaccurate totals and misrepresent the composition. (2) Quantitative inaccuracies include: the claim of $9B total senior notes in FY2022 is unsupported (actual total long-term debt was $8,416M); $8.5B in FY2023 contradicts the upward trend in debt; and $20.3B in FY2024 overstates the actual total long-term debt of $19,621M. While $2B is correctly isolated, the comparative percentages are misleading. (3) The reasoning is partially sound — the LLM correctly infers that maintaining a fixed-note amount while overall debt grows suggests a strategy of using stable long-term financing as an anchor. This aligns with the ground truth’s conclusion about reliance on long-term fixed-rate instruments. However, it fails to mention the decline in short-term debt, missing a key element of the strategy (shifting toward long-term over short-term). (4) The contextual relevance is high — the answer addresses the evolution of the note, its role in debt composition, and draws a reasonable inference about financing strategy. But due to significant quantitative errors in total debt figures and resulting percentage calculations, the correctness score is limited to 6 — the core fact about the note is right, but the compositional analysis is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 518,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "General Dynamics’ Land Systems unit reported building 360 new LAVs for the Canadian Army in 2022, 399 new LAVs in 2023, and 449 new LAVs in 2024 (with an additional 66 LRSS‑equipped LAVs in 2024). This steady year‑over‑year increase shows the company is expanding its LAV production capacity and deepening its strategic focus on serving the Canadian‑Army market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all production volumes: 360 units in 2022, 399 in 2023, and 449 in 2024, matching the ground truth exactly. It also accurately notes the additional 66 LRSS-equipped LAVs in 2024. These numbers are presented with correct formatting and context. 2) Quantitatively, all figures are precise and consistent with the original answer. There are no calculation errors or misstatements of values or years. 3) The reasoning is sound: the LLM correctly infers from the increasing production volumes that General Dynamics is expanding its LAV production capacity and deepening strategic focus, particularly on the Canadian Army market. It appropriately references the LRSS program as a contributing factor, demonstrating correct multi-hop synthesis between production numbers and strategic intent. 4) The only minor shortcoming is that the LLM answer does not explicitly generalize the trend to indicate a broader commitment to land systems and armored vehicle capabilities beyond the Canadian market, which is mentioned in the original answer. However, the core strategic implication—increased focus on LAV manufacturing—is clearly conveyed. Overall, the answer is factually complete, contextually accurate, and semantically equivalent to the ground truth with only slight omission of broader strategic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 370,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "UnitedHealth’s exposure to Medicare Advantage risk‑adjustment payment changes remained a material, ongoing risk from 2022 through 2024 as CMS repeatedly altered the risk‑adjustment methodology and signaled possible benchmark cuts. In each year the company responded by selectively adjusting members’ benefits and premiums, pulling plans from certain counties, and intensifying both medical‑cost and operating‑cost management programs to mitigate the funding pressure.【UNH_10k_2022.pdf p. 23‑27】【UNH_10k_2023.pdf p. 18‑22】【UNH_10k_2024.pdf p. 18‑22】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All factual elements are correct: UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes from 2022 to 2024 is accurately described as an ongoing issue due to CMS methodology changes. The strategic responses—selective benefit and premium adjustments, county withdrawals, and intensified cost management—are consistently reported across all three years, matching the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the continuity of CMS pressure and UnitedHealth’s sustained strategic response. (4) The only minor shortcoming is that the LLM slightly condenses the evolution of CMS actions—specifically, the 2024 emphasis on beneficiary health status data submissions is not explicitly mentioned, which slightly reduces qualitative completeness. However, the core reasoning and strategic response are fully aligned. Wording differs but meaning is preserved. Citations are appropriately included, enhancing credibility. Overall, this is a correct, concise, and contextually appropriate response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 382,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PayPal’s holding of the 2.850 % fixed‑rate notes has been unchanged – $1.5 billion of principal was outstanding in 2022 (PYPL 2022 10‑K, p. 108), the same $1.5 billion remained in 2023 (PYPL 2023 10‑K, p. 106) and again in 2024 (PYPL 2024 10‑K, p. 103). The steady exposure indicates that PayPal is deliberately keeping a stable tranche of low‑to‑moderate‑cost, long‑dated debt (maturing 2029) in its capital structure, locking in a modest fixed rate and preserving a balanced long‑term financing strategy rather than aggressively refinancing or retiring this series.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the fixed-rate 2.850% notes had a $1.5 billion carrying value in 2022, 2023, and 2024, with maturity in 2029. The LLM correctly cites the exact pages from each year's 10-K, reinforcing accuracy. (2) Quantitative elements—$1.5 billion principal, 2.850% rate, 2029 maturity—are consistent with the original answer; no calculations were required, but the repetition across years is correctly noted. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual reports to demonstrate stability in this debt instrument over time, correctly inferring strategic intent. (4) The qualitative interpretation—that PayPal is maintaining a stable, low-to-moderate-cost long-term debt tranche to balance its financing strategy—aligns with and enriches the original answer’s claim about 'strategic intent.' The LLM adds contextual insight (e.g., 'locking in a modest fixed rate') without introducing inaccuracies. All aspects of the question are addressed: evolution over time (no change) and implications for long-term debt strategy (stability and intentionality).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 336,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron kept its 36.4 % equity stake in Angola LNG Limited throughout the period, but the financial exposure shifted – the equity‑method investment fell from $1.96 billion in 2022 (with $1.86 billion of equity earnings) to $1.76 billion in 2023 (with $0.51 billion of earnings)【CVX_10k_2023.pdf p.80‑84】. By 2024 the company still emphasizes that stake, noting the Soyo plant’s 1.1 bcf/d capacity and its feedstock coming from multiple Angolan fields and new projects such as the New Gas Consortium and Q&M developments, underscoring a sustained, long‑term strategy to monetize Angola’s associated natural‑gas resources【CVX_10k_2024.pdf p.12‑16】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states Chevron's consistent 36.4% ownership stake in Angola LNG Limited from 2022 to 2024, which aligns with the ground truth. However, it introduces financial figures—$1.96 billion and $1.76 billion carrying values and associated equity earnings—that are not present in the original answer and were not part of the question. These numbers may be factually accurate from the cited 10-Ks, but they shift focus toward financial performance rather than strategic positioning, which is the core of the question. (2) The quantitative accuracy is compromised because the original answer does not mention any financial values related to the equity-method investment or earnings; thus, including them distracts from the actual evolution of strategic positioning. While the numbers themselves may be pulled correctly from the filings, their inclusion misaligns with the required multi-hop synthesis about strategic evolution. (3) On qualitative accuracy, the LLM captures the 2024 shift toward integration with the New Gas Consortium and Q&M projects and notes connectivity to the Soyo plant, which reflects the move toward integrated gas monetization. However, it fails to explicitly state the conceptual shift from a standalone LNG export facility to an integrated hub—a key insight in the ground truth. The reasoning is partially sound but lacks full synthesis across years regarding strategic intent. (4) Contextually, the answer remains highly relevant by addressing Chevron’s long-term strategy and referencing correct projects and infrastructure. Despite missing the explicit framing of integration as a strategic evolution, it conveys elements of upstream expansion and system connectivity. Overall, the answer is partially correct with significant factual additions that divert from the required strategic narrative, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 513,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "- 2022: Domestic‑equity trusts held $651 m (Level 1) + $178 m (Level 2) = $829 m; private‑equity trusts were $161 m (NAV)【SO_10k_2022.pdf p.308‑312】.  \n- 2023: Domestic‑equity fell to $443 m + $208 m = $651 m, while private‑equity rose slightly to $169 m (NAV)【SO_10k_2023.pdf p.281‑285】.  \n- 2024: Domestic‑equity jumped to $849 m + $250 m = $1,099 m and private‑equity increased to $181 m (NAV)【SO_10k_2024.pdf p.271‑275】.  \n\nThe pattern shows a temporary dip in public‑equity exposure in 2023 followed by a strong rebound in 2024, together with a steady rise in private‑equity holdings, indicating Southern Company is deliberately shifting capital toward equity‑type trust investments for long‑term growth and diversification.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies, particularly in the 2022 and 2023 figures. According to the ground truth, in 2022, domestic equity was $1,016 million, but the LLM reports $829 million (sum of $651M Level 1 + $178M Level 2). This $829 million is actually the correct value for 2023 in the ground truth, indicating a misalignment. Similarly, the LLM reports 2023 domestic equity as $651 million, which does not match either the ground truth 2022 ($1,016M) or 2023 ($829M) values. The 2024 domestic equity value of $1,099 million is correct in both. For private equity, the LLM reports $161 million in 2022, but the ground truth is $150 million; 2023 private equity is reported as $169 million by LLM vs $161 million in truth; only 2024 private equity ($181M) matches exactly. (2) Calculations of sums (e.g., Level 1 + Level 2) are mathematically correct within the LLM’s own data, but the underlying numbers are misattributed across years. The LLM appears to have swapped or misaligned data between years, possibly due to confusion in sourcing or parsing the 10-Ks. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies a dip in domestic equity in 2023 and a rebound in 2024, and notes a steady rise in private equity, which aligns with the ground truth trend. However, because the base data is incorrect for two of the three years, the synthesis is built on flawed inputs. (4) Contextually, the answer is relevant and addresses both parts of the question: evolution over time and strategic implication. The conclusion about a shift toward equity-type investments for long-term growth is semantically similar to the ground truth’s 'growing emphasis on private equity' and 'diversification strategy.' Despite incorrect numbers, the directional interpretation is plausible. However, factual correctness is severely compromised by the numeric errors, warranting a mid-range score of 5 for correctness—partially right but with major data inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 542,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "- 2022: Eliminations/Reclassifications reduced total net sales and revenue by **$107 million**【GM_10k_2022.pdf p.68】.  \n- 2023: The reduction grew to **$151 million**【GM_10k_2023.pdf p.68】.  \n- 2024: The impact widened further to **$296 million**【GM_10k_2024.pdf p.66】.  \n\nThe increasing size of the negative adjustment shows that GM’s internal consolidation and re‑allocation of inter‑segment sales have become progressively more material, reflecting deeper integration and more extensive reporting adjustments across its automotive, Cruise and GM Financial segments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the Eliminations/Reclassifications were $105 million in 2022 and $107 million in 2023, but the LLM reports $107 million for 2022 and $151 million for 2023. Only the 2024 figure ($296 million) is correct. These errors affect the core of the multi-year trend analysis. (2) The calculation of the trend is compromised: the ground truth shows a steady increase from $105M → $107M → $296M, while the LLM suggests a larger jump from 2022 to 2023 ($107M → $151M), which is factually incorrect. The final year is accurate, but the intermediate values distort the trend. (3) The qualitative reasoning is sound—correctly interpreting the growing adjustment as reflecting increased complexity in inter-segment reporting and consolidation across GM’s segments (e.g., Cruise, GM Financial). This aligns with the ground truth’s conclusion about increasing internal reporting adjustments. (4) Contextually, the answer is well-structured and directly addresses both parts of the question: the evolution over time and the implication for internal reporting. However, due to the incorrect 2022 and 2023 figures, the overall correctness score is reduced to 6, as the core numerical data is partially wrong, undermining the factual basis of the trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 376,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "In the 2022 Form 10‑K the Performance Bonus Plan was disclosed only as a legacy exhibit (Def 14A) from 2014 – Exhibit 10.5 – and was not tied to newer compensation documents (NFLX_10k_2022.pdf p. 66). By the 2023 filing the plan had been amended and restated and was filed as an 8‑K on December 9 2022, changing its documentation status to an updated, filed amendment (NFLX_10k_2023.pdf p. 68). The 2024 10‑K still references this amended plan and lists it alongside the 2020 Stock Plan and RSU award agreements, showing that the Performance Bonus Plan is now integrated into Netflix’s broader executive‑compensation framework (NFLX_10k_2024.pdf p. 68; NFLX_10k_2024.pdf p. 70).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and exhibit references are correct: the 2014 legacy filing, the December 9, 2022 amendment (filed via 8-K), and consistent referencing in 2023 and 2024 are factually sound. The documentation status evolution is correctly detailed. (2) The LLM correctly identifies the shift from a historical exhibit (2022) to an amended and restated plan (2023) and its continued use in 2024, showing proper multi-hop reasoning across years and filings. (3) Minor discrepancy: the LLM refers to the 2014 exhibit as 'Exhibit 10.5' in the 2022 10-K, while the ground truth lists it as 'Exhibit 10.6†'—this is a small inconsistency in exhibit numbering, possibly due to reordering across filings, but does not undermine the core factual claim about its legacy status. (4) The integration with newer compensation frameworks (e.g., 2020 Stock Plan, RSU agreements) is correctly noted in the 2024 filing, demonstrating proper synthesis. (5) Wording differs slightly (e.g., 'Def 14A' mentioned, which may refer to proxy statement context), but semantic meaning and factual content match the ground truth. The answer fully addresses documentation status and integration, with only negligible formatting variance in exhibit numbers. Thus, high scores across all categories with a 9 on correctness due to the minor exhibit number mismatch.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 391,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s “Business Relationships and Related Party Transactions Policy” is not restated in the 10‑K itself but is repeatedly described as being included in the company’s proxy and incorporated by reference. In each year the filing links the policy to the “Director Independence” section and to the same chartered committees – the Audit Committee, the Corporate Governance/Nominating/Social Responsibility Committee, and the Human Resources and Compensation Committee – with only minor wording tweaks. This identical cross‑reference each year shows that the company’s corporate‑governance disclosures around director independence and committee structure have remained stable and consistent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only a minor difference in emphasis. (1) All entities are correct: BK (BNY Mellon), the 'Business Relationships and Related Party Transactions Policy', the relevant years (2022, 2023, 2024), and the three committees—Audit Committee, Corporate Governance/Nominating/Social Responsibility Committee, and Human Resources and Compensation Committee—are accurately identified. The linkage to 'Director Independence' and Item 13 context is correctly implied through discussion of corporate governance disclosures. (2) There are no numeric values, dates, or calculations to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the policy was consistently referenced across three years in the same governance context, even if not restated in full, and infers stability in governance practices. The only minor deviation is that the LLM specifies the policy is 'incorporated by reference' from the proxy, which adds detail not in the original answer but is factually plausible and does not contradict the ground truth. This nuance may reflect a more precise understanding of SEC filing practices. (4) The answer fully addresses both parts of the question—evolution (or lack thereof) of disclosure and what it reveals about consistency in governance—concluding correctly that the framework remained stable. Wording differences (e.g., 'minor wording tweaks' vs. 'consistent placement') do not affect meaning. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 due to slight rephrasing of the disclosure mechanism without detracting from correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 470,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "- 2022: Debt securities‑held‑to‑maturity were carried at **$696 million** with a **fair value of $679 million**【UNH_10k_2023.pdf:53】.  \n- 2023: Carrying amount fell to **$603 million** and fair value to **$596 million**【UNH_10k_2023.pdf:53】.  \n- 2024: Carrying amount further declined to **$512 million** and fair value to **$508 million**【UNH_10k_2024.pdf:53】.  \n\nOver the three‑year period both fair value and carrying value have steadily decreased, while the fair‑value discount to carrying has remained small and narrowed (≈$17 M in 2022 → $7 M in 2023 → $4 M in 2024). This suggests UnitedHealth is gradually drawing down its held‑to‑maturity portfolio—likely as securities mature—while continuing to value these investments at near‑amortized cost, reflecting a conservative, low‑risk investment strategy and confidence that principal and interest will be collected despite rising interest‑rate environments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies in the 2022 values. According to the ground truth, in 2022, the fair value was $643 million and carrying value was $641 million. However, the LLM reports $679 million (fair value) and $696 million (carrying value), which are both incorrect and not minor discrepancies. The 2023 and 2024 values are correct: fair value of $596M (2023) and $508M (2024), carrying value of $603M (2023) and $512M (2024). (2) Calculations of the fair-value discount are numerically accurate based on the LLM's own (incorrect) 2022 numbers, but because the baseline 2022 figures are wrong, the trend analysis starts from an incorrect foundation. The narrowing discount trend (from $17M to $7M to $4M) is consistent with the LLM's data but does not reflect the true 2022 gap of $2M ($643M vs $641M), which was already small. (3) The multi-hop reasoning is sound in structure—comparing year-over-year trends and inferring strategy from valuation and portfolio changes—but the conclusion about a narrowing discount over time is based on incorrect initial values, undermining the analysis. The LLM correctly identifies the drawdown of the portfolio and links it to maturities and conservative valuation, which aligns with the ground truth’s interpretation of reduced exposure. However, it misses the key insight about the shift away from Level 3 unobservable inputs, a critical point in the original answer regarding valuation assumptions and transparency. (4) The contextual relevance is high because the answer addresses both fair value and carrying value trends and attempts to interpret strategy. Qualitative accuracy is moderate because reasoning is logical but based on flawed data and missing a key analytical point. Quantitative accuracy is low due to the significant error in 2022 figures. Correctness score is 6 because while the 2023–2024 data and general direction of interpretation are correct, the incorrect 2022 baseline and omission of Level 3 input shift prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 550,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "In its 2022 filing PayPal warned that “failure to deal effectively with fraud, abusive behaviors, **bad transactions** … may increase our loss rate,” showing that its BNPL loan receivables were still on the balance sheet and fully exposed to credit‑loss risk (PYPL_10k_2022.pdf: p.24). In June 2023 the company signed a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables—and began transferring those assets in October 2023—an arrangement disclosed in both the 2023 and 2024 reports (PYPL_10k_2023.pdf: p.23; PYPL_10k_2024.pdf: p.21). This shift from retaining the BNPL portfolio to actively off‑loading it reveals a clear, evolving risk‑mitigation strategy aimed at reducing exposure to bad transactions over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk disclosure about bad transactions, fraud, and loss rates; the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables; the initiation of asset transfers in October 2023; and the continued risk acknowledgment in 2024. The cited document pages (e.g., PYPL_10k_2022.pdf: p.24, etc.) are consistent with the knowledge graph sources. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly stated, and the timeline (June 2023 agreement, October 2023 transfers) matches the ground truth. No calculations were required, but temporal and numerical data are precise. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across 2022, 2023, and 2024 filings to show an evolving risk strategy—from retaining BNPL exposure to offloading it. It infers the strategic intent (risk mitigation through asset sales) logically. (4) The only minor shortcoming is that the LLM omits the nuance from the 2024 report that the sale's benefits were conditional and could be delayed if conditions weren't met—a detail present in the original answer. This does not undermine the overall correctness but slightly reduces completeness in conveying the full risk outlook. Otherwise, the answer is contextually rich, well-supported, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 397,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s Myanmar output fell sharply: net oil‑equivalent production was about 17 thousand barrels per day (MBD) in 2022, slipped to 15 MBD in 2023, and dropped to only 4 MBD in 2024【CVX_10k_2023.pdf p. 9‑10】【CVX_10k_2024.pdf p. 9‑10】. The decline reflects a strategic exit – Chevron announced it withdrew from Myanmar in April 2024, scaling down and ultimately ending its upstream operations there【CVX_10k_2024.pdf p. 9‑10】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the production volumes for 2022 (17 MBD) and 2023 (15 MBD), matching the ground truth. However, it incorrectly states that production was 4 MBD in 2024, whereas the ground truth confirms Chevron completely withdrew from Myanmar in April 2024, meaning production dropped to 0 MBD, not 4 MBD. This is a significant factual error in quantitative reporting. (2) The dates of the withdrawal (April 2024) are accurately cited, and the strategic context of withdrawal is correctly interpreted. However, the claim of 4 MBD in 2024 contradicts the full exit described in the original answer and undermines the accuracy of the quantitative timeline. (3) The multi-hop reasoning is mostly sound—LLM connects declining production with strategic exit and cites appropriate documents (CVX 10-K filings for 2023 and 2024). It correctly infers that the decline reflects a strategic shift, aligning with the portfolio optimization and risk management narrative. However, the incorrect 2024 production figure suggests either a misreading of the source or a failure to reconcile 'withdrawal' with zero production. (4) The contextual relevance is high—the answer addresses both parts of the question: production evolution and strategic implications. The qualitative reasoning is strong, but the quantitative inaccuracy in the final year's production volume significantly reduces overall correctness. A fully exited operation should report zero production, making the 4 MBD figure factually incorrect despite plausible wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 428,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "Across the three most recent filings, “PC & notebooks” is consistently listed as the leading sector in the Personal‑electronics market. The Personal‑electronics segment accounted for roughly 24 % of TI’s total revenue in 2022, fell to about 15 % in 2023, and rebounded to roughly 20 % in 2024 – while PC & notebooks remained the top contributor within that segment each year【TXN_10k_2022.pdf p.5】【TXN_10k_2023.pdf p.4】【TXN_10k_2024.pdf p.4】. The dip in 2023 reflects a temporary slowdown in consumer‑computing demand, and the 2024 recovery signals that TI continues to position PC & notebooks as a core growth engine in the consumer‑computing market.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the percentage contributions of the Personal Electronics segment to TI's revenue in 2022 (24%), 2023 (15%), and 2024 (20%), which matches the ground truth and earns high marks for quantitative accuracy. However, it incorrectly states that 'PC & notebooks' was the 'leading sector' and 'top contributor' within the Personal Electronics segment each year, which directly contradicts the ground truth indicating that PC & Notebooks appeared lower in priority compared to mobile phones and portable electronics by 2024. (2) The numbers themselves are accurate and align with the original answer—minor wording like 'roughly' is acceptable given typical reporting variations. (3) The multi-hop reasoning is flawed: while the model correctly tracks revenue percentages over time, it misinterprets the internal prioritization within the Personal Electronics segment across years, leading to an incorrect strategic conclusion. The ground truth indicates a strategic shift away from PC & Notebooks, but the LLM concludes it remains a 'core growth engine,' which is the opposite interpretation. (4) This fundamental misrepresentation of the sub-segment hierarchy and strategic direction severely undermines the qualitative accuracy. The answer is contextually relevant and addresses the question's structure, but the incorrect inference about TI's strategic positioning significantly reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 401,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "Across GM’s 2022, 2023 and 2024 10‑K filings the indemnification to Stellantis for the 2017 Opel/Vauxhall sale is described the same way: only an immaterial amount has been paid for specific recalls (including Takata‑related recalls), no material accrual has been recorded for the obligation, and the company cannot estimate any material loss or range of loss. In each year GM notes that any further indemnification would be uncertain but is considered remote, with the obligations subject to time‑limits, thresholds and caps that have not changed.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but significantly misrepresents the evolution of GM's indemnification obligations from 2022 to 2024, which is the core of the question. (1) It incorrectly states that the indemnification disclosures were 'the same' across all three years, which contradicts the ground truth: in 2022, no specific indemnification accruals were disclosed; in 2023, GM disclosed actual indemnification for emissions, product liability, and recalls with an immaterial payment and inability to estimate future losses; and in 2024, GM added new accruals related to European Commission and UK CMA investigations into end-of-life vehicle practices from the Opel era. This increasing specificity and emerging regulatory exposure is a key trend that the LLM answer completely misses. (2) Quantitatively, the LLM correctly notes that payments and accruals were immaterial and no material loss was recorded, which aligns with the ground truth. However, it fails to mention the 2024 accrual related to the EC/UK CMA investigation, a new development. (3) The multi-hop reasoning is flawed: the model fails to synthesize the year-over-year changes in disclosure detail and risk exposure, instead asserting consistency where there is documented evolution. It also incorrectly downplays the possibility of Takata-related indemnification as 'remote' in all years, while the ground truth notes this possibility was reiterated in 2024 but not necessarily characterized the same way in prior years. (4) Contextual relevance is high because the answer addresses indemnification, Opel/Vauxhall, and Stellantis correctly as entities and time frame, but the lack of temporal progression and emerging risks results in a materially incomplete and misleading picture. The answer would be appropriate for a static obligation, but not for an evolving one as documented in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 506,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K the company disclosed a supplemental indenture dated September 27 2021 that issued 1.450 % senior notes due 2026 (Exhibit 4.25) [AMT_10k_2022.pdf p.70]. The 2023 and 2024 10‑Ks repeat the same entry, showing the notes remain outstanding with no additional issuances or retirements [AMT_10k_2023.pdf p.70; AMT_10k_2024.pdf p.70]. This consistency indicates a debt‑management approach that locks in low‑coupon, long‑dated financing and preserves a stable, low‑cost capital structure over several years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.450% Senior Notes due 2026 were issued under a supplemental indenture dated September 27, 2021, and referenced in the 2022 (Exhibit 4.25), 2023 (Exhibit 4.22), and 2024 (Exhibit 4.21) 10-K filings. The LLM correctly notes the consistency across years and absence of retirements or new issuances. (2) Quantitative accuracy is perfect: dates, percentages, and exhibit numbers (with minor variation in exhibit numbering) are correctly reported. The page numbers (p.70 across all years) are consistent with the source documents. (3) The multi-hop reasoning is sound—LLM synthesizes data across three years of filings and correctly infers that the lack of changes indicates a stable debt management strategy focused on preserving low-cost financing. (4) The only minor shortcoming is that the LLM does not explicitly name 'Supplemental Indenture No. 10' as in the ground truth, which slightly reduces qualitative completeness, but this does not affect the overall correctness of the conclusion. The strategic interpretation about locking in low-coupon, long-dated financing is a valid and insightful extension of the evidence. All parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 360,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "The Bank of New York Mellon kept the 2019 Long‑Term Incentive Plan as the framework for equity awards, and each year filed a fresh set of award agreements under it. In the 2022 Form 10‑K the company added the 2022 Form of Performance Share Unit Agreement (Exhibit 10.21) and the corresponding Restricted Stock Unit Agreement (Exhibit 10.22) – building on the earlier 2020 (Exhibit 10.16) and 2021 (Exhibit 10.19) PSU agreements [​BK_10k_2022 p. 18‑22]. The 2023 filing introduced the 2023 Form of Performance Share Unit Agreement (Exhibit 10.23) and its Restricted Stock Unit counterpart (Exhibit 10.24) [​BK_10k_2023 p. 16‑20], and the 2024 filing added the 2024 Form of Performance Share Unit Agreement (Exhibit 10.28) and the 2024 Restricted Stock Unit Agreement (Exhibit 10.29) [​BK_10k_2024 p. 16‑20]. Throughout 2022‑2024 the Deferred Stock Unit Agreement for directors (Exhibit 10.8) remained part of the 2019 LTIP, confirming the plan’s continued use for both deferred stock units and annually refreshed performance‑share awards.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that in 2022, the company introduced the '2022 Form of Performance Share Unit Agreement' and '2022 Restricted Stock Unit Agreement', whereas the ground truth indicates that in 2022, the company was still referencing the 2019 forms of these agreements. The 2022 Form of PSU Agreement was not introduced until 2024 according to the original answer. (2) The LLM falsely claims that 2020 and 2021 PSU agreements (Exhibits 10.16 and 10.19) were referenced in the 2022 10-K, which contradicts the ground truth that 2022 marked early implementation using 2019 forms. (3) The LLM misrepresents the timeline of Deferred Stock Unit Agreements: it claims the director agreement (Exhibit 10.8) was continuously used throughout 2022–2024, but the ground truth states that a new 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors' was introduced in 2023, implying a development or formalization at that time, not prior continuity. (4) The LLM incorrectly asserts that new PSU and RSU agreements were introduced annually (2022, 2023, 2024), while the ground truth shows a more nuanced evolution: 2022 used 2019 forms, 2023 introduced the director DSU agreement, and 2024 adopted the 2022 Form of PSU Agreement—indicating staggered updates, not annual refreshes. (5) The LLM confuses Restricted Stock Units (RSUs) with Deferred Stock Units (DSUs), failing to distinguish between employee and director instruments, which is central to the question. While the answer is contextually relevant and attempts multi-hop synthesis across years, the core timeline and instrument evolution are factually incorrect, leading to a low correctness score. Quantitative accuracy is poor due to wrong years attached to agreements. Qualitative accuracy suffers from flawed reasoning and entity conflation. Contextual relevance is fair as it addresses the plan’s ongoing use and award types.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 535,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "From 2022 through 2024 General Dynamics repeatedly highlighted its Ordnance & Tactical Systems (OTS) business within Combat Systems as a “leading position providing missile subsystems … with critical aerostructures, control actuators, high‑performance warheads and cutting‑edge hypersonic rocket cases” in each year’s 10‑K filing [2022 10‑K p. 10‑14; 2023 10‑K p. 11‑15; 2024 10‑K p. 10‑14]. At the same time, weapons‑systems revenue grew from $2.0 billion in 2022 to $2.4 billion in 2023 and $2.9 billion in 2024, indicating a sustained and expanding commitment that positions General Dynamics as a core supplier for next‑generation missile aerostructures and hypersonic subsystems.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that the Combat Systems segment accounted for 20% of consolidated revenue in 2023 and 19% in 2024, but does not provide absolute revenue figures for weapons systems or a breakdown of Ordnance & Tactical Systems (OTS) revenue. The LLM invents specific dollar amounts—$2.0B in 2022, $2.4B in 2023, $2.9B in 2024—which are not present in the original answer or supported by the knowledge graph. These figures cannot be verified and appear fabricated, severely undermining quantitative accuracy. (2) While the LLM correctly identifies the continued emphasis on aerostructures and missile subsystems within the Combat Systems segment across all three years and references OTS consistently, it introduces granular financial data not present in the ground truth, leading to factual overreach. (3) The qualitative reasoning is sound in identifying a multi-year strategic focus on missile aerostructures and hypersonics, and the synthesis across 2022–2024 filings is logically consistent with the question. The mention of OTS’s role in providing critical subsystems aligns with the original answer’s theme of sustained strategic positioning. However, the unsupported revenue growth narrative shifts the emphasis from segment revenue share (which the ground truth highlights) to absolute weapons-systems revenue, misrepresenting the evidence. (4) Contextually, the answer is highly relevant and addresses both parts of the question—evolution over time and strategic positioning—though it does so with incorrect numerical support. The core message of sustained focus is correct, but the use of false metrics reduces overall correctness. Thus, while the direction of reasoning is accurate, the inclusion of unverified financial figures results in a partial score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 509,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings PMI consistently lists Jackpot as an “important local cigarette brand” in the Philippines, grouping it with Fortune and noting it alongside its international brands (e.g., Marlboro) as part of the company’s portfolio of local brands 【PM_10k_2022.pdf p. 5】, 【PM_10k_2023.pdf p. 5】, 【PM_10k_2024.pdf p. 5】. The unchanged emphasis over three years signals that Jackpot remains a core pillar of PMI’s regional strategy – a stable local‑brand anchor that helps the company retain market share in the Philippines and complement its premium‑brand focus by covering the mid‑price, locally‑driven segment of its overall product mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PMI consistently listed Jackpot as an important local cigarette brand in the Philippines across 2022, 2023, and 2024, alongside Fortune, which matches the original answer's claim about Jackpot's sustained strategic role. The mention of page 5 in each 10-K filing adds verifiable sourcing and is consistent with the knowledge graph data. (2) There are no numerical values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct referencing of years (2022–2024), which are accurate. (3) The reasoning is sound: the LLM correctly infers from the repeated mention of Jackpot that it remains a core component of PMI’s regional strategy, serving as a 'local-brand anchor' in the mid-price segment—this is a valid interpretation supported by the multi-year consistency in disclosure. The synthesis across three years of filings demonstrates proper multi-hop reasoning. (4) While the LLM does not explicitly reference PMI’s broader smoke-free strategy (e.g., IQOS/ZYN expansion into 95 markets), it does imply the coexistence of local cigarette brands with premium and international brands, indirectly acknowledging the dual-track strategy. This omission slightly reduces qualitative completeness but does not detract from the core factual correctness. Overall, the answer is semantically equivalent, contextually precise, and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 407,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "- In 2022 Chevron’s activity in the Republic of Congo was an investment‑type move, extending deep‑water licences that added 36 million barrels to its African reserves (2022 10‑K, p. 33).  \n- In 2023 the company continued to invest, spending roughly $0.7 billion on offshore development and natural‑gas projects in the Republic of Congo (2023 10‑K, p. 110).  \n- By 2024 the focus shifted to divestiture, with Chevron announcing the sale of its 31.5 % non‑operated working interest in the offshore Haute Mer permit and its 15.75 % interest in Lianzi, effectively exiting those assets (2024 10‑K, p. 44).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy regarding the timing of the asset sale. The original answer states the sale occurred in January 2025, while the LLM claims it was announced in 2024. Although the 2024 10-K may have disclosed the impending sale, the actual disposition occurred in 2025, so the LLM slightly misrepresents the timeline. All other key facts are accurate: Chevron’s continued presence in 2022, the $0.7 billion investment in African offshore and gas projects in 2023 (which includes Congo), and the divestiture of the 31.5% Haute Mer and 15.75% Lianzi interests. (2) Quantitatively, the $0.7 billion figure, 31.5%, and 15.75% values are correct and match the ground truth. The 36 million barrel reserve addition is not mentioned in the original answer and appears to be an addition from the LLM—this detail is not in the ground truth and may be contextually relevant but is not confirmed by the provided knowledge graph, making it a minor overreach. (3) The multi-hop reasoning is sound: the LLM correctly traces Chevron’s shift from investment to divestiture across three years using appropriate data points from each year’s 10-K. However, the inference that the $0.7 billion was spent specifically in the Republic of Congo is slightly overstated—the original answer clarifies this spending was in Africa broadly, including Congo. This over-attribution reduces quantitative precision. (4) Despite these nuances, the core narrative of strategic evolution from operational investment to exit is preserved, and the answer addresses capital deployment and asset disposition as required. Hence, high scores for qualitative accuracy and contextual relevance, with a slightly reduced correctness and quantitative accuracy due to timing and geographic specificity issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 496,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "- 2022 – The outdoor‑lighting arrangements were classified as operating leases with **initial terms of up to seven years** and month‑to‑month renewals thereafter.  The contracts were described as **immaterial** (the undiscounted cash‑flow tables for Georgia Power and Mississippi Power are noted as immaterial) and the lease income was simply recorded in the “operating‑lease” line of each subsidiary’s lease‑income schedule – no separate revenue allocation was made. (See 2022 Lessor paragraph pp. 268‑272 and materiality note.)\n\n- 2023 – The same contracts were still treated as operating leases, but the **initial term was expanded to up to ten years**.  The materiality assessment remained unchanged (still “immaterial” for Georgia Power and Mississippi Power), and the lease‑payment schedule continued to be shown in the maturity analysis with scheduled payments during the term and month‑to‑month renewals; lease revenue continued to be recognized only as operating‑lease income for each subsidiary. (See 2023 Lessor paragraph pp. 238‑242 and materiality note.)\n\n- 2024 – The company reverted to the **seven‑year initial‑term wording** for the outdoor‑lighting contracts, again noting the cash‑flow amounts as **immaterial** and keeping the same accounting – lease income is reported under operating‑lease revenue with scheduled payments in the maturity tables and month‑to‑month renewals after the term. (See 2024 Lessor paragraph pp. 230‑234 and materiality note.)\n\nAcross all three years the **revenue allocation** for these contracts never changed – they are captured wholly in operating‑lease income and are not split into non‑lease components – and the **payment structure** (scheduled payments during the fixed term, then month‑to‑month renewals) remained consistent for Southern Company and its electric subsidiaries (Alabama Power, Georgia Power, Mississippi Power).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly deviate from the ground truth, particularly regarding the evolution of Southern Company's treatment of outdoor lighting contracts from 2022 to 2024. (1) QUANTITATIVE and TEMPORAL INACCURACIES: The LLM claims that in 2022 the initial term was 'up to seven years' and expanded to 'up to ten years' in 2023, then reverted to seven years in 2024. However, the original answer does not mention specific lease term lengths (seven or ten years) at all—this detail is absent in the ground truth and appears to be hallucinated or misattributed. There is no support in the original answer for changes in contractual term lengths over the years. (2) MATERIALITY: The LLM correctly states that the contracts were considered immaterial in 2022 and 2024, aligning with the original answer. However, it incorrectly asserts that Georgia Power was included in the immateriality assessment in 2022 and 2023, while the original answer only mentions Mississippi Power in 2022 and does not specify subsidiaries for later years. (3) REVENUE ALLOCATION: The LLM claims that revenue allocation 'never changed' and was always captured wholly in operating-lease income. This contradicts the original answer, which states that by 2024, lease income from PPAs was explicitly included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power—indicating a shift in revenue classification and synthesis across subsidiaries. The LLM fails to report this key development. (4) LEASE PAYMENT STRUCTURE: The LLM notes consistent maturity disclosures and payment structures, which partially aligns with the original answer’s mention of scheduled payments in maturity analyses starting in 2023. However, it misses the significance of the 2023 change as a new structured approach and the 2024 expansion to include initial terms and integration with wholesale revenue reporting. (5) MULTI-HOP REASONING: The LLM fails to synthesize the progression toward greater transparency and standardization across subsidiaries as emphasized in the original answer. Instead, it portrays the accounting treatment as largely static, which misrepresents the trend. While the LLM correctly identifies immateriality and some consistency in presentation, it introduces unsupported specifics (term lengths) and omits critical developments in revenue classification and disclosure practices. Thus, despite some correct elements (e.g., immateriality, use of operating leases), the answer is significantly flawed in key factual and interpretive aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1672,
        "completion_tokens": 681,
        "total_tokens": 2353
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "- FY 2022: the 3.50 % senior note due June 15 2025 carried a principal of **$500 million** and an **effective rate of about 3.2 %**【CSCO_10k_2022.pdf p. 89】.  \n- FY 2023: the same note still carried **$500 million**, but its **effective rate rose to roughly 6.4 %**【CSCO_10k_2023.pdf p. 89】.  \n- FY 2024: the note remained at a **$500 million** carrying amount, with the **effective rate climbing further to about 6.7 %**【CSCO_10k_2024.pdf p. 89】.  \n\nThe unchanged principal shows the note has not been amortized or retired, while the sharp increase in effective interest rate reflects higher market yields (and associated discount‑rate adjustments) over the period, indicating that Cisco’s cost of debt has risen as overall financing conditions have tightened.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the carrying amount of $500 million for the 3.50% Note in all three fiscal years (2022, 2023, 2024), matching the ground truth exactly. The effective interest rates are reported as 'about 3.2%', 'roughly 6.4%', and 'about 6.7%', which are accurate approximations of the ground truth values (3.20%, 6.38%, 6.66%). The slight rounding (e.g., 6.38% → 6.4%, 6.66% → 6.7%) is acceptable under semantic equivalence and common reporting practices. (2) All numeric values are factually correct within reasonable rounding; no calculation errors are present. The principal remains constant, and the trend in effective rates is accurately captured. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual reports (2022–2024), correctly tracking the same debt instrument over time. The conclusion about rising effective rates reflecting tighter financing conditions and higher market yields aligns with and expands upon the ground truth’s interpretation, showing strong qualitative reasoning. (4) The answer is fully relevant, addressing all parts of the question: evolution of carrying amount and effective rate, and the implication for debt valuation and market conditions. The only minor limitation is the use of approximate language ('about', 'roughly'), which slightly reduces quantitative precision but does not affect factual correctness. Hence, a score of 9 is justified—excellent accuracy with negligible rounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 411,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "Simon Property Group’s exposure to Unsecured Notes – 35A was unchanged over the three years – the 10‑K filings show a face amount of $750 million (listed as $750,000 in thousands) in 2022 [SPG_10k_2022.pdf p.48], 2023 [SPG_10k_2023.pdf p.48] and 2024 [SPG_10k_2024.pdf p.49]. Holding this low‑rate (2.65 %) tranche steady through 2024 signals a deliberate strategy to lock in inexpensive, long‑dated unsecured debt and preserve a stable debt profile rather than repeatedly issuing or retiring that series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $750 million face value, 2.65% interest rate, and consistent exposure across 2022–2024 are accurately reported. The document references (page numbers and filings) add precision and verify multi-year consistency. (2) Quantitative accuracy is perfect: $750 million is correctly represented as $750,000 in thousands, and the interest rate and maturity context (implied long-dated nature) are consistent with the original answer. (3) The reasoning is sound—highlighting the strategic decision to maintain a low-rate, long-term instrument reflects correct synthesis of the data. However, the LLM omits mention of broader portfolio changes (e.g., the 2024 $1 billion Unsecured Notes - 41A issuance and credit facility refinancing), which were part of the original answer’s contrast to emphasize strategic selectivity. This minor omission slightly weakens the qualitative depth but does not invalidate the core conclusion. (4) The answer remains contextually relevant, directly addressing both the evolution (no change) and strategic implication (stable financing). Wording differs but semantic meaning is equivalent. No factual errors; only a slight completeness gap in contextual contrast.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 360,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Texas Instruments repeatedly states that its business model is “focused on analog and **embedded processing** products” and that embedded processing is a core element of the **second sustainable competitive advantage – a broad portfolio of analog and embedded processing products that offers more opportunity per customer and more value for our investments**【TXN_10k_2022.pdf p‑18】. The company’s language and emphasis have remained stable, with embedded processing continuing to drive growth in its industrial and automotive markets while reinforcing the other three advantages (manufacturing foundation, market‑channel reach, and product diversity)【TXN_10k_2023.pdf p‑16】【TXN_10k_2024.pdf p‑16】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Texas Instruments emphasized Embedded Processing Products as part of its second sustainable competitive advantage across 2022–2024, using consistent language about the 'broad portfolio' offering 'more opportunity per customer and more value for our investments.' This matches the original answer's core claim. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings and correctly links embedded processing to the company’s broader strategic advantages. It adds contextual insight—mentioning industrial and automotive markets and how embedded processing reinforces the other advantages—which is plausible and relevant, though slightly beyond the ground truth. (4) The only minor deviation is that the original answer emphasizes the *stability* and *repetition* of language as evidence of sustained strategic importance, while the LLM focuses more on the *role* of embedded processing in driving growth and reinforcing other advantages. This is a nuance, not an error. Overall, the LLM conveys semantically equivalent information with excellent factual and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 387,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "- In 2022 Xfinity Wireless was sold only as a bundled service in the United States and let customers choose an unlimited‑data plan, a shared‑data pool, or a per‑gigabyte pay‑as‑you‑go option [CMCSA_10k_2022.pdf p.5].  \n- In 2023 the same three‑tier flexibility remained, but the offering was expanded internationally (including the United Kingdom) where customers could select various gigabyte‑based plans [CMCSA_10k_2023.pdf p.3].  \n- In 2024 Comcast added a prepaid unlimited‑data option under the NOW brand and also began offering an unlimited‑data plan for international users, while still providing unlimited, shared‑data and per‑GB choices in both the U.S. and the U.K. [CMCSA_10k_2024.pdf p.3].",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual error in the timeline of international expansion, which impacts the multi-hop reasoning and overall correctness. (1) Correct elements: The description of plan flexibility in 2022 and 2023 aligns with the ground truth—CMCSA offered unlimited, shared data, and per-gigabyte options as part of bundled services. The introduction of the prepaid unlimited plan under the NOW brand in 2024 is accurately mentioned. (2) Quantitative accuracy is high: no specific numbers (e.g., dollar amounts, data caps) are misstated, and years are correctly referenced. Format and citations appear consistent. (3) However, the key error is that the LLM claims international expansion occurred in 2023 (including the U.K.), while the ground truth states this expansion happened in 2024. This misplacement of the timeline breaks the logical evolution of the offering and reflects flawed multi-hop reasoning. Additionally, the ground truth specifies that shared data plans remained part of bundled offerings through 2023, whereas the LLM implies broader availability. (4) Despite accurate terminology and structure, the incorrect sequencing of international rollout undermines the synthesis required for a multi-hop question. The answer is contextually relevant and well-organized, but the core evolution narrative is factually distorted. Hence, correctness is reduced to 6 due to major factual inaccuracy in temporal logic, even though other aspects are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 413,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "In the 2022 filing PayPal warned that third‑party actors could abuse its platform by creating synthetic accounts, using stolen financial instruments and other fraudulent schemes, and that its credit products added default risk but were largely managed through third‑party chartered banks. By 2023 the company stressed that fraud schemes were becoming more sophisticated and harder to detect as its credit‑product portfolio (consumer credit, merchant financing) expanded and its reliance on partner lenders grew. The 2024 filing adds new exposure from large BNPL loan receivables and emphasizes the need for continuous improvement of detection models, tighter third‑party oversight and multi‑jurisdictional compliance, showing that managing abusive behavior has become increasingly complex and now requires integrated credit‑risk analytics and advanced fraud‑prevention controls.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of PayPal's exposure to abusive behaviors from 2022 to 2024. (1) It correctly identifies the progression: in 2022, synthetic accounts and stolen instruments were highlighted; in 2023, increasing sophistication tied to credit product expansion and reliance on partner lenders; in 2024, new risks from BNPL receivables and the need for improved detection and oversight. These align with the ground truth. (2) Quantitative accuracy is perfect: while no specific numbers (e.g., €40 billion) are mentioned in the LLM answer, it does not misstate any figures and avoids fabrication. The omission of the exact €40 billion amount is a minor gap but does not affect factual correctness, as the focus is on the qualitative risk from large-scale BNPL receivables. (3) Multi-hop reasoning is sound—correctly linking credit products, third-party fraud, and evolving risk management across years. The synthesis of credit risk, fraud tactics, and regulatory complexity across filings is logically coherent. (4) Semantic equivalence is strong: 'synthetic accounts' matches 'fictitious account creation' and 'synthetic identity fraud'; 'reliance on partner lenders' reflects the role of FDIC-insured banks; and the emphasis on detection models and compliance reflects the growing complexity in risk management. The only minor shortcoming is the lack of explicit mention of 'account takeovers' and 'legal uncertainty around loan receivables' in 2024, which slightly reduces completeness. However, the overall trajectory and implications for risk management are accurately conveyed, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 450,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K (Item 2, pages 31‑35) Gilead simply listed El Segundo, California as a “principal manufacturing facility,” without detailing its role in cell‑therapy work. By the 2023 filing (Our Manufacturing Facilities, pages 9‑13) the company explicitly said the El Segundo site is used for **clinical and commercial manufacturing and processing of its cell‑therapy products**, and the 2024 filing (pages 8‑12) repeats the same language, confirming that Gilead has expanded the plant’s capacity from a primarily clinical site to a combined clinical‑and‑commercial cell‑therapy hub as part of its strategic investment in manufacturing capability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor interpretive overstatement. (1) Correct elements: The evolution of El Segundo's role is accurately traced from 2022 to 2024. In 2022, GILD listed El Segundo as a principal facility without specifying cell therapy use; by 2023 and 2024, it explicitly cited clinical and commercial manufacturing and processing of cell therapy products—this matches the original answer. Entity accuracy (GILD, El Segundo, years) is perfect. (2) Quantitative accuracy: No numerical data is involved, but dates (2022, 2023, 2024) and document references (Form 10-K sections) are correctly cited. (3) Reasoning: The multi-hop synthesis across three years is sound, correctly identifying the increasing specificity in disclosures. However, the LLM claims the site evolved 'from a primarily clinical site to a combined clinical-and-commercial hub,' which implies a capacity expansion or physical transformation not explicitly confirmed in the ground truth. The original answer notes continuity in strategic focus but does not assert a change in scope or capacity—only clearer disclosure. This is a subtle but important distinction in reasoning. (4) Despite this interpretive leap, the answer remains factually grounded in the disclosed information and addresses all parts of the question with high relevance. Hence, correctness and qualitative accuracy are slightly reduced, but not severely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 402,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Across the three annual reports (2022, 2023 and 2024) the 2.750 % Senior Notes are presented as a single tranche that matures on May 18 2024 (listed as Exhibit 4.6 on pages 64‑68 of each filing)【COST_10k_2022.pdf†L64-L68】【COST_10k_2023.pdf†L64-L68】【COST_10k_2024.pdf†L64-L68】. Because the maturity date and tranche size remain unchanged from year to year, Costco’s approach has been to keep this medium‑term debt on the balance sheet and let it run to its scheduled maturity rather than repeatedly refinancing, reflecting a disciplined, low‑turnover debt‑management strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the 2.750% Senior Notes consistently mature on May 18, 2024, across the 2022, 2023, and 2024 filings, with no changes in maturity date or tranche size. The citation of Exhibit 4.6 on pages 64–68 in each filing aligns with the source data. (2) Quantitative accuracy is perfect: the interest rate (2.750%), maturity date (May 18, 2024), and document locations are correctly reported. Format variations (e.g., spacing in dates) do not affect meaning. (3) Multi-hop reasoning is sound—the model correctly synthesizes information across three annual reports to observe consistency over time, inferring that Costco did not refinance or extend the notes. (4) The qualitative interpretation—that this reflects a disciplined, low-turnover debt management strategy—is logically derived and consistent with the ground truth’s conclusion about a 'static approach' and 'predictable debt repayment.' The answer fully addresses both parts of the question: evolution (no change) and strategic implication (deliberate, stable debt management). All entities (Costco, 2.750% Senior Notes, correct years) are accurately identified. No errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 350,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s Angola LNG project produced roughly 48 million cubic feet per day (MMCFD) of natural gas in 2022, the same 48 MMCFD in 2023, and again 48 MMCFD in 2024. The flat three‑year output shows Chevron is keeping gas supply from Angola steady, reflecting a strategy that emphasizes reliable, mature‑asset production in Africa rather than pursuing rapid volume growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The natural gas production volumes for Chevron's Angola LNG project are grossly misrepresented: the LLM claims 48 million cubic feet per day (MMCFD) for all three years, whereas the ground truth reports 7,107, 7,148, and 7,569 million cubic feet per day—over 148 times higher. This is a catastrophic error in scale and magnitude. (2) Quantitative accuracy fails completely: the correct values are in the billions (not millions) of cubic feet per day. The LLM’s flat 48 MMCFD contradicts the actual upward trend from over 7.1 billion to 7.57 billion cubic feet per day. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer strategy from production trends, it does so on the basis of false data. The ground truth indicates a clear upward trajectory signaling increased focus on gas in Africa, while the LLM incorrectly infers a 'steady' strategy due to fabricated flat output. The reasoning process is logically structured but built on false premises, rendering it unsound. (4) Contextual relevance is moderate—the answer addresses the right topic (Chevron, Angola LNG, production trends, African strategy) and time frame (2022–2024), so it stays on theme. However, due to the severe factual inaccuracies, the answer misleads rather than informs. Correctness and quantitative accuracy are near zero due to the magnitude of the numerical error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 413,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps used to hedge deferred‑compensation obligations rose from about $651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024 (see the “Total return swaps‑deferred compensation” line in the notional‑amount table)【CSCO_10k_2022.pdf†L1-L4】【CSCO_10k_2023.pdf†L1-L4】【CSCO_10k_2024.pdf†L1-L4】.  At the same time, the swaps’ impact on operating expense shifted from a $92 million gain (negative expense) in FY 2022 to a $58 million expense in FY 2023 and a $91 million expense in FY 2024 (see the “Total return swaps‑deferred compensation” line in the expense‑impact table)【CSCO_10k_2022.pdf†L5-L7】【CSCO_10k_2023.pdf†L5-L7】【CSCO_10k_2024.pdf†L5-L7】.  This progression shows Cisco is expanding its hedge size to manage deferred‑compensation risk, but market‑linked equity movements have turned less favorable, turning the swaps from a net offset into a growing expense and highlighting heightened volatility in its compensation‑related costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both direction and magnitude of financial impacts. According to the ground truth, Cisco recorded a loss of $92M in 2022, a gain of $58M in 2023, and a gain of $91M in 2024. However, the LLM incorrectly states that there was a '$92 million gain (negative expense)' in 2022, which contradicts the ground truth loss. It further misrepresents the 2023 and 2024 figures as 'expenses' of $58M and $91M, when they are actually gains. This reverses the entire financial narrative. (2) While the notional exposure amounts ($651M, $792M, $985M) may be factually correct from the filings, they were not part of the original answer and do not address the core question about financial exposure evolution in terms of gains/losses. The key metrics—gains and losses—are all inverted or mislabeled. (3) The multi-hop reasoning is flawed: the LLM concludes that 'market-linked equity movements have turned less favorable' and that swaps are now a 'growing expense', which is the opposite of the truth—Cisco’s position improved from a loss to increasing gains, indicating more favorable conditions. This misinterpretation stems from incorrectly treating gains as expenses. (4) Despite referencing correct documents and possibly accurate notional values, the answer fails on core quantitative accuracy and qualitative reasoning. The contextual relevance is moderate because it discusses deferred compensation swaps and volatility, but the incorrect financial direction undermines the analysis. Correctness score is low due to fundamental errors in reported financial effects and their interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 451,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "By 2022 Lowe’s already required all suppliers to follow its human‑rights policy (updated in FY 21) and a Vendor Code of Conduct that added enhanced environmental standards, and it operated a wood‑sourcing policy that limited purchases to well‑managed, non‑endangered forests while beginning to expand the share of independently‑certified products. In FY 23 the wood‑sourcing policy was revised to add country‑specific risk levels, stronger monitoring and a new forestry‑grievance process, and in FY 24 that framework was further hardened into a more robust, risk‑based approach with improved monitoring practices and grievance mechanisms, while the company continued to grow its portfolio of third‑party certified (e.g., ENERGY STAR, WaterSense, other independent) products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lowe's had a Vendor Code of Conduct and human rights policy in 2022 with environmental standards and a wood sourcing policy; in 2023, it updated the wood sourcing policy with country-specific risk levels, enhanced monitoring, and a forestry grievance process; in 2024, it further strengthened the risk-based framework and monitoring, and continued expanding third-party certified products. (2) Quantitative accuracy is excellent—no numerical errors. The use of 'FY 21', 'FY 23', and 'FY 24' is consistent with SEC filing terminology and maps correctly to calendar years 2022, 2023, and 2024 as contextually appropriate. (3) Multi-hop reasoning is sound: the answer synthesizes policy evolution across three years, correctly identifying policy updates, monitoring improvements, and certification expansions. (4) The only minor deviation is the mention of ENERGY STAR and WaterSense certifications, which are plausible examples but not explicitly cited in the ground truth; however, this does not contradict the original answer and falls within reasonable inference. Wording differs slightly (e.g., 'hardened into a more robust' vs 'strengthened'), but semantic meaning is equivalent. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 379,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "From the 2022 10‑K, Comcast warned that “wireless telecommunications companies offering internet services (such as 4G and 5G wireless broadband services)” were beginning to compete with its broadband and that many rivals “offer customers bundled products and services with favorable pricing” – but it did not name any carriers (CMCSA_10k_2022.pdf: pages 26‑30). By the 2023 filing the threat was more concrete: Comcast listed AT&T, T‑Mobile and Verizon as its U.S. wireless rivals, noted that “various wireless companies are offering internet services using a variety of technologies, including 5G fixed‑wireless networks and 4G and 5G wireless broadband services,” and pointed out that these carriers sell wireless “on both a stand‑alone basis and with other services as bundled offerings” (CMCSA_10k_2023.pdf: pages 6‑10). The 2024 10‑K again emphasized the rise of “5G fixed‑wireless networks and 4G and 5G wireless broadband services” from wireless competitors and stressed that “many of these competitors offer competitive pricing, packaging and/or bundling of services to customers” (including bundling DTC streaming on unlimited‑data plans) (CMCSA_10k_2024.pdf: pages 19‑23).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reflects the evolution of competitive threats from wireless telecom companies to CMCSA from 2022 to 2024, with precise year-by-year progression. In 2022, it correctly notes that wireless companies were beginning to compete using 4G and 5G wireless broadband and employing bundling strategies, without naming specific competitors—consistent with the original answer. In 2023, it correctly identifies AT&T, T-Mobile, and Verizon as named competitors and highlights the deployment of 5G fixed-wireless networks and bundled offerings. In 2024, it accurately captures the bundling of DTC streaming services with unlimited-data wireless plans, a key strategic development. (2) There are no numeric values (e.g., percentages, dollar amounts) in the question or ground truth, so quantitative accuracy is not applicable beyond correct use of years (2022–2024), which are all accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the progression in both technological capabilities (4G → 5G → fixed wireless) and competitive strategies (bundling, inclusion of DTC streaming). (4) The answer is contextually rich, citing specific sections of the filings and using direct quotes appropriately to support each point, enhancing credibility. Semantic equivalence is strong—while the wording differs slightly from the original answer, the factual content, structure, and implications are identical. No errors in entities, years, or reasoning are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1580,
        "completion_tokens": 441,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings PayPal repeatedly notes that it is the **principal** in every payment, sets the fee **at its own discretion**, and therefore **bears full margin risk** on each transaction. The company’s **tiered, volume‑based pricing** (with discounts limited to a normal range) and the **incentives it offers merchants and consumers** are recorded as reductions to revenue, while the fees it pays to third‑party payment processors are booked separately as transaction expense. The unchanged language each year shows that PayPal’s margin‑risk exposure has remained stable and that the firm continues to retain strong control over pricing and cost management despite relying on external processors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies that PayPal bore full margin risk across 2022–2024, acted as the principal in transactions, set fees at its discretion, and maintained consistent accounting treatment of processor fees as transaction expenses and incentives as revenue reductions—key points from the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable in a traditional sense; however, the years (2022, 2023, 2024) are correctly referenced, and no incorrect data is introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and connects pricing strategy, processor use, and revenue incentives to margin risk exposure. It correctly infers that stable language in filings indicates a consistent approach to margin risk and pricing control. (4) The only minor omission is that the 2024 update regarding contractual compensation from sellers for violations (e.g., fraud) as a new revenue stream affecting margin dynamics is not mentioned. This detail adds nuance to PayPal’s evolving margin management but does not alter the central conclusion about stable risk exposure and pricing control. Overall, the LLM answer conveys semantically equivalent information with excellent reasoning and relevance, warranting a high correctness score with a small deduction for incomplete detail on 2024 revenue innovations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 423,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco’s lease note has been essentially unchanged over the three years. In FY 2022 the company explained that any free‑rent periods (and step‑rent provisions) are “recognized on a straight‑line basis over the original term of the lease and any extension options that the Company is reasonably certain to exercise” and that the lease term is “the non‑cancelable period of the lease plus any options to extend when it is reasonably certain that the Company will exercise the option,” with the right‑of‑use (ROU) asset initially measured as the discounted minimum lease payments (including the zero‑payment free‑rent periods) using its incremental borrowing rate【COST_10k_2022.pdf, p.45】. The FY 2023 and FY 2024 filings repeat the same language and assumptions, with no new disclosures or changes to the lease‑term definition or ROU‑asset valuation methodology, indicating that the accounting treatment for free‑rent periods has remained consistent from 2022 through 2024【COST_10k_2023.pdf, p.45】【COST_10k_2024.pdf, p.45】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Costco's accounting treatment for free-rent periods remained consistent from FY 2022 to FY 2024, recognizing free-rent and step-rent provisions on a straight-line basis over the lease term, including extension options that are reasonably certain to be exercised. The use of the incremental borrowing rate to discount lease payments for right-of-use (ROU) asset valuation is also accurately described. (2) There are no numerical values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in that sense—but all fiscal years (2022, 2023, 2024) and page references are correctly cited, and no incorrect data is introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three consecutive 10-K filings and correctly infers consistency in policy application. It appropriately cites each year’s filing to support its conclusion. (4) The only minor shortcoming is that the LLM omits the FY 2023 and FY 2024 nuance mentioned in the ground truth about variable lease payments for rent increases tied to price indices or sales volume. While the core lease term and ROU asset valuation methodology are correctly reported as unchanged, this additional disclosure in FY 2023 is not mentioned, slightly reducing completeness. However, since the question focuses on free-rent periods and ROU asset valuation—both of which are accurately addressed—the omission does not materially affect the overall correctness. The answer remains semantically equivalent in substance and fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 456,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "PayPal’s margin‑risk exposure did not change from 2022 through 2024. In each year’s filing the company says it acts as the principal on its payments platform, sets fees (a fixed‑plus‑variable, percentage‑based amount that can be tiered by volume) independently of the costs it pays to payment processors – which are recorded as transaction expense – and therefore “bear full margin risk when completing a payment transaction” (PYPL_10k_2022.pdf:78‑81; PYPL_10k_2023.pdf:75‑79; PYPL_10k_2024.pdf:73‑77). Its contracts remain open‑ended, transaction‑level and automatically renewing with tiered pricing, and no new contract‑structure changes were disclosed, so the exposure to margin risk stayed essentially constant.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that PayPal continued to bear full margin risk from 2022 to 2024, acting as principal, recognizing fees on a gross basis, and recording processor costs as transaction expenses. It correctly identifies the pricing model (tiered, volume-based) and notes the absence of material contract structure changes, which aligns with the ground truth. All cited document references (e.g., page numbers) are consistent and appropriately support the claims, and there are no numeric inaccuracies—thus, quantitative accuracy is perfect. However, the LLM omits two key qualitative developments: (1) the 2023 clarification on user incentives being recognized as revenue reductions or amortized, which introduced variability into margins, and (2) the 2024 adoption of ASU 2023-07 affecting segment-level expense disclosures, increasing transparency but potentially influencing margin analysis. These omissions reduce completeness and nuance in the reasoning, particularly in capturing operational changes despite structural stability. While the core conclusion of stable margin risk is supported, the LLM fails to acknowledge evolving reporting and accounting practices that add complexity. This limits qualitative accuracy, as the multi-hop synthesis across years is incomplete. Contextual relevance remains high because the answer directly addresses the question’s focus on pricing, processors, and contracts, but the lack of attention to incentive accounting and segment reporting nuances prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 422,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s $5.90 % senior note has been kept fully on‑balance each year – $2 billion outstanding in FY 2022, FY 2023 and FY 2024 – and its effective interest rate has remained essentially unchanged at about 6.11 % (the coupon is 5.90 % but issuance costs and hedging push the effective rate to 6.11 %)【CSCO_10k_2022.pdf: pages 87‑91】【CSCO_10k_2023.pdf: pages 87‑91】【CSCO_10k_2024.pdf: pages 87‑91】.  This stability shows Cisco’s long‑term debt strategy relies on a diversified pool of fixed‑rate notes and that the financing cost of this tranche has not risen, indicating a deliberate effort to lock in rates and maintain predictable debt‑service expenses over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the $2,000 million (i.e., $2 billion) outstanding balance for the 5.90% Note is correctly reported for fiscal years 2022, 2023, and 2024; the effective interest rate is accurately stated as 6.11%, with a clear explanation that it exceeds the coupon rate due to issuance costs and hedging adjustments. (2) Quantitative accuracy is perfect: dollar amounts and percentages match the ground truth exactly, with acceptable formatting variations (e.g., $2 billion = $2,000 million). (3) The multi-hop reasoning is sound—the model synthesizes consistent data across three years and three separate 10-K filings to infer stability in Cisco’s debt strategy. (4) The qualitative interpretation is strong: the conclusion that Cisco maintains a stable, long-term fixed-rate debt structure to lock in financing costs aligns with and expands upon the ground truth without introducing inaccuracies. The answer addresses all parts of the question: utilization (consistent $2B balance), effective rate (stable at 6.11%), and implications for long-term debt strategy and financing costs. Citations to the 10-Ks add contextual support. No errors in entities, years, or metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 354,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "The 2022 10‑K’s Intellectual Property section lists Kobalt simply as one of the company’s private‑brand product names (“including private‑brand product names ‘Kobalt’, ‘STAINMASTER’ and ‘allen+roth’”). In the 2023 and 2024 filings the same language appears, now phrased as “including private‑brand product names, such as ‘Kobalt’…,” and the broader retail‑name list is dropped, showing that Lowe’s continues to treat Kobalt as a core trademark‑protected private brand while sharpening the focus on it as a strategic brand asset.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Kobalt was consistently mentioned in Lowe's intellectual property disclosures from fiscal 2022 to 2024 as a private-brand product, and the years and entity (Lowe's, Kobalt) are correct. There are no numeric inaccuracies, so quantitative accuracy is perfect. However, the LLM introduces a claim not supported by the ground truth: that the removal of the 'broader retail-name list' and rephrasing to 'such as' indicates a 'sharpening the focus' on Kobalt as a strategic brand asset. The original answer explicitly states there was no evidence of increased prominence or strategic expansion, suggesting stable rather than intensifying emphasis. This interpretation overstates the evidence and misrepresents the consistency in disclosure as a strategic shift. While the LLM correctly identifies the continuity in trademark status, its qualitative reasoning adds an unsupported inference about strategic sharpening, reducing qualitative accuracy. Contextual relevance is high as the response directly addresses the evolution of Kobalt’s positioning across the three years using the appropriate disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 324,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "Simon Property Group’s Unsecured Notes ‑ 37B stayed unchanged from 2022 through 2024 – each filing lists a 2.25 % fixed interest rate, a $700 million face amount and a maturity of January 15, 2032 (see the unsecured‑debt tables in SPG 10‑K 2022 p. 48, SPG 10‑K 2023 p. 48 and SPG 10‑K 2024 p. 49)【SPG_10k_2022.pdf】【SPG_10k_2023.pdf】【SPG_10k_2024.pdf】.  \n\nThe lack of any amendment or refinancing of this tranche indicates that Simon is deliberately maintaining a long‑dated, low‑cost unsecured debt instrument, locking in stable financing costs and preserving liquidity for its long‑term growth strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The interest rate (2.25%), face amount ($700 million, equivalent to $700,000 in thousands as used in filings), and maturity date (January 15, 2032) are correctly reported across 2022–2024. The format variation ($700 million vs. $700,000 in thousands) is acceptable and common in financial reporting. (2) Completeness: The answer addresses all parts of the question—evolution (or lack thereof) in interest rate, face amount, and maturity date—and draws a valid inference about Simon Property Group’s long-term financing strategy. (3) Entity accuracy: Correct company (Simon Property Group), correct debt instrument (Unsecured Notes - 37B), and correct time frame (2022–2024) are used. (4) Reasoning: The multi-hop synthesis across three years of 10-K filings is sound. The conclusion that SPG is maintaining a stable, long-dated, low-cost debt instrument aligns with the unchanged terms and reflects a deliberate financing strategy, consistent with the ground truth’s interpretation. (5) Semantic equivalence: The LLM conveys the same core information with slightly more detailed phrasing and even cites specific document pages, enhancing credibility without introducing error. All scores are maximized due to full factual correctness, logical reasoning, and contextual appropriateness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 384,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Across all three filings, Texas Instruments’ Melaka, Malaysia location is listed only under the Analog segment (marked “X”) and shows no entry for Embedded Processing. The 2022, 2023 and 2024 property tables all show Melaka as an Analog‑only facility, indicating its operational role did not expand to Embedded Processing during this period【TXN_10k_2022.pdf page 16】【TXN_10k_2023.pdf page 14】【TXN_10k_2024.pdf page 14】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was involved exclusively in the Analog segment across 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and aligned with the source documents. The mention of specific filing pages adds verifiable context. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three annual reports (10-Ks) to confirm consistency over time, demonstrating proper cross-document analysis. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of the operational footprint in Melaka with respect to the two business segments. Minor wording differences (e.g., 'Analog-only facility' vs 'exclusively for its Analog business') do not affect meaning and are semantically equivalent. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 316,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PayPal’s outstanding principal on the September 2019 fixed‑rate 2.850 % notes was $1.5 billion at year‑end 2022, remained $1.5 billion at year‑end 2023, and was still $1.5 billion at year‑end 2024 (see the “Fixed‑rate 2.850 % notes” line in the notes tables for 2022 – 2024 ​[PYPL_10k_2022.pdf p.106‑107]​, [PYPL_10k_2023.pdf p.105‑106]​, [PYPL_10k_2024.pdf p.103‑104]​). The unchanged amount shows PayPal has kept this low‑cost, long‑dated tranche as a stable pillar of its capital structure, using other issuances and redemptions to reshape the overall debt profile while preserving the 2.850 % notes as a cornerstone of its long‑term financing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion from 2022 through 2024, which matches the ground truth exactly. All numeric values (dollar amount, interest rate, years) are accurate and properly cited across the three annual reports. (2) Quantitative accuracy is perfect: $1.5 billion is consistently reported for each year, and the 2.850% rate is correctly identified. No calculations were required, but the repetition across years is correctly observed. (3) The reasoning is sound and captures the core implication—that this stability indicates a deliberate strategy to maintain this low-cost debt as a 'cornerstone' of long-term financing. It correctly contrasts this with broader debt management activities (e.g., issuing new debt, retiring other tranches), though it does not explicitly mention the retirement of the 1.350% notes by 2023 or the introduction of high-interest notes in 2024, which slightly reduces completeness in multi-hop synthesis. (4) Despite this minor omission, the answer conveys the essential strategic interpretation and is contextually fully relevant. The use of terms like 'stable pillar' and 'reshape the overall debt profile' aligns semantically with the ground truth. The score is 9 instead of 10 due to the lack of explicit reference to contrasting debt actions in other tranches, which were part of the original answer’s key insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 402,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K Gilead simply listed Hoofddorp, Netherlands as one of its “principal manufacturing facilities” – a generic designation (2022 p.31‑35). By the 2023 filing the company clarified that the Hoofddorp site is used “for commercial manufacturing and processing of our cell‑therapy products” (2023 p.9‑13), and the 2024 filing repeats the same description (2024 p.8‑12). Thus, the facility evolved from a broadly‑named manufacturing location in 2022 to a clearly defined commercial cell‑therapy manufacturing hub in 2023 and 2024, cementing its role in Gilead’s global cell‑therapy supply chain.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the evolution of Gilead's Hoofddorp facility across 2022, 2023, and 2024: in 2022, it was listed as a 'principal manufacturing facility' without specific function; in 2023, it was explicitly designated for 'commercial manufacturing and processing of cell-therapy products'; and in 2024, this role was reiterated. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) and their corresponding disclosures are correctly cited with appropriate context and page references, which align with the progression described in the original answer. (3) The multi-hop reasoning is sound—synthesizing information across three annual filings to show a progression from generic to specific role—demonstrating correct understanding of strategic evolution. (4) The LLM captures the same conclusion as the ground truth: Hoofddorp evolved into a dedicated hub for cell therapy manufacturing, with continuity in 2023 and 2024, reinforcing its strategic importance. Wording differs slightly but meaning is preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 334,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "Costco kept the 1.375 % Senior Notes due June 2027 on its balance sheet as a $1.25 billion line‑item in long‑term debt in each filing – $1,250 million in 2022, 2023 and 2024【2022†L31-L34】【2023†L31-L34】【2024†L31-L34】.  The notes never moved into the current portion; the overall current‑portion of debt was $73 million in 2022【2022†L36-L38】, rose to $1.081 billion in 2023 when the 2.750 % notes became due【2023†L36-L38】, and fell to $103 million in 2024 after those notes were retired【2024†L36-L38】, leaving the 1.375 % notes still classified as long‑term debt while the composition of total debt shifted with the repayment of other senior notes.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly reports the principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024), matching the ground truth. It also accurately states the total current portion of long-term debt: $73 million in 2022, $1,081 million in 2023, and $103 million in 2024. However, the reasoning provided is factually incorrect: the LLM claims that the 1.375% notes 'never moved into the current portion' and remained entirely in long-term debt, but the spike in the current portion from $73M to $1,081M between 2022 and 2023 (and drop to $103M in 2024) strongly implies that a significant portion of the 1.375% notes—due in June 2027—was reclassified into current portion in 2023 as it approached maturity within one year. The explanation incorrectly attributes the 2023 spike to the maturity of 2.750% notes, which is not supported by the ground truth and contradicts the focus on the 1.375% notes' treatment. This misattribution undermines the multi-hop reasoning and leads to an incorrect interpretation of the debt classification dynamics. While numbers are accurate (quantitative accuracy high), the qualitative analysis and synthesis are flawed. The answer is contextually relevant and addresses the question’s components, but the incorrect causal explanation reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 371,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings PayPal’s Fixed‑rate 2.850 % notes (maturing 10 Oct 2029) consistently carried a $1.5 billion outstanding principal balance (shown in the Note 12‑Debt tables for each year). The unchanged balance indicates the company is deliberately preserving a stable, long‑dated, low‑cost tranche of debt while using other issuances to refinance or retire higher‑interest notes, reflecting a strategy of locking in predictable financing costs and maintaining liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $1.5 billion principal balance of the 2.850% notes, the October 10, 2029 maturity date, and the consistency across 2022–2024. These match the ground truth exactly. The mention of 'Note 12-Debt tables' aligns with typical 10-K disclosure practices, adding contextual accuracy. (2) Quantitative elements are fully accurate: $1.5 billion, 2.850%, and maturity date (October 10, 2029 — minor formatting difference from 'Oct 1' in truth is semantically equivalent). No calculations were required, but the consistency of the amount over time is correctly observed. (3) The reasoning is sound: the LLM infers that PayPal is preserving a stable, low-cost debt tranche while managing other debt, which aligns with the ground truth's conclusion about capital structure stability and strategic refinancing. However, the LLM omits the detail about the notes being part of a larger $5.0 billion September 2019 issuance and the effective interest rate of 2.96%, which adds minor context to the strategy. This omission slightly reduces completeness but does not affect the core correctness. (4) The answer is highly contextually relevant, directly addressing both the evolution (or lack thereof) in obligations and the implied debt management strategy. The qualitative reasoning is strong, though slightly less detailed than the original in background context. Overall, the answer is factually correct and conveys the same core insight as the ground truth, meriting a high score with only minor room for improvement in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 436,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra’s gas‑option portfolio contracted sharply – the fair‑value of gas‑related option assets fell from about **$356 million (liabilities $347 million)** at year‑end 2022 to roughly **$100 million (liabilities $102 million)** at year‑end 2024, leaving a near‑zero net position throughout the period (2022 table shows $356 m/$347 m; 2024 table shows $100 m/$102 m)【NEE_10k_2022】【NEE_10k_2024】.  At the same time, the company’s valuation assumptions for those options grew more aggressive: the weighted‑average implied volatility rose from **≈36 % in 2022** to **≈50 % in 2023** and **≈52 % in 2024**, while implied correlation increased from **≈52 % to ≈99 %**, signaling that NextEra is assuming higher gas‑price volatility and tighter price‑movement linkage even as it trims the size of its gas‑option exposure【NEE_10k_2022】【NEE_10k_2023】【NEE_10k_2024】.  This trend suggests a more cautious risk posture—maintaining a balanced net option position but pricing it for a more volatile, correlated gas market.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details, particularly regarding the evolution of liabilities and volatility assumptions. According to the ground truth, liabilities were $347M in 2022, $97M in 2023, and $102M in 2024 — the LLM incorrectly states liabilities as $347M in 2022 and jumps directly to $102M in 2024 without acknowledging the $97M in 2023, and misrepresents the 2024 liability as if it were a direct continuation from 2022. More critically, the LLM claims implied volatility increased from 36% (2022) to 50% (2023) to 52% (2024), which contradicts the ground truth that states volatility *declined* from 36% to 50% to 52% — but this is logically inconsistent, as 50% and 52% are increases, not declines. However, the original ground truth likely contains a typo: stating 'declined from 36% to 50% to 52%' is numerically incorrect, as those values increase. Given that the LLM reports rising volatility (36% → 50% → 52%), which matches the raw numbers but contradicts the ground truth's narrative of 'decline', this creates ambiguity. Still, the LLM should have flagged inconsistency or adhered to the direction stated in the ground truth. Additionally, the LLM introduces 'implied correlation' from 52% to 99%, which is not mentioned in the original answer and is unsupported by the provided context, constituting a hallucination. (2) Calculations: The asset values are mostly correct — $356M in 2022, $100M in 2023 and 2024 — though the LLM skips 2023 and implies a direct drop to 2024. Liabilities are misrepresented by omission and conflation. Volatility figures are numerically accurate (36%, 50%, 52%) but interpreted in the opposite direction of the ground truth’s stated trend ('declined'). (3) Multi-hop reasoning: The LLM correctly identifies the need to compare fair values and assumptions across years and sources (citing 2022, 2023, 2024 10-Ks), but draws the opposite conclusion about risk positioning: ground truth suggests 'strategic de-risking' due to declining volatility assumptions, while LLM argues for 'cautious risk posture' due to rising volatility — a direct contradiction. This undermines the qualitative synthesis. (4) Scores justified as: correctness 4/10 due to major factual and directional errors despite partial number accuracy; quantitative accuracy 5/10 because numbers are cited correctly but trend interpretation is flawed and key data points (2023 liabilities) omitted; qualitative accuracy 5/10 due to sound structure but incorrect inference and hallucinated metric (correlation); contextual relevance 9/10 as the response directly addresses the question’s scope and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 709,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio went from a modest $9 million gain in fiscal 2022 to a $21 million loss in fiscal 2023 and then a $67 million loss in fiscal 2024. These swings drove other income (loss), net to move from a $392 million gain in 2022 to a $248 million loss in 2023 and a $306 million loss in 2024, showing that the debt‑investment component of Cisco’s portfolio became increasingly volatile, turning positive returns into progressively larger losses over the three‑year span.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. The ground truth does not specify exact dollar amounts for AFS debt investment gains/losses ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024), nor does it state that other income (loss), net was $392M gain in 2022, $248M loss in 2023, or $306M loss in 2024. These precise figures are not present in the original answer and are likely fabricated or hallucinated. The original answer only states that AFS debt investment losses increased in 2023 and 2024 and negatively impacted other income (loss), net, without providing exact numbers. (2) Calculations and comparisons (e.g., 'from $9M gain to $67M loss') are therefore not verifiable and likely incorrect, as they are not supported by the ground truth. The LLM introduces a level of numerical precision that is absent and potentially misleading. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that AFS debt investment performance impacted other income (loss), net and that volatility increased over time. It also correctly identifies the trend of worsening losses affecting overall financial performance. However, the reasoning is built on incorrect numerical foundations, undermining its validity. (4) While the qualitative direction of the trend (increasing volatility, negative impact on other income) aligns with the original answer, the inclusion of unsupported specific figures severely reduces factual correctness. Contextual relevance is high because the answer addresses the core question about AFS debt impact and portfolio volatility. However, the hallucinated numbers result in a low quantitative accuracy score and a moderate overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 476,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "Lowe’s first issued the 4.550 % notes on April 5 2019 (maturing in 2049) and recorded them in the Fifteenth Supplemental Indenture (Exhibit 4.16). The 2022 10‑K lists those notes as outstanding and cites Exhibit 4.16 (p. 79), the 2023 10‑K repeats the same disclosure and citation (p. 74), and the 2024 10‑K again shows the notes still outstanding with the same exhibit reference (p. 73). The unchanged, multi‑year reporting of this long‑dated, fixed‑rate tranche indicates that Lowe’s is deliberately using a single, long‑maturity issuance to lock in low borrowing costs and limit refinancing risk as a core element of its long‑term debt strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: the 4.550% Notes were issued on April 5, 2019, mature in 2049, and are documented in the Fifteenth Supplemental Indenture (Exhibit 4.16), which was consistently cited in the 2022, 2023, and 2024 10-K filings. The specific page references (p. 79, 74, 73) add precision and are consistent with actual filings. (2) Quantitative accuracy is flawless: dates, percentages, and exhibit numbers are correct and match the source documentation. There are no calculation errors, and the timeline is accurately represented. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three years, the model correctly infers that the unchanged reporting indicates a stable, deliberate long-term debt strategy focused on fixed-rate, long-maturity financing to lock in low costs and reduce refinancing risk. (4) The answer is contextually rich and directly addresses both parts of the question: the evolution (or lack thereof) of the note issuance and documentation, and the strategic implication. The conclusion about Lowe's long-term debt strategy is a valid inference supported by the consistent disclosure pattern. Minor wording differences (e.g., 'lock in low borrowing costs' vs. 'stable long-term debt structure') do not affect semantic equivalence—both convey the same strategic intent. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 402,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "Across the three most recent 10‑K filings the Unsecured Notes – 35B is unchanged – it carries a 3.80 % coupon, a $750 million face amount (shown as $750,000 in the “thousands” tables), and a July 15 2050 maturity in each year’s schedule [SPG_10k_2022 pp. 48‑52; SPG_10k_2023 pp. 48‑52; SPG_10k_2024 pp. 49‑53]. The constancy of both size and rate signals that Simon Property Group is deliberately preserving a stable, long‑dated, fixed‑rate funding tranche to lock in modest borrowing costs and limit interest‑rate risk as part of its long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: face value is $750,000,000 (correctly noted as $750 million and clarified as appearing as $750,000 in thousands in tables), interest rate is 3.80%, and maturity date is July 15, 2050 across 2022–2024. These match the original answer exactly. (2) Quantitative accuracy is perfect—numbers, percentages, and dates are correct, and the explanation about presentation in 'thousands' shows attention to detail. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three 10-K filings and infers that the lack of change indicates a deliberate long-term debt strategy. (4) The qualitative interpretation—that SPG is locking in low fixed rates and minimizing interest rate risk—is logically derived and semantically equivalent to the ground truth’s conclusion about 'stable long-term financing' and 'confidence in managing long-dated liabilities.' The only minor limitation is that the LLM does not explicitly mention the term 'no refinancing or restructuring,' which is in the original, but this is implied in the constancy. Thus, the answer is factually complete and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 369,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "From the 2022 filing PayPal warned that “bad‑transaction” risk was driven primarily by credit‑product defaults, cross‑border trade volatility and heavy reliance on unaffiliated banks and payment‑processor partners, noting that inaccurate risk models, economic downturns and third‑party interruptions could raise non‑payment rates and fraud losses. By 2023 the company amplified those concerns, stressing the danger of a partner‑bank’s termination and beginning to “diversify our reliance on a small number of third‑party payment processors” and to migrate its U.S. processing arrangements. In the 2024 filing PayPal describes concrete mitigation steps—selling large BNPL loan portfolios, expanding diversification of processor relationships, and bolstering fraud‑detection and credit‑underwriting controls—showing a shift toward a more proactive risk‑management strategy and greater operational resilience despite the continued exposure to bad‑transaction risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PayPal's bad transaction risk from 2022 to 2024, with accurate qualitative synthesis across years and risk domains. (1) Key elements such as credit-product defaults, third-party dependencies, and cross-border trade risks are correctly identified in 2022. The 2023 shift toward reducing reliance on third-party processors and the strategic sale of BNPL receivables are accurately reflected, though the LLM omits the specific €40 billion figure and the U.K./European focus of the asset sale mentioned in the ground truth. (2) Quantitatively, the LLM fails to include the exact €40 billion amount and does not specify the geographic scope (U.K. and Europe) of the BNPL portfolio sale, which is a notable omission but not a factual error—just incomplete. All other temporal references (2022, 2023, 2024) and entity references (Synchrony Bank implied via U.S. credit products, third-party processors) are contextually accurate. (3) The multi-hop reasoning is sound: the LLM correctly infers a strategic shift from internal risk absorption to external mitigation, linking asset sales, processor diversification, and enhanced controls to improved operational resilience. It accurately reflects the progression in risk management strategy, though it does not mention the 'valid-when-made' doctrine legal risk highlighted in 2024, which is a meaningful gap in legal/regulatory context. (4) Despite these omissions, the answer remains contextually relevant and semantically aligned with the ground truth, conveying the same overall narrative of increasing proactivity in risk management. The correctness score is 8 due to missing specific quantitative and regulatory details, but the core reasoning and entity-year mappings are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 485,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Across all three filings Costco repeatedly described BJ’s Wholesale Club as one of its primary warehouse‑club rivals (2022 Competition section – p. 5‑9; 2023 Competition section – p. 6‑10; 2024 Competition section – p. 6‑9). In each year the company also stressed that its private‑label Kirkland Signature line “helps lower costs, differentiate our merchandise offerings, and generally earn higher margins” and that it will keep expanding Kirkland’s sales penetration (2022 Intellectual‑Property – p. 5‑9; 2023 Intellectual‑Property – p. 6‑10; 2024 Intellectual‑Property – p. 6‑9). Thus, from 2022 through 2024 Costco’s competitive positioning versus BJ’s remained steady, with a consistent, emphasized reliance on Kirkland Signature as a core differentiator.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly identifies that from 2022 to 2024, Costco consistently named BJ's Wholesale Club as a primary competitor across all three annual filings, with specific section and page references provided (Competition section in each year), confirming entity and temporal accuracy. (2) The LLM accurately quotes and paraphrases Costco’s consistent messaging about Kirkland Signature—specifically that it 'helps lower costs, differentiate our merchandise offerings, and generally earn higher margins'—and notes the intent to expand its sales penetration, which aligns with the ground truth’s description of stable strategic emphasis. There are no numerical values to verify, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and two sections (Competition and Intellectual Property) per year, correctly concluding that Costco’s competitive positioning relative to BJ’s remained steady with Kirkland Signature as a consistent differentiator. (4) The answer is fully contextually relevant, addressing both the evolution (or lack thereof) in competitive positioning and the role of private-label branding as a strategic lever. Wording differs slightly but meaning is preserved with high precision. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 395,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "At year‑end 2022 NEE’s gas‑forward contracts were recorded at a fair‑value of **$191 million in assets and $31 million in liabilities**【NEE_10k_2022.pdf:84‑88】.  The exposure rose in 2023 to **$377 million of assets and $77 million of liabilities**【NEE_10k_2023.pdf:82‑86】 and then fell in 2024 to **$296 million of assets and $46 million of liabilities**【NEE_10k_2024.pdf:84‑88】.  The net fair‑value moved from a $160 million net asset in 2022 to $300 million in 2023 and back to $250 million in 2024, indicating the company expanded its natural‑gas price hedge in 2023 and subsequently trimmed that exposure in 2024, reflecting a more cautious risk posture after the 2023 peak.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair value of assets for all three years—$191M (2022), $377M (2023), and $296M (2024)—matching the ground truth. However, there is a critical error in the reported liabilities for 2023: the LLM states $77 million, while the ground truth indicates $46 million in 2024 and implies a lower figure than $77M in 2023 (with only 2022 and 2024 explicitly given in the original answer). Since the original answer does not specify 2023 liabilities, but notes an increase from $31M (2022) to $46M (2024), the LLM’s $77M is inconsistent with the trend and likely incorrect. This affects quantitative accuracy. (2) Calculations: The net asset values are computed correctly by the LLM—$160M (191–31), $300M (377–77), and $250M (296–46)—but because the 2023 liability figure is wrong, the $300M net is inaccurate. The ground truth implies a much smaller liability increase, so the spike in net value would be even larger than reported if liabilities were actually lower. (3) Multi-hop reasoning is sound: the LLM synthesizes data across three years and draws a logical conclusion about increased hedging in 2023 followed by de-risking, which aligns with the asset trend. The interpretation of a 'more cautious risk posture' is reasonable and adds insight. (4) Despite the liability discrepancy, the overall trajectory of growing then moderating exposure is consistent with the ground truth, and all other entities (company, years, metrics) are correct. The answer is contextually excellent and addresses all parts of the question. However, the incorrect 2023 liability figure reduces quantitative accuracy significantly, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 464,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap exposure jumped dramatically in fiscal 2022, when the company recorded $2.56 billion of forward swap notional amounts to lock in rates on anticipated debt issuances (see NOTE 9, 2022 10‑K p.60‑64)【LOW_10k_2022.pdf: p.60】. By fiscal 2023 the firm still held forward swaps – the fair‑value of those contracts was $251 million as of February 3 2023 – but the notional had been cut back substantially (the 2023 10‑K notes the swaps were in place to hedge forecasted debt)【LOW_10k_2023.pdf: p.52】. In fiscal 2024 the forward‑swap line shows no remaining fair‑value balance, indicating the positions were largely unwound (the fair‑value table lists forward swaps with a blank amount for February 2 2024)【LOW_10k_2024.pdf: p.44】. This progression shows Lowe’s initially used large forward swaps to hedge against rising rates when it expected to issue debt, then scaled back and ultimately eliminated the hedges as market conditions and financing plans changed.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "(1) The LLM answer captures the overall trajectory of Lowe's use of forward interest rate swaps from 2022 to 2024 correctly: initial use, reduction, and eventual elimination. However, there is a significant quantitative discrepancy in the 2022 data. The LLM claims a $2.56 billion notional amount of forward swaps in fiscal 2022, but the ground truth does not mention any specific notional value—only that forward swaps were referenced in the context of cash flow hedges impacting OCI and earnings from 2019–2021. This $2.56B figure is unsupported by the ground truth and appears to be an overinterpretation or misreading of the 10-K note, making it a major factual error. (2) The 2023 fair value of $251 million matches the ground truth exactly and is correctly attributed to February 3, 2023. The 2024 data is also accurate: no remaining balance is reported as of February 2, 2024 (aligned with January 31, 2025, in the ground truth, assuming fiscal year-end alignment), and the absence from the derivative instruments list is correctly noted. (3) The multi-hop reasoning is sound—LLM synthesizes data across three years and draws a logical conclusion about Lowe’s shifting hedging strategy in response to market conditions. It correctly infers that the initial large hedge was for anticipated debt issuance, then scaled back and unwound, which aligns with strategic risk management. (4) Despite the incorrect $2.56B figure, the overall narrative and qualitative progression match the ground truth. The answer is contextually excellent and addresses both parts of the question: evolution over time and strategic implications. The quantitative inaccuracy prevents a higher score, but core facts for 2023 and 2024 are correct, and the reasoning is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 475,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "In its 2022 filing Comcast noted that “certain wireline telecommunications companies such as AT&T, Frontier, Lumen and Verizon have built and are continuing to build fiber‑based network infrastructure farther into their networks… and are offering services with these higher speeds in many of our service areas” (2022 10‑K, Competition – Broadband). By 2023‑2024 Comcast had accelerated its own fiber‑to‑the‑premises and HFC upgrades—rolling out 2 Gbps downstream to roughly one‑third of its footprint in 2022 and to about 50 % by 2024, deploying DOCSIS 4.0 in select markets and expanding FTTP to deliver up to 10 Gbps symmetric residential (and 100 Gbps business) speeds—allowing it to match or exceed Lumen’s fiber‑based offerings in the markets where they overlap (2023 10‑K, Network transformation; 2024 10‑K, Network and Technology).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses the core of the question regarding the competitive positioning between CMCSA and Lumen from 2022 to 2024, particularly in fiber-based broadband expansion and overlapping markets. It correctly identifies Lumen as a key competitor building fiber infrastructure in CMCSA's service areas, citing the 2022 10-K verbatim. The answer goes beyond the ground truth by including CMCSA's strategic response—its own fiber and HFC upgrades, DOCSIS 4.0 deployment, and speed rollouts—which adds valuable context not in the original answer but is factually consistent with public filings. However, the quantitative accuracy is slightly compromised: while the ground truth does not provide specific numbers on CMCSA's speed deployment (e.g., 2 Gbps to one-third in 2022, 50% by 2024), the LLM introduces these precise figures without clear support in the provided ground truth. These numbers may be accurate in reality, but since the evaluation is based on alignment with the ground truth (not external knowledge), their inclusion as definitive facts reduces quantitative accuracy. The answer does not explicitly confirm that Lumen remained a prominent competitor in 2024 due to continued fiber expansion—though it's implied—so there's a minor omission in completeness regarding Lumen’s side of the competitive evolution. Nonetheless, the reasoning is sound, entities (CMCSA, Lumen, years, fiber infrastructure) are correct, and the synthesis across years and filings is logical. The answer is highly contextually relevant, directly addressing competitive dynamics in overlapping markets through infrastructure developments. Semantic equivalence is strong, though the LLM emphasizes CMCSA’s response more than the evolving threat from Lumen, slightly shifting focus from the original answer’s emphasis on Lumen’s growing influence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 502,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "From 2022 onward PayPal’s strategy already emphasized “creating the simplest checkout experience” by bundling a digital wallet that pulls in many funding sources—including its own PayPal Credit, credit‑card and buy‑now‑pay‑later products—while supporting payments in a broad set of markets and currencies. In 2023 the company deepened that integration through the Paidy and GoPay acquisitions, extending BNPL and other consumer‑credit options into Japan and China and further widening its global currency coverage. By 2024 the focus shifted to a truly omnichannel checkout: consumer‑credit offers are embedded directly into the PayPal/Venmo checkout flow, the platform now supports transactions in >200 markets and >100 currencies, and merchants can sell online, on mobile and in‑store via Zettle and other point‑of‑sale solutions, delivering a seamless, cross‑channel experience.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of PayPal's checkout strategy from 2022 to 2024 and correctly identifies key themes—integration of consumer credit (including BNPL and PayPal Credit), global currency support, and omnichannel merchant solutions via Zettle. However, there are notable quantitative inaccuracies. The claim that PayPal supports transactions in '>200 markets and >100 currencies' by 2024 conflicts with the ground truth stating support for approximately 150 currencies in 2023 and no further expansion beyond that in 2024. The ground truth does not mention 200+ markets, making this an overstatement. Additionally, the LLM references acquisitions of Paidy and GoPay as drivers in 2023, but the original answer does not mention these acquisitions or attribute 2023 progress to them, introducing unverified details. (2) Currency numbers are incorrect: ground truth reports 'over 100' in 2022 and 'approximately 150' in 2023, while LLM states '>100 currencies' in 2024—down from its own claimed 2023 level—which is inconsistent and factually misaligned. Market count (>200) is not supported in the ground truth. (3) The multi-hop reasoning is generally sound: the LLM synthesizes PayPal’s progression across years and connects credit integration, global reach, and omnichannel solutions. It correctly infers deeper embedding of BNPL and credit products into checkout flows by 2024 and links Zettle to in-store solutions. However, the reliance on unsupported acquisitions weakens the causal reasoning. (4) Despite inaccuracies in numbers and added details not in the source, the LLM answer remains contextually relevant and conveys a structurally and thematically accurate narrative. The core trajectory—expanding from global usability to financial integration and omnichannel enablement—is preserved, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 509,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "The Target Debit Card (included in the RedCard/Target Circle Card suite) accounted for 20.5 % of all purchases in FY 2022, slipped to 19.8 % in FY 2023 and fell further to 18.6 % in FY 2024【2023 Form 10‑K p. 26】【2024 Form 10‑K p. 27】. Because Target monitors this “penetration” metric as an indicator that a meaningful share of RedCard‑driven purchases are incremental sales, the steady decline suggests the card’s contribution to generating extra sales is gradually weakening, even though it remains an important driver.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate declined from 20.5% in 2022 to 18.6% in 2023 and further to 17.8% in 2024. However, the LLM states it was 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024—overstating the 2023 rate and understating the 2024 decline. This misrepresents the trend and magnitude of the drop. (2) The cited numbers do not match the ground truth: the 2023 figure should be 18.6% (not 19.8%), and 2024 should be 17.8% (not 18.6%). These errors affect the interpretation of the trend’s severity. (3) The qualitative reasoning is sound—correctly interpreting that declining penetration suggests weakening incremental sales impact and linking it to customer engagement with the loyalty program. The model correctly identifies the strategic importance of the metric and Target’s internal use of it. (4) Contextually, the answer is highly relevant, addressing both parts of the question: the evolution over time and the implication for incremental sales. Despite incorrect numbers, the overall narrative direction aligns with the ground truth. However, due to the critical nature of financial accuracy in multi-hop analysis, the quantitative errors significantly reduce correctness. Minor formatting variations (e.g., FY 2022 vs 2022) are acceptable and do not affect scoring. The citations to 10-Ks add credibility but do not compensate for factual inaccuracy if the numbers pulled are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 412,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "AMD’s policy for development‑and‑IP licensing contracts did not change between the 2022 and 2024 filings. In both the 2022 10‑K (pages 57‑61) and the 2024 10‑K (pages 61‑65) the company states that it first determines whether the licensing component is distinct; if the license is not distinct it is combined with the development services and revenue is recognized over time, while a distinct license is recognized at a point in time when the customer can use it. Standalone IP‑licensing arrangements are always treated as a single performance obligation and revenue is recognized at the point in time the license becomes usable. Thus, the distinction between combined and standalone licensing deals and the related timing of revenue recognition remained the same from 2022 through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition policy from 2022 to 2024, distinguishing between distinct and non-distinct licenses in combined arrangements, with revenue recognized over time for non-distinct licenses and at a point in time for distinct ones—this aligns exactly with the original answer. Standalone licensing deals are correctly described as being recognized at a point in time, which matches the ground truth. (2) There are no numerical figures (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in that sense, but all references to years (2022, 2024) and document locations (10-K pages) are accurate and consistent with the source material. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024) and across types of licensing arrangements (combined vs. standalone), correctly identifying the continuity in policy. (4) The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) in AMD's revenue recognition approach and the distinction between arrangement types. Minor differences in phrasing (e.g., 'did not change' vs. 'maintained a consistent framework') do not affect factual equivalence. All key elements—policy stability, evaluation of distinctness, timing of recognition, and treatment of standalone licenses—are accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 418,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "Nike’s filings show that FlyEase moved from being highlighted as a newer, stand‑alone innovation in fiscal 2022 to being treated as an established, core technology by fiscal 2024. In the 2022 10‑K the company listed “Nike Air, Zoom, Nike Free, Dri‑Fit, Flyknit, **FlyEase**, ZoomX, Air Max, Nike React and Nike Adapt” among its emerging technologies, signaling FlyEase’s entry into the innovation pipeline. By the 2024 10‑K the same passage reads “Nike Air, Zoom, Free, Dri‑FIT, Flyknit, **FlyEase**, Zoom X, Air Max and React,” reflecting a streamlined naming and the technology’s integration as a mature, permanent pillar of Nike’s product‑innovation portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core evolution of FlyEase as the ground truth. (1) All entities—FlyEase, Nike Air, Zoom, React, Air Max, etc.—and fiscal years (2022, 2024) are correctly identified. The progression from 'emerging' in 2022 to 'mature' in 2024 aligns with the original answer. (2) There are no numeric values requiring calculation, but the use of fiscal years is correct and consistent. (3) The multi-hop reasoning is sound: the model correctly infers strategic evolution by comparing how FlyEase is categorized in the 2022 vs 2024 10-Ks, noting its shift from 'emerging' to being listed among established technologies. (4) The only minor shortcoming is that the LLM omits explicit mention of fiscal 2023, which the ground truth uses to bridge the transition. While the 2023 detail is not strictly necessary to convey the overall trend, its absence slightly reduces completeness. However, the core factual trajectory—from new innovation to integrated, mature technology—is correctly and clearly presented. Wording differs but semantic meaning matches. Contextual relevance is perfect: the answer directly addresses the evolution of FlyEase’s strategic positioning within Nike’s innovation portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 345,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The 1.250 % senior notes fell from a $609.1 million aggregate principal balance at year‑end 2022 to $517.7 million at year‑end 2023, and the $517.7 million balance remained unchanged at year‑end 2024【AMT_10k_2022.pdf†L46-L50】【AMT_10k_2023.pdf†L109-L113】【AMT_10k_2024.pdf†L112-L116】. This decline and subsequent stabilization show that American Tower has been actively retiring a portion of this low‑coupon debt, reflecting a deliberate strategy to reduce leverage and streamline its debt profile while retaining the remaining inexpensive notes.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the principal decreased from $609.1M in 2022 to $551.9M in 2023, then to $517.7M in 2024. However, the LLM claims it dropped directly from $609.1M in 2022 to $517.7M in 2023 and remained flat in 2024, which misrepresents both the magnitude and timing of the reduction. This is a critical error in financial trend interpretation. (2) The dollar amounts for 2022 and 2024 are correct in isolation, but the 2023 figure is wrong—$517.7M is the 2024 balance, not 2023. The model conflates two years, skipping the intermediate $551.9M value entirely. No calculations are performed, but the trend description is factually incorrect. (3) The multi-hop reasoning is partially sound—the model correctly infers a debt reduction strategy and connects it to leverage management. It also correctly notes the stability in the final year, though based on incorrect data. The synthesis across three years of filings is attempted and cited properly, but the factual foundation is flawed. (4) Contextual relevance is high—the answer addresses the debt trend and strategic implications directly. However, due to the major numerical error in the 2023 principal amount and the resulting mischaracterization of the trend (sharp drop then stabilization vs. consistent annual decline), the correctness score is limited to 5. The qualitative reasoning is reasonable but built on faulty data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 407,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "NVIDIA’s 3.50 % senior notes due 2040 were disclosed at a Level 2 fair‑value of **$891 million in FY 2022**, **$870 million in FY 2023**, and **$851 million in FY 2024**, while the notes remain recorded on the balance sheet at their original issuance amount, net of unamortized discount and issuance costs (Level 2 liability)【NVDA_10k_2022.pdf: pages 78‑82】【NVDA_10k_2023.pdf: pages 65‑69】【NVDA_10k_2024.pdf: pages 70‑74】.  \nThe modest, steady decline in fair value alongside unchanged accounting treatment shows NVIDIA’s strategy of retaining long‑dated, low‑coupon debt to lock in cheap financing and manage interest‑rate risk over the long term.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported fair values of NVIDIA's 3.50% Notes Due 2040. According to the ground truth, the fair value was $1,066 million in FY2022, $851 million in FY2023, and $1,000 million in FY2024. However, the LLM reports $891M (FY2022), $870M (FY2023), and $851M (FY2024), which are incorrect for all years except FY2023 (where it matches the ground truth for FY2023). The FY2024 value is particularly wrong—the LLM states $851M, but the correct value is $1,000M. Additionally, the LLM omits the effective interest rate of 3.54% in FY2024, which is a key detail in the original answer. (2) The quantitative inaccuracies are severe: the FY2022 value is off by $175 million, and the FY2024 value is off by $149 million. The trend described—'modest, steady decline'—is incorrect because the actual trajectory shows a drop from 2022 to 2023 but then a rebound to $1,000M in 2024, indicating stabilization, not continued decline. This misrepresents the financial trend. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that maintaining long-term debt reflects a strategy of securing low-cost financing. However, due to incorrect data, the conclusion about a 'steady decline' is flawed. The correct trajectory (drop then stabilization) supports a different interpretation: active management of debt valuation amid market conditions, not passive retention. (4) Scores reflect: low quantitative accuracy due to major number errors; moderate qualitative accuracy because reasoning structure is logical but based on wrong data; high contextual relevance as the answer addresses the right documents, metric, and strategic interpretation framework, despite factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 476,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "- 2022 – Netflix launched a lower‑priced ad‑supported subscription and began adding mobile games to its catalog; the 2022 risk factor warned that if members did not value the new games or the ad‑supported pricing model, it could hurt both new‑member acquisition and existing‑member retention.  \n\n- 2023 – Netflix expanded the same strategy by introducing live programming on top of its games offering and continued to tweak pricing and plan structures, with the 2023 risk disclosure cautioning that any poor reception of games, live content or price changes could impair its ability to attract and keep members.  \n\n- 2024 – Netflix further scaled the ad‑supported tier, broadened its gaming and live‑programming slate, and signaled ongoing price adjustments, and the 2024 risk narrative again noted that if these new features or pricing moves are not well‑received, member growth could stall and churn could rise.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the sequencing and attribution of strategic initiatives across years, despite using semantically plausible language and maintaining contextual relevance. (1) In 2022, Netflix only introduced games — not an ad-supported tier, which was launched in 2023. The LLM incorrectly states that both the ad-supported tier and games were introduced in 2022, reversing the correct timeline. (2) Live programming was introduced in 2024, not in 2023 as claimed; the LLM incorrectly assigns live programming to 2023. (3) The 2023 risk disclosure correctly references pricing and feature changes, but the LLM misattributes live programming to that year, which was not part of the 2023 strategy. (4) The 2024 description is mostly accurate in direction — scaling ad-supported tier, expanding games and live programming, ongoing price adjustments — and the associated risk is correctly framed. However, the misplacement of key initiatives across years breaks the multi-hop reasoning required to accurately trace the evolution year-by-year. (5) Quantitatively, there are no numeric values to verify (dates are used but incorrectly applied), so quantitative accuracy is scored highly as no numbers are wrong per se, only misattributed in context. (6) The qualitative reasoning fails because the model conflates the rollout sequence, undermining the core of the multi-year evolution analysis. While the risk themes around member acquisition and retention are consistently and correctly echoed across years, the incorrect alignment of features to years results in a partially correct answer with major factual omissions and misstatements. Hence, correctness is penalized significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 467,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth’s venture‑investment exposure grew markedly after 2022. The company’s equity‑securities portfolio – which is dominated by venture stakes – rose from $3.7 billion at 12/31/2022 to $4.9 billion at 12/31/2023 and held steady at $4.9 billion in 2024 (UNH 2023 10‑K, p. 48‑49; UNH 2024 10‑K, p. 50‑51). At the same time, equity‑method investments in operating health‑care businesses fell slightly from $1.5 billion in 2022 to $1.4 billion in 2023, then surged to $3.8 billion in 2024 (UNH 2023 10‑K, p. 50‑51; UNH 2024 10‑K, p. 52‑53). This pattern shows UnitedHealth first expanded its venture portfolio, then maintained that level while dramatically increasing its direct ownership in health‑care operators, signaling a strategic shift toward deeper, integrated positioning in the sector.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy in the equity-method investment value for 2022. The ground truth states $1.3 billion in 2022, while the LLM claims $1.5 billion, which is incorrect. All other numbers are accurate: equity securities correctly reported as $3.7B (2022), $4.9B (2023), and steady in 2024; equity-method investments correctly noted as $1.4B in 2023 and $3.8B in 2024. (2) Calculations and trends are sound—LLM correctly identifies the increase in equity securities and the sharp rise in equity-method investments in 2024. The only numerical error is the 2022 equity-method figure, which affects quantitative accuracy slightly. (3) Multi-hop reasoning is strong: the LLM synthesizes data across 2022–2024, distinguishes between equity securities and equity-method investments, and draws a logical strategic conclusion about UnitedHealth’s shift toward deeper integration in healthcare. The reasoning aligns with the ground truth, despite the minor data discrepancy. (4) Contextual relevance is perfect—the answer directly addresses the evolution of investment exposure and infers strategic positioning accurately. The incorrect 2022 equity-method value prevents a top score in correctness and quantitative accuracy, but qualitative reasoning and overall message remain robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 374,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "Nike’s relationship with Sojitz America stayed essentially unchanged from FY 2022 through FY 2024.  Sojitz America remained the sole holder of Nike’s $0.3 million of redeemable preferred stock, with the same $0.10‑per‑share cumulative dividend payable each May 31 and no new issuances or alterations to the preferred‑stock terms in any of the three years (2022 Note 10; 2024 Note 8).  The Japanese trading firm continued to provide import‑export financing services for Nike and retained limited voting rights on major corporate actions (sale of assets, merger, trademark assignment), underscoring a stable financial and strategic partnership throughout the period (2024 p. 4).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the $0.3 million par value of redeemable preferred stock, the $0.10 per share cumulative dividend, and the consistent ownership by Sojitz America across fiscal years 2022–2024 are all correctly reported, with acceptable citation formats (e.g., '2022 Note 10', '2024 Note 8'). These match the ground truth exactly, warranting a perfect quantitative accuracy score. The entity (Sojitz America), metric (preferred stock, dividend), and time period (FY2022–FY2024) are correctly identified, supporting high contextual relevance. However, the qualitative accuracy is lower because the LLM fails to capture the key evolution highlighted in the original answer: the shift in narrative from a primarily financial relationship in 2022–2023 to a more strategically emphasized operational role in 2024, particularly regarding import-export financing amid rising trade risks. While the LLM mentions that Sojitz provides import-export financing and has limited voting rights, it frames the relationship as 'essentially unchanged' and 'stable,' which contradicts the ground truth's emphasis on a strategic evolution in 2024. This misrepresents the multi-hop synthesis required—linking unchanged financial terms with an evolving strategic context. Thus, while core facts are correct, the reasoning and interpretation of the relationship’s evolution are incomplete, leading to a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 400,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "NVIDIA’s 3.50 % Notes due 2050 were carried at $1.637 billion at the end of FY 2022【NVDA_10k_2022.pdf p.78】, remained $1.637 billion at the end of FY 2023【NVDA_10k_2024.pdf p.70】, and fell to $1.604 billion at the end of FY 2024【NVDA_10k_2024.pdf p.70】. The stable level through 2023 followed by a modest decline in 2024 indicates NVIDIA is only slightly reducing this long‑dated, low‑interest debt, maintaining a substantial long‑term financing base while beginning a gradual deleveraging.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported carrying values and trends. According to the ground truth, the carrying value was $2,147 million in fiscal 2022, decreased to $1,604 million in 2023, then increased to $2,000 million in 2024. However, the LLM claims it was $1.637 billion in both 2022 and 2023, then $1.604 billion in 2024—this misrepresents both the starting value and the trend. The correct trend is a decrease followed by a significant increase, whereas the LLM describes stability and a slight decline. (2) The numbers are quantitatively inaccurate: $1.637 billion (i.e., $1,637 million) in 2022 contradicts the true value of $2,147 million—a difference of over $500 million. The 2023 value is also wrong ($1,637M vs. correct $1,604M), and the 2024 value is incorrectly reported as a decrease to $1.604M instead of an increase to $2,000M. These are not minor rounding differences but material misstatements. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize data across the three fiscal years, likely due to incorrect extraction from source documents. It draws an incorrect conclusion about 'stable' debt levels and 'gradual deleveraging,' which contradicts the ground truth indicating a temporary reduction followed by strategic repositioning to increase long-term debt. (4) Contextual relevance is moderate—the answer addresses the right metric (carrying value of 3.50% Notes Due 2050) and attempts to interpret the trend in terms of long-term debt positioning—but the incorrect data renders the analysis invalid. Due to major factual and quantitative errors, the correctness score is low despite relevant structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 465,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s short‑term funding rose sharply after a modest dip: short‑term debt (including commercial paper) was $175 million at year‑end 2022, fell to $119 million in 2023, then jumped to $465 million in 2024 [MET_10k_2023.pdf p.111; MET_10k_2024.pdf p.101]. Throughout 2022‑2024 the company emphasized that its liquidity and capital come from a broad mix of global sources—preferred and common equity, short‑ and long‑term debt, collateral‑financing arrangements, PABs, credit facilities and a shelf registration—which it says “enhances our funding flexibility, limits dependence on any one market or source of funds and generally lowers the cost of funds” [MET_10k_2022.pdf p.125; MET_10k_2023.pdf p.109; MET_10k_2024.pdf p.99].",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values for short-term debt ($175M in 2022, $119M in 2023, $465M in 2024) that are not present in the original ground truth answer. There is no mention of these figures in the provided ground truth, which focuses on qualitative strategy rather than quantitative trends. Without confirmation from the knowledge graph that these numbers are accurate, their inclusion constitutes a significant factual risk. Since the evaluation must be based on alignment with the ground truth (not external data), introducing unverified figures severely undermines correctness. (2) The calculation of a 'sharp rise' after a dip relies on these numbers, but the ground truth states there were 'no major structural changes' and emphasizes consistency, contradicting the narrative of volatility. Thus, the quantitative claims are inconsistent with the ground truth's characterization. (3) Qualitatively, the LLM correctly identifies MetLife’s strategy of using diverse funding sources—including commercial paper, credit facilities, equity, and other instruments—to enhance flexibility and lower funding costs. It accurately reflects the multi-year emphasis on reducing dependence on any single market, which aligns with the original answer’s core message. The citations suggest proper sourcing from 10-Ks across all years, indicating sound multi-hop synthesis across documents. (4) Contextually, the answer addresses the key aspects of the question: evolution over time, use of short-term debt, and reliance on diverse sources to lower cost of capital. However, the incorrect numerical claims distort the overall picture, especially the implied volatility in short-term debt usage, which the ground truth explicitly refutes by stating the structure remained stable. Therefore, while the strategic framing is correct, the fabricated numbers lead to a low correctness and quantitative accuracy score despite strong contextual and partial qualitative alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 537,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth’s contract‑level risk from service‑level guarantees stayed negligible – the filing notes that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31, 2024, 2023 or 2022” (Note 4, 2024 10‑K) – so the company’s exposure to such guarantees did not change. At the same time, its financing with subsidiaries shifted dramatically: the current portion of notes payable to subsidiaries rose from $8.7 billion in 2022 to $9.9 billion in 2023, then fell to $2.0 billion in 2024, while long‑term notes payable to subsidiaries, previously undisclosed, grew to $14.4 billion by year‑end 2024 (balance‑sheet data). This indicates UnitedHealth moved liquidity commitments from short‑term, on‑demand borrowings toward larger, longer‑term obligations, reducing short‑term contractual risk while increasing a stable, long‑term funding commitment to its subsidiaries.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend in notes payable to subsidiaries and correctly identifies that service-level guarantees were consistently immaterial. However, there are significant quantitative inaccuracies: the original answer states total notes payable to subsidiaries were $8.1B in 2022, but the LLM claims $8.7B for the 'current portion' alone, which contradicts the ground truth that does not break down current vs. long-term in prior years. Additionally, the LLM introduces a 'long-term notes payable to subsidiaries' of $14.4B by 2024, which is not mentioned in the original answer—only a drop to $2.0B total in 2024 is reported. This suggests a misinterpretation of the balance sheet structure or conflation with another line item. The original answer shows a sharp decline to $2.0B in 2024, implying a net reduction, while the LLM implies a restructuring into long-term debt without evidence from the ground truth. The reasoning about shifting from short-term to long-term obligations is speculative and not supported by the original data. While the qualitative point about stable risk from service-level guarantees is correct and well-sourced, the financial narrative around internal debt evolution is partially fabricated. The answer is contextually relevant and addresses both parts of the multi-hop question (service guarantees and liquidity commitments), but the quantitative errors undermine the correctness of the synthesis. Semantic equivalence fails on the key financial figures, and the model adds details (current vs. long-term breakdown, $14.4B long-term) absent in the source, indicating overinference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 444,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From 2022 through 2024 American Express has remained the fourth‑largest general‑purpose card network behind China UnionPay, Visa and Mastercard, but competition has sharpened as legacy networks and fast‑growing digital platforms such as Alipay, PayPal and Venmo vie for merchants and high‑spending card‑holder relationships. At the same time, regulators have intensified scrutiny of network‑related practices—interchange‑fee caps, non‑discrimination and “honor‑all‑cards” rules—and the company has responded by exiting its network‑licensing businesses in the EU and Australia, strengthening its compliance framework, and in 2024 accepting a Category III regulatory classification that subjects it to heightened supervisory expectations, reflecting an increasing regulatory dependency on its card‑network operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All key facts are correct: American Express remained the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard from 2022–2024; competition intensified from both traditional networks and digital platforms like Alipay, PayPal, and Venmo; regulatory scrutiny increased over interchange fees, network routing, and related practices; Amex exited its network licensing businesses in the EU and Australia; and in 2024, it became a Category III firm under U.S. federal regulation. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but all dates (2022–2024) and categorical designations (Category III) are accurate. (3) The multi-hop reasoning is sound—correctly synthesizing competitive dynamics, regulatory developments, and strategic responses across years and jurisdictions. The answer captures the evolution from competitive differentiation to regulatory dependency, though it slightly condenses the nuance in the original about regional systems like NPCI. (4) The LLM omits minor contextual details (e.g., mention of National Payments Corporation of India) and does not explicitly frame the shift as a transformation from 'market-driven competition to regulatory navigation' using those exact terms, but the core meaning and factual trajectory are preserved. Wording differences are acceptable under semantic equivalence. No factual errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 413,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "ConocoPhillips’ cash‑settled PSUs have not changed in how they treat dividend equivalents for performance periods that start in 2018 or later – the awards provide an **accrued reinvested dividend equivalent that is charged to compensation expense and paid only at settlement** (2022 10‑K pp. 136‑138; 2023 10‑K pp. 122‑124; 2024 10‑K pp. 124‑126). By keeping this dividend‑equivalent mechanism consistent, the company signals that it wants executive rewards to track shareholder dividend returns while deferring the cash outflow until the performance award is settled, reinforcing a long‑term incentive framework that aligns management interests with sustained shareholder value.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key feature of ConocoPhillips' dividend equivalent structure for performance periods beginning in 2018 or later — that recipients receive accrued reinvested dividends paid at settlement, with compensation expense recognized over time. This aligns with the ground truth and is consistently reported across the 2022–2024 10-Ks. The dates (2018 onward) and treatment (accrued reinvestment, paid at settlement) are factually accurate. (2) Quantitatively, there are no numbers, percentages, or dollar amounts in dispute; the answer avoids making up figures and accurately references the timing threshold (2018), which matches the ground truth. Thus, quantitative accuracy is perfect. (3) However, the LLM answer fails to mention the contrast with pre-2018 awards — specifically, that no dividend equivalents were paid during the performance period and payments only began after its conclusion. This comparative evolution is a core part of the question and the ground truth, and its omission represents a significant gap in multi-hop reasoning. The answer implies consistency since 2018 but does not acknowledge the policy shift that occurred in 2018, thus missing the 'evolution' aspect from 2022 to 2024 in historical context. (4) Despite this, the answer correctly infers the strategic rationale — long-term alignment, deferral of cash outflows, tracking shareholder returns — which is semantically aligned with the ground truth’s conclusion. Contextual relevance is high as it directly addresses the incentive alignment implications. Due to the missing pre-2018 comparison, the qualitative accuracy and overall correctness are reduced, but not severely, as the core mechanism and its implications are correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 482,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "NextEra’s Special Use Funds rose from roughly $8.7 billion in 2022 (and stayed at that level in 2023) to about $9.8 billion in 2024【NEE_10k_2023.pdf p.84‑88】【NEE_10k_2024.pdf p.62‑66】, while the cash and letters‑of‑credit posted as derivative collateral fell from about $4.6 billion in 2022 to $2.3 billion in 2023【NEE_10k_2024.pdf p.62‑66】. The larger SUF pool and the decline in posted collateral give NextEra a stronger liquidity cushion, comfortably covering its current derivative‑related collateral postings and the $510 million‑$2.4 billion of additional collateral that could be required under rating‑downgrade scenarios【NEE_10k_2024.pdf p.62‑66】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers. According to the ground truth, Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, but the LLM incorrectly states that the amount was $8.7 billion in 2022 and 'stayed at that level in 2023', which contradicts the ground truth that does not provide a 2022 figure and explicitly shows a 2023 value of $8,698 million. More critically, the LLM claims that 'cash and letters-of-credit posted as derivative collateral fell from about $4.6 billion in 2022 to $2.3 billion in 2023' — this is incorrect. The ground truth states that actual cash collateral posted increased from $84 million in 2022 to $691 million in 2023. The $2.4 billion figure in the ground truth refers to potential collateral required upon a downgrade (not actual posted collateral), which the LLM conflates. The LLM also introduces a range of '$510 million-$2.4 billion' in additional collateral, which is not in the original answer and misrepresents the $2.7 billion figure from 2022 and $2.4 billion in 2023 as downgrade-triggered obligations. (2) Calculations and comparisons are flawed: the LLM implies a decline in actual collateral posted, when in fact it increased significantly. It also mischaracterizes the $2.4 billion as both a posted amount and a potential obligation. (3) Multi-hop reasoning is partially sound — the model attempts to link Special Use Funds growth with collateral obligations and liquidity positioning — but fails due to incorrect data synthesis. It correctly identifies the strategic implication of stronger liquidity but bases it on false premises. (4) Scores reflect that while the answer addresses the right topic and draws a plausible conclusion about improved liquidity, it is undermined by major quantitative errors and misinterpretation of derivative collateral disclosures, leading to a partially correct but factually unreliable response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 528,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower’s 1.600 % senior notes were issued for $700 million and have been amortized in a front‑loaded fashion – $3.7 million in 2022, $2.6 million in 2023 and $1.5 million in 2024 – leaving roughly $696.3 million, $693.7 million and $692.2 million of principal outstanding at the end of each year respectively【AMT_10k_2023.pdf p.108‑112】【AMT_10k_2024.pdf p.111‑115】. The shrinking annual amortization suggests a deliberate strategy to gradually retire this low‑cost, long‑dated debt while preserving liquidity for other corporate needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that the outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across 2022, 2023, and 2024. However, the LLM claims the principal decreased each year — to $696.3M, $693.7M, and $692.2M — implying amortization of principal, which contradicts the original data. Additionally, the LLM states amortization amounts of $3.7M (2022), $2.6M (2023), and $1.5M (2024), but the ground truth only reports adjustments to principal (possibly accrued interest or other non-principal amortization) of (3.7)M in 2022 and (2.6)M in 2024 — with no data point for 2023 or $1.5M in 2024. The LLM fabricates a value for 2024 and misrepresents the nature of the adjustment as principal amortization. (2) Calculations are therefore incorrect: subtracting $3.7M from $700M gives $696.3M (correct arithmetic), but this does not reflect reality since no principal reduction occurred. The pattern of decreasing amortization is also misrepresented — the ground truth shows only two data points with a decline, but not the consistent front-loaded schedule claimed. (3) Multi-hop reasoning fails: the LLM incorrectly infers a principal amortization schedule from what the ground truth describes as stable principal with declining adjustments (possibly interest-related), leading to a flawed interpretation of debt management strategy. The conclusion about 'gradually retiring' the debt is unsupported, as the principal did not decrease. (4) Scores reflect major factual and quantitative errors (correctness: 2), very poor number accuracy (quantitative: 2), flawed reasoning and entity interpretation (qualitative: 3), though the response is on-topic and attempts to address debt strategy (contextual relevance: 6).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 493,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth’s 2022 10‑K warned that CMS could change the methodology for Medicare Advantage risk‑adjustment payments, creating a potential revenue‑risk exposure. By the 2023 filing the company said it was already mitigating that exposure by selectively adjusting members’ benefits and premiums, withdrawing plans from certain counties and intensifying both medical‑ and operating‑cost management, and the 2024 filing reiterated the same regulatory risk while confirming those cost‑control and selective‑plan actions—along with a heightened focus on risk‑adjustment data validation—remain in place.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor omissions in descriptive detail. (1) All key facts are correct: UnitedHealth Group (UNH) faced ongoing exposure to CMS changes in Medicare Advantage risk adjustment payments from 2022 to 2024, and responded with strategic adjustments. The years (2022, 2023, 2024), entities (UnitedHealth, CMS), and regulatory context are accurately identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracing the evolution of risk exposure and response strategies. It captures the core actions: adjusting benefits and premiums, exiting counties, cost management, and adding risk-adjustment data validation in 2024. The only minor gap is that the original answer notes CMS made 'changes each year'—specifically in 2022, 2023, and 2024—while the LLM implies the risk was anticipated in 2022 and then mitigated in 2023–2024, slightly understating the annual active recalibration by CMS. However, this does not distort the overall correctness. (4) The LLM answer is highly contextually relevant, directly addressing both parts of the question: evolution of exposure and strategic responses. Wording differs but meaning aligns closely with the original. The addition of 'risk-adjustment data validation' in 2024 is a specific detail consistent with intensified controls in the ground truth. Final scores reflect high accuracy with a 9 on correctness and qualitative accuracy due to slight compression of CMS's annual actions, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 480,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Target’s employee merchandise discount has remained a steady element of its benefits package, described each year simply as “merchandise and other discounts” in the Compensation and Benefits section of the 2022 Form 10‑K (p. 6), the 2023 Form 10‑K (p. 6) and the 2024 Form 10‑K (p. 6). While the discount language itself did not change, the surrounding benefits expanded—2023 and 2024 added a $15‑$24 hourly wage range, sick‑pay and broader health and financial perks—showing that Target is preserving a consistent employee discount while strengthening overall compensation to support team‑member financial well‑being.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: merchandise discounts were consistently mentioned in the Compensation and Benefits section of Target’s 10-K filings from 2022 to 2024, and the starting wage range of $15–$24 per hour in 2023 and 2024 is correctly reported. The inclusion of sick pay and expanded health/financial perks is also accurate. (2) Quantitative accuracy is perfect: dollar amounts and years match the original answer, with no calculation errors. (3) The multi-hop reasoning is sound—LLM correctly infers that while the discount language remained unchanged, the broader benefits context evolved, indicating a strategic enhancement in employee financial well-being. It synthesizes information across three years of filings and connects wage increases and new benefits to a larger support strategy. (4) The only minor omission is that the 2024 framing around 'equitable pay and belonging' and 'free virtual healthcare and expanded mental health services' is not explicitly mentioned, which slightly reduces completeness in conveying the full evolution of narrative emphasis. However, the core progression and strategic implication are accurately captured. Thus, the answer is semantically equivalent in intent and fact, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 372,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio remained modest and essentially unchanged over the three‑year span – the fair‑value balance was about $630 million each year (2022 – 2024) and, as shown in Note 4 of the 2022 10‑K (pp. 119‑123), 2023 10‑K (pp. 133‑137) and 2024 10‑K (pp. 175‑179), more than 98 % of the holdings were due within one year with only $1‑$2 million in the 1‑5‑year and 5‑10‑year buckets.  The weighted‑average yields were low – roughly 1.7 % for the short‑term slice and under 5 % for any longer‑dated exposure – indicating a conservative risk appetite and a strategic emphasis on high‑quality, short‑duration, liquid assets in its investment‑security mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that American Express's foreign government bond portfolio had 'more than 98% of the holdings due within one year' and only $1–2 million in longer-term buckets, which contradicts the ground truth showing meaningful allocations to bonds due after one but within five years and actual yield data for those categories. The LLM also states yields were 'roughly 1.7%' for short-term and 'under 5%' for longer-dated, which misrepresents the dynamic evolution: in 2023, short-term yield was 6.45% and 1–5 year was 4.48%, and in 2024, long-term yield dropped to 2.03%. These are not minor discrepancies but fundamental errors in both magnitude and trend. (2) Quantitative accuracy is very low: the LLM fails to report the correct yields for 2023 and 2024, omits the sharp rise and subsequent drop in yields, and incorrectly characterizes maturity distribution. While the $630 million balance is correctly noted, the rest of the numbers are either vague ('roughly 1.7%') or false. (3) The multi-hop reasoning is flawed: the question asks how the investment evolved over three years in terms of yield and maturity distribution, requiring synthesis across three annual reports. The LLM instead asserts no change and a static conservative strategy, missing the key shift to higher yields in 2023 and pullback in 2024. This leads to an incorrect conclusion about 'conservative risk appetite' when the ground truth suggests a dynamic, market-responsive strategy. (4) Contextual relevance is moderate because the answer addresses the right company, time frame, and asset class, and cites correct document locations (Note 4 of 10-Ks), but fails to extract or report the actual data. The conclusion about liquidity and quality is plausible but unsupported by the presented evidence and contradicted by the real yield volatility. Overall, the answer is factually incorrect on key metrics and reasoning, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 539,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements (recorded in “Other assets, including intangibles – net”) fell sharply: $1.494 billion at 12/31/2022, $800 million at 12/31/2023, and $491 million at 12/31/2024【XOM_10k_2023.pdf pages 100‑101】【XOM_10k_2024.pdf pages 97‑98】. The consistent decline suggests the company is reducing the amount of collateral needed for its derivative positions—likely through tighter netting, lower margin requirements or a smaller net derivative exposure—indicating more efficient management of its derivative risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,494 million (or $1.494 billion) in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly with acceptable format variation (e.g., $1.494 billion = $1,494 million). (2) All calculations and trends are accurately described—the consistent decline over the three years is correctly identified. (3) The multi-hop reasoning is sound: the answer synthesizes data across two 10-K filings (2023 and 2024) and correctly attributes the collateral amounts to the appropriate line item ('Other assets, including intangibles - net') and time periods. (4) The qualitative interpretation aligns with and expands upon the ground truth: while the original answer states the trend suggests a strategic reduction in derivative exposure or shift in risk management, the LLM provides plausible mechanisms (tighter netting, lower margin requirements, smaller net exposure) that are consistent with industry practices and represent a reasonable, more detailed inference. The answer fully addresses both parts of the question—quantitative change and its implication for derivative exposure management—demonstrating high factual accuracy, completeness, and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 354,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "AMT first issued $700 million of 2.700 % senior unsecured notes on March 29 2021, with interest payable on April 15 and October 15 and a par‑call on Jan 15 2031 (2022 filing)【AMT_10k_2022.pdf, p. 46】. The 2023 filing shows the outstanding principal had risen to $750 million – a $50 million reopening at the same 2.700 % rate – while the 2024 filing reports the balance back at $700 million, indicating the extra amount was repaid or refinanced, with the rate and payment schedule unchanged throughout (2023 filing)【AMT_10k_2023.pdf, p. 109】; (2024 filing)【AMT_10k_2024.pdf, p. 112】. This pattern reveals that AMT used the 2.700 % series as a low‑cost, flexible financing tool, tapping the market for cheap debt when conditions allowed and then retiring the additional issuance as it shifted to higher‑yielding notes, reflecting a strategy of cost‑effective funding amid evolving market demand.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the aggregate principal amount of the 2.700% Notes remained consistently at $700.0 million across 2022, 2023, and 2024. However, the LLM incorrectly states that the outstanding principal rose to $750 million in 2023 and then dropped back to $700 million in 2024, which is not supported by the original data. This misrepresents a key quantitative fact. Additionally, the maturity date is inaccurately described: the ground truth states the maturity date is January 15, 2031 (consistent across years), while the LLM cites April 15 and October 15 as interest payment dates (which may be correct) but incorrectly references a par-call date of January 15, 2031 as a maturity in the 2022 context. (2) The interest rate spread decrease from (5.0) to (4.4) in 2024 — a key detail in the ground truth indicating reduced borrowing costs — is entirely omitted. Instead, the LLM fabricates a narrative about issuing and repaying an additional $50 million, which is not present in the original answer. (3) The multi-hop reasoning is flawed: the model infers strategic reopening and refinancing activity without evidence from the ground truth, which shows stable principal and terms. The conclusion about shifting to higher-yielding notes is unsupported. (4) While the LLM attempts to interpret the company's financing strategy — showing contextual relevance — the reasoning is based on incorrect data, undermining qualitative and quantitative accuracy. The core facts (principal amount, maturity, interest spread trend) are wrong or missing, leading to a low correctness score despite some accurate elements like interest payment frequency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 471,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVIDIA’s liability for the 2.00 % Notes Due 2031 rose modestly each year – $1,030 million in 2022, $1,044 million in 2023, and $1,057 million in 2024【NVDA_10k_2022.pdf】【NVDA_10k_2023.pdf】【NVDA_10k_2024.pdf】. This gradual increase shows the company is slowly expanding its long‑term, low‑coupon debt pool, using inexpensive, long‑dated notes to fund growth while keeping overall debt costs and refinancing risk low.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values. According to the ground truth, the fair value was $1.2 billion in 2022, not $1.03 billion as stated. The 2023 values are partially correct: $1.044 billion at the beginning and $1.057 billion at year-end, but the LLM incorrectly presents $1.044 billion as the full-year 2023 value and $1.057 billion as the 2024 value. However, in 2024, the reported value is the carrying value of $1.25 billion (not $1.057 billion), which the LLM completely misses. (2) The numbers are inconsistent with the ground truth: $1,030M vs $1.2B in 2022 is a material understatement; $1.057B in 2024 is incorrect as that was the 2023 year-end fair value, not the 2024 carrying value. The LLM fails to distinguish between fair value and carrying value, which are distinct accounting concepts. (3) The multi-hop reasoning is flawed: the model incorrectly assumes a steady annual increase based on mismatched data points and misaligned years. It does not reflect the stability from 2023 to 2024 in fair value nor the jump to $1.25B carrying value in 2024. The conclusion about 'gradual increase' and 'expanding debt pool' is not supported by the actual data, which shows relative stability. (4) While the answer addresses the question's structure and attempts to interpret strategy, the factual foundation is weak, leading to an incorrect inference. Contextual relevance is high as it discusses the right notes and timeframe, but correctness is severely impacted by quantitative errors. Thus, correctness and quantitative accuracy are low; qualitative reasoning is partially sound but based on wrong data; relevance remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 463,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances were relatively small in the 2022 filing – the company disclosed about **$1.8 billion of deposit assets and $1.4 billion of deposit liabilities** (the same amounts reported for the two prior years)【MET_10k_2022.pdf†p214-L31】.  By year‑end 2023 those figures had jumped to **$5.1 billion of assets and $1.3 billion of liabilities**, and they eased slightly in 2024 to **$4.6 billion of assets and $1.2 billion of liabilities**【MET_10k_2024.pdf†p204-L24-L27】.  The sharp increase in 2023 reflects MetLife’s strategic use of a large modified‑coinsurance reinsurance transaction (e.g., with Global Atlantic) that it records under the deposit method to fund recoverables and offset risk, while the modest 2024 decline suggests a gradual unwinding as the arrangement matures.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a key factual error in the 2024 deposit assets: it reports $4.6 billion, while the ground truth states $5.1 billion. The 2022 and 2023 figures are accurate ($1.8B assets / $1.4B liabilities in 2022; $5.1B assets / $1.3B liabilities in 2023). However, the 2024 liability figure is correct at $1.2 billion. The LLM incorrectly suggests a decline from 2023 to 2024 in assets, whereas the ground truth shows assets remained at $5.1 billion—no decrease. 2) Quantitative accuracy is compromised due to this incorrect asset number. The calculation of trends is thus flawed: there is no 'modest 2024 decline' in assets as claimed. The $5.1B figure in both 2023 and 2024 indicates stability, not unwinding. 3) Qualitatively, the reasoning is sound—correctly identifying the Global Atlantic transaction as a driver for the 2023 increase and linking the deposit method to risk management. The interpretation of strategic reinsurance use aligns with the ground truth. 4) Contextual relevance is excellent: the response directly addresses the evolution of deposit assets/liabilities, ties in the accounting method, and infers strategic intent. Despite the numerical error in 2024 assets, the overall narrative is coherent and focused. The score is reduced primarily due to the incorrect asset value, which affects trend interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 379,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity (HTM) debt portfolio has been shrinking and its market value has been falling each year: at 12/31/2022 the HTM securities were carried at $696 million with a fair value of $679 million; at 12/31/2023 the carrying amount fell to $603 million and fair value to $596 million; and at 12/31/2024 they were carried at $512 million with a fair value of $508 million【UNH_10k_2023.pdf: page 53】【UNH_10k_2024.pdf: page 53】. The decreasing balances show the company is reducing the size of its HTM holdings, while the narrowing gap between fair and carrying values (‑$17 M → ‑$7 M → ‑$4 M) suggests UNH is managing the portfolio to limit unrealized losses and maintain a low‑risk, intent‑to‑hold investment strategy despite market‑driven valuation declines.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers for fair value and carrying value across 2022–2024 are accurate: 2022 ($679M fair, $696M carrying), 2023 ($596M, $603M), 2024 ($508M, $512M), with correct formatting and sourcing. (2) The answer addresses all parts of the question: it traces the evolution of both fair and carrying values over three years, notes the consistent decline, and interprets the trend in terms of investment strategy and market valuation. (3) Entity accuracy is perfect: UnitedHealth Group (UNH), 'Debt Securities - Held-to-Maturity', and correct fiscal years (12/31/2022 to 12/31/2024) are correctly identified. (4) The reasoning is sound and adds value beyond the ground truth by calculating the gap between fair and carrying values (-$17M, -$7M, -$4M) and interpreting the narrowing spread as evidence of risk management and intent-to-hold strategy, which is a logical and insightful extension consistent with accounting principles for HTM securities. This demonstrates strong multi-hop synthesis and contextual understanding. All elements are factually correct, complete, and semantically aligned with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 340,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "The Target‑branded credit‑card (RedCard) penetration fell from 20.5 % of purchases in fiscal 2022 to 19.8 % in fiscal 2023 and to 18.6 % in fiscal 2024【2023 Form 10‑K】. The steady decline indicates that a smaller share of guest spending is being funded with the Target card, suggesting the card program’s incremental‑sales boost is weakening even though it still represents a sizable portion of transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. All numeric values and trends are accurate. (2) Quantitative accuracy is perfect—percentages and their year-over-year decline are correctly stated with no calculation errors. Format variations (e.g., spacing in '20.5 %') do not affect meaning. (3) The reasoning correctly identifies the downward trend and its implication—that the card’s impact on incremental sales may be weakening. The LLM captures the core strategic concern, though it omits the explicit mention that Target still sees 'a meaningful portion of incremental purchases' contributing to sales, which slightly weakens the qualitative completeness. However, the phrase 'still represents a sizable portion of transactions' conveys a similar idea, preserving semantic equivalence. (4) Contextual relevance is high—the answer directly addresses both parts of the question: the evolution of penetration rate and its implication for Target's credit card strategy. The citation to the 2023 Form 10-K is appropriate for the 2022–2023 data, though 2024 data would come from a later filing (e.g., 2024 10-K), but this is a minor documentation point that does not undermine factual correctness. Overall, the answer is factually complete and well-reasoned, warranting a high score with only a slight deduction in qualitative accuracy for the softened treatment of Target's internal assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 414,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike’s Laakdal, Belgium distribution center was identified as one of its most significant non‑U.S. facilities and was explicitly described as **owned** in the FY 2022 filing (2022 10‑K, Item 2, p. 26). The FY 2023 filing repeats the same description (2023 10‑K, Item 2, p. 27), and the FY 2024 filing again confirms that the Laakdal site remains an owned, key European hub (2024 10‑K, Item 2, p. 25). This continuity of ownership shows Nike’s strategic emphasis on retaining direct control of a dedicated European logistics platform rather than leasing or outsourcing, underscoring its focus on strengthening NIKE Direct and wholesale supply‑chain capabilities in Europe.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns with the ground truth. (1) It accurately states that Nike owned the Laakdal, Belgium distribution facility throughout fiscal years 2022–2024, with consistent descriptions across all three 10-K filings. The characterization of the facility as one of Nike’s most significant non-U.S. (or international) distribution centers is correctly reported for each year. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the fiscal years (2022, 2023, 2024) and document references (Item 2, specific page numbers) are correctly cited, demonstrating precise sourcing. Format variations in year presentation (FY 2022 vs. 2022) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports, confirming no change in ownership or operational role over time. It correctly infers that the continuity reflects a strategic choice to maintain direct control over European logistics infrastructure. (4) The LLM adds contextual insight—linking the ownership model to NIKE Direct and wholesale supply chain capabilities—that is consistent with and expands upon the ground truth without introducing inaccuracies. All aspects of the question (evolution over time, ownership, operational footprint, strategic implications) are addressed with factual precision and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 393,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Lumentum Holdings is listed as a competitor in NVIDIA’s networking‑interconnect and optical‑module space in every filing – the FY 2022 competition section names “Lumentum Holdings” among interconnect/switch/cable providers, and the same bullet appears unchanged in the FY 2023 and FY 2024 competition tables【NVDA_10k_2022.pdf p.13‑17】【NVDA_10k_2023.pdf p.7‑11】【NVDA_10k_2024.pdf p.7‑11】. However, NVIDIA’s later 10‑Ks place far more emphasis on expanding a redundant, global supplier network and on a robust IP‑protection regime (see the expanded supplier‑relationship discussion and detailed patents/IP sections in FY 2024), indicating that while Lumentum remains a noted rival, NVIDIA’s broader supply‑chain diversification and tighter IP controls may lessen Lumentum’s relative competitive pressure compared with earlier years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entity accuracy, timeline, and context. It correctly identifies Lumentum Holdings as a consistent competitor of NVIDIA in the networking and interconnect space across fiscal years 2022, 2023, and 2024, citing the unchanged listing in NVIDIA’s 10-K filings. The citations to specific documents and page numbers suggest accurate sourcing. Quantitatively, there are no numerical claims requiring verification (e.g., financial figures, dates), so the score of 10 is justified as no inaccuracies exist. The qualitative reasoning is sound: the LLM correctly observes that while Lumentum remains a named competitor, NVIDIA has increasingly emphasized supply chain diversification and IP protection in later filings—particularly in FY2024—indicating a strategic shift that may affect competitive dynamics. However, the LLM slightly diverges from the original answer by implying that Lumentum’s 'relative competitive pressure' may have lessened due to NVIDIA’s strategies, whereas the ground truth emphasizes Lumentum’s 'persistent competitive force' and continued relevance despite those same strategies. This interpretive difference slightly weakens the multi-hop synthesis, as the original answer stresses continuity of competitive significance rather than diminished pressure. Still, the LLM captures the core evolution and strategic context, making the answer mostly accurate with only a minor deviation in emphasis. Contextual relevance is perfect—the response directly addresses the evolution of competitive positioning in relation to supply chain and IP strategies across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 454,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "Across the three filings Netflix repeatedly stresses that its library still hinges on obtaining distribution rights from studios and other rights‑holders, but the tone shifts. In the 2022 filing the company warns that studios launching their own services can withdraw titles and drive up licensing fees, prompting a focus on securing exclusive rights and original content; the 2023 filing repeats that risk while noting that “as competition increases, we see the cost of certain programming increase” and that it remains selective about titles; the 2024 filing adds that new regulatory pressures (content‑quota rules, levies and investment obligations) further complicate licensing and underscores an even stronger emphasis on original programming and exclusive deals to blunt that reliance. Together, the evolution shows Netflix is progressively hedging its dependence on external licensors by investing more in its own content and exclusive agreements as competition intensifies and regulators impose new constraints.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key points from the original answer are correctly reflected: Netflix's ongoing reliance on rights holders, the evolving risk due to competition (especially studios launching their own platforms), rising licensing costs, and the addition of regulatory pressures in 2024 such as content quotas and investment obligations. The strategic shift toward original and exclusive content is clearly and correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning across 2022–2024 filings is sound: the LLM correctly synthesizes how the framing of licensing risks evolved year-over-year, showing a progression from competitive threats to include regulatory constraints, and infers the strategic response (increased investment in original/exclusive content). (4) The LLM uses slightly different phrasing (e.g., 'hedging its dependence' vs. 'strategic shift') but conveys the same meaning. All entities—Netflix, studios, rights holders, regulatory changes—are accurately referenced. The answer fully addresses both parts of the question: evolution of reliance and what it reveals about strategy. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 380,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "In the 2022 10‑K Southern Company said its outdoor‑lighting arrangements were operating leases with initial terms of **up to seven years**, that the scheduled payments for those contracts were shown in the lease‑payment maturity tables, and that the cash‑flow amounts were **immaterial** for Georgia Power and Mississippi Power; the lease income from those contracts was kept separate from wholesale revenue.  \n\nIn the 2023 and 2024 filings the description was revised to **up to ten years** for the initial term, the immaterial‑ity comment remained unchanged, and the maturity analysis continued to list the scheduled payments (now explicitly noted as “initial‑term” payments) while the revenue from the contracts stayed classified as operating‑lease income, not included in wholesale revenues.  \n\nThus, from 2022‑2024 the materiality assessment and revenue classification stayed the same, but the contract‑term language was lengthened and the presentation of the scheduled payments was clarified to focus on the contracts’ initial terms.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies that significantly deviate from the ground truth. (1) Incorrectly states that in 2022, scheduled lease payments were included in the maturity tables; the original answer clarifies that in 2022, the undiscounted cash flows were considered immaterial—implying they were not meaningfully presented in maturity analyses. This is a critical factual error. (2) Claims the immateriality comment remained unchanged in 2023 and 2024, but the ground truth shows a shift: by 2023, payments were actively included in maturity analyses (alongside tolling and PPAs), indicating increased materiality or at least enhanced disclosure, contradicting the claim of unchanged immateriality. (3) States contract terms changed from 'up to seven years' to 'up to ten years'—this detail is absent from the original answer and introduces unsupported specifics. (4) While the LLM correctly notes revenue classification remained as operating lease income and separate from wholesale revenue, this is the only accurate element. (5) The reasoning fails on multi-hop synthesis: it misrepresents the evolution—ground truth shows a progression from immaterial (2022) to structured inclusion in maturity analyses (2023–2024), whereas LLM claims consistent immateriality and table inclusion since 2022. Quantitative accuracy is partially acceptable due to lack of numeric data, but unsupported timeframes reduce score. Qualitative accuracy is low due to flawed logic and incorrect entity-state mapping. Contextual relevance is high as the answer addresses the right topic areas (materiality, revenue classification, presentation), but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 453,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "AVGO’s 5.0 % senior notes due April 2030 carried an outstanding principal of **$1,000 million in FY 2022** (AVGO 10‑K 2022, p. 101‑105). The balance was **reduced to $606 million in FY 2023** (AVGO 10‑K 2023, p. 79‑83) and **remained at $606 million in FY 2024** (AVGO 10‑K 2024, p. 79‑83). The sharp drop between 2022 and 2023 shows AVGO actively repaid a large portion of this tranche to cut interest expense and leverage, and the flat balance thereafter suggests the company is now maintaining the remaining amount until its scheduled maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports the FY 2022 outstanding principal balance as $1,000 million, whereas the ground truth is $1,086 million. This $86 million discrepancy is notable but does not drastically alter the interpretation. The FY 2023 and FY 2024 balances ($606 million) are reported accurately. (2) Calculations and comparisons are logically sound—the sharp reduction from ~$1,000M to $606M aligns with the actual drop from $1,086M to $606M (a reduction of ~$480M), so the characterization of a 'sharp drop' and active repayment is valid. The flat balance in 2024 is correctly noted. (3) Multi-hop reasoning is strong: the model synthesizes data across three fiscal years from presumably different 10-K filings, correctly tracks the evolution of the debt instrument, and infers a plausible debt management strategy—active repayment in 2023 followed by stabilization. (4) The qualitative reasoning about reducing interest expense and leverage is a reasonable interpretation, slightly more specific than the ground truth’s suggestion of shifting capital allocation priorities, but not contradictory. Wording differs but semantic meaning is equivalent. The answer fully addresses both parts of the question: the evolution of the balance and the strategic implication. The only deduction is for the incorrect FY 2022 figure, hence a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 396,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "GM’s weighted‑average long‑term rate‑of‑return assumption for its U.S. pension plans was 6.3 % for both 2022 and 2023, then rose to 6.5 % for 2024 (GM_10k_2023.pdf pages 85‑89; GM_10k_2024.pdf pages 86‑90). The higher assumption coincides with a shift in the strategic asset mix—equity exposure grew from 8 % in 2022 to 11 % in 2023‑24 and the “Other” (private‑equity/real‑estate) share increased—indicating GM is tilting the pension portfolio toward higher‑return, higher‑risk assets to improve funded status and respond to market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported rate of return assumptions. According to the ground truth, the rate was 5.4% in 2022, 6.3% in 2023, and 6.5% in 2024, showing an increase over time. However, the LLM claims it was 6.3% in both 2022 and 2023, which contradicts the ground truth and misrepresents the trend. This error affects the entire quantitative trajectory and undermines the accuracy of the answer. (2) The calculation of the change over time is therefore incorrect: the actual increase is 1.1 percentage points from 5.4% to 6.5%, but the LLM implies only a 0.2 percentage point increase from a flat 6.3% to 6.5%. Additionally, the LLM introduces specific asset allocation figures (e.g., equity exposure increasing from 8% to 11%) that are not present in the original answer and cannot be verified against the ground truth, introducing unsupported details. (3) While the multi-hop reasoning about strategic asset mix shifting toward higher-risk, higher-return assets aligns with the ground truth's interpretation, the faulty input data weakens the logic. The conclusion is directionally plausible but based on incorrect premises. (4) Despite the factual inaccuracies, the answer is contextually relevant, addressing both parts of the question—evolution of return assumptions and strategic asset mix implications—and cites appropriate document sources. However, the core numerical inaccuracies severely reduce correctness, warranting a low score on quantitative accuracy and a moderate penalty on overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 430,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "American Tower’s 2.700 % Senior Notes due 2031 are listed in the supplemental‑indenture exhibits of each of its recent 10‑K reports – the March 29 2021 supplemental indenture that includes “the 1.600 % Senior Notes due 2026 and the 2.700 % Senior Notes due 2031” appears in the 2022 filing [AMT_10k_2022.pdf p.70‑71], the 2023 filing [AMT_10k_2023.pdf p.68‑70] and again in the 2024 filing [AMT_10k_2024.pdf p.70‑71]. The fact that these notes remain disclosed as outstanding in every filing shows that the company is retaining this low‑coupon, long‑dated debt rather than retiring or refinancing it, reflecting a financing strategy that emphasizes stable, low‑cost, long‑term capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core conclusion as the ground truth: American Tower's consistent treatment of the 2.700% Senior Notes due 2031 across its 2022–2024 filings reflects a stable, long-term financing strategy centered on retaining low-cost debt. (1) All factual elements are correct: the notes are referenced via the March 29, 2021 Supplemental Indenture No. 8 in each filing (2022, 2023, 2024), and the LLM correctly identifies the inclusion of both the 1.600% due 2026 and 2.700% due 2031 notes in that indenture. Page numbers cited (e.g., p.70–71) align across filings. (2) Quantitative accuracy is perfect: percentages (2.700%, 1.600%), dates (March 29, 2021), and maturities (2026, 2031) are all correct. (3) Multi-hop reasoning is sound—the model synthesizes data across three years of filings and correctly infers that the continued disclosure indicates no refinancing or modification, signaling strategic stability. (4) The only minor shortcoming is that the LLM does not explicitly name 'Supplemental Indenture No. 8' as the ground truth does, instead describing it by content and date. However, referencing the same document by its date and content constitutes acceptable semantic equivalence. The conclusion about low-cost, long-term capital is logically sound and contextually appropriate. Thus, the answer is factually complete and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 414,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "From 2022 to 2024 PayPal’s filings repeatedly warned that abusive behavior—fraudulent accounts, synthetic‑identity attacks and rising defaults on its consumer‑credit and merchant‑financing products—could lift loss rates, and that cross‑border trade, while higher‑margin, amplified those fraud and regulatory risks. To curb the exposure, PayPal first diversified its payment‑processor base and bolstered buyer‑seller protection (2022), then sold most of its U.K. and European BNPL loan receivables, pursued alternative third‑party funding and migrated away from a single U.S. processor (2023), and by 2024 had further invested in advanced fraud‑detection, enhanced credit‑risk models and tighter monitoring of cross‑border transactions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PayPal's exposure to abusive behaviors from 2022 to 2024 and the strategic actions taken. It accurately notes the increasing risk in credit products and cross-border transactions, and the company's response over time. The key factual point about the 2023 sale of U.K. and European BNPL loan receivables is present, though the exact €40 billion figure from the ground truth is omitted—this is a minor quantitative omission but does not distort the overall meaning. (2) Quantitatively, the LLM does not include the specific €40 billion amount mentioned in the original answer, which slightly reduces precision. However, no incorrect numbers are stated, and the years (2022, 2023, 2024) are correctly aligned with corresponding actions. The absence of a specific dollar/euro amount is the only quantitative shortcoming. (3) The multi-hop reasoning is sound: the LLM synthesizes risk identification (2022), strategic offloading of risk via receivables sale and processor diversification (2023), and enhanced detection and monitoring (2024). It correctly links abusive behaviors to credit products and cross-border transactions across the three years. The mention of third-party funding and processor migration aligns with the ground truth’s emphasis on third-party dependencies, though the reputational risk aspect is less explicitly stated. (4) The answer is contextually fully relevant, addressing all parts of the question—evolution of risk, relation to credit and cross-border activities, and mitigation strategies per year. The reasoning trajectory (identify → act → reinforce) mirrors the ground truth. The omission of the exact receivables sale value prevents a perfect score, but the core facts, timeline, and strategic logic are accurate and well-synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 496,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP’s pension plan allocation to Collective Trust and Other Funds dropped from **$622 million in 2022** to **$382 million in 2023** and then to **$370 million in 2024** (UNP 10‑K 2022 – Collective trust = 622; UNP 10‑K 2023 – Collective trust = 382; UNP 10‑K 2024 – Collective trust = 370). The steady decline signals a deliberate de‑risking of the pension portfolio, moving assets away from commingled fund vehicles toward a higher share of debt‑oriented, lower‑volatility investments to better support the company’s long‑term employee‑benefit strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, UNP's allocation was $756 million in 2022, but the LLM reports $622 million, which is incorrect. The 2023 value of $382 million matches the ground truth and is accurate. For 2024, the LLM claims a specific dollar amount of $370 million, but the original answer states that no updated dollar value is provided in the filings—instead, the focus shifted to NAV-based valuation. Thus, the $370 million figure is unsupported and false. (2) Calculations and comparisons are based on incorrect inputs: the claimed 'steady decline' from $622M to $382M to $370M is factually wrong because the starting point and endpoint are inaccurate. The actual drop from $756M to $382M is a much steeper decline (~49.5%), which the LLM underrepresents due to incorrect numbers. (3) The multi-hop reasoning is partially sound—the conclusion about de-risking aligns with the ground truth's interpretation—but it is based on fabricated data for 2024 and an incorrect 2022 baseline. The LLM incorrectly asserts a continued decline into 2024 with a precise number, whereas the ground truth emphasizes a shift in reporting methodology (NAV-based valuation), not a further reduction in allocation. (4) Contextual relevance is high because the answer addresses both parts of the question—trend over time and strategic implication—and attempts to synthesize across years. However, the use of incorrect figures and unsupported 2024 data undermines factual reliability. The qualitative reasoning about de-risking is consistent with the ground truth, but the lack of fidelity to actual numbers severely limits correctness. Minor note: ticker 'UNP' and metric 'Collective Trust and Other Funds' are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 492,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "Pfizer’s disclosures show that the BPA award continued to be valued at grant‑date intrinsic value (using the closing price of the common stock) and the cost was amortized on a straight‑line basis over the probable vesting term with periodic adjustments for share price, probability of achievement and vesting term – the same language appears in the BPA description in 2022 (p. 99), 2023 (p. 95) and 2024 (p. 94). After the 2021 grant year, the 2023 filing’s activity table for 2022 contains no BPA column (indicating no grants or outstanding awards in 2022) and the 2023 and 2024 filings explicitly state “No BPAs were granted … and no BPAs were outstanding as of December 31, 2023” and “…as of December 31, 2024” (2023 p. 95; 2024 p. 94), showing that grant activity ceased and the accounting treatment remained unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) Quantitative inaccuracy: The LLM claims no BPAs were granted or outstanding in 2022, directly contradicting the ground truth, which states that 1,165 thousand BPAs were issued in 2022 with 859 thousand outstanding at year-end. This is a critical error in both grant activity and outstanding status. (2) The LLM incorrectly asserts that the accounting treatment remained unchanged across all years, citing identical language in 2022–2024 filings. However, the ground truth shows a meaningful evolution: active grants and valuations in 2022, no outstanding awards in 2023 (indicating discontinuation or full resolution), and a new formalized methodology introduced in 2024. The LLM misinterprets the presence of similar disclosure language as unchanged treatment, failing to recognize that the 2024 methodology represents a structural shift despite similar phrasing. (3) Multi-hop reasoning is flawed: the model fails to synthesize the progression from active issuance (2022) to zero outstanding (2023) to a new framework (2024), instead concluding continuity. (4) The mention of page numbers and citation of filings adds apparent precision but does not compensate for factual inaccuracies. While the answer addresses the question's structure (grant activity, outstanding status, accounting), its core facts are inverted or incorrect. Semantic equivalence fails due to contradictory numerical and conceptual claims. Contextual relevance is moderate as it discusses the right topic and documents, but with incorrect conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 439,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements fell sharply over the three‑year span – $1.494 billion at 12/31/2022, $800 million at 12/31/2023, and $491 million at 12/31/2024【XOM_10k_2023.pdf:100‑101】【XOM_10k_2024.pdf:97‑98】.  The downward trajectory indicates that the firm’s net derivative exposure and the associated initial‑margin requirements have been decreasing, suggesting either lower derivative usage or more efficient netting and risk‑management that reduces the need for large collateral postings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all values are accurate: $1,494 million (or $1.494 billion) in 2022, $800 million in 2023, and $491 million in 2024 — format variations (billion vs million) are semantically equivalent and correctly represented. (2) The answer addresses both parts of the multi-part question: it details the change in collateral over time and interprets the trend regarding derivative exposure and margin requirements. (3) Entities are correct: ExxonMobil (XOM), the correct time periods (2022–2024), and the financial concept (collateral under master netting arrangements) are accurately identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the downward trend is correctly interpreted as indicating reduced derivative exposure or lower margin requirements, with plausible explanations such as decreased derivative usage or improved risk management. The inclusion of source citations further supports the validity of the data extraction. Overall, the answer is factually precise, complete, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 317,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Across the three 10‑K filings Broadcom’s industrial‑fiber‑optics story widens. In the 2022 filing (pages 8‑12) the product appears only as a discrete “industrial fiber optics” line‑item in the industrial family, with a brief note that it serves factory‑automation and automotive electronics. By 2023 (pages 3‑7) the filing groups it with optocouplers, sensors and motion‑encoders and explicitly calls out “factory automation, renewable energy and automotive electronics” as its target markets. In the 2024 filing (pages 3‑7) the narrative expands further, describing industrial fiber optics as part of a diversified industrial suite that spans industrial automation, power‑generation and distribution, medical, defense, aerospace and vehicle subsystems. This progression shows Broadcom deliberately broadening the scope of its industrial‑fiber‑optics portfolio to capture a wider set of high‑growth industrial applications, signaling a strategic focus on deepening its foothold in the industrial market.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the description of Broadcom's positioning of Industrial Fiber Optics across the years, despite correct entity identification (AVGO, Industrial Fiber Optics) and appropriate timeframes (2022–2024). (1) The evolution described is factually inverted: the LLM claims the scope 'widens' from 2022 to 2024, but the ground truth shows a move toward more structured, streamlined presentation—not expansion. In 2022, the application scope was already broad (including medical, defense, aerospace, automotive, etc.), while 2023 and 2024 actually reflect a narrowing and reorganization for clarity, emphasizing Factory Automation, Renewable Energy, and Automotive Electronics in a table format. (2) The LLM incorrectly states that the 2024 filing 'expands further' and includes 'power-generation and distribution, medical, defense, aerospace', which contradicts the ground truth: by 2024, while these areas may still be served, the presentation is more integrated and streamlined, not expanded. (3) Multi-hop reasoning is flawed—the model fails to correctly synthesize the directional shift in communication strategy: from broad listing (2022) to structured focus (2023) to integrated, solution-oriented framing (2024). Instead, it infers an incorrect trend of 'broadening'. (4) Quantitative accuracy is scored highly because there are no numerical claims to verify or falsify—dates and years are correct, and no financial figures are misstated. (5) Contextual relevance is moderate: the answer addresses the right company, product, and time periods, and attempts to infer strategic intent, but the conclusion about 'broadening' and 'high-growth applications' is based on incorrect factual premises. Thus, while the structure and intent of the response are relevant, the core factual trajectory is reversed, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 515,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "PayPal’s margin‑risk exposure has not changed – in each of the three filings the company says it is the **principal** on every payment, sets the fee **at its own discretion**, and therefore **bears full margin risk** even though the actual processing is performed by third‑party payment processors. The 2022 10‑K (Note 2‑Revenue, “We recognize fees…we therefore bear full margin risk…”) [pages 78‑82], the 2023 10‑K (same language in Note 2‑Revenue) [pages 75‑79], and the 2024 10‑K (identical disclosure in Note 2‑Revenue) [pages 73‑77] all repeat this description, showing that PayPal’s control over transaction pricing and its full‑margin‑risk profile have remained consistent from 2022 through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures the key factual points: PayPal bore full margin risk in 2022, 2023, and 2024; maintained discretion over pricing; used third-party processors; and recognized processor fees as transaction expenses. The narrative of consistency across years is correctly emphasized. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the years (2022–2024) and document references (10-K, Note 2-Revenue, page ranges) are correctly cited, with acceptable format variation in page numbers. (3) The multi-hop reasoning is sound—information is correctly synthesized across three annual filings (2022, 2023, 2024), and the conclusion of no material change in risk profile is logically supported by the repetition of identical disclosures. (4) The LLM uses slightly different wording (e.g., 'principal on every payment', 'at its own discretion') but conveys the same meaning as the original. All entities (PayPal, third-party processors, 10-K filings, Note 2) are correctly identified. The answer fully addresses the question’s focus on evolution (or lack thereof) in margin risk, pricing control, and third-party processor use. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 371,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "In the 2022 filing Pfizer disclosed that the December 31, 2021 sale of Meridian for about $51 million produced a $167 million after‑tax loss (including a $345 million pre‑tax legal charge) as a discontinued operation. By the 2023 filing the company had formalized a post‑sale framework—interim transition‑service agreements (completed by year‑end) and a three‑year manufacturing‑supply agreement with a two‑year extension—while the discontinued‑operations line turned modestly positive, and the 2024 filing contains no further Meridian‑related revenues, costs or contracts, indicating the divestiture is fully wound down and reflecting Pfizer’s long‑term strategy to exit peripheral businesses and concentrate on its core biopharma portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $51 million sale price and $167 million net loss from the 2021 sale of Meridian, consistent with the ground truth. It also accurately notes the three-year manufacturing supply agreement with a two-year extension option, which aligns with the contractual arrangements in 2023. However, it incorrectly states that the sale occurred on December 31, 2021, while the ground truth only confirms 'late 2021'—a minor but notable date inaccuracy. More significantly, the LLM claims that by 2024 there are 'no further Meridian-related revenues, costs or contracts,' which contradicts the ground truth stating that Meridian was still listed in Pfizer's 2024 glossary as 'Meridian Medical Technologies, Inc.,' indicating an ongoing formalized relationship. This omission misrepresents the evolution of the strategic positioning. (2) Quantitative elements (sale price, loss amount) are correct, though the mention of a '$345 million pre-tax legal charge' is not in the ground truth and introduces unverified detail, reducing quantitative reliability. (3) The multi-hop reasoning is partially sound—correctly linking the sale to discontinued operations and transition agreements—but fails in the final hop by concluding the relationship is fully wound down in 2024 when evidence suggests it persists in a reduced, formalized form. (4) The contextual relevance is high as the answer addresses financial impact, contractual terms, and strategic implications. However, due to the significant error in portraying the 2024 status and introducing unsupported details, the correctness and qualitative accuracy scores are reduced to 6 and 6 respectively. Quantitative accuracy is 7 due to mostly correct numbers but one unverified addition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 482,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "- In the 2022 10‑K (pages 13‑17) PMI warned that new product‑regulation could “commoditise” tobacco and “impede adult consumers’ ability to convert to our RRPs,” because rules that limit product differentiation and restrict truthful adult‑consumer communication about reduced‑risk products (RRPs) would erode its competitive edge.  \n\n- The 2023 filing (pages 18‑22) kept the same concern but expanded the language to note that such regulation “diminishes the ability to differentiate tobacco products, restricts adult consumer access to truthful and non‑misleading information about our RRPs, **or disproportionately impacts the commercialization of our products relative to competitors**.”  \n\n- By the 2024 10‑K (pages 17‑21) the discussion shifted to “SFPs” (smoke‑free products) while still stressing that “product regulation that diminishes the ability to differentiate tobacco products, restricts adult consumer access to truthful and non‑misleading information about our SFPs, **or disproportionately impacts the commercialization of our products in relation to our competitors**” continues to threaten PMI’s competitive positioning.  \n\nThus, from 2022 to 2024 the company’s view has evolved from a general warning about commoditisation and communication limits for RRPs to a more detailed, explicit risk that regulatory limits on differentiation and adult‑consumer messaging—now framed around SFPs—can disproportionately harm PMI’s market position versus rivals.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key points from the original answer are correctly reflected: the evolution of regulatory concerns from 2022 to 2024, the shift in terminology from RRPs to SFPs in 2024, and the increasing emphasis on disproportionate commercialization impacts relative to competitors. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings, identifies the evolving language and framing of regulatory risks, and draws a logical conclusion about the deepening regulatory challenge. (4) The answer is highly contextually relevant, directly addressing how product regulation has affected PMI’s competitive positioning over time, particularly regarding product differentiation and adult consumer communication. Minor wording differences (e.g., 'commoditise' vs. 'limit differentiation') do not affect meaning and are consistent with semantic equivalence. The inclusion of specific page numbers (13–17, 18–22, 17–21) adds precision and supports verifiability. Overall, the LLM answer matches the ground truth in all critical aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 374,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements fell sharply – from **$1.494 billion at 12/31/2022** to **$800 million at 12/31/2023** and then to **$491 million at 12/31/2024**, a total reduction of roughly **$1.0 billion**【XOM_10k_2023.pdf p. 100‑104】【XOM_10k_2024.pdf p. 97‑101】. This downward trend suggests the company is tightening its margin exposure and improving netting of its derivative positions, reflecting a more disciplined derivative‑risk‑management approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values: $1,494 million (2022), $800 million (2023), and $491 million (2024), matching the ground truth exactly, with acceptable formatting variations (e.g., $1.494 billion = $1,494 million). The total reduction of roughly $1.0 billion is accurate (1,494 - 491 = 1,003 million). (2) All calculations and time periods are correct, with proper fiscal year-end references (12/31/2022, etc.), and citations align with the source documents. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and two 10-K filings, correctly identifying the trend and linking it to derivative risk management. (4) The qualitative interpretation is largely consistent with the ground truth—'tightening margin exposure' and 'improving netting' align with 'strategic reduction in derivative exposure' and 'proactive risk mitigation.' The only minor difference is in phrasing: the LLM emphasizes 'disciplined approach' while the original highlights 'lower margin requirements or shift in practices,' but the semantic meaning is closely aligned. No entity errors—correct company (ExxonMobil/XOM), metric (collateral under master netting arrangements), and years. All parts of the question are addressed: the change over time and its implication for risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 371,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "In the 2022 filing Duke Energy’s TSR‑based performance‑award model used an expected volatility of 26.9% for the peer group; the 2023 filing raised that assumption to 28.6%, but the 2024 filing lowered it sharply to 18.7% (see the performance‑award sections of the 2022, 2023 and 2024 10‑Ks). The rise from 2022 to 2023 signals a perception of higher market risk, while the subsequent drop in 2024 suggests the company now views its stock’s relative volatility as much lower, indicating a more optimistic view of market risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three volatility values—26.9% in 2022, 28.6% in 2023, and 18.7% in 2024—matching the ground truth exactly. These numbers are critical and accurately cited. (2) The quantitative accuracy is perfect: all percentages and years are correct, and the directional changes (increase from 2022 to 2023, sharp drop in 2024) are properly described. No calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual filings (2022–2024), correctly identifies the trend, and infers the implication about market risk perception. It acknowledges the short-term increase and the significant 2024 decline, linking them logically to risk perception. (4) The only minor shortcoming is that the LLM answer does not explicitly note the 'notable decline over the three-year period' despite the 2023 uptick, which slightly weakens the synthesis compared to the original answer’s emphasis on the overall downward trend. However, the core reasoning and conclusion about reduced perceived risk by 2024 are valid and well-supported. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses both parts of the question: the evolution of volatility and its implication for market risk perception.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 367,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried a principal balance of **$495 million in FY 2022, FY 2023 and FY 2024**, with no change from one year to the next (AVGO_10k_2022.pdf p. 103; AVGO_10k_2023.pdf p. 81; AVGO_10k_2024.pdf p. 81).  The unchanged balance shows the company kept this low‑coupon, short‑term liability steady while using larger senior‑note issuances and term‑loan repayments in 2024 to refinance higher‑cost debt, indicating a strategy of preserving inexpensive short‑term financing and concentrating refinancing activity on other, longer‑dated obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal amount of $495 million and the note's coupon (3.125%) and maturity (January 2025), which aligns with the ground truth for fiscal years 2022 and 2023. However, it incorrectly states that the balance remained $495 million in FY 2024, whereas the ground truth indicates that by FY 2024, the note had transitioned into the current portion of long-term debt—implying it was reclassified as short-term debt due to impending maturity, even if the principal remained unchanged. This is a critical distinction in financial reporting and debt management analysis. (2) The numbers themselves ($495M) and years (2022–2024) are factually present in the filings, so quantitative accuracy is partially correct, but the interpretation of the FY2024 status is inaccurate. There are no calculation errors, but the failure to recognize the reclassification undermines the financial insight. (3) The multi-hop reasoning is partially sound—LLM correctly tracks the note across three 10-Ks—but fails to synthesize the key implication: that a stable principal in the final year before maturity signals active refinancing planning or liquidity preparation, not merely a decision to 'keep the balance steady.' The LLM introduces unsupported claims about 'larger senior-note issuances and term-loan repayments in 2024' to explain refinancing strategy, which are not in the ground truth and represent speculative overreach. (4) Contextual relevance is high—the answer addresses the evolution of the debt and attempts to infer strategy—but correctness is reduced due to the misrepresentation of FY2024 data and unsupported strategic narrative. Thus, the answer is partially correct but contains significant factual and inferential errors that affect the overall conclusion about Broadcom’s short-term debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 502,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "Across all three filings AMD’s stance with add‑in‑board (AIB) partners stayed essentially unchanged. In the 2022 10‑K (pages 9‑13) AMD said its agreements with AIB manufacturers “protect their inventory of our products against price reductions,” and noted that system integrators “often use discrete graphics solutions as a means to differentiate their products and add value to their customers.” The 2023 filing (pages 11‑15) repeats the same inventory‑protection clause and the same emphasis on discrete‑graphics‑driven differentiation, and the 2024 10‑K (pages 9‑13) again reaffirms those provisions. Thus, from 2022 through 2024 AMD consistently protected AIB inventory from price cuts and continued to position discrete graphics as a key differentiator for its system‑integrator customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AMD maintained consistent inventory protection policies for AIB manufacturers from 2022 to 2024, explicitly citing the protection against price reductions across all three years—this matches the original answer's claim of a stable policy. (2) There are no numerical values (e.g., revenue figures, percentages) in either the question or the ground truth, so no calculations are required; thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the continuity in language and strategic emphasis on discrete graphics as a differentiation tool for system integrators. It accurately reflects that the role of discrete graphics in differentiation was consistently highlighted. (4) The only minor shortcoming is that the LLM does not explicitly mention AMD’s supply of component-level graphics and chipset products to AIBs, nor does it reference the 'short design cycles' and 'rapid response to new technologies' aspects emphasized in the original answer. While the core strategic positioning is correctly conveyed, this omission slightly reduces completeness in qualitative synthesis. However, the answer remains semantically equivalent in its key claims and fully addresses the main thrust of the question regarding inventory protection and differentiation via discrete graphics. Wording differences are acceptable and do not affect factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 430,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "Disney’s DTC playbook moved from an initial rollout‑and‑cost‑realignment phase in 2022—when it announced an ad‑supported Disney+ tier, new pricing and a DMED re‑organization to “advance our DTC strategies” and said it expected subscription‑fee and ad‑revenue growth to more‑than‑offset linear‑network declines【DIS_10k_2022.pdf:25‑29】—to a deeper restructuring in 2023 that added a content‑curation overhaul, the launch of an ESPN flagship DTC service and a focus on subscriber additions, churn management and pricing/bundling as the key levers for DTC profitability【DIS_10k_2023.pdf:51‑55】. By 2024 Disney framed DTC as the primary growth engine, committing “strategic investments in our DTC offerings” and reiterating that the expected rise in subscription and advertising revenue would outweigh the ongoing loss of affiliate and linear‑network ad revenue, while repeatedly noting that its DTC services now face “an increasing number of competitors’ DTC offerings”【DIS_10k_2024.pdf:21‑25】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer in terms of the evolution of Disney's DTC strategy from 2022 to 2024. (1) All key facts are correct: in 2022, Disney expressed caution about DTC losses and restructured DMED, introduced ad-supported tiers, and expected DTC revenue to offset linear declines; in 2023, it emphasized strategic investments, subscriber growth, churn, and bundling; by 2024, DTC was framed as the primary growth engine amid rising competition. These points match the ground truth’s narrative of shifting from caution to strategic dependence. (2) There are no numeric inaccuracies—while no specific dollar figures or percentages are cited in either answer, the qualitative financial expectations (e.g., revenue growth offsetting affiliate losses) are correctly represented. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the progression in tone, strategic focus, and competitive context. (4) Semantic equivalence is strong—though the LLM adds slightly more operational detail (e.g., 'content-curation overhaul', 'ESPN flagship DTC'), these are consistent with the source documents and do not contradict the ground truth. The only minor gap is that the LLM does not explicitly mention the 'increasing competitive pressures on subscription fees and advertising rates' in 2024 as a financial impact, though it does cite growing competition. This slight omission prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, contextually rich, and directly responsive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 446,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "PayPal’s September 2019 Fixed‑rate 2.850 % notes have stayed unchanged – $1.5 billion of principal remains outstanding and the maturity stays at October 1 2029 in each filing (2022, 2023 and 2024 all list $1,500 million for this tranche)【PYPL_10k_2023.pdf page 106】【PYPL_10k_2024.pdf page 104】. While the company’s overall term‑debt grew (≈$10.418 bn in 2022, $10.638 bn in 2023 and $10.574 bn in 2024) and the current portion of debt shifted, the 2.850 % notes remained a non‑current senior unsecured component with a fixed $1.5 bn principal due in 2029.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PayPal's 2.850% fixed-rate notes remained unchanged at $1.5 billion outstanding from 2022 to 2024, with a maturity date of October 1, 2029—consistent with the ground truth. All numeric values (principal amount, maturity date, and overall term debt figures for 2023 and 2024) are accurate. The LLM reports total term debt as ≈$10.418 billion in 2022, which is a minor approximation of the ground truth $9.0 billion; however, this discrepancy may stem from differing definitions (e.g., inclusion of current portions or other debt instruments). The ground truth states $9.0 billion in 2022, so this is a notable but not critical deviation. (2) Quantitative accuracy is otherwise perfect: $1.5 billion principal, 2029 maturity, and exact figures for 2023 ($10.638B) and 2024 ($10.574B) match. The LLM correctly notes no changes in the 2.850% notes across years. (3) The multi-hop reasoning is sound—LLM synthesizes consistent treatment of the 2.850% notes over three years while contextualizing them within broader debt trends. It correctly infers that these notes remained a stable long-term liability despite overall debt growth and new higher-rate issuances in 2024 (implied by mention of shifting financing strategy, though not explicitly stated in LLM answer). (4) The answer is semantically equivalent to the original, with only slight variation in framing. The omission of explicit mention of new 5.150% and 5.500% notes in 2024 slightly reduces qualitative accuracy, but the core insight about stable 2.850% notes amid evolving debt structure is preserved. Contextual relevance is excellent—directly addresses debt structure evolution and maturity obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 469,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension‑plan holdings of corporate stock fell dramatically from ≈ $1.11 billion in 2022 (Corporate stock = $1,104 + $7 = $1,111 million)【UNP_10k_2022.pdf p. 70‑74】to only about $0.18 billion in 2023 (Corporate stock = $176 + $5 = $181 million)【UNP_10k_2023.pdf p. 56‑60】, then rose modestly to roughly $0.23 billion in 2024 (Corporate stock = $220 + $6 = $226 million)【UNP_10k_2024.pdf p. 54‑58】. The sharp 2023 decline mirrors the plan’s de‑risking move that cut equity exposure from 48 % of assets in 2022 to 24 % in 2023, while the slight 2024 increase signals a cautious re‑allocation back toward equities, though still well below the 2022 level.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The ground truth states UNP's corporate stock allocation was $1,990 million in 2022, but the LLM incorrectly reports it as $1,111 million, likely due to misreading or miscalculating line items from the 10-K (citing $1,104 + $7). This is a major quantitative error. The 2023 value of $181 million matches the ground truth and the LLM's calculation ($176 + $5) is correct. However, the LLM introduces a 2024 figure of $226 million ($220 + $6), which contradicts the ground truth: by 2024, UNP had reclassified its common stock holdings and no longer reported corporate stock in the same way—there is no $226 million figure in the ground truth, and the strategic shift implies a structural change, not a rebound in equity allocation. (2) The LLM invents a 'rise' to $226 million in 2024 unsupported by the original answer, which states the company moved to Level 1/Level 2 classifications and reduced overall equity exposure. This misrepresents the trend. Additionally, the LLM introduces percentages (48% to 24%) not present in the ground truth, adding unsupported context. (3) The multi-hop reasoning is partially sound—comparing across years and citing sources—but flawed due to incorrect data extraction and synthesis. The conclusion about 'cautious re-allocation back toward equities' directly contradicts the ground truth's assertion of a strategic reduction and shift to more structured, transparent equity exposure. (4) Despite correct citation format and relevance to the question’s intent, the answer fails on core factual accuracy, especially in the 2022 and 2024 figures and the overall interpretation of strategy. The contextual relevance is high because it addresses allocation evolution and strategy, but correctness is severely undermined by incorrect numbers and misinterpretation of the 2024 shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 514,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s long‑term private‑equity holdings fell from **$800 million at year‑end 2022** to **$719 million at year‑end 2024**, a decline of roughly **$81 million (about 10 %)**【PFE_10k_2023.pdf pp.84‑88】【PFE_10k_2024.pdf pp.81‑85】. This modest reduction indicates the company is trimming its exposure to illiquid alternative assets, suggesting a strategic shift toward a slightly lower allocation to private‑equity investments over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Pfizer's long-term investment in private equity securities increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. The LLM incorrectly states the 2022 value as $800 million (should be $623 million), omits the 2023 figure entirely, and presents a linear decline from 2022 to 2024, which misrepresents the actual trend. The claimed 10% decline (~$81 million) is based on incorrect starting and ending values and does not reflect the real trajectory. (2) Calculations are flawed: the actual change from 2022 to 2023 is an increase of $132 million (+21.2%), followed by a decrease of $36 million (-4.8%) to 2024. The LLM’s calculation uses incorrect inputs and ignores the intermediate year. (3) The multi-hop reasoning is partially sound in that it draws from multiple filings (2023 and 2024 10-Ks), but it fails to synthesize the full three-year trend, missing the critical increase in 2023. This omission undermines the conclusion about strategic allocation. (4) While the final observation about a modest reduction by 2024 aligns with the truth, the overall interpretation of a 'strategic shift toward lower allocation' overlooks the prior aggressive increase, leading to an incomplete and misleading characterization of Pfizer’s strategy. The contextual relevance is high because the answer addresses the right metric and time frame and attempts to interpret strategic intent, but the factual foundation is weak. Scores reflect major quantitative errors (3/10), partial qualitative accuracy due to correct sourcing and directionality in 2024 but flawed reasoning (5/10), and good relevance to the question (8/10). Correctness is scored at 4 due to partial correctness in the endpoint values but failure to capture the full trend and key dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 518,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "Mastercard’s multi‑layered security model in 2022 already combined a robust cyber‑risk program, third‑party assessments and public‑private partnerships, and supported real‑time account‑based payments in 12 of the world’s top‑GDP markets (2022 10‑K, pp. 9‑10). In 2023 the same framework added new services such as Mastercard Receivables Manager, extended real‑time payment infrastructure to 13 markets and kept its third‑party benchmarking and resilience measures (2023 10‑K, pp. 11‑12). By 2024 the firm explicitly managed risks from third‑party providers, broadened real‑time clearing and settlement to “several countries worldwide,” and reinforced cyber‑resilience through its Security Operations, Fusion and Intelligence Centers, enterprise‑resilience program and regular testing (2024 10‑K, pp. 11‑12).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correct elements: The evolution across 2022–2024 is accurately portrayed with correct emphasis on third-party collaboration, real-time payment expansion, and cyber resilience. The number of real-time payment markets is correctly stated as 12 in 2022 (implied via 'top-GDP markets' though not explicitly 12 in original answer, but consistent with context) and 13 in 2023, matching the ground truth. The 2024 expansion to 'several countries worldwide' is a slight softening of 'globally' but semantically acceptable. (2) Quantitative accuracy: All numeric references (12 markets in 2022, 13 in 2023) are consistent with the original answer and filings. The original answer does not specify 'top-GDP' but the LLM adds contextual detail without inaccuracy. No calculation errors. (3) Reasoning: Multi-hop synthesis across years and domains (security infrastructure, third-party integration, real-time payments) is sound. The LLM correctly traces the evolution of third-party involvement from assessments in 2022 to explicit risk management in 2024, and infrastructure growth from 12 to 13 to broader global reach. (4) Minor deduction in correctness and qualitative accuracy due to slightly less precise phrasing in 2024 ('several countries worldwide' vs. 'expanded globally' in ground truth), which slightly underrepresents the scale. However, core facts, entities, and progression are correct. Contextual relevance is perfect—directly addresses all three dimensions in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 426,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements (recorded in the “Other assets, including intangibles – net” line) fell sharply: it was **$1.494 billion at 12/31/2022**, dropped to **$800 million at 12/31/2023**, and declined further to **$491 million at 12/31/2024**【XOM_10k_2023.pdf】【XOM_10k_2024.pdf】. The consistent reduction suggests the company is either scaling back its derivative positions or improving netting and margin‑management practices, resulting in lower initial‑margin collateral needs and tighter control of its derivative exposure over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in both numbers and dates. According to the ground truth, the collateral amounts are: $641 million (end of 2021, reported in 2022 filing), $800 million (end of 2022, reported in 2023 filing), and $491 million (end of 2023, reported in 2024 filing). However, the LLM incorrectly states $1.494 billion at 12/31/2022, $800 million at 12/31/2023, and $491 million at 12/31/2024 — all of which are factually wrong in terms of both values and timing. The $1.494 billion figure does not appear in the ground truth and is a significant overstatement. Additionally, the time frame is misaligned: the question asks about changes from 2022 through 2024, meaning data points should be for years ending 2022, 2023, and 2024 (as reported in 2023, 2024, and 2025 filings respectively), but the ground truth only goes up to end-of-2023 (reported in 2024 filing), with no data for end-of-2024. The LLM fabricates a 2024 data point. (2) Calculations are therefore also incorrect: the claimed trend from $1.494B to $491M implies a ~67% drop, but the actual trend from $800M (2022) to $491M (2023) is a 38% decrease, as correctly stated in the original answer. The LLM’s quantitative inaccuracies are severe and materially distort the trend. (3) Multi-hop reasoning is partially sound — the model correctly identifies that collateral under master netting arrangements is recorded within 'Other assets, including intangibles - net' and attempts to track changes over time and infer implications for derivative exposure management. However, because the underlying data is wrong, the reasoning is based on false premises. The conclusion about reduced derivative exposure or improved margin management is plausible but unsupported by the incorrect data. (4) Contextual relevance is fair — the answer addresses the right metric, company, and conceptual question about derivative exposure management. But due to severe quantitative errors and fabricated data points, the correctness score is low. The answer misrepresents the actual trend and cannot be considered factually accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 568,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "The relative‑TSR model assumed an expected stock‑price volatility of **26.9 % for the 2022 grants**【DUK_10k_2022.pdf p.212‑216】, **28.6 % for the 2023 grants**【DUK_10k_2023.pdf p.204‑208】, and **18.7 % for the 2024 grants**【DUK_10k_2024.pdf p.213‑217】. The modest rise in 2023 followed by a sharp drop in 2024 indicates that market participants’ view of Duke Energy’s stock‑price risk has softened, suggesting a perception of lower future price uncertainty and a more stable outlook for the company.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages—26.9% for 2022, 28.6% for 2023, and 18.7% for 2024—are accurately reported with correct years and consistent with the original answer. Minor formatting differences (e.g., spacing in '26.9 %') do not affect accuracy. (2) The answer is complete, addressing both the change in expected volatility over the three-year period and the implied market risk perception. (3) Entity accuracy is correct: Duke Energy is the focus, the metric is expected stock volatility from the relative TSR model, and the years align with grant years referenced in the filings. (4) The reasoning is sound: the LLM correctly identifies the increase from 2022 to 2023, the sharp decline in 2024, and interprets this trend as a softening of perceived risk and greater stability, which is semantically equivalent to the ground truth’s conclusion about reduced uncertainty and stabilization relative to peers. The multi-hop synthesis across three annual reports is accurately executed, and the interpretation is contextually appropriate and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 320,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "- In the 2022 filing GM noted that, under the 2017 Opel/Vauxhall sale, its wholly‑owned subsidiary had agreed to indemnify Stellantis for “certain emissions and product liabilities” and that consumer lawsuits were pending, but the company could not estimate any loss and recorded no material accrual for those obligations【GM_10k_2022.pdf p. 89‑93】.  \n- The 2023 and 2024 filings repeat the same indemnification for emissions claims and add that GM has indemnified Stellantis for an “immaterial amount” for Takata‑inflator recalls in legacy Opel vehicles, stating that any further Takata‑related indemnity is considered remote and no material accruals have been recorded【GM_10k_2023.pdf p. 90‑94】【GM_10k_2024.pdf p. 91‑95】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that GM had indemnification obligations to Stellantis stemming from the 2017 Opel/Vauxhall sale, covering emissions claims and Takata recalls. The characterization of the Takata-related indemnification as 'immaterial' in 2023 and 2024, and the assessment that further indemnification is 'remote,' matches the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts), but the use of 'immaterial' and 'no material accruals' is consistent with the ground truth's 'immaterial amount' and lack of significant financial exposure—this is factually and quantitatively accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years (2022–2024) and two liability types (emissions and Takata), correctly tracking the evolution of GM’s disclosures. One minor omission: the 2024 ground truth specifically notes an immaterial accrual related to European Commission and UK CMA investigations into pre-sale Opel conduct, which the LLM answer does not explicitly mention, though it references ongoing emissions liabilities. This missing detail prevents a perfect 10 on qualitative accuracy. (4) The answer is contextually relevant, directly addressing the question’s focus on indemnification evolution and accruals. Overall, the LLM conveys the same core conclusion: GM’s financial exposure remained minimal and stable, with no material accruals recorded.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 415,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings AMD’s exhibit list repeatedly includes the line “*10.1 2011 Executive Incentive Plan… is hereby incorporated by reference” (see the exhibit tables on pages 91‑95 of the 2022 filing, 99‑103 of the 2023 filing and 96‑100 of the 2024 filing). The wording and citation are identical in each year, showing that AMD has kept the 2011 Executive Incentive Plan as a stable, enduring component of its executive‑compensation framework, signalling a long‑term, consistent approach to rewarding senior leadership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AMD consistently referenced the 2011 Executive Incentive Plan in its 2022, 2023, and 2024 filings with identical wording, which matches the original answer's claim of no amendments or new disclosures. The exhibit number (10.1) and the incorporation by reference are accurately reported. (2) All dates and exhibit references are consistent with the ground truth; while the original answer notes the plan was 'filed on April 2, 2011', the LLM does not mention this specific date but focuses on the consistency of citation across years, which is still factually sound. No calculations are involved, so quantitative accuracy is perfect. (3) The multi-hop reasoning is solid: the model synthesizes information across three years of filings and correctly infers that the unchanged references indicate a stable executive compensation strategy. The conclusion about a 'long-term, consistent approach' is a valid interpretation of the consistency. (4) The only minor omission is the lack of explicit mention that the plan was originally filed on April 2, 2011, which slightly reduces completeness in qualitative accuracy, but this does not detract from the core factual correctness. Overall, the answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 377,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "PayPal’s 2022 filing already warned that “bad‑transaction” risk was material because its expanding credit‑product portfolio could generate higher defaults, cross‑border trade (which carries higher loss rates and regulatory complexity) remained a key source of revenue, and the company was heavily dependent on third‑party banks, lenders and payment processors for funding and processing (see the 2022 risk‑factor sections on credit products, cross‑border trade and third‑party reliance). In 2023 the company said the risk persisted but began to mitigate it by diversifying its processor base and migrating away from a primary U.S. processor, entering a multi‑year €40 billion BNPL‑receivable sale and forward‑flow agreement to off‑load credit exposure, and exploring alternative third‑party funding and stronger risk‑model monitoring (2023 risk‑factor discussion); the 2024 filing still flags the exposure as present and potentially heightened by economic and cross‑border pressures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PayPal's increasing exposure to bad transaction risk in 2022 due to credit products, cross-border trade, and third-party dependencies, aligning with the original answer. It accurately notes the 2023 strategic action of entering a multi-year agreement to sell up to €40 billion in BNPL receivables in Europe and the U.K., which matches the ground truth. The continuation of risk into 2024 is also correctly stated. However, the LLM adds details not present in the original answer—specifically, 'diversifying its processor base and migrating away from a primary U.S. processor' and 'exploring alternative third-party funding and stronger risk-model monitoring'—which are not mentioned in the ground truth. While plausible, these additions introduce unverified mitigation actions beyond the documented receivables sale. (2) Quantitatively, the €40 billion figure is correct and properly attributed to the 2023 BNPL receivable sale; no calculations are required, and the number format is accurate. (3) The multi-hop reasoning is largely sound: the LLM connects risk factors across years and correctly synthesizes credit risk, geographic exposure, and third-party reliance. The core strategic action (BNPL receivable sale) is correctly identified as a key mitigation. However, the inclusion of additional mitigation strategies not in the original answer slightly weakens the qualitative accuracy. (4) The answer is highly contextually relevant, addressing all components of the question—evolution of risk from 2022–2024, credit products, cross-border trade, third-party dependencies, and 2023 mitigation actions. The only deviation is the addition of unconfirmed mitigation steps, which prevents a perfect score. Overall, the answer is factually strong with minor overreach in detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 496,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive base has been shrinking and getting older – owned units fell from 6,204 in the 2022 filing (covering 2021) to ≈5,973 in the 2024 filing (covering 2023), leased units dropped from 1,038 to 920, and total units declined from 7,242 to 6,893, while the average age rose from 22.5 years to 25.2 years【UNP_10k_2022.pdf:22-26】【UNP_10k_2023.pdf:17-21】【UNP_10k_2024.pdf:17-21】. This pattern shows the company is retiring older multiple‑purpose locomotives and relying less on leasing, indicating a strategic shift toward a smaller, more modern fleet—likely replacing aging units with newer, more efficient locomotive types through its capital‑intensive modernization program.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the numeric values for owned units (6,204 to 5,973), leased units (1,038 to 920), and average age increase (22.5 to 25.2 years), which match the ground truth exactly. The total fleet size calculation (7,242 to 6,893) is accurate as a sum of owned and leased units. Thus, quantitative accuracy is high. (2) However, the qualitative interpretation is flawed. While the ground truth concludes that the aging fleet and reduced leasing indicate a cost-control strategy over aggressive modernization, the LLM incorrectly infers a shift toward a 'more modern fleet' and a 'capital-intensive modernization program.' This contradicts the evidence: the average age increased significantly (from 22.5 to 25.2 years), which does not support fleet modernization. A modernizing fleet would typically show stable or decreasing average age, not a nearly 3-year increase. (3) The multi-hop reasoning fails in synthesis: although the model pulls correct data from multiple filings (2022, 2023, 2024), it misinterprets the implications. Reducing both owned and leased units while aging increases suggests deferred investment, not modernization. The conclusion is therefore logically unsound despite correct inputs. (4) Contextual relevance is strong because the answer addresses ownership changes, aging trends, and strategic implications as asked. However, the strategic interpretation is factually incorrect, leading to a moderate correctness score. Quantitative accuracy is high due to precise numbers and correct calculations. Qualitative accuracy is low due to flawed reasoning and incorrect inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 447,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements fell sharply – from **$1.494 billion at 12/31/2022** (the 2022 figure disclosed in the 2023 filing) to **$491 million at 12/31/2024** (the 2024 filing), a reduction of roughly two‑thirds. This decline, together with the concurrent drop in the 2023 amount ($800 million), indicates the company has been able to lower the margin collateral it must post, reflecting tighter counter‑party limits, more effective netting and a generally more disciplined approach to managing its derivative exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, ExxonMobil's collateral exposure was $641 million in 2022, $800 million in 2023, and $491 million in 2024. However, the LLM states it was $1.494 billion in 2022, which is more than double the correct amount. This error undermines the core factual basis of the response. The 2024 figure ($491 million) is correct, and the 2023 figure ($800 million) is mentioned but not properly contextualized as an increase from 2022. (2) Calculations are partially correct — the drop from $1.494B to $491M is indeed roughly two-thirds, but since the starting value is wrong, the comparison is misleading. The actual trend shows an increase from 2022 to 2023, then a decline in 2024, which the LLM fails to capture. Instead, it implies a continuous decline, missing the peak in 2023 entirely. (3) The multi-hop reasoning is flawed because the model does not correctly synthesize the three-year trend. It omits the increase in 2023 and incorrectly frames the 2022–2024 change as a straightforward reduction. This misrepresents the dynamic nature of the exposure. (4) While the conclusion about improved risk management or more disciplined exposure could be a plausible interpretation of a decline in 2024, it ignores the prior increase and thus lacks balance. The ground truth notes the fluctuation reflects dynamic risk positioning, which the LLM overlooks. The mention of 'tighter counter-party limits' and 'more effective netting' is speculative and not supported directly by the data provided. However, the answer is contextually relevant and uses appropriate financial terminology. The 2024 number is accurate, and the general direction of change from high to low is correct in magnitude by the end, but the path is misrepresented. Hence, partial credit is given for directional understanding but docked heavily on factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 521,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "Starbucks’ “Other” segment was described in each filing as being made up of **packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, serveware and other items** (footnote 3 in the 2022, 2023 and 2024 10‑Ks).  Revenue from this mix rose from **$6.9 billion (≈21 % of total revenue) in FY 2022** to **$7.7 billion (≈22 % of total) in FY 2023**, then slipped slightly to **$7.5 billion (≈21 % of total) in FY 2024**, showing a stable composition with modest growth and a small decline in the most recent year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures ($6.9B in 2022, $7.7B in 2023, $7.5B in 2024) and percentages (21%, 22%, 21%) that are not present in the original ground truth answer. The ground truth makes no mention of any quantitative data about the 'Other' category's revenue or its share of total revenue, only describing the composition and stability of the category. Therefore, these numbers are unverified and likely fabricated or hallucinated. (2) There is no way to verify the accuracy of the calculations (e.g., 21% of total revenue) because the ground truth does not provide any financial figures for the 'Other' category or total revenue in any year. Including such precise numbers without source support constitutes a major factual error. (3) On qualitative aspects, the LLM correctly identifies the consistent composition of the 'Other' category across years—packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware—which aligns with the ground truth. It also correctly notes that the description remained stable across 2022–2024, which reflects accurate multi-hop synthesis from the 10-K filings. However, the addition of 'other items' at the end slightly overgeneralizes compared to the more precise listing in the original. (4) Contextually, the answer addresses the evolution of the revenue composition as asked, focusing on the components and their consistency over time, which is relevant. However, the inclusion of unsupported quantitative data significantly undermines factual correctness. While the qualitative reasoning about stability is sound, the hallucinated numbers make the answer misleading. Thus, the correctness score is low due to false precision, despite correct reasoning about composition stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 493,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "Across the three filings the company’s treatment of Google‑Network inventory – which includes the ads served through Google Ad Manager – stayed the same but was refined. In 2022 the MD&A explained that impressions on Network properties (AdMob, AdSense and Google Ad Manager) are the basis for revenue recognition, with “cost‑per‑impression … defined as impression‑based and click‑based revenues divided by our total number of impressions” (2022 p. 29‑33). The filing also noted that “we generally report advertising revenues for ads placed on Google Network properties on a gross basis, that is, the amounts billed to our customers are recorded as revenues, and amounts paid to Google Network partners are recorded as cost of revenues” (2022 p. 29‑33). The 2023 and 2024 reports repeat this framework – still using impression‑based revenue recognition and gross‑basis reporting – while stating that the company “periodically review, refine, and update our methodologies for … counting the number of impressions, and for identifying the revenues generated by the corresponding … activity” (2023 p. 55‑59; 2024 p. 56‑60). Thus, from 2022 to 2024 the monetization of inventory through Google Ad Manager remained impression‑driven and gross‑reported, with only incremental methodological refinements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Google monetized advertising inventory through Google Ad Manager on Network properties using impression-based and click-based models from 2022 to 2024. The key metrics—cost-per-impression defined as total impression- and click-based revenues divided by impressions—and the gross revenue reporting model are accurately described for 2022, with direct citations to page ranges. (2) There are no numeric values (e.g., dollar amounts, percentages, impression counts) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to years (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent treatment over time, notes the continuity in gross revenue reporting and impression-based recognition, and adds value by referencing methodological refinements in 2023 and 2024, which reflects an evolution in transparency and measurement accuracy—consistent with the ground truth’s emphasis on increasing clarity. (4) The only minor gap is that the LLM does not explicitly mention Google's role as principal in the transaction (a key accounting rationale for gross reporting), which the original answer highlights in 2023–2024. However, it does correctly state the gross reporting model and cites the same disclosures, so this is a small omission rather than an error. Overall, the answer is factually correct, comprehensive, and contextually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 423,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "MDLZ’s 10‑K filings for 2022, 2023 and 2024 all contain the same disclosure that the company is subject to sales‑ and media‑marketing restrictions, specifically front‑of‑pack labeling rules based on nutrient‑profile or environmental claims, and to extended‑producer‑responsibility (EPR) regimes that now cover more than 25 EU countries and are expanding to other jurisdictions such as India, Vietnam and certain U.S. states. The wording and scope of these exposures are unchanged across the three years, indicating a consistent but ongoing regulatory risk rather than a material increase or reduction.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements, such as the mention of EPR policies covering over 25 EU countries and expansion into India, Vietnam, and U.S. states, which aligns with the ground truth. However, it incorrectly states that the disclosures were 'unchanged across the three years' and that the 'wording and scope of these exposures are unchanged,' which directly contradicts the original answer. The ground truth shows a clear evolution: in 2022, focus was on advertising restrictions and EPR in EU; in 2023, increased attention to front-of-pack labeling and plastic bans in Southeast Asia; in 2024, formal adoption of the EU Packaging Directive and shift from contemplation to enforcement in new jurisdictions. The LLM answer fails to capture this progression and instead asserts consistency, missing the core of the question about evolution. (2) Quantitatively, the reference to 'over 25 EU countries' is accurate as per 2022 and 2023 disclosures, and the jurisdictions mentioned (India, Vietnam, U.S. states) are correct by 2024. No explicit dollar amounts or percentages are involved, so numerical accuracy is acceptable. (3) The multi-hop reasoning is flawed: the model should have synthesized changes year-over-year but instead concluded no change, indicating failure to recognize evolving regulatory trends across the filings. It conflates recurring risk disclosures with static content, ignoring incremental updates in emphasis and scope. (4) While the entities (MDLZ, EPR, front-of-pack labeling, correct jurisdictions) are mostly accurate and contextually relevant, the conclusion about 'consistent but ongoing regulatory risk' misrepresents the growing and expanding nature of the exposure described in the ground truth. Thus, the answer is partially factually accurate but fails on the key dimension of change over time, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 513,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Across 2022, 2023 and 2024 Mastercard’s Class A shares were consistently described as having “one vote per share” and “dividend rights” in the capital‑stock tables of each Form 10‑K 【MA_10k_2022.pdf†p94】, 【MA_10k_2023.pdf†p97】, 【MA_10k_2024.pdf†p90】, and the company repeatedly declared quarterly cash dividends on both Class A and Class B stock in each year’s dividend section【MA_10k_2022.pdf†p94】, 【MA_10k_2023.pdf†p99】, 【MA_10k_2024.pdf†p92】. The unchanged voting and dividend entitlements for Class A shares over three years signal Mastercard’s deliberate strategy to maintain a stable dual‑class capital structure that preserves voting control while delivering consistent dividend participation to shareholders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that A Class shares maintained 'one vote per share' and 'dividend rights' across 2022, 2023, and 2024, with no changes—matching the original answer's claim of consistency. (2) There are no numerical values requiring calculation (e.g., dollar amounts or percentages), but the years (2022–2024) and qualitative descriptors (voting and dividend rights) are correctly cited and consistent with the source documents. The answer references specific document sections (e.g., Form 10-K pages), enhancing verifiability. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings (2022, 2023, 2024) to identify a pattern of stability, then infers the strategic implication—preservation of a stable dual-class capital structure. This goes beyond repetition to provide a logical interpretation consistent with the ground truth. (4) The answer is semantically equivalent to the original: while it adds contextual detail (e.g., mention of quarterly dividends and dual-class structure), all additions are factually supported and enrich the response without introducing error. The conclusion about Mastercard’s 'deliberate strategy' is a reasonable interpretation of the observed consistency. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 382,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil’s master‑netting collateral fell sharply – it was $1.494 billion at 12/31/2022, dropped to $800 million at 12/31/2023, and fell further to $491 million at 12/31/2024【XOM_10k_2023.pdf†L100-L104】【XOM_10k_2024.pdf†L97-L101】. This downward trend indicates that the company’s net derivative exposure (and the initial‑margin required to support it) has been decreasing, suggesting either reduced derivative activity or more efficient collateral use over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values, particularly for 2022. The ground truth states that collateral was $641 million in 2022, but the LLM claims $1.494 billion, which is more than double the correct amount. The 2023 value ($800 million) matches the ground truth, and the 2024 value ($491 million) is also correct. However, the trend described—'sharp decline'—is incorrect due to the erroneous starting point. In reality, collateral increased from 2022 to 2023 before decreasing in 2024, a fluctuating pattern the LLM fails to capture. (2) The quantitative inaccuracies are severe: the 2022 figure is wrong by over $850 million, invalidating any analysis based on trend direction or magnitude. Calculations or comparisons involving the 2022 number are therefore flawed. (3) The reasoning is partially sound in interpreting decreasing collateral as indicating lower derivative exposure or margin requirements, but this logic is applied to an incorrect trend. The multi-hop synthesis across years fails because the model misrepresents the 2022 data, likely due to misreading or misattributing a number from the source document (possibly confusing total receivables with collateral under netting arrangements). (4) Contextual relevance is fair—the answer addresses the right metric, time frame, and implications regarding derivative exposure—but the severe numerical error undermines the conclusion. Correctness score is low due to the critical inaccuracy in the foundational data point, despite correct values in 2023 and 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 433,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "- In the FY 2022 10‑K Starbucks noted that “total purchase commitments, together with existing inventory, are expected to provide an adequate supply of green coffee **through fiscal 2023**.” The FY 2023 filing updated that language to say the same commitments would cover supply **through fiscal 2024**. The FY 2024 10‑K now states the commitments and inventory will secure supply **through fiscal 2025**. \n\n- By lengthening the horizon of its fixed‑price, price‑to‑be‑fixed and hedging contracts each year, Starbucks is deliberately locking in longer‑term coffee purchases and price‑risk protection, signaling a strategy to smooth coffee‑price volatility and safeguard supply continuity.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy in the timeline progression compared to the ground truth. The original answer states that in FY2022, supply was secured through FY2023; in FY2023, it was extended to FY2025 (not FY2024 as the LLM claims); and maintained through FY2025 in FY2024. However, the LLM incorrectly states that the FY2023 10-K updated the supply assurance only through FY2024, when it actually projected through FY2025. This misrepresents the pace of the extension. The LLM correctly identifies the trend of lengthening commitments and links it to price volatility and supply continuity, capturing the strategic intent. It also correctly references the use of hedging mechanisms (implied via 'hedging contracts') though it omits explicit mention of forward contracts, futures, and collars noted in the ground truth. The reasoning is sound and contextually relevant, with only the quantitative misstatement of the FY2023-to-FY2025 jump affecting precision. Semantic equivalence is mostly preserved, but the error in the forward-looking period reduces full factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 314,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "In fiscal 2023 ACN’s target mix for its defined‑benefit plans was 95 % debt and 5 % cash for U.S. plans, and for non‑U.S. plans 19 % equity, 43 % debt, 6 % cash, 22 % insurance contracts and 10 % other. By fiscal 2025 the U.S. target shifts to 100 % debt (cash eliminated) and the non‑U.S. target moves to 28 % equity, 36 % debt, 7 % cash, 21 % insurance contracts and 8 % other. This gradual increase in equity and modest reduction in debt for non‑U.S. plans—paired with a fully debt‑focused stance for U.S. plans—signals a long‑term strategy of seeking higher return potential while preserving liability‑matching and risk‑adjusted performance to meet the plans’ inflation‑adjusted return objectives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not provide specific numerical breakdowns of ACN's target asset allocation by percentage for U.S. and non-U.S. plans in fiscal 2023 or 2025. Instead, it describes a general strategic emphasis on risk-adjusted returns, liability matching, and adaptive flexibility in asset allocation without citing exact percentages like '95% debt' or '28% equity'. These precise figures are not present in the original answer and appear to be fabricated or hallucinated. (2) There are no verifiable calculations in the original answer to validate sums or differences, but the LLM presents a false sense of precision with detailed allocations that do not align with the source. The shift from '5% cash to 0% cash' and changes in insurance contracts and other categories are not supported by the ground truth. (3) The multi-hop reasoning is flawed because the LLM invents granular data that was not in the source material. While it attempts to infer strategic intent—such as increasing equity for higher returns and maintaining liability matching—this interpretation is based on non-existent quantitative inputs. The original answer emphasizes continuity and adaptive flexibility without indicating a clear directional shift like increasing equity exposure. (4) Despite the factual errors, the LLM captures some contextual elements: it references long-term return objectives, risk-adjusted performance, and liability matching, which are mentioned in the original. However, the hallucination of specific percentages severely undermines correctness. Thus, the quantitative accuracy is very low, qualitative reasoning is partially sound but built on false premises, and relevance is moderate due to alignment with thematic concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 490,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "In the 2022 filing Olpasiran was listed as a Phase‑2 siRNA that lowers lipoprotein (a) and is being studied for atherosclerotic cardiovascular disease. By the 2023 filing Amgen had moved the molecule into Phase‑3 development, still positioning it as a cardiovascular‑disease candidate, and disclosed composition‑of‑matter patents covering Olpasiran in the United States and Europe with an estimated expiration in 2036—a protection timeline that is reiterated unchanged in the 2024 filing.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Olpasiran as an siRNA in Phase 2 in 2022 for atherosclerotic cardiovascular disease and accurately reports the U.S. and European patent protection with an estimated expiration in 2036, which aligns with the ground truth. However, it incorrectly states that Olpasiran was moved into Phase 3 by 2023, which is not supported by the original answer—there is no mention of Phase 3 advancement, only continued Phase 2 investigation in 2022 and a 2024 indication listing without explicit phase update. The 2024 filing only confirms the cardiovascular indication and does not confirm Phase 3 status. (2) Quantitatively, all dates (2022, 2023, 2024, 2036) are correct and match the ground truth; no calculations are involved. Format variations are not an issue. (3) The multi-hop reasoning is partially sound—information is synthesized across years and domains (clinical development, IP, therapeutic focus), but the inference about Phase 3 advancement is unsupported and introduces a factual error, weakening the reasoning chain. (4) Scores reflect high factual accuracy in numbers and context, but the incorrect phase progression reduces qualitative and overall correctness. The answer remains highly relevant and captures the strategic IP and therapeutic focus evolution accurately, except for the erroneous development stage claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 383,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "American Express’s filings show a steady deepening of its use of merchant‑acquirer aggregators: the 2022 10‑K first notes that the company “has increasingly relied on merchant acquirers, aggregators and processors to manage certain aspects of our merchant relationships,” the 2023 filing repeats that same reliance, and the 2024 filing still highlights aggregators as a core part of its merchant‑relationship model. In 2022 the risk warning focused on the possibility that aggregators’ business interests could be inconsistent with American Express’s goals; in 2023 the company added that third‑party providers “may act in ways that could materially harm our business,” stressing misaligned incentives and operational impact; and by 2024 the disclosure broadened the risk narrative to include the operational‑complexity, governance, service‑disruption, data‑security and heightened regulatory‑scrutiny risks that stem from relying on these aggregators.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express's increasing reliance on aggregators from 2022 to 2024 is accurately described, with proper evolution of risk disclosures each year. The 2022 focus on misaligned interests, 2023 emphasis on third-party actions harming the business, and 2024 expansion to operational complexity, governance, service disruption, data security, and regulatory scrutiny are all consistent with the original answer’s trajectory from merchant behavior to systemic and legal risks. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic way; the years (2022–2024) are correctly used throughout. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of disclosures, correctly identifying the progression in both reliance and risk emphasis. It captures the nuanced shift in tone and scope of risk disclosure over time. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'merchant steering' and 'surcharging'—which were specifically emphasized in the 2023 and 2024 disclosures in the ground truth—but it does reference 'misaligned incentives' and 'operational impact,' which are related. However, the omission of these specific terms slightly reduces qualitative accuracy, though the overall meaning remains largely intact. Contextual relevance is perfect, as the response directly addresses both parts of the question: evolution of reliance and associated risks per year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 440,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks repeatedly warned that green‑coffee price swings are driven in part by trading activity from hedge funds and commodity‑index funds, and it manages that risk with a mix of fixed‑price and price‑to‑be‑fixed purchase contracts plus forward, futures and collar hedges 【SBUX_10k_2022.pdf†p10‑p14】.  In each successive filing the company pushed its forward‑supply horizon out one year – the 2022 10‑K said its purchase commitments would cover supply through fiscal 2023, the 2023 10‑K extended that to fiscal 2024, and the 2024 10‑K now expects the commitments (plus inventory) to be adequate through fiscal 2025 【SBUX_10k_2023.pdf†p10‑p14】【SBUX_10k_2024.pdf†p10‑p14】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Starbucks' exposure to commodity index funds and its use of hedging strategies across fiscal years 2022–2024, and accurately describes the extension of forward supply commitments. However, there is a key factual discrepancy in the timeline: the LLM states that the forward supply horizon was extended each year—'pushed out one year' successively—implying the 2023 10-K extended coverage to fiscal 2024 and the 2024 10-K to fiscal 2025. But the ground truth states that by 2023, Starbucks extended its outlook to fiscal 2025 (a two-year jump), and this remained unchanged in 2024. Thus, the LLM incorrectly implies a gradual, annual one-year extension, when in fact the shift was a single leap to 2025 that was then maintained. (2) Quantitatively, the fiscal years mentioned (2023, 2024, 2025) are correct, but the mapping to the filings is inaccurate: the original answer confirms that in 2022, supply was expected through 2023; by 2023, it was extended to 2025 (not 2024); and in 2024, it remained through 2025. The LLM misattributes the 2024 coverage to the 2023 filing and 2025 to the 2024 filing, introducing a misalignment in the multi-year strategy portrayal. (3) The reasoning is mostly sound—correctly identifying the role of index funds, hedging instruments, and forward commitments—but fails in the multi-hop synthesis by misrepresenting the pace and timing of the supply horizon extension. The strategic shift to longer-term risk mitigation is noted, but the LLM misses the stabilization in 2024 because it incorrectly frames the extension as incremental. (4) Despite the timeline error, the answer is contextually relevant, cites correct documents, and captures the core risk factors and mitigation strategies. The correctness score is 7 due to accurate entities and general trend description but flawed temporal progression; quantitative accuracy is 7 due to correct years but incorrect assignment to filings; qualitative accuracy is 8 due to strong reasoning but flawed synthesis; contextual relevance is 10 as all content directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 569,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "Accenture’s buy‑back program has steadily expanded – the company repurchased about $4.1 billion of its Class A shares in fiscal 2022 (12.2 million shares for $4,111 million) with $3.13 billion of unused authorization remaining (ACN 2022 10‑K, p. 91‑95).  In fiscal 2023 the company continued to use the program at a similar scale, and by fiscal 2024 it had bought roughly $4.5 billion of shares (including $605 million in Q4) while the pool of available authorization fell to $2.69 billion (as of Aug 31 2024) – even as the board added $4 billion of fresh authority, raising total outstanding authority to $6.69 billion (ACN 2024 10‑K, p. 37‑41).  This multi‑year pattern of consistent, sizable repurchases coupled with periodic increases in authorized capacity signals a deliberate, ongoing capital‑return strategy that relies heavily on share buybacks to return cash to shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the reported repurchase amounts. The ground truth states that in fiscal 2022, Accenture had $3.13 billion in available authorization but does not state that $4.1 billion was repurchased that year—this figure is fabricated. The LLM claims Accenture repurchased $4.111 billion in fiscal 2022 (12.2 million shares), but the original answer does not mention any repurchase volume for 2022, only the available authorization. This is a major quantitative error. For fiscal 2023, the LLM states 'continued at a similar scale' implying ~$4.1B, but the ground truth reports only $605 million purchased in fiscal 2023, a massive discrepancy. The LLM also claims $4.5 billion repurchased in fiscal 2024 including $605 million in Q4, but the original answer does not provide total repurchases for 2024—only that $4 billion in new authorization was added. These repurchase figures are unsupported and incorrect. (2) The available authorizations are partially correct: $3.13 billion in 2022 (matches $3,129,296), $2.69 billion as of Aug 31, 2024 (matches $2,694 million), and $6.69 billion total after $4 billion addition (matches $6,694 million). These calculations are accurate and correctly reflect the increase. However, the timing is confused—available authorization of $2.69 billion is cited as of Aug 31, 2024 (fiscal 2024), not fiscal 2023 as implied. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a pattern of capital return via buybacks and recognizes the significance of increased authorization. It synthesizes information across years and draws a reasonable conclusion about capital return strategy. However, the flawed input data undermines the reasoning. (4) Contextual relevance is high—the answer addresses the evolution of repurchase activity and authorization and interprets the strategic implication. But due to severe quantitative inaccuracies in repurchase volumes, the correctness score is low. While the authorization figures and strategic interpretation are directionally correct, the invented repurchase amounts make the answer misleading. Quantitative accuracy is severely compromised; qualitative accuracy is moderate due to correct entity and time identification but flawed data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 618,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "Alphabet’s long‑term lock‑up portion of marketable equity rose from $803 million at year‑end 2022 to $1.4 billion at year‑end 2023, then fell sharply to $266 million at year‑end 2024 – a net drop of roughly $537 million from 2022 to 2024【GOOGL_10k_2022.pdf:64】【GOOGL_10k_2023.pdf:64】【GOOGL_10k_2024.pdf:64】. The swing suggests the company actively manages its illiquid equity holdings, expanding them when opportunities arise and quickly reducing exposure as lock‑up restrictions lift or strategic priorities shift.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the reported values and trend. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. However, the LLM claims it rose from $803 million in 2022 to $1.4 billion in 2023 and then fell to $266 million in 2024 — all of which contradicts the original data. The $266 million figure is entirely incorrect and unsupported by the ground truth. (2) The calculation of a 'net drop of $537 million' is based on erroneous inputs: using $803M (incorrect 2022 value) and $266M (fabricated 2024 value) leads to a false conclusion. The actual net change from 2022 to 2024 is $0 (from $1.4B to $1.4B), with a temporary decrease in 2023. (3) The multi-hop reasoning is flawed because the model failed to correctly extract and synthesize data across the three years from the 10-K filings. It misidentifies the starting point (using 2022 as $803M instead of $1.4B) and invents a final value not present in the source. While the general idea of active management of illiquid assets has some plausibility, the conclusion about 'quickly reducing exposure' does not align with the actual rebound to $1.4B in 2024. (4) The contextual relevance is moderate because the answer addresses the right topic (lock-up restrictions and investment strategy), but the incorrect numbers and trend undermine the validity. The qualitative reasoning would score higher if based on accurate data. Quantitative accuracy is very low due to multiple incorrect figures and a false net change calculation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 440,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "- In 2022 GE’s Electric Insurance Company (EIC) was still a captive property‑and‑casualty insurer in its run‑off insurance portfolio, providing coverage to GE and its employees with net claim reserves of roughly $0.2 billion (2022 10‑K, p. 45‑46).  \n- In Q4 2022 GE re‑positioned EIC as a non‑core asset, classifying it as “held for sale”; in 2023 it signed a binding sale agreement, recorded a $109 million loss on the disposal group (assets $541 million, liabilities $378 million, valuation allowance increased to $124 million) which reduced earnings that year (2023 10‑K, p. 48‑49).  \n- The divestiture was completed in Q2 2024 when GE sold EIC to Riverstone International Holdings for $120 million cash, removing the assets and liabilities from the balance sheet and delivering a modest net gain of about $11 million (sale proceeds less the prior loss) before tax (2024 10‑K, p. 46‑47).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: EIC was a captive insurer with $0.2 billion in net claim reserves in 2022; in 2023, it was classified as held for sale with assets of $541M and liabilities of $378M, and a $109M loss was recorded; in 2024, it was sold to Riverstone International Holdings Inc. for $120M in cash. (2) Quantitative accuracy is strong: the $109M loss and final sale price match exactly. The LLM adds a detail not in the original answer—a modest net gain of about $11M before tax in 2024 based on sale proceeds minus prior loss—which is a reasonable inference (since $120M proceeds vs. $109M loss implies a small gain), though this specific gain figure is not confirmed in the ground truth. This is a minor extrapolation but not factually incorrect. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across three years and filings, showing strategic evolution from captive insurer to held-for-sale to divestiture. (4) Entity names (Electric Insurance Company, Riverstone International Holdings), years, and financial metrics are accurate. The only reason for not scoring a 10 is the introduction of the $11M gain, which, while plausible, is not explicitly stated in the ground truth and involves a calculation not requested. Otherwise, the answer is complete, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 396,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen reported 13 Phase 3 programs as of February 8 2022, which rose to 18 by January 31 2023 and to 24 by January 31 2024, reaching 25 programs by early 2025 (the 2024 filing notes the increase to 25 as of February 4 2025)【AMGN_10k_2022.pdf p. 23‑27】【AMGN_10k_2023.pdf p. 24‑28】【AMGN_10k_2024.pdf p. 23‑27】. This near‑doubling of Phase 3 assets reflects a deliberate pipeline expansion driven by new study initiations, FDA approvals and the acquisition of Horizon’s programs, underscoring Amgen’s strategic focus on diversifying its R&D across biosimilars, novel biologics and small‑molecule targets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the evolution of Amgen's Phase 3 programs: 13 in 2022, 18 in 2023, and 24 in 2024, aligning with the ground truth. It accurately notes the increase to 25 programs, though it specifies February 4, 2025, as the date (from the 2024 filing), which is consistent with forward-looking disclosures in annual reports. The ground truth states the total reached 25 by 2024, which may be interpreted as by the end of the year or in disclosures filed in 2024, so this is a minor timing nuance rather than a factual error. (2) All numeric values and dates are accurate: 13 → 18 → 24 → 25 progression is correctly reported. The LLM correctly identifies the Horizon acquisition as a driver, consistent with the knowledge graph. (3) Multi-hop reasoning is sound: the answer synthesizes data across three 10-K filings (2022–2024), correctly tracks the year-over-year growth, and attributes the expansion to acquisitions, new initiations, and approvals—matching the ground truth’s strategic interpretation. (4) The LLM adds contextual detail not in the ground truth (e.g., mention of biosimilars, novel biologics, small molecules), which is plausible and enhances relevance without contradicting facts. The only minor discrepancy is the phrasing of 'early 2025' for the 25th program, while the ground truth implies it was reached by 2024; however, since the 2024 filing notes the increase as of February 2025, this is a correct interpretation of the source. Thus, the answer is factually accurate, complete, and contextually rich, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 435,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "In its 2022 filing, American Express said its global card network was the fourth‑largest worldwide, competing with Visa, Mastercard, UnionPay and others, and it highlighted growing regulator focus on network practices such as interchange‑fee pricing and non‑discrimination rules (2022 10‑K, pp. 10‑14). By the 2024 filing the company noted that it had already exited network‑licensing operations in the EU and Australia because of regulatory actions, was now classified as a Category III firm subject to heightened U.S. supervisory expectations, and was reshaping its network strategy to address new interchange‑fee caps, honor‑all‑cards provisions and pending Visa/Mastercard settlement proposals while still competing as a major global network (2024 10‑K, pp. 32‑36).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies American Express's competitive positioning in 2022 against Visa, Mastercard, and UnionPay, and notes regulatory focus on interchange fees and non-discrimination rules, consistent with the original answer. By 2024, it accurately reports AXP’s exit from network-licensing operations in the EU and Australia due to regulatory actions, matching the ground truth. It also correctly references heightened U.S. supervision (Category III designation) and strategic shifts in response to interchange caps and honor-all-cards rules. (2) There are no numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all dates (2022, 2024) and regulatory developments are correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and regulatory jurisdictions, showing evolution from competition to regulatory constraint. It captures the shift in relationship with global networks from competitive to compliance-driven, though it omits minor contextual details about competitive dynamics with Alipay/PayPal and cobrand uncertainty in the EU mentioned in the original. (4) Despite these small omissions, the core facts, timeline, and synthesis are correct, and the answer remains semantically equivalent in substance. The LLM uses specific 10-K page references, enhancing credibility. Only a slight deduction in qualitative accuracy due to less emphasis on competitive dynamics beyond regulation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 430,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "ConocoPhillips sold its remaining 91 million CVE common shares in the first quarter of 2022, generating roughly $2.1 billion of proceeds (the $2.138 billion recorded as short‑term‑investment sales) that were applied to repurchase 87.7 million of its own shares that year【COP_10k_2024.pdf p.110】【COP_10k_2022.pdf p.141】.  In 2023 the company repurchased an additional 48.6 million shares, bringing the cumulative total to 383 million shares at a cost of $29 billion through year‑end 2023【COP_10k_2023.pdf p.108】, and in 2024 it repurchased another 49.1 million shares, raising the cumulative total to 433 million shares at a cost of $34.3 billion (about $5.3 billion spent in 2024)【COP_10k_2024.pdf p.110】.  The share‑repurchase volumes are shown in the 10‑K tables for each year (2022 = 87,709,187 shares【COP_10k_2022.pdf p.139】; 2023 = 48,641,899 shares【COP_10k_2023.pdf p.108】; 2024 = 49,135,049 shares【COP_10k_2024.pdf p.110】).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in structure and reasoning, addressing the evolution of ConocoPhillips' monetization and share repurchases from 2022 to 2024 with proper multi-hop synthesis across three 10-K filings. However, there are key quantitative inaccuracies that reduce the correctness score. First, the LLM claims the 91 million CVE shares were sold in Q1 2022 for $2.1 billion, citing short-term investment sales of $2.138 billion. While the share volume (91 million) matches the ground truth, the original answer does not specify the exact proceeds from the CVE sale, and the LLM incorrectly equates total short-term investment sales with the CVE proceeds alone—this is an unsupported inference. Second, the LLM reports 87.7 million shares repurchased in 2022, but the ground truth states a cumulative 383 million shares repurchased by end-2022. The LLM then incorrectly implies that only 87.7 million were repurchased in 2022, and adds 48.6 million in 2023 and 49.1 million in 2024 to reach the 433 million total. However, the ground truth states 383 million cumulative by end-2022, meaning the 2023 and 2024 repurchases must be much smaller (only ~50 million total), which contradicts the LLM's annual breakdown. The LLM likely misinterpreted the cumulative nature of the 383 million figure, treating it as an endpoint in 2023 rather than 2022. This leads to a significant error in the allocation of repurchase volumes across years. Despite these calculation and interpretation flaws, the LLM correctly identifies the progression from asset monetization to capital return, cites specific document pages, and reports the correct final cumulative totals ($34.3 billion for 433 million shares by 2024) and the $65 billion authorization increase (though this last point is missing in the LLM answer). The reasoning is sound in direction but flawed in numerical synthesis. Contextual relevance is excellent—every part of the question is addressed with appropriate detail and sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 534,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "The company’s share pool for the Omnibus Stock Incentive Plans fell sharply over the period – about 117 million shares were available at January 30 2022, roughly 77 million were left as of January 28 2024, and the pool had contracted to about 70 million shares by February 2 2025 (the most recent 2024 filing)【HD_10k_2022.pdf†L…】【HD_10k_2023.pdf†L…】【HD_10k_2024.pdf†L…】.  This steady decline shows Home Depot has been actively issuing awards from its authorized pool, but the remaining tens‑of‑millions of shares still give it ample capacity to continue granting stock‑based compensation in the future.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer gets the core numbers mostly correct—117 million in 2022 and 70 million in 2024 align with the ground truth. However, it incorrectly states that 77 million shares were available as of January 28, 2024, attributing this to the 2023 plan, when in fact the 77 million figure corresponds to 2023 (fiscal year ending January 29, 2023), not 2024. Additionally, the LLM cites a date of February 2, 2025, for the 2024 filing, which is incorrect; the 2024 10-K would cover the fiscal year ending January 28, 2024, and be filed in early 2024, not 2025. This misalignment of years and figures reduces quantitative accuracy. (2) The numbers themselves (117M, 77M, 70M) are accurate, but their assignment to years is flawed—the 77M should be for 2023, not presented as a 2024 data point. The trend of decline is correctly identified, but the timeline is distorted. (3) The reasoning about steady utilization and ongoing capacity is sound and matches the ground truth’s interpretation. The model correctly infers that the drawdown indicates active use of equity awards and that remaining shares still allow for future grants. It also correctly identifies the existence of a replenishment mechanism, though this is implied rather than explicitly stated. (4) Despite the date/period mislabeling, the answer captures the essential trend and its implications, earning high marks for qualitative reasoning and relevance. The error in temporal alignment prevents a higher score on quantitative accuracy, but the overall conclusion remains directionally correct and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 438,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized 127 million Class A ordinary shares in the 2022 filing, was raised to 141 million shares in the 2023 filing, and the 2024 filing confirms the same 141 million‑share ceiling. This upward adjustment shows Accenture is deliberately expanding its equity‑award pool, using a larger share‑based compensation program to attract, retain and motivate talent while aligning employee interests with shareholders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the number of shares authorized was 127 million in 2022, increased to 141 million in 2023, and remained at 141 million in 2024. The formatting '127 million' and '141 million' is equivalent to 127,000,000 and 141,000,000. (2) Quantitative accuracy is perfect—no calculation errors, and the progression is correctly described. (3) The multi-hop reasoning across years is sound: the model correctly synthesizes data from 2022, 2023, and 2024 filings to show a trend. (4) The qualitative interpretation—that Accenture is expanding its equity award pool to attract talent and align employee-shareholder interests—matches the original answer’s strategic implication. The answer is complete, addressing both the numerical evolution and the strategic significance. All entities (Accenture plc, Amended 2010 SIP, Class A ordinary shares) are correctly identified. No irrelevant or extraneous information is present. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 298,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "American Express’s weighted‑average yield on its foreign government bonds and obligations rose sharply – from roughly **2.2 % in 2022** to about **4.2 % in 2024** (see the “Non‑U.S. short‑term investment securities” average‑yield line for 2022 = 2.2 % and 2024 = 4.2 %). This upward move shows the portfolio is now earning higher returns, indicating that the company’s exposure to international interest‑rate environments has increased as global rates have risen.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the weighted average yield on American Express's foreign government bonds due within one year was 5.86% in 2022, increased to 6.45% in 2023, and returned to 5.86% in 2024. The LLM incorrectly states yields as 2.2% in 2022 and 4.2% in 2024, which are not supported by the data. Additionally, the LLM omits the 2023 figure entirely, failing to capture the peak and subsequent decline. (2) The numbers cited (2.2% and 4.2%) do not match the ground truth (5.86%, 6.45%, 5.86%), and the dollar amount of $630 million in holdings is missing. The calculation of trend (increase from 2.2% to 4.2%) is internally consistent but based on incorrect data. (3) The reasoning is flawed due to reliance on incorrect figures; the conclusion about increasing exposure to international interest rates ignores the reversal in 2024, which is a key part of the trend. The model fails to perform the necessary multi-hop synthesis across three years and misidentifies the relevant yield category (possibly confusing it with another line item like 'Non-U.S. short-term investment securities'). (4) While the answer addresses the general question about yield trend and interest rate exposure, the severe quantitative errors and omission of the full trend significantly undermine correctness. Contextual relevance is moderate because it attempts to interpret the implication of yield changes, but the analysis is based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 417,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio was heavily front‑loaded in 2022, with $628 million of the $630 million fair‑value concentrated in securities maturing within one year (the balance split between the 1‑5‑year and 5‑10‑year buckets)【AXP_10k_2022.pdf pp 119‑123】.  The weighted‑average yield on this segment fell from 6.45 % at the end of 2023 to 5.85 % at the end of 2024【AXP_10k_2023.pdf pp 133‑137】【AXP_10k_2024.pdf pp 175‑179】, signalling that the company trimmed exposure to higher‑coupon, longer‑dated sovereign debt as overall market yields declined and shifted toward a more conservative, lower‑duration mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: $630 million total fair value in 2022 with $628 million maturing within one year, 6.45% weighted average yield in 2023, and 5.85% in 2024. These match the ground truth exactly, with acceptable formatting (e.g., $628 million vs $628M). (2) Quantitative accuracy is perfect—no errors in numbers, percentages, or timeframes. The yield decline from 6.45% to 5.85% is correctly stated and contextualized. (3) The multi-hop reasoning is sound: the model synthesizes data from 2022 (maturity profile), 2023 (yield), and 2024 (yield) filings to infer a strategic shift. It correctly interprets the yield drop as a sign of changing market conditions or portfolio rebalancing toward lower duration, aligning with the ground truth’s interpretation. However, the LLM slightly overreaches by stating the company 'trimmed exposure to higher-coupon, longer-dated sovereign debt'—the ground truth emphasizes short-duration focus in 2022 and does not confirm a shift away from longer-dated debt, only a possible change in mix. This is a minor interpretive difference, not a factual error. (4) The answer is contextually complete and relevant, addressing both the evolution of the yield profile and its implications for strategy and market conditions. The citation of specific documents and page ranges adds credibility. Overall, the answer is factually excellent with only a slight nuance missing in the strategic interpretation, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 419,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "In the 2022 Form 10‑K the “7 % Debentures due 2029” were lumped together with the common‑stock entry in a single row of the Section 12(b) securities table. The 2023 filing broke the debt out into its own line—showing “7 % Debentures due 2029” with a separate CUSIP and exchange—while the 2024 filing again presented the debentures together with the common‑stock line (or in a combined format). This shows that ConocoPhillips has consistently disclosed the debenture each year, but it experimented with a clearer, stand‑alone presentation in 2023 before reverting to a more consolidated layout, indicating a pragmatic approach that balances transparency with streamlined reporting.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partially correct information but makes a critical factual error in the 2024 disclosure description. According to the ground truth, in 2024 COP maintained the separated, stand-alone disclosure of the 7% Debentures due 2029 with its own CUSIP (718507BK1), continuing the clearer format introduced in 2023. However, the LLM incorrectly states that the 2024 filing 'again presented the debentures together with the common-stock line (or in a combined format)', which contradicts the ground truth. This misrepresents the multi-year progression and leads to an incorrect conclusion that COP 'reverted to a more consolidated layout'. In reality, the trend was consistent improvement in transparency, not experimentation or reversion. The quantitative elements (percentage, year, security type) are accurate, hence a moderate quantitative accuracy score. Qualitatively, the reasoning is flawed due to the incorrect synthesis of the 2024 data, undermining the conclusion about the company's reporting approach. Contextually, the answer addresses the right question and uses appropriate terminology, so relevance is high. The core failure is in the multi-hop synthesis across years, particularly the mischaracterization of the 2024 filing, which invalidates the overall conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 360,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVIDIA’s liability for the 2.00 % senior unsecured notes due 2031 stayed essentially flat at about **$1.25 billion** over the three‑year span – it was reported at $1.25 bn in FY 2022 (NVDA_10k_2022.pdf p.78), again at $1.25 bn in FY 2023 (NVDA_10k_2023.pdf p.65) and at $1.25 bn in FY 2024 (NVDA_10k_2024.pdf p.70). This unchanged exposure shows that NVIDIA has relied on a stable, low‑cost, long‑dated debt instrument, opting to maintain rather than expand or retire the issuance, which reflects a disciplined long‑term debt‑management strategy focused on preserving liquidity while keeping borrowing costs low.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.2 billion in 2022, decreased to $1.057 billion in 2023, and then increased to $1.25 billion in 2024. The LLM incorrectly states that the amount was consistently $1.25 billion across all three years, which contradicts the actual progression. This misrepresentation fundamentally undermines the answer’s correctness. (2) The numbers cited in the LLM answer do not match the ground truth: $1.25B in 2022 and 2023 is wrong (should be $1.2B and $1.057B respectively); only the 2024 figure ($1.25B) is correct. There is no indication of the decrease in 2023, nor the recovery in 2024. The LLM also cites specific document pages, but the values on those pages (if they existed as claimed) would still be inconsistent with the verified truth from the knowledge graph. (3) The multi-hop reasoning is flawed because the model fails to detect the variation over time, instead asserting stability. The conclusion about a 'disciplined' strategy based on flat exposure is invalid since the exposure actually fluctuated. The ground truth suggests a stable *overall* position with slight increases, while the LLM fabricates complete stability. (4) Despite the factual errors, the answer is contextually relevant—addressing the right instrument, time frame, and strategic interpretation—and uses appropriate financial terminology. Hence, it scores moderately on qualitative and contextual dimensions, but very low on quantitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 442,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "- In fiscal 2022 Marvel was highlighted mainly on the balance sheet – it was listed as one of the company’s indefinite‑lived intangible assets (a trademark) along with ESPN and Pixar 【DIS_10k_2022.pdf p.108‑112】.  \n- By fiscal 2023 Disney began emphasizing Marvel as a marquee streaming brand, describing Disney+ (and Disney+ Hotstar) as a service that presents “Disney, Pixar, Marvel, Star Wars and National Geographic” as top‑level tiles in the interface 【DIS_10k_2023.pdf p.5‑9】.  \n- In fiscal 2024 that positioning remained unchanged: Marvel continues to appear as a top‑level tile on Disney+ and is still recorded as an indefinite‑lived intangible asset (trademark) 【DIS_10k_2024.pdf p.112‑116】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Marvel's inclusion as an indefinite-lived intangible asset in 2022 and 2024 alongside ESPN and Pixar is accurately reported, and its elevation to a top-level branded tile on Disney+ in 2023 is correctly identified. (2) There are no numerical values requiring calculation in this question, but the fiscal years (2022, 2023, 2024) are correctly referenced and aligned with the appropriate disclosures. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years and two domains (financial reporting of intangible assets and strategic branding on streaming platforms), demonstrating a clear understanding of how Marvel’s strategic positioning evolved. (4) The LLM answer matches the original in both substance and implication, conveying that Disney leverages Marvel’s brand equity both financially (as a long-term intangible asset) and operationally (via prominent placement in Disney+). Minor differences in phrasing (e.g., 'marquee streaming brand' vs. 'driving subscriber engagement') do not affect factual equivalence. All citations are appropriately referenced to the correct filings and page ranges.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 352,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "From 2022 through 2024 American Express kept discount revenue on its books at the moment a Card‑Member transaction occurs—deducting the merchant discount from the payment to the merchant and, when a third‑party acquirer is used (e.g., under the OptBlue program or other GNS partners), recording the individually‑negotiated network‑rate fee as discount revenue (2022 10‑K p. 102‑106). The company’s merchant contracts remained split between open‑ended agreements for small‑ and mid‑size merchants and fixed‑term (typically 3‑ to 7‑year) agreements with auto‑renewal for large merchants, and across 2023‑2024 the filings added an explicit, amplified focus on expanding merchant coverage—especially in low‑to‑plastic and new‑to‑plastic segments and priority international cities and verticals—by leveraging more third‑party acquirers and negotiating network‑rate fees to broaden acceptance worldwide (2023 10‑K p. 101‑105; 2024 10‑K p. 91‑95).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that discount revenue is recognized at the time of transaction and that network rate fees from third-party acquirers (e.g., OptBlue, GNS partners) are individually negotiated and recorded as discount revenue—consistent across 2022–2024. The evolution in contractual arrangements and merchant coverage expansion strategies is accurately reflected, particularly the increased focus in 2023–2024 on leveraging third-party acquirers to expand globally, especially in low-to-plastic markets and priority international segments. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to years (2022–2024) and document locations (10-K pages) are correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly tracing the evolution from revenue recognition mechanics to strategic shifts in merchant coverage and acquirer collaboration. (4) The only minor omission is that the LLM does not explicitly mention 'processed revenue' from network partnership agreements (e.g., royalties) introduced in 2023, which is part of the revenue structure evolution. While the focus on merchant expansion and network fees is well-covered, this missing element slightly reduces completeness in revenue structure description. However, the core facts, entities, timeline, and strategic direction are all correct and contextually well-supported. Hence, the answer is factually strong with only a small gap in full revenue stream coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 460,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "- In the 2022 filing Amgen warned that many of its products and product candidates rely on third‑party drug‑delivery devices, that delays or failures in device development, approval or supply could hold up product approvals, and that the FDA had previously examined its Neulasta Onpro kit – prompting device‑ and label‑enhancements and ongoing monitoring of complaints and malfunctions (AMGN_10k_2022.pdf: 32‑36).  \n\n- The 2023 filing expanded that risk narrative, naming the specific autoinjectors and companion‑diagnostic devices (e.g., AutoTouch, Repatha SureClick, ConfiPen), stressing that regulators may require contemporaneous approval of the device and drug, and adding that post‑marketing obligations now include systematic collection of device‑related adverse‑event reports, periodic safety assessments and other REMS‑type commitments (AMGN_10k_2023.pdf: 52‑54).  \n\n- By the 2024 filing the disclosure further emphasized heightened FDA scrutiny of device safety, routine inspections and the possibility of device‑related recalls or restrictive labeling, and it explicitly referenced post‑marketing study requirements for device performance, making clear that any safety problem with a delivery device could trigger regulatory action that would affect the associated drug (AMGN_10k_2024.pdf: 51‑53).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key elements of the evolution in Amgen's regulatory risk disclosures from 2022 to 2024 are correctly identified: in 2022, general risks around third-party drug delivery devices and the Neulasta Onpro kit review are noted; in 2023, increased specificity around device types (AutoTouch, SureClick, ConfiPen), contemporaneous approval requirements, and post-marketing obligations including adverse event reporting and REMS-type commitments are detailed; in 2024, heightened FDA scrutiny, inspections, recalls, and the linkage between device safety and regulatory action on the drug are emphasized. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only qualitative disclosures across years, which are accurately represented. The cited page numbers (e.g., 32–36, 52–54, 51–53) are consistent with typical 10-K formatting and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracing the evolution from general dependencies to specific post-marketing and safety compliance risks. It adds granular detail (specific device names, REMS, adverse event reporting) not in the original answer but consistent with and supportive of the stated trend. (4) The only reason for not scoring a perfect 10 is that the LLM does not explicitly mention LUMAKRAS or the Complete Response Letter context highlighted in the ground truth, which is a minor omission in an otherwise comprehensive and semantically equivalent response. However, the core trajectory of increasing regulatory scrutiny on confirmatory trials and post-marketing requirements is implied through discussion of systematic safety assessments and regulatory enforcement risks. Overall, the answer is factually correct, contextually rich, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1620,
        "completion_tokens": 532,
        "total_tokens": 2152
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "In the 2022 filing ConocoPhillips described its HSE audit as a unit‑level “HSE audit” of business units and staff groups, with any improvement actions identified and tracked to completion and the results reported to the Executive Leadership Team (ELT) and the Board of Directors. The 2023 filing repeats the same language. By the 2024 filing the program is framed as a “Corporate HSE audit” that still covers business units and staff groups, retains the practice of identifying improvement actions and tracking them to completion, and continues to report progress to the ELT and Board, reflecting a more formalized, enterprise‑wide governance structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, entities, and the evolution of ConocoPhillips' HSE audit program from 2022 to 2024. It correctly identifies the shift from unit-level audits in 2022 to 'Corporate HSE audits' in 2024, maintains accurate reporting lines (ELT and Board), and confirms consistent tracking of improvement actions. Quantitative accuracy is perfect—no numerical or date errors, and all years and terminology (e.g., 'Corporate HSE audit') are correctly cited. Contextual relevance is strong, directly addressing scope, improvement tracking, and governance. However, the LLM omits key qualitative details present in the original answer: the 2023 expansion into human capital management, Life Saving Rules, Process Safety Fundamentals, and the stop work policy. While it states the 2023 filing 'repeats the same language,' this is partially incorrect—the 2023 report did evolve contextually even if the audit structure remained similar. This omission reduces completeness and weakens the multi-hop synthesis, particularly in explaining how the program matured beyond conformance to include broader safety systems. Thus, while the core facts and timeline are correct, the answer lacks depth in capturing the full evolution, justifying a score of 8 rather than 9 or 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 360,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "In its 2022 filing Accenture warned that AI, cloud and data advances could change the way it earns revenue and that it would need “new pricing or commercial models that reflect the value of these technological developments.” By the 2023 and 2024 reports the language shifts to an active effort – the firm is “developing and introducing new pricing models for AI‑, cloud‑ and data‑based services” to capture that value and counteract client spending delays. Across all three years Accenture consistently flags the risk that if it cannot roll out—or clients do not adopt—these new pricing models, delayed spend and insufficient uptake could depress revenue and materially hurt its results of operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution and risks described in the ground truth. (1) All factual elements are correct: Accenture's shift from acknowledging the need for new pricing models in 2022 to actively developing them in 2023–2024 in response to AI, cloud, and data advancements is accurately represented. The consistent risk across years—failure to roll out or achieve client adoption of new models leading to revenue depression and material impact on operations—is correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly infers the progression in Accenture’s strategic posture and the persistent risk theme. (4) Semantic equivalence is strong—while the LLM uses slightly more concise phrasing (e.g., 'roll out' vs 'introduce quickly enough'), the meaning matches the original. One minor point preventing a perfect 10 is that the LLM omits explicit mention of 'strategic investments in AI-based services' highlighted in 2024 in the ground truth, which adds depth to the 'active effort' but is not critical to the main point. Overall, the answer is factually correct, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 385,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s AerCap senior‑note position grew each year – it was $900 million at 12/31/2022, rose to $944 million at 12/31/2023, and reached $982 million at 12/31/2024【NOTE 21 2022 $900 M】【NOTE 21 2023 $944 M】【NOTE 21 2024 $982 M】. The steady increase indicates that, after selling its AerCap equity, GE has been expanding its exposure to AerCap’s investment‑grade debt, using the note as a core, low‑risk asset in its run‑off insurance portfolio and signaling confidence in AerCap’s credit profile.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of GE's holdings in the AerCap note. The original answer states that GE's holdings decreased from $993 million (end of 2021, reported in 2022) to $944 million (end of 2023, reported in 2024), indicating a decline. In contrast, the LLM claims the position increased from $900M in 2022 to $944M in 2023 to $982M in 2024—this contradicts the ground truth. The LLM also introduces a figure for 2024 ($982M), which is not present in the original answer and unsupported by the provided truth. (2) Quantitative accuracy is severely compromised: the starting value is wrong ($900M vs $993M), the trajectory is inverted (growth vs decline), and an unsupported 2024 value is introduced. Even if formatting variations are allowed, the numbers do not align with the ground truth. (3) The multi-hop reasoning is flawed—the LLM incorrectly infers a strategy of expanding exposure and confidence in AerCap’s credit, while the original answer suggests a strategic reduction in exposure as part of portfolio management. This reflects a complete misinterpretation of the trend. (4) Contextual relevance is low because the answer describes an increasing investment where the truth shows a divestment. The mention of 'run-off insurance portfolio' and 'investment-grade debt' adds detail but is not substantiated in the original and distracts from the core factual error. Overall, the answer is nearly opposite to the truth in both data and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 418,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "In the 2022 Form 10‑K, Bemarituzumab was listed as a Phase 3 program that had just initiated a Phase 3 study, and its composition‑of‑matter patents were projected to expire in 2029 in both the United States and Europe (2022 10‑K, pp. 23‑27). The 2023 filing showed the same status – still a Phase 3 candidate with the 2029 expiration dates unchanged (2023 10‑K, pp. 24‑27). By the 2024 filing, Bemarituzumab remained a Phase 3 candidate for GEJ adenocarcinoma while also being explored in Phase 2 (other tumors) and Phase 1 (NSCLC) studies, and its patent expiration continued to be estimated for 2029 in the U.S. and Europe (2024 10‑K, pp. 24‑28).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the Phase 3 initiation in 2022, continued Phase 3 status through 2024, and patent expiration estimated at 2029 in both the U.S. and Europe are all correctly reported and align with the ground truth. These numbers and dates are consistent across the cited 10-K filings, satisfying quantitative accuracy. However, the LLM answer lacks completeness in capturing the qualitative evolution described in the original answer. While it notes Bemarituzumab's exploration in Phase 2 (other tumors) and Phase 1 (NSCLC) by 2024, it does not emphasize the strategic shift in Amgen’s positioning—specifically, the expanded investigational scope to gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC as a broader therapeutic repositioning. The original answer highlights a narrative shift from clinical development to IP and therapeutic expansion, which the LLM answer underrepresents. The reasoning is sound in tracking status over time but misses the synthesis of how Amgen’s description evolved from a narrow focus to a more comprehensive mechanism and indication strategy. Contextual relevance is high because all information provided is pertinent and correctly cited, but the deeper strategic interpretation is underdeveloped. Thus, while factually correct, the answer falls short in fully conveying the multi-hop evolution in development and IP positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 399,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "In the 2022 filing American Express warned that the “dynamic and rapid growth of alternative payment and financing mechanisms” – from digital wallets to buy‑now‑pay‑later and other fintech platforms – was creating “intense competition” that could erode merchant discount rates and required the company to “invest in technology and innovation” to stay relevant. By the 2024 filing the language shifts to a proactive stance, stating that the firm must “continue to invest in technology across all areas…including AI/ML, open‑banking, tokenization, real‑time settlement and alternative‑payment mechanisms” to compete with fintech rivals, revealing a long‑term strategy that moves from defensive acknowledgement of competitive pressure to an aggressive, technology‑driven response aimed at preserving its network and brand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in American Express's strategic positioning from 2022 to 2024. (1) It correctly identifies the key themes: in 2022, American Express acknowledged alternative payment mechanisms (digital wallets, BNPL, fintech) as competitive threats affecting merchant discount rates, and the need to invest in innovation. By 2024, the tone shifts to proactive investment in technologies like open banking, tokenization, and real-time settlement. These align with the ground truth's description of a shift from defensive recognition to strategic integration. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024), correctly infers a strategic shift in tone and intent, and links it to long-term fintech disruption response. One minor omission: the 2023 expansion to include payment facilitators and broader ecosystem awareness is not mentioned, slightly reducing completeness. Also, the LLM groups AI/ML into the tech investments, which while plausible, is not explicitly stated in the ground truth—this is a slight overextension but not factually incorrect. (4) Despite these small gaps, the LLM conveys the essential semantic meaning: American Express evolved from viewing alternative payments as a threat to treating them as necessary for competitiveness. The answer is contextually excellent, directly addressing competitive pressure, technological investment, and long-term strategy. Thus, correctness is 9 (not 10 due to missing 2023 nuance), qualitative accuracy 9, and full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 475,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "The weighted‑average grant‑date fair value of cash‑settled PSUs rose from $91.58 per unit for awards granted in 2022, jumped to $112.50 for 2023 grants, and then eased slightly to $110.39 for 2024 grants【COP_10k_2023.pdf p.124】【COP_10k_2024.pdf p.124】. This pattern shows ConocoPhillips initially lifted the value of its cash‑settled long‑term incentives to enhance senior‑management compensation, then moderated the increase – suggesting a move to balance incentive generosity with cost control or a shift toward other compensation forms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. The ground truth states that the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024, implying a steady or increasing trend. However, the LLM claims a jump to $112.50 in 2023 and then a decrease to $110.39 in 2024, which contradicts the ground truth. This misrepresents both the values and the trend. (2) The 2022 figure ($91.58) is correct, but the 2024 value is wrong—$110.39 vs. the correct $112.50—and the 2023 value of $112.50 is not supported by the ground truth, which does not provide an intermediate 2023 value. Thus, the model fabricates a data point and misstates the trajectory. (3) The multi-hop reasoning is partially sound in that it attempts to interpret the trend in incentive strategy, but it is based on incorrect data. The conclusion about 'balancing incentive generosity with cost control' is speculative and not supported by the ground truth, which indicates a consistent structure and a strategic shift toward higher-value incentives. (4) While the answer addresses the question's structure and cites documents appropriately, the core numerical inaccuracies severely undermine correctness. The qualitative reasoning would score higher if based on accurate data. Contextual relevance is high because the response stays on topic and attempts proper synthesis, but factual fidelity is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 399,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "PayPal’s risk‑factor disclosures show that its exposure to abusive behavior has broadened and become more specific over the three years. In the 2022 filing the company warned only that its credit‑product portfolio and third‑party lenders create a “risk that account holders … will default” and that “third parties … may attempt to abuse … our payments services” (PYPL_10k_2022.pdf pp. 24‑27). By 2023 the filing added that fraudsters are creating “fictitious PayPal accounts using stolen or synthetic identities” and that credit‑risk models may mis‑price borrowers, making the exposure to both credit‑product defaults and sophisticated third‑party schemes more acute (PYPL_10k_2023.pdf pp. 23‑25). The 2024 filing again stresses that these abusive schemes are “often difficult to detect” and that “continuous improvement” in detection is required, indicating the problem has persisted and even intensified (PYPL_10k_2024.pdf pp. 21‑25). This progression of increasingly detailed warnings suggests PayPal is strengthening its risk‑management controls, but the growing and evolving nature of fraud and credit‑product risk shows its risk‑management is still being tested and has not fully contained the exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the evolution of PayPal's exposure to abusive behaviors from 2022 to 2024 and correctly identifies increasing concerns around fraud and credit products. It accurately reflects that in 2022, PayPal noted risks from third-party abuse and defaults; in 2023, it highlighted fictitious accounts and synthetic identities; and in 2024, it emphasized persistent detection challenges. There are no numeric inaccuracies—no specific numbers (e.g., €40 billion) are incorrectly stated or miscalculated, so quantitative accuracy is perfect. However, the LLM omits a key multi-hop element from the original answer: the €40 billion multi-year receivables sale agreement in the U.K. and Europe, which is a critical strategic risk mitigation action. This omission affects completeness and weakens the synthesis of how PayPal is actively managing risk. Additionally, the LLM concludes that risk management is 'still being tested,' implying improvement efforts are ongoing but not necessarily effective, whereas the original answer emphasizes reliance on third-party risk mitigation and regulatory clarity as structural responses. The reasoning is sound but less precise in capturing the strategic dimension of PayPal’s response. Contextual relevance is high as the answer directly addresses the question’s focus on trends and risk management implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 388,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "In the 2022 10‑K, Cyramza was described as a second‑line therapy for advanced gastric, NSCLC, colorectal and hepatocellular cancers and as a first‑line option for EGFR‑mutated NSCLC, with compound patents protecting the molecule in the U.S. (through 2026), Europe (2028) and Japan (2026) and data‑exclusivity covering the U.S. (2026), Europe (2024) and Japan (2023) (LLY_10k_2022.pdf pp. 3‑7). By the 2024 filing the therapeutic labeling remained unchanged, but the European and Japanese data‑protection periods have now expired (2024) or are about to lapse (2023), leaving only the compound patents for protection (LLY_10k_2024.pdf pp. 4‑8). This trajectory shows Lilly is banking on Cyramza’s broad multi‑indication footprint while relying on its remaining patents—and likely pursuing new patents or combination regimens—to extend exclusivity, reflecting a long‑term oncology strategy that emphasizes diversified indications and sustained IP protection.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and provides a detailed, well-reasoned response that aligns with the ground truth in most aspects. (1) Correct elements include: Cyramza's therapeutic positioning in 2022 across gastric, NSCLC, colorectal, and liver cancers; compound patents extending to 2026 in the U.S. and Japan; data exclusivity expiring in Japan in 2023; and the unchanged therapeutic positioning in 2024. The inference about Eli Lilly’s long-term oncology strategy—leveraging multi-indication breadth and preparing for patent expiry—is logically sound and contextually appropriate. (2) Quantitative inaccuracies: The LLM incorrectly states that data exclusivity in Europe expires in 2024 and compound patents in Europe extend to 2028. The original answer (ground truth) does not mention European patent or data protection timelines, so introducing these specific dates constitutes an overreach not supported by the provided knowledge graph. This addition, while plausible, introduces unverified data and undermines strict factual accuracy. (3) Multi-hop reasoning is strong: the model correctly synthesizes information across 2022 and 2024 filings, tracks changes in IP protection over time, and infers strategic intent based on patent cliffs and unchanged indications. (4) Despite the extraneous and unverified European dates, the core facts about U.S. and Japanese IP timelines and therapeutic positioning are accurate, and the strategic interpretation is consistent with the ground truth. Hence, the answer earns a high score but is penalized for introducing unsupported quantitative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 436,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "Philip Morris kept its 3.875 % Notes due 2042 on the balance sheet in each filing – they appear in the 2022, 2023 and 2024 securities tables – while continually reshaping the rest of its debt portfolio. Between 2022 and 2024 the company retired older series (e.g., the 2.375 % and 2.500 % notes due 2022, the 2.625 % and 2.125 % notes due 2023, and the 3.600 % notes due 2023) and issued new issues such as 0.125 % notes due 2026, 3.125 % notes due 2027/2028, and a 3.750 % note due 2031, expanding the range of coupons and maturities. This reflects a strategy of preserving a stable long‑term anchor (the 2042 notes) while actively managing the remaining debt to diversify funding sources, extend maturities and optimize financing costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the quantitative details, despite capturing the general strategic theme of maintaining the 3.875% Notes due 2042 as a long-term anchor while managing other debt. (1) The specific debt instruments cited as retired or issued are largely incorrect. The LLM claims retirement of 2.375%, 2.500%, 2.625%, 2.125%, and 3.600% notes due in 2022 and 2023, and issuance of 0.125% due 2026, 3.125% due 2027/2028, and 3.750% due 2031—none of which are supported by the ground truth. The original answer specifies that the 4.125% Notes due 2043 and 4.875% Notes due 2043 were present in 2022 but gone by 2024, and that 4.125% and 4.250% Notes due 2043 and 2044 were added in 2023 but also retired or refinanced by 2024. These key long-dated instruments are entirely omitted in the LLM response. (2) The LLM introduces short- and medium-term notes (e.g., due 2026–2031), which are not mentioned in the ground truth and contradict the focus on long-dated instruments beyond 2040. (3) While the LLM correctly identifies the consistent presence of the 3.875% Notes due 2042 across all three years, it fails to accurately represent the evolution of the long-term debt portfolio, particularly the introduction and subsequent retirement of the 2043 and 2044 tranches. (4) The reasoning about 'diversifying funding sources' and 'extending maturities' is plausible but not supported by the actual pattern in the ground truth, which shows a narrowing of long-dated instruments by 2024, suggesting consolidation rather than expansion. Thus, while the high-level interpretation of active management around a stable core is semantically aligned, the factual foundation is flawed, leading to a low quantitative accuracy and partial qualitative accuracy. Contextual relevance is moderate as the answer addresses capital structure evolution but with incorrect instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 511,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "In its 2022 filing PayPal warned that abusive behavior—such as synthetic‑identity fraud, account‑takeover and other misuse of its platform—was a growing risk that could drive higher defaults on its consumer‑ and merchant‑credit products and was amplified by its heavy reliance on third‑party lenders and payment processors. To curb that exposure, the company in 2023 signed a multi‑year €40 billion sale of U.K. and European BNPL loan receivables and began migrating away from its primary U.S. payment processor to diversify its third‑party relationships, and in 2024 it accelerated that diversification, pursued alternative funding structures for its credit portfolio and strengthened its fraud‑detection and third‑party risk‑management programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal identified abusive behaviors (e.g., synthetic identity fraud) in 2022 as a growing risk to its credit products; in 2023, it entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables; in 2024, it enhanced fraud detection and third-party risk management. The numbers (€40 billion), years (2022–2024), and entities (PayPal, BNPL, U.K./Europe) are accurate. (2) Quantitative accuracy is perfect: the €40 billion figure matches exactly, and no calculations are required. (3) The multi-hop reasoning is sound—information is correctly synthesized across years and strategic domains (credit risk, third-party reliance, mitigation actions). The only minor gap is that the LLM adds detail not in the original—specifically about migrating away from its primary U.S. payment processor and pursuing alternative funding structures—which, while plausible and contextually consistent, is not present in the ground truth. This does not introduce inaccuracy but adds unverified detail. (4) The answer fully addresses all parts of the question: evolution of risk (2022–2024), relation to credit products and third-party risk, and specific mitigation actions in 2023 and 2024. Semantic equivalence is strong, with slightly expanded phrasing but no factual deviation. Hence, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance, and a 9 in qualitative accuracy due to minor extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 426,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD has listed the risk of “loss or modification of exemptions for taxes and tariffs” in each of its recent 10‑Ks (2022 p. 35‑39; 2023 p. 39‑43; 2024 p. 38‑42). In 2022 the language was a generic mention of the risk, but by 2023 the filing added recent sanctions on Russia, Belarus and Ukraine, and the 2024 filing further expanded the discussion to include heightened geopolitical tensions such as China‑Taiwan, Ukraine‑Russia and Israel‑Hamas, indicating that AMD’s exposure to tax‑ and tariff‑related regulatory changes has broadened and become more acute, reflecting growing regulatory uncertainty in its global operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies AMD's evolving discussion of tax and tariff exemption risks across 2022–2024, noting the progression from a generic mention to inclusion of geopolitical contexts. The specific conflicts cited (Russia-Ukraine, China-Taiwan, Israel-Hamas) are consistent with the increasing emphasis on geopolitical drivers. (2) There are no numerical values to verify, but the years (2022, 2023, 2024) and document references (10-K pages) are factually appropriate and contextually accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly infers increasing regulatory concern, and links it to broader geopolitical tensions. The only minor shortcoming is that the original answer emphasizes AMD’s explicit linkage of the risk to financial and operational stability in 2024, which the LLM answer implies but does not directly state. (4) The answer is fully relevant, directly addressing how AMD’s exposure perception evolved and what it suggests about regulatory uncertainty. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies; minor omission of 'financial and operational stability' impact keeps it just below perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 363,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco’s total‑return‑swap results tied to deferred compensation swung from a **$92 million loss in FY 2022** to a **$58 million gain in FY 2023** and then a **$91 million gain in FY 2024**【CSCO_10k_2022.pdf†L...】.  The shift from a negative to increasingly positive outcomes—alongside rising notional amounts ( $651 m in 2022, $792 m in 2023, $985 m in 2024)【CSCO_10k_2024.pdf†L...】—suggests Cisco is successfully using total‑return swaps to hedge its deferred‑compensation expense, reducing volatility and turning the derivative exposure into a net earnings benefit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024—matching the ground truth exactly. Number formats are consistent and acceptable, with minor stylistic variations (e.g., use of thin spaces). (2) Quantitative accuracy is perfect: all dollar amounts and fiscal years are correct, and no calculations were required beyond accurate reporting. The additional data on notional amounts ($651M, $792M, $985M) is factually consistent with the source and enhances context without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes performance trends over three fiscal years and infers strategic implications regarding hedging effectiveness and reduced volatility. While the original answer attributes the trend to 'improved market conditions or strategic shift,' the LLM narrows it to a more confident interpretation—'successfully using swaps to hedge'—which is plausible but slightly more assertive than the original cautious phrasing. This does not make it incorrect but represents a subtle interpretive difference. (4) Contextual relevance is excellent: the answer addresses both parts of the question—evolution of gains/losses and what it indicates about strategy—and adds relevant context (notional amounts) that strengthens the analysis. Overall, the answer is factually complete, numerically precise, and logically coherent, warranting a high correctness score with only minor deductive confidence difference in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 432,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "From FY 2022 Disney’s DTC strategy was limited to launching an ad‑supported Disney+ tier, revising pricing and reorganizing its DMED unit to fund streaming growth. In FY 2023 the company deepened that push with large strategic outlays—an $8.6 billion payment for Hulu’s redeemable non‑controlling interest, a $0.7 billion contribution to acquire a 20 % stake in its ESPN‑flagship DTC sports business, and a content‑curation overhaul—while continuing to reorganize its media‑entertainment operations. By FY 2024 Disney is committing still larger content spend (projecting roughly $24 billion in FY 2025) and expects subscription‑fee and advertising‑revenue growth to offset declining linear affiliate fees, but it now faces intensified competition, higher content‑cost pressures and the need for additional financing. This trajectory shows that scaling Disney’s streaming services requires ever‑larger cash outlays, higher leverage and the risk of impairments, and that the business is increasingly exposed to competitive pricing pressure, subscriber‑churn risk and macro‑economic volatility that amplify its financial risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the correct strategic evolution of Disney's DTC offerings from FY2022 to FY2024 and accurately reflects the increasing financial risks and market pressures, aligning well with the ground truth in terms of reasoning and context. It correctly identifies Disney's strategic moves: launching an ad-supported tier and reorganizing DMED in 2022, major investments in 2023 (Hulu, ESPN, content), and continued scaling with projected $24B content spend in 2025. However, the quantitative accuracy is compromised by the inclusion of specific dollar figures not present in the original answer—namely the $8.6B Hulu payment, $0.7B ESPN stake, and $24B projected content spend—which, while plausible, are not supported by the provided ground truth and thus introduce unverified data. The original answer does not include any numerical figures, so these specifics cannot be confirmed and represent overprecision. Despite this, the qualitative progression—increasing investment, competitive pressures, rising costs, and financial risk—is sound and logically synthesized across the three fiscal years. The answer fully addresses the multi-part question about strategic evolution and financial risks, demonstrating strong contextual relevance and correct entity identification (Disney, DTC, Hulu, ESPN, linear affiliate fees). The reasoning correctly infers that scaling streaming requires growing cash outlays and increases exposure to pricing pressure and churn, which matches the ground truth’s conclusion. While the core narrative is accurate and well-structured, the unsupported numbers reduce quantitative accuracy, preventing a top score. Semantic equivalence is largely maintained, but the added specifics cross into speculative territory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 475,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "PayPal’s margin‑risk exposure has not changed from 2022 through 2024 – in each year the company states that it “has full discretion in determining the fee charged to our customers, which is independent of the costs we incur … with payment processors or other financial institutions” and therefore “bear[s] full margin risk when completing a payment transaction,” with those processor fees recorded as transaction expense (2022 p.78‑82; 2023 p.75‑78; 2024 p.73‑77).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures the consistent exposure to margin risk across 2022, 2023, and 2024, correctly stating that PayPal bore full margin risk in each year and maintained discretion in setting fees independent of processor costs. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy pertains to correct use of years and page references—these are accurate and consistently cited across the three annual reports. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and multiple disclosures, correctly identifying the continuity in accounting treatment and risk exposure despite changes in reporting standards (e.g., ASU 2023-07, though not explicitly mentioned, does not alter the conclusion). (4) The LLM includes precise and relevant direct quotes from filings, reinforcing factual accuracy. All entities—PayPal, payment processors, transaction expenses, fee-setting discretion—are correctly identified and logically connected. The answer is concise, complete, and contextually fully aligned with the question, with no omissions or inaccuracies. Minor omission of the 2024 accounting standard (ASU 2023-07) is not material to the core conclusion about margin risk stability and is compensated by correct inference of unchanged risk and cost treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 403,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Honeywell’s risk factor for its Aerospace business (renamed “Aerospace Technologies” in 2024) consistently warns that a downturn in global air‑travel demand could delay or cancel new aircraft orders, which would hurt the segment’s results – the same language appears in the 2022 filing [HON_10k_2022.pdf:30‑31], is unchanged in the 2023 filing [HON_10k_2023.pdf:30‑31], and is reiterated in the 2024 filing [HON_10k_2024.pdf:30‑31]. The fact that this risk has remained a prominent, unchanged concern over three years signals that, although commercial‑aviation demand is gradually rebounding, the market’s recovery is still fragile and order‑cancellation risk remains material, indicating ongoing uncertainty about the sector’s stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claim: Honeywell consistently highlighted the risk of new aircraft order cancellations due to air-travel demand downturns across 2022–2024, with identical or nearly identical language in each year’s 10-K filing (supported by correct document citations). Quantitatively, there are no numbers, dates, or financial figures to verify, and the years (2022–2024) are correctly referenced, earning a perfect score on quantitative accuracy. Contextual relevance is strong—the response directly addresses the evolution of the risk and what it indicates about sector recovery and stability. However, the qualitative accuracy is slightly lower because the LLM fails to capture the nuanced evolution in risk factors described in the ground truth. While it correctly notes the consistency of the risk warning, it misses the shift in underlying causes: from pandemic-specific concerns in 2022 to broader geopolitical, environmental, and competitive factors (e.g., new market entrants) in 2023 and 2024. The ground truth emphasizes a qualitative evolution in the nature of the risk, whereas the LLM portrays it as static ('unchanged' language), which oversimplifies the progression. This lack of synthesis across the multi-hop dimensions—how the same risk category masks changing drivers—reduces the depth of reasoning. Still, the conclusion about fragile recovery and ongoing uncertainty aligns with the ground truth, warranting a high but not top score on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 412,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "In its 2022 filing, PMI warned that product regulation could erode its ability to differentiate its reduced‑risk products (RRPs) and limit truthful adult‑consumer communication, threatening its competitive position. By the 2023 and 2024 filings, the company broadened that risk to include smoke‑free products (SFPs) and stressed that tightening rules on branding, packaging and communication are increasingly constraining differentiation and adult‑consumer engagement across both RRPs and SFPs, revealing an intensifying regulatory squeeze on its competitive edge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of regulatory impact on PMI's competitive positioning from 2022 to 2024. It correctly identifies that in 2022, PMI raised concerns about regulation limiting product differentiation and truthful communication for Reduced-Risk Products (RRPs). It accurately notes the expansion of these concerns in 2023 and 2024 to include Smoke-Free Products (SFPs), reflecting the strategic shift mentioned in the ground truth. The answer correctly conveys the intensifying regulatory constraints on branding, packaging, and consumer communication, aligning with the original answer’s theme of increasing pressure. The only minor omission is the absence of specific mention of 'digital media spreading misleading information' in 2023 and the explicit point about 'disproportionate impact relative to competitors' and 'regulatory asymmetries' in 2024, which slightly weakens the depth of the multi-hop synthesis. However, the overarching narrative of escalating regulatory pressure affecting competitive differentiation and adult consumer access to information is preserved. There are no numerical inaccuracies (dates are correct, no faulty calculations), and all entities (PMI, RRPs, SFPs, years) are correctly identified. The reasoning is sound and contextually appropriate, with strong semantic equivalence to the ground truth despite slightly less granular detail in the 2023–2024 evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 397,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "PayPal’s margin‑risk profile has been essentially unchanged from 2022 to 2024. In each filing the company states that it acts as the principal on every payment, sets fees (including a variable‑percentage component and volume‑based tiered pricing) at the transaction level, and therefore “bears full margin risk” while any fees paid to payment processors are recorded as transaction expense (PYPL_10k_2022.pdf: p.78‑82; PYPL_10k_2023.pdf: p.75‑79; PYPL_10k_2024.pdf: p.73‑77). Likewise, incentives such as fee discounts, rebates, rewards or coupons are consistently treated as reductions of revenue, so the company’s exposure to margin risk remains fully on its own balance sheet across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: PayPal bears full margin risk in 2022, 2023, and 2024; fees to payment processors are recorded as transaction expenses; incentives are treated as revenue reductions. The LLM correctly identifies the consistency of this risk profile across years and notes the structural elements of pricing (e.g., variable-percentage and tiered pricing), which are relevant to margin risk. (2) There are no numeric values in the original or LLM answer requiring calculation, but all qualitative financial treatments (e.g., expense recognition, revenue reduction) are accurately described—thus quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying consistent exposure and evolving disclosures. It references specific page numbers (e.g., p.78-82 in 2022), which supports traceability. (4) The only reason for not scoring a 10 in correctness and qualitative accuracy is that the LLM omits the 2024-specific point about the independence of customer fees from processor costs—a nuance highlighted in the original answer that adds depth to the explanation of how margin risk is managed. However, this is a minor omission rather than an error. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 394,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "Across AMD’s 2022, 2023 and 2024 10‑K filings the company’s AIB strategy stayed anchored on two points: its contracts with add‑in‑board (AIB) manufacturers continue to protect those partners’ inventory from any price reductions (AMD_10k_2022 pp. 9‑13; AMD_10k_2023 pp. 11‑15; AMD_10k_2024 pp. 9‑13), and it stresses that system integrators (SIs) use AMD’s discrete‑graphics solutions to differentiate their offerings. While the inventory‑protection language is unchanged, the 2024 filing adds a clearer focus on selling directly to SIs and on the short‑design‑cycle, rapid‑technology response of SIs, underscoring an evolving emphasis on leveraging discrete graphics as a key differentiator.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection for AIB manufacturers from 2022 to 2024, and consistently emphasized discrete graphics as a differentiator for system integrators (SIs). The LLM correctly identifies that this policy was unchanged across years and cites the relevant sections of the 10-K filings. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the temporal references (2022, 2023, 2024) are accurate. (3) The multi-hop reasoning is sound—LLM synthesizes AMD’s evolving messaging across three years and correctly infers a subtle strategic shift in 2024 toward SIs with rapid technology response and short design cycles. (4) The only minor gap is that the LLM mentions 'selling directly to SIs' in 2024, which is not explicitly stated in the ground truth; instead, the original emphasizes 'SIs selling based on regional or product-based strengths' and 'strategic alignment' rather than direct sales. This is a slight overinterpretation but does not undermine the overall correctness. The core themes—inventory protection, role of discrete graphics, and evolving SI engagement—are accurately conveyed with strong contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 379,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "Disney’s policy on investment‑credit exposure has been essentially unchanged from FY 2022 through FY 2024: the company only enters derivative or investment transactions with counterparties that have a credit rating of A‑ or better and it requires collateral if a counterparty’s rating falls below A‑ or if aggregate exposures exceed the limits set in the contract, while also capping the amount of credit exposure to any single institution. The concentration threshold has remained at 10 % of total cash and cash equivalents, but the actual exposure shifted – in FY 2022 (and FY 2023) no institution breached the 10 % limit, whereas by FY 2024 balances exceeding 10 % of cash and cash equivalents represented 24 % of total cash and cash equivalents. (See the “Credit Concentrations” sections of the FY 2022, FY 2023 and FY 2024 10‑K filings.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: the 24% concentration in FY2024 is accurately reported, and the absence of such concentration in FY2022 (and by implication FY2023) matches the original answer. The 10% concentration threshold is correctly stated, even though not explicitly mentioned in the ground truth; this additional detail is consistent with typical disclosure practices and does not contradict the source. (2) The fiscal years (2022–2024) and entities (The Walt Disney Company, counterparties, financial institutions) are correctly identified. (3) The reasoning is sound: the LLM correctly synthesizes that while Disney’s counterparty credit rating policy (A- or better) and collateral triggers remained stable, there was a strategic shift in cash concentration, with 24% held at a single institution in FY2024 versus none exceeding the 10% threshold previously. This reflects proper multi-hop reasoning across policy and actual exposure. (4) The answer adds minor clarifying detail (explicit mention of 10% threshold) not in the original but plausibly inferred and contextually appropriate. No factual errors are present; the slight deduction in qualitative accuracy is due to the unverified specificity of the 10% threshold, which, while reasonable, was not confirmed in the ground truth. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 405,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "PayPal’s exposure to the September 2019‑issued Fixed‑rate 2.850 % notes that mature on 10 Oct 2029 has been unchanged at **$1.5 billion** each year – $1.5 bn in 2022 (2022 10‑K, p. 108), $1.5 bn in 2023 (2023 10‑K, p. 106) and $1.5 bn in 2024 (2024 10‑K, p. 103). The steady‑size, long‑dated tranche suggests a deliberate strategy to lock in low‑cost, fixed‑rate financing for the long term, providing interest‑rate stability and a predictable maturity profile rather than repeatedly refinancing or retiring that portion of debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: the exposure to the 2.850% notes maturing in 2029 remained constant at $1.5 billion across 2022, 2023, and 2024, matching the ground truth of $1,500 million (equivalent to $1.5 billion). The maturity date (10 Oct 2029) and issuance context (September 2019) are accurate and add contextual precision not in the original answer but consistent with filing data. 2) Quantitatively, all dollar amounts are correct and consistently reported; the format variation ($1.5 billion vs $1,500 million) is acceptable and semantically equivalent. No calculations were required, but the consistency across years is correctly observed. 3) The multi-hop reasoning is sound: the model synthesizes data across three annual 10-K filings (2022, 2023, 2024), correctly identifying the same debt instrument across years. It infers a strategic rationale—locking in low-cost, fixed-rate financing and ensuring predictability—which aligns with the ground truth’s suggestion of a strategic decision to retain favorable terms. 4) The only minor gap is that the LLM answer does not explicitly mention the issuance of higher-interest debt in 2024 (e.g., 5.150% and 5.500% notes), which the original answer uses to contrast the retention of the 2.850% notes. While not strictly necessary to answer the question, this context strengthens the strategic interpretation. However, the LLM’s conclusion is still logically sound and semantically aligned. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for overall correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 441,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell’s filings repeatedly warned that raw‑material demand and supply could hurt the Performance Materials and Technologies business (renamed Energy and Sustainability Solutions in 2024) (2022 10‑K p.30; 2023 10‑K p.30; 2024 10‑K p.30). The share of its raw‑material supply base covered by contracts rose only modestly—from roughly 63 % in 2022 (2022 10‑K p.31) to 64 % in 2023 (2023 10‑K p.31) and was described as a “majority” in 2024 (2024 10‑K p.31)—showing a gradual reduction in exposure. However, the persistent risk‑factor language each year indicates that Honeywell remains vulnerable to commodity‑market volatility despite the slight improvement in contractual coverage.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth—namely, that the share of raw-material supply covered by contracts increased from 63% in 2022 to 64% in 2023 and was described as a 'majority' in 2024. These percentages and the claim about contractual coverage are absent from the original answer and cannot be verified from the provided ground truth. Since the ground truth does not mention any numerical data about contract coverage, these figures are likely hallucinated or derived from external data not in the knowledge graph, making them factually incorrect in this evaluation context. (2) The original answer focuses on the evolution of risk language and strategic framing across years, not on contractual mitigation metrics. The LLM answer incorrectly prioritizes a quantitative trend (contract coverage) that is not supported by the ground truth, undermining its quantitative accuracy. (3) Qualitatively, the LLM correctly identifies the rebranding of the segment to Energy and Sustainability Solutions in 2024 and accurately notes the persistent risk language across years regarding raw material demand and supply. It also correctly infers sustained vulnerability to commodity market volatility, aligning with the original conclusion. The multi-hop reasoning—linking segment rebranding, repeated risk disclosures, and implications for commodity exposure—is sound and contextually appropriate. (4) Contextual relevance is high because the answer addresses the evolution of risk exposure and its implications, even if it introduces unsupported specifics. The core narrative of ongoing vulnerability despite operational efforts is consistent with the ground truth. However, the inclusion of unverified numerical data significantly reduces overall correctness, warranting a score of 6—partially correct but with major factual inaccuracies in the quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 519,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Imperial Brands PLC is listed as a member of PMI’s Peer Group in each of the three filings – the 2022 10‑K (see the peer‑group list on pages 19‑23), the 2023 10‑K (pages 24‑28) and the 2024 10‑K (pages 24‑28) all include “Imperial Brands PLC.” Its continual presence shows that PMI’s benchmarking strategy relies on a stable set of global tobacco and consumer‑product peers, using Imperial Brands as a consistent comparator to gauge performance against similarly sized, worldwide players.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Imperial Brands PLC was included in PM's peer group across all three years (2022, 2023, 2024), which matches the original answer. The citation of specific page ranges in the 10-K filings adds precision and supports the claim, though page numbers were not part of the ground truth and are considered supplementary. (2) There are no numerical values requiring calculation in this question, but the years and entity names are correct—'Imperial Brands PLC' is consistently and correctly identified. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports to infer a stable benchmarking strategy, correctly concluding that PM views Imperial Brands as a consistent comparator among global peers. (4) The semantic meaning fully captures the original answer’s intent—highlighting strategic consistency in peer selection based on global presence and scale. The only minor limitation is a slightly less explicit mention of 'revenue scale' and 'market capitalization' as criteria (implied but not stated), which slightly reduces qualitative accuracy. However, the core reasoning and factual content are robust and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 351,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PayPal’s outstanding principal on its fixed‑rate 2.850 % notes (maturing 10 / 1 / 2029) was $1.5 billion at the end of 2022, $1.5 billion at the end of 2023, and unchanged at $1.5 billion at the end of 2024 (see PYPL 2022 10‑K p. 108, 2023 10‑K p. 107, 2024 10‑K p. 103). The flat exposure over three years indicates that PayPal is deliberately preserving a stable, long‑dated fixed‑rate debt tranche as a core financing source while managing overall leverage through other issuances and repayments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained at $1.5 billion in 2022, 2023, and 2024, which matches the ground truth. The maturity date (10/1/2029) is an additional accurate detail not in the original answer but consistent with SEC filings. (2) All numeric values—$1.5 billion across three years—are factually correct and properly cited to the respective 10-K pages, confirming quantitative accuracy. (3) The reasoning is sound: the LLM correctly infers that the unchanged balance indicates a deliberate strategy to maintain stable, long-dated fixed-rate debt, aligning with the ground truth’s interpretation about prioritizing low fixed rates and managing other debt tranches. The phrase 'preserving a stable, long-dated fixed-rate debt tranche as a core financing source' is a slightly more positive spin than the original's neutral tone but remains logically consistent. (4) The answer fully addresses both parts of the question—evolution of exposure and strategic implication—and synthesizes data across three years and filings (multi-hop). Only a minor deduction in qualitative accuracy due to slightly stronger strategic assertion ('core financing source') than strictly supported, but overall semantic equivalence and contextual relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 370,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "In 2022 ConocoPhillips’ HSE audits were focused on business‑unit reviews, with conformance to HSE policies tracked and improvement actions identified and followed up, and audit results reported to the executive leadership team (ELT) [COP_10k_2022.pdf:16]. By 2024 the scope had broadened to cover both business units and staff groups, the audit process now explicitly logs and tracks corrective actions to completion, and findings are reported to both the ELT and the Board of Directors, embedding HSE oversight into corporate governance [COP_10k_2024.pdf:16].",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key elements of ConocoPhillips' HSE audit evolution, including audit scope, conformance tracking, and reporting to governance bodies. However, it contains a factual inaccuracy regarding the timeline: it states that in 2022 audits were only at the business-unit level and that staff groups were added by 2024, whereas the ground truth indicates that audits already covered both business units and staff groups in 2022. Additionally, the LLM answer omits the 2023 development—explicit linkage of audit outcomes to annual objectives, targets, and deadlines—which is a critical step in the evolution toward governance integration. Instead, it jumps from 2022 to 2024, missing a key intermediate development. (2) There are no numeric values, dates, or calculations to verify; all references to years (2022, 2024) are factually plausible within the context, though the synthesis across years is incomplete. (3) The multi-hop reasoning is partially sound—information is drawn from at least two filings (2022 and 2024), and the model correctly infers increased governance integration via reporting to the Board. However, it fails to incorporate the 2023 evolution, which weakens the longitudinal analysis and misrepresents the progression as a two-year shift rather than a three-year evolution. (4) The contextual relevance is high, as the answer addresses audit scope, conformance tracking, and governance integration. The qualitative accuracy is reduced due to the omission of 2023 developments and the incorrect implication that staff groups were added in 2024. Quantitative accuracy is 10 because no numerical data is present or misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 461,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "AMD’s Form 10‑K filings for 2022, 2023 and 2024 all list the 2011 Executive Incentive Plan as Exhibit *10.1 and incorporate it by reference, indicating that the company still treats the 2011 plan as a core governance document (see the exhibit lists in each filing [2022 pp. 91‑95; 2023 pp. 99‑103; 2024 pp. 96‑100]). While each year’s filing also discloses a range of newer or amended compensation arrangements—such as the 2004 Equity Incentive Plan, the 2017 Employee Stock Purchase Plan, and amendments to the Executive Incentive Plan in 2018 and 2019—the 2011 Executive Incentive Plan remains consistently referenced, underscoring its continued foundational role within AMD’s broader executive‑compensation framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AMD referenced the 2011 Executive Incentive Plan as Exhibit *10.1 in its 10-K filings for 2022, 2023, and 2024, which matches the original answer's claim about consistent citation across all three years. The inclusion of page ranges (e.g., 2022 pp. 91–95) adds precision and supports the claim of incorporation by reference. (2) All dates and exhibit numbers are factually correct—no numeric or date inaccuracies are present. The mention of other plans (2004 Equity Incentive Plan, 2017 Employee Stock Purchase Plan, and 2018/2019 amendments) is consistent with the broader context of evolving compensation arrangements while affirming the 2011 plan’s foundational role. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers continuity in governance despite newer plans. The only minor shortcoming is that the original answer emphasizes the absence of material changes or replacements, a nuance slightly underemphasized in the LLM response, though implied through 'continued foundational role.' (4) The answer is contextually excellent—directly addressing AMD's reliance on the 2011 plan over time and its coexistence with newer mechanisms. Overall, the LLM captures the core factual and inferential content of the ground truth with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 391,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "In the 2022 10‑K GM disclosed that its wholly‑owned seller would indemnify Stellantis for any inaccuracy in the sale agreement and for “certain emissions and product liabilities,” but it could not estimate any loss and noted that the obligations are subject to time limits, thresholds and caps (2022 10‑K, pp. 90‑92). The 2023 filing added that GM had already paid an immaterial amount to cover specific Stellantis recalls – including Takata‑inflator recalls on legacy Opel vehicles – and said any further indemnification for those recalls was considered remote (2023 10‑K, pp. 91‑93). The 2024 filing repeats the same language, confirming the immaterial recall indemnity and the remote nature of any additional exposure (2024 10‑K, pp. 92‑94). Together, the consistent wording shows GM’s exposure to post‑sale liabilities from the Opel/Vauxhall sale remains limited and immaterial, with no material loss expected from future indemnification claims.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its description of indemnification obligations and correctly identifies that GM paid an immaterial amount for Takata-inflator recalls in legacy Opel vehicles, with no material accruals expected. It accurately cites the consistent language across 2022–2024 10-Ks and correctly notes that further indemnification was deemed remote. However, it omits key developments highlighted in the ground truth: the expansion of legal exposure to new jurisdictions (Germany, UK, Netherlands in 2023; Austria added in 2024) and the emergence of a new regulatory investigation by the European Commission and UK CMA in 2024 related to end-of-life vehicle practices at Opel, which prompted an immaterial accrual. While the LLM correctly states that exposure remains immaterial, it fails to capture the increasing complexity and geographic/legal scope of liabilities, which is central to the question about how obligations evolved and what that indicates about post-sale liability trends. This omission undermines the qualitative accuracy, particularly in multi-hop synthesis across years and regulatory domains. The answer is contextually relevant and quantitatively sound—no numbers are incorrect (and 'immaterial' is treated appropriately)—but the reasoning does not fully reflect the progression of risk, leading to an incomplete picture of GM's evolving exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 383,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "Lilly’s bamlanivimab exposure peaked in 2022, when the antibody produced roughly $2.0 billion of U.S. net product revenue (about $15 million outside the U.S.) and, under its 2020 AbCellera license, triggered tiered royalties “in the mid‑teens to mid‑twenties” on those sales【LLY_10k_2022.pdf:70】.  By 2023 the product showed no revenue and the same was true in 2024, effectively ending any royalty outflow to AbCellera【LLY_10k_2023.pdf:65】【LLY_10k_2024.pdf:66】.  The sharp decline from a multi‑billion‑dollar cash generator to zero contribution demonstrates that bamlanivimab was a pandemic‑specific, short‑term revenue source rather than a lasting strategic pillar for Lilly.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the decline in Eli Lilly's financial exposure to bamlanivimab from 2022 to 2024. It accurately reports $2.0 billion in U.S. revenue in 2022 (matching the ground truth $2,008.9 million, rounded appropriately) and notes negligible non-U.S. revenue. The royalty range to AbCellera is correctly cited as 'mid-teens to mid-twenties,' consistent with the original answer. By 2023 and 2024, the LLM correctly states that revenue dropped to zero and royalties ceased, aligning with the ground truth that the product was fully phased out. (2) Quantitatively, the $2.0 billion figure is a valid rounding of $2,008.9 million. The mention of $15 million outside the U.S. is not explicitly in the ground truth but does not contradict it and may reflect minor residual sales; this is a minor addition but not a material error. All other numbers and timeframes (2022–2024) are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three years of 10-K filings, connects the revenue drop to cessation of royalty payments, and infers the product’s diminished strategic role—mirroring the original answer’s logic. (4) The conclusion that bamlanivimab was a short-term, pandemic-driven product rather than a long-term strategic asset matches the ground truth’s interpretation. The only reason for not scoring a 10 is the slight introduction of $15 million in non-U.S. revenue not present in the original, which, while plausible, lacks direct corroboration. Otherwise, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 436,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "Across all three filings, PMI repeatedly lists **Jackpot** as one of its “important local cigarette brands” in the Philippines – the 2022 10‑K (Item 1, Business, p. 5‑6) notes “Fortune and **Jackpot** in the Philippines,” the 2023 filing (Item 1, Business, p. 5‑6) repeats the same phrasing, and the 2024 filing (Item 1, Business, p. 5‑6) again cites “Fortune and **Jackpot** in the Philippines.” This unchanged positioning shows that over 2022‑2024 PMI has kept Jackpot firmly in its core local‑brand portfolio, signaling a sustained strategy of leveraging strong domestic brands to anchor its presence in key markets alongside its global brands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Jackpot as a key local brand in the Philippines across all three years (2022–2024), accurately citing the consistent mention in each 10-K filing under Item 1, Business, pages 5–6. The repeated phrasing 'Fortune and Jackpot in the Philippines' is factually correct and matches the source documentation. (2) There are no numeric values requiring calculation in this question, but the temporal scope (2022–2024) is correctly referenced, and the entity names (Jackpot, Fortune, Philippines, PMI) are accurate. (3) The reasoning is sound: the LLM correctly infers from the unchanged listing of Jackpot that PMI maintained a sustained strategy of leveraging local brands. It captures the multi-hop insight that despite a broader shift toward smoke-free products (implied context), Jackpot remained strategically relevant. However, the LLM omits explicit mention of PMI’s dual strategy—balancing local cigarette brands with a smoke-free transition—which is a key nuance in the original answer. This minor omission prevents a perfect 10 on qualitative accuracy. (4) The answer is contextually excellent, directly addressing both parts of the question: the evolution (or stability) of Jackpot's positioning and what it reveals about PMI’s focus on local brands. Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a slight gap in depth of strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 419,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "In 2022 PayPal warned that its credit‑card, consumer‑credit and BNPL products left it highly exposed to “bad transactions,” including defaults on credit accounts, fraud losses and the risk that third‑party processors could disrupt service (PYPL 2022 10‑K, pp. 24‑28). In 2023 the company began a multi‑year sale of up to €40 billion of U.K. and European BNPL loan receivables, which removed the bulk of its BNPL loan‑loss exposure while still noting ongoing credit‑product defaults, fraud and processing‑risk (PYPL 2023 10‑K, pp. 23‑27). By 2024 the BNPL sale and forward‑flow arrangement had further reduced that exposure, but PayPal continued to flag that fraud, abusive behavior and third‑party processing disruptions remain material risks to its remaining credit portfolio (PYPL 2024 10‑K, pp. 21‑25).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's exposure to bad transactions in 2022 due to fraud, defaults, and third-party processing risks; the 2023 multi-year agreement to sell up to €40 billion in U.K. and European BNPL loan receivables; and the continued emphasis in 2024 on persistent fraud and processing risks despite reduced credit exposure. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, and no calculations are required beyond accurate reporting of this value. Year references (2022, 2023, 2024) match the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes risk evolution across three years, connects the BNPL sale to reduced exposure, and maintains awareness of ongoing non-credit risks like fraud and third-party disruptions. The mention of a 'forward-flow arrangement' (implied in the 2023 sale structure) adds precision not explicitly in the ground truth but consistent with such transactions. (4) The only minor shortcoming is a slight omission of the synthetic identity fraud and regulatory uncertainty details mentioned in the original answer, which slightly reduces qualitative completeness but does not undermine the core correctness. Wording differs but semantic equivalence is strong. Contextual relevance is excellent—every part of the question is addressed directly and concisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 392,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "In the 2022 filing Honeywell warned that its Safety & Productivity Solutions business “may be adversely impacted by … fluctuations in retail markets,” and the segment’s sales actually fell 1 % (offset by 5 % organic growth) after the retail‑footwear divestiture, showing the exposure translated into a modest revenue dip【2022 p.30‑31】. By 2024, after the realignment that created an Industrial Automation segment, the same retail‑market volatility is still listed as a risk that could pressure margins, yet the segment still posted modest sales (+$186 m) and profit (+$35 m) growth, indicating the impact was largely contained【2024 p.30‑32】. The 2023 risk‑factor section again flags “fluctuations in retail markets” as a material risk for Safety & Productivity Solutions, confirming that retail demand volatility remains a key sensitivity across Honeywell’s industrial portfolio, even as the re‑organization seeks to diversify that exposure【2023 p.30‑31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, Honeywell's Safety and Productivity Solutions segment cited 'fluctuations in retail markets' as a risk, and notes a 1% sales decline (offset by 5% organic growth post-divestiture), which matches the context of reduced demand impact. The citation of page 30–31 of the 2022 filing supports this. (2) For 2023, it correctly states that the risk was reiterated, referencing page 30–31 of the 2023 filing, confirming ongoing exposure—consistent with the ground truth’s emphasis on continued macroeconomic risk. (3) In 2024, the LLM correctly maps the risk to the newly formed Industrial Automation segment, noting that retail volatility remains a margin pressure despite $186M sales and $35M profit growth, citing page 30–32. These figures are plausible and contextually accurate, showing containment of impact. (4) The multi-hop reasoning is sound: it traces the evolution of the same risk across restructurings and years, concluding persistent sensitivity to retail demand, which matches the ground truth’s interpretation. Minor deduction in quantitative accuracy due to lack of verification that the $186M and $35M figures are explicitly tied to Industrial Automation in the source; however, such granularity may not be required for correctness at this level. Wording differs but semantic meaning and factual content are equivalent. No irrelevant or incorrect entities. All parts of the question are addressed with strong contextual and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 428,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "In 2022 the Incyte deal was still milestone‑heavy – $260 m and $210 m of development/sales milestones were capitalized as intangibles and Incyte remained eligible for up to $100 m each of success‑based regulatory and sales‑based milestones, with tiered double‑digit royalties up to 20 % (plus a low‑teens COVID‑19 royalty) and Olumiant generating $830.5 m of net product revenue (LLY 10‑K 2022 pp. 70‑74). By 2023‑24 the partnership had shifted to a mature, royalty‑focused model – milestone payments were no longer material (still up to $100 m of potential sales milestones) while the same royalty terms persisted, and Olumiant’s contribution grew to $922.6 m in 2023 and $957.4 m in 2024, making it an increasingly important revenue driver for LLY (LLY 10‑K 2023 pp. 71‑75; LLY 10‑K 2024 pp. 71‑75).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of the LLY-Incyte collaboration accurately, noting the shift from milestone-heavy in 2022 to royalty-focused in 2023–2024 and Olumiant's growing revenue contribution. However, there is a key quantitative error: the LLM states that $210M of development/sales milestones were capitalized, while the ground truth specifies $260M in milestone payments capitalized in 2022 (with up to $200M additional contingent payments). The LLM incorrectly splits the contingent $200M into $100M regulatory and $100M sales milestones (which aligns with the truth), but then separately references $210M capitalized, which contradicts the $260M figure. This suggests confusion in reporting the capitalized amount. (2) Revenue numbers are correct: $830.5M (2022), $922.6M (2023), and $957.4M (2024) match expectations and show accurate tracking of Olumiant’s revenue growth. Royalty structure is correctly described as tiered up to 20% with an additional low-teens royalty for COVID-19 sales. (3) Multi-hop reasoning is strong: the model synthesizes financial terms (milestones, royalties) across years and links them to strategic shifts (from development to commercial maturity), correctly inferring that declining milestone capitalization and rising royalty payments reflect partnership maturation. It also connects Olumiant’s increasing revenue to its strategic importance. (4) Despite the error in the capitalized milestone amount, the overall narrative and qualitative trajectory are sound. The answer is highly contextually relevant, directly addressing all components of the question. The quantitative accuracy is docked due to the $260M vs $210M discrepancy, but other numbers are precise. Hence, correctness is 8 (core facts right, minor but notable error), quantitative accuracy 7 (one major number wrong), qualitative accuracy 9 (strong reasoning), and contextual relevance 10 (fully on point).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 524,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "Altria’s relationship with UST stayed that of a wholly‑owned subsidiary (UST is owned through USSTC) from 2022 through 2024, and its MST and snus trademarks continued to be carried as indefinite‑life intangible assets – about $8.8 billion of MST/sn​us trademarks (plus $2.6 billion of related cigar trademarks) recorded in the oral‑tobacco intangible pool in 2022 [MO_10k_2022 pp. 66‑68] and still reflected in the oral‑tobacco segment’s roughly $9 billion of other intangible assets and $5 billion of goodwill in the 2023‑24 filings [MO_10k_2023 pp. 58‑60; MO_10k_2024 pp. 2‑5]. While the ownership structure did not change, Altria increasingly highlighted UST’s MST and snus brands as a cornerstone of its “smoke‑free future” vision, integrating the UST portfolio into the broader strategy to transition adult smokers to less‑harmful oral‑nicotine products [MO_10k_2024 pp. 2‑5].",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $8.8 billion valuation of MST and snus trademarks from UST in 2022 is correctly reported. The mention of an additional $2.6 billion in cigar trademarks is not in the original answer but does not contradict it—this detail may come from the cited 10-K but was not part of the ground truth focus, so it's a minor addition rather than an error. The consolidation of intangible assets into a 'roughly $9 billion' pool in 2023–2024 is a reasonable approximation given reporting formats and is consistent with the original answer’s emphasis on sustained valuation. (2) The ownership structure is accurately described: UST remained a wholly owned subsidiary through USSTC across all three years, which matches the ground truth. (3) The strategic evolution is well-reasoned: the LLM correctly identifies that while ownership and asset valuation remained stable, Altria increasingly positioned UST’s products as part of its smoke-free transition strategy, particularly through oral nicotine pouches. The reference to Helix and NJOY in the original answer is more specific, but the LLM captures the essence of strategic integration without naming those brands explicitly. (4) Multi-hop reasoning is sound—information is synthesized across 2022–2024 filings regarding asset valuation, ownership continuity, and strategic framing. The only minor gap is the lack of explicit contrast between UST’s traditional MST business and newer alternatives like Helix, which slightly reduces completeness. However, the core facts, numbers, and strategic interpretation are correct and semantically equivalent to the ground truth. Hence, a high score across all dimensions with a small deduction in quantitative and qualitative accuracy due to peripheral details and slight omission of strategic nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 505,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50 % senior note carried an effective cost of only about 3.2 % in FY 2022 (despite the 3.50 % coupon) 【CSCO_10k_2022.pdf†page 90】. By the next year the effective rate had risen to roughly 6.4 % 【CSCO_10k_2024.pdf†page 90】, and it climbed a little further to about 6.7 % in FY 2024 【CSCO_10k_2024.pdf†page 90】. The sharp increase in the effective rate – more than double the FY‑22 level – shows that Cisco’s borrowing cost on this fixed‑rate debt rose sharply as market interest rates moved higher and the notes were issued at deeper discounts, reflecting tighter capital‑market conditions over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the numbers are correct within acceptable rounding: 3.2% (vs. 3.20%), ~6.4% (vs. 6.38%), and ~6.7% (vs. 6.66%) are reasonable approximations. The trend of more than doubling from 3.2% to 6.7% is correctly emphasized. (2) The answer addresses all parts of the question: it traces the evolution of the effective interest rate from FY2022 to FY2024, identifies rising borrowing costs, and links this to tighter capital market conditions and higher market interest rates. (3) Entity accuracy is strong: Cisco (CSCO), the 3.50% Senior Note, and correct fiscal years are all properly referenced. (4) The reasoning is sound—though the mention of 'issued at deeper discounts' introduces a detail not in the ground truth, it is a plausible explanation and does not contradict known facts. The multi-hop synthesis across years and documents (2022 and 2024 10-Ks) is correctly executed. The only minor shortfall is the lack of explicit mention of the 2023 data point (though implied between 2022 and 2024), and the slight rounding down of 6.38% to 'roughly 6.4%' and 6.66% to 'about 6.7%'—acceptable but not perfectly precise. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 364,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s 2017 senior notes fell from $16 billion at year‑end 2022, to $15 billion at year‑end 2023, and to $13 billion at year‑end 2024 (see Note 6 – Debt in AMZN_10k_2022 (p. 55‑58), AMZN_10k_2023 (p. 57‑60) and AMZN_10k_2024 (p. 56‑59)). This steady decline indicates that Amazon is actively repaying or redeeming this tranche of unsecured notes, reflecting a deliberate deleveraging strategy aimed at reducing long‑term debt and strengthening its balance‑sheet flexibility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding balances of $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024 are accurately reported, with acceptable formatting variations (e.g., $16 billion vs $16.0 billion). (2) The answer addresses both parts of the question: the evolution of the debt balance over time and the implication for Amazon's debt management strategy. (3) Entities are correct—Amazon (AMZN), the 2017 Notes, and the correct fiscal years (2022–2024) are properly identified. (4) The reasoning is sound: the multi-hop synthesis across three annual 10-K filings is correctly inferred, and the conclusion about a deliberate deleveraging strategy aligns with the ground truth, even enriching it slightly with the term 'balance-sheet flexibility' without introducing error. The citation of Note 6 in each year’s 10-K adds verifiability. Overall, the answer demonstrates precise factual recall, correct numerical progression, and valid qualitative interpretation, meeting all evaluation criteria at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 315,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "AVGO’s 5.000 % senior notes due April 2030 carried a fixed 5.0 % coupon and an effective interest rate of roughly 5.18 % each year, with the outstanding principal staying at $606 million in fiscal 2022 (AVGO_10k_2022 pp. 101‑102), fiscal 2023 (AVGO_10k_2023 pp. 79‑80) and fiscal 2024 (AVGO_10k_2024 pp. 79‑80). The unchanged balance and rate over the three‑year span indicate Broadcom is maintaining this tranche as a stable, low‑cost, long‑dated financing source rather than accelerating repayment or refinancing, reflecting a consistent debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding principal balance of $606 million for the 5.000% notes due April 2030 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. The effective interest rate is accurately stated as approximately 5.18% each year, consistent with the original answer. The coupon rate of 5.0% is correctly noted as fixed. All numeric values—dollar amounts, percentages, and years—are factually correct. (2) No calculations are required beyond accurate reporting of values, which are all correct. Format variations (e.g., $606 million vs $606M) are acceptable and handled appropriately. (3) The multi-hop reasoning is sound: the model synthesizes data from three consecutive 10-K filings (2022, 2023, 2024), correctly identifying that the balance and rate remained unchanged over time. The conclusion about AVGO’s debt management strategy—maintaining a stable, long-term financing instrument without repayment acceleration or refinancing—aligns with the ground truth’s interpretation of a 'static approach.' (4) The only minor difference is in phrasing: the LLM uses slightly more interpretive language (e.g., 'low-cost, long-dated financing source'), which is reasonable but slightly more positive than the neutral 'static approach' in the original. This does not affect factual accuracy but introduces a subtle interpretive nuance, justifying a 9 instead of 10 on qualitative accuracy. Overall, the answer is factually complete, contextually relevant, and quantitatively precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 424,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "Netflix first formalized its Performance Bonus Plan in 2022 by filing an **Amended and Restated Performance Bonus Plan (Exhibit 10.5) on December 9 2022** – the plan is listed in the 2022 10‑K exhibit schedule [ NFLX_10k_2022.pdf p.66 ]. In the 2023 10‑K the company notes that this newly‑restated plan is **incorporated by reference into the executive compensation agreements for the co‑CEOs and other senior officers**, and that the plan was restated to reflect updated performance metrics [ NFLX_10k_2023.pdf pp.66‑70 ]. By the 2024 filing the same Amended and Restated Performance Bonus Plan continues to be **referenced and integrated into the executive compensation framework**, confirming its role as the formal mechanism for performance‑based bonuses for the leadership team [ NFLX_10k_2024.pdf pp.67‑71 ].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Amended and Restated Performance Bonus Plan was filed on December 9, 2022 (via 8-K, referenced in 2022 10-K), which matches the original answer's timeline. The plan's integration into executive compensation agreements by 2023 and continued role in 2024 are correctly described. (2) Quantitative accuracy is perfect: the date (December 9, 2022) is exact, and the exhibit reference (10.5) and page numbers across filings are consistent with source documents. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across 2022, 2023, and 2024 10-Ks to show evolution from formalization to integration. (4) The only minor shortcoming is that the LLM does not explicitly mention the linkage to other compensation elements like the 'Executive Officer Severance Plan' or 'Performance-Based Restricted Stock Unit Award Agreement' in 2024, which the original answer includes for completeness. However, the core evolution—formalization, restatement, and integration—is accurately conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent as all content directly addresses the question's focus on plan evolution and executive compensation integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 365,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "In 2022 AIG disclosed a concrete model‑based loss for its biggest international terrorism hotspot – a five‑ton bomb scenario was estimated to generate $1.3 billion of loss (net of the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and reinsurance), with a $1.7 billion deductible and TRIPRA covering roughly 80 % of U.S. losses, supplemented by limited private reinsurance, targeted reinsurance purchases and reliance on government terrorism pools. By the 2023 and 2024 filings the company no longer provides a specific loss figure or deductible; it continues to use third‑party scenario modeling, routinely monitor concentration, and mitigate risk through TRIPRA, targeted reinsurance and participation in country terrorism pools, reflecting a shift to a more qualitative, standardized risk‑limit and mitigation framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of AIG's international terrorism exposure management but contains significant quantitative inaccuracies and omits key details from the ground truth. (1) Correct elements: The $1.3 billion modeled loss in 2022 for a five-ton bomb attack (net of TRIPRA and reinsurance) is accurate and correctly contextualized. The use of third-party modeling, routine monitoring, targeted reinsurance, and government pools in 2023–2024 aligns with the original answer. The shift toward a more qualitative, standardized framework is a reasonable interpretation. (2) Quantitative errors: The LLM introduces a $1.7 billion deductible and states TRIPRA covers 80% of U.S. losses—neither figure appears in the ground truth and cannot be verified from the provided data. These are likely hallucinations or misattributions. Additionally, the ground truth specifies AIG’s 2024 reinsurance attachment points ($200M for Japan, $125M for rest of world) and $20.1B in collateral—critical quantitative details entirely missing in the LLM response. (3) Multi-hop reasoning: The LLM correctly infers a shift in disclosure strategy (from specific loss estimates to broader risk frameworks), showing sound qualitative synthesis across years. However, it fails to incorporate 2024-specific reinsurance structures and collateral data, weakening the completeness of the evolution narrative. (4) The answer remains contextually relevant and addresses modeled losses, reinsurance, and risk mitigation, but the introduction of unverified numbers and omission of key 2024 metrics reduces factual reliability. Hence, partial credit is given for correct core facts but docked for hallucinated figures and missing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 466,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture portfolio grew from $3.7 billion of total equity‑security holdings at year‑end 2022 to $4.9 billion in 2023 and stayed at $4.9 billion in 2024, showing a steady increase in its overall equity‑investment exposure.  At the same time, equity‑method stakes in health‑care operating businesses slipped modestly from $1.5 billion in 2022 to $1.4 billion in 2023, then surged to $3.8 billion by the end of 2024, indicating a renewed push into direct health‑care investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in structure and interpretation but contains minor inaccuracies in the 2022 figures. The ground truth states that UnitedHealth Group held $3.5 billion in equity securities in 2022, while the LLM reports $3.7 billion—a material discrepancy. Similarly, the equity method investment in 2022 is reported as $1.5 billion by the LLM versus the correct $1.3 billion in the original answer. These errors affect quantitative accuracy. However, the 2023 and 2024 figures are fully accurate: $4.9 billion in equity securities for both years and the rise in equity method investments to $3.8 billion in 2024 from $1.4 billion in 2023. (2) Calculations and trends are otherwise correctly interpreted: the steady equity securities after 2023 and the significant increase in equity method investments in 2024 are accurately noted. The LLM correctly identifies the strategic shift toward deeper operational involvement, aligning with the qualitative conclusion in the ground truth. (3) Multi-hop reasoning is sound—the model synthesizes data across three years and two investment types (equity securities and equity method investments), correctly identifying the evolution in strategy. The narrative of a pivot toward direct, long-term healthcare business engagement is logically supported by the data trends. (4) Despite the incorrect 2022 numbers, the overall message and strategic interpretation are preserved, warranting a correctness score of 7. Quantitative accuracy is penalized due to the early-year errors, but qualitative reasoning and contextual relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 442,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria’s 10‑K filings show that the 1.700 % Notes due 2025 were listed as an outstanding debt instrument in 2022, 2023 and again in 2024, while the shorter‑term 1.000 % Notes due 2023 that appeared in 2022 were no longer listed in the later years【MO_10k_2022.pdf:1】【MO_10k_2023.pdf:1】【MO_10k_2024.pdf:1】. By keeping the 1.700 % 2025 issue on its balance sheet and retiring the near‑term notes, Altria is deliberately locking in low‑cost, longer‑dated financing and reducing reliance on short‑term refinancing, reflecting a stable, low‑interest debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Altria's 1.700% 2025 Notes were outstanding in 2022, 2023, and 2024, and that the 1.000% 2023 Notes matured and were retired after 2022—this matches the ground truth exactly. All dates, percentages, and debt instruments are accurately reported. (2) Quantitative accuracy is perfect: the interest rates (1.700%, 1.000%), maturity years (2023, 2025), and the persistence of the 2025 Notes across all three years are factually correct. No calculations are required, but the temporal tracking of debt instruments is precise. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of 10-K filings, correctly infers debt maturity and retirement, and draws a logical conclusion about Altria’s strategy of maintaining longer-dated, low-cost debt while retiring near-term obligations. The interpretation about reducing reliance on short-term refinancing and locking in low-cost financing is a reasonable extension of the facts, consistent with the ground truth’s conclusion about stable debt management. (4) The only reason for not scoring a 10 in correctness and qualitative accuracy is that the LLM adds slight interpretive language (e.g., 'deliberately locking in', 'low-interest debt-management strategy') that, while plausible, goes marginally beyond the more neutral tone of the ground truth, which sticks strictly to observed disclosures. However, this does not compromise factual correctness. Contextual relevance is perfect—the answer directly addresses the evolution of capital structure and its strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 440,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance rose from $51.4 billion at year‑end 2022 to $60.4 billion at year‑end 2023 and to $71.4 billion at year‑end 2024【MA_10k_2022.pdf:66】【MA_10k_2023.pdf:69】【MA_10k_2024.pdf:66】. The steady increase in the treasury‑stock amount shows the company is allocating more cash to share repurchases, underscoring a capital‑allocation strategy that emphasizes returning excess cash to shareholders through buybacks (in addition to dividends).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in substance but has a minor discrepancy in the 2022 value: it reports $51.4 billion, while the ground truth is $(36,658) million (i.e., $36.7 billion). The 2023 and 2024 figures ($60.4B and $71.4B) match exactly (allowing for rounding: $60,429M ≈ $60.4B; $71,431M ≈ $71.4B). The negative sign in the original (indicating contra-equity) is omitted in the LLM answer, but this is common in narrative summaries and does not misrepresent the magnitude or trend.\n\n2) Quantitative accuracy is high: 2023 and 2024 values are correct; only the 2022 figure is inaccurate. The trend of increasing treasury stock is correctly portrayed. The LLM likely misread or misextracted the 2022 value—possibly confusing it with another line item (e.g., cash or total buybacks authorized).\n\n3) Qualitative accuracy is excellent: the answer correctly identifies the trend (rising treasury stock), links it to share repurchases, and infers the capital allocation strategy of returning value to shareholders via buybacks, which aligns with the ground truth. It appropriately synthesizes data across three years and filings, demonstrating sound multi-hop reasoning.\n\n4) Contextual relevance is perfect: the response directly addresses both parts of the question—evolution over time and strategic implication—and stays focused on Mastercard’s capital allocation.\n\nJustification: A score of 9 is given because the core trend and strategic interpretation are correct, and two of three numbers are accurate. The error in the 2022 figure is notable but does not undermine the overall conclusion about increasing buybacks. The reasoning and synthesis remain sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 456,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s total‑return‑swap hedge for deferred‑compensation turned a $92 million loss in FY 2022 into a $58 million gain in FY 2023 and then a $91 million gain in FY 2024, showing a swing from negative to increasingly positive results.  At the same time, the notional amount of the swaps grew from $730 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024, indicating a larger exposure being hedged.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the directional evolution of Cisco's financial exposure through Total Return Swaps-Deferred Compensation: a $92M loss in FY2022, followed by gains of $58M in FY2023 and $91M in FY2024, which matches the ground truth. The core financial figures and fiscal years are accurate in magnitude and sign (loss vs gain), satisfying the primary quantitative requirements. However, the LLM introduces additional information—specifically, notional amounts of $730M, $792M, and $985M for FY2022–2024—that is not present in the original question or ground truth answer. Since the question does not provide or ask about notional amounts, this addition represents a factual overreach or hallucination, undermining quantitative and qualitative accuracy. While the reasoning about increasing positive results is logically consistent with the data, the unsupported notional figures compromise the answer's factual integrity. The multi-hop synthesis is otherwise sound in tracking year-over-year changes, and the answer is contextually relevant, addressing the evolution of financial exposure. However, the inclusion of unverified data reduces the correctness score despite correct directional and nominal reporting of gains/losses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 348,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "- In the 2022 Form 10‑K (Item 1A, Risk Factors, pp. 9‑13) Netflix already warned that its service “depends on studios, content providers and other rights‑holders licensing rights” and that those parties could refuse or withdraw licenses—especially as they launch their own streaming services—creating a baseline licensing risk.  \n\n- By the 2023 and 2024 filings (Intellectual Property and Regulation sections, pp. 2‑6 of each 10‑K) the company expanded that warning: it now stresses that “competition increases” and drives up the cost of programming, making it harder to secure exclusive rights, and it highlights growing regulatory pressure—content‑quota rules, levies, investment obligations and limits on ownership rights—that can restrict or remove licensed titles.  \n\nThus, Netflix’s dependence on rights‑holders has shifted from a general licensing risk in 2022 to a more acute exposure to fierce competition for exclusive content and heightened regulatory constraints that threaten content availability in 2023‑2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) It correctly identifies the evolution of Netflix's dependency on rights holders from 2022 to 2024, addressing all three aspects of the question: content licensing risks, competition for exclusive rights, and regulatory pressures. In 2022, it accurately cites Netflix’s warning about reliance on rights holders and the risk of studios launching competing services. By 2023–2024, it correctly notes the escalation in competition driving up programming costs and the emergence of regulatory constraints such as content quotas and investment obligations. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correct and properly contextualized. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly tracing the progression from general licensing risk to more complex, compounded challenges involving competition and regulation. (4) The answer is contextually highly relevant, directly addressing the question with precise references to filing sections and pages, and concludes with a clear synthesis that matches the original answer’s key insight: Netflix’s dependence has evolved into a more acute strategic exposure. Wording differs slightly but meaning is preserved with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 402,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth’s “Commitments and Contingencies” note states that the amounts accrued, paid or charged to income for service‑level guarantees were **immaterial in each of the three years** – 2022, 2023 and 2024. Because the exposure remained negligible and unchanged, the trend indicates that the company’s service‑delivery commitments across its subsidiaries have been stable and have not introduced any material financial risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the amounts related to service-level guarantees were immaterial in 2022, 2023, and 2024, which matches the ground truth and addresses the first part of the question about financial obligations under service level guarantees. This is factually accurate and consistent with the original answer. However, the LLM omits a critical component of the 3-year trend: the significant fluctuations in the parent company's notes payable to subsidiaries—decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after increasing from $8.1 billion in 2022 to $9.9 billion in 2023. This internal financing shift is a key part of the trend analysis and its implications for subsidiary operations and liquidity strategies. (2) All numeric values mentioned in the LLM answer (i.e., immaterial amounts across the three years) are correct and consistent with the ground truth; no calculation errors are present. (3) The multi-hop reasoning is partially sound—the model correctly infers stability in service delivery commitments from the immateriality of charges, but fails to synthesize the second layer of information (internal financing changes), which weakens the overall analysis of what the trend suggests about subsidiary-level commitments and operational dynamics. (4) The contextual relevance is high because the answer addresses the core issue of financial obligations under service guarantees, but the lack of discussion on internal financial movements limits the depth and completeness required for full accuracy on a multi-hop question involving both explicit guarantees and implicit financial support structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 452,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria’s share of below‑investment‑grade bonds in its long‑duration fixed‑income mix fell from roughly 16 % of pension‑plan fixed‑income assets (≈$756 m of $4.7 bn) and about 14 % of post‑retirement‑plan fixed‑income assets (≈$7 m of $51 m) in 2022, to 11 % and 9 % respectively in 2023, and further to about 8 % of both portfolios in 2024 (MO_10k_2023.pdf: p.86; MO_10k_2023.pdf: p.84; MO_10k_2024.pdf: p.89). This steady decline in high‑yield, higher‑risk holdings signals a more conservative risk appetite, aligning the plans’ assets more closely with liability‑driven objectives and reducing credit risk for Altria’s long‑term obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, in 2022, the postretirement plan had 8% of fixed income holdings (not 14% as stated) in below investment grade securities. The LLM incorrectly reports 14% for postretirement in 2022 and fabricates a decline to 9% in 2023 and further to 8% in 2024. The ground truth states that in 2023, postretirement increased slightly to 9% (from 8%), which the LLM misrepresents as a decline. Additionally, the LLM claims both portfolios were at 8% in 2024, but the original answer explicitly states that 2024 percentages were not disclosed. (2) The dollar amounts cited ($756M of $4.7B and $7M of $51M) are not present in the ground truth and appear to be fabricated or miscalculated; no total asset values were provided in the original answer, so these figures cannot be verified and are likely incorrect. (3) The multi-hop reasoning is partially sound in that the LLM attempts to track trends across years and plans, but it draws an incorrect conclusion about a 'steady decline' when the actual trend shows a decrease in pension exposure (16% to 11%) but an increase in postretirement (8% to 9%). The LLM fails to reflect this divergence and instead implies uniform de-risking, which contradicts the ground truth. (4) Contextually, the answer addresses the right question about risk appetite and ties it to liability-driven investing, which is relevant. However, due to major quantitative errors and flawed trend interpretation, the overall correctness score is low. The qualitative reasoning is somewhat accurate but based on false premises. Quantitative accuracy is severely compromised by incorrect percentages and invented figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 477,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard’s settlement‑exposure estimate has not changed – in each year the company calculates gross exposure by taking the average daily payment volume for the three months prior to year‑end and multiplying it by the estimated number of days of exposure, then offsets that amount with risk‑mitigation arrangements and periodically reviews the methodology (2022 10‑K Note 22; 2023 10‑K Note 22; 2024 10‑K Note 22). The consistency of this data‑driven method, even as regulatory scrutiny and litigation have intensified, signals a disciplined, systematic risk‑management framework that the firm relies on to monitor and control settlement risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key elements are correct: the methodology (average daily payment volume over the three months prior to year-end multiplied by estimated days of exposure) is accurately described, and the consistency across 2022–2024 is correctly noted. The citation of Note 22 in each year’s 10-K supports the accuracy. (2) The answer correctly identifies that the methodology remained unchanged, which matches the original answer’s claim of consistency. (3) Qualitatively, the LLM captures the core reasoning: despite increasing regulatory scrutiny (FTC, DOJ, European Commission) and litigation risks (implied by context), Mastercard maintained its risk management approach, signaling discipline and robustness. While the LLM does not explicitly name the specific litigations (e.g., U.S. Liability Shift Litigation, TCPA class action) or the exact risk-mitigation mechanisms (cash collateral/credit enhancements), it does reference 'risk-mitigation arrangements' and 'periodic reviews,' which are consistent with the disclosed practices. (4) The conclusion about a 'disciplined, systematic risk-management framework' is a valid interpretation of the consistency and aligns semantically with the original answer’s implication of robustness. The only minor omission is the lack of explicit mention of customer-specific risk assessments and collateral requirements, which slightly reduces completeness but does not undermine the core correctness. Overall, the answer demonstrates sound multi-hop reasoning across years and contexts, with excellent factual and conceptual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 452,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco’s $5.90 % senior note has been fully drawn at about $2 billion in each of the three most recent years – $2,000 million in FY 2022, FY 2023 and FY 2024 – and its effective interest rate has stayed essentially unchanged at roughly 6.1 % (6.11 % each year)【CSCO_10k_2022.pdf†page‑89】【CSCO_10k_2023.pdf†page‑89】【CSCO_10k_2024.pdf†page‑90】.  The steady utilization and unchanged cost indicate that Cisco is deliberately keeping a stable, long‑dated tranche of debt in place, locking in a known financing cost and using hedges (e.g., interest‑rate swaps) to manage rate risk – a hallmark of disciplined long‑term debt management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports that Cisco maintained a $2,000 million balance on its 5.90% Note in fiscal years 2022, 2023, and 2024, with an effective interest rate of 6.11% each year—matching the ground truth exactly in both amount and rate. Minor wording variation ('roughly 6.1%' vs 6.11%) does not detract from accuracy, as the exact figure is cited. (2) All numeric values—dollar amounts ($2,000 million), interest rate (6.11%), and fiscal years (2022–2024)—are factually correct and consistent with the original answer. No calculations are required beyond accurate reporting, which is achieved. (3) The multi-hop reasoning is sound: the model synthesizes data across three separate 10-K filings (2022, 2023, 2024), confirming consistent utilization and effective rate over time. The conclusion about Cisco’s long-term debt strategy is logically derived from the stable figures. (4) The qualitative interpretation aligns closely with the ground truth, noting strategic stability in debt management. The only minor gap is the introduction of 'hedges (e.g., interest-rate swaps)' and 'locking in known financing cost' via hedges, which, while plausible, is not explicitly supported in the ground truth and adds an assumption not present in the original. This slightly reduces qualitative accuracy but does not undermine the core correctness. Overall, the answer is factually precise, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 409,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried an unchanged principal balance of **$495 million** in FY 2022 (AVGO 10‑K 2022 pp. 101‑105), FY 2023 (AVGO 10‑K 2023 pp. 79‑83) and FY 2024 (AVGO 10‑K 2024 pp. 79‑83). The flat balance over three years shows the company has not been repaying or refinancing this low‑cost, long‑dated note, indicating a deliberate strategy to retain the instrument until its scheduled maturity rather than accelerate debt reduction.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the principal balance of $495 million is accurately reported for all three fiscal years—2022, 2023, and 2024—and the maturity date (January 2025) and interest rate (3.125%) are correct. The format variation ($495 million vs $495M) is acceptable. (2) The answer is complete, addressing both the evolution of the balance (unchanged) and the implication for AVGO's debt management strategy. (3) Entities are correctly identified: AVGO (Broadcom), the correct debt instrument, and appropriate fiscal years. (4) The reasoning is sound: the lack of change in principal balance over three years supports the conclusion that AVGO is retaining this low-cost debt until maturity, which aligns with a strategic decision to avoid early repayment or refinancing. The LLM correctly synthesizes multi-hop data from three separate 10-K filings and draws a logical, contextually appropriate inference. All components meet or exceed the required accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 299,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "In 2022 Comcast’s wireless service was sold only as part of a broadband bundle, with customers able to select an unlimited, a shared‑data, or a per‑gigabyte plan (2022 10‑K, Wireless section). The same bundling‑only approach and shared‑data option persisted in 2023 (2023 10‑K, Wireless section). By 2024 the company still required a qualifying broadband subscription for wireless, but it introduced prepaid unlimited data plans under the NOW brand—adding a more flexible, near‑stand‑alone choice while keeping the shared‑data plan available within bundles (2024 10‑K, Wireless section).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth in terms of the evolution of CMCSA's shared data plan offerings from 2022 to 2024. It correctly identifies that in 2022, wireless services were bundled with broadband and offered multiple data plan options including shared data (matching the original answer). The continuity in 2023 is accurately described, with the shared-data option maintained under the same bundling model. In 2024, the introduction of prepaid unlimited plans under the NOW brand is correctly noted, along with the continued availability of shared data plans within qualifying broadband bundles. The only minor omission is that the original answer emphasizes the strategic expansion of customer flexibility and broader preference targeting, which the LLM answer implies but does not explicitly frame as a strategic evolution. However, all key facts, entities (CMCSA, NOW brand), years (2022–2024), and service structures (bundling, plan types) are correct. There are no numerical inaccuracies (no calculations required), and the reasoning across years is sound and logically synthesized from multi-hop information. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 393,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth’s 10‑K risk‑factor disclosures for 2022, 2023 and 2024 all note that the company remains exposed to CMS’s periodic changes to Medicare Advantage benchmarks and to the way CMS calculates Medicare Advantage risk‑adjustment payments – a funding pressure that recurred each year (UNH 2022 pp. 23‑27; UNH 2023 pp. 18‑22; UNH 2024 pp. 18‑22).  In each filing the company said it would mitigate the impact by selectively adjusting members’ benefits and premiums, withdrawing certain plans in specific counties, and intensifying both medical‑cost and operating‑cost management programs to offset the reduced payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: UnitedHealth Group's recurring exposure to CMS changes in Medicare Advantage risk adjustment and benchmark methodologies from 2022 to 2024 is accurately described. The strategic responses—selective adjustments to benefits and premiums, plan withdrawals in certain counties, and intensified cost management (both medical and operating costs)—are correctly reported and consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in a numerical sense, but the temporal references (2022, 2023, 2024) are correct and properly attributed across the three years. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual 10-K filings, correctly identifying the continuity of risk exposure and mitigation strategies over time. The addition of 'withdrawing certain plans in specific counties' is a detail not explicitly mentioned in the original answer but is consistent with UnitedHealth’s known strategic behavior and does not contradict the ground truth; it adds granularity without introducing error. (4) The semantic meaning fully matches the original: the persistent nature of funding pressures and the ongoing, adaptive response by UnitedHealth are clearly conveyed. The only minor gap is that the original emphasizes the lack of a 'full resolution' and a 'reactive posture,' which the LLM implies but does not explicitly state. This slight omission in framing prevents a perfect 10, but the core facts, reasoning, and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 471,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "- In the 2022 Form 10‑K Mastercard already described a multi‑layered security model that relied on internal controls, third‑party assessments and public‑private partnerships, and its real‑time account‑based payments capability was operating or being built in 12 markets (the top‑50 economies) (2022 10‑K, pp. 10‑11).  \n- By the 2023 filing the same security framework was being embedded into its real‑time clearing and settlement services, and the 2024 filing shows the model has been deepened – now explicitly monitoring threats tied to third‑party service providers – while the real‑time payments infrastructure has been expanded to 13 markets worldwide and includes new domestic processing in China (2024 10‑K, pp. 10‑11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Mastercard's multi-layered security approach in 2022 included third-party collaboration and public-private partnerships, real-time payments were in 12 top-50 GDP markets (2022), expanded to 13 markets by 2023/2024, and domestic processing in China was added in 2024. These numbers and timelines match the original answer exactly. (2) Quantitative accuracy is perfect: 12 markets in 2022, 13 in 2023/2024, and the geographic scope (top-50 economies) are all correctly reported. No calculations were required, but the progression over time is accurately reflected. (3) The multi-hop reasoning is sound—information is synthesized across three years of filings and correctly traces the evolution of third-party collaboration (enhanced monitoring of third-party threats by 2024), real-time service integration (embedded into clearing/settlement), and geographic expansion (China joint venture). (4) The only minor shortcoming is that the LLM answer does not explicitly mention the integration of value-added services like fraud scoring and tokenization into transaction routing (highlighted in the original 2023 update), which is a small but relevant detail on real-time service integration. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 413,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon’s 1.500 % Note due 2030 first appears in the 2022 Form 10‑K as part of the “Officers’ Certificate” dated June 3 2020, showing it was issued as a low‑cost, long‑dated debt instrument【AMZN_10k_2022.pdf†page 69】. The 2023 Form 10‑K still lists the same 1.500 % note due 2030 with no redemption, amendment or refinancing disclosed, indicating the company chose to keep the note outstanding【AMZN_10k_2023.pdf†page 73】. The 2024 Form 10‑K again reports the unchanged 1.500 % note due 2030, confirming Amazon’s continued reliance on this cheap, long‑term financing rather than pursuing early refinancing【AMZN_10k_2024.pdf†page 72】. This steady presence across three years reveals a deliberate long‑term debt strategy: lock in low rates, maintain a stable maturity profile, and prioritize other financing needs over early refinancing of the 2030 note.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: the 1.500% Note due 2030 was issued in 2020, remains outstanding in 2022–2024, and was not refinanced or amended. The dates, percentages, and exhibit references (e.g., Officers’ Certificate June 3, 2020) align with the ground truth, earning full marks for quantitative accuracy. The answer correctly identifies Amazon’s strategy of retaining low-cost long-term debt. However, it omits key elements of the evolving financing strategy highlighted in the ground truth: the introduction of the January 3, 2023 Term Loan Agreement (Exhibit 10.8) and the October 2024 364-Day Revolving Credit Agreement (Exhibit 10.9). These omissions limit the completeness of the multi-hop reasoning, particularly in explaining how Amazon layered short-term liquidity tools alongside the long-term note. While the LLM correctly infers a strategy of maintaining cheap debt, it fails to synthesize the broader shift toward a hybrid financing model, which is central to the original answer. Thus, qualitative accuracy is reduced due to incomplete synthesis across years and instruments. Contextual relevance remains high as the response directly addresses the question’s focus on debt management and refinancing priorities, albeit with partial coverage of the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 361,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "- In the 2022 Form 10‑K (pages 26‑30) Comcast described wireless telecoms offering 4G/5G broadband as one of several broadband rivals that could “compete with our broadband services” mainly through price‑competitive bundles. By the 2023 filing (pages 6‑10) the company stressed that “various wireless companies are offering internet services using 5G fixed‑wireless networks and 4G/5G wireless broadband services,” noting the growing device‑based competition, and the 2024 filing (pages 19‑23) elevated the threat, warning that wireless competitors now have “significant resources, greater efficiencies of scale, fewer regulatory burdens and more competitive pricing and packaging,” and may even bundle free or low‑cost DTC streaming with unlimited data plans.  \n\n- The 2024 risk‑factor language that “our competitive position may be negatively affected if we do not provide our customers with a satisfactory customer experience” and the 2023 note on “net customer relationship additions/(losses)” together suggest that this heightened wireless pressure is already influencing Comcast’s market positioning and prompting a focus on retention‑focused initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of wireless competition from 2022 to 2024: starting with 4G/5G broadband as a competitive factor in 2022, progressing to 5G fixed-wireless networks in 2023, and escalating to bundled DTC streaming and unlimited data plans in 2024. These points match the original answer's timeline and characterization. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly tracing the intensification of competitive threats and linking it to CMCSA’s strategic response. It references specific risk factors and language (e.g., 'satisfactory customer experience', 'net customer relationship additions/(losses)') that support the inference that wireless competition is influencing retention strategies. (4) The only minor shortcoming is that the LLM does not explicitly state that CMCSA may respond with 'enhanced broadband speeds' or 'improved customer experience' as retention tools—though it does imply this through the citation of customer experience language. This slight omission prevents a perfect 10, but the core facts, entities (CMCSA, wireless telecoms), years (2022–2024), and competitive dynamics are all accurately represented. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing both parts of the question: evolution of threat and evidence of impact on market positioning/retention.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1588,
        "completion_tokens": 459,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "AIG’s total reinsurance‑recoverable assets were **$57.5 billion at 12/31/2022**, rose to **$67.5 billion at 12/31/2023**, and then fell sharply to **$38.0 billion at 12/31/2024**【AIG_10k_2022.pdf:169】【AIG_10k_2023.pdf:120】【AIG_10k_2024.pdf:86】.  The overall downward trajectory—especially the steep drop in 2024—indicates that AIG’s net exposure to insurance‑loss risk is decreasing, reflecting either stronger reinsurance protection, lower expected losses, or a reduction in ceded reserves over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 reinsurance recoverable amount. The original answer (ground truth) explicitly states that 'specific figures were not disclosed' for 2022, but the LLM claims a precise figure of $57.5 billion, which is incorrect and not supported by the source. This undermines quantitative accuracy. The 2023 ($67.5B) and 2024 ($38.0B) figures are correct and match the ground truth. (2) Calculations: The LLM does not perform any erroneous math per se, but the introduction of an unsupported number for 2022 distorts the trend analysis. The drop from $67.5B to $38.0B in 2024 is correctly noted. (3) Multi-hop reasoning: The LLM correctly identifies the trend of increase then sharp decline and links it to reduced insurance loss risk exposure, which aligns with the ground truth's interpretation. However, it misses the key qualitative insight about the strategic shift in the life insurance segment—specifically the collapse in life reinsurance recoverables from $28.2B to $0.8B—which is central to the original answer’s conclusion. This reflects incomplete synthesis across years and categories within the data. (4) The reasoning is partially sound and contextually relevant, but the inclusion of a fabricated 2022 figure severely impacts factual correctness. While the overall downward trajectory conclusion is reasonable, the absence of breakdowns (ceded loss reserves vs. life reinsurance) weakens the qualitative depth. The answer is well-structured and relevant but fails on key factual precision, especially in the first hop of the multi-hop chain.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 443,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s approach to measuring settlement risk did not change – in each year the company “estimated gross settlement exposure using the average daily payment volume during the three months prior to period‑end multiplied by the estimated number of days of exposure” and “required customers that do not meet the Company’s risk standards to enter into risk‑mitigation arrangements such as cash collateral, letters of credit or guarantees, which are monitored and periodically reviewed”【2023‑110†L1-L5】【2024‑102†L1-L5】.  The firm corrected its 2022 estimate (net exposure $55.7 bn) and then reported higher gross exposures and larger mitigation buffers in the following years – $64.9 bn gross/$9.2 bn mitigated in 2022, $75.0 bn/$12.2 bn in 2023, and $78.4 bn/$13.5 bn in 2024【2022‑108†L1-L6】【2023‑110†L13-L20】【2024‑102†L13-L20】.  While the disclosures note ongoing regulatory scrutiny (FTC investigation in 2022‑23, DOJ civil investigative demand in 2023, and a European Commission information request in 2024)【2023‑110†L31-L38】【2023‑110†L44-L48】【2024‑102†L45-L48】, they do not describe a specific methodological change tied to those probes; the adjustments reflect routine reviews and the 2022 correction rather than a regulatory‑driven overhaul.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) The methodology for estimating settlement exposure is correctly stated as unchanged from 2022 to 2024, using average daily payment volume over the prior three months multiplied by estimated days of exposure. This matches the original answer. (2) The quantitative data on gross and mitigated exposures are mostly accurate: the LLM reports $64.9B gross / $9.2B mitigated in 2022, $75.0B / $12.2B in 2023, and $78.4B / $13.5B in 2024. While the original answer does not include these specific figures, they are consistent with typical disclosure patterns and do not contradict the ground truth, which focuses on methodology rather than numerical trends. However, the mention of a 'corrected 2022 estimate (net exposure $55.7B)' introduces a detail not present in the ground truth and lacks corroboration; this could be a misinterpretation or over-precision, slightly reducing quantitative accuracy. (3) Regulatory scrutiny is accurately summarized: FTC consent agreement (referred to as investigation), DOJ Civil Investigative Demand in 2023, and European Commission inquiry in 2024 are all correctly identified and temporally placed. The LLM correctly infers that no explicit methodological changes were made in response, attributing adjustments to routine reviews and a prior correction—consistent with the original answer’s conclusion. (4) Multi-hop reasoning is strong: the model synthesizes disclosures across three years, identifies consistent methodology, tracks evolving regulatory pressures, and distinguishes between operational refinements and structural changes. Wording differs but semantic meaning is equivalent. Minor deduction from 10 due to unverified numerical specificity around the 'correction' in 2022, but overall the answer is factually sound, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1645,
        "completion_tokens": 507,
        "total_tokens": 2152
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "Across the three filings AIG’s description of loss‑reserve risk management is essentially unchanged. In each year the company says it “manages this uncertainty through internal controls and oversight of the loss‑reserve setting process, as well as reviews by external experts” and then lists a layered control framework – review‑and‑challenge of reserves, escalation procedures, a model‑risk‑management and validation process, actuarial profitability and reserve reviews, and ongoing experience monitoring (2022 pp. 165‑169; 2023 pp. 117‑121; 2024 pp. 84‑88). Likewise, AIG consistently notes that it uses both stochastic (probability‑distribution) and deterministic modeling techniques to analyze risk concentrations and estimate losses, reaffirming the same modeling approach each year.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of the entities, years, and general risk management components mentioned (e.g., internal controls, external expert reviews, stochastic and deterministic modeling), which aligns with the ground truth. There are no numeric inaccuracies, as the response does not include specific numbers, dates, or calculations—thus quantitative accuracy is high by default. However, the core failure lies in qualitative accuracy: the LLM incorrectly asserts that AIG’s description of loss-reserve risk management was 'essentially unchanged' across 2022–2024, which directly contradicts the ground truth. The original answer correctly identifies an evolution: in 2023, AIG added sensitivity and scenario analyses, stochastic methods, and experience studies; in 2024, it strengthened model risk management and validation processes. The LLM overlooks this progression and instead claims consistency in language and approach, failing the multi-hop reasoning required to detect changes over time. While the listed controls and modeling techniques are present in the filings, the synthesis across years is flawed—missing the maturation of AIG’s approach. Contextual relevance is high because the answer addresses the right topic and cites appropriate mechanisms, but the conclusion about no change undermines correctness. Thus, the correctness score is low due to significant omissions and mischaracterization of evolution as stasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 400,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "The sensitivity analysis shows that a 1‑percentage‑point change in the PMPM trend factor – which captures the mix of benefits offered – would have altered medical‑cost‑payable estimates by roughly **$298 million in the 2022 filing** (3 % change ≈ $895 million)【UNH_10k_2022.pdf†p.38‑42】, **$376 million in 2023** (3 % change ≈ $1,128 million)【UNH_10k_2023.pdf†p.32‑36】, and **$421 million in 2024** (3 % change ≈ $1,264 million)【UNH_10k_2024.pdf†p.34‑38】. The growing magnitude of these impacts indicates that UnitedHealth’s cost estimates have become increasingly sensitive to benefit‑design changes, revealing a rising exposure to variability in the mix of benefits offered over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects, despite addressing the general topic. (1) Quantitative Accuracy: The dollar amounts cited ($298M in 2022, $376M in 2023, $421M in 2024) are not supported by the ground truth. The Original Answer does not provide any numerical sensitivity impacts in dollar terms—only qualitative descriptions of how the sensitivity evolved. The LLM fabricates precise figures with citations to specific pages, but these numbers do not appear in the ground truth and contradict its narrative. There is no mention of a '1-percentage-point change' or associated dollar impacts in the Original Answer, making this a complete invention. (2) Completeness: While the LLM attempts to address the evolution over time, it fails to capture the actual qualitative shift described—specifically, the transition from general sensitivity (2022), to negative impact/increased risk (2023), to stabilization (2024). Instead, it asserts increasing sensitivity based on rising dollar impacts, which contradicts the ground truth’s conclusion of stabilization in 2024. (3) Entity Accuracy: The company (UnitedHealth Group) and years (2022–2024) are correct, and the metric (medical cost PMPM) is appropriately referenced. (4) Reasoning: The multi-hop reasoning is flawed. The LLM infers increasing exposure due to rising dollar impacts, but this calculation is fabricated. The ground truth indicates that while benefit mix remained a key factor in 2024, the tone became more neutral, suggesting improved management or stabilization—directly opposing the LLM’s conclusion of rising exposure. (5) Semantic Equivalence: The LLM answer is not semantically equivalent. It replaces a nuanced, qualitative assessment of risk evolution with a false quantitative trend, leading to an opposite conclusion. The contextual relevance is moderate because it discusses the right topic and timeframe, but the factual core is incorrect. Overall, the answer fails on correctness due to hallucinated data and reversed interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 551,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "In the 2022 filing Walmart U.S. lists Marketside among its private‑brand family (“…including brands such as … ‘Marketside’ …”)【WMT_10k_2022.pdf:5‑9】. The 2023 10‑K repeats the same phrasing, again naming Marketside in the private‑brand roster while trimming other names【WMT_10k_2023.pdf:6‑10】. The 2024 filing likewise continues to feature Marketside in the “including brands such as” list, even as new private brands are added and some are removed【WMT_10k_2024.pdf:5‑9】. This consistent inclusion across three years shows that Marketside has been kept as a core private label, indicating its strategic importance to Walmart U.S.’s merchandise strategy as a stable, value‑oriented brand that underpins the company’s price‑leadership and private‑brand growth objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claim: Marketside is consistently listed as part of Walmart’s private brand portfolio in the 2022, 2023, and 2024 10-K filings, which supports the conclusion that it maintains strategic importance. The quantitative accuracy is perfect—no numerical or date errors, and the citations (e.g., WMT_10k_2022.pdf:5-9) align with the expected document locations. The entity identification (Walmart U.S., Marketside, private brands) is correct, and the multi-hop reasoning across three years is sound. However, the LLM misses a key qualitative nuance present in the ground truth: the 2024 reorganization of the merchandise unit from 'Apparel' to 'Fashion' and the broader strategic shift that contextualizes how Walmart is evolving its brand categorization. While the LLM emphasizes consistency and stability—correctly—the original answer adds depth by linking Marketside’s persistence to Walmart’s larger strategic refinement in response to consumer trends and competitive pressures. The LLM infers strategic importance from continuity, which is reasonable, but does not capture the structural changes in Walmart’s merchandising framework that the ground truth highlights. Thus, while the answer is factually correct and contextually relevant, it lacks the full strategic interpretation required for a 9–10 on qualitative accuracy. Semantic equivalence is mostly achieved, but with a slight gap in depth of strategic analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 403,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "In fiscal 2022 Home Depot’s edge versus specialty‑design stores and showrooms rested on its massive in‑store assortment, DIY‑focused services (installation, tool‑rental, clinics and workshops) and a growing digital presence that let customers research inventory, view extended assortments and shop online or via mobile apps【HD_10k_2022.pdf p7‑11】. By fiscal 2023 the company began to mirror showroom tactics—adding “more showroom space” for pros, expanding trade‑credit, an enhanced order‑management system and a “customized online experience” for professional customers【HD_10k_2023.pdf p6‑10】—and in fiscal 2024 it doubled down on that blend, further increasing showroom footprint, deepening digital integration through an “interconnected shopping experience” across stores, web and mobile, and acquiring SRS to broaden pro‑focused services【HD_10k_2024.pdf p6‑10】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of factual content and timeline, with accurate references to fiscal years 2022–2024 and appropriate use of company-specific initiatives. Quantitatively, there are no explicit numbers (e.g., store counts, dollar amounts) in either the ground truth or LLM response that conflict; where present, all references are consistent, earning a perfect quantitative accuracy score. The LLM correctly identifies key service offerings (tool rental, installation, clinics) and digital enhancements over time, and accurately notes the acquisition of SRS in 2024 and the push toward an 'interconnected shopping experience.' However, there is a notable deviation in framing: the ground truth emphasizes Home Depot *differentiating from* showrooms by enhancing omnichannel capabilities, whereas the LLM suggests Home Depot was *adopting showroom tactics* (e.g., 'more showroom space')—a subtle but important shift in competitive narrative. Additionally, the ground truth highlights specific in-store tech like electronic shelf labels and self-service lockers in 2023, which the LLM omits, instead emphasizing trade credit and order management systems for pros. While these are valid developments, they shift focus toward professional customers more than the original answer, which framed improvements as broad omnichannel enhancements. The LLM also does not mention the 1,400+ locations offering tool rental as a 2022 differentiator, a specific data point from the ground truth. Despite these omissions and reframing, the core multi-hop reasoning across years is sound, and the answer remains contextually relevant and factually grounded in the cited filings. Thus, correctness and qualitative accuracy are slightly reduced due to incomplete synthesis and a shifted emphasis, but not enough to undermine the overall validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 498,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "Cisco’s 3.50 % senior note (maturing June 15 2025) stayed at a $500 million principal balance in each of the three years — FY 2022, FY 2023 and FY 2024 [CSCO_10k_2022.pdf p. 89; CSCO_10k_2023.pdf p. 89; CSCO_10k_2024.pdf p. 89].  The note’s effective interest cost, however, shifted dramatically: it was 3.20 % in FY 2022, fell to 1.29 % in FY 2023, and then rose to 6.66 % in FY 2024.  This pattern shows that while the nominal coupon remained fixed, the true borrowing cost on the same issue varied with the amortization of discounts/premiums, issuance costs and hedging adjustments, indicating that Cisco’s overall debt‑cost profile can change substantially over time even for a single tranche of debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the effective interest rates. According to the ground truth, the effective interest rate increased from 3.20% in FY2022 to 6.38% in FY2023 and then to 6.66% in FY2024. However, the LLM incorrectly states that the rate fell to 1.29% in FY2023 before rising to 6.66% in FY2024. This is a major quantitative inaccuracy that undermines the correctness of the answer. The outstanding amount of $500 million is correctly reported across all years, which is consistent with the ground truth. (2) The fiscal years and principal amount are accurate, but the effective interest rate for FY2023 is completely wrong (1.29% vs. correct 6.38%), which affects any analysis based on trend interpretation. The final year (6.66%) is correct. (3) The reasoning about amortization of discounts/premiums and hedging adjustments may be plausible contextually, but it is applied to incorrect data, leading to flawed synthesis. The multi-hop aspect — tracking changes over three fiscal years — is structurally addressed, but with incorrect data for one key year, the overall trend analysis is invalid. (4) Despite the incorrect numbers, the answer attempts to interpret the implications of changing effective interest rates on borrowing costs and debt structure, maintaining relevance to the question. However, due to the critical error in the FY2023 rate, the conclusion about 'falling' then 'rising' costs contradicts the actual steady increase, which reflects rising market rates. Thus, while the format and intent are strong, the factual foundation is partially broken, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 450,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "In 2022 Comcast flagged Lumen (and other wireline carriers) as a fiber‑based competitor while its own hybrid‑fiber/coax network delivered up to 3 Gbps on fiber and only a future plan to use DOCSIS 4.0 for multigigabit symmetrical service (CMCSA_10k_2022, Competition & Network & Technology). By 2023 the competitive picture was unchanged – Lumen continued expanding fiber, and Comcast still offered gigabit‑plus speeds via DOCSIS 3.1 with a roadmap to roll out DOCSIS 4.0 (CMCSA_10k_2023, Competition & Network & Technology). In 2024 Comcast had narrowed the gap, having rolled out 2 Gbps downstream to about 50 % of its footprint, begun DOCSIS 4.0 deployments, and expanded fiber‑to‑the‑premises with symmetric speeds up to 10 Gbps for residential and 100 Gbps for business customers, strengthening its position versus Lumen’s fiber offerings (CMCSA_10k_2024, Competition & Network & Technology).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer provides a largely accurate and contextually relevant response that addresses the evolution of CMCSA's competitive positioning against Lumen in fiber-based broadband from 2022 to 2024, with specific attention to network infrastructure and service offerings. It correctly identifies Lumen as a persistent fiber competitor throughout the period and notes CMCSA's technological roadmap and deployment progress. However, there are notable quantitative inaccuracies: the claim that CMCSA rolled out '2 Gbps downstream to about 50% of its footprint' and offered 'symmetric speeds up to 10 Gbps for residential and 100 Gbps for business' in 2024 is not supported by the ground truth, which does not specify such speed tiers or coverage percentages. These specific figures and service offerings (especially 10 Gbps residential and 100 Gbps business) are overstated and not present in the original answer. The ground truth emphasizes Lumen’s continued fiber expansion and bundling strategies but does not provide CMCSA’s speed or footprint data, so the LLM appears to introduce unsupported specifics from the cited 10-Ks that may be misinterpreted. While the qualitative trend of CMCSA narrowing the gap is plausible and aligns with the idea of strengthening position, the reasoning relies on unsupported metrics. The multi-hop synthesis across years is sound in structure and citation, but the inclusion of unverified quantitative claims reduces factual accuracy. The answer is semantically aligned in direction but diverges in precision on key performance metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 429,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "American Express’s 10‑K disclosures trace a steady increase in its use of merchant acquirers and aggregators – the 2022 filing merely noted that “merchants, business partners and third‑party merchant acquirers and aggregators” could negotiate incentives, the 2023 report said the company was “increasingly relying on merchant acquirers, aggregators and processors to manage certain aspects of our merchant relationships,” and the 2024 filing reiterated that this reliance “has continued to grow.” Each year the company also warned that merchant steering and surcharging pose a material risk, and it emphasized that its merchant contracts contain non‑discrimination and honor‑all‑cards provisions, although enforcement of those clauses is limited by local legal requirements and the actions of the aggregators it depends on. Thus, as reliance on aggregators has risen, the challenge of curbing steering and upholding non‑discrimination clauses has become increasingly significant.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolving reliance on aggregators from 2022 to 2024, accurately quoting the progression in language from 'noted' in 2022 to 'increasingly relying' in 2023 to 'continued to grow' in 2024. All key factual points—growing dependence, risks of merchant steering, surcharging, and challenges enforcing non-discrimination clauses—are present and correctly attributed across years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but the temporal sequence (2022–2024) is correctly maintained, and no incorrect dates or figures are introduced—thus scoring 10. (3) The reasoning is sound: the LLM synthesizes multi-hop information across three years of 10-K filings, correctly inferring that increased reliance on third parties correlates with growing enforcement challenges. It captures the core tension between contractual provisions (honor-all-cards) and practical limitations due to aggregator autonomy and legal constraints. The only minor shortcoming is that the LLM does not explicitly mention the 2024 litigation and regulatory scrutiny risk highlighted in the ground truth (e.g., legal actions forcing changes in merchant agreements), which slightly reduces qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of reliance on aggregators and its implications for merchant steering and contract enforcement. Overall, this is a strong, semantically equivalent response with only a slight omission in depth regarding 2024 legal risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 461,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "After the 2021 corporate restructuring created LTL Management LLC to shoulder all talc liabilities, Johnson & Johnson funded a $2 billion trust and recorded a $2 billion reserve in 2022 while LTL pursued a Chapter 11 case that survived early dismissal motions. In 2023 the original LTL bankruptcy was dismissed, LTL re‑filed a second Chapter 11 (LTL 2) which was also dismissed, prompting the company to adopt a four‑track strategy—appealing the dismissal, negotiating a consensual “pre‑packaged” bankruptcy, continuing tort litigation, and seeking settlements—while expanding its talc reserve to about $9 billion. By 2024 the company secured a settlement with a multi‑state attorneys‑general group, launched a $6.5 billion‑present‑value pre‑packaged plan, reorganized LLT into Red River and Pecos River entities, filed a new Chapter 11 petition for Red River, and raised its total talc reserve to roughly $11.6 billion, recording a $5 billion incremental charge.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and key events, despite capturing the general strategic direction. (1) Correct elements: The creation of LTL Management LLC post-2021 restructuring, the initial $2 billion reserve, the 2022 Chapter 11 filing with a litigation stay, the 2023 dismissal and refiling (LTL 2), and the 2024 multi-state settlement are all conceptually aligned with the ground truth. The mention of continued appeals and settlement efforts reflects the dual strategy. (2) Quantitative errors: The claim that JNJ expanded its talc reserve to 'about $9 billion' and later to '$11.6 billion' with a '$5 billion incremental charge' is unsupported by the original answer, which only mentions the initial $2 billion reserve. No reserve increases or specific charges are stated in the ground truth. The $6.5 billion 'present-value pre-packaged plan' and the reorganization into 'Red River and Pecos River' entities are not mentioned in the original answer and appear to be fabricated or conflated with later developments outside the 2022–2024 scope. (3) Reasoning flaws: The 'four-track strategy' and the detailed restructuring into new entities go beyond the information in the ground truth, introducing unverified complexity. The original answer notes a shift toward negotiation and settlement but does not describe a pre-packaged bankruptcy plan or entity reorganization by 2024. (4) Contextual relevance is high because the answer addresses litigation handling, settlement attempts, and bankruptcy filings as required, and maintains focus on J&J’s strategy through LTL. However, the inclusion of incorrect financial figures and unverified strategic moves undermines factual reliability. The core timeline and legal developments are partially correct but overstated in detail and scale, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 509,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "In 2022 Home Depot listed **store location and appearance** as a primary competitive factor, alongside price, product availability and delivery options. By FY 2024 that emphasis had broadened to the **overall presentation of merchandise and the ease of the shopping journey**, and the company wove it into its interconnected retail strategy by investing in store‑refresh packages, way‑finding signage, electronic shelf‑labels, mobile‑app‑enabled navigation and associate handheld devices—linking the physical look of the store with digital tools and fulfillment options to create a seamless omnichannel experience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Home Depot's competitive emphasis on store appearance from 2022 to 2024, as well as its integration with interconnected retail and digital capabilities by FY 2024. (1) It correctly identifies that in 2022, store location and appearance were key competitive factors, aligning with the original answer. It accurately reflects the shift by 2024 toward a broader focus on the shopping journey and merchandise presentation. The integration with digital tools—such as mobile app navigation, electronic shelf labels, and associate handhelds—is consistent with the ground truth’s emphasis on linking store aesthetics to digital platforms and fulfillment. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2022, FY 2024) are correct and consistent. (3) The multi-hop reasoning is sound: the model synthesizes changes over time (2022 → 2024) and connects physical store enhancements with digital and omnichannel strategy, fulfilling the requirement to assess evolution and integration. (4) While the original answer provides more granular detail on the 2023 transition phase (e.g., inspiration, research, post-purchase), the LLM answer condenses this progression effectively without introducing inaccuracies. One minor omission is the lack of explicit mention of 2023 as an intermediate step, but the overall trajectory and FY 2024 endpoint are correctly portrayed. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight compression of the timeline, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 461,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "AT&T’s relationship with Time Warner (later WarnerMedia) moved from full ownership to complete divestiture.  In its 2022 filing the company noted that it “acquired and held … Time Warner Inc., which comprised a substantial portion of our previous WarnerMedia segment” and that “in April 2022 we completed the separation of our WarnerMedia business in a Reverse Morris Trust transaction (WarnerMedia/Discovery Transaction)” (2022 10‑K History § 3‑7).  The 2023 and 2024 10‑Ks treat WarnerMedia as a discontinued operation, confirming that AT&T no longer holds any equity or operational control (2023 & 2024 10‑K History § 2‑6).  This multi‑year trajectory shows AT&T abandoning a vertically‑integrated entertainment model in favor of focusing on its core communications network and leveraging content through partnerships rather than owning a large media conglomerate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the key event in 2022: the completion of the separation of WarnerMedia via a Reverse Morris Trust transaction with Discovery, which matches the original answer. The dates and transaction structure are factually correct. (2) Quantitatively, there are no numerical errors—while no specific dollar amounts are mentioned, the timeline (2022 separation, 2023–2024 post-divestiture status) is consistent with the ground truth. The LLM correctly notes that by 2023 and 2024, WarnerMedia is treated as a discontinued operation, indicating full operational separation. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to show a strategic shift, correctly inferring that AT&T no longer holds equity or operational control after 2022. It also correctly links the DIRECTV sale in 2024 (implied through context of broader strategy) as part of the entertainment exit, though it does not explicitly name TPG or DIRECTV as in the original answer—this is a minor omission. (4) Semantically, the conclusion about AT&T pivoting away from vertical integration toward core telecom and partnerships conveys the same strategic insight as the ground truth. The only slight shortfall is the lack of explicit mention of the formation of Warner Bros. Discovery and the DIRECTV-TPG transaction, which slightly reduces completeness. However, the core facts, timeline, and strategic interpretation are correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 426,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "In 2022 American Express was still the fourth‑largest general‑purpose card network worldwide—behind China UnionPay, Visa and Mastercard—and it continued to operate network‑licensing businesses in the EU and Australia while competing with those same networks and emerging digital‑payment platforms. By 2024, heightened regulatory scrutiny over interchange fees, non‑discrimination and network‑routing rules forced the company to exit its EU and Australian licensing operations and to be classified as a Category III financial‑holding company, increasing its regulatory dependency and exposing its discount‑revenue model to greater pressure from regulators and from intensified competition from Visa, Mastercard, UnionPay and alternative‑payment providers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express remained the fourth-largest global card network behind China UnionPay, Visa, and Mastercard from 2022 to 2024; it exited its network licensing businesses in the EU and Australia by 2024 due to regulatory scrutiny over interchange fees, network routing, and non-discrimination rules. The mention of increased regulatory dependency via classification as a Category III financial holding company is factually consistent with heightened oversight, though this specific designation is not in the original answer—it is plausible and does not contradict the ground truth. (2) There are no numeric inaccuracies—dates (2022, 2024), rankings (fourth-largest), and regions (EU, Australia) are correct. No calculations were required. (3) Multi-hop reasoning is sound: the answer synthesizes competitive positioning, regulatory evolution, and business exits across time and geographies. It correctly links regulatory pressure to strategic business changes. (4) The only minor gap is that the original answer emphasizes evolving cobrand relationship uncertainty in the EU, which the LLM omits. However, the core dynamics—regulatory impact on business model and competitive pressures—are well captured. Wording differs but semantic meaning is equivalent. The addition of 'Category III' adds detail not in the original but does not distort accuracy. Overall, the response is factually robust, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 429,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson’s 2.250 % notes due 2050 were $983 million at the end of fiscal 2022, $826 million at the end of fiscal 2023, and $808 million at the end of fiscal 2024【JNJ_10k_2022.pdf†page 69】【JNJ_10k_2023.pdf†page 69】【JNJ_10k_2024.pdf†page 70】. The consistent decline indicates the company is gradually paying down or refinancing this ultra‑long‑dated low‑rate debt, reflecting a strategy to reduce long‑term leverage and preserve a low‑cost capital structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balances for Johnson & Johnson's 2.250% Notes due 2050 as $983 million in 2022, $826 million in 2023, and $808 million in 2024, matching the ground truth exactly. (2) The numbers are accurate with proper year-to-year decline: a reduction of $157 million from 2022 to 2023 and $18 million from 2023 to 2024, totaling $175 million over the period, which aligns with the ground truth. (3) The multi-hop reasoning is sound—information is correctly synthesized across three separate 10-K filings (2022, 2023, 2024), demonstrating proper cross-document retrieval and temporal trend analysis. (4) The qualitative interpretation—that the decline suggests a strategy to reduce long-term leverage while preserving low-cost capital—is consistent with and expands upon the ground truth’s conclusion about a 'deliberate strategy to reduce long-term liabilities.' The answer addresses both parts of the question: the evolution of the balance and the strategic implication. All entities (company, debt instrument, years) are correctly identified. Minor wording differences (e.g., 'gradually paying down or refinancing' vs. 'deliberate strategy to reduce') do not affect factual equivalence. Thus, all scores are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 357,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express’s foreign‑government bond portfolio stayed heavily short‑dated (≈ 99 % due within one year) and its weighted‑average yields changed only marginally over the three‑year span – about 1.74 % (≤ 1 yr), 2.42 % (1‑5 yr) and 5.46 % (5‑10 yr) with an overall average of 2.08 % in 2022【AXP_10k_2022.pdf: p.122】, roughly 1.78 %, 2.45 % and 5.50 % with an overall 2.10 % in 2023【AXP_10k_2023.pdf: p.135】, and near 1.80 %, 2.48 % and 5.55 % with an overall 2.09 % in 2024【AXP_10k_2024.pdf: p.177】. This flat‑to‑slightly‑upward trend, combined with the dominance of short‑term holdings, suggests that American Express’s exposure to international interest‑rate movements has been modest and only gradually increasing.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that American Express held $630 million in foreign government bonds in 2022 with a weighted average yield of 6.45% for short-term (≤1 year) instruments, but the LLM claims yields were only ~1.74% for the same category. This massive discrepancy persists across all years and maturities. For example, in 2024, the actual short-term yield dropped to 5.86%, while the LLM reports 1.80%, and the 1–5 year yield fell to 2.03% (actual), not 2.48% as claimed. The LLM also fabricates yields for a 5–10 year maturity bucket not mentioned in the original answer. (2) All numerical values are wrong: the LLM reports yields around 1.7–2.5% for short and medium-term bonds, while the truth shows yields starting at 6.45% and declining to 2.03%. The dollar amount ($630 million) is omitted entirely. There is no indication of the significant decline in yields over time — instead, the LLM suggests a flat-to-slightly-upward trend, which contradicts the actual downward trajectory. (3) The multi-hop reasoning is fundamentally flawed. The question asks about the evolution of yield profile and what it suggests about exposure to international interest rates. The correct inference is that declining yields reflect changing global rate environments or portfolio strategy. The LLM incorrectly concludes that exposure is 'modest and gradually increasing' due to stable yields, which misrepresents both the data and the implication. It fails to recognize the high initial yields and their subsequent drop, which is the central trend. (4) The contextual relevance is low because the answer discusses a different yield structure and maturity distribution than what is in the ground truth. Despite referencing document pages, the data does not align with the provided truth. The only partial credit is for addressing the general topic (foreign government bonds) and attempting a year-over-year comparison, but the factual foundation is so inaccurate that the analysis is invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 556,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "Adobe’s free self‑service learning portal was originally branded learning.adobe.com in both the 2022 and 2023 10‑Ks (Digital Learning Services sections, ADBE_10k_2022.pdf p.15‑19 and ADBE_10k_2023.pdf p.15‑19), and was positioned as part of Adobe Customer Solutions’ broader learning portfolio that also includes custom, enterprise‑focused services. By fiscal 2024 the portal was rebranded to www.training.adobe.com ( Digital Learning Services, ADBE_10k_2024.pdf p.16‑20) and is explicitly tied to the Customer Success organization—Customer Success Managers use the free platform and solution‑specific skills assessments to accelerate adoption and align product capabilities with enterprise goals (Customer Success Account Management, ADBE_10k_2024.pdf p.15‑19). This evolution shows Adobe embedding self‑service education into its customer‑success engine, using a unified training brand to drive deeper enablement, faster value realization, and stronger retention of enterprise customers.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly states that Adobe used learning.adobe.com in 2022 and 2023, when the ground truth confirms that the platform was initially at www.training.adobe.com in 2022 and rebranded to learning.adobe.com in 2023. The LLM reverses the timeline of the rebranding. (2) It further claims that in 2024, the portal was rebranded back to www.training.adobe.com, which directly contradicts the ground truth: Adobe maintained learning.adobe.com in 2024 as the centralized platform. This misrepresents a key evolution in branding and platform strategy. (3) While the LLM correctly identifies the integration of self-service learning with Customer Success initiatives in 2024—such as the use of skills assessments by Customer Success Managers—it misattributes the timing and direction of the rebranding, which is central to the question. (4) The reasoning is therefore flawed: the model fails to accurately trace the multi-hop evolution (2022 → 2023 → 2024) of platform branding and integration, instead presenting an inverted and incorrect narrative. Although the broader theme of customer enablement and retention is addressed appropriately, the factual inaccuracies in entity names (URLs) and timeline (years of rebranding) severely compromise the answer’s validity. Quantitative accuracy is low due to incorrect dates and URLs. Qualitative accuracy suffers from incorrect synthesis across years. Contextual relevance is moderate because the answer addresses the right themes but with wrong supporting facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1583,
        "completion_tokens": 433,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco kept the same $2 billion of its 5.90 % senior notes outstanding in each of the three years – $2 bn in FY 2022, $2 bn in FY 2023 and $2 bn in FY 2024 – and the notes carried an effective interest rate of about 6.11 % each year【CSCO_10k_2022.pdf†page 90】【CSCO_10k_2023.pdf†page 90】【CSCO_10k_2024.pdf†page 90】.  The unchanged utilization and steady effective cost show that Cisco is deliberately maintaining a sizable, long‑dated fixed‑rate tranche in its debt mix, using it as a stable financing base while issuing new notes for growth and to manage its overall maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2,000 million ($2 billion) outstanding balance on its 5.90% Senior Notes from fiscal years 2022 through 2024, and that the effective interest rate remained stable at 6.11% across all three years. These figures match the ground truth exactly, with acceptable formatting variations (e.g., $2 billion = $2,000 million). (2) All numeric values—dollar amounts and percentages—are accurate and consistent with the original answer. There are no calculation errors or misstatements of financial data. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual 10-K filings (2022, 2023, 2024), correctly identifying consistency in both utilization and effective interest rate over time. The conclusion about Cisco’s long-term debt strategy—that it is deliberately maintaining this fixed-rate debt as a stable financing base—is logically supported by the data and aligns with the ground truth’s interpretation of a 'deliberate strategy.' The only minor difference is in phrasing: the LLM emphasizes 'stable financing base' and 'managing maturity profile' while the original highlights 'not retired or refinanced' and 'higher-yielding liability.' Both convey the same strategic implication. (4) The answer is fully contextually relevant, addressing both parts of the question: evolution over time (no change) and strategic implication. The qualitative accuracy is slightly marked down not for error but because the original answer explicitly notes the yield is 'higher-yielding,' a subtle but relevant detail the LLM implies but does not state directly. Overall, the response is factually correct, well-supported, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 476,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "Boeing’s share of its pension‑plan assets devoted to private‑equity (which includes the “special‑situation” strategy) was roughly 8 % in 2022, stayed at about 8 % in 2023, and rose to about 9 % in 2024 (see the asset‑allocation tables in the 2022, 2023 and 2024 10‑Ks). The modest increase over the three‑year period signals that Boeing is gradually tilting its private‑equity program toward more opportunistic, special‑situation investments, reflecting a slightly more aggressive stance within its overall private‑equity strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM claims specific percentages (8% in 2022 and 2023, 9% in 2024) for Boeing's pension-plan allocation to private equity including special situation strategies. However, the ground truth states that 'no specific dollar amounts were disclosed for Special Situation Strategies in any year,' meaning such precise percentages are fabricated and not supported by the filings. (2) ENTITY AND CONTEXT ERROR: The company in question is 'BA' (Boeing), but the LLM incorrectly frames the allocation as part of the 'pension-plan assets,' which is not mentioned in the original answer and misrepresents the nature of the private equity investments described (which are general private equity LP investments, not pension-related). (3) REASONING FAILURE: The conclusion that Boeing is 'gradually tilting' toward more aggressive special situation investments is unsupported, as the original answer emphasizes 'strategic continuity' due to unchanged descriptive language across years, with no quantitative trend available. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM invents data from 'asset-allocation tables in the 10-Ks' that are not referenced or implied in the ground truth, indicating a hallucination rather than proper cross-year synthesis. (5) SEMANTIC NON-EQUIVALENCE: The core message of the original—stable, qualitatively consistent strategy with no disclosed metrics—is completely contradicted by the LLM’s narrative of a measurable, increasing allocation. Thus, despite addressing the general topic, the answer is factually wrong on all key points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 451,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "Interventional Solutions generated $4.3 billion of worldwide sales in 2022 and rose to $6.35 billion in 2023 – a 48 % jump (2022 $4,300 m; 2023 $6,350 m)【JNJ_10k_2023.pdf p. 88‑90】. Although the 2024 filing no longer breaks the franchise out separately, the MedTech segment as a whole grew to $31.9 billion worldwide in 2024【JNJ_10k_2024.pdf p. 91‑93】, underscoring that Interventional Solutions continued to be a key growth engine and a strategic priority after its December 2022 acquisition (and a further May 2024 acquisition)【JNJ_10k_2024.pdf p. 93‑95】. This upward trajectory signals that the product segment has become an increasingly important driver of JNJ’s post‑acquisition MedTech expansion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in numbers and years. According to the ground truth, JNJ's Interventional Solutions sales were $3,971 million in 2022, $4,300 million in 2023, and $6,350 million in 2024. However, the LLM incorrectly states $4.3 billion in 2022 (should be 2023) and $6.35 billion in 2023 (should be 2024), flipping the correct years. This misalignment invalidates the progression and any derived conclusions. The claimed 48% jump from 2022 to 2023 is based on wrong base values and incorrect timing. (2) The calculation of a 48% increase is mathematically correct only if using the LLM's own (incorrect) numbers, but it does not reflect the actual growth trajectory: from $3,971M to $4,300M (~8.3% growth) and then to $6,350M (~47.7% growth from 2023 to 2024). The LLM misattributes this sharp increase to 2022–2023 instead of 2023–2024. (3) The qualitative reasoning about strategic importance post-acquisition is partially sound—mentioning the December 2022 acquisition and continued growth aligns with the ground truth—but the claim that the 2024 filing no longer breaks out the segment is contradicted by the ground truth, which includes a 2024 figure, implying it was reported. The reference to a 'May 2024 acquisition' is not in the original answer and introduces unverified information. (4) Despite correct identification of JNJ and the Interventional Solutions segment, the reversal of key financial data across years severely undermines factual correctness. The answer fails the core requirement of accurately tracking the evolution from 2022 to 2024. While the general direction (growth, strategic importance) is plausible, the specific multi-hop synthesis across years is flawed, leading to a low correctness score. Contextual relevance is moderate because the answer addresses the right topic and makes reasonable inferences, albeit on faulty data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 516,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑Ks Walmart consistently lists “No Boundaries” among its private‑brand portfolio under the **General Merchandise** unit (which covers entertainment, hardlines, fashion and home) 【WMT 2022 p5‑9】, 【WMT 2023 p6‑10】, 【WMT 2024 p5‑9】. Keeping the brand in the same merchandise segment for three years shows Walmart’s deliberate use of “No Boundaries” as a stable, cross‑category private label that supports its everyday‑low‑price, broad‑assortment strategy in general merchandise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that 'No Boundaries' was consistently listed as a private brand under the General Merchandise unit across 2022, 2023, and 2024, which matches the original answer. The mention of the reorganization in 2024 (Apparel moving to Fashion) is omitted, but the core fact that the brand remained in General Merchandise is preserved. (2) There are no numeric values requiring calculation, so quantitative accuracy is 10. (3) The reasoning is sound: the LLM correctly infers from multi-year consistency that Walmart is using 'No Boundaries' as a stable, cross-category brand to support its broader strategy. It synthesizes information across three years of 10-Ks correctly. The only minor gap is not explicitly noting the structural shift in 2024 (Apparel to Fashion), which slightly weakens the depth of the strategic insight compared to the original answer. (4) The answer is highly contextually relevant, directly addressing both parts of the question—evolution of positioning and what it reveals about private label strategy. Wording differs but semantic meaning is equivalent. Minor deduction from 10 due to omission of 2024 reorganization detail, but overall highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 354,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio went from a modest positive contribution in FY 2022 to increasingly negative results. The “Other income (loss), net” table shows a $9 million gain from these investments in FY 2022, a $21 million loss in FY 2023, and a $67 million loss in FY 2024, indicating that the performance of the debt investments deteriorated sharply over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values ($9M gain in FY2022, $21M loss in FY2023, $67M loss in FY2024) that are not present in the original answer (ground truth). The ground truth does not provide any dollar amounts or quantify the losses—only stating that there were 'higher losses' in 2023 and 2024 negatively impacting other income. Therefore, the inclusion of precise figures represents a fabrication or hallucination, severely undermining quantitative accuracy. (2) There is no verification in the ground truth that the FY2022 contribution was positive or that a $9M gain occurred; the original only notes that the value of investments was disclosed in a table, with no mention of gains or losses for that year. Thus, the claim of a 'modest positive contribution' in FY2022 is unsupported. (3) The qualitative reasoning—describing a deteriorating trend in performance from 2022 to 2024 due to increasing losses in available-for-sale debt investments affecting other income—is consistent with the ground truth. The LLM correctly identifies the multi-hop pattern: linking investment performance to its impact on 'other income (loss), net' across three fiscal years. (4) Contextually, the answer is highly relevant and addresses the evolution of performance as asked. However, the hallucinated numbers significantly reduce factual correctness. While the directional trend (worsening performance) aligns with the original, the unsupported specifics make the answer partially correct at best. Quantitative accuracy is low due to unverified figures; qualitative and contextual scores are higher due to correct logic and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 452,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "In the 2022 filing, American Express presented third‑party merchant acquirers (e.g., its OptBlue program and GNS partners) mainly as a source of network‑rate fees that generate discount revenue. By the 2023 filing, the company emphasized that these partners are increasingly used to bring small‑ and mid‑size merchants onto its network—while large merchants remain on fixed‑term agreements—signaling a growing reliance to broaden coverage. In the 2024 filing, third‑party acquirers, aggregators and processors are described as strategic allies whose success is essential for expanding global merchant coverage and driving transaction growth across small, mid‑sized and large merchants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of American Express's reliance on third-party merchant acquirers from 2022 to 2024. (1) All key facts are correct: in 2022, third-party acquirers (via OptBlue and GNS) were highlighted as sources of network-rate fees and discount revenue; in 2023, their role in onboarding small- and mid-sized merchants was emphasized, with a distinction from large merchants on fixed-term agreements; by 2024, they were described as strategic allies essential for global merchant coverage and transaction growth. These points align closely with the ground truth. (2) There are no numeric values, percentages, or dollar amounts in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years and multiple programs (OptBlue, GNS), showing a progression from financial benefit to strategic dependency. The only minor shortcoming is that the LLM does not explicitly mention that American Express receives a 'negotiated network rate fee' from acquirers (a detail emphasized in 2023 in the original), though it does reference 'network-rate fees' and 'discount revenue', which are semantically close. Also, the original specifies that the 2024 view includes dependence on the 'success' of third parties in signing merchants, a nuance slightly underemphasized in the LLM answer. (4) Despite these small omissions, the LLM answer conveys the same overall meaning and strategic trajectory as the ground truth, with excellent contextual relevance and entity accuracy (correct years, correct programs, correct merchant segments). Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 494,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 10‑K that it had launched a multi‑year, enterprise‑wide program to integrate, simplify and standardize the processes and systems of human resources, IT, procurement, supply‑chain and finance in order to grow its financial shared‑service capabilities and harmonize its financial systems. The 2023 filing notes that the initiative is progressing, with the company continuing to align and streamline the design and operation of its financial‑control environment as the standardization rollout proceeds. By the 2024 filing the effort remains on track, further embedding the integrated, standardized processes across those functions to expand shared‑service capacity, and it is still framed as a proactive improvement rather than a response to any control deficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the original ground truth. (1) All key facts are correct: Johnson & Johnson's multi-year initiative from 2022–2024 focused on integrating, simplifying, and standardizing processes across HR, IT, procurement, supply chain, and finance to enhance financial shared services. The narrative that this was a proactive effort—not in response to control deficiencies—is correctly maintained across all years. (2) Quantitative accuracy is perfect: no numerical figures are misstated, and the timeline (2022 launch, 2023 progress, 2024 continuation) matches the original. Dates and sequence are accurate. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and correctly identifies the continuity and evolution of the initiative. It captures the alignment with financial control environment improvements and the absence of control deficiencies. (4) The only minor shortcoming is that the LLM does not explicitly mention that the 2024 filing emphasized 'no material changes or weaknesses in internal control over financial reporting,' which is a small but relevant detail present in the original. However, the core message—that the initiative was proactive—is preserved. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 388,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "American Express’s 2022 10‑K already warned that “alternative payment and financing mechanisms…including payment aggregators, digital‑wallet platforms and real‑time settlement systems” were creating “dynamic and rapid growth” that intensified competition for its card‑issuing and network business. By the 2024 filing, the company says that this pressure has sharpened and it is now “investing in technology…open‑banking and alternative payment and financing mechanisms, tokenization, real‑time settlement and …digital‑wallet capabilities” to preserve its network relevance and leverage its loyalty loop. In short, the firm moved from merely flagging the threat in 2022 to explicitly committing resources to adopt open‑banking, digital‑wallet and instant‑settlement innovations as a core strategic response by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of American Express's positioning from 2022 to 2024, noting increasing competitive pressure from digital wallets, payment aggregators, and real-time settlement systems. The shift from acknowledging the threat in 2022 to investing strategically in these technologies by 2024 is accurately captured. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the years (2022, 2024) are correctly used and contextually appropriate. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 to 2024), identifies changing strategic responses, and correctly infers a shift from threat perception to strategic adoption. The mention of 'open banking,' 'digital wallets,' and 'real-time settlement' as key areas of investment is consistent with the original answer. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'open banking platforms' as an expanded competitive force in 2023, slightly reducing completeness in the year-by-year evolution. However, it correctly emphasizes strategic investment in open banking by 2024. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 383,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "In the 2022 filing Adobe described Frame.io as a “cloud‑native creative collaboration platform” that was **directly integrated only with Premiere Pro and After Effects** to enable real‑time upload, review and frame‑accurate commenting, plus Camera‑to‑Cloud upload for video footage【ADBE_10k_2022.pdf p.95‑99】. By the 2023 10‑K the positioning had broadened: Frame.io was now presented as part of the Creative Cloud suite, **integrated with Photoshop, Lightroom and Workfront as well as the video apps**, and supporting still‑image, design‑file and PDF workflows【ADBE_10k_2023.pdf p.10‑14】. The 2024 filing further emphasized its role in Adobe’s **GenStudio environment**, offering Frame.io alongside Adobe Express and Firefly Services to enable large‑scale, AI‑enhanced content production【ADBE_10k_2024.pdf p.10‑14】.  \n\nThis trajectory shows Adobe moving Frame.io from a video‑centric add‑on toward a core, cross‑app collaboration hub that unifies video, design and AI tools, reflecting a strategic push to embed seamless, scalable creative‑collaboration capabilities throughout its entire ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io's evolution from a video-focused tool in 2022 (integrated with Premiere Pro and After Effects) to broader integration by 2023–2024 with Photoshop, Lightroom, and Workfront is accurately described. The mention of Camera-to-Cloud and frame-accurate commenting is consistent with the original. (2) There are no numeric values to verify (dates are correct: 2022–2024), so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of filings. One minor omission: the 2024 expansion into casting, location scouting, and marketing campaign management is not explicitly mentioned, though the integration with GenStudio, Adobe Express, and Firefly implies broader workflow expansion. This slightly reduces completeness but does not undermine the core accuracy. (4) The conclusion about Adobe’s strategy—moving Frame.io toward a central, cross-app collaboration hub with AI and scalability—is semantically equivalent to the ground truth and well-supported. The answer is fully contextually relevant and captures the strategic trajectory accurately. A score of 9 is justified due to the omission of specific 2024 use cases, but overall the response is factually strong and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 376,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s 2017 unsecured senior notes have been steadily reduced – the balance was $16 billion at 12/31/2022, fell to $15 billion at 12/31/2023, and further declined to $13 billion at 12/31/2024【AMZN_10k_2023.pdf: Note 6 table shows $16,000 m (2022) and $15,000 m (2023)】【AMZN_10k_2024.pdf: Note 6 table shows $15,000 m (2023) and $13,000 m (2024)】. This downward trend indicates that Amazon is actively repaying and retiring portions of the 2017 issuance, using cash flow to shrink its long‑term debt exposure and manage the overall debt profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding balances of $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024) are accurately reported, with correct formatting variations ($16 billion = $16,000 million). (2) The answer is complete, addressing both the evolution of the debt balance and the implication for Amazon's debt management strategy. (3) Entities are correct: Amazon, 2017 Notes, and the specified years are all properly identified. (4) The reasoning is sound: the multi-hop synthesis across the 2023 and 2024 10-K filings (cited via Note 6 tables) correctly traces the balance changes over time, and the conclusion about active repayment and debt reduction aligns with the data. The semantic meaning is equivalent to the original answer, with slightly more detail on the mechanism (use of cash flow) which is a reasonable inference. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 278,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K Business sections, Boeing’s Global Services segment is described in virtually identical language – “…engineering, maintenance and modifications, **upgrades and conversions**, spare parts, pilot and maintenance training….” The term appears each year without being reduced or removed, showing a steady, even reinforced, emphasis on upgrades and conversions. This three‑year consistency signals that Boeing is deliberately making platform‑sustainment through upgrades and conversions a core pillar of its aftermarket strategy, focusing on extending aircraft life‑cycles and generating recurring service revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that 'Upgrades and Conversions' were consistently mentioned in Boeing's 10-K filings from 2022 to 2024 within the Global Services segment, using nearly verbatim language from the filings to support its point. All entities—Boeing, Global Services, 'Upgrades and Conversions', and the three-year timeframe (2022–2024)—are correct. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct referencing of years, which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports to infer a strategic trend, correctly concluding that the consistent inclusion of the service indicates a deliberate, sustained focus on platform sustainment and lifecycle management. The LLM adds value by interpreting the repetition as a sign of a reinforced strategic pillar, which is a reasonable inference. (4) The only reason for not scoring a 10 in qualitative accuracy is that the LLM does not explicitly mention other services (e.g., supply chain management, training) as context for the segment’s offerings, slightly reducing completeness compared to the original answer. However, the core message about strategic focus is fully preserved. Semantic equivalence is strong, and the answer is highly contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 394,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings Johnson & Johnson repeatedly reaffirmed the same pension‑plan amendment: in a January 2021 announcement (re‑stated in each filing) the company said that, effective 1 January 2026, **all eligible U.S. non‑union employees – regardless of hire date – will earn benefits under the Retirement Value formula**, and that the change does **not** affect benefits accrued under the Final Average Pay formula for service before that date. No new eligibility rules or timeline shifts were introduced; the firm simply reiterated the universal eligibility and the 2026 implementation date each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2026 implementation date, the January 2021 announcement, the applicability of the Retirement Value formula to all U.S. non-union employees regardless of hire date, and the protection of accrued benefits under the Final Average Pay formula for pre-2026 service. These match the original answer exactly. (2) Quantitative accuracy is perfect: dates (2021 announcement, 2026 effective date) are correct and consistently reported; no numerical calculations are required, but temporal references are precise. (3) The multi-hop reasoning is sound—information is synthesized across 2022–2024 filings, and the LLM correctly infers that the lack of changes across filings indicates consistency in strategy and communication. The only minor omission is that the original answer notes in 2023 J&J clarified that employees hired after 2014 were already under the Retirement Value formula—a detail absent in the LLM response. While not critical to the core conclusion, it adds contextual nuance about phased implementation and employee segmentation that the LLM overlooks. (4) Despite this omission, the LLM captures the central theme of consistent reiteration and unchanged eligibility and timeline, making the answer semantically equivalent in intent and substance. Hence, a score of 9 is warranted—excellent accuracy with a minor gap in completeness regarding the 2023 clarification on post-2014 hires.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 412,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO’s 5.000 % senior notes due April 2030 carried an outstanding principal of **$606 million in fiscal 2022**, and the same **$606 million** was reported in both **fiscal 2023** and **fiscal 2024** (AVGO 10‑K 2022 pp. 101‑105; AVGO 10‑K 2023 pp. 79‑83; AVGO 10‑K 2024 pp. 79‑83). The balance has not changed, indicating the company has chosen to keep this low‑cost, long‑dated debt on its balance sheet rather than accelerating repayment, reflecting a strategy of preserving stable, inexpensive financing for the instrument.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, AVGO's outstanding principal for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, not $606 million as stated by the LLM. The LLM correctly reports $606 million for fiscal years 2023 and 2024, but incorrectly asserts no change from 2022, when in fact there was a significant reduction from $1,086M to $606M. This error undermines the entire analysis. (2) The calculation of the change over time is therefore wrong: the actual decrease was $480 million from 2022 to 2023, which the LLM fails to capture. The LLM’s claim of a stable balance contradicts the ground truth showing a deliberate reduction. (3) The multi-hop reasoning is flawed because the model did not correctly synthesize data across the three fiscal years. It incorrectly pulls the same value for all three years, failing to recognize the drop in 2023. This suggests either misreading of the source documents or incorrect data retrieval. (4) The qualitative interpretation is based on false premises: the LLM infers a strategy of maintaining low-cost debt due to stability, while the ground truth indicates an active repayment strategy. While the response addresses both parts of the question (evolution and strategy), the factual inaccuracies severely compromise correctness. Contextual relevance is moderate because the structure and intent align with the question, but factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 414,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T’s relationship with Time Warner shifted from integration to divestiture over the 2022‑2024 period. After acquiring Time Warner in 2018, AT&T folded the business into its WarnerMedia segment and, in May 2021, entered into a deal to combine WarnerMedia with Discovery; that transaction closed in April 2022 via a Reverse Morris Trust, reclassifying WarnerMedia (including the former Time Warner assets) as a discontinued operation and removing it from AT&T’s reportable segments (2022 10‑K, History). The 2023 and 2024 filings confirm the WarnerMedia separation was completed in April 2022 and the segment no longer appears in AT&T’s operating structure, marking the full divestiture of the Time Warner‑derived businesses (2023 10‑K, History; 2024 10‑K, History).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T acquired Time Warner in 2018, formed WarnerMedia, and completed the Reverse Morris Trust transaction with Discovery in April 2022. The LLM correctly notes the deal was announced in May 2021 and closed in April 2022, which matches public records. (2) Quantitative accuracy is perfect: dates (May 2021 announcement, April 2022 closing) are correct, and there are no numerical errors. The LLM accurately cites the 2022, 2023, and 2024 10-Ks as sources for the separation and post-divestiture structure. (3) Multi-hop reasoning is sound: the answer synthesizes information across years and filings, correctly identifying the progression from integration to divestiture and the reclassification of WarnerMedia as a discontinued operation. (4) The only minor shortcoming is that the LLM does not mention the 2024 divestiture of DIRECTV as the final step in unwinding the entertainment strategy, which was included in the original answer as part of the broader strategic pivot. While the core narrative of WarnerMedia's exit is complete, the omission of DIRECTV in 2024 slightly reduces completeness on the 'broader WarnerMedia segment' aspect of the question. However, the focus on Time Warner/WarnerMedia is fully accurate. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses integration, restructuring, and divestiture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 406,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "In 2022 AIG quantified its terrorism risk with a third‑party vendor model that included specific scenarios (e.g., conventional bombs, anthrax, nuclear) and disclosed a five‑ton bomb loss of $1.3 bn net of the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and reinsurance, with TRIPRA covering 80 % of losses above a $1.7 bn deductible and limited private reinsurance plus targeted treaty purchases and government pools for international coverage; the international reinsurance attachment points were $200 m for Japan and $100 m for the rest of the world [167‑166]. By 2023 and 2024 the firm continued to use third‑party scenario‑based modeling and TRIPRA (still with limited private reinsurance and pool reliance) but stopped disclosing specific loss figures, while the attachment points were adjusted to $150 m for Japan/$125 m for the rest of the world in the 2024 program and then restored to $200 m/$125 m in the 2025 program [119‑120; 86‑87].",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains key quantitative inaccuracies. It correctly identifies the $1.3 billion modeled loss in 2022 for a five-ton bomb attack net of TRIPRA and reinsurance, aligning with the ground truth. However, it incorrectly states that in 2022 the international attachment points were $200M for Japan and $100M for the rest of the world, while the ground truth specifies $125M for the rest of the world by 2024, not $100M in 2022. The LLM also introduces a $150M/$125M configuration for 2024 and mentions a '2025 program', which is outside the requested 2022–2024 scope and not supported by the original answer. The original answer does not mention any fluctuation or restoration of attachment points, only a stable $200M for Japan and $125M for the rest of the world by 2024. (2) The TRIPRA details (80% coverage above $1.7B deductible) are accurate but were not part of the original answer, so while factually plausible, they add unsupported detail. The core error is the misstatement of the non-Japan attachment point as $100M in 2022 and the speculative evolution to $150M/$125M in 2024, which contradicts the original answer’s simpler progression. (3) The multi-hop reasoning is sound in tracking changes over time and linking modeling, reinsurance, and geographic attachment points across years. The LLM correctly infers a continued use of third-party models and reliance on pools/reinsurance, consistent with the original answer’s theme of increasing sophistication. However, it overextends by introducing unverified program changes beyond 2024. (4) The contextual relevance is perfect—it directly addresses all three aspects of the question (modeled loss scenarios, reinsurance protections, geographic attachment points) across the specified years. The qualitative accuracy is high due to correct identification of AIG, proper use of terrorism risk terminology, and logical synthesis, but docked for unsupported numerical claims. The correctness score is 7 because the core narrative of evolving sophistication is preserved, but key financial figures are inaccurate or extrapolated beyond the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 577,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "Emerson’s pipe‑working line still centers on the classic pipe‑wrench family, but the mix has shifted from a broad “mechanical‑crimping‑and‑tubing‑tools” set in 2022 (“Products include pipe wrenches, pipe cutters, pipe threading and roll‑grooving equipment, mechanical crimping tube joining systems…diagnostic systems, including closed‑circuit‑television pipe inspection” EMR 2022 p. 7‑11) to a tighter portfolio that adds battery‑hydraulic press tools and modern inspection cameras while retaining the core wrenches, cutters, threading and roll‑grooving gear (“Pipe‑working tools include pipe wrenches and cutters, pipe threading and roll‑grooving equipment, battery hydraulic tools for press connections, drain cleaners and diagnostic systems, including sewer inspection cameras” EMR 2024 p. 71‑75).  \n\nThis evolution shows Emerson deliberately deepening its professional‑tools offering with higher‑value, power‑assist and digital‑diagnostic products, reinforcing its market‑leadership strategy and positioning the company for growth in the professional tools segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Emerson maintained core mechanical tools like pipe wrenches, cutters, and threading equipment from 2022 to 2024, while adding battery-hydraulic tools and advanced diagnostic systems (e.g., sewer inspection cameras) by 2024. The cited product lines and technological enhancements match the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are used appropriately even if 2023 is implied rather than explicitly detailed in the LLM response. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes portfolio changes across years using document excerpts, identifying a strategic shift toward higher-value, technologically integrated tools. The inference about market leadership and growth positioning is logically supported. (4) Semantic equivalence is strong—though the LLM does not explicitly mention 2023 as a transition year, it captures the overall progression from 2022 to 2024 and the strategic implication. One minor omission: the original answer notes 2023 as the year of introduction for battery-hydraulic and diagnostic tools, which the LLM implies but does not explicitly state. This slight lack of granularity prevents a perfect 10, but the core facts, reasoning, and strategic interpretation are fully accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 408,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco’s treatment of free‑rent periods has been unchanged from 2022‑2024. In each filing the company states that “some leases include free‑rent periods … which are recognized on a straight‑line basis over the original term of the lease and any extension options that the Company is reasonably certain to exercise” (2022, 2023, 2024 10‑K – Leases note, pp. 43‑47). Because the straight‑line rent expense is derived from the discounted minimum lease payments, the free‑rent periods are built into the calculation of the lease liability and therefore increase the initial right‑of‑use (ROU) asset; the disclosures merely add minor wording refinements (e.g., clarifying the control date and referencing step‑rent/variable payments) but do not alter the underlying methodology or its impact on ROU asset valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Costco maintained a consistent straight-line recognition methodology for free-rent periods across 2022–2024, explicitly citing the lease term and extension options—this matches the original answer. (2) All non-numeric details are factually correct: the use of discounted minimum lease payments to derive straight-line rent expense, the impact on ROU asset valuation, and the reference to incremental borrowing rates (implied via discounting) are all consistent with the 2022 disclosure. (3) The LLM accurately notes that disclosures remained substantively unchanged, with only minor wording refinements—this reflects the decreased disclosure depth mentioned in the ground truth. However, the LLM does not explicitly mention the *absence* of the detailed discounting and ARO explanations in 2023 and 2024, which is a key nuance in the original answer regarding evolving disclosure practices. While the LLM implies consistency, it misses the subtle but important point about reduced explanatory detail post-2022, suggesting a slightly less complete qualitative synthesis. (4) Despite this minor omission, the core accounting treatment, impact on ROU assets, and overall disclosure trend are correctly conveyed. No numeric inaccuracies exist—dates, years, and financial concepts are used appropriately. The answer is contextually fully relevant and demonstrates strong multi-hop reasoning across years and disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 417,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "Microsoft’s 2.000 % senior notes appear in the exhibit index on pages 103‑107 of the 2022‑2024 Form 10‑Ks as follows: the Tenth Supplemental Indenture (exhibit 4.13, dated Nov 3 2015) documents 2.000 % Notes due 2020, and the Eleventh Supplemental Indenture (exhibit 4.14, dated Aug 8 2016) documents 2.000 % Notes due 2023. By the 2022 filing the 2020 notes had already matured, leaving only the 2023 notes outstanding; the 2023 filing shows those notes reaching maturity that year, and the 2024 filing no longer lists any 2.000 % notes, indicating they have been retired while the original supplemental indentures remain the governing documents.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual discrepancies compared to the ground truth. (1) Quantitatively, the LLM correctly identifies the Eleventh Supplemental Indenture dated August 8, 2016, as governing the 2.000% Notes due 2023, which aligns with the original answer. However, it incorrectly introduces a Tenth Supplemental Indenture (Nov 3, 2015) for 2.000% Notes due 2020, which is not mentioned in the ground truth and is irrelevant to the question about the 2.000% Notes across 2022–2024. More critically, the LLM claims that the 2024 filing no longer lists any 2.000% notes, stating they have been retired. This directly contradicts the ground truth, which states that the 2.000% Notes due 2023 were still present in the 2024 exhibit list as part of historical indentures. (2) The dates and percentages are partially accurate but include extraneous details (e.g., 2020 notes) not relevant to the query. (3) The reasoning is flawed in the multi-hop synthesis: while the LLM correctly tracks maturity timelines up to 2023, it fails to recognize that even post-maturity, the notes remain documented in filings as part of the company's indenture history. The conclusion that they are 'no longer listed' in 2024 is factually incorrect per the ground truth. (4) Contextual relevance is high because the answer addresses maturity timelines and indenture documentation as asked, but the core factual error about the disappearance of the notes in 2024 undermines correctness. The original answer emphasizes continuity and stable documentation presence, which the LLM misses entirely. Thus, while some elements are accurate, the key conclusion is wrong, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 470,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "- In the 2022 Form 10‑K (AMZN_10k_2022 pp. 1‑5) Amazon explained that commissions from third‑party seller services are recognized when the related product is shipped to a carrier or delivered to the customer, while fulfillment fees are recognized when the fulfillment activity is performed. 【AMZN_10k_2022.pdf p. 1‑5】\n\n- The 2023 filing (AMZN_10k_2023 pp. 41‑45) refined that language, stating that both commissions and fulfillment fees are recognized when the services are rendered – which generally occurs upon delivery of the product to a third‑party carrier or, for Amazon‑fulfilled orders, to the customer. 【AMZN_10k_2023.pdf p. 41‑45】\n\n- The 2024 Form 10‑K (AMZN_10k_2024 pp. 1‑5) further clarified the composition, adding “any related fulfillment **and shipping** fees” to the commissions, but kept the same timing: revenue is recognized at the point the service is rendered (delivery to a carrier or directly to the customer). 【AMZN_10k_2024.pdf p. 1‑5】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the timing of revenue recognition for commissions and fulfillment fees is consistently tied to service delivery—either upon shipment to a carrier or delivery to the customer—across all three years. The evolution in disclosure clarity from 2022 to 2024 is accurately portrayed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in that sense, but all referenced years, document types (Form 10-K), and page numbers are correctly cited, supporting traceability. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings, correctly identifying how Amazon’s disclosures evolved—starting with general recognition principles in 2022, refining the language in 2023 to group commissions and fulfillment fees under 'services rendered,' and further clarifying in 2024 by explicitly including shipping fees. This matches the ground truth’s emphasis on increasing disclosure clarity. (4) The only minor shortcoming is that the LLM implies a slight incremental change in 2024 by highlighting the addition of 'shipping fees' in the description, which, while plausible, was not explicitly confirmed in the ground truth; however, this does not contradict it and falls within reasonable interpretation. Overall, the answer is factually correct, complete, and contextually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 423,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s 10‑K notes show that it still backs the debt of its legacy SBC subsidiaries – the company lists a guarantee of Southwestern Bell Telephone Co.’s obligations and, under contingent‑liabilities, projects purchase‑obligation guarantees of roughly $28.9 million for 2022 and $24.6 million for the combined 2023‑2024 periods【NOTE 22 Contingent Liabilities】. By continuing to guarantee these legacy obligations, AT&T signals a long‑term liability‑management strategy that keeps historic telecom entities financially supported within the consolidated group, protecting credit standing and containing risk from older debt even as the business evolves.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that AT&T's continued guarantee is evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings across 2022–2024, indicating a consistent legal and financial commitment. However, the LLM introduces specific dollar amounts—$28.9 million for 2022 and $24.6 million for 2023–2024—citing Note 22 on Contingent Liabilities. These figures are not present in the ground truth and contradict the original answer, which makes no mention of any numerical obligations or breakdowns by year. There is no support for these numbers in the provided truth, suggesting fabrication or misattribution. (2) The calculation of $24.6 million covering both 2023 and 2024 is unsupported and introduces a false sense of precision. The original answer emphasizes the *unchanging nature* of the guarantee language, not fluctuating or projected liability amounts. Thus, the quantitative accuracy is low due to the introduction of incorrect financial data. (3) On qualitative reasoning, the LLM correctly infers that continued guarantees suggest a strategy of maintaining financial support for legacy entities and risk containment. This aligns with the ground truth’s interpretation of a 'deliberate and stable strategy.' However, it fails to mention the key evidence—Exhibit 4-b’s consistent inclusion—which is central to the multi-hop reasoning in the original answer. This omission weakens the synthesis across years and filings. (4) Contextually, the answer addresses the question about long-term liability management and draws a reasonable conclusion about consolidated group support and credit protection. While the direction of reasoning is relevant and partially sound, the reliance on incorrect numerical data undermines factual correctness. The answer is semantically related but factually divergent on critical points, warranting a moderate score for relevance but a low score overall due to inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 547,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "- In the 2022 filing the 2.250 % Notes due 2050 were shown at **$983 million**【JNJ_10k_2022.pdf p.65‑68】.  \n- In the 2023 filing the same series was down to **$826 million** (the 2022 balance shown as $808 million)【JNJ_10k_2023.pdf p.69‑71】.  \n- In the 2024 filing the balance fell further to **$808 million** (2023 balance $826 million)【JNJ_10k_2024.pdf p.70‑73】.  \n\nThe steady decline from $983 m in 2022 to $808 m in 2024 shows J&J is gradually reducing its exposure to this ultra‑long‑dated, low‑cost debt, suggesting a strategy of paying down or refinancing older low‑rate obligations while still retaining a modest, inexpensive long‑term financing tranche to support its overall debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the dollar amounts for Johnson & Johnson's 2.250% Notes due 2050: $983 million in 2022, $826 million in 2023, and $808 million in 2024 — matching the ground truth exactly. The formatting variation (e.g., $983 m) is acceptable and semantically equivalent.\n\n2) Quantitative accuracy is perfect: all values are correct, and the progression (decline from $983M to $808M) is accurately described. No calculations were required beyond simple observation of trends, which the model handled correctly.\n\n3) The multi-hop reasoning is sound — the model synthesizes data across three annual filings (2022–2024) and correctly identifies the trend of gradual reduction. The interpretation that J&J is 'gradually reducing exposure' to this long-dated debt aligns with the ground truth's characterization of a 'cautious approach' and 'minor reductions'. The LLM infers a plausible strategic rationale (paying down or refinancing older obligations while retaining low-cost debt), which is consistent with, though slightly less detailed than, the ground truth’s mention of maintaining a 'stable cost of capital at a fixed effective rate of 2.29%'. This specific rate is missing in the LLM answer, which prevents a perfect qualitative score.\n\n4) Contextual relevance is excellent: the response directly addresses both parts of the question — the evolution of the investment and what it indicates about long-term debt strategy. The conclusion is logically derived and relevant.\n\nOverall, the answer is factually correct and well-reasoned, with only a minor omission (the 2.29% effective rate) preventing full marks on qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 452,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco’s $1.375 % senior notes due June 2027 were carried at $1.25 billion in each of the 2022, 2023 and 2024 balance sheets (COST_10k_2022.pdf Note 4; COST_10k_2023.pdf Note 4; COST_10k_2024.pdf Note 4). Over the same period total long‑term debt fell from $6.59 billion in 2022 to $5.92 billion in 2024 as the company retired other notes (e.g., the 2.75 % notes due 2024) and reduced other borrowings (COST_10k_2022.pdf Note 4; COST_10k_2024.pdf Note 4). This shows Costco’s capital‑management strategy of preserving a stable, low‑cost, long‑dated financing tranche while using cash flow to pay down higher‑cost or nearer‑term debt, thereby strengthening its balance‑sheet profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Costco's 1.375% Senior Notes due June 2027 remained constant at $1.25 billion (i.e., $1,250 million) across 2022, 2023, and 2024, matching the ground truth exactly. Total long-term debt is reported as decreasing from $6.59 billion in 2022 to $5.92 billion in 2024, which aligns with the ground truth values of $6,590M → $6,484M → $5,919M when rounded to two decimal places in billions. The slight discrepancy in 2023 ($6.484B vs implied $6.59B to $5.92B path) is not explicitly mentioned in the LLM answer, but the overall trend and endpoints are accurate, and the omission does not materially distort the conclusion. (2) All numbers, percentages, and dates are correct. The $1.25B note amount, 1.375% rate, June 2027 maturity, and total debt figures are all factually accurate and consistent with the knowledge graph. The reference to retiring the 2.75% notes due 2024 is a valid example supporting the broader debt reduction narrative. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and multiple debt tranches, identifying that while the low-cost 1.375% notes were held constant, overall debt declined—indicating selective repayment. The inference about capital management strategy—preserving low-cost, long-dated debt while retiring higher-cost or near-term obligations—is logically derived and semantically equivalent to the ground truth. (4) The answer is highly relevant, complete, and factually accurate. The only minor limitation is the lack of explicit mention of the 2023 total debt figure ($6.484B), but since the focus is on the trend from 2022 to 2024 and the 2023 note balance is confirmed, this does not undermine correctness. Thus, a score of 9 is justified—excellent accuracy with negligible omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 493,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "From 2022 to 2024 Mastercard’s multi‑layered security model—anchored by a robust cyber‑risk program, continuous third‑party assessments, dedicated Security Operations, Fusion and Intelligence Centers, and collaboration on industry standards such as EMV—was repeatedly strengthened as its real‑time payments platform grew, moving from real‑time infrastructure in 12 markets at the end of 2022, to 13 markets by the end of 2023, and then to “several countries around the world” in 2024. This parallel expansion shows that Mastercard deliberately embeds ever‑more comprehensive risk‑mitigation controls into each new payment capability, ensuring that its global scaling of real‑time processing is underpinned by a resilient, layered security framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: 12 markets as of end of 2021 (reported in 2022 filing), 13 markets by end of 2023 (per 2023 data), and the shift to 'several countries around the world' in 2024 are all factually consistent with the original answer. The timeline and market counts are precise and correctly attributed across years. (2) The LLM slightly misattributes the 12-market figure to 'end of 2022' rather than 'as of December 31, 2021' (reported in the 2022 filing), which is a minor temporal inaccuracy but does not materially distort the trend. This is the only deviation. (3) Qualitatively, the multi-hop reasoning is sound: the answer correctly synthesizes the parallel development of security and real-time payments across three years, identifies the continuity of the multi-layered security framework, and infers Mastercard's strategic intent to embed risk controls as it scales—consistent with the original conclusion. The mention of EMV, Security Operations, Fusion and Intelligence Centers adds contextual detail that, while not explicitly in the ground truth, is plausibly aligned with Mastercard’s known security practices and does not contradict the source. (4) The answer fully addresses both parts of the question—evolution of security and infrastructure, and strategic implications—making it contextually excellent. The conclusion that security is 'deliberately embedded' mirrors the original's assertion of intentional parallel scaling. The only reason for not scoring a 10 is the minor misdating of the 12-market milestone.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 447,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Microsoft’s 4.000 % Notes due 2021 were issued only once – under the third supplemental indenture dated February 8 2011 (Exhibit 4.6) 【MSFT_10k_2022.pdf p.102】【MSFT_10k_2023.pdf p.102】【MSFT_10k_2024.pdf p.102】.  By fiscal 2022 the notes had already matured and were not re‑issued in FY 2023 or FY 2024, so the 10‑K filings for those years show no new issuance of that series.  This pattern shows Microsoft’s long‑term debt strategy of issuing fixed‑rate notes with staggered maturities and then allowing them to run to maturity rather than continuously rolling over the same series.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error regarding the maturity and post-maturity treatment of the 4.000% Notes due 2021, which undermines the overall correctness. Quantitatively, the dates (February 8, 2011 issuance), exhibit number (4.6), and note rate (4.000%) are accurately cited across all three years, and the absence of new issuances in 2023 and 2024 is correctly noted—this supports a score of 8 for quantitative accuracy. However, the claim that the notes 'had already matured' by fiscal 2022 is misleading: Microsoft's fiscal year 2022 ended June 30, 2022, and the notes matured in February 2021, so they were indeed past maturity by FY2022. The key discrepancy lies in interpretation: the original answer notes that Microsoft continued to disclose the notes post-maturity (in 2024), suggesting possible rollover, delayed settlement, or disclosure requirements. The LLM instead concludes Microsoft simply allows notes to mature without rollover, which contradicts the ground truth implication of ongoing disclosure possibly indicating rollover or administrative continuity. This reflects a failure in multi-hop reasoning—while the LLM correctly observes no re-issuance, it misinterprets the continued disclosure as mere administrative carryover rather than a potential signal of debt management strategy involving rollover or extended obligations. Thus, qualitative accuracy is scored 5 due to flawed synthesis and conclusion. Contextual relevance is high—the answer addresses the evolution across years and attempts to infer strategy—hence 8. Overall, the answer gets key facts right but draws an incomplete or potentially incorrect inference about debt strategy, warranting a 5 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 471,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s 10‑K filings for 2022, 2023 and 2024 all list the same **1.500 % Note due 2030** (see Exhibit 4.6 in each year – AMZN_10k_2022 p. 69‑73; AMZN_10k_2023 p. 73‑77; AMZN_10k_2024 p. 72‑76). By repeatedly retaining this low‑coupon, long‑dated bond, Amazon is anchoring its capital structure with cheap, fixed‑rate financing that stretches the maturity profile, while newer debt issuances carry higher rates (e.g., 4.700 % due 2024, 4.600 % due 2025) and revolving credit facilities. This pattern shows a strategic emphasis on locking in low‑cost long‑term funding and diversifying away from higher‑cost, shorter‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core insights of the ground truth. (1) All numeric values are correct: the 1.500% Note due 2030 is accurately cited, as are the 4.700% Note due 2024 and 4.600% Note due 2025 (the latter slightly differs from the ground truth's mention of a 4.700% Note due 2032, but the LLM correctly identifies newer, higher-yielding instruments). The years (2022–2024) and exhibit references (Exhibit 4.6) are factually supported. (2) Quantitative accuracy is perfect: percentages and maturities match across filings. (3) The multi-hop reasoning is sound—LLM correctly infers that Amazon is maintaining a long-term, low-cost debt instrument while issuing newer, higher-cost debt, indicating a strategic, layered capital structure. It correctly synthesizes data across three years of filings to support this. (4) The only minor shortcoming is that the LLM does not explicitly mention the broader 2060 maturity referenced in the 2022 filing or the specific 2032 note from 2024, which slightly reduces qualitative completeness. However, the core strategic insight—using long-dated, fixed-rate debt to lock in low-cost capital while layering in new debt—is fully captured. Wording differs but semantic meaning aligns closely with the ground truth. Contextual relevance is excellent, directly addressing Amazon’s capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 379,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "In 2022 AT&T reported that it “continue[d] to hold a 41.3 % interest in SKY Mexico, a leading pay‑TV provider in Mexico,” and that the investment was accounted for under the equity‑method of accounting (2022 10‑K, p. 93). The 2023 filing still listed SKY Mexico among its equity‑method affiliates, showing the stake remained unchanged through the year (2023 10‑K, p. 66‑70). In June 2024 AT&T sold its 41.3 % interest in SKY Mexico, and the 2024 filing notes the disposition and removes SKY Mexico from the equity‑method investment table (2024 10‑K, p. 64‑68). This three‑year progression—from holding a significant minority, equity‑method stake to a complete exit—mirrors AT&T’s broader strategy of divesting non‑core international pay‑TV assets (e.g., Vrio, other video businesses) to focus on its core U.S. telecom and streaming operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitative accuracy: The 41.3% ownership stake is correctly reported for 2022, 2023, and the 2024 sale. The June 2024 exit timing aligns with the knowledge graph's 'mid-2024' characterization. All financial and ownership metrics are accurate. (2) Completeness: The answer addresses all parts of the multi-part question—ownership stake evolution, equity method accounting treatment across years, the exit event, and the broader strategic implications. (3) Entity accuracy: SKY Mexico, AT&T, Vrio (as a reference point), and the correct years (2022–2024) are properly identified. The citations to the 10-K pages (though not scored for correctness) reflect appropriate attention to source grounding. (4) Reasoning: The multi-hop synthesis is sound—connecting the sustained equity-method accounting in 2022–2023 to the eventual 2024 exit demonstrates understanding of the phased divestiture. The conclusion about AT&T’s broader strategy of exiting non-core international pay-TV assets (e.g., Vrio) to focus on U.S. telecom and streaming operations is logically derived and semantically equivalent to the original answer. (5) Semantic equivalence: While the LLM uses slightly different phrasing (e.g., 'disposition' instead of 'exit'), the meaning is identical. The answer captures the phased, strategic nature of the divestiture and correctly infers the intent behind the 3-year trajectory. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 418,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path policy ties the “growth” portion of the U.S. qualified plan to the funded ratio – the better‑funded the plan, the less it allocates to equities and the more it shifts into liability‑hedging, fixed‑maturity assets.  Accordingly, the target mix fell from **15 % equity, 75 % fixed‑maturity and 10 % other (2022)**【308】to an **actual 2023 mix of about 8 % equity, 77 % fixed‑maturity and 15 % other**【250‑251】, and the plan’s **2024 target is 9 % equity, 80 % fixed‑maturity and 11 % other**【250‑251】.  This steady reduction in equity exposure and increase in fixed‑income holdings shows AIG deliberately de‑risking the pension portfolio as the plan’s funded status improves.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct de-risking trend and general strategy but contains significant quantitative inaccuracies that undermine factual correctness. (1) The LLM states a 2022 target allocation of 15% equity, 75% fixed-maturity, and 10% other, but the ground truth does not provide specific percentage allocations—only the strategic glide path logic based on funded status. These exact numbers are not verifiable from the original answer and appear to be fabricated or misattributed. (2) The LLM cites an 'actual 2023 mix' of 8% equity, 77% fixed-maturity, and 15% other, but the original answer discusses target allocations for future years (e.g., 2024 target based on 2023 funded status), not actual realized mixes. This misrepresents the data type (actual vs. target). (3) The 2024 target is given as 9% equity, 80% fixed-maturity, and 11% other—again, these precise figures are absent in the ground truth, which only describes a qualitative continuation of de-risking. (4) The reasoning about de-risking in response to improved funded status is sound and aligns with the original answer’s emphasis on liability-driven investing and glide path evolution. The multi-hop synthesis of strategy over time is conceptually accurate. (5) Contextually, the answer is highly relevant, addressing both the evolution of the glide path and the implications for de-risking. However, the inclusion of unsourced numerical values significantly reduces quantitative accuracy, even though the directional trend (equity down, fixed income up) is correct. Thus, while the qualitative logic and intent are mostly accurate, the incorrect specificity in numbers leads to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 458,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "Mastercard’s credit‑risk safeguards grew markedly, with risk‑mitigation arrangements (cash collateral, letters of credit and guarantees) rising from roughly $6 bn in the 2022 filing (covering $52 bn of gross settlement exposure) to $9 bn in 2023 and $13 bn in 2024 as gross exposure expanded to $78 bn, while the company also built a $589 mn qualified cash‑settlement fund and increased accruals for merchant claims. At the same time it answered mounting regulatory scrutiny—signing an FTC consent agreement, cooperating with DOJ and a European Commission information request, and tightening its risk‑management policies—showing a proactive, adaptable approach to credit and litigation risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth does not mention specific dollar amounts for risk mitigation arrangements ($6B in 2022, $9B in 2023, $13B in 2024), gross settlement exposure ($52B, $78B), or a $589M qualified cash-settlement fund. These figures are entirely fabricated and not supported by the original answer. The original answer emphasizes consistency in credit risk strategies and low losses but does not provide numerical values for collateral or exposure. (2) The calculation and comparison of financial metrics are therefore invalid, as the numbers themselves are incorrect. There is no mention in the ground truth of increasing collateral amounts or accruals for merchant claims. (3) While the LLM correctly identifies key regulatory developments—the FTC consent agreement, DOJ antitrust investigation, European Commission inquiry, and U.S. Liability Shift Litigation—and links them to risk management evolution, it misrepresents the company's response. The original answer states that Mastercard maintained a consistent framework, refining rather than markedly growing its safeguards. The LLM overstates adaptability as a quantitative expansion of mitigation tools, whereas the truth emphasizes methodological continuity amid escalating external risks. (4) Despite incorrect numbers, the LLM captures some contextual elements: regulatory pressures increased from 2022–2024 and Mastercard responded by adjusting policies. However, the core claim of growing collateral and fund creation undermines factual correctness. Thus, while the qualitative direction (increased scrutiny leading to tighter policies) has partial alignment, the lack of numerical support and invention of data severely damages accuracy. Correctness score is low due to fabricated metrics; qualitative accuracy is moderate due to correct identification of events but flawed synthesis; contextual relevance is fair as it addresses the question’s scope but with incorrect evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 551,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "The Home Depot share pool for future equity awards fell sharply – about 117 million shares were available at January 30 2022, the pool had contracted to roughly 77 million shares by January 28 2024, and it was down to about 70 million shares by February 2 2025 (the most recent 2024 filing)【HD_10k_2022.pdf: page 65】【HD_10k_2023.pdf: page 66】【HD_10k_2024.pdf: page 68】. This steady decline shows the company is drawing down its authorized pool, suggesting a tightening of its stock‑based compensation program to limit dilution while still supporting equity awards.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the quantitative evolution of available shares: 117 million in 2022, 77 million by January 28, 2024 (reflecting 2023 data), and 70 million by February 2, 2025 (2024 data), which matches the ground truth. Dates and numbers are accurate with acceptable formatting (e.g., 'about' used appropriately). (2) Quantitative accuracy is high—values match exactly as reported in the original answer and filings, with correct fiscal year alignment. The use of 'January 30, 2022' instead of a 2022 fiscal year-end date is a minor discrepancy but acceptable given Home Depot’s fiscal calendar (ends January), and the 2022 figure is correctly attributed. (3) The multi-hop reasoning is sound—information is correctly synthesized across three 10-K filings. However, the interpretation diverges from the ground truth: while the original answer suggests increased reliance on stock-based compensation due to declining shares, the LLM concludes a 'tightening' of the program to 'limit dilution,' which implies a more conservative strategy. This is a significant qualitative difference in reasoning and implication. (4) The answer is contextually relevant and complete in addressing both parts of the question—evolution of shares and strategic interpretation—but the strategic inference is partially misaligned. Hence, correctness is reduced to 7 due to flawed qualitative reasoning despite strong factual and numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 403,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "Broadcom carried $622 million of principal on its 3.625 % senior notes due October 2024 in FY 2022, the same $622 million remained outstanding in FY 2023, and the balance was eliminated by FY 2024 (the note shows a “‑” balance in the 2024 schedule)【AVGO_10k_2022.pdf:101】【AVGO_10k_2024.pdf:79‑83】.  This drop to zero indicates that Broadcom chose to retire the instrument ahead of its scheduled maturity, reflecting an active debt‑reduction strategy that removes older, higher‑cost borrowings as part of its overall capital‑structure management.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $622 million obligation in FY 2022, no change in FY 2023, and reduction to $0 in FY 2024. The mention of a '‑' balance in the 2024 schedule aligns with the elimination of the liability. (2) Quantitative accuracy is perfect: dollar amounts ($622 million), interest rate (3.625%), and maturity date (October 2024) match the original. No calculations are required beyond tracking the balance over time, which is correctly presented. (3) Multi-hop reasoning is sound—information is synthesized across three fiscal years (2022, 2023, 2024) from different filings (2022 and 2024 10-Ks cited), demonstrating proper cross-document inference. (4) The interpretation—that Broadcom retired the notes ahead of maturity as part of an active debt-reduction and capital-structure management strategy—is logically supported by the data and adds appropriate qualitative insight consistent with the ground truth’s conclusion about deliberate debt management. Minor wording differences (e.g., 'retire the instrument' vs 'full repayment or restructuring') do not affect factual equivalence, as retiring debt before maturity is a common method of proactive debt management. All parts of the question are addressed: evolution across years and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 379,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "In 2022 AT&T still treated the former Time Warner assets as the centerpiece of its WarnerMedia segment and announced a “combine‑with‑Discovery” plan that was slated to close in the second quarter of 2022 (2022 10‑K, pp. 3‑7). By 2024 the WarnerMedia business had been spun out in a Reverse Morris Trust, recorded as discontinued operations, and AT&T also moved to sell its remaining DIRECTV interest—its final step out of the entertainment portfolio (2024 10‑K, pp. 2‑6). Together, these moves show AT&T shedding the content side of its business to concentrate on core telecommunications—5G, fiber and network services—rather than pursuing a combined telecom‑media model.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, T (AT&T) still held Time Warner Inc. as part of its WarnerMedia segment and was planning the combination with Discovery, which matches the original answer. The mention of the 'second quarter of 2022' for the planned close is more specific than the ground truth but consistent with public timelines; however, the actual completion occurred in April 2022, so this detail is factually sound. (2) The LLM correctly states that by 2024, the WarnerMedia business had been spun out via a Reverse Morris Trust and was recorded as discontinued operations—this aligns with the 2023 completion of the transaction, with financial reporting effects extending into 2024. The sale of the remaining DIRECTV interest is accurately presented as the final exit step from entertainment. (3) The reasoning is sound: the LLM correctly infers that these actions represent a strategic retreat from content and media to refocus on core telecom (5G, fiber, network services), which is consistent with the original answer’s conclusion about a shift back to telecommunications. (4) Minor point: the original answer specifies the divestiture planning and execution occurred in 2023 (transaction completion), while the LLM attributes the spin-out to 2024. This is slightly imprecise—the deal closed in 2022—but reporting and full separation impacts were reflected through 2023 and 2024, so the LLM’s framing based on 10-K disclosures is contextually acceptable. Overall, all key entities (AT&T, Time Warner, Discovery, DIRECTV), strategic moves (Reverse Morris Trust, divestiture), and the overarching strategic shift are correctly identified and logically synthesized. The answer is semantically equivalent to the ground truth with only slight variation in temporal emphasis, not factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 507,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "In Emerson’s 2022 filing the pipe‑cutters were described simply as a core mechanical item in the Safety & Productivity segment’s pipe‑working tools, listed alongside battery‑hydraulic press tools and separate diagnostic systems such as sewer‑inspection cameras (EMR_10k_2022 pdf pp. 7‑11). By the 2024 filing the company was positioning pipe‑cutters as part of an increasingly integrated, battery‑powered tool family that embeds diagnostic capability, framing them as connected, mobile‑workforce solutions within the Safety & Productivity segment (EMR_10k_2024 pdf pp. 71‑75). This reflects a shift from a purely mechanical offering toward a digitally‑enabled, battery‑driven product line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Emerson's Pipe Cutters from a standalone mechanical tool in 2022 to an integrated, battery-powered, and diagnostic-capable product line by 2024. The mention of sewer-inspection cameras and battery-hydraulic press tools in 2022 as separate systems, and their integration by 2024, matches the original answer. (2) There are no numeric values requiring calculation, but the years (2022, 2024) are correctly used and contextualized. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years (2022 and 2024), correctly inferring a strategic shift toward integration and digital enablement. It accurately captures the progression even though 2023 is not explicitly mentioned—the core trend from 2022 to 2024 is preserved. (4) The only minor omission is the lack of explicit reference to 2023, where the product line was linked with battery hydraulic tools for press connections. However, the 2024 description implies this development, so the omission does not undermine the overall correctness. Wording differs slightly (e.g., 'digitally-enabled' vs 'smart, integrated tooling'), but semantic equivalence is maintained. The answer is fully contextually relevant and addresses all key aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 373,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 10‑K that it had launched a multi‑year, enterprise‑wide effort to integrate, simplify and standardize the processes and systems for HR, IT, procurement, supply‑chain and finance – specifically to grow its financial shared‑service capabilities and standardize its financial systems. The same description appears unchanged in the 2023 and 2024 filings, showing the program is still ongoing and not a reaction to any control deficiency. This continuity underscores J&J’s strategic focus on building a uniform, streamlined finance operating model and reinforcing financial‑process standardization across the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative was launched in 2022, spans multiple functions including finance, and aims to integrate, simplify, and standardize processes and systems. The initiative is explicitly tied to enhancing financial shared services and standardizing financial systems, and it is correctly noted as not being a response to control deficiencies. This description remains consistent in the 2023 and 2024 filings. (2) There are no numeric values requiring calculation, but the years (2022–2024) are correctly cited, and the absence of changes across filings is accurately reported. (3) The multi-hop reasoning is sound—information is synthesized across three years of disclosures to infer ongoing strategic commitment. The LLM correctly infers that the unchanged language indicates continuity and strategic prioritization. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'streamlining of the financial control environment'—a key phrase emphasized in 2023 and 2024 in the ground truth. While the concept of a 'streamlined finance operating model' is mentioned, the specific focus on the 'control environment' is slightly underdeveloped. However, the core strategic focus on standardization and operational efficiency is correctly captured. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent with only minor omissions in nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 421,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Costco’s 10‑K filings for FY 2022, FY 2023 and FY 2024 all list the Executive Health Plan as Exhibit 10.1, but the “Filed Herewith” column is left blank – the plan is incorporated by reference rather than attached as a separate exhibit (e.g., “10.1* Costco Wholesale Executive Health Plan … |  | 10‑K | 9/2/2012 | 10/19/2012” in each year’s exhibit table)【COST_10k_2022.pdf p.64‑68】【COST_10k_2023.pdf p.64‑68】【COST_10k_2024.pdf p.64‑68】. The unchanged filing status across three consecutive years shows that Costco treats the Executive Health Plan as a stable, long‑term component of its executive‑benefit package, reflecting a consistent commitment to this benefit in its overall compensation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the Executive Health Plan is consistently listed as Exhibit 10.1* (minor notation variance in asterisk placement is formatting, not factual), with the same 'Period Ended' date of September 2, 2012, and 'Filing Date' of October 19, 2012, across FY 2022–2024. These dates match the ground truth exactly. (2) The answer correctly notes that the plan is incorporated by reference (not filed anew), evidenced by the blank 'Filed Herewith' column, which supports the conclusion of no material updates. (3) The reasoning is sound: the lack of new filings over three years is correctly interpreted as stability in executive benefits strategy. (4) The only minor shortcoming is that the LLM does not explicitly state that no amendments were filed—this is implied but not directly stated, slightly reducing qualitative precision. However, the conclusion about a stable, long-term benefit strategy is semantically equivalent to the ground truth. The answer is fully contextually relevant and addresses both the evolution (or lack thereof) and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 330,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "The cash dividend on Mastercard’s Class A common stock rose each year – $2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024 (MA_10k_2022.pdf p.96; MA_10k_2023.pdf p.99; MA_10k_2024.pdf p.92) – while the voting entitlement for Class A remained unchanged at one vote per share throughout the period (MA_10k_2022.pdf p.96; MA_10k_2023.pdf p.98; MA_10k_2024.pdf p.90). This steady one‑share‑one‑vote structure combined with progressively higher dividends reflects a governance strategy that preserves a clear, stable voting framework for public shareholders while consistently enhancing shareholder returns.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding dividend rights. The ground truth states that A Class Shares had 'standard dividend rights' with no mention of specific cash dividend amounts per share, while the LLM fabricates precise annual dividends ($2.04, $2.37, $2.74), which are not disclosed as per-share payouts for Class A shares in the provided context. These figures may reflect total dividends paid by the company or other metrics but are incorrectly attributed to Class A shares specifically. The voting rights are correctly identified as one vote per share across all years, which aligns with the ground truth. (2) The quantitative accuracy is low because the dollar amounts are not supported by the ground truth and introduce false precision. There is no verification that these per-share dividends were actually distributed to Class A shareholders as claimed, making the numbers misleading. (3) The reasoning is partially sound in linking stable voting rights to governance stability, but the conclusion about 'progressively higher dividends' reflecting a strategic enhancement of shareholder returns is based on incorrect data. The multi-hop synthesis fails because it conflates overall dividend trends (if any) with class-specific rights, which were explicitly stated to be unchanged. (4) Contextual relevance is high because the answer addresses both dividend and voting rights over the 2022–2024 period and attempts to infer governance strategy. However, the core factual error about dividend amounts undermines the correctness score, limiting it to partial accuracy. The qualitative accuracy is moderate due to correct entity identification (MA, Class A shares, years) and correct voting rights, but flawed financial attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 484,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Broadcom’s Security Insights Platform was described in each filing as a solution that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps … This data is available for use with in‑house tools for security information and event management.” The same language appears in the Mainframe Software Portfolio sections of the 2022, 2023 and 2024 10‑K reports (AVGO_10k_2022 pp. 9‑13; AVGO_10k_2023 pp. 8‑12; AVGO_10k_2024 pp. 8‑12), indicating that its integration with customers’ in‑house security tools and its risk‑identification capabilities remained consistent across those fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Broadcom's Security Insights Platform maintained consistent functionality across fiscal years 2022, 2023, and 2024, with stable integration with in-house security tools and risk identification capabilities. The core description — assessing mainframe security posture, identifying risks, and enabling use with in-house tools — is accurately reflected. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in a traditional sense; however, the fiscal years (2022, 2023, 2024) are correctly cited, and the document references (AVGO_10k_2022, etc.) and page numbers are accurately provided, supporting factual precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings to conclude that the platform’s description and capabilities remained unchanged, indicating consistent integration and functionality. This supports the conclusion of a mature offering, even if the term 'mature' is implied rather than stated. (4) The LLM answer captures the semantic meaning of the original answer, though it omits the explicit mention of 'remediation planning' becoming more emphasized in 2023 and the observation about 'stable functionality' suggesting maturity in the portfolio. These are minor contextual nuances, not critical omissions. Wording differs slightly but conveys equivalent information. Overall, the answer is factually correct, well-supported, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 444,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "AIG’s loss‑reserve risk oversight has been built on internal controls, a formal reserve‑setting process and external‑expert reviews throughout the period (2022 pp. 165‑169; 2023 pp. 117‑121; 2024 pp. 84‑88). In the 2022 filing the company described its reserve adequacy assessment mainly through actuarial models and deterministic estimates, supplemented by external expert validation, while the 2023 filing added “sensitivity and scenario analyses, stochastic methods, and experience studies” and a model‑risk management/validation framework (2023 pp. 119‑121); the 2024 filing reiterates the same advanced quantitative techniques and continued reliance on external experts to review and challenge reserve assumptions (2024 pp. 85‑88).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AIG consistently used internal controls and external expert reviews from 2022–2024, which is correctly noted. The evolution in methodology is accurately captured—2022 relied on deterministic estimates and actuarial models with external validation; 2023 introduced stochastic methods, sensitivity/scenario analyses, and model-risk frameworks; 2024 maintained these advanced techniques with continued external review. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects full correctness on available data. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying progression in methodology and consistency in external expert involvement. (4) Minor difference from ground truth: the original emphasizes structural enhancements in governance (e.g., ERM second-line reviews, budget/expense monitoring in 2024), which the LLM mentions less explicitly. However, the core evolution in quantitative methods and external validation is fully and correctly conveyed. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies—only slight omission of governance details in 2024, not central to the main thrust of methodology evolution. Hence, a high score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 405,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "In the 2022 filing Emerson still grouped electrical‑distribution gear under the broad “Industrial Solutions” product line of its Automation Solutions segment (“Industrial Solutions provides fluid control and pneumatic mechanisms, **electrical distribution equipment**, and materials‑joining …”). By the 2023 and 2024 filings the company had created a dedicated **Discrete Automation** segment and placed electrical‑distribution equipment there together with solenoid valves, pneumatic devices, motion solutions and software. The move from a generic industrial‑solutions bucket to the Discrete Automation segment shows Emerson is deliberately refocusing that business toward discrete‑automation customers, emphasizing growth in the discrete‑automation market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Emerson's Electrical Distribution Equipment positioning across 2022, 2023, and 2024. (1) It correctly states that in 2022, the equipment was part of the Industrial Solutions segment under Automation Solutions, grouped with fluid control and materials-joining products. In 2023 and 2024, it accurately notes the reorganization into a dedicated Discrete Automation segment, listing relevant product lines like solenoid valves and motion solutions. The strategic interpretation—that this shift reflects a deliberate refocusing toward discrete automation markets—is consistent with the ground truth. (2) There are no numeric values to verify, but all dates (2022, 2023, 2024) and entity names (Emerson, EMR, Discrete Automation, Industrial Solutions) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes across three years and infers strategic intent from structural reorganization. One minor omission: the 2024 detail about closer grouping with electric linear motion and programmable control systems is mentioned only generally as 'motion solutions and software,' slightly reducing completeness. (4) Despite this, the answer conveys the essential meaning and strategic implication accurately, with excellent contextual relevance. The slight lack of specificity in describing the 2024 integration justifies a 9 instead of 10 on qualitative accuracy, but overall correctness remains very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 408,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "From 2022 through 2024 Johnson & Johnson’s U.S. non‑union pension plans still used two parallel formulas – a Final Average Pay formula for employees hired before 1 Jan 2015 and a Retirement Value formula for those hired after 2014 – while the company repeatedly noted its 2021 announcement that, effective 1 Jan 2026, **all** eligible U.S. non‑union employees will accrue benefits under the Retirement Value formula (JNJ_10k_2022 p.73; JNJ_10k_2023 p.74; JNJ_10k_2024 p.75). The multi‑year transition, which does not alter benefits earned under the old formula for service before 2026, reflects a deliberate long‑term workforce strategy to unify pension accruals, promote equity across hire cohorts and align retirement benefits with total career compensation, thereby simplifying plan administration and supporting employee retention.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the transition to the Retirement Value formula effective January 1, 2026, applies to all eligible U.S. non-union employees, with pre-2026 benefits preserved under the Final Average Pay formula. The citations to the 2022, 2023, and 2024 10-Ks (pp. 73, 74, 75) are consistent with the source disclosures. (2) The mention of a dual-track system based on hire date (pre- and post-2015) prior to 2026 is factually accurate and adds contextual detail not contradicted by the ground truth, though the original answer does not specify the 2015 cutoff. This detail is consistent with typical pension plan transitions and does not constitute an error. (3) The reasoning is sound: the multi-year consistency in disclosure reflects a deliberate, unreversed strategy, and the conclusion about standardization, equity, cost predictability, and administrative simplicity is well-supported. (4) The LLM enhances the original answer with additional nuance (e.g., 'promote equity across hire cohorts', 'simplifying plan administration') that are reasonable interpretations and improve completeness without introducing inaccuracies. The only minor gap is that the original emphasizes 'total years of service and compensation' as the new basis, while the LLM says 'total career compensation'—slightly less precise but semantically close. Overall, the answer is factually correct, contextually rich, and demonstrates proper multi-hop synthesis across three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 430,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "The 10‑K excerpts for 2022, 2023 and 2024 all list Downy as one of the headline brands in the Fabric & Home Care segment (see the “Reportable Segments” tables in each year’s filing), but none of the provided pages disclose a specific percentage of segment net‑sales that Downy contributed. Because the exact share isn’t disclosed, we can’t quantify a rise or fall, yet its consistent inclusion among the segment’s key brands over the three years signals that Downy remains a core, strategically important brand in P&G’s portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. The ground truth states that the Fabric & Home Care segment's net sales contribution to P&G increased from 35% in 2022 to 36% in 2023 and 2024, and that Downy is a key brand within this growing segment. The LLM incorrectly claims that no percentage contribution for Downy is disclosed, when the original answer clearly infers Downy’s strategic importance from the segment-level trend. While the LLM correctly identifies Downy as a consistently listed brand, it fails to report the actual segment contribution percentages that were available in the knowledge graph. (2) The quantitative accuracy is very low because the LLM denies the availability of key percentages (35% → 36%) that are central to the original answer. These numbers are critical to addressing the question about the evolution of Downy’s contribution. (3) The reasoning is partially sound in that the LLM correctly infers strategic importance from consistent mention in filings, which is a valid qualitative signal. However, it fails to perform the correct multi-hop synthesis: linking Downy’s role to the growing segment share (35% to 36%) to infer sustained strategic importance. Instead, it defaults to a disclosure limitation argument, contradicting the ground truth that such trend information is available. (4) Contextual relevance is high because the LLM addresses the right segment, brand, and time frame, and attempts to reason about strategic importance. However, the failure to report the actual numerical trend significantly undermines correctness. The answer is plausible but factually misaligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 459,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One’s “total senior and subordinated notes” carried a value of **$27.2 billion** at year‑end 2022, rose to **$31.2 billion** at year‑end 2023, and then slipped modestly to **$30.7 billion** at year‑end 2024【COF_10k_2022.pdf†page=188】【COF_10k_2023.pdf†page=176】【COF_10k_2024.pdf†page=186】. The jump in 2023 shows the company deliberately increased its long‑term note financing—likely to fund growth or refinance existing debt—while the slight decline in 2024 suggests a pull‑back or restructuring, indicating a strategy of expanding debt when needed and then moderating exposure to keep the capital structure balanced.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value was $27,219 million in 2022, increased to $31,248 million in 2023, and remained at $31,248 million in 2024 (no decrease). However, the LLM incorrectly states that the value decreased to $30.7 billion in 2024, which contradicts the ground truth. This error affects the core factual accuracy of the response. (2) Number verification: $27.2 billion in 2022 is approximately correct (rounding $27,219 million). $31.2 billion in 2023 is a reasonable rounding of $31,248 million. However, reporting $30.7 billion in 2024 is incorrect—ground truth shows no change from 2023 to 2024. The LLM likely misread or misreported the 2024 value. (3) Multi-hop reasoning is partially sound: the model correctly identifies the increase from 2022 to 2023 and infers strategic debt issuance, which aligns with the ground truth. However, the conclusion about a 'pull-back or restructuring' in 2024 is based on incorrect data and thus invalidates that part of the reasoning. The ground truth shows a stable peak in 2023–2024, suggesting sustained reliance on notes, not moderation. (4) Despite the incorrect 2024 figure, the answer is contextually relevant and attempts appropriate interpretation. The qualitative reasoning is logical given the assumed numbers, but the factual error in the final year reduces overall correctness. Hence, correctness_score is 5 due to major quantitative error in trend direction for 2024, despite mostly correct structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 431,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "In 2022 AT&T still owned a 41.3 % stake in SKY Mexico and, as disclosed in the Vrio disposition note, it was accounted for under the equity‑method of accounting for “investments in partnerships, joint ventures and less‑than‑majority‑owned subsidiaries” (2022 10‑K, pp. 91‑95). The 2023 filing shows that the SKY Mexico interest remained on the balance sheet as an equity‑method investment alongside DIRECTV and Gigapower (2023 10‑K, pp. 66‑70). By June 2024 AT&T sold the entire 41.3 % interest, removing SKY Mexico from its equity‑method investments (2024 10‑K, pp. 64‑68). This three‑year path—from holding a minority stake, to retaining it under equity‑method accounting, to a complete exit—mirrors AT&T’s broader strategy of winding down its Latin‑American pay‑TV exposure, first divesting the larger Vrio operation and then shedding the remaining SKY Mexico holding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: T (AT&T) held a 41.3% stake in SKY Mexico throughout 2022–2023 and exited in June 2024. The equity method accounting treatment is correctly noted for 2022 and 2023, with removal in 2024. (2) Quantitative accuracy is perfect: the 41.3% ownership stake and June 2024 exit date match the original answer. Page references to 10-K filings add precision, though not required. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across three years and multiple filings, tracking the evolution from holding to divestiture. It also correctly links the SKY Mexico exit to the broader Latin American pay-TV divestiture strategy, referencing the prior Vrio divestiture as context. (4) The only minor shortcoming is that the original answer emphasizes T’s broader strategy of exiting non-core international assets to focus on domestic operations, which the LLM mentions but frames slightly more narrowly around Latin American pay-TV. However, this does not detract from factual correctness. Wording differs but semantic meaning is equivalent. No calculation errors. All entities (SKY Mexico, DIRECTV, Gigapower, Vrio) are correctly identified. Overall, this is a factually precise, well-supported, and contextually appropriate response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 373,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "BNY Mellon’s 2022 Form 10‑K first warned that the Board’s discretion to pay dividends or repurchase shares could be curtailed by U.S. banking statutes, capital‑planning rules, Delaware law and the requirement to pay its preferred stock dividends in full and on time, and that a failure to remain “well‑capitalized” or “well‑managed” would limit its activities. The 2023 filing reiterated those same constraints but added a clearer focus on meeting the Federal Reserve’s capital‑adequacy and liquidity ratios, noting that any shortfall in those regulatory capital standards would directly restrict shareholder‑return actions. By the 2024 Form 10‑K the company again stressed the Board’s discretion but explicitly tied any capital return to compliance with U.S. banking capital‑planning requirements, maintaining “well‑capitalized” status, and fulfilling full preferred‑dividend payments, showing a more integrated emphasis on regulatory capital, dividend policy and capital‑return limits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's disclosures from 2022 to 2024 consistently reference U.S. banking laws, capital-planning rules, Delaware law, preferred dividend obligations, and the importance of maintaining 'well-capitalized' and 'well-managed' status. The evolution across years is accurately portrayed—2022 introduced key constraints, 2023 maintained them with added emphasis on Federal Reserve capital and liquidity ratios (consistent with ESG and regulatory pressure context), and 2024 reinforced these with a more integrated view of capital returns tied to regulatory compliance and strategic initiatives. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable in terms of calculations, but all referenced requirements (e.g., capital ratios, dividend payments) are correctly named and contextualized—thus scoring 10. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying both continuity and incremental changes in language and emphasis, particularly around regulatory capital, dividend policy, and capital-return limitations. The only minor gap is that the LLM does not explicitly mention the Parent company’s reliance on subsidiary dividends or the impact of strategic transformation on liquidity—details included in the 2024 disclosure per the ground truth—hence a slight deduction in qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing regulatory requirements, dividend policies, and capital adequacy across the three-year horizon as asked. Overall, the LLM captures the core trend: stable regulatory constraints with increasing complexity in disclosure framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 489,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "In the 2022 and 2023 10‑Ks, 3M listed “Structural adhesives and tapes” as a stand‑alone line item within the Safety & Industrial segment (see the Business‑Segment‑Products tables on 2022 pp. 129‑133 and 2023 pp. 105‑109). By 2024, the company reorganized the segment, creating an “Industrial Specialties” division that absorbed the former Industrial Adhesive and Tapes business and bundled those adhesives with closure, masking and personal‑safety products (2024 pp. 108‑112). This shift from a discrete adhesive line to a cross‑product specialty grouping signals that 3M now treats adhesives as a strategic, platform technology that can be sold alongside adjacent industrial solutions, reinforcing their role as a core enabler of broader industrial applications.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in factual content and aligns well with the ground truth, with high quantitative and contextual accuracy. (1) All dates (2022, 2023, 2024) and document references (10-K pages) are accurately cited, and there are no numerical inaccuracies—this supports a perfect quantitative accuracy score. (2) The answer correctly identifies the evolution: Structural Adhesives were a standalone category in 2022 and 2023, and by 2024 were integrated into a broader 'Industrial Specialties' division. This matches the ground truth’s description of a shift toward specialized industrial applications. (3) The multi-hop reasoning is sound—comparing product categorizations across three years and inferring strategic intent from structural changes in reporting. However, there is a slight discrepancy: the LLM claims adhesives were bundled with 'personal-safety products' in 2024, which is not mentioned in the ground truth; instead, the truth emphasizes construction, maintenance, and packaging systems. This overreach in entity linkage slightly reduces qualitative accuracy. (4) The conclusion about adhesives becoming a 'platform technology' is semantically equivalent to the ground truth’s 'foundational component in complex industrial systems,' showing strong reasoning. The answer fully addresses both parts of the question—evolution of positioning and strategic implications—making it contextually excellent. Minor deduction in correctness due to the slight mischaracterization of adjacent offerings in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 419,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "From the 2022 filing through the 2024 filing, Lilly continued to market Cyramza as a multi‑indication oncology product—primarily a second‑line therapy for advanced gastric, NSCLC, colorectal and hepatocellular cancers and as a first‑line option for EGFR‑mutated metastatic NSCLC—without adding new approved indications during that period. Its intellectual‑property shield stayed anchored by compound patents that run to 2026 in the United States and Japan and 2028 in major European countries, plus data‑package protection that extends to 2024 in Europe and 2023 in Japan, preserving exclusivity in those key markets. This consistent therapeutic focus combined with a stable patent‑and‑data‑exclusivity timeline reflects Lilly’s strategy of leveraging Cyramza’s existing indication portfolio while relying on its established IP portfolio to sustain market protection.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding intellectual property (IP) protection timelines, which directly contradict the ground truth. The ORIGINAL ANSWER states that Cyramza's data protection expired in Japan in 2023, with European data protection expiring in 2024 and U.S. biologics data protection ending in 2026. However, the LLM claims compound patents run to 2026 in the U.S. and Japan and 2028 in Europe, and that data-package protection extends to 2024 in Europe and 2023 in Japan—this misrepresents the type and timing of protections. The ground truth emphasizes *data protection* expirations, not *compound patents*, and does not mention 2028 in Europe or patent protection as the primary shield. This is a critical error in both entity type (data vs. compound patent) and dates (2028 vs. 2026). Additionally, the LLM incorrectly frames Cyramza as a first-line option for EGFR-mutated NSCLC, which is not supported by the original answer. While the therapeutic indications (gastric, NSCLC, colorectal, liver cancers) are correctly identified, the addition of a first-line indication introduces inaccuracy. The reasoning is partially sound in identifying a lifecycle management strategy, but the flawed IP timeline undermines the multi-hop synthesis. The answer is contextually relevant and addresses both indications and IP, but the quantitative and qualitative inaccuracies severely reduce correctness. Minor flexibility is allowed for wording, but the conflation of patent types and incorrect expiration dates constitutes major factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 434,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s fixed‑rate unsecured senior notes grew from a carrying value of **$24.1 billion in 2022** to **$27.2 billion in 2023**, then edged down to **$26.9 billion in 2024**.  The weighted‑average interest rate was roughly **4.45 % in both 2022 and 2023**, rising to **about 4.84 % in 2024**【COF_10k_2023.pdf p.176‑180】【COF_10k_2024.pdf p.186‑190】.  This pattern shows the company added a sizable amount of fixed‑rate senior debt in 2023, but as market rates climbed it paid a higher average coupon in 2024, suggesting a strategy of preserving a large fixed‑rate funding base while accepting higher financing costs as rates increased.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's fixed unsecured senior debt carrying value was $19,975 million in 2022, but the LLM reports $24.1 billion, which is off by over $4 billion. The 2023 value is not present in the ground truth (which only provides 2022 and 2024), yet the LLM fabricates a $27.2 billion figure for 2023. While the 2024 carrying value is approximately correct ($26.9 billion vs. $26,930 million), the interest rate in 2022 is wrong: the LLM states 4.45%, but the ground truth is 2.91%, a major discrepancy. The 2024 rate (4.84%) is correctly reported. (2) Calculations and comparisons are flawed due to incorrect base numbers. The LLM implies a stable rate in 2022–2023 before rising in 2024, but the ground truth shows a clear increase from 2.91% to 4.84% over the two-year period, suggesting rising financing costs throughout. The LLM’s narrative is thus based on incorrect data. (3) Multi-hop reasoning is partially sound—the LLM attempts to synthesize trends in carrying value and interest rates over time and draws a plausible conclusion about preserving a fixed-rate funding base. However, because the underlying data is inaccurate, the reasoning is compromised. The model cites specific document pages, suggesting access to sources, but misrepresents the data. (4) The contextual relevance is high—the answer addresses the evolution of debt, discusses strategy and financing costs, and uses appropriate financial terminology. However, due to major factual errors in key metrics, especially the starting carrying value and interest rate, the correctness score is limited to 5. The qualitative accuracy is moderate because the structure and intent are correct, but quantitative accuracy is low due to incorrect numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 495,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s exposure to the total‑return swaps used to hedge its deferred‑compensation obligations grew each year – the notional amount rose from $651 million in FY 2022, to $792 million in FY 2023, and to $985 million in FY 2024【CSCO_10k_2022.pdf p. 90‑94】【CSCO_10k_2023.pdf p. 89‑93】【CSCO_10k_2024.pdf p. 89‑93】.  The accounting impact swung dramatically, posting a $92 million loss in FY 2022, a $58 million gain in FY 2023, and a $91 million gain in FY 2024, indicating that the swap position is highly volatile and sensitive to market movements over the three‑year period【CSCO_10k_2022.pdf p. 90‑94】【CSCO_10k_2023.pdf p. 89‑93】【CSCO_10k_2024.pdf p. 89‑93】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures for gains and losses: $92 million loss in FY 2022, $58 million gain in FY 2023, and $91 million gain in FY 2024 — matching the ground truth exactly. These numbers are critical and accurately reflected. (2) While the original answer does not mention notional amounts ($651M, $792M, $985M), the LLM provides additional context about the growing exposure via notional value, which is factually correct per the cited 10-Ks and enhances the response without contradicting the ground truth. This extra detail does not detract from accuracy but adds depth. (3) The multi-hop reasoning is sound — the LLM synthesizes data across three fiscal years and correctly infers that the swing from loss to gains indicates high volatility and market sensitivity, aligning with the original conclusion. (4) The semantic meaning and factual core fully match the ground truth; the only difference is the inclusion of notional amounts, which improves completeness without introducing error. Thus, the answer earns a 9 for correctness due to full factual alignment and enhanced context, with perfect scores in quantitative accuracy and contextual relevance. Qualitative accuracy is 9 because while reasoning is strong, the focus on notional growth slightly shifts emphasis from the primary question about gains/losses, though it remains relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 387,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "In 2022 Home Depot’s strategy highlighted visual‑merchandising and store‑reset projects to improve store appearance and differentiate the brand from multichannel and online rivals. By 2023 the focus shifted to a systematic store‑refresh program—adding way‑finding signage, electronic shelf‑labels, self‑service lockers, curbside pickup and redesigned front‑end and checkout areas—and the company said these upgrades were “driving higher customer‑satisfaction scores.” The 2024 filing shows Home Depot continued to invest in those refresh packages and again cites the resulting rise in customer‑satisfaction metrics as evidence that its upgraded store appearance has strengthened its competitive position against multichannel and purely online competitors.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the evolution of The Home Depot's store appearance strategy from 2022 to 2024 and its competitive implications. It correctly identifies the increasing strategic integration of store appearance with customer experience and competitive positioning against online and multichannel retailers. The answer accurately reflects the progression: in 2022, focus on visual merchandising and store resets as differentiators; in 2023, expansion into a broader store-refresh program tied to customer satisfaction; and in 2024, continued investment with measurable improvements in customer satisfaction metrics. While the original answer emphasizes the integration of store appearance into an 'interconnected' or 'omnichannel' model—highlighting digital tools, mobile platforms, and support for Pros and DIY customers—the LLM answer captures this implicitly through references to self-service lockers, curbside pickup, and electronic shelf labels, which are components of that hybrid model. However, the LLM answer does not explicitly mention the strategic pivot to omnichannel or the role of digital platforms in blending physical and digital experiences, which is a key nuance in the original answer. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), and all entities (Home Depot, years, competitive context) are correct. The reasoning is sound and contextually relevant, though slightly less comprehensive in synthesizing the full strategic evolution toward interconnected retail. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 447,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "NVIDIA’s 3.50 % notes due 2050 were carried at $1,637 million at the end of FY 2022, remained essentially unchanged at $1,637 million in FY 2023, and fell modestly to $1,604 million in FY 2024【NVDA_10k_2022.pdf pp 78‑82】【NVDA_10k_2023.pdf pp 65‑69】【NVDA_10k_2024.pdf pp 70‑74】. The slight decline reflects the amortization of the note’s discount and a small pay‑down, indicating that NVIDIA’s long‑term debt base is stable but gradually being reduced.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported carrying values and years. According to the ground truth, the carrying value was $2,147 million in FY 2022, decreased to $1,637 million in FY 2023, and stabilized at $2,000 million in FY 2024. However, the LLM incorrectly states that the value was $1,637 million in FY 2022 (wrong year), remained unchanged in FY 2023 (partially correct value but misaligned year), and decreased to $1,604 million in FY 2024 (incorrect value and trend). The correct progression shows a drop from 2022 to 2023 and then a notable increase in 2024, which the LLM completely misses. (2) The quantitative inaccuracies are severe: the LLM misassigns the $1,637 million figure to both 2022 and 2023, when it should only apply to 2023, omits the correct 2022 value ($2,147M), and fabricates a $1,604M value for 2024 instead of the correct $2,000M. These are not formatting or rounding issues but fundamental errors. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize data across the three fiscal years, misaligning values with years and thus drawing an incorrect conclusion about a 'modest decline' and 'gradual reduction', when the actual data shows a decrease followed by a strategic increase or stabilization. The ground truth interpretation correctly identifies this as a temporary reduction followed by repositioning, which the LLM misses entirely. (4) Contextual relevance is moderate—the answer addresses the right topic (carrying value of long-term debt and its implications), uses correct terminology, and cites sources, but due to factual inaccuracies, the analysis is based on false premises. Hence, correctness and quantitative accuracy are very low; qualitative accuracy is slightly higher due to correct metric and entity identification, but reasoning is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 503,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022 onward, 3M capped its Scotchgard exposure with a $65 million New York settlement (final approval Feb 2022) and a Wolverine‑related Michigan settlement (final payment Jun 2023), while still defending dozens of individual New York actions and water‑utility suits in the South (2022 10‑K, pp.124‑125). In 2023 the docket grew to roughly 40 New York cases, multiple Alabama and Georgia water‑utility claims, and new lawsuits in California, Delaware, New Jersey and other states, adding co‑defendants such as Saint‑Gobain, Honeywell, Wolverine, Georgia‑Pacific, DuPont and Chemours (2023 10‑K, pp.93‑95). By 2024 the litigation had spread further to land‑owner suits in Georgia (Gordon, Lyerly and Murray counties), a firefighter‑gear class action in Connecticut, a carpet‑treatment RICO case in Minnesota and additional state‑level actions, expanding the pool of named defendants to well over a dozen across the United States and U.S. territories (2024 10‑K, pp.96‑98).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Correctly identifies the $65 million New York settlement in 2022 involving 3M, Saint-Gobain, and Honeywell, with final approval in February 2022, and notes 3M's share as immaterial (consistent with 'non-material' in ground truth). The June 2023 final payment in the Michigan Wolverine-related case is accurately dated and contextualized. (2) Quantitatively, all key figures—settlement amount ($65M), timing (Feb 2022, Jun 2023), and geographic expansion (Alabama, Georgia, California, etc.)—are correct. The mention of 'roughly 40 New York cases' in 2023 is specific and plausible, though not in the original answer; however, it does not contradict it, as the original notes ongoing individual actions. (3) Multi-hop reasoning is sound: the answer synthesizes developments across three years, tracks geographic expansion (New York → South → additional states), and correctly identifies increasing numbers of co-defendants (Saint-Gobain, Honeywell, Wolverine, DuPont, Chemours, Georgia-Pacific, etc.), matching the ground truth's emphasis on growing complexity. (4) The LLM adds detail not in the original (e.g., Connecticut firefighter case, Minnesota RICO case, U.S. territories), but these are consistent with the trend described and likely drawn from the cited 10-Ks; they enhance rather than distort the narrative. Only minor deduction from 10 is due to slightly more expansive detail than in the ground truth, but without factual error. Semantic equivalence is strong, and all question components—case settlements, geographic expansion, number of defendants—are thoroughly addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 457,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "AbCellera’s agreement continues to provide Eli Lilly with a tiered royalty of roughly mid‑teens to mid‑twenties percent on worldwide net sales of bamlanivimab and bebtelovimab, and the filing notes that no new milestone payments were disclosed for the 2022‑2024 period. Accordingly, net product revenue from the COVID‑19 antibodies dropped from $2.02 billion in 2022 to zero in both 2023 and 2024 as sales ceased.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: net product revenue was $2.02 billion in 2022 and dropped to zero in 2023 and 2024; royalty structure was tiered from mid-teens to mid-twenties percent on worldwide net sales; no new milestone payments were made during 2022–2024. These match the ground truth exactly. (2) Quantitative accuracy is perfect: the dollar amount ($2.02 billion), years (2022, 2023, 2024), and royalty range (mid-teens to mid-twenties) are all correctly reported with no calculation errors. Format variations are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—LLM synthesizes information across time periods and financial metrics (revenue, royalties, milestones) for the LLY-AbCellera collaboration. It correctly infers that zero sales imply no royalty payments despite the unchanged royalty structure, which is logically consistent with the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly state that the royalty structure 'remained consistent' or that commercial activity 'ceased' due to lack of demand or regulatory authorization, which adds slight contextual nuance. However, the core facts and implications are accurately conveyed. Thus, the answer is factually complete and semantically equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 372,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "Across all three filings Dawn is consistently presented as a core home‑care brand within the Fabric & Home Care segment. In 2022 the MD&A notes that “our global home‑care market share is **nearly 25%**, primarily behind our Cascade, **Dawn**, Febreze and Swiffer brands,” and Dawn appears in the segment’s major‑brand list; the 2023 and 2024 filings use the same phrasing (changing only to “about 25%”) and keep Dawn alongside Cascade, Febreze and Swiffer. This steady placement shows that Dawn remains a flagship dish‑soap that drives a sizable share of the segment’s performance, highlighting its enduring strategic importance to P&G’s portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment from 2022 to 2024, accurately reflecting its sustained strategic importance. The qualitative reasoning and synthesis across years are sound, noting consistent mention alongside Cascade, Febreze, and Swiffer, which aligns with the ground truth. (2) However, there is a quantitative discrepancy: the LLM cites P&G's global home-care market share as 'nearly 25%' in 2022 and 'about 25%' in 2023–2024, but this specific market share figure is not present in the ground truth, which instead provides segment-level financial contributions (35–36% of net sales, 31–34% of earnings). The LLM introduces a metric (global home-care market share) not included in the original answer, which may be accurate in context but diverges from the verified data provided. The ground truth does not mention market share percentages, so this addition—while plausible—cannot be confirmed and shifts focus from the financial performance metrics that were actually reported. (3) The multi-hop reasoning is strong: the LLM correctly infers strategic importance from consistent positioning across filings and links Dawn to segment performance. It synthesizes information across all three years and brands appropriately. (4) The answer is contextually excellent and captures the core conclusion—Dawn’s enduring strategic role—despite the introduction of an unverified metric. The correctness score is 8 due to the accurate qualitative assessment and synthesis, but docked for introducing a non-verified percentage instead of relying on the provided financial contribution data. Quantitative accuracy is 7 because the numbers cited are not factually incorrect per se, but they are not the ones in the ground truth and could mislead if taken as equivalent. Qualitative accuracy is 9 due to strong reasoning, and contextual relevance is 10 as the answer directly addresses the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 540,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from **$883 million in 2022** to **$538 million in 2023** and then rose modestly to **$562 million in 2024** (Table 8.1 – 2023 10‑K and Table 9.1 – 2024 10‑K).  Its long‑term debt rose modestly from **$47.8 billion in 2022** to **$49.3 billion in 2023**, then declined to **$45.0 billion in 2024** (Table 8.1 – 2023 10‑K; Table 9.1 – 2024 10‑K).  \n\nAcross the three‑year span the company eliminated its **floating‑rate unsecured senior debt**, which dropped from **$1.6 billion in 2022** to **$349 million in 2023** and to **$0 in 2024**, shifting the debt mix toward fixed‑rate senior notes and raising the weighted‑average rate on unsecured senior debt from roughly **4.5 % (2022‑23)** to about **4.8 % (2024)**, thereby reducing its exposure to interest‑rate volatility.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies, particularly in the values for short-term borrowings and long-term debt. According to the ground truth, total short-term borrowings and long-term debt were $43.086B (2022), $48.715B (2023), and $45.551B (2024). However, the LLM reports short-term borrowings as $883M, $538M, $562M and long-term debt as $47.8B, $49.3B, $45.0B, which when summed yield totals of $48.683B (2022), $49.838B (2023), and $45.562B (2024)—substantially misaligned with the correct figures. The LLM appears to have misclassified or misread the components of debt, treating short-term borrowings and long-term debt separately with incorrect base values. (2) The floating unsecured senior debt values are mostly correct: $1.6B (vs. $1.709B), $349M (correct), and $0 (correct), though the initial value is slightly off. The weighted-average interest rate on fixed unsecured senior debt is inaccurately summarized as 'roughly 4.5% (2022–23)' when it was 2.91% in 2022 and 4.45% in 2023—this misrepresents a key trend. The LLM incorrectly implies the rate was already at 4.5% in 2022, missing the significant increase from 2.91% to 4.45%. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward fixed-rate debt and reduced interest rate exposure due to the elimination of floating-rate debt. It also correctly identifies the trend of declining floating-rate exposure and rising fixed-rate reliance. However, it fails to accurately link the rising weighted-average interest rate trend over three years due to incorrect rate inputs. (4) Despite these errors, the answer addresses all parts of the question—evolution of debt, 3-year trend, debt structure, and interest rate exposure—and draws a qualitatively reasonable conclusion about reducing interest rate volatility. Hence, contextual relevance is high, qualitative reasoning is acceptable but flawed, and quantitative accuracy is low due to incorrect base figures and misstated interest rates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 548,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco kept the 5.90 % senior note unchanged at a $2 billion principal amount and an effective rate of 6.11 % in FY 2022, FY 2023 and FY 2024, and it continued to be reported as a senior fixed‑rate note within long‑term debt [CSCO_10k_2022.pdf p.90] [CSCO_10k_2023.pdf p.90] [CSCO_10k_2024.pdf p.90]. Although the note’s size and rate stayed the same, its share of Cisco’s overall debt fell as total debt rose—from roughly 22 % of $8.9 bn total debt in FY 2022 to about 10 % of $20.1 bn total debt in FY 2024—reflecting new senior‑note issuances that expanded the long‑term debt base.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Cisco maintained a $2,000 million (i.e., $2 billion) principal amount of the 5.90% Note with an unchanged effective interest rate of 6.11% across FY2022–FY2024, and that the note remained a fixed-rate component of long-term debt—this aligns fully with the ground truth. However, there are minor quantitative discrepancies in total debt figures: the LLM reports $8.9 billion total debt in FY2022 and $20.1 billion in FY2024, whereas the ground truth specifies $8,416 million (i.e., $8.416 billion) and $19,621 million (i.e., $19.621 billion), respectively. These differences affect the calculated proportions: LLM states the note’s share fell from ~22% to ~10%, while using ground truth numbers, the actual share was approximately 23.8% in 2022 ($2,000 / $8,416) and 10.2% in 2024 ($2,000 / $19,621), meaning the directional trend is correct but the exact percentages are slightly off due to incorrect base totals. (2) The LLM correctly infers that the declining proportion reflects new debt issuances expanding the long-term debt base, which is a sound interpretation of the trend and consistent with the ground truth’s conclusion about debt portfolio expansion. (3) Multi-hop reasoning is strong: the model synthesizes data across three years and multiple 10-K filings, correctly identifying stability in the note’s terms while analyzing its relative composition within a changing total debt structure. (4) The answer is contextually complete and relevant, addressing all three aspects of the question—debt composition, interest rate, and long-term classification—though the use of slightly inaccurate total debt figures prevents a perfect quantitative score. Wording variations (e.g., 'senior note', 'fixed-rate') are semantically acceptable and supported by typical SEC filing terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 499,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "- The 1.55 % Notes Due 2028 were carried at $1,099 million at the end of FY 2022 (NVDA 10‑K 2022, pp. 78‑82) and remained $1,099 million at FY 2023 (NVDA 10‑K 2023, pp. 65‑69), then rose modestly to $1,115 million by FY 2024 (NVDA 10‑K 2024, pp. 70‑74).  \n- The effective interest rate on this series was essentially unchanged at about 1.64 % in each of the three years (shown in the “Effective Interest Rate” tables of the 2022‑2024 filings).  \n\nThis pattern—stable, low‑cost financing with only a slight increase in carrying amount—shows NVIDIA’s strategy of locking in inexpensive, long‑dated debt to fund growth while minimizing refinancing risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both carrying values and effective interest rates compared to the ground truth. According to the original answer, the carrying value was $1,200 million in FY2022, decreased to $1,099 million in FY2023, and increased to $1,250 million in FY2024. However, the LLM claims the value was $1,099 million in both FY2022 and FY2023 and only rose to $1,115 million in FY2024—missing the initial higher value and the larger increase in 2024. This represents a major quantitative error. Additionally, the LLM states the effective interest rate was 'essentially unchanged at about 1.64%' across all years, while the ground truth indicates that the rate *increased to* 1.64% in FY2024, implying it was lower in prior years (e.g., implied from market pricing in 2022). Thus, the LLM incorrectly portrays stability in the rate when the trend was one of increase. (2) Calculations and comparisons are flawed: the LLM fails to capture the dip and rebound in carrying value and misrepresents the evolution of the interest rate. The $1,200M → $1,099M → $1,250M trajectory shows a U-shaped pattern suggesting reacquisition or reissuance, which the LLM misses entirely. (3) Multi-hop reasoning is unsound: the model does not correctly synthesize data across the three 10-K filings to identify the trend. Instead, it reports flat carrying value and flat rates, leading to an incorrect interpretation. (4) While the LLM attempts to provide strategic interpretation (locking in low-cost debt), this conclusion is based on incorrect data and contradicts the ground truth’s insight about temporary reduction and rising borrowing costs. The response is contextually relevant in structure and intent but fails on factual and analytical accuracy, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 495,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "In the 2022 filing (pages 5‑9) Pixel phones were reported simply as part of the “devices” component of Google subscriptions, platforms, and devices revenue, with a note that device sales pressure margins. By the 2023 filing (pages 31‑35) the same devices line still housed Pixel sales, but the report highlighted new Pixel models (Pixel 5a 5G, Pixel 6) and stressed heavy operating, capital‑expenditure and R&D investment to drive hardware innovation, and the 2024 filing (pages 57‑61) kept Pixel phones in the hardware‑revenue category while reiterating a strategic focus on hardware through continued heavy spending on operating and capital expenditures and an increased R&D commitment to advance Pixel and AI‑enabled devices.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. While it correctly identifies that Pixel devices were part of the 'devices' segment within the Subscriptions, Platforms, and Devices revenue stream in 2022–2024, it misrepresents the evolution: the ground truth states that in 2022, Pixel was grouped among other hardware like Fitbit and Nest as part of a strategic investment focus, but the LLM incorrectly claims Pixel was already in a distinct 'devices' category in 2022 filings, which contradicts the original answer’s point that the explicit categorization emerged in 2023. Additionally, the LLM cites specific models (Pixel 5a 5G, Pixel 6) in the 2023 filing, but these models were launched earlier and are not reflective of 2023 innovation emphasis per the ground truth, which focuses on strategic integration with AI and cloud rather than naming outdated models. (2) There are no explicit numerical values (e.g., revenue figures, R&D spending amounts) in either answer, so quantitative accuracy cannot be penalized heavily, but the mention of 'heavy operating, capital-expenditure and R&D investment' lacks specificity and is not tied to actual figures, reducing precision. (3) The multi-hop reasoning is partially sound—LLM connects hardware investment across years and notes continued strategic focus—but fails to capture the key transformation from 'investment in hardware' (2022) to 'mature, strategically embedded product line' (2024) integrated with AI and cloud, which is central to the original answer. It also omits the significance of revenue categorization changes between 2022 and 2023. (4) Contextual relevance is high because the response stays on topic and references appropriate filings and strategic themes, but qualitative and factual shortcomings—especially misrepresenting the timing of segment categorization and focusing on obsolete models—reduce correctness. Thus, the answer is partially correct but misses key nuances in the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 546,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s Item 14 contains the identical statement that the ratification of KPMG LLP as its principal accountant is set out in the proxy’s “Item 3 – Ratification of KPMG LLP” and that KPMG’s PCAOB firm identification number is 185. The unchanged wording and lack of any new or altered disclosure show that the company has retained the same auditor throughout, signalling a stable, uninterrupted audit relationship.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that BNY Mellon consistently disclosed the ratification of KPMG LLP as principal accountant in its 10-K filings from 2022 to 2024, with identical language referencing the Proxy's 'Item 3' and including KPMG's PCAOB identification number as 185—this matches the original answer exactly. (2) There are no numerical or date inaccuracies; the years (2022–2024), entity name (KPMG LLP), and PCAOB ID (185) are all correct and consistently reported. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and filings (10-K and Proxy) to infer stability in the audit relationship based on unchanged disclosure. (4) The conclusion about audit relationship stability due to consistent presentation is logically derived and fully aligned with the original answer. All aspects of the question—evolution of disclosure and implications for audit stability—are addressed with precise, relevant, and complete information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 302,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "Lilly’s private‑alternative portfolio (hedge‑fund and equity‑like fund holdings) was about $7.9 billion in 2022 (≈$3.25 bn + $4.01 bn in the defined‑benefit plan and $0.30 bn + $0.33 bn in the retiree‑health plan), fell to roughly $7.8 billion in 2023 (≈$3.13 bn + $4.09 bn and $0.28 bn + $0.34 bn) and declined further to about $7.6 billion in 2024 (≈$3.06 bn + $3.93 bn and $0.29 bn + $0.35 bn). This modest, steady reduction shows Lilly is maintaining a substantial but slightly decreasing exposure to illiquid assets, suggesting a long‑term strategy that values diversification and higher‑return potential while prudently rebalancing to manage liquidity and risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of LLY's private alternative investment allocations. The ground truth shows an increase from $10,542.5 million in 2022 to $10,335.2 million in 2023, then to $10,051.0 million in 2024. However, the LLM claims a decreasing trend from $7.9B to $7.8B to $7.6B — all values are significantly lower and the trend is opposite. These numbers appear to be derived from summing specific components (defined-benefit and retiree-health plans), but they do not reflect the total company-level allocation reported in the ground truth. (2) The quantitative inaccuracies are severe: all dollar amounts are off by over $2.5 billion per year, and the trend (decreasing vs actual increasing) contradicts the ground truth. Calculations within the LLM’s own logic ($3.25B + $4.01B + $0.30B + $0.33B = ~$7.89B) are approximately correct, but these component figures are either misextracted or not representative of total private alternatives. (3) The multi-hop reasoning fails because the model synthesizes data from sub-funds or plans rather than the consolidated entity-level figure required. It also draws an incorrect strategic conclusion — claiming a 'slightly decreasing exposure' when the actual trajectory is increasing, leading to flawed interpretation of long-term strategy. (4) Despite incorrect facts and reasoning, the answer is contextually relevant — it addresses the right company (LLY), time frame (2022–2024), asset class (private alternatives), and attempts to infer strategic intent. Hence, contextual relevance is moderate, but correctness and accuracy scores are low due to fundamental factual and directional errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 464,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "In 2022, Tampax was presented simply as a major brand within the broad “Feminine Care” category (grouped together with adult‑incontinence products) of the Baby, Feminine & Family Care segment【PG_10k_2022.pdf†page21】. By the 2023 filing, P&G split the feminine‑care portfolio into a specific “Menstrual Care” sub‑category and called out Tampax (alongside Always) as a leading brand in that sub‑category【PG_10k_2023.pdf†page20】【PG_10k_2023.pdf†page19】. The 2024 filing kept the same classification, continuing to emphasize Tampax in the Menstrual Care sub‑category of Feminine Care and its role in the segment’s market‑share leadership【PG_10k_2024.pdf†page20】【PG_10k_2024.pdf†page19】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Tampax's positioning from 2022 to 2024, noting the shift from 'Feminine Care' to the more specific 'Menstrual Care' sub-category by 2023 and the continued emphasis on Tampax within that category in 2024. It accurately reflects the branding and categorization changes and cites appropriate document sources. However, it omits key quantitative details present in the ground truth: the segment's contribution to net sales (25% in 2022, 24% in 2023 and 2024) and the strategic removal of 'Baby Care' from the segment in 2024, which signals a meaningful strategic shift. These omissions affect completeness and weaken the synthesis of multi-hop information across years. While the qualitative reasoning about category reclassification is sound, the answer does not fully capture the structural changes in the segment (e.g., removal of Baby Care), which is a significant part of the strategic evolution. Number formats and dates are consistent and accurate where provided, earning a high but not perfect quantitative score. The answer remains contextually relevant and well-structured, addressing the core of the question with correct entity and year alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 338,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "- **2022:** Net derivative liabilities were reported at **$31 million** and were valued with a **discounted‑cash‑flow (DCF) model** that used **swap rates** as the only significant unobservable input (swap‑rate range ≈ 1 % and weighted‑average ≈ 1 %)【COF_10k_2023.pdf p. 208】.  \n\n- **2023:** The liability balance fell to **$5 million**; the DCF approach was unchanged, but the swap‑rate input range widened to **1‑2 %** (still a 1 % weighted‑average)【COF_10k_2023.pdf p. 208】.  \n\n- **2024:** Net derivative liabilities rose to **$69 million**. The valuation continued to rely on a **DCF model**, but the swap‑rate assumption increased to **about 4 %** (both range and weighted‑average)【COF_10k_2024.pdf p. 217】.  \n\n*Default‑rate assumptions were not a primary driver for the net derivative liabilities; they appear only for other Level 3 assets (e.g., retained securitization interests).*",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both financial figures and valuation methodology compared to the ground truth. (1) Quantitative Accuracy: The reported net derivative values are incorrect—LLM states $31M (2022), $5M (2023), and $69M (2024), whereas ground truth reports $19M (2022) and $58M in both 2023 and 2024. These discrepancies are substantial and affect all years. Additionally, the LLM claims swap rates were ~1% in 2022 and 1–2% in 2023, but ground truth indicates a 3–5% range starting in 2023, with no disclosure in 2022. Default rates cited by LLM are entirely absent, while ground truth highlights them as key unobservable inputs in 2023–2024 (53–163%). (2) Completeness: The question asks about evolution in valuation assumptions including DCF models and key unobservable inputs like default and swap rates. The LLM incorrectly claims DCF was used in 2022 (ground truth says not disclosed), omits default rates entirely, and misrepresents swap rate ranges. It also fails to note the transparency improvement in 2023. (3) Reasoning: The multi-hop synthesis is flawed—LLM suggests decreasing liability from $31M to $5M to $69M, implying volatility, while truth shows an increase from $19M to $58M and stabilization. This misrepresents the trend. The claim that default rates were not a primary driver contradicts the ground truth, which explicitly includes them as key inputs in 2023 and 2024. (4) Semantic Equivalence: Despite using similar terminology (e.g., DCF models, swap rates), the answer conveys a different and factually incorrect narrative. Contextual relevance is moderate because it addresses valuation methods and inputs, but factual errors severely undermine usefulness. Overall, major factual and numerical errors result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 486,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s available‑for‑sale (AFS) debt portfolio went from a small positive contribution in FY 2022 to increasingly larger negative impacts on “other income (loss), net.”  The AFS‑debt line showed a $9 million gain in FY 2022, a $21 million loss in FY 2023 and a $67 million loss in FY 2024【source: Other Income (Loss), Net table】.  This swing mirrors the rise in unrealized and credit losses on the debt holdings (gross unrealized‑and‑credit losses grew from $40 million in FY 2021 to $522 million in FY 2022, while net realized gains fell from $53 million to $9 million)【source: AFS debt summary FY 2022 vs. FY 2021】, indicating that the portfolio’s fair‑value performance deteriorated and its risk profile increased over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no specific performance metrics were provided for AFS debt investments in fiscal 2022, but the LLM claims a $9 million gain, which is not supported. For 2023 and 2024, the LLM reports losses of $21M and $67M, respectively, but the original answer does not provide exact figures—only qualitative descriptions of material negative impact. These numbers are therefore fabricated or hallucinated. Additionally, the LLM references unrealized losses growing from $40M in FY2021 to $522M in FY2022, but the original answer does not mention FY2021 or these figures, making this data unsupported. (2) Calculations and comparisons are based on incorrect numbers. The claim of a swing from $9M gain to $67M loss implies a deterioration, but since these values are not in the ground truth, the quantitative narrative is invalid. (3) The multi-hop reasoning is partially sound in structure—linking AFS debt performance to 'other income (loss), net' and inferring increasing risk—but it relies on non-existent numerical data, undermining the logic. The original answer emphasizes lack of disclosure in 2022 and qualitative deterioration in 2023–2024, while the LLM constructs a precise but false quantitative trend. (4) The contextual relevance is fair because the LLM addresses the right metric, time frame, and risk implications, but correctness is severely compromised by hallucinated data. Thus, while the direction of reasoning aligns (increasing negative impact), the factual foundation does not, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 445,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "Starbucks’ outlook for green‑coffee supply has been pushed out one year at a time. In its FY 2022 10‑K the company said that “total purchase commitments, together with existing inventory, are expected to provide an adequate supply of green coffee **through fiscal 2023**” (SBUX_10k_2022.pdf p.12). The FY 2023 filing updated that language to “through fiscal 2024” (SBUX_10k_2023.pdf p.12), and the FY 2024 filing now projects adequacy “through fiscal 2025” (SBUX_10k_2024.pdf p.12). This sequential extension shows Starbucks is deliberately lengthening its forward purchase commitments and inventory cushions, reflecting a sourcing strategy that secures supply well in advance and mitigates risks from price volatility, climate impacts and delivery disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and projections are correct: FY2022 report projects adequacy through FY2023, FY2023 report extends to FY2024, and FY2024 report extends to FY2025. The citations (document names and page numbers) are consistent with the expected sources. (2) The answer correctly captures the year-by-year extension of supply adequacy, which matches the multi-hop progression required by the question. (3) The reasoning is sound: the LLM infers that Starbucks is lengthening purchase commitments and inventory buffers to mitigate risks such as price volatility, climate, and delivery disruptions—this aligns with the ground truth's emphasis on risk mitigation and sourcing strategy. (4) The only minor shortcoming is that the LLM does not explicitly mention 'strengthening sourcing strategy' or 'improving inventory management' in the same structured way as the original, but it conveys equivalent meaning through 'lengthening forward purchase commitments' and 'inventory cushions'. Thus, semantic equivalence is maintained. The answer is fully relevant, directly addressing the evolution and strategic implications. Minor deduction from 10 to 9 due to slightly less precise framing of inventory management improvements, though the core insight is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 372,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA’s fair‑value exposure to its 2.00 % Notes due 2031 was $1,044 million in FY 2022 (NVDA_10k_2022.pdf: pp. 78‑82), stayed at $1,044 million in FY 2023 (NVDA_10k_2024.pdf: pp. 70‑74), and rose modestly to $1,057 million in FY 2024 (NVDA_10k_2024.pdf: pp. 70‑74). The near‑flat exposure with a slight uptick shows that NVIDIA relies on a stable, low‑coupon, long‑dated debt base and is only incrementally expanding its long‑term liabilities, reflecting a conservative, long‑term financing strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial exposure values. According to the ground truth, NVIDIA's exposure was $1,200 million in FY2022, $1,044 million in FY2023, and $1,250 million in FY2024. However, the LLM claims it was $1,044 million in both FY2022 and FY2023, and only $1,057 million in FY2024—missing the correct starting value and underreporting the 2024 figure by over $190 million. These are major quantitative errors that distort the trend. (2) The calculation and comparison of values are incorrect: the ground truth shows a drop from 2022 to 2023 followed by a rebound in 2024, but the LLM describes a flat trend with a slight increase, which misrepresents the pattern. (3) The multi-hop reasoning is flawed because the model fails to correctly extract and synthesize data across the three fiscal years from the appropriate filings. While it references document pages, the data pulled is inconsistent with the ground truth, suggesting either misreading or sourcing from incorrect instruments. (4) Despite incorrect numbers, the LLM attempts to interpret the trend and connects it to a long-term debt strategy, which shows contextual understanding. However, the conclusion about a 'conservative, incremental' strategy contradicts the ground truth interpretation of a 'dynamic approach' due to significant fluctuations. Thus, while the answer is relevant and structured appropriately, the core financial data is wrong, severely undermining correctness. Quantitative accuracy is very low due to incorrect figures; qualitative accuracy is partially preserved due to logical framing; contextual relevance is acceptable as the response addresses the right instrument and strategic implications, albeit based on faulty data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 485,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "Both the 2022 filing (see MMM 10‑K 2022 pp. 129‑133) and the 2024 filing (see MMM 10‑K 2024 pp. 108‑112) list fall‑protection together with other personal‑protective‑equipment items – “Respiratory, hearing, eye **and fall protection solutions**” – under the Safety and Industrial segment. The wording is unchanged, indicating that fall‑protection remains bundled with the broader PPE portfolio and has not been given a distinct or heightened emphasis relative to the segment’s other industrial‑safety offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key nuances in the evolution of MMM's positioning of Fall Protection Solutions from 2022 to 2024, particularly regarding the 2024 shift. (1) The answer correctly identifies that in both 2022 and 2024, fall protection was listed alongside respiratory, hearing, and eye protection under the Safety and Industrial segment, and that the phrasing 'respiratory, hearing, eye and fall protection solutions' appears in both years. This supports the claim that the wording remained largely unchanged. However, it fails to mention the 2023 filing, which the ground truth includes as part of the multi-year analysis, weakening the completeness. (2) Quantitatively, there are no numbers, dates, or financial metrics in dispute—dates (2022, 2024) and segment names (Safety and Industrial) are accurate. (3) The reasoning is flawed in that it concludes no change in emphasis based solely on similar wording, while the ground truth notes a subtle but meaningful shift in 2024: Fall Protection Solutions were 'presented with a slightly revised grouping' and aligned more closely with industrial specialty products and broader safety systems, suggesting a strategic repositioning even if terminology was similar. The LLM overlooks this qualitative evolution, interpreting textual consistency as static categorization, which contradicts the ground truth’s inference of a 'subtle shift.' (4) Contextual relevance is high—the response addresses product categorization and emphasis over time and cites appropriate sections of the 10-Ks. However, the failure to detect the nuanced repositioning in 2024, especially the alignment with industrial systems, results in a significant gap in qualitative accuracy and overall correctness. Thus, while factually consistent with surface-level data, the LLM misses the deeper analytical point required for full credit.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 507,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "In 2022 Eli Lilly recorded about $2.0 billion of revenue from bamlanivimab (shown under “COVID‑19 antibodies” – $2,008.9 m in the U.S. and $14.7 m outside the U.S.)【LLY_10k_2022.pdf p. 70‑71】. The 2023 and 2024 filings list a “‑” for that line, indicating no bamlanivimab sales in either year【LLY_10k_2023.pdf p. 65‑66】【LLY_10k_2024.pdf p. 66‑67】. This steep decline to zero shows that the company’s COVID‑19 antibody portfolio, once a major revenue source, has been essentially phased out and is no longer a significant contributor to earnings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) Quantitatively, the revenue figure for 2022 is accurately reported as approximately $2.0 billion, matching the ground truth $2.01 billion (the minor difference is due to rounding and is acceptable; $2,008.9M + $14.7M = $2,023.6M, which may reflect additional granularity in the source but the LLM correctly summarizes it as ~$2.0B). The answer correctly states zero revenue in 2023 and 2024, consistent with the '‑' notation in the filings indicating no sales. (2) The answer is complete, addressing both parts of the question: the revenue evolution (decline from $2.0B to $0) and the implication about Eli Lilly's reliance on its COVID-19 antibody portfolio. (3) Entity accuracy is correct: Eli Lilly (LLY), bamlanivimab, the correct years (2022–2024), and the proper context of the 'COVID-19 antibodies' line item are all accurately identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers from the absence of revenue entries in 2023 and 2024 filings that sales dropped to zero, and logically concludes that the portfolio has been phased out and is no longer a significant revenue contributor—directly mirroring the ground truth's interpretation. (5) Semantic equivalence is strong: while the LLM provides additional detail (U.S. vs. international breakdown), the core message—that revenue collapsed to zero and indicates declining reliance—is identical in meaning to the original answer. All aspects of the evaluation criteria are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 434,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "In its 2022 filing Starbucks noted that coffee‑price volatility “is also impacted by trading activities in the arabica coffee futures market, including hedge funds and **commodity‑index funds**” (2022 10‑K, Product Supply). By the 2024 filing the company still references that same exposure but adds that it “uses forward contracts, futures contracts, and collars to hedge ‘C’ price exposure” and that “total purchase commitments, together with existing inventory, are expected to provide an adequate supply of green coffee **through fiscal 2025**” (2024 10‑K, Product Supply). The shift from merely acknowledging the commodity‑index‑fund risk in 2022 to actively hedging and locking in long‑term purchase commitments by 2024 reveals a progressively stronger risk‑management approach aimed at insulating the business from coffee‑price swings while securing green‑coffee supply well into fiscal 2025.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies Starbucks' ongoing exposure to commodity index funds in both 2022 and 2024, consistent with the original answer. (2) All dates and fiscal years (2022, 2024, and projections through fiscal 2025) are accurate and properly contextualized. There are no numerical values requiring calculation, but the reference to supply commitments extending through fiscal 2025 matches the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years (implied by the progression from 2022 to 2024), connects the continued acknowledgment of index fund influence with an evolving hedging strategy, and infers a strengthening risk management approach—exactly as stated in the original answer. (4) The answer addresses all parts of the question: evolution of exposure (acknowledged throughout), trend in risk management (increased use of derivatives and long-term commitments), and what it reveals about supply security through 2025. Wording differs but meaning is preserved, including key mechanisms like forward contracts, futures, and collars. No factual errors, omissions, or misstatements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 345,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "In 2022 Alphabet’s MD&A already emphasized that impressions on Google Network properties—chiefly via AdMob, AdSense and **Google Ad Manager**—were a core driver of ad revenue, with cost‑per‑impression used to gauge monetization (2022 10‑K, pp. 29‑33). The 2024 filing repeats this focus, showing that impression‑based revenue and the Google Ad Manager platform remain central to Google Services’ monetization strategy (2024 10‑K, pp. 56‑60). The 2023 accounting change that extended the useful lives of servers and network equipment from four/five to six years cut depreciation expense by $3.9 billion and lifted net income by $3.0 billion, thereby improving margins and reinforcing the long‑term profitability of the impression‑based ad model (2023 10‑K, pp. 55‑59).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google Ad Manager's role in impression-based monetization in 2022 and 2024 is accurately described, and the 2023 change in server/network equipment depreciation schedules (from 4 to 6 years for servers, 5 to 6 years for network equipment) is correctly reported. (2) Quantitative accuracy is perfect: the $3.9 billion reduction in depreciation expense and $3.0 billion increase in net income match the ground truth exactly, with acceptable formatting. (3) Multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024 filings, linking infrastructure accounting changes to profitability implications for Ad Manager operations. (4) The only minor omission is that the 2024 answer does not explicitly mention that Google continued to report Google Network revenues on a 'gross basis,' a detail present in the original answer that reinforces strategic importance. However, the core message about sustained reliance on Ad Manager and improved profitability through cost optimization is fully conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing evolution over time and long-term profitability implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 364,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "From 2022 to 2024 BNY Mellon steadily broadened its use of Performance Share Unit Agreements under the 2019 Long‑Term Incentive Plan – each filing shows a larger number of PSU awards and a refreshed agreement form that tightens the performance criteria. This upward trend reflects a strategic move toward heavier reliance on performance‑linked equity to align executive pay with long‑term shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It refers to 'BNY Mellon' instead of 'BK', which is a critical entity error—BK refers to Burger King or Restaurant Brands International, not BNY Mellon, a financial institution. This misidentification invalidates the entire response. (2) The claim of a 'larger number of PSU awards' and 'tightened performance criteria' is unsupported by the ground truth, which does not mention quantities of awards or changes in performance stringency. Instead, the actual evolution is procedural: referencing 2021 agreements in 2022, re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024—indicating a cyclical update process, not an expansion in scope or intensity. (3) The multi-hop reasoning fails: the ground truth requires tracing document references across years (Exhibit 10.45 in 2022, 10.14 in 2023, 10.18 in 2024), but the LLM fabricates trends without citing these exhibits or their significance. (4) While the general theme of 'aligning executive pay with performance' is contextually plausible, it is too generic and does not reflect the specific adaptive-consistency strategy described in the original answer. The response lacks the correct dates, entities, document references, and qualitative progression, resulting in a low correctness score despite some thematic relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 379,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "Across all three years the Safety & Industrial segment lists the same bullet‑point description for its electrical business – “Electrical products and materials for construction and maintenance, power distribution and electrical original equipment manufacturers (OEMs)” – (2022 p. 131; 2023 p. 106; 2024 p. 108). The wording and placement of this item are unchanged, indicating that 3M has kept a broad, generic categorisation of its electrical offerings and continues to treat the electrical OEM market as a steady, core part of its Safety & Industrial portfolio rather than expanding or redefining it.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that the description remained unchanged across 2022, 2023, and 2024. The original answer (ground truth) correctly states that there was a progressive evolution in wording: from 'electrical OEMs' in 2022, to 'electrical original equipment manufacturers (OEMs)' in 2023 (with expanded terminology), and further refined in 2024 to include 'power distribution and electrical original equipment manufacturers (OEMs)'—indicating increasing specificity. The LLM incorrectly asserts that the exact same bullet point appears verbatim in all three years, which contradicts the ground truth. While the LLM correctly identifies the segment (Safety and Industrial) and the general product categories, it fails to detect the nuanced but meaningful changes in descriptive language across the years. This undermines the multi-hop reasoning required to assess the strategic shift toward greater focus on electrical OEM markets. The conclusion that 3M maintained a 'broad, generic categorisation' is therefore incorrect and opposite to the actual trend of increasing precision. Quantitative accuracy receives full credit because no numerical data is misstated (the error is qualitative). Contextual relevance is moderate because the answer addresses the right segment and topic but draws the wrong inference due to incorrect observation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 380,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "Capital One’s fixed‑rate unsecured senior notes rose sharply from $19.975 billion in 2022, when they carried a weighted‑average interest rate of about 2.9%, to $27.168 billion in 2023 with the average rate climbing to roughly 4.5%【COF_10k_2022.pdf p.186‑187】. In 2024 the balance was essentially flat at $26.93 billion but the weighted‑average rate rose again to about 4.8%【COF_10k_2024.pdf p.186‑187】. This pattern shows Capital One deliberately expanding its fixed‑rate senior‑debt pool—accepting higher yields—to lock in longer‑dated funding and diversify its long‑term capital structure, even as the overall amount stabilizes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative data: the carrying values of $19,975 million (stated as $19.975 billion), $27,168 million ($27.168 billion), and $26,930 million ($26.93 billion) for 2022, 2023, and 2024 respectively are accurate. The weighted-average interest rates are correctly approximated as 2.9%, 4.5%, and 4.8%, aligning with the ground truth values of 2.91%, 4.45%, and 4.84%. Minor rounding is acceptable and does not affect factual correctness. (2) All calculations and comparisons are logically sound—growth from 2022 to 2023, slight decline in 2024, and steady rate increases are accurately described. (3) The multi-hop reasoning across years and metrics is correct: the synthesis of carrying value and interest rate trends over three years is properly executed, and the conclusion about long-term debt strategy reflects the intended inference. The LLM correctly infers a strategic move to lock in fixed-rate funding despite rising costs. (4) The only minor shortcoming is that the LLM describes the 2024 balance as 'essentially flat' compared to 2023, while there is actually a small decline from $27,168M to $26,930M (a $238M decrease). This is a slight mischaracterization but does not undermine the overall accuracy. Otherwise, entities (Capital One/COF), metrics (carrying value, weighted-average interest rate), and years are correct. The answer is contextually complete and directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 407,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "NVIDIA disclosed that the 3.50 % Notes Due 2040 were valued at roughly **$890 million** in FY 2022, fell to **$870 million** in FY 2023, and declined further to **$851 million** in FY 2024 (NVDA_10k_2024.pdf pp. 70‑74).  In each year the notes were **carried on the balance sheet at their original issuance amount, net of unamortized discount and issuance costs** (NVDA_10k_2022‑2024.pdf Note 9).  The steady, modest drop in fair‑value while keeping the accounting treatment unchanged shows NVIDIA’s strategy of issuing long‑dated, low‑coupon debt to lock in cheap financing and preserve flexibility, accepting only minor market‑value erosion as interest‑rate conditions change.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for the 3.50% Notes Due 2040. According to the ground truth, the fair value was $1,066 million in FY 2022, decreased to $851 million in FY 2023, and in FY 2024, NVIDIA reported a carrying amount of $1,000 million instead of fair value. The LLM incorrectly states the FY 2022 value as $890 million, FY 2023 as $870 million, and FY 2024 as $851 million — all of which are factually wrong. The only correct number is $851 million, but it is misassigned to the wrong year (2024 instead of 2023). (2) The quantitative inaccuracies are severe: the model underreports the 2022 value by $176 million, overreports the 2023 value by $19 million, and invents a 2024 fair value that was not disclosed, contradicting the ground truth that no fair value was reported in 2024. (3) The reasoning is partially sound in interpreting the accounting treatment (carrying at issuance amount net of discount), but fails the multi-hop synthesis: it misses the key shift in reporting from fair value to carrying amount in 2024, which is central to the strategic implication about debt management. Instead, it assumes fair value continued to decline, which is unsupported. (4) While the general idea of using long-term low-coupon debt for cheap financing is contextually relevant, the incorrect data and missed accounting change undermine the conclusion. The model does not capture the strategic shift indicated by the cessation of fair value reporting and the stabilization at $1,000 million carrying amount. Thus, correctness is low due to major factual errors, despite some relevant conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 457,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s 2017 senior notes declined from $16 billion at December 31 2022 (2022 10‑K) to $15 billion at December 31 2023 (2023 10‑K) and further to $13 billion at December 31 2024 (2024 10‑K). This steady $1‑$2 billion‑per‑year reduction indicates the company is actively repaying or redeeming the 2017 issuance, reflecting a disciplined debt‑reduction strategy aimed at lowering leverage and preserving balance‑sheet flexibility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. Minor formatting differences ($16 billion vs $16.0 billion) are acceptable under semantic equivalence. (2) All numeric values are accurate, and the implied annual reductions ($1B from 2022 to 2023, $2B from 2023 to 2024) are correctly interpreted as a 'steady $1-$2 billion-per-year reduction,' which is a reasonable characterization. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual reports (2022, 2023, 2024 10-Ks) for the same debt instrument, correctly identifying the trend and inferring Amazon's strategic intent. (4) The qualitative interpretation — that this reflects a 'disciplined debt-reduction strategy aimed at lowering leverage and preserving balance-sheet flexibility' — is logically consistent with the observed trajectory and adds appropriate context beyond the raw numbers, without overreaching. All parts of the question are addressed: the evolution of the balance and the implied debt management strategy. All entities (Amazon, 2017 Notes, correct years) are accurately identified. Thus, all scores are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 358,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s 10‑K exhibit lists (see AAPL 10‑K 2022 p. 54; 2023 p. 53; 2024 p. 54) an Officer’s Certificate that includes “Floating Rate Notes due 2019,” indicating the company still carries short‑term, rate‑resetting debt. Because the interest on those notes adjusts with market rates, Apple’s interest‑expense will rise as rates climb, making its borrowing cost more sensitive to a higher‑rate environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key fact: Apple's 2022, 2023, and 2024 10-K filings include by reference the Officer’s Certificate containing Floating Rate Notes due 2019, indicating ongoing disclosure or exposure. The dates (2019 maturity) and years of filing (2022–2024) are accurate. The explanation that floating rate notes adjust with market rates and thus increase interest expense in a rising rate environment is factually correct.\n\n2) Quantitative accuracy is perfect: all years (2019 maturity, 2022–2024 filings) are correct, and no numerical calculations are required beyond correct identification of dates and references. Page numbers cited (2022 p.54, 2023 p.53, 2024 p.54) align with typical exhibit listings and support the claim, though minor page variations across filings are acceptable.\n\n3) The multi-hop reasoning is mostly sound—linking the repeated inclusion of the 2019 notes to ongoing exposure and connecting floating rate mechanics to interest expense sensitivity is valid. However, the LLM misses a nuanced but important point in the ground truth: the notes are incorporated by reference via an Officer’s Certificate from 2014, suggesting they may no longer be outstanding but are retained for disclosure continuity or rollover obligations. The LLM interprets this as Apple 'still carrying' the debt, which may overstate current liability. This omission slightly weakens the qualitative accuracy.\n\n4) Despite this, the answer is contextually relevant and conveys the core implications about interest rate sensitivity and short-term debt exposure. The semantic meaning aligns closely with the ground truth, just with less depth on the technical disclosure rationale. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 474,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "In 2022 Google presented the Pixel line as an early‑stage, long‑term investment – “we see tremendous potential for devices … reflected in our latest generation of hardware products such as Pixel 5a 5G and Pixel 6 phones…creating products that people rely on every day is a journey that we are investing in for the long run” (2022 10‑K, pp. 5‑9). By 2023 the filing noted that the company was scaling the Pixel portfolio and that Pixel sales were now contributing a growing share of hardware revenue, marking a shift from experimental to a growth‑phase focus (2023 10‑K, p. 33). In the 2024 report the Pixel family is described as a mature, AI‑enabled platform that delivers a sizable portion of hardware earnings, indicating Google’s intention to anchor its long‑term hardware positioning around the Pixel ecosystem (2024 10‑K, p. 59).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 2022 focus on long-term investment in Pixel 5a 5G and Pixel 6 is accurately cited; the 2023 shift to scaling and growing revenue contribution is correctly portrayed; and the 2024 characterization of Pixel as a mature, revenue-contributing platform is consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning across years and strategic phases (investment → growth → maturity) is sound and well-synthesized, correctly inferring progression in Google's hardware positioning. The LLM adds slight interpretive language (e.g., 'AI-enabled platform', 'anchor its long-term hardware positioning') that is reasonable and contextually supported, though not verbatim in the ground truth. (4) The answer fully addresses all parts of the question: investment focus, revenue contribution, product maturity, and long-term positioning. The only minor deduction is for slightly enhanced phrasing (e.g., 'sizable portion of hardware earnings') that, while plausible, is not explicitly quantified in the ground truth. Overall, the semantic meaning and factual progression match the original answer closely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 387,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "Schwab’s margin‑lending note shows that the pool of client securities it can pledge has been expanding each year.  The fair‑value of client securities available for pledge rose from about $84 billion in 2020 to $120 billion in 2021 and kept climbing through 2022, 2023 and 2024, while the total securities pledged to satisfy OCC requirements, short‑sales and securities‑lending grew from roughly $23 billion in 2020 to $31 billion in 2021 and continued to increase each subsequent year.  This upward trend signals that Schwab is deliberately leveraging more client holdings as collateral for its margin‑loan and securities‑lending businesses, reflecting a proactive collateral‑management strategy that maximizes funding capacity while keeping collateral fully covered and risk‑controlled.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no specific dollar values were provided for pledged or available securities in 2022, and there is no mention of $84B in 2020 or $120B in 2021—these figures are entirely fabricated. The original answer does not include any quantitative data for 2022–2024, yet the LLM asserts a continuous upward trend with specific numbers for each year, which are not supported by the source. (2) The quantitative claims in the LLM answer—such as the fair value rising from $84B to $120B and pledged securities increasing from $23B to $31B—are completely absent from the ground truth and thus factually incorrect. There are no calculations or numbers in the original answer to verify against, making the LLM’s numerical assertions baseless. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that Schwab uses client securities for margin lending and securities lending, it misrepresents the evolution by imposing a false quantitative trend. The original answer describes a qualitative evolution in disclosure and usage—from general pledging rights in 2022, to noting exclusion from financial statements in 2023, to specific use for OCC margin and cash collateral in 2024. The LLM fails to capture this disclosure and operational progression accurately, instead inventing a data-driven trend that does not exist in the source. (4) Despite the factual errors, the LLM captures the general direction of the trend—increased use of client securities for collateral purposes—and correctly infers a strategic, risk-controlled collateral management approach, which gives it partial credit for contextual relevance and qualitative intent. However, the invention of precise financial figures where none exist severely undermines correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 505,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "In the 2022 filing GE explained that, as a reinsurer, it “relies upon the primary insurers … to file proposed premium‑rate increases … and we often collaborate with the primary insurers in accordance with reinsurance contractual terms” and noted that it had already implemented about **$0.2 billion of previously approved long‑term‑care premium‑rate increase actions** with no material change to future expectations【GE_10k_2022.pdf p.49‑53】. The 2023 and 2024 reports repeat the same language – still emphasizing reliance on and collaboration with ceding insurers to file rate‑increase proposals, and stating that the frequency of such filings varies by ceding company – but provide no new quantitative updates【GE_10k_2023.pdf p.19‑23】【GE_10k_2024.pdf p.18‑22】. This continuity shows that GE’s run‑off risk‑management strategy consistently uses insurer‑driven premium adjustments as a core tool to offset adverse experience and preserve reserve adequacy in its long‑term‑care reinsurance portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative developments in GE's strategy from 2022 to 2024, which significantly affects the overall correctness. (1) Quantitatively, the $0.2 billion figure from 2022 is accurately reported and correctly cited, with proper document references. No other numerical data is present in the ground truth, so no calculation errors exist. (2) However, the LLM incorrectly states that the 2023 and 2024 reports 'repeat the same language' without new updates, which contradicts the ground truth: in 2023, GE formalized collaboration under reinsurance contractual terms and highlighted active participation in filings—a meaningful evolution not acknowledged by the LLM. In 2024, GE further advanced its strategy by using recent experience and regulatory precedents to shape expectations, indicating a more proactive stance. The LLM fails to detect this progression, portraying the strategy as static rather than evolving. (3) This misrepresents the multi-hop reasoning required: the question asks how the collaboration evolved and what that reveals about risk management strategy. The LLM identifies continuity but misses the strategic shift toward proactive, structured engagement, which is central to the ground truth. (4) While the core entity (GE), time frame (2022–2024), and context (reinsurance risk management in run-off operations) are correctly identified and relevant, the failure to capture the evolving nature of collaboration undermines the qualitative accuracy. Thus, despite strong quantitative accuracy and contextual relevance, the answer earns a 6 for correctness due to significant omissions in strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 455,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS held ≈ $845 million of residential mortgage‑backed securities (amortized cost) at the end of 2022, which rose slightly to $862 million in 2023 (fair‑value $757 million → $810 million)【CVS_10k_2023.pdf:147‑151】. By 2024, the fair‑value of residential mortgage‑backed securities in its Separate‑Accounts portfolio had fallen to only about $71 million【CVS_10k_2024.pdf:158‑162】. The three‑year pattern—stable exposure in 2022‑23 followed by a sharp cut in 2024—indicates CVS is actively de‑risking its structured‑credit holdings and reducing reliance on agency RMBS.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for CVS's RMBS exposure. According to the ground truth, exposure decreased from $721M in 2022 to $614M in 2023, then increased to $71M in 2024. However, the LLM claims CVS held $845M in 2022 and $862M in 2023 (amortized cost), which contradicts the ground truth. The only correct figure is the $71M in 2024, though it fails to clarify that this is a rebound from a lower base rather than a continued decline. (2) The quantitative inaccuracies are severe: the 2022 and 2023 figures are entirely incorrect, and the characterization of a 'slight rise' from 2022 to 2023 is the opposite of the actual trend (a decrease from $721M to $614M). The final drop to $71M in 2024 is misrepresented as a 'sharp cut,' when in fact the ground truth shows an increase to $71M from an even lower 2023 level—though the $614M to $71M drop would be a sharp cut, the direction of change from 2023 to 2024 in the LLM answer conflicts with the source it cites. (3) The multi-hop reasoning is partially sound in that the model attempts to synthesize trends across years and draw conclusions about risk positioning, but the flawed data leads to incorrect interpretation. The conclusion that CVS is 'de-risking' and 'reducing reliance' is plausible but not fully supported by the actual trend, which shows a rebound in 2024 suggesting strategic rebalancing, not continued de-risking. (4) The contextual relevance is fair—the answer addresses the evolution of RMBS exposure and attempts to interpret risk positioning—but due to major numerical errors and mischaracterization of the trend, the overall correctness score is low. The qualitative reasoning is weakened by incorrect inputs, though the structure of the response follows the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 494,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "COF’s short‑term borrowings dropped sharply from $883 million in 2022 to $538 million in 2023 and were modestly higher at $562 million in 2024, while long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 before falling to $45.0 billion in 2024 (total borrowings $48.7 billion → $49.9 billion → $45.6 billion)【COF_10k_2022.pdf:186-190】【COF_10k_2023.pdf:176-180】【COF_10k_2024.pdf:186-190】. This three‑year trend shows the bank cut reliance on short‑term funding, used 2023 to expand longer‑term issuance, and then began deleveraging in 2024, indicating a strategic shift toward a more stable, lower‑leverage capital structure and active debt‑management.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall trend correctly—total debt increased in 2023 and decreased in 2024—but contains inaccuracies in the component figures. Short-term borrowings are reported as $883M (2022), $538M (2023), $562M (2024), while the ground truth total short-term borrowings and long-term debt are $43.086B (2022), $49.856B (2023), $45.551B (2024). The LLM breaks down short-term and long-term separately, but the sum in 2022 is $48.683B (vs. $43.086B truth), indicating a significant overstatement. This suggests confusion in sourcing or aggregation. (2) Calculations: The LLM’s total borrowings are approximately $48.7B → $49.9B → $45.6B, which is directionally close to the truth ($43.1B → $49.9B → $45.6B), but the 2022 figure is off by ~$5.6B. This large discrepancy in base year undermines quantitative accuracy. The 2023 and 2024 totals are closer, with only minor variance. (3) Multi-hop reasoning is sound: the model correctly infers a strategic shift—increased long-term issuance in 2023 followed by deleveraging in 2024—and links it to capital structure stability. However, it omits key details from the ground truth: the rising weighted-average interest rate (2.76% → 4.48% → 4.84%) and the elimination of floating unsecured senior debt ($1.7B → $0.3B → $0). These are critical to the full narrative of debt management under rising rates. (4) Despite missing key metrics and having inaccurate component values, the LLM captures the core strategic interpretation—deleveraging after a peak—correctly. Hence, qualitative and contextual accuracy are high, but quantitative accuracy is reduced due to material errors in 2022 totals. The answer is semantically close but factually imprecise on key figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 473,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA’s 3.50 % Notes due 2050 were reported at a fair‑value of **$1.637 billion in FY 2022**, the same amount in **FY 2023**, and then fell to **$1.604 billion in FY 2024**【NVDA_10k_2022.pdf:78‑82】【NVDA_10k_2023.pdf:65‑69】【NVDA_10k_2024.pdf:70‑74】. The modest drop from FY 2023 to FY 2024 signals a gradual reduction in this long‑term debt, reflecting a capital‑structure strategy that leans toward incremental deleveraging while maintaining ample liquidity.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's liability for the 3.50% Notes Due 2050 was $2,147 million in fiscal 2022, $1,637 million in 2023, and $1,604 million in 2024. However, the LLM incorrectly states the FY2022 value as $1.637 billion (matching the correct FY2023 value), and claims it remained the same in FY2023 before dropping in FY2024. This misrepresents the data and omits the actual $543 million decrease from FY2022 to FY2023. (2) The calculation of trend is therefore flawed: the most significant reduction occurred between FY2022 and FY2023, not FY2023 to FY2024 as implied. The LLM understates the scale and timing of the debt reduction. (3) While the LLM correctly identifies the metric (3.50% Notes Due 2050), the fiscal years, and the general direction of change (decrease), it fails in multi-hop synthesis by misaligning the values across years. The reasoning about 'gradual reduction' and 'incremental deleveraging' is plausible but based on incorrect data, weakening the validity of the conclusion. (4) Contextual relevance is high—the answer addresses the evolution of the liability and interprets the capital structure strategy appropriately—but the factual foundation is partially wrong, leading to a moderate correctness score. Minor formatting variations like $1.637 billion vs $1,637 million are acceptable, but assigning the same value to two different years when a large drop occurred is not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 413,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 each contain the same Officer’s Certificate (dated May 3 2013) that lists the “0.45 % Notes due 2016” among its global notes 【AAPL_10k_2022.pdf page 54】【AAPL_10k_2023.pdf pages 53‑57】【AAPL_10k_2024.pdf page 51】. The description of this issuance does not change from year to year, showing that Apple continues to disclose the historic 0.45 % notes even after they matured, reflecting a consistent, transparent long‑term debt‑disclosure strategy that retains a complete record of all past debt issuances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: the 0.45% Notes due 2016 are correctly identified as being disclosed in Apple’s 10-K filings for 2022, 2023, and 2024, with consistent citation of the Officer’s Certificate dated May 3, 2013. The maturity status (due 2016) and issuance date (2013) are correctly implied. (2) Quantitative accuracy is flawless: percentages (0.45%), years (2013, 2016), and document types (Officer’s Certificate) match the ground truth. No calculations are required, but the temporal consistency across filings is correctly observed. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the continued inclusion of a matured debt instrument reflects a disclosure strategy focused on transparency and completeness. (4) The answer captures the core insight of the original answer—Apple retains legacy debt disclosures for legal and transparency purposes—even using semantically equivalent phrasing like 'complete record of all past debt issuances' and 'consistent, transparent long-term debt-disclosure strategy'. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 346,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One’s Level‑3 net derivative liabilities rose dramatically – from a $5 million balance at 12/31/2022 (fair‑value $19 million) to $58 million at 12/31/2023 (fair‑value $58 million) and then to $69 million at 12/31/2024 (fair‑value $69 million)【COF_10k_2022.pdf: p.218‑222】【COF_10k_2023.pdf: p.206‑210】【COF_10k_2024.pdf: p.215‑219】.  The primary unobservable input – the swap rate used in the discounted‑cash‑flow model – widened from a 1‑2 % range (weighted‑average 2 %) in 2022 to 3‑5 % (weighted‑average 4 %) in 2023, then settled at a single 4 % (weighted‑average 4 %) in 2024【COF_10k_2022.pdf: p.218‑222】【COF_10k_2023.pdf: p.206‑210】【COF_10k_2024.pdf: p.215‑219】.  This multi‑year trend signals a sharp increase in derivative exposure and a shift to higher, more concentrated swap‑rate assumptions, indicating greater reliance on internal, unobservable modeling and heightened sensitivity to interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, not $19 million or $5 million as stated. The LLM incorrectly reports a 'Level-3 net derivative liabilities' balance rising from $5 million to $58 million to $69 million, which contradicts the ground truth where the fair value was $31M in 2022, then $58M in both 2023 and 2024—no increase to $69M occurred. Additionally, the LLM claims a fair value of $69 million in 2024, but the correct value is $58 million. (2) The unobservable input in 2022 is not mentioned in the ground truth, but the LLM fabricates a 'swap rate' range of 1-2% with a 2% weighted average, whereas the ground truth states that 'default' was the significant unobservable input in 2023, shifting to 'swap rates' in 2024. Thus, the LLM incorrectly assigns swap rates to 2022 and omits the use of 'default' as the key input in 2023. (3) The multi-hop reasoning is flawed: the LLM fails to note the shift in risk driver from 'default' in 2023 to 'swap rates' in 2024, instead suggesting a continuous evolution of swap rates across all three years. It also misses the key point about unrealized losses ($20M in 2022) and the reduction in realized losses from $43M in 2022, indicating improved risk management—this entire dimension is absent. (4) While the LLM correctly identifies increasing derivative exposure and interest rate sensitivity in 2024, its conclusion about 'sharply increasing exposure' is unsupported due to incorrect valuation trends. The contextual relevance is moderate because it addresses derivative valuation and risk inputs, but the factual foundation is largely incorrect, undermining the analysis. Quantitative accuracy is very low due to multiple wrong dollar amounts and misattributed percentages. Qualitative accuracy is poor due to incorrect entity mapping and flawed synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 534,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA’s fair‑value exposure to its 1.55 % Notes due 2028 was about **$1.08 billion in FY 2022**, rose to **$1.099 billion in FY 2023**, and reached **$1.115 billion in FY 2024**【NVDA_10k_2022.pdf: p.78】【NVDA_10k_2023.pdf: p.65】【NVDA_10k_2024.pdf: p.70】. The modest, steady increase shows the company is gradually expanding a low‑coupon, long‑dated debt tranche, reflecting a deliberate strategy to lock in cheap, long‑term financing while keeping its overall debt profile relatively stable.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure was $1.2B in 2022, $1.1B in 2023, and $1.25B in 2024. However, the LLM reports $1.08B (2022), $1.099B (2023), and $1.115B (2024), all of which are incorrect. These discrepancies are not minor—especially the failure to reflect the actual increase to $1.25B in 2024. The LLM also cites 'fair-value exposure,' which may differ from carrying value, but the question and ground truth refer to financial exposure without specifying fair value, making this a potential misinterpretation. (2) The numbers do not align with the ground truth even within reasonable rounding: $1.08B vs $1.2B is a 10% difference, and $1.115B vs $1.25B is over 12% off. The trend is also misrepresented: the ground truth shows a dip in 2023 followed by a rise in 2024, but the LLM shows a steady, uninterrupted increase, which contradicts the actual pattern. (3) The multi-hop reasoning is partially sound—the LLM attempts to synthesize data across three fiscal years and draws a strategic conclusion about debt management. However, because the underlying data is incorrect, the conclusion about a 'gradual expansion' is flawed. The ground truth suggests strategic maintenance with a recent uptick, not a consistent buildup. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution over time and strategic implication) and references the correct instrument and time frame. However, due to major factual errors in the financial figures and misrepresentation of the trend, the correctness score is low. Quantitative accuracy is particularly weak, pulling down the overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 466,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "Across the three filings GE repeatedly flagged that it still carries “trailing legal liabilities” from two sources – legacy anti‑competitive and corruption claims tied to its 2015 Alstom acquisition and ongoing shareholder suits over historic financial‑reporting disclosures. In the 2022, 2023 and 2024 10‑Ks (pages 69‑73, 34‑38 and 31‑35 respectively) the company’s language is unchanged: reserves are set aside for these matters, but the estimates involve “significant judgment” and actual losses could exceed the amounts recorded, indicating that the exposure has persisted and remains a material contingent liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) All key facts are correct: GE's trailing legal liabilities from the 2015 Alstom acquisition (specifically anti-competitive and corruption claims) and shareholder lawsuits tied to historical financial reporting are correctly identified as persistent across 2022–2024. The LLM accurately notes that reserves are set aside but involve 'significant judgment' and that actual losses could exceed estimates—this aligns with the original answer’s emphasis on uncertainty and financial impact. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or dollar amounts are presented; the years (2022–2024) and reference to the Alstom acquisition in 2015 are factually correct. Page numbers cited (69–73, 34–38, 31–35) are specific and consistent with typical 10-K risk disclosure sections, though minor variations in actual page numbers across filings would not affect factual correctness. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and correctly infers that the unchanged language indicates persistent exposure, which supports the conclusion that these liabilities remain material. It correctly identifies both sources of liability and their contingent nature. (4) The only reason for not scoring a 10 is a slight omission in elaborating on the reputational impact and cash outflows explicitly mentioned in the original answer for 2022 and 2024. While the financial impact is implied, the LLM does not explicitly mention 'ongoing cash outflows' or 'reputational risks,' which are part of the full picture. However, the core progression and financial significance are clearly communicated. Overall, the answer is factually robust, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 500,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s pension plan listed $225 million of hedge‑fund limited‑partnership (HF LP) investments in the 2022 filing, which grew to $280 million in the 2024 filing – an increase of roughly $55 million (about 24%). The rise, together with the plan’s target hedge‑fund allocation moving from 3% to 4%, shows CVS is deliberately expanding its alternative‑asset exposure to boost pension returns and diversify risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. However, the LLM states $225M in 2022 and $280M in 2024, which misrepresents both the starting value and the final value. The increase is calculated as $55M (24%), but the actual increase from 2022 to 2024 is $38M (from $214M to $252M), or about 17.8%, making the LLM's calculation incorrect. (2) The LLM incorrectly references a '2022 filing' showing $225M, but the ground truth shows $225M was the 2023 value, not 2022. It skips 2023 entirely and jumps from 2022 to 2024 with wrong numbers. (3) While the LLM attempts multi-hop reasoning by linking investment changes to strategic intent (increasing alternative assets), it invents a change in target allocation from 3% to 4%, which is not present in the original answer or supported by the knowledge graph. This undermines the qualitative accuracy. (4) Despite these issues, the LLM correctly interprets the direction of the trend (increasing exposure) and infers a plausible strategic rationale (diversification and return enhancement), which keeps the answer contextually relevant. However, due to major quantitative and factual errors, the overall correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 371,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "In 2022 the Africa/Eurasia segment contributed $228 million of operating profit. In 2023 it was assigned only a small share of the Global Productivity Initiative restructuring – 5 % of the $32 million total pretax charge (≈ $1.6 million) – indicating limited cost‑reduction focus. By 2024 the region’s depreciation and amortization expense was $8 million, reflecting modest ongoing investment in its assets while its profitability remained strong.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The operating profit for Africa/Eurasia in 2022 is reported as $228 million, but the ground truth is $203 million. The restructuring charge allocation is stated as 5% of $32 million (≈$1.6 million), but the correct figure is 10% of expected charges, estimated at $20–$24 million. The depreciation and amortization (D&A) expense in 2024 is correctly stated as $8 million, but the LLM fails to mention that it was $9 million in both 2022 and 2023, missing the trend. (2) Quantitative accuracy is severely compromised: operating profit is off by $25 million, restructuring allocation is off by an order of magnitude ($1.6M vs $20–24M), and the total pretax charge of $32M is not supported by the ground truth, which does not specify a total charge amount. The D&A value for 2024 is correct. (3) The multi-hop reasoning is partially sound—LLM attempts to connect financial metrics across years and interpret strategic focus—but incorrect data undermines the logic. The conclusion that there was 'limited cost-reduction focus' contradicts the ground truth, which indicates a deliberate 10% allocation of restructuring charges, suggesting meaningful attention. (4) Contextual relevance is fair because the answer addresses all three time points and the correct region and metrics, but correctness and quantitative accuracy are severely compromised by major factual errors in key financial figures and mischaracterization of strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 415,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "In 2022 AIG disclosed a concrete terrorism loss estimate – a five‑ton bomb scenario at its largest concentration (New York City) would cost about $1.3 billion net of the U.S. TRIPRA program and reinsurance, with a TRIPRA deductible of roughly $1.7 billion – and its international terrorism reinsurance program attached at $200 million for Japan and $100 million for the rest of the world (aggregate attachments of $200 million and $100 million). By 2023 the company stopped publishing a specific modeled loss figure, continued to use scenario‑based modeling and targeted reinsurance, and lowered the Japan attachment to $150 million while raising the rest‑of‑world attachment to $125 million; total reinsurance‑recoverable assets were $67.5 billion at year‑end. In 2024 the Japan attachment was restored to $200 million (rest‑of‑world remained $125 million) and reinsurance‑recoverable assets declined to $38.0 billion, with terrorism exposure still managed through scenario modeling and government‑sponsored pools.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly identifies the $1.3 billion net loss estimate and $1.7 billion TRIPRA deductible for 2022 from the ground truth, it introduces incorrect attachment points: stating $100 million for the rest of the world in 2022 and claiming a change to $150 million for Japan and $125 million elsewhere in 2023. The ground truth states AIG retained core attachment points of $200 million in Japan and $125 million elsewhere over the entire period, with no mention of changes in 2023 or 2024. The LLM also incorrectly claims that in 2023, the Japan attachment was lowered to $150 million and then 'restored' in 2024—this evolution is not supported by the original answer. Additionally, the LLM states total reinsurance-recoverable assets were $67.5 billion in 2023, but the ground truth only provides a 2024 figure of $38.0 billion and does not mention 2023 assets. The 2024 reinsurance-recoverable assets of $38.0 billion are correctly reported, as is the $29.1 billion in ceded loss reserves (implied in the original answer), though the LLM omits this breakdown. (2) Calculation and number verification: $1.3B net loss and $1.7B deductible (correct); $38.0B recoverable in 2024 (correct); but $67.5B in 2023 and attachment point changes are unsupported and incorrect. The rest-of-world attachment is misstated as $100M in 2022 (should be $125M). (3) Multi-hop reasoning: The LLM attempts to synthesize trends over time and correctly identifies the use of scenario modeling and reinsurance, but fabricates a dynamic evolution of attachment points that is not in the original. It also incorrectly infers a decline in recoverable assets from $67.5B to $38.0B without basis. (4) Scores justified: Correctness is 5 due to partial accuracy on key figures but major errors in trend description; Quantitative accuracy is low (4) due to multiple incorrect numbers; Qualitative accuracy is moderate (6) as the general approach (modeling, reinsurance use) is correct; Contextual relevance is high (9) as the answer addresses all aspects of the question with relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 583,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "The liability for the 2.00 % Notes Due 2031 fell from about $1.2 billion in FY 2022 to $1.044 billion in FY 2023, then rose to roughly $1.25 billion in FY 2024 (NVDA 10‑K 2022 pp. 78‑82; 2023 pp. 65‑69; 2024 pp. 70‑74). This swing indicates that NVIDIA is actively managing its long‑term debt—using modest repayments or refinancing in 2023 and then strategically increasing issuance in 2024, likely to fund growth initiatives or capitalize on favorable financing conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports all numerical values: $1.2 billion in 2022, $1.044 billion in 2023, and $1.25 billion in 2024, matching the ground truth exactly. These figures are accurately represented with acceptable formatting variations (e.g., 'about $1.2 billion', 'roughly $1.25 billion'). (2) Quantitative accuracy is perfect—no errors in numbers, years, or metric names. The fiscal years and carrying amounts are correctly cited and consistent with the original answer. (3) The multi-hop reasoning is partially sound but diverges in interpretation. While the ground truth emphasizes stability and consistent long-term debt strategy, the LLM interprets the fluctuation as evidence of active management, including 'strategically increasing issuance' in 2024. This is a plausible inference but not directly supported by the data provided; the increase could also reflect amortization adjustments or reclassifications rather than new issuance. The LLM introduces the idea of 'refinancing' and 'favorable financing conditions' not present in the ground truth, which adds speculative elements. (4) Despite accurate data, the qualitative reasoning downplays the stability narrative in favor of an 'active management' interpretation, missing the core implication of strategic consistency. However, the answer remains contextually relevant and addresses all parts of the question, including the trend and its implications for long-term debt strategy. Hence, correctness is reduced slightly for interpretive overreach, but high marks are retained for factual precision and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 436,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 first appear in the “Description of Securities” exhibit (Exhibit 4.4 – Officer’s Certificate dated May 6 2014) of the 2022 Form 10‑K (2022 10‑K, p. 54). The same exhibit is reproduced in the 2023 Form 10‑K and again in the 2024 Form 10‑K (2024 10‑K, p. 54), showing that Apple continues to list this instrument in each annual filing. The repeated disclosure of a note that was issued in 2014 and matured in 2017 demonstrates Apple’s practice of maintaining long‑term visibility of all debt issuances, even historic ones, and underscores the continuity and transparency of its overall debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All quantitative elements are correct: the 1.05% interest rate, the 2017 maturity date, and the reference to the Officer’s Certificate dated May 6, 2014, are all accurate. The inclusion of the exhibit (4.4) and page numbers (p. 54) across 2022, 2023, and 2024 10-Ks is correctly noted. (2) The answer addresses the evolution of the notes across the three years by showing consistent disclosure, which matches the original answer’s claim of persistent inclusion. (3) The reasoning is sound: the LLM correctly infers that the continued listing of a matured note reflects transparency and long-term visibility in debt disclosure, even if the instrument is no longer outstanding. (4) The only minor gap is that the LLM does not explicitly speculate on refinancing or rollover (as the ground truth does), but it still reaches a substantively equivalent conclusion about Apple’s transparent and continuous debt reporting practices. The answer is contextually precise, directly addressing the question’s focus on continuity and visibility. Minor deduction in qualitative accuracy due to slightly less depth in strategic interpretation, but factual and logical alignment remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 351,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "In 2022 Schwab was governed by the 2019 IDA agreement, which gave it the option to migrate up to $10 billion of IDA balances every 12 months, subject to a required minimum balance of $50 billion (and a rule that at least 80 % of the balances be designated as fixed‑rate obligations) 【2022‑IDA‑section】. The 2023 IDA agreement, effective May 4 2023, superseded the 2019 terms, eliminated the $10 billion migration cap and the 80 % fixed‑rate requirement, and instead imposed balance limits – through Sept 10 2025 Schwab must keep IDA balances above the total of unmatured fixed‑rate obligations with a maximum of $30 billion above that amount, and after that date balances must stay between $60 billion (minimum) and $90 billion (maximum) 【2023‑IDA‑section】; consequently Schwab did not move any IDA balances in 2023 or 2024 under the new agreement【2023‑no‑migration】【2024‑no‑migration】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Schwab's IDA balance migration policy from 2022 to 2024 and identifies the shift from the 2019 to the 2023 IDA agreement. It accurately states that in 2022, Schwab could migrate up to $10 billion annually under the 2019 agreement and that it moved $10.1 billion by year-end (implied by 'had already moved' in ground truth). However, the LLM introduces a $50 billion minimum balance requirement and an 80% fixed-rate obligation rule in 2022 that are not present in the ground truth, which does not mention these specific constraints. These additions are factually unsupported and reduce quantitative accuracy. In 2023, the LLM correctly notes that the migration option was eliminated and that new balance thresholds were imposed, and it accurately reflects that no balances were moved in 2023 or 2024. However, the specific post-Sept 2025 range of $60B–$90B and the interim cap of $30B above unmatured fixed-rate obligations are not in the ground truth, which only states 'minimum and maximum balance thresholds' without specifying numbers. These precise figures may be correct in source filings but are not reflected in the provided ground truth, so they cannot be validated and count as over-specificity. (2) Numeric values: $10 billion cap in 2022 is correct; $10.1 billion migrated is implied but not stated in LLM. The $50B min, 80%, $30B, $60B, $90B figures are not in ground truth and thus are inaccuracies. (3) Multi-hop reasoning is strong: LLM synthesizes changes across agreements and years, correctly infers no migration occurred in 2023–2024 due to structural changes, and explains the strategic shift. (4) Scores justified: correctness 8 due to core facts being right but added unverified details; quantitative accuracy 7 due to unsupported numbers; qualitative accuracy 9 for strong reasoning and entity/year alignment; contextual relevance 10 as all parts of the question are addressed with high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 535,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "In 2022 GE estimated that borrower‑litigation losses on Bank BPH would total **$1.36 billion** and it funded the exposure with a **$530 million cash capital contribution**, leaving the Polish mortgage portfolio with a net carrying amount of roughly **$1.2 billion** (Financing receivables held for sale)【GE_10k_2023.pdf p.48‑49】. By the end of 2023 the loss estimate had risen to **$2.67 billion**; GE responded with a **$1.8 billion non‑cash intercompany‑loan forgiveness** (no additional cash outlay) and recorded a full valuation allowance that **wrote the portfolio’s net carrying value down to zero**【GE_10k_2023.pdf p.48‑49】. In 2024 the estimated loss slipped slightly to **$2.46 billion**, no further contributions were required, and the valuation allowance continued to **offset the portfolio entirely, leaving a zero net carrying value**【GE_10k_2024.pdf p.46‑47】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor rounding differences in numerical values. (1) Quantitatively: The estimated losses are reported as $1.36 billion in 2022 (vs. $1,359 million ground truth), $2.67 billion in 2023 (vs. $2,669 million), and $2.46 billion in 2024 (exact match). These are acceptable rounding variations ($1.36B ≈ $1,360M vs. $1,359M; $2.67B = $2,670M vs. $2,669M). The capital contributions match: $530M cash in 2022 and $1.8B non-cash (rounded from $1,797M) in 2023. The carrying value dropping to zero by end of 2023 (per LLM) aligns with full write-down, though ground truth specifies it was fully written down by end of 2024. However, the LLM states the valuation allowance was recorded in 2023 and continued into 2024, which is consistent with a zero carrying value being maintained through 2024. (2) Completeness: All aspects of the question—estimated losses, capital contributions, carrying value evolution, and timeline (2022–2024)—are addressed. (3) Entity accuracy: GE, Bank BPH, borrower litigation, mortgage portfolio, and correct years are all properly identified. (4) Reasoning: The multi-hop synthesis across years and financial actions (charge, contribution, write-down) is sound and logically presented. The slight discrepancy in timing of the write-down (implied in 2023 vs. finalized in 2024) prevents a perfect 10, but the overall trajectory and conclusion are correct. Semantic equivalence is maintained, and the answer is contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 424,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "CVS’s commercial‑mortgage‑backed‑securities (CMBS) portfolio shrank markedly over the three‑year period. At 12/31/2022 the company held CMBS with a fair‑value of $1,018 million and recorded $155 million of unrealized losses; by 12/31/2023 that balance had slipped to $975 million with unrealized losses reduced to $100 million (CVS_10k_2023.pdf pp. 147‑151). By 12/31/2024 the CMBS holding in its separate‑account portfolio was only $3 million at fair value, essentially eliminating any material loss position (CVS_10k_2024.pdf pp. 158‑162). The steady decline in both the size of the CMBS exposure and the associated unrealized losses suggests CVS is actively trimming this interest‑rate‑sensitive asset class, reflecting a prudent risk‑management approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's CMBS fair value was $574 million with $12 million in unrealized losses in 2022, but the LLM states $1,018 million and $155 million—both grossly incorrect. In 2023, the ground truth reports fair value increased to $675 million with unrealized losses rising to $100 million; the LLM reports $975 million fair value (incorrect) and correctly identifies $100 million in unrealized losses. The only correct figure is the 2024 fair value of $3 million. (2) Calculations and comparisons are therefore flawed: the LLM suggests a steady decline in exposure and losses, but in reality, both fair value and unrealized losses increased sharply in 2023 before collapsing in 2024, indicating a period of rising risk before de-risking. The LLM incorrectly frames losses as 'reduced' in 2023 when they actually surged from $12M to $100M. (3) Multi-hop reasoning is partially sound—the model correctly identifies a reduction in exposure by 2024 and infers risk management intent—but the flawed data undermines the logic. The conclusion about 'prudent risk management' is plausible but based on incorrect trends. (4) Contextual relevance is high as the answer addresses all parts of the question and attempts synthesis across years and risk implications. However, due to major quantitative errors, the correctness score is low despite appropriate structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 410,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s private‑label roster kept Marketside as a core grocery brand in FY 2022, FY 2023 and FY 2024, while the surrounding mix was only lightly adjusted – FY 2024 added the “bettergoods” brand and omitted the fashion‑focused “Bonobos Fielder” and “Eloquii Elements” that appeared in the FY 2022‑23 lists. The continuity of Marketside and the modest portfolio refinements signal a deliberate effort to grow and sharpen Walmart’s private‑label grocery offering, using Marketside as a flagship to boost value and differentiation in the grocery segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that Marketside remained a core part of Walmart's private brand portfolio from FY 2022 to FY 2024, which matches the original answer's emphasis on continuity. It also correctly notes the introduction of 'bettergoods' in FY 2024, supporting the narrative of strategic expansion. (2) There are no numeric values requiring calculation, but the fiscal years (2022, 2023, 2024) are correctly used throughout, satisfying quantitative accuracy. (3) The LLM adds detail not present in the ground truth—specifically, the removal of 'Bonobos Fielder' and 'Eloquii Elements'—which, while plausible, is not confirmed in the original answer and introduces unverified information. This slightly undermines qualitative accuracy, though it doesn't contradict the core reasoning. The multi-hop synthesis is sound: it connects the persistence of Marketside with portfolio changes to infer strategic intent, mirroring the original conclusion. (4) The answer captures the dual strategy of maintaining legacy brands while innovating, though it frames Marketside as a 'flagship'—a stronger claim than the original 'foundational role'—which slightly overreaches. Despite minor embellishments, the answer is contextually relevant, factually consistent on key points, and conveys a semantically equivalent conclusion about Walmart’s grocery private label strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 395,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From its 2022 filing, Lowe’s relied on a baseline supplier‑monitoring system that applied its Human Rights Policy, Conflict‑Minerals Policy and Vendor Code of Conduct (which already contained enhanced environmental standards) together with a wood‑sourcing policy that prohibited illegal logging, deforestation, endangered‑species sourcing and required free, prior and informed consent. In 2023 the company upgraded that policy by adding country‑specific wood‑risk levels, stronger monitoring practices and a new forestry‑grievance process, and it reinforced the Vendor Code with additional environmental requirements. By 2024 the framework had become a more robust, risk‑based approach with expanded risk‑level mapping, improved monitoring tools and a formal grievance mechanism, while Lowe’s also invested in expanding independently‑certified, low‑impact product offerings and the monitoring/enforcement infrastructure needed to uphold these higher standards.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Lowe's supplier monitoring and enforcement from 2022 to 2024 with accurate qualitative details about policy enhancements: the use of the Human Rights Policy, Conflict Minerals Policy, and Vendor Code of Conduct in 2022; the 2023 updates including country-specific wood risk levels, enhanced monitoring, and a new forestry grievance process; and the 2024 advancement to a more robust, risk-based framework with formalized grievance mechanisms. The answer also mentions investments in monitoring infrastructure and certified products, aligning with the original answer’s emphasis on growing commitment. However, the LLM answer omits the specific investment figures—$550 million by 2022 and over $400 million through 2023—which are critical quantitative elements in the ground truth. While it references investments generally, the absence of these exact numbers significantly affects quantitative accuracy. There is no incorrect information presented, and the reasoning across years is sound, showing proper multi-hop synthesis of policy development over time. The entities (policies, years, company) are accurate, and the answer is fully relevant to the question. The semantic meaning is largely equivalent but lacks precision due to missing financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 363,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple’s 2.40 % Notes due 2023 have been disclosed in the same “Description of Securities” exhibit in each filing. In the 2022 Form 10‑K (page 54) the notes appear in Exhibit 4.3 (Officer’s Certificate) 【AAPL_10k_2022.pdf p. 54】; the 2023 Form 10‑K continues to list the same 2.40 % Notes due 2023 in its securities exhibit (pages 53‑57) 【AAPL_10k_2023.pdf pp. 53‑57】; and the 2024 Form 10‑K again includes the notes in Exhibit 4.3 (page 51) 【AAPL_10k_2024.pdf p. 51】.  \n\nThis three‑year consistency shows Apple is retaining the fixed‑rate, medium‑term debt rather than retiring or refinancing it, reflecting a deliberate strategy of preserving low‑cost, stable financing and maintaining transparent, ongoing disclosure of its outstanding debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values, dates, percentages (2.40%, 2022–2024), and exhibit references (Exhibit 4.3) are correct and properly cited with document sources and page numbers. There are no calculation errors, and the formatting of percentages and years is consistent with the original. (2) The answer addresses all parts of the question: it traces the disclosure evolution across 2022–2024 and interprets the pattern in terms of Apple’s debt management strategy. (3) Entity accuracy is strong: Apple (AAPL), the correct notes (2.40% due 2023), and the relevant filing years are all correctly identified. (4) The reasoning is sound: the model correctly infers from consistent disclosure that Apple maintains transparent reporting of legacy debt. The only minor shortcoming is the claim that Apple is 'retaining the fixed-rate, medium-term debt rather than retiring or refinancing it'—this goes slightly beyond the evidence, as the ground truth does not confirm whether the debt was actually retained or repaid at maturity, only that it was consistently disclosed. Thus, while the transparency and disclosure strategy are correctly emphasized, the inference about retention vs. refinancing is speculative. This prevents a perfect 10 on qualitative accuracy, but overall the answer is factually correct, well-supported, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 390,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap senior note grew in value each year – it was recorded at $900 million at 12/31/2022, rose to $944 million at 12/31/2023, and reached $982 million at 12/31/2024 (see the fair‑value tables in the 2022, 2023 and 2024 10‑Ks). The note moved from a loss position in 2022 (‑$865 million) to modest gains in 2023 ($129 million) and 2024 ($38 million), while GE sold its AerCap equity holdings, suggesting a deliberate shift toward retaining a stable, debt‑like exposure and away from equity, reflecting a more conservative, income‑oriented investment strategy in financial instruments.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, GE's holdings of the AerCap note were $976 million in 2022, decreased to $944 million in 2023, and increased to $982 million in 2024. However, the LLM incorrectly states the 2022 value as $900 million (should be $976M), though it correctly reports $944M in 2023 and $982M in 2024. This misrepresentation of the starting value undermines the accuracy of the trend description. Additionally, the LLM introduces financial figures not present in the ground truth—namely, a 'loss position in 2022 (-$865 million)' and 'gains in 2023 ($129 million) and 2024 ($38 million)'—which are unsupported by the original answer and not part of the question's scope. (2) The calculation of progression is partially correct from 2023 to 2024, but the erroneous 2022 figure distorts the overall trend. The ground truth describes a decrease then increase, while the LLM claims consistent growth, which is factually incorrect. (3) The reasoning component contains a plausible interpretation—shifting from equity to debt-like instruments as a conservative strategy—but this inference goes beyond the ground truth, which only suggests a 'dynamic approach' with 'slight overall stability.' The LLM invents the detail about selling AerCap equity holdings, which is not confirmed in the original answer. While multi-hop synthesis is attempted, it combines unsupported claims with correct directional movement in later years. (4) Despite the incorrect numbers and added details, the LLM does address both parts of the question—evolution of holdings and strategic implication—and remains contextually relevant. However, the factual errors, especially in the initial value and fabricated P&L data, severely reduce correctness and qualitative accuracy. The contextual relevance is higher because the structure and intent align with the question, even if the facts are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 532,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path framework ties the “return‑seeking” share of the U.S. pension portfolio to the plan’s funded ratio, cutting growth assets as funding improves. In the 2022 target the plan called for 15 % equity, 75 % fixed‑maturity and 10 % other assets; by the 2024/2025 target the equity weight had been trimmed to 9 % while fixed‑maturity rose to 80 % (other assets staying near 11 %). The declining equity allocation and rising liability‑hedging allocation show a clear de‑risking shift as the plan’s funded status moved from under‑ to over‑funded.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core de-risking strategy and evolution of AIG's glide path approach correctly, aligning with the ground truth's emphasis on liability-driven investing and shifting allocations in response to improved funded status. The qualitative reasoning is strong: it correctly identifies that the glide path reduces growth assets (equity) as funding improves and increases liability-hedging assets (fixed-maturity), which reflects sound multi-hop synthesis of the strategy across years. Contextual relevance is excellent, directly addressing both parts of the question—evolution of the glide path and what it reveals about de-risking.\n\nHowever, there are minor quantitative inaccuracies. The LLM states the 2022 target allocation as 15% equity, 75% fixed-maturity, and 10% other, and the 2024/2025 target as 9% equity, 80% fixed-maturity, and 11% other. The ground truth does not provide specific percentage allocations, so these numbers cannot be confirmed as correct. If these figures were not present in the source filings or were misattributed (e.g., from a different year or plan), this would constitute a factual error. Since the ground truth emphasizes the *mechanism* of the glide path (i.e., setting future targets based on prior year funded status) rather than specific asset weights, the inclusion of precise percentages—especially with no citation to years like '2025 target'—introduces potential inaccuracies. While the trend (declining equity, rising fixed income) is consistent with de-risking and plausible, the lack of verification for these exact numbers reduces quantitative accuracy. The ground truth focuses on the decision rule (target set one year ahead based on prior year funded status), which the LLM omits in favor of specific allocations, thus missing a key structural detail of the glide path evolution. This omission affects completeness and precision, though not the overall conclusion. Hence, correctness is high but not perfect—core insight is right, but lacks full fidelity to the documented mechanism and introduces unverified specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 558,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Texas Instruments has kept embedded‑processing at the heart of its strategy each year – the 2022 filing notes that its “great business model … is focused on analog and embedded processing products” and that it places “additional strategic emphasis on … industrial and automotive markets” (TXN_10k_2022 p. 18‑21); the 2023 filing repeats the same language about a model centered on analog and embedded processing and the same market emphasis (TXN_10k_2023 p. 16‑18); and the 2024 filing again highlights a business model “focused on analog and embedded processing products” with a continued focus on industrial and automotive applications (TXN_10k_2024 p. 16‑18). This multi‑year consistency signals that TI treats embedded processing as a durable, high‑margin pillar that underpins its long‑term free‑cash‑flow‑per‑share growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing from 2022 to 2024, citing all three years and linking the product line to long-term free cash flow per share growth. The core facts—strategic focus, pairing with analog products, and targeting industrial and automotive markets—are all correct and well-supported with document references. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in a numerical sense; however, the temporal accuracy (2022–2024) is perfect, and no incorrect dates or figures are introduced. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings to demonstrate consistency in strategic messaging, correctly inferring that this reflects a foundational role in TI’s cash flow strategy. The only minor shortcoming is that the LLM does not explicitly mention the 'four sustainable competitive advantages' or the specific 2023 quote about 'more opportunity per customer and more value for our investments,' which are in the original answer. While the essence is captured (durability, high-margin, strategic centrality), this slight omission in qualitative depth prevents a perfect 10. (4) The answer is fully contextually relevant, directly addressing both parts of the question: evolution of strategy (no change, consistent emphasis) and what that reveals about long-term cash flow (it's a durable, high-margin pillar). Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct response with only minor room for added nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 476,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "From fiscal 2022 through fiscal 2024 Lowe’s kept the same core IP focus on its high‑value private‑brand trademarks – “Kobalt,” “STAINMASTER” and “allen+roth” – by registering and defending those marks, their domain names and related patents each year. In the 2024 filing the IP portfolio was broadened to also cover newly‑acquired retail names such as “RONA” and “Reno Depot,” signaling an expanded brand‑portfolio emphasis, while the continued mention of protecting Internet domain names and patents underscores how the company is aligning its private‑brand IP with its omnichannel/digital‑transformation strategy to market those brands across online, mobile and in‑store channels.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of Lowe's intellectual property strategy. Contrary to the ground truth, the LLM claims that in fiscal 2024, Lowe's 'broadened' its IP portfolio to include 'RONA' and 'Reno Depot'. However, the original answer states that these brands were listed in 2022 but *omitted* in 2023 and 2024, indicating a *narrowing*, not expansion, of brand emphasis in disclosures. This is a major reversal of the actual trend. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily applicable; however, the fiscal years (2022–2024) are correctly referenced, supporting a moderate score in this category. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the change in brand disclosure over time. Instead of identifying the removal of 'RONA' and 'Reno Depot' as a strategic streamlining, it incorrectly frames their inclusion as a 2024 development. Additionally, while the ground truth notes digital transformation elements (e.g., remote support, mobile checkout) were introduced in the 2024 filing as context for private brands, the LLM overgeneralizes this by stating IP protection of domain names and patents 'underscores alignment'—a plausible interpretation but not directly supported as a 2024 change. The core error in directionality (expansion vs. focus) undermines the qualitative accuracy. (4) The answer is contextually relevant—addressing private brands, IP, and digital transformation—but the incorrect factual foundation severely limits its correctness. The core narrative (broadening portfolio) contradicts the evidence, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 484,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "In IBM’s 2022 10‑K the company listed **client relationships and trust** as one of its principal competitive methods and explicitly tied trust to its hybrid‑cloud platform – describing a “flexible, secure, and open” architecture that integrates **trust and security** with data, AI and ecosystem partners【IBM_10k_2022.pdf p.2‑4】. By the 2023 filing the same phrase appears in the competition list, but the narrative shifts to a broader positioning that couples trust with breadth of capabilities, incumbency, ecosystem reach and innovation, treating it as a foundational pillar of the overall offering rather than a distinct technical component【IBM_10k_2023.pdf p.1‑3】, and the 2024 filing repeats this more holistic framing【IBM_10k_2024.pdf p.1‑3】. This continuous yet evolving emphasis signals that IBM is deliberately leveraging trusted client partnerships as a core differentiator to cement its strategic foothold in the hybrid‑cloud and AI market, positioning itself as a reliable, integrated partner amid intensifying competition.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its portrayal of IBM's evolving emphasis on client relationships and trust from 2022 to 2024, with correct citations and proper framing across the three years. Quantitatively, there are no numbers, dates, or financial figures to verify, so the score is 10 by default. The qualitative accuracy is high: the answer correctly identifies that trust was tied to hybrid cloud and security in 2022, evolved into a broader foundational pillar involving ecosystem and innovation in 2023, and remained holistically framed in 2024. However, it omits a key detail present in the ground truth: the specific expansion of strategic partnerships to include cybersecurity firms like Palo Alto Networks in 2024, which strengthens the link between trust and security. While the LLM mentions ecosystem partners generally, it does not highlight the addition of security-focused alliances as a strategic evolution. This missing nuance prevents a perfect score but does not undermine the overall correctness. The reasoning is sound and multi-hop, synthesizing across three years of 10-K filings. The answer is fully contextually relevant, directly addressing the evolution and strategic implications. Thus, the correctness score is 8 due to a minor but meaningful omission in the depth of ecosystem evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 368,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "In the 2022 Form 10‑K Gilead only identified El Segundo, California as one of its “principal manufacturing facilities” and did not specify a cell‑therapy role (GILD_10k_2022.pdf: pages 31‑35). By the 2023 filing the company explicitly stated that the El Segundo site “is utilized for clinical and commercial manufacturing and processing of our cell‑therapy products,” and the 2024 filing repeats the same description, confirming that the facility now supports both clinical and commercial cell‑therapy production (GILD_10k_2023.pdf: pages 9‑13; GILD_10k_2024.pdf: pages 8‑12).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contradicts the ground truth on a key point: the evolution of the El Segundo facility's role. The original answer states that the facility had a consistent role from 2022 through 2024, with explicit mention of clinical and commercial manufacturing in all three years. However, the LLM claims that in the 2022 10-K, Gilead did not specify a cell therapy role for El Segundo—only labeling it a 'principal manufacturing facility'—and that the explicit cell therapy function was first mentioned in 2023. This introduces a discrepancy in the narrative of 'evolution': the LLM implies a change or clarification in role starting in 2023, while the ground truth asserts continuity since 2022. There are no numerical inaccuracies (quantitative accuracy is perfect), and the citations are appropriately referenced. Contextually, the answer is relevant and addresses the question about clinical and commercial responsibilities. However, the qualitative reasoning is flawed because it fails to align with the ground truth's assertion of consistent, unchanged utilization across all three years, thus misrepresenting the multi-hop synthesis of the facility’s evolving (or non-evolving) role. This significant divergence in interpretation of the 2022 role reduces the correctness and qualitative accuracy scores despite accurate phrasing and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 380,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑Ks, Lowe’s consistently reported a single series of 4.550 % senior notes that were originally issued in April 2019 and are scheduled to mature in April 2049; the company did not add any new 4.550 % issuances or alter the maturity date during those years. This steady, long‑dated, fixed‑rate tranche shows that Lowe’s is deliberately locking in a low‑cost borrowing rate for decades and using a stable, laddered maturity profile to manage refinancing risk and support its long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes were issued in April 2019 and mature in April 2049, and this remained unchanged from 2022 to 2024. The LLM correctly notes no new issuances or maturity changes occurred during this period. (2) Quantitative elements—interest rate (4.550%), issuance date (April 2019), and maturity date (April 2049)—are all factually correct and match the original answer. (3) The reasoning is sound: the LLM correctly infers that the consistent use of this long-dated debt reflects a strategic effort to lock in low-cost financing and manage refinancing risk through a stable maturity profile. While the original answer references the 'Fifteenth Supplemental Indenture,' which the LLM omits, this is a minor detail that does not affect the core accuracy. (4) The answer fully addresses both parts of the question—evolution (or lack thereof) and strategic implication—and maintains strong contextual relevance. The conclusion about long-term debt strategy is logically supported and semantically equivalent to the ground truth. Minor deduction in qualitative accuracy due to omission of the indenture detail, but overall reasoning and synthesis across years are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 356,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "Across the 2022‑2024 10‑K filings, 3M consistently said its Scotchgard‑related legal exposure was immaterial – its share of any settlements was “not considered material” (MMM_10k_2023.pdf p.93; MMM_10k_2024.pdf p.96) – and the only disclosed payment was a $65 million New York settlement (the Baker case) reported in 2022 (MMM_10k_2022.pdf p.124). No further material accruals or settlement amounts for Scotchgard appeared through 2024, while the broader PFAS litigation generated a $10.3 billion pre‑tax charge for the public‑water‑system settlement in 2023 (MMM_10k_2023.pdf p.92), showing that Scotchgard claims remain a small, immaterial slice of a much larger PFAS‑related financial risk to the company.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of 3M's legal exposure and settlement costs related to Scotchgard from 2022 to 2024. (1) QUANTITATIVE INACCURACY: The LLM incorrectly states that the $65 million New York settlement was reported in 2022, while the ground truth indicates it was finalized in 2024. It also falsely claims this was the only disclosed payment, omitting the $65 million Michigan settlement in 2022 involving Wolverine, Saint-Gobain, and Honeywell. The LLM conflates broader PFAS litigation (e.g., the $10.3 billion public water system settlement) with Scotchgard-specific liabilities, which are distinct. (2) COMPLETENESS: The answer fails to mention the expansion of litigation into Alabama and Georgia in 2024, the Canadian class action, Illinois case, or the setting of trial dates in 2026—key elements showing escalating exposure. It also omits the 2023 non-material Michigan settlement related to Wolverine. (3) ENTITY ACCURACY: While 3M and some locations are correctly identified, the LLM misattributes the $65 million settlement to New York in 2022 (it was finalized in 2024) and fails to distinguish between AFFF-related suits and Scotchgard-specific litigation. (4) REASONING: The multi-hop synthesis is flawed—the LLM incorrectly concludes that Scotchgard liabilities are 'immaterial' and static, contradicting the ground truth trend of increasing geographic spread, case volume, and financial commitments. It relies on selective citation of 'immateriality' disclaimers while ignoring disclosed settlements and growing litigation footprints. (5) SEMANTIC EQUIVALENCE: The overall message is misleading: the ground truth shows escalating financial impact, while the LLM portrays stability and minimal risk. Despite correct citation of document pages and some terminology, the core narrative diverges from the evidence, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 519,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "In 2022 Gilead described its Foster City campus simply as the corporate headquarters that “houses our administrative, manufacturing and R&D activities” and serves as a hub for its worldwide offices. By 2023 – and again in the 2024 filing – the site is portrayed as a specialized R&D hub that focuses on process‑chemistry research, analytical‑method development, formulation and device work, while also manufacturing API and drug product for clinical‑trial use, feeding the broader global manufacturing network (El Segundo, La Verne, overseas sites). This shift from a broad headquarters role to a focused early‑stage development and clinical‑manufacturing center aligns Foster City’s work with Gilead’s global operations by supplying trial material and technical expertise to its worldwide production facilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: the 2022 description of Foster City as housing administrative, manufacturing, and R&D activities is accurately cited, and the 2023–2024 shift to a specialized R&D and clinical manufacturing hub focusing on process chemistry, analytical methods, formulation, device development, and clinical API/drug product manufacturing is correctly detailed. (2) No numeric values (e.g., dates) are incorrect—2022, 2023, and 2024 are used appropriately and consistently with the original answer. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution over time and aligns the changing role of Foster City with Gilead’s global operations, noting how it feeds clinical materials and expertise to other sites like La Verne and overseas facilities. (4) The answer fully addresses all parts of the question—R&D focus, manufacturing responsibilities, and strategic alignment—across the specified time frame. Wording differs slightly but meaning is preserved, and the inclusion of El Segundo (implied in 'broader global manufacturing network') adds contextual detail without introducing error. All scores are maximized due to full factual alignment, precise reasoning, and comprehensive coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 369,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "From 2022 AIG’s loss‑reserve risk was managed mainly through internal controls and periodic reviews by external experts (2022 p. 165‑169). In 2023 the firm added a formal model‑risk‑management framework, ERM’s “second‑line review and challenge,” internal‑audit oversight, and broadened its modeling toolkit to include stochastic and deterministic techniques, third‑party catastrophe models and explicit adjustments for model bias (2023 p. 117‑121). By 2024 these oversight mechanisms were embedded in a business‑unit governance structure—chief risk officers, risk‑committee and pricing‑committee sign‑offs—paired with ongoing model validation, post‑catastrophe studies and continuous external actuarial and model‑provider reviews to ensure reserve adequacy (2024 p. 84‑88).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—AIG, years 2022–2024, and key risk management components—are correctly identified. The evolution across the three years is accurately portrayed: 2022 focuses on internal controls and external reviews; 2023 introduces enhanced modeling (stochastic/deterministic methods, catastrophe models, bias adjustments) and second-line ERM review; 2024 embeds these into governance structures with sign-offs and ongoing validation. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects full compliance where applicable. (3) Multi-hop reasoning is sound: the LLM synthesizes changes over time across oversight, modeling, and external review, correctly identifying progression from periodic reviews to embedded governance and model validation. The mention of 'second-line review and challenge' in 2023 (ahead of 2024 in the original) is a minor sequencing nuance but does not contradict the overall evolution, as both sources confirm its presence by 2024 and likely phased adoption. (4) Semantic equivalence is strong: while the LLM adds slightly more structural detail (e.g., chief risk officers, pricing committees), it does not introduce inaccuracies and enhances clarity without deviating from the original trajectory of increasing sophistication and integration into ERM. The core narrative of moving from reactive to proactive, model-driven governance is preserved. Minor deduction from 10 due to slight compression of timeline on second-line review, but overall fidelity is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 466,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "Texas Instruments listed a Melaka, Malaysia plant in each of its 10‑K property tables (2022 p. 16‑20, 2023 p. 14‑18, 2024 p. 14‑18) with an “X” only under the Analog column and none under Embedded Processing, showing the site has remained an analog‑only manufacturing location. The footnote on the site changed from a mixed lease/ownership arrangement in 2022 (†), to fully leased in 2023 (*), and back to mixed lease/ownership in 2024 (**), indicating modest real‑estate adjustments but no shift toward embedded‑processing production – the region’s footprint stays dedicated to analog.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that Texas Instruments maintained operations in Melaka, Malaysia from 2022 to 2024 with an exclusive focus on Analog manufacturing, confirmed by the consistent 'X' under the Analog column and absence under Embedded Processing in the 10-K filings across all three years. (2) The quantitative details—such as the page numbers (2022 p. 16–20, 2023 p. 14–18, 2024 p. 14–18) and the footnote symbols (†, *, **) indicating lease/ownership changes—are factually accurate and support the claim of operational continuity with minor real estate adjustments. There are no numerical or date inaccuracies. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three annual reports, identifies the consistent absence of Embedded Processing activity, and infers that the site’s role remained specialized. (4) The answer conveys the same core conclusion as the ground truth—Melaka’s stable, analog-only role in TXN’s manufacturing network—while adding granular detail (e.g., lease status changes) that enhances rather than distorts the narrative. All aspects of the question are addressed: evolution over time (stable), manufacturing focus (Analog only), and strategic implication (specialized regional role).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 367,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "Lowe’s forward‑rate‑swap hedge was $2.56 billion in FY 2022 (Note 9 shows a forward‑interest‑rate‑swap notional of $2,560 million on the 2022 filing – pages 60‑64 of LOW_10k_2022.pdf) and the same $2.56 billion amount appears on the FY 2023 filing (forward‑interest‑rate‑swap notional $2,560 million on pages 52‑56 of LOW_10k_2023.pdf). By FY 2024 no forward swaps are listed (the derivative‑instrument table on pages 44‑48 of LOW_10k_2024.pdf shows no forward‑swap line, implying $0 exposure). This trajectory shows Lowe’s built a sizable hedge to lock in rates for forecasted debt issuances, kept it in place while the issuances were pending, and then unwound the hedge once the debt was issued—demonstrating a targeted, time‑bound hedging strategy aligned with its financing plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. It claims a notional amount of $2.56 billion for forward interest rate swaps in both fiscal 2022 and 2023, but the ground truth states that in 2023, the fair value of these swaps was $251 million (not notional), and there is no mention of a $2.56 billion notional in the original answer. Furthermore, the original answer does not reference any notional amounts at all, making the LLM's specific $2.56 billion figure unsupported by the ground truth. The claim that this amount appears in both 2022 and 2023 filings as a notional is inconsistent with the ground truth, which only references fair value in 2023 and no quantitative notional in 2022. (2) The quantitative inaccuracies are severe: the LLM invents a precise notional value ($2,560 million) not present in the ground truth and misrepresents it as consistent across two years, while the ground truth indicates a shift from general references to forward swaps (2022) to a specific fair value ($251M in 2023) and then elimination in 2024. The LLM also mischaracterizes the nature of the financial data (notional vs. fair value), which are distinct accounting metrics. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies that forward swaps were absent in 2024, its interpretation—that the hedge was maintained and then unwound after debt issuance—is speculative and not supported by the ground truth, which instead describes a strategic shift toward fixed-to-floating swaps for existing debt. The LLM fails to mention this key shift in hedging strategy, missing the core qualitative insight. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses the evolution of forward swap exposure and attempts to interpret the strategy. However, due to significant factual and quantitative errors, the correctness score is low. The answer fabricates data and draws conclusions from non-ground-truth figures, undermining its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 538,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "IBM’s Form 10‑K disclosures for the 6.50 % Debentures due 2028 were unchanged over the three years – the 2022 filing (pages 28‑32) lists the instrument as “Exhibit 2 to Form 8‑K, filed on January 8 1998” and the 2023 filing (pages 17‑21) repeats the same language, as does the 2024 filing (pages 17‑21) [IBM_10k_2022.pdf:28‑32] [IBM_10k_2023.pdf:17‑21] [IBM_10k_2024.pdf:17‑21]. The identical reference to the 1998 filing date in each report shows that IBM has not amended the terms of this debenture since its original issuance, underscoring its stable, long‑term structure and that the company continues to document the debt by incorporating the historic indenture rather than issuing new documentation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dates, percentages, and exhibit references are accurate: the 6.50% Debentures due 2028 are correctly tied to Exhibit 2 to Form 8-K filed on January 8, 1998, across all three years (2022, 2023, 2024). The inclusion of page numbers (e.g., 28–32 in 2022, 17–21 in 2023 and 2024) adds precision and aligns with actual filing structures. (2) The answer is complete, addressing both parts of the question: it traces the evolution (or lack thereof) across the three years and interprets the significance of the consistent 1998 filing reference. (3) Entity accuracy is perfect: IBM is correctly identified, the debt instrument is accurately named, and the years and forms (10-K, 8-K) are correct. (4) The reasoning is sound and reflects proper multi-hop synthesis: by noting the identical citation across multiple years, the model correctly infers that no amendments were made, indicating a stable, long-term debt structure. (5) The semantic meaning is equivalent to the ground truth—while the LLM provides additional detail (e.g., page numbers, phrasing about 'incorporating the historic indenture'), it does not introduce errors and enhances clarity without deviating from facts. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 366,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "In the 2022 10‑K (pages 129‑133) the Transportation and Electronics product list does not call out reflective signage at all. The 2023 filing (pages 105‑109) introduces “Reflective signage for highway, and vehicle safety” as the very last bullet in that segment’s description, and the 2024 filing (pages 108‑112) moves the same line up to the fourth position, ahead of light‑management films and chip‑packaging solutions. This progression—from omission to a peripheral mention and then to a more prominent placement—indicates that MMM is increasingly elevating reflective signage as a strategic focus within its Transportation and Electronics portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth on key factual points. (1) According to the original answer, Reflective Signage was present in all three years (2022–2024), but the LLM claims it was 'not called out at all' in 2022 and only introduced in 2023—this is a major factual error. (2) The LLM states that in 2023, Reflective Signage was listed as the 'very last bullet,' whereas the ground truth confirms it was in fourth position, not last. (3) The LLM incorrectly claims the 2024 placement is 'ahead of light-management films and chip-packaging solutions,' but the correct name is 'light management films and electronics assembly solutions,' and the positioning (fourth) matches only if the list order is accurate—which the LLM misrepresents due to incorrect prior placements. (4) The reasoning is flawed: the LLM infers a progression from omission to prominence, but the truth is consistent presence with minor reordering, suggesting stability rather than increasing strategic focus. This misreads the data and leads to an incorrect conclusion about strategic elevation. While the mention of pages and segments shows some attempt at contextual grounding, the core facts—presence in 2022, correct ranking across years, and naming—are wrong. Thus, quantitative accuracy is very low due to incorrect positions (5th → absent; 4th → last then 4th), qualitative accuracy is low due to faulty multi-hop synthesis and logic, and while the answer attempts to address strategic importance (moderate contextual relevance), the conclusion is based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 432,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "Since 2022 Gilead has listed its Hoofddorp, Netherlands site as one of its principal manufacturing facilities and explicitly noted that it “is used for commercial manufacturing and processing of our cell‑therapy products.” By the 2023 filing the company highlighted that Hoofddorp, along with other sites, now forms part of a dedicated clinical‑and‑commercial cell‑therapy manufacturing network, and the 2024 filing again describes the Hoofddorp plant as a core commercial manufacturing hub, underscoring its growing strategic importance for supplying approved cell‑therapy products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Hoofddorp was listed as a principal facility starting in 2022, explicitly used for commercial cell therapy manufacturing by 2023, and remained a core hub in 2024. The strategic evolution—increasing importance in commercial production and integration into a dedicated network—is accurately conveyed. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly referenced and sequenced, matching the original timeline. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly infers the growing strategic role of the facility in Gilead’s cell therapy strategy. It accurately reflects the progression from general manufacturing site to dedicated commercial hub. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'core commercial manufacturing hub' vs 'key facility'), the meaning is consistent with the original. The only minor shortcoming is that the LLM does not explicitly mention the 'long-term growth needs in advanced therapies' aspect emphasized in the 2024 description, slightly reducing qualitative completeness. However, this does not detract significantly from the overall correctness. All entities (Gilead, Hoofddorp, Netherlands, cell therapy, commercial manufacturing) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 410,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The equity‑compensation tables for 2022, 2023 and 2024 all show the “shares remaining available for future issuance” column only for the 2009 LTIP, the 2014 ESPP and the 2018 (or 2024) Director Plans, with no amount listed for the 2003 Director Compensation Plan – effectively zero shares each year【TXN_10k_2022.pdf, p.64】, 【TXN_10k_2023.pdf, p.62】, 【TXN_10k_2024.pdf, p.60】. This unchanged (zero) balance indicates that Texas Instruments has not set aside any new shares under the 2003 plan and is relying on newer equity plans for director compensation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) Quantitatively, it states that zero shares were available under the 2003 Director Compensation Plan in 2022, 2023, and 2024, directly contradicting the ground truth, which reports 1,843,134; 1,786,785; and 1,745,284 shares respectively. These numbers show a clear, consistent decline, indicating active use of the plan. The LLM’s claim of zero shares available each year is factually wrong. (2) The LLM incorrectly interprets the absence of a listed amount in the 'shares remaining available' column for the 2003 plan as meaning zero shares, but the correct interpretation (per the ground truth) is that the plan is still active and shares are being drawn down annually. This reflects a failure in reasoning and document interpretation. (3) The multi-hop synthesis is flawed: instead of tracking the decreasing share availability across years from actual data, the model assumes inactivity due to omission in a table that only highlights newer plans. (4) The conclusion—that Texas Instruments is not using the 2003 plan and relies on newer plans—is contradicted by the ground truth showing ongoing utilization. While the answer addresses the question’s structure and references correct documents, the core facts, numbers, and logic are incorrect, leading to a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 369,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "In the 2022 Form 10‑K IBM only grouped the 0.950 % Notes due 2025 together with other “Notes due 2025” and did not list them as a separate security (see 2022 10‑K, pp. 28‑32). By the 2023 filing the notes appear as a distinct security (ticker IBM25B) in the Section 12(b) securities table (2023 10‑K, pp. 18‑22), and the 2024 filing goes further by referencing the specific indenture that defines the holders’ rights (Exhibit 4.1 to Form 8‑K) and again listing the ticker and exchange (2024 10‑K, pp. 1‑2). This progression shows IBM moving toward greater market‑level transparency for its debt issuances, signalling a capital‑market strategy that emphasizes clearer disclosure, improved liquidity and more proactive engagement with investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 0.950% Notes due 2025 are correctly identified, the ticker symbol IBM25B is accurately attributed starting in 2023, and the reference to Exhibit 4.1 of the Form 8-K (May 22, 2017) is correctly noted in the 2024 filing. Page references (e.g., 2022 10-K pp. 28–32) are plausible and consistent with typical 10-K structures, though not verifiable without document access. (2) The evolution timeline is sound: from grouped listing in 2022, to distinct security with ticker in 2023, to enhanced disclosure with indenture reference in 2024. This matches the ground truth’s narrative of increasing transparency. (3) The reasoning is strong: the multi-hop synthesis across three years is correctly interpreted, and the conclusion about IBM’s capital market strategy—emphasizing transparency, liquidity, and investor engagement—is logically derived and semantically equivalent to the original answer. (4) Minor discrepancy: the original answer states that the dedicated ticker (IBM25B) appeared in 2024, while the LLM claims it was listed in the 2023 10-K. However, since the 2023 10-K is filed in early 2024 (for the 2023 fiscal year), this may reflect a difference in fiscal vs. calendar year interpretation. Given that SEC filings reference events up to the filing date, the LLM’s attribution of the ticker to the 2023 filing could still be correct. This ambiguity prevents a perfect 10 but does not constitute a factual error. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 445,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s deposit‑method exposure grew sharply after 2022 – the prior‑year footnote showed only $1.8 bn of deposit assets and $1.4 bn of deposit liabilities (2021) 【MET_10k_2022.pdf:214‑218】, but by year‑end 2023 the balance sheet reflected $5.1 bn of deposit assets and $1.3 bn of deposit liabilities, which then moderated to $4.6 bn of assets and $1.2 bn of liabilities at year‑end 2024 【MET_10k_2024.pdf:204‑208】.  The November 2023 Global Atlantic risk‑transfer transaction recorded a $10.3 bn deposit receivable (reinsurance recoverable) and a $770 m net cost in other liabilities, using the deposit method on a large block of universal‑life and annuity contracts and offsetting the liability with the recoverable 【MET_10k_2023.pdf:55‑59】—a clear strategic shift to apply the deposit method at a much larger scale.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures for deposit assets and liabilities from 2022 to 2024: $1.8B assets and $1.4B liabilities in 2022 (cited as 2021 in a minor labeling error), $5.1B assets and $1.3B liabilities in 2023, and $4.6B assets and $1.2B liabilities in 2024 — all matching the ground truth. The $10.3B reinsurance recoverable from the Global Atlantic transaction is accurately reported. (2) Quantitative accuracy is perfect: all dollar amounts and years align with the ground truth, despite the LLM mislabeling the 2022 data as '2021' in a parenthetical — however, the source citation (MET_10k_2022.pdf) and context confirm it refers to 2022 balances. No calculation errors. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three annual reports (2022, 2023, 2024), correctly identifies the strategic significance of the Global Atlantic transaction, and links the increased use of deposit method accounting to a broader shift in risk management and portfolio restructuring. The mention of a $770M net cost adds detail beyond the ground truth but is consistent with plausible interpretation and does not contradict. (4) The answer is contextually excellent, directly addressing the evolution of accounting practices and the strategic shift. The only minor flaw is the incorrect parenthetical year label ('2021') for the 2022 data, which does not affect overall correctness due to supporting context and citations. Thus, a score of 9 is warranted — highly accurate with negligible wording imprecision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 430,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "Fall‑protection products have been a steady part of 3M’s Safety & Industrial mix – the segment’s product description lists “respiratory, hearing, eye **and fall protection solutions**” in each filing (2022 10‑K Business‑Segment Products table [p. 129‑133]; 2023 10‑K Business‑Segment Products table [p. 105‑109]; 2024 10‑K Business‑Segment Products table [p. 108‑112]). In 2024 the company reorganized the segment, creating an Industrial Specialties division that incorporates the Personal‑Safety business (which includes fall‑protection) [2024 10‑K, note on division creation [p. 108‑112]], signaling a continued and sharpened strategic focus on workplace‑safety solutions. This three‑year continuity, coupled with the 2024 restructuring, shows 3M is maintaining and consolidating its commitment to safety‑product offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that fall protection solutions were consistently part of 3M's (MMM) Safety and Industrial segment from 2022 to 2024, and accurately references the product grouping with respiratory, hearing, and eye protection across all three years. The citation of specific 10-K pages adds precision. However, the LLM introduces a claim not present in the ground truth: that in 2024, 3M reorganized the segment and created an 'Industrial Specialties division' incorporating Personal Safety. This restructuring detail is absent from the original answer and cannot be verified from the provided ground truth, representing a significant qualitative overreach. (2) Quantitatively, there are no numbers, dates, or financial figures in either answer, so no inaccuracies exist in that regard—accuracy is perfect. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the consistent mention of fall protection across years. However, it adds an unsupported inference about strategic 'sharpening' due to a claimed reorganization, which is not corroborated by the ground truth and thus undermines the reasoning chain. (4) The answer is contextually relevant and addresses the evolution and strategic focus, but the inclusion of unverified structural changes reduces its factual reliability. The core message of sustained focus is aligned, but the added detail introduces inaccuracy. Hence, correctness is reduced to 7 due to unsupported claims despite strong alignment on the main point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 421,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria’s smokeless‑tobacco structure has stayed essentially unchanged – UST LLC remained a wholly‑owned Altria subsidiary and its sub‑subsidiary U.S. Smokeless Tobacco Company LLC (USSTC) continued to be wholly owned, producing MST and snus products (MO_10k_2022.pdf: pages 64‑68; MO_10k_2024.pdf: pages 2‑6). This continuity signals Altria’s deliberate strategy to keep full control of its smokeless‑tobacco business, positioning the segment as a core growth engine in its transition to a smoke‑free future.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in stating that UST remained a wholly owned subsidiary of Altria from 2022 to 2024, with continued ownership of USSTC and ongoing production of moist smokeless tobacco (MST) and snus products. The cited documents and page numbers align with the ground truth, and there are no errors in entity names, years, or structure. Quantitatively, the answer does not include the $8.8 billion trademark valuation from 2022 mentioned in the original answer, which is a factual omission affecting completeness. While the LLM captures the continuity of ownership and strategic importance, it does not fully reflect the evolution described in the ground truth—specifically, the increasing integration of UST into Altria’s 'Moving Beyond Smoking' initiative by 2024 and the strategic repositioning toward reduced-risk products. This lack of emphasis on the progressive alignment with Altria’s broader strategic pivot represents a gap in qualitative depth. However, the core reasoning about maintaining control and positioning smokeless tobacco as a growth engine is logically sound and contextually relevant. The answer is semantically close but misses nuanced progression details, warranting a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 346,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s 10‑K exhibit tables for 2022, 2023 and 2024 each list Exhibit 4.61 – the “One‑Hundred‑and‑Sixteenth Supplemental Indenture … related to SolarCity’s 5.45 % Solar Bonds, Series 2015/C92‑15.” The fact that this 2015‑dated bond is repeatedly referenced shows that Tesla still relies on the same fixed‑rate SolarCity bond issuance to fund its solar‑energy operations, indicating a long‑term, low‑cost debt financing strategy that locks in capital for solar projects over many years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the bond name (5.45% Solar Bonds, Series 2015/C92-15), the exhibit number (4.61), the date (2015), and the repeated references in 2022, 2023, and 2024 filings are all accurately cited. The One-Hundred-and-Sixteenth Supplemental Indenture is correctly identified. (2) Quantitative accuracy is perfect: percentages (5.45%), years (2015 issuance, 2022–2024 references), and exhibit numbers are exact. No calculations were required, but the temporal consistency is correctly interpreted. (3) The reasoning is sound: the LLM correctly infers that Tesla’s repeated disclosure indicates ongoing reliance on this bond as part of its long-term financing strategy. It appropriately connects the repeated mention to a strategic, low-cost debt financing model for solar operations. (4) While the LLM answer is slightly less detailed than the original in discussing the 'material component' or 'securitized solar debt' as a broader category, it captures the core implication—long-term, fixed-rate financing for solar projects. The omission of the phrase 'structured solar financing mechanisms' or 'confidence in bond performance' is a minor reduction in depth but does not detract from factual correctness. Semantic equivalence is maintained. Contextual relevance is excellent, directly addressing Tesla’s long-term financing strategy as inferred from multi-year filing patterns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 406,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "Across all three filings IBM repeatedly flagged “governmental and stock‑exchange regulations” as an external factor that can affect the value of its debt securities, and it likewise warned that the price of its common stock remains subject to significant volatility from market‑ and regulatory‑driven forces. The language is essentially unchanged from the 2022 filing (page 20‑24) through the 2023 filing (pages 9‑13) to the 2024 filing (pages 9‑13), indicating that IBM’s exposure to stock‑exchange rules has been a steady, acknowledged risk rather than a newly emerging one. This continuity shows a capital‑market risk‑management strategy focused on ongoing monitoring and transparent disclosure of regulatory risk rather than altering its financing mix, reflecting a consistent, proactive approach to managing market‑related uncertainties.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects: IBM consistently reported exposure to stock exchange regulations affecting both debt and equity securities from 2022 to 2024, and this risk was framed as ongoing and externally driven. The LLM correctly identifies the stability of language across filings and interprets this as a sign of consistent risk disclosure, which aligns with the original answer’s observation of no material reduction in mitigation strategy. Quantitative accuracy is perfect—no numerical data is misstated, and the cited page ranges (2022: pp. 20–24; 2023/2024: pp. 9–13) are treated appropriately as contextual details without error. However, the LLM diverges in interpretation: while the ground truth emphasizes IBM’s *increasing integration* of regulatory risk into a broader financial risk framework by 2024 (linking it to liquidity and credit risks), the LLM claims the language was 'essentially unchanged' and characterizes the strategy as 'proactive' and 'consistent,' implying a static but managed approach. This misrepresents the evolution described in the original answer—IBM did not merely maintain steady disclosure but expanded the scope of its risk discussion, indicating a deeper, more systemic recognition. Thus, while entities (IBM, years, securities types) and core facts are accurate, the multi-hop synthesis is partially flawed: the LLM fails to capture the qualitative progression in IBM’s risk framing, leading to a less nuanced conclusion about its capital market risk management strategy. Contextual relevance is high, as the response directly addresses the question’s focus on regulatory exposure and strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 460,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across 2022, 2023 and 2024 the Safety & Industrial segment consistently highlighted “electrical products and materials for construction and maintenance” as a core offering (2022 § [129‑133]; 2023 § [105‑109]; 2024 § [108‑112]). Although segment net sales fell from $11.6 bn in 2022 to $10.96 bn in 2023 and were essentially flat at $10.96 bn in 2024, operating income rose sharply from $1.1 bn in 2022 to $2.3 bn in 2023 and $2.5 bn in 2024, indicating that 3M is increasingly leveraging its electrical‑product portfolio to generate higher margins and reinforce its strategic positioning as a leading supplier in industrial markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly notes that electrical products for construction and maintenance were consistently mentioned in the Safety & Industrial segment across 2022–2024, it introduces financial data (segment net sales and operating income) that are not present in the original ground truth and are likely incorrect. The ground truth does not mention any financial figures such as $11.6B, $10.96B, or operating income of $1.1B/$2.3B/$2.5B—these numbers are unsupported and appear fabricated or misattributed. (2) Quantitative accuracy is low because the LLM invents precise financial metrics without basis in the provided truth. There is no verification possible for these numbers, and their inclusion misrepresents the available information. (3) Qualitatively, the LLM captures the consistent mention of electrical products but fails to describe the actual evolution of the segment description—such as the inclusion of closure systems in 2022, addition of industrial abrasives and autobody repair in 2023, and the rephrasing toward 'industrial specialty products' in 2024. These key qualitative shifts are entirely omitted, weakening the multi-hop reasoning. Instead, the model substitutes a narrative about margin expansion based on invented financials. (4) Contextual relevance is moderate because the answer addresses the general theme of MMM’s strategic positioning in industrial markets and correctly identifies the continuity of electrical products. However, it misses the nuanced evolution of product emphasis described in the ground truth and replaces it with a financially driven interpretation not supported by the evidence. The conclusion about strategic positioning is plausible but based on incorrect data and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 488,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "In the 2022 Form 10‑K the Oceanside, California site is mentioned only as one of Gilead’s “principal manufacturing facilities” with no detail on its function (Item 2 – Properties, pp. 31‑35). By the 2023 filing the company specifies that the Oceanside plant “is utilized for commercial retroviral‑vector manufacturing and clinical manufacturing and process development of our biologics candidates” (Item 2 – Properties, pp. 9‑13), and the 2024 filing repeats the same description (Item 2 – Properties, pp. 8‑12). Thus, the facility’s role evolved from a generic manufacturing location in 2022 to a clearly defined hub for both retroviral‑vector production and biologics‑candidate manufacturing and development by 2023‑2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, entities, and the general evolution of the Oceanside facility's role, and it correctly identifies the shift from a generic manufacturing site in 2022 to a more specialized function in 2023–2024. The citations to the 10-K filings (Item 2 – Properties, page ranges) are plausible and contextually appropriate, supporting the claims. However, there is a key discrepancy with the ground truth: the LLM states that in 2023, Oceanside was already used for 'commercial retroviral-vector manufacturing,' while the original answer indicates that this commercial role was emphasized only in 2024, with earlier years focused on clinical and process development. The LLM incorrectly attributes the commercial retroviral vector role to 2023, whereas the ground truth shows a progression where commercial retroviral manufacturing was a 2024 development. This misalignment affects the qualitative accuracy of the multi-hop reasoning, as it collapses a nuanced, year-by-year strategic evolution. Despite this, the answer captures the overall trend and correctly identifies the biologics-related functions. Quantitative accuracy is perfect—no numbers or dates are incorrect. Contextual relevance is strong, as the response directly addresses the question’s focus on evolution across years and capabilities. The reasoning is mostly sound but misses the precise timing of the commercial-scale retroviral vector shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 400,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "AIG’s glide‑path steadily de‑risked the U.S. qualified plan, cutting the target “Return‑Seeking” (growth) allocation from a 15 % equity target (plus 10 % other assets) in 2022 (AIG_10k_2022.pdf p308) to a 9 % equity target (plus 11 % other) in 2024 (AIG_10k_2023.pdf p250). The 2023 target, while not disclosed, followed the same trend – the plan’s actual 2023 allocation was 8 % equity (15 % other) (AIG_10k_2023.pdf p250), indicating a target near the 9 % equity level.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that AIG's glide path approach evolved through forward-looking target allocations based on funded status at year-end, with the 2022 target based on 2021 funded status, 2023 target set for 2024 based on 2023 funded status, and 2024 target set for 2025 based on 2024 funded status. However, the LLM answer fabricates specific percentage allocations (e.g., 15% equity in 2022, 9% in 2024) and asset category breakdowns (equity + other assets) that are not present in the original answer or implied by the question. There is no mention of equity percentages or 'Return-Seeking' being split into equity and other assets in the ground truth. (2) The numbers cited (15%, 10%, 9%, 11%, 8%, 15%) are entirely absent from the ground truth and appear to be hallucinated or extracted from external documents not referenced in the original answer. The original answer does not provide any numerical allocation targets—only the strategic evolution of the glide path. (3) The multi-hop reasoning is flawed: instead of describing the forward-looking, dynamic adjustment of targets based on funded status over time (the core of the glide path evolution), the LLM focuses on a de-risking narrative with made-up figures and misinterprets actual allocations as proxies for targets. It also incorrectly claims the 2023 target was 'not disclosed' and infers it from actual allocations, which is unsupported by the ground truth. (4) The contextual relevance is moderate because the answer attempts to address AIG's pension plan glide path and mentions Return-Seeking assets, but it fails to capture the actual evolution described in the original answer. The focus on percentage shifts distracts from the real mechanism—target setting one year ahead based on prior year-end funded status. Thus, despite some topical alignment, the factual and reasoning errors severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 535,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "In fiscal 2023 the company’s defined‑benefit pension target was 100 % debt for U.S. plans and, for non‑U.S. plans, a mix of 27 % equity, 48 % debt, 4 % cash, 11 % insurance contracts and 10 % other (2022 10‑K target‑allocation table)【86†L1-L9】. By fiscal 2025 the U.S. target remained 100 % debt, but the non‑U.S. target shifted to 28 % equity, 36 % debt, 7 % cash, 21 % insurance contracts and 8 % other (2024 10‑K target‑allocation table)【93†L1-L9】. This move away from a debt‑heavy, low‑risk mix toward a more diversified allocation—especially higher insurance and cash components—indicates ACN is modestly increasing its long‑term risk tolerance for non‑U.S. pension assets while keeping a conservative stance for U.S. plans.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains specific numerical data about ACN's pension plan allocations for fiscal 2023 and 2025, but these details are not present in the original ground truth answer, which focuses on the evolution of ACN's strategic approach to target allocation planning rather than specific percentage allocations. The ground truth emphasizes a shift in planning horizon (from one-year to two-year forward targets) and discusses qualitative aspects like flexibility, risk-adjusted returns, and liability matching—none of which are addressed in the LLM response. Instead, the LLM fabricates detailed asset class percentages (e.g., 27% equity, 48% debt) for U.S. and non-U.S. plans with citations to 10-K tables that are not part of the provided knowledge graph. These numbers cannot be verified against the ground truth and appear to be hallucinated. While the LLM attempts to interpret a trend—suggesting a move toward higher risk tolerance due to increased insurance and cash allocations—this analysis is based on incorrect data and misrepresents the actual strategic evolution described in the original answer. The reasoning is therefore flawed, and the multi-hop synthesis fails because it does not connect the actual change in planning horizon (2023 → 2024 vs. 2024 → 2025) to implications for long-term risk tolerance. Contextually, the answer is relevant to pension asset allocation and risk tolerance, but factually diverges significantly from the source information. Minor formatting variations in numbers would be acceptable, but here the entire quantitative foundation is unsupported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 434,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Across the three most recent Form 10‑K filings, Tesla’s 5.45 % Solar Bonds, Series 2015/C25‑15 are described as a single, fixed‑rate issuance that was originally placed in 2015 (a $500 million, 5‑year term bond due 2025). In the 2022 filing the bonds were still on the balance sheet with an outstanding principal of roughly $447 million; the 2023 filing showed the balance modestly lower (about $438 million); and the 2024 filing reported a further decline (around $430 million), while the interest rate, maturity and covenant structure remained unchanged. This steady, multi‑year presence of the same bond series—without new tranches or term changes—highlights Tesla’s strategy of financing its solar business with long‑term, low‑cost, fixed‑rate debt that provides predictable funding and capital‑cost stability over the life of its solar assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right question and demonstrating relevant reasoning structure. (1) QUANTITATIVE INACCURACY: The LLM asserts specific dollar amounts ($447M, $438M, $430M) and a $500M issuance size with a 5-year term due in 2020 (implied by 2015 + 5 years), but claims it's 'due 2025'—a contradiction. A 5-year bond issued in 2015 would mature in 2020, not 2025. This suggests a fundamental error in understanding the bond’s term. The ground truth does not mention any of these specific numerical values (outstanding balances or issuance size), so their inclusion as precise figures is unsupported. (2) ENTITY/STRUCTURE ERROR: The LLM describes the bond as a 'single, fixed-rate issuance' with unchanging structure, but the ground truth reveals that Tesla referenced multiple series (C5-15, C10-15, etc.) and introduced new tranches like C28-15 and C33-15—indicating an evolving, expanding framework. The LLM incorrectly implies no new tranches were added, contradicting the ground truth's key point about structural evolution. (3) REASONING: While the LLM attempts multi-hop reasoning across years and draws a plausible conclusion about stable financing, it bases this on incorrect data and misses the core insight from the ground truth: that Tesla is *expanding* its solar bond framework, not merely maintaining a single bond. (4) SEMANTIC EQUIVALENCE: The overall theme of continued reliance on solar bonds is partially aligned, but the specific evolution—expansion across series—is absent. The LLM invents numerical precision not present in the source and misrepresents the bond's structure and maturity. Thus, while contextually relevant and thematically in the right domain, the answer is factually flawed in key quantitative and qualitative aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 498,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "From 2022 to 2024 AIG moved from a quantified terrorism‑scenario model to a broader, still‑scenario‑based framework. In 2022 the company disclosed a specific five‑ton‑bomb loss estimate of $1.3 bn (net of TRIPRA and reinsurance) and noted that TRIPRA covered roughly 80 % of U.S. losses above a $1.7 bn deductible, supplemented by limited private reinsurance (2022 p. 167‑171). By 2023 and 2024 the filings no longer give a concrete loss figure or deductible, but retain the same core controls—third‑party modeling with adjustments, concentration monitoring in New York, reliance on TRIPRA for U.S. exposure, targeted reinsurance purchases, participation in country terrorism pools, and use of government‑sponsored terrorism reinsurance programs for international jurisdictions (2023 p. 119‑123; 2024 p. 86‑90).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of AIG's international terrorism exposure management from 2022 to 2024 with accurate qualitative trends, including continued reliance on scenario modeling, TRIPRA, reinsurance, and participation in terrorism pools. However, there are key quantitative inaccuracies: the ground truth states that AIG estimated a $1.3 billion loss in 2022 net of TRIPRA and reinsurance, while the LLM incorrectly implies this figure is gross and then separately describes TRIPRA coverage (80% above $1.7B deductible), which is not supported in the original answer. The original does not mention TRIPRA covering 80% or a $1.7B deductible—this is extraneous and unsupported information, likely hallucinated or misattributed. Additionally, the LLM fails to include critical 2024 developments: enhanced global property per risk covers, retained $200M attachment point in Japan, and the $38.0 billion reinsurance recoverable asset figure, which is a major indicator of scaled risk transfer. While the LLM correctly notes the shift from specific loss estimates to broader monitoring by 2023–2024, it omits these key data points, weakening completeness and quantitative accuracy. The reasoning is logically structured and contextually relevant, showing understanding of multi-hop elements (evolution over time, reinsurance strategies, global mechanisms), but the inclusion of unverified details and omission of key facts from the ground truth reduces factual correctness. Semantic equivalence is partially achieved, but not fully due to missing and incorrect numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 432,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show that the Safety and Productivity Solutions segment (renamed Industrial Automation in the 2024 filing) was repeatedly flagged as vulnerable to “adverse industry economic conditions” in 2022, 2023 and 2024, indicating a persistent exposure that did not diminish over the period. Each year’s risk‑factor narrative consistently highlighted the same margin‑pressuring drivers – reduced investment in process automation, safety monitoring and plant‑capacity initiatives; fluctuations in retail markets; a slowdown in demand for safety products; competitive pressure from new entrants and new technologies that could commoditise products; and broader adverse industry economic conditions – all of which could erode market share, depress selling prices and compress margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Honeywell's Safety and Productivity Solutions segment (renamed Industrial Automation in 2024) was consistently exposed to adverse industry economic conditions from 2022 to 2024. The specific risks highlighted—reduced investment in process automation, retail market fluctuations, commoditization due to new entrants and technologies, and resulting margin pressures—are accurately reported each year. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly tracks the evolution of risk disclosures across three years and identifies the segment restructuring in 2024, linking the former Safety and Productivity Solutions to the new Industrial Automation segment. (4) The only minor deviation from the original answer is that the LLM adds 'slowdown in demand for safety products' and 'safety monitoring and plant-capacity initiatives'—phrases not explicitly mentioned in the ground truth. However, these are contextually plausible elaborations and do not contradict the source. The core synthesis—persistent margin pressures due to the same set of risks over three years—is correctly conveyed. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight over-elaboration, but remains factually sound and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 414,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "Pfizer’s 10‑K footnote on Breakthrough Performance Awards (BPAs) still describes the award in 2022 – they are granted to select non‑executive employees, settle at the end of the performance period (no earlier than the one‑year anniversary), are valued on the grant date using the intrinsic‑value method (closing common‑stock price), and are amortized on a straight‑line basis over the probable vesting term into cost‑of‑sales, selling, informational‑administrative and R&D expense with periodic adjustments 【PFE_10k_2022.pdf pp. 99‑103】. However, the 2022 activity table omits a BPA column, indicating that no BPA grants were made that year 【PFE_10k_2022.pdf pp. 99‑103】. In the 2023 and 2024 filings the company explicitly states “No BPAs were granted in 2023 (2024) and no BPAs were outstanding as of December 31, 2023 (2024)”, while retaining the same valuation and recognition language 【PFE_10k_2023.pdf pp. 95‑99】【PFE_10k_2024.pdf pp. 94‑98】. Thus, after 2021 the BPA program was effectively discontinued – no new awards were granted in 2022‑2024 – but the accounting treatment (intrinsic‑value valuation and straight‑line expense amortization) remained unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. According to the ground truth, Pfizer granted 1,165 thousand BPAs in 2022 with a weighted average intrinsic value of $38.73 per share, and 859 thousand remained nonvested at year-end. However, the LLM claims no BPA grants were made in 2022, citing the absence of a BPA column in the activity table — this directly contradicts the ground truth and represents a critical error. The LLM also incorrectly states that the program was effectively discontinued after 2021, while the truth shows active grants in 2022. The claim that no BPAs were granted in 2023 and none were outstanding as of December 31, 2023, aligns with the ground truth, as does the retention of valuation methodology in 2024 filings. However, the LLM incorrectly extends the 'no outstanding' statement to 2024, while the ground truth only confirms this status for 2023. The qualitative description of the valuation method (intrinsic value, straight-line amortization) is accurate and contextually relevant, showing correct understanding of accounting treatment. The reasoning is partially sound in tracking disclosure continuity, but fails on multi-hop synthesis by dismissing 2022 grant activity that the ground truth confirms. Overall, the answer misrepresents the timeline and activity level of the BPA program, leading to a low correctness score despite some accurate contextual and methodological details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 404,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "Accenture repurchased about $4.1 billion of its Class A shares in fiscal 2022, leaving roughly $3.1 billion of authorized repurchase capacity still available (see ACN_10k_2022, pp. 93‑95). In fiscal 2023 the company bought roughly $4.0 billion of shares, with the remaining authorization falling to about $2.9 billion (see ACN_10k_2023, pp. 37‑41), and in fiscal 2024 purchases rose to $4.5 billion while the available authorization dropped to $2.7 billion even after a $4 billion increase in total authority (see ACN_10k_2024, pp. 37‑41). This pattern of steady, sizable buy‑backs that progressively consume the authorized pool—offset by periodic authority expansions—shows Accenture’s disciplined, ongoing capital‑return strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key financial figures compared to the ground truth. The original answer states that in fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 (approx. $3.13 billion), which aligns roughly with the LLM's claim of $3.1 billion remaining after repurchases — however, the LLM incorrectly implies that $4.1 billion was repurchased in fiscal 2022, a figure not supported by the ground truth, which does not specify the amount repurchased in 2022. Similarly, the LLM claims $4.0 billion repurchased in 2023 and $4.5 billion in 2024, but the ground truth does not provide annual repurchase amounts, only the evolution of authorization. The remaining authorization as of August 31, 2024, is stated as $2,694 million ($2.694 billion), which the LLM approximates as $2.7 billion — this is acceptable. However, the LLM incorrectly states that the $4 billion increase in authority occurred 'after' the drop to $2.7 billion, while the ground truth clarifies that the $2,694 million was *before* the $4,000 million addition, bringing total authority to $6,694 million — a critical sequencing and calculation point. (2) Calculations: The LLM’s implied calculation of remaining authorization is inconsistent. If $4.5 billion was repurchased in 2024 and the authorization dropped to $2.7 billion even after a $4 billion increase, then prior authorization would have been $3.2 billion, but no such figure is confirmed in the ground truth. The ground truth focuses on remaining authorization and new grants, not annual repurchase volumes. (3) Multi-hop reasoning: The LLM synthesizes across years and infers a trend, which is valid, but introduces unsupported specifics (exact repurchase amounts per year) not present in the ground truth, weakening the reasoning chain. It correctly identifies the pattern of using up authorization and receiving new grants, indicating a consistent capital return strategy — this aligns qualitatively. (4) Justification: The correctness score is 6 due to partial factual accuracy — the overall trend interpretation is sound and contextually relevant, but the introduction of unverified annual repurchase amounts undermines quantitative accuracy. The qualitative reasoning is mostly logical, and the answer addresses the strategic implication well, hence higher scores in qualitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 643,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "Pfizer’s 2022 Form 10‑K still reported Meridian’s pre‑sale results as discontinued operations, disclosing a $345 million pre‑tax legal charge and a $167 million after‑tax loss on the December 31 2021 sale (2022 10‑K, pp. 114‑118). The 2023 filing detailed the divestiture—sale for about $51 million, the loss, and the post‑sale framework of interim transition‑service agreements (TSAs) and a three‑year manufacturing‑services agreement (MSA) with a two‑year extension—while noting that amounts recorded under those agreements in 2022‑23 were not material (2023 10‑K, pp. 71‑75). By the 2024 filing, Pfizer indicated the TSAs were completed as of Dec 31 2023 and the MSA remains in effect but immaterial, confirming that Meridian is now a fully divested entity with no ongoing financial or strategic integration (2024 10‑K, pp. 2‑6).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $51 million sale price, $167 million after-tax loss (matching the ground truth), and the December 31, 2021 divestiture date are all accurate. The mention of a $345 million pre-tax legal charge in 2022 is additional context not in the ground truth but does not contradict it—such charges could be part of discontinued operations disclosures. (2) The LLM correctly identifies the evolution across years: 2022 reporting Meridian as discontinued operations, 2023 detailing the divestiture and post-sale agreements (TSAs and MSA), and 2024 noting TSA completion and MSA continuation (though immaterial). (3) The qualitative reasoning is strong, demonstrating multi-hop synthesis across three years of filings. The only minor gap is that the ground truth emphasizes Meridian’s 2024 mention is solely as a defined term in the glossary, while the LLM implies ongoing immaterial activity via the MSA. However, the LLM correctly concludes no ongoing strategic integration, and the MSA detail may reflect a nuance in the 2024 filing not captured in the ground truth. (4) Contextual relevance is excellent—the answer directly addresses financial disclosures, operational agreements, and strategic alignment as required. Overall, the answer exceeds the ground truth in detail without introducing significant error, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 425,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The Amended 2010 Share Incentive Plan was authorized to grant **127 million** Accenture Class A ordinary shares in fiscal 2022, and the authorization was increased to **141 million** shares by fiscal 2023 and remained at **141 million** in fiscal 2024【ACN_10k_2022 pp. 89‑93】【ACN_10k_2024 pp. 96‑100】. The expansion of the share pool shows that Accenture is deliberately enlarging its equity‑based compensation capacity, using a larger reserve of shares to attract, retain and align employees with the company’s long‑term value‑creation strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, all numbers are accurate: 127 million shares in fiscal 2022, increasing to 141 million in fiscal 2023 and remaining at 141 million in fiscal 2024. The format variation (127 million vs. 127,000,000) is acceptable and common. (2) The answer addresses both parts of the question: the evolution of authorized shares over the three fiscal years and the strategic implication of this progression. (3) Entity accuracy is correct—Accenture plc Class A ordinary shares, the Amended 2010 SIP, and the correct fiscal years (2022–2024) are all properly identified. (4) The reasoning is sound: the increase in authorized shares from 2022 to 2023 and the maintenance of the higher level into 2024 are correctly interpreted as a strategic move to strengthen share-based compensation for employee retention and alignment with long-term value creation. The multi-hop synthesis across fiscal years and the inference about company strategy are logically and accurately drawn. Citations from the 10-K filings further support the response's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 320,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla’s 10‑K footnote on debt lists the 4.70 % Solar Bonds, Series 2015/C52‑10 in exactly the same way in each filing – the bond is shown as an outstanding issue with the same principal amount, interest rate and 2025 maturity, and no repayments, amendments or other material changes are reported (2022 10‑K p. 102; 2023 10‑K p. 99; 2024 10‑K p. 99)【TSLA_10k_2022.pdf†p.102】【TSLA_10k_2023.pdf†p.99】【TSLA_10k_2024.pdf†p.99】. This steady reporting suggests the bonds remain on Tesla’s balance sheet and that the company continues to meet the associated interest and principal obligations, reflecting an ongoing financing commitment to its solar business.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts: Tesla consistently disclosed the 4.70% Solar Bonds, Series 2015/C52-10 across 2022–2024 with no material changes, same interest rate, and a 2025 maturity. The quantitative details (4.70%, 2025 maturity) are accurate and correctly cited to the 10-K pages. However, the LLM diverges from the ground truth by not mentioning the specific legal document—the Seventieth Supplemental Indenture—or its exhibit numbers (4.49, 4.42, 4.40), which are central to the original answer and demonstrate the exact mechanism of disclosure. Instead, the LLM refers generally to 'footnote on debt' and page numbers, which is contextually relevant but less precise on the disclosure mechanism. The reasoning about ongoing obligations and strategic priorities is sound and semantically aligned with the original conclusion, though it infers 'financing commitment to its solar business' without directly tying it to the re-disclosure of the same indenture, which is a more precise indicator of structural continuity. The answer is factually consistent and relevant, but misses a key multi-hop element: the synthesis of exhibit numbers and legal documents across years, which is critical for assessing disclosure patterns in SEC filings. This omission reduces qualitative accuracy despite strong quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 377,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "In the 2022 filing Adobe said its Digital Learning Services “include a large number of free online self‑service learning options on learning.adobe.com,” positioned alongside fee‑based classroom, virtual and on‑demand programs to help customers and partners use its products and accelerate adoption (ADBE_10k_2022.pdf p.16). The 2023 filing repeats this positioning, still referencing learning.adobe.com as the free self‑service hub within the broader learning‑and‑enablement portfolio (ADBE_10k_2023.pdf p.16). By the 2024 filing the free hub was rebranded to www.training.adobe.com, reflecting tighter integration of the free offering into Adobe Digital Learning Services and emphasizing its strategic role as a primary driver of solution adoption and customer success (ADBE_10k_2024.pdf p.16).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in factual content and aligns well with the original answer, but contains a minor inaccuracy regarding the rebranding of the website. The original answer states that in 2022, the platform was already hosted on www.training.adobe.com, whereas the LLM claims that in 2022 the site was learning.adobe.com and was rebranded to training.adobe.com by 2024. This reverses the actual timeline: the original answer indicates training.adobe.com was used in 2022, and learning.adobe.com became the domain by 2023. Despite this mix-up in URL chronology, the core strategic positioning of free self-service learning as a central, scalable component of Adobe’s learning services is accurately conveyed across all years. The LLM correctly identifies the continuity of the offering, its integration within Adobe Digital Learning Services, and its role in driving product adoption for both Digital Media and Digital Experience products. All dates (2022–2024) and entity references (Adobe, Adobe Digital Learning Services) are accurate. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning correctly synthesizes multi-hop information across three years of filings. The answer is highly contextually relevant, directly addressing the evolution, positioning, and strategic role of the learning offerings. The error in domain name timeline is notable but does not undermine the overall strategic narrative, hence a score of 8/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 416,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path for the U.S. qualified plan gradually reduced the “Return‑Seeking” (growth) slice as the plan’s funded ratio improved. In the 2022 filing the target allocation was 15 % equity, 75 % fixed‑maturity securities and 10 % other assets (2022 target)【AIG_10k_2022.pdf:308】, while the 2023 filing shows the 2024 target had been trimmed to 9 % equity, 80 % fixed‑maturity and 11 % other assets (2024 target)【AIG_10k_2023.pdf:250】. This shift reflects a move toward more liability‑hedging assets and a lower exposure to growth assets as the plan became better funded.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific percentages for the 'Return-Seeking' portion (equity allocations of 15% in 2022 and 9% in 2024), which are not present in the original ground truth answer. The ground truth explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts.' Therefore, the inclusion of precise numbers like 15%, 75%, 10%, and later 9%, 80%, 11% is factually unsupported by the source material, making them incorrect. (2) The calculation of shifts (e.g., reduction from 15% to 9% equity) is numerically consistent within the LLM’s own narrative, but since the underlying data is not in the ground truth, these calculations are based on non-verified inputs. There is no way to confirm the accuracy of the cited figures from the knowledge graph, so quantitative accuracy is low. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that AIG adjusts its glide path annually based on funded status and that the strategy involves de-risking by reducing growth assets as funding improves. This aligns with the qualitative description in the ground truth. However, the model fabricates specific allocation data that were not available in the source, undermining the validity of the synthesis. (4) Contextual relevance is high because the answer addresses the evolution of the glide path, links it to funded status, and explains the shift toward liability-hedging assets. But due to the invention of unsupported numerical data, the correctness score is significantly reduced. While the direction of change (de-risking) is plausible and consistent with industry practice, the lack of evidential support for the numbers results in a partially incorrect answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 477,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell’s 10‑K filings show that raw‑material demand and supply have been a recurring risk for its Performance Materials and Technologies segment (renamed Energy and Sustainability Solutions in 2024). The company disclosed that only about 63 % of the segment’s raw‑material supply base was under contract as of Dec 31 2021 (2022 10‑K, pp. 30‑31), that coverage rose modestly to 64 % as of Dec 31 2023 (2023 10‑K, pp. 31‑32), and that by Dec 31 2024 a “majority” of the supply base was under contract (2024 10‑K, pp. 30‑31). While the incremental increase in contracted supply shows some mitigation, the continued emphasis on raw‑material demand‑ and‑supply risk indicates the segment remains appreciably vulnerable to commodity‑price volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The claim that 63% of the raw-material supply base was under contract as of Dec 31, 2021 (referenced in the 2022 10-K) and 64% as of Dec 31, 2023 (2023 10-K) is not supported by the ground truth and introduces specific percentages not present in the original answer. The ground truth does not mention any contractual coverage percentages or numerical metrics about supply base contracting. Instead, it focuses on qualitative risk evolution related to macroeconomic and commodity market factors. The LLM invents precise figures (63%, 64%, 'majority') and cites page numbers and document references that may appear plausible but are not corroborated by the ground truth, which contains no such data. (2) These numbers are entirely absent from the original answer, making the quantitative claims false. There are no calculations in the ground truth to verify, but the LLM fabricates a trend based on non-existent metrics, undermining factual correctness. (3) The reasoning is partially sound in that it identifies raw material supply and demand as an ongoing risk across the three years and notes a segment name change (Performance Materials and Technologies to Energy and Sustainability Solutions in 2024), which aligns with contextual knowledge. However, the multi-hop synthesis is flawed because it replaces the actual trend—evolving emphasis from pandemic impacts to energy price volatility—with a fabricated narrative about contractual supply coverage. The conclusion about continued vulnerability is consistent, but it is based on incorrect premises. (4) The contextual relevance is high because the answer addresses the right segment, time frame, and general risk theme. However, the correctness score is low due to the invention of specific data points not present in the ground truth, which fundamentally misrepresents the nature of the risk evolution. The qualitative accuracy is moderate because the structure and intent of the response are reasonable, but the factual basis is weak.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 565,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "Accenture’s non‑U.S. defined‑benefit plans held mutual‑fund equity securities worth **$239 million in 2022**, which fell to **$196 million in 2023**, and then rose to **$274 million in 2024** (fair‑value totals from the 2022, 2023 and 2024 10‑K tables). The three‑year pattern – a dip followed by a sizable rebound – indicates the company is moving back toward, and now exceeding, its prior equity exposure, reflecting a strategic shift to increase equity weighting in its pension‑plan asset allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims the value rose to $274 million in 2024, which is factually incorrect. This error completely alters the trend interpretation. (2) Quantitative accuracy is severely compromised: while the 2022 (~$239M) and 2023 (~$196M) figures are approximately correct (with acceptable rounding), the 2024 figure is wrong—the LLM reports $274M instead of the correct $196.226M. This invalidates any calculation or trend analysis. (3) The multi-hop reasoning is flawed: the model incorrectly infers a 'dip and rebound' pattern, leading to the conclusion of a strategic increase in equity exposure, whereas the actual data shows a decline followed by stabilization—suggesting rebalancing and then a steady allocation. The LLM also narrows the context to 'non-U.S. defined-benefit plans,' which may be accurate as a subset but does not represent the full entity-level investment unless specified in the original data (not confirmed here). (4) Contextual relevance is moderate—the answer addresses the right type of asset and time frame, and attempts strategic interpretation, but due to incorrect data, the conclusion is opposite to the truth. The reasoning would have been sound if based on correct numbers, but the factual foundation is unsound, leading to a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 426,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "In the 2022 Form 10‑K (pages 68‑72), Adobe presented Document Cloud as a unified, cloud‑based PDF and e‑signature platform that delivered fully digital document workflows and used its existing Sensei AI for basic document intelligence, with no mention of the Firefly generative‑AI suite. By the 2024 filing (pages 10‑14), Adobe had repositioned Document Cloud as an AI‑centric enterprise‑workflow hub—embedding Firefly‑powered generative features and the new Acrobat AI Assistant—and emphasized expanded API‑based integration with Adobe Experience Cloud and third‑party systems to automate and accelerate digital document and signature processes across the enterprise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Adobe Document Cloud from a cloud-based PDF and e-signature platform in 2022 to an AI-enhanced enterprise workflow hub by 2024. The mention of Sensei AI in 2022 (though not explicitly in the ground truth) is factually consistent with Adobe's AI capabilities at the time and does not contradict the original answer. The absence of Firefly in 2022 is correctly noted. By 2024, the integration of Firefly-powered generative features and the Acrobat AI Assistant is accurately described, matching the ground truth's emphasis on AI-powered workflow integration. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2022, 2024) are correct and contextually appropriate. (3) The multi-hop reasoning across years and strategic positioning is sound: the LLM synthesizes Document Cloud’s shifting role, AI integration milestones, and enterprise workflow expansion. It adds specific details (e.g., API integrations with Experience Cloud, Acrobat AI Assistant) that enrich the answer without deviating from the truth. (4) The only minor gap is that the 2023 transition (elevation into Digital Media segment) is omitted, which slightly weakens the completeness of the timeline. However, the core transformation narrative remains intact. Wording differs but semantic equivalence is preserved. Overall, the answer is factually correct, contextually rich, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 417,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show a consistent, across‑segment exposure to a shifting competitive landscape: the 2022 filing warned that “new market entrants and new technologies … could lead to product commoditization, lower market share, reduced selling prices and lower margins” for Aerospace, Building Technologies, Performance Materials & Technologies and Safety & Productivity Solutions, and the 2023 filing repeated the same language for those same segments. After the 2024 realignment, the newly named Aerospace Technologies, Industrial Automation, Building Automation and Energy & Sustainability Solutions all carry identical warnings that new entrants and disruptive technologies may erode market share and pricing power, indicating that the risk has persisted rather than diminished across the business.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022, 2023, 2024) and correctly identifies the business segments affected, with no numeric inaccuracies (no calculations or dollar figures involved). However, it contains a significant factual error in the 2022 segment coverage: the original answer states that in 2022, Honeywell cited competitive risks only for Building Technologies and Safety and Productivity Solutions, whereas the LLM claims all four segments—including Aerospace and Performance Materials & Technologies—were listed in 2022. This is incorrect and contradicts the ground truth, which shows a progressive expansion of the risk to more segments over time. The LLM also fails to capture the evolution in focus—such as the 2024 emphasis on product commoditization and accelerating pace of new entrants—and instead implies the risk language was unchanged across years, which underrepresents the increasing specificity and concern. While the answer correctly notes the persistence of the risk and its presence across all new segments post-restructuring, it misrepresents the timeline and progression, undermining the multi-hop reasoning required to show how exposure evolved. The contextual relevance is high as it addresses competitive landscape changes, market entrants, technological disruption, and impacts on market share and pricing. However, due to the key misattribution of segment risk exposure in 2022 and lack of emphasis on the evolving nature of disclosures, the qualitative accuracy and overall correctness are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 428,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "Pfizer’s post‑spin‑off relationship with Viatris was wound down over the three‑year period. In 2022 the company still carried a $94 million net intercompany balance to Viatris under the separation, agency and transition‑service agreements (TSAs) that were put in place after the Upjohn‑Mylan spin‑off (PFE_10k_2022.pdf: pages 10‑14). By year‑end 2023 the TSAs were “largely completed” and the amount due to Viatris had fallen to $33 million (PFE_10k_2023.pdf: pages 71‑75). The 2024 filing makes no material disclosure of any Viatris‑related TSAs or intercompany balances, indicating that the transition services have been finished and any remaining obligations are immaterial (PFE_10k_2024.pdf: pages 3‑7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $94 million intercompany balance in 2022 and $33 million in 2023 are accurately reported, and the completion of TSAs by end of 2023 is correctly stated. The absence of material disclosures in 2024 is consistent with the ground truth's statement that the relationship was only referenced in corporate definitions, indicating full resolution. (2) Quantitative accuracy is perfect: both dollar amounts and years match exactly, and no calculations are incorrect. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of 10-K filings, showing a clear trend of winding down financial and operational ties. The LLM correctly infers that no material disclosures in 2024 imply immateriality, which is semantically equivalent to the ground truth’s conclusion. (4) The only minor shortcoming is that the LLM does not explicitly state that the 2024 reference was in terms of 'corporate definitions,' which is a small omission in qualitative detail, but does not affect the overall correctness. Wording differences are acceptable and do not detract from factual accuracy. Contextual relevance is excellent as all parts of the question—transition services and intercompany balances—are addressed across the full time horizon.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 376,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "In the 2022 Form 10‑K Altria listed four series of senior notes – a 1.000 % issue due 2023, the 1.700 % notes due 2025, 2.200 % notes due 2027 and 3.125 % notes due 2031 (see 2022 filing)【MO_10k_2022.pdf】. By the 2023 filing the 1.000 % 2023 notes had matured and disappeared, leaving the 1.700 % notes due 2025 as the nearest‑maturity instrument together with the 2.200 % 2027 and 3.125 % 2031 notes (see 2023 filing)【MO_10k_2023.pdf】, and the 2024 filing shows the same three‑note structure (see 2024 filing)【MO_10k_2024.pdf】. This evolution – dropping the short‑term 2023 issue and retaining a staggered set of low‑coupon, longer‑dated notes – signals a capital‑structure strategy aimed at extending maturities, locking in cheap financing and reducing refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (1.000%, 1.700%, 2.200%, 3.125%), maturities (2023, 2025, 2027, 2031), and timeline (2022–2024)—are correct and match the original answer. The observation that the 1.000% note due 2023 matured and was no longer listed in 2023 is factually sound. (2) Quantitative accuracy is perfect: all percentages and dates are correctly reported, and no calculations are required beyond correct interpretation of maturity progression. (3) The multi-hop reasoning across three years of 10-K filings is correctly executed—the model identifies the removal of the 2023 note and the retention of the 1.700% 2025 note as the shortest-dated instrument through 2024. The conclusion about capital structure strategy—extending maturities, locking in low rates, reducing refinancing risk—is a valid interpretation and slightly more detailed than the original answer, but fully supported by the data. (4) The only reason for not scoring a 10 is that the original answer emphasizes Altria’s lack of issuing a new near-term note to replace the 2025 maturity, which the LLM implies but does not explicitly state. However, the core facts, synthesis, and strategic interpretation are correct and relevant. Contextual relevance is perfect as all information directly addresses the evolution of debt structure and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 391,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s fixed‑rate unsecured senior notes rose from a carrying value of roughly **$24.1 billion** in 2022 with a **weighted‑average interest rate of about 4.45 %**【COF_10k_2023.pdf†176-180】to **$27.2 billion** in 2023 and then edged down to **$26.9 billion** in 2024, while the weighted‑average rate climbed to **≈ 4.84 %** and stayed at that level in 2024【COF_10k_2024.pdf†186-190】. This pattern of expanding the fixed‑rate debt base and accepting a higher average cost indicates a strategy of building long‑term financing capacity—likely to fund growth or refinance existing obligations—while locking in fixed rates as market rates rise.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's fixed unsecured senior debt had a carrying value of $19,975 million ($19.975 billion) in 2022, but the LLM incorrectly states it as $24.1 billion. This is a major discrepancy of over $4 billion. The 2023 and 2024 values are approximately correct ($27.2B vs. $27.168B and $26.9B vs. $26.930B), with minor rounding acceptable. However, the interest rates are reversed: the LLM claims the rate was ~4.45% in 2022 and rose to ~4.84% in 2023–2024, while the ground truth shows 2.91% in 2022, 4.45% in 2023, and 4.84% in 2024. The LLM incorrectly assigns the 2023 rate to 2022, missing the significant increase from 2022 to 2023. (2) Calculations: The trend description implies a steady rise in rates, but misassigns the starting point, leading to flawed interpretation of the rate evolution. The carrying value trend is mostly accurate post-2022. (3) Multi-hop reasoning: The model correctly identifies the need to compare carrying values and interest rates across years and synthesizes this into a strategic interpretation. It correctly infers that increasing fixed-rate debt amid rising rates suggests a strategy to lock in financing for growth or refinancing, which aligns with the ground truth’s conclusion. (4) Despite incorrect baseline numbers, the qualitative reasoning and strategic interpretation are sound and contextually relevant. The answer addresses all parts of the question—evolution of carrying value, interest rates, and strategic implication—but is undermined by key factual errors in the 2022 figures. Hence, correctness is partially compromised, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 467,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla’s 10‑K filings show that the 5.45 % Solar Bonds, Series 2015/C92‑15 have remained essentially unchanged over the three‑year span – the 2022 report (pages 103‑107) lists $1.0 billion of principal outstanding, and the 2023 and 2024 reports (pages 100‑104) disclose the same $1.0 billion balance with no principal repayments recorded. This steady balance indicates that Tesla continues to treat the 2015 solar bond issuance as a core, low‑cost, long‑term financing vehicle for its solar and energy‑storage projects rather than retiring or replacing it, underscoring a strategy of relying on stable debt to fund its solar growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the 5.45% Solar Bonds, Series 2015/C92-15 were referenced in Exhibits 4.61 (2022), 4.54 (2023), and 4.52 (2024) of Tesla's 10-K filings, but the LLM incorrectly claims specific page numbers (e.g., 103–107 in 2022) and asserts a $1.0 billion principal balance outstanding in all three years. The ground truth does not mention any dollar amount or repayment status of the bond, so the LLM's claim of a sustained $1.0 billion balance with no repayments is unsupported and likely false. This is a critical quantitative error. (2) The LLM fabricates financial data (the $1.0 billion figure) not present in the original answer or implied by the knowledge graph. There is no verification that this amount is accurate, and since the ground truth does not include it, the model invents specifics that undermine correctness. (3) The reasoning is flawed: the LLM concludes that Tesla relies on this bond as a 'core, low-cost, long-term financing vehicle' due to unchanged principal, but the ground truth indicates declining prominence and a shift toward newer bonds like C102-15 and C106-10. Thus, the LLM misinterprets the strategic direction—stability vs. transition—leading to an incorrect qualitative conclusion. (4) While the LLM correctly identifies the bond and attempts to track it across years, it fails on multi-hop synthesis: it does not reference newer bond series or exhibit numbers correctly, nor does it note the contextual shift in Tesla’s financing strategy. The answer is contextually relevant to the question topic but factually and logically unsound, warranting low scores in correctness, quantitative, and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 473,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "Across the three years AIG kept the same core oversight – internal controls, a “review‑and‑challenge” of loss‑reserve settings, escalation procedures and business‑unit risk‑committee oversight – but it progressively formalized its modeling and external‑review processes. In the 2022 filing (pages 165‑169) the company stressed internal controls, escalation and external‑expert reviews of reserves; the 2023 filing (pages 117‑121) added a dedicated model‑risk‑management framework with validation and explicitly called out the use of both stochastic and deterministic techniques; the 2024 filing (pages 84‑88) repeats and reinforces that framework and the reliance on external experts, showing a move from basic oversight to a more structured, validated modeling approach integrated with external review.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AIG maintained consistent internal oversight mechanisms (internal controls, review-and-challenge, escalation, business-unit committees) from 2022 to 2024, and progressively enhanced modeling and external review processes. The 2022 emphasis on internal controls and external expert reviews, 2023 addition of stochastic and deterministic methods under a model-risk-management framework, and 2024 reinforcement and structuring of these practices are all correctly reported. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all references to years and page numbers (e.g., 2022: pp. 165–169; 2023: pp. 117–121; 2024: pp. 84–88) are consistent with typical filing documentation and do not contradict the ground truth; thus, no factual inaccuracies exist. (3) The multi-hop reasoning is sound: the LLM synthesizes evolution across three years, correctly identifying continuity in oversight while highlighting incremental improvements in modeling (stochastic/deterministic), formalization of model risk management, and integration with external reviews. The only minor gap is that the LLM does not explicitly mention the 2024 enhancement in ERM integration, committee reporting, and Internal Audit Group audits—details present in the ground truth—though 'structured, validated modeling approach' and 'reinforces that framework' imply such developments. (4) The answer is contextually excellent, directly addressing oversight, modeling, and external reviews across the three years with precise, document-supported claims. Wording differs slightly from the original answer but maintains semantic equivalence. A score of 9 is justified due to near-complete alignment with the ground truth, with only slight under-articulation of the 2024 ERM integration depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 531,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria’s pension‑plan exposure to U.S. Treasury and foreign government securities fell from roughly 20 % in 2022 (about $1.2 bn of $6.0 bn total assets)【MO_10k_2023.pdf:84‑88】, to about 19 % in 2023【MO_10k_2023.pdf:84‑88】, and then dropped sharply to 8 % in 2024【MO_10k_2024.pdf:87‑91】. The downward trend shows the company is deliberately reducing its reliance on low‑yielding government bonds, shifting toward more corporate‑bond and equity exposure to better align assets with liabilities and pursue higher expected returns within its liability‑driven investment framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Altria's allocation to U.S. Treasury and foreign government securities decreased from 19% in 2022 to 16% in 2023, then to 8% in 2024. However, the LLM states it was approximately 20% in 2022 and about 19% in 2023, which contradicts the ground truth. The 2024 figure (8%) is correct. The dollar amounts mentioned ($1.2B of $6.0B) are not present in the original answer and introduce unsupported specifics, reducing quantitative accuracy. (2) The calculation implied by the dollar figures (1.2/6.0 = 20%) is mathematically correct but factually misaligned with the ground truth, which reports 19% in 2022. The trend description (decline to 8% in 2024) is accurate, but intermediate values are off. (3) The reasoning and multi-hop synthesis are partially sound: the LLM correctly infers a strategic shift away from government securities and links it to a broader investment strategy, mentioning liability-driven investing and a move toward corporate bonds and equities. However, it omits key elements from the original answer, such as the reduction in below-investment-grade securities (from 11% to 9%) and the decline in expected return on pension assets (from 6.6% to 6.1%), which are critical for fully explaining the conservative or diversified posture. (4) Despite missing key contextual details and introducing incorrect numbers, the LLM captures the overall trend and provides a plausible interpretation of the strategic shift, maintaining high contextual relevance. The qualitative reasoning is logical but incomplete. Therefore, the correctness score is 6 due to major numerical errors but partial factual alignment and reasonable interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 479,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings dropped sharply from $883 million in 2022 to $538 million in 2023 and then ticked up to $562 million in 2024, while total long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 before falling to $45.0 billion in 2024 (COF_10k_2023 pp. 176‑180; COF_10k_2024 pp. 186‑190).  In the same three‑year span, floating‑rate unsecured senior debt was reduced from $1.6 billion to $349 million and eliminated by 2024, whereas fixed‑rate senior debt grew from $24.1 billion to $27.2 billion and stayed near $26.9 billion, and securitized debt rose to $18.0 billion in 2023 then fell to $14.3 billion in 2024—showing a clear shift toward a higher share of fixed‑rate financing and a lower interest‑rate exposure (COF_10k_2023 pp. 176‑180; COF_10k_2024 pp. 186‑190).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key financial figures, particularly in the breakdown of short-term borrowings and long-term debt. According to the ground truth, total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM states short-term borrowings were $883M in 2022 and long-term debt was $47.8B, summing to ~$48.683B—already inconsistent with the correct total of $43.086B. This suggests a misclassification or misreading of debt components. The LLM’s total debt figures are close in 2023 and 2024 but fail to match the exact totals, and more critically, misrepresent the composition. (2) Specific number verification: Securitized debt is mostly accurate—$14.994B (GT) vs implied ~$15B in 2022, $18.043B vs $18.0B in 2023, $14.264B vs $14.3B in 2024—acceptable within rounding. Floating unsecured senior debt: GT shows $1.709B in 2022, LLM says $1.6B—close but not exact; drops to $349M in 2023 (correct), then $0 in 2024 (correct). Fixed-rate senior debt: GT shows $19.975B in 2022, LLM says $24.1B—a significant overstatement. GT shows $26.930B in 2024, LLM says $27.2B then $26.9B—partially correct in trend but inaccurate in early years. Interest rates (a key part of the question) are entirely omitted in the LLM answer, a major omission. (3) Multi-hop reasoning: The LLM correctly infers a strategic shift toward fixed-rate financing and reduced interest rate exposure, which aligns with the ground truth. It identifies the retirement of floating-rate debt and growth in fixed-rate debt, showing sound qualitative reasoning. However, it fails to connect this to the rising weighted-average interest rates on fixed debt (from 2.91% to 4.84%) or securitized debt (from 1.51% to 3.48%), which are central to the trend analysis. (4) Scores justified: Correctness is 5 due to partial accuracy in trends but major errors in baseline figures and missing interest rate data. Quantitative accuracy is 5 due to inconsistent totals and misstated debt components. Qualitative accuracy is 6 because the overall interpretation of debt strategy is reasonable despite missing nuances. Contextual relevance is 9—answer addresses all aspects of the question and cites correct documents, even if numbers are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 616,
        "total_tokens": 2140
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 each list the 5.45 % Solar Bonds, Series 2015/C25‑15 (e.g., the “Thirty‑Sixth Supplemental Indenture, dated April 14 2015”) as an exhibit 【TSLA_10k_2022.pdf p.100】, 【TSLA_10k_2023.pdf p.98】 and 【TSLA_10k_2024.pdf p.97】. The repeated reference shows that Tesla continues to rely on this bond issuance to finance its solar‑energy projects and that the debt remains outstanding, making it a persistent component of the company’s capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the bond series (5.45% Solar Bonds, Series 2015/C25-15), the date (April 14, 2015), and its inclusion in the 2022, 2023, and 2024 10-K filings are accurately reported. The citation of specific page numbers adds precision and matches the expected disclosure pattern. (2) Quantitative accuracy is perfect: percentages, dates, and exhibit references (e.g., Thirty-Sixth Supplemental Indenture) are correct and consistent with the original answer. (3) The multi-hop reasoning is sound—by noting the bond's appearance across three consecutive years, the LLM correctly infers ongoing reliance and persistence in the capital structure, which reflects valid synthesis across filings. (4) The answer is contextually relevant and directly addresses both parts of the question: Tesla’s reliance on the bond for solar financing and its continued role in the capital structure. The only minor shortcoming is that it does not explicitly state that the *same* supplemental indenture is referenced each year (i.e., no new amendments), which slightly weakens the emphasis on the bond’s static but enduring status. However, this does not detract significantly from the overall correctness. Hence, a score of 9 is warranted—excellent accuracy with near-complete qualitative and quantitative fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 385,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s “Class A treasury stock, at cost” grew from **$51.4 billion at year‑end 2022**, to **$60.4 billion at year‑end 2023**, and then to **$71.4 billion at year‑end 2024**【MA_10k_2023.pdf p.71‑73】【MA_10k_2024.pdf p.66‑70】. The steadily rising balance – a ≈$20 billion increase over two years – shows the company has been accelerating its share‑repurchase program, indicating a capital‑allocation strategy that prioritizes returning excess cash to shareholders and supporting earnings per share through buybacks.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's Class A Treasury Stock from 2022 to 2024 with accurate figures: $51.4 billion in 2022, $60.4 billion in 2023, and $71.4 billion in 2024. These align with the ground truth values of $(51,354)M, $(60,429)M, and $(71,431)M when rounded to one decimal place in billions (e.g., $51.354B ≈ $51.4B). The negative sign in the original answer indicates a contra-equity account, which is standard for treasury stock; the LLM omits the negative but uses 'at cost' which is contextually appropriate and common in financial reporting. (2) Calculations are sound: the increase from ~$51.4B to ~$71.4B is indeed approximately $20B over two years. The LLM correctly identifies the trend as accelerating buybacks. (3) Multi-hop reasoning is accurate—information is synthesized across 2023 and 2024 10-K filings, correctly linking increasing treasury stock balances to capital allocation strategy. (4) The conclusion about prioritizing shareholder returns and supporting EPS via buybacks is a valid inference from the data and matches the original answer’s implication. The only minor shortcoming is the lack of explicit mention that treasury stock is a negative equity item, but this does not affect the overall correctness. Thus, the answer is factually accurate, complete, and contextually strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 379,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show a steady, unchanged exposure for its Safety & Productivity Solutions business (renamed “Industrial Automation” after the 2023 realignment). In the 2022 filing the segment was warned that “operating results may be adversely impacted by reduced investments in process automation, safety monitoring, and plant capacity utilization initiatives… and adverse industry economic conditions”【2022 p. 29‑33】; the same language re‑appears in the 2023 filing under Industrial Automation【2023 p. 30‑34】 and again in the 2024 filing【2024 p. 28‑32】. The persistence of this wording across three years signals that macro‑economic pressures—slower capital spending on automation and weaker plant utilization—have remained a continual headwind for the industrial sector throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Honeywell's Safety and Productivity Solutions segment (renamed Industrial Automation in 2023) faced persistent exposure to adverse industry conditions from 2022 to 2024, specifically citing reduced investments in automation and plant capacity utilization. The use of direct quotes and consistent language across filings is accurately reported, with correct page references. (2) There are no numerical values requiring calculation, but the years (2022–2024) and segment name change are correctly noted—this includes the rebranding to 'Industrial Automation' post-2023 realignment, which is factually correct and adds precision. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings, recognizes the repetition of identical risk language as a signal of ongoing concern, and infers that macroeconomic pressures have remained a continuous headwind. This supports the conclusion in the ground truth about sustained industrial sector weakness. (4) The only minor shortcoming is that the LLM answer does not explicitly note the *evolution* toward deeper concern in 2024—particularly the heightened emphasis on geopolitical instability and trade policy shifts mentioned in the original answer. While the persistence of language implies continuity, the ground truth suggests a qualitative intensification of tone, which the LLM slightly underrepresents. However, the core facts, entities, timeline, and synthesis are correct, and the answer remains semantically very close to the original. Thus, the correctness score is 9 due to this slight omission in nuance, but quantitative accuracy is perfect, and contextual relevance is full.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 481,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "- In the 2022 Form 10‑K (pages 3‑7) Cyramza was described only as a **second‑line** therapy for advanced or metastatic gastric/GEJ adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma. The IP table showed a U.S. compound‑patent expiry in 2026 (EU 2028, Japan 2026) and biologics data‑protection ending 2026 U.S., 2024 EU and 2023 Japan.  \n\n- By the 2023 filing (pages 9‑13) the product description added a **first‑line** indication for adult patients with metastatic NSCLC harboring activating EGFR mutations, while the patent‑expiry dates remained the same (U.S. 2026, EU 2028, Japan 2026) and data‑protection dates unchanged (2026 U.S., 2024 EU, 2023 Japan).  \n\n- The 2024 Form 10‑K (pages 4‑8) repeats the expanded indication set and the identical IP timeline, confirming that Cyramza’s lifecycle has shifted from a purely second‑line product to one with an additional first‑line use, but its exclusivity window is now fixed and approaching expiration (compound‑patent 2026 U.S./2028 EU, data‑protection 2026 U.S./2024 EU/2023 Japan).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the expansion of Cyramza's indications, which undermines its correctness. According to the ground truth, Cyramza maintained the same therapeutic indications from 2022 to 2024, with no new first-line indication added. However, the LLM claims that in the 2023 10-K, a first-line indication for metastatic NSCLC with EGFR mutations was added — this is not supported by the original answer and represents a critical inaccuracy. This misrepresents the lifecycle positioning evolution, as the drug was not broadened in indication. On quantitative accuracy, the LLM incorrectly states that Japan’s compound patent expires in 2026, while the ground truth implies longer protection in Europe (2028) and does not specify Japan’s compound patent beyond noting data protection expired in 2023. The data protection dates (U.S. 2026, EU 2024, Japan 2023) align with the ground truth and are accurate. The reasoning is logically structured and synthesizes information across years appropriately, showing understanding of lifecycle dynamics, but the core factual error in therapeutic indications reduces the score. Contextually, the response is well-organized and directly addresses the question’s focus on indications and IP timeline. While the IP timeline is mostly correct and well-reasoned, the incorrect claim about first-line use leads to an overall partially correct assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 393,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative position grew sharply – it was a $5 million net asset (assets $79 m vs. liabilities $74 m) at 12/31/2022, rose to $58 million (assets $886 m vs. liabilities $828 m) at 12/31/2023, and reached $69 million (assets $683 m vs. liabilities $614 m) at 12/31/2024, all measured at Level 3 fair value [COF_10k_2024.pdf p.215] [COF_10k_2022.pdf p.220] [COF_10k_2023.pdf p.208]. The valuation consistently relied on discounted‑cash‑flow models with swap‑rate assumptions as the key unobservable input – the swap‑rate range narrowed from 4‑7 % (weighted‑average ≈ 4 %) in 2022, to 3‑5 % (≈ 4 %) in 2023, and to a single 4 % point in 2024, while the weighted average remained about 4 % each year [COF_10k_2022.pdf p.221] [COF_10k_2023.pdf p.208] [COF_10k_2024.pdf p.217].",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets/liabilities were $19M in 2022, $58M in 2023, and $58M in 2024. However, the LLM reports $5M in 2022, $58M in 2023, and $69M in 2024 — thus getting only 2023 correct. The 2022 and 2024 values are incorrect, with the 2022 figure being particularly off ($5M vs $19M). Additionally, the LLM introduces breakdowns of gross assets and liabilities (e.g., $79M assets vs $74M liabilities in 2022) not present in the ground truth and potentially misleading. (2) The unobservable inputs are partially accurate: the LLM correctly notes swap rates narrowing from 4–7% in 2022 to 3–5% in 2023 and a 4% weighted average, aligning with the ground truth’s mention of 3–5% and 4% in 2023 and 2024. However, the ground truth does not mention a 'single 4%' point in 2024 or a 4–7% range in 2022 — instead, it states 3–5% for 2023 and 2024. The LLM also introduces default rates of 53–163% in 2023, which is absent from its response, indicating incomplete synthesis. (3) The multi-hop reasoning is partially sound — the model attempts to track changes over time and references valuation methodologies consistently across years, but fails to accurately extract or reconcile the net derivative values from the filings, especially for 2022 and 2024. The inclusion of Level 3 fair value and discounted cash flow models is relevant and correctly contextualized. (4) The correctness score is 4 due to major quantitative errors in two out of three years, despite some accurate qualitative elements. Quantitative accuracy is low (3) due to incorrect dollar amounts and unverified ranges. Qualitative accuracy is moderate (5) as the general trend and methodology are somewhat aligned. Contextual relevance is high (8) because the answer addresses the right concepts and time periods with appropriate sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 525,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "In fiscal 2022 Qualcomm reported that “thousands of our employees around the world utilized our charitable‑match program, benefiting more than 1,500 charitable organizations,” and by fiscal 2024 the same “thousands” of employees still participated, but the program supported “more than 1,300 charitable organizations.” This sustained, large‑scale employee involvement is a key element of the company’s human‑capital agenda, which the Board’s HR and Compensation Committee ties to executive bonuses through a non‑financial performance modifier (used for both the 2022 and 2024 bonus calculations).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and years are correct: 'thousands of employees' in both 2022 and 2024, with over 1,500 organizations supported in 2022 and over 1,300 in 2024—matching the original answer exactly. No calculations were required, and the fiscal year references are accurate. (2) The answer correctly identifies the continuity of the charitable match program and the slight decrease in supported organizations, demonstrating proper synthesis across years. (3) The LLM accurately links sustained employee participation to Qualcomm’s human capital goals and correctly states that the non-financial performance modifier (0.9 to 1.1) is used in executive bonus calculations, noting its application in both 2022 and 2024. While the original answer specifies the modifier range and ties progress to 2025 DEI goals, the LLM captures the essential linkage to executive compensation and human capital strategy. (4) The only minor omission is the lack of explicit mention of the 2025 DEI goals, which slightly reduces completeness in qualitative reasoning, but the core multi-hop synthesis—connecting employee charitable engagement to executive compensation via non-financial modifiers—is sound and relevant. Wording differences are acceptable under semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 373,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "- In the 2022 Form 10‑K (pages 4‑8) Adobe described Acrobat as the flagship PDF engine of its Document Cloud, tightly integrated with Adobe Sign to deliver fully digital document workflows and highlighted market‑leadership in document‑intensive industries, new web‑based Acrobat, mobile Reader with “Liquid Mode,” AI‑enhanced features via Sensei and open PDF/Acrobat Sign APIs.  \n- The 2023 filing (pages 1‑5) kept Acrobat at the core of Document Cloud but emphasized expanding its web functionality and task‑based actions, deepening Adobe Sign integration across all surfaces, and using Adobe Sensei and the PDF/Acrobat Sign APIs to unlock more business workflows and drive revenue growth.  \n- By the 2024 Form 10‑K (pages 94‑98) Acrobat is positioned as a unified component of Document Cloud that continues to improve web ease‑of‑use, broaden digital‑document and workflow actions, and integrate seamlessly with Adobe Sign, Adobe Scan and AI‑driven capabilities, delivering a consistent cross‑device experience and cementing its role as the central hub of Adobe’s document‑productivity ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Acrobat's role as a core component of Document Cloud is consistently emphasized across years; integration with Adobe Sign, Creative Cloud tools, and AI via Sensei is accurately noted; and the evolution toward AI-enhanced productivity is well captured. The mention of 'Liquid Mode,' APIs, and cross-device experience adds valuable detail supported by filings. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly tracing the evolution from market leadership (2022) to expanded web/AI functionality (2023) to a central hub in the document-productivity ecosystem (2024). The only minor omission is that the 2024 filing specifically mentions the 'Acrobat AI Assistant' as a registered trademark, which signals a more concrete step in AI integration than general 'AI-driven capabilities'—this nuance is missing but does not undermine the overall correctness. (4) The answer is contextually excellent, directly addressing all parts of the question: Acrobat’s role in Document Cloud, integration with other services, and product enhancements each year. Wording differs slightly from the original answer but maintains semantic equivalence. A score of 9 is justified due to this high level of accuracy with only a small detail about the formal branding of AI Assistant omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 439,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022 Eli Lilly recorded $2.02 billion of net product revenue from its COVID‑19 antibodies (bamlanivimab and bebtelovimab), and paid AbCellera royalty at a “mid‑teens to mid‑twenties” percentage of those sales – a material cost‑of‑sales expense [LLY_10k_2022.pdf:70]. By contrast, the company reported **no** sales of those antibodies in either 2023 or 2024, so net product revenue fell to $0 and the royalty payments to AbCellera ceased [LLY_10k_2023.pdf:71; LLY_10k_2024.pdf:72].",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $2.02 billion net product revenue in 2022 is accurately reported, and the 'mid-teens to mid-twenties' royalty range aligns with the original answer. The LLM correctly states zero sales and no royalty payments in 2023 and 2024. (2) All calculations and comparisons are accurate—there are no erroneous computations, and the progression from $2.02B to $0 is correctly portrayed. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three years (2022–2024) from different 10-K filings, correctly inferring that no sales imply no royalties, which demonstrates proper causal and temporal logic. (4) Entities—Eli Lilly (LLY), AbCellera, bamlanivimab, bebtelovimab, net product revenue, royalty payments—are all correctly identified and contextualized. The answer is semantically equivalent to the ground truth, with slightly more concise phrasing but no loss of meaning. Minor stylistic differences (e.g., use of em dashes, citation markers) do not affect accuracy. All parts of the question are addressed: evolution of financial implications, net revenue, and royalty payments over the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 341,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife’s reliance on the modified‑coinsurance arrangement stayed essentially unchanged – the company reported that an unaffiliated third‑party reinsurer covered roughly 59 % of the closed block in 2022 (59.25 % in the 2022 filing) and the same 59 % in both the 2023 and 2024 filings【MET_10k_2022.pdf†L212-L216】【MET_10k_2023.pdf†L225-L229】【MET_10k_2024.pdf†L202-L206】. This steady share signals a deliberate, long‑term risk‑transfer strategy, using the modified coinsurance structure to consistently shift a substantial portion of closed‑block risk to external reinsurers while preserving capital and managing exposure over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the percentages (59.25% in 2022, 59% in 2023, and 59% in 2024) are correctly reported with proper sourcing from the respective 10-K filings. Minor formatting differences (e.g., 'roughly 59%' vs exact figures) do not affect accuracy, as the precise values are also cited. (2) Quantitative accuracy is perfect—each percentage matches the ground truth, and no calculations were required beyond correct reporting. (3) The multi-hop reasoning across three years and filings is sound: the model correctly synthesized data from MET_10k_2022, 2023, and 2024 to identify consistency over time. (4) The qualitative interpretation—that this stability reflects a deliberate, long-term risk transfer strategy—is logically derived and aligns with the original answer’s conclusion about strategic continuity. The answer addresses both parts of the question: the evolution (stable) and the strategic implication (intentional risk-sharing). All entities (MetLife, closed block, modified coinsurance agreement) are correctly identified and contextualized. No errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 332,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "From 2022 to 2024 Mastercard’s multi‑layered security model has become more explicit about third‑party risk and the protection of its expanding real‑time payment platform. In 2022 the company described a “multi‑layered approach… assessed by third parties” and noted collaboration with public‑private partners and industry groups to set technical standards (2022 Security section). By 2024 the language was sharpened to say it monitors “threats and incidents associated with the use of services provided by third‑party providers” (2024 Security section), while its real‑time clearing and settlement infrastructure grew from 12 markets in 2021 to 13 markets by end‑2023 (2022 vs 2024 Account‑Based Payments sections). This evolution shows a cybersecurity strategy that layers traditional defenses with heightened third‑party governance and dedicated safeguards for its real‑time payment ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Mastercard's security strategy from 2022 to 2024, with accurate qualitative insights into third-party collaboration and real-time payment infrastructure expansion. However, there are minor quantitative inaccuracies: the LLM states real-time infrastructure grew from 12 markets in 2021 to 13 by end-2023, while the ground truth specifies 12 markets in 2022 and 13 in 2023, making the LLM's reference to 2021 incorrect. Additionally, the ground truth notes 'several countries globally' in 2024, which the LLM omits, instead referencing only the 13-market figure from 2023. Despite this, the LLM correctly identifies the trend of increasing third-party threat monitoring and links it to real-time payment expansion. The reasoning is sound, showing multi-hop synthesis between years and themes (security, third-party risk, infrastructure). Wording differs but meaning is semantically close. The answer is fully contextually relevant, addressing all parts of the question with appropriate focus on collaboration, infrastructure, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 316,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "LLY’s equity‑like fund holdings were roughly $4.35 billion in 2022 (‑ $4,014.1 m in the defined‑benefit plan + $332.8 m in the retiree‑health plan), rose to about $4.43 billion in 2023 (‑ $4,093.7 m + $335.1 m), and then fell to roughly $4.28 billion in 2024 (‑ $3,931.5 m + $346.1 m). The allocation remains large and relatively flat, indicating that LLY continues to treat private‑equity‑style, illiquid assets as a core long‑term component of its portfolio while making modest re‑balancing adjustments in response to market or strategic considerations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the direction and magnitude of LLY's allocation to equity-like funds. According to the ground truth, LLY's allocation increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip to $4,014.1 million in 2023. However, the LLM claims allocations were $4.35B in 2022, $4.43B in 2023, and $4.28B in 2024—values that are all substantially higher and misrepresent the trend. The LLM incorrectly reports a peak in 2023 and decline in 2024, contradicting the actual upward trajectory. (2) The numbers cited by the LLM appear to be miscalculations or misattributions—specifically, it references negative values (e.g., '‑$4,014.1 m') which are nonsensical in this context and suggests confusion between different plans. The ground truth does not mention retiree-health plan allocations or negative amounts. The LLM also reports $3,931.5 m in 2024, which contradicts the correct value of $4,093.7 m. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution of private alternative investment allocations over time and introduces unverified data from sub-plans not mentioned in the original answer. It incorrectly infers a 'relatively flat' trend when the actual data shows a clear 44% increase from 2022 to 2024. (4) While the LLM attempts to interpret strategic implications (long-term use of illiquid assets), its conclusion is based on incorrect data, undermining qualitative accuracy. The contextual relevance is moderate because it addresses the right topic and attempts to discuss strategy, but factual errors severely limit usefulness. Quantitative accuracy is very low due to incorrect figures, signs, and trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 476,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "In both the 2022 and 2024 Form 10‑K filings, Cascade is still listed as one of the “major brands” of the Fabric & Home Care segment and is grouped under the Home‑Care sub‑category (dish‑care) rather than the fabric‑care sub‑category 【2022 table showing “Fabric & Home Care – 35 % of net sales … Tide Cascade”】 and 【2024 table showing “Fabric & Home Care – 36 % of net sales … Tide Cascade”】.  While the brand’s own share isn’t broken out, the segment’s contribution to total net sales rose modestly from about 35 % in 2022 to roughly 36 % in 2024, indicating that Cascade’s role within a slightly larger Fabric & Home Care segment remained stable and even grew a little in relative importance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the Fabric & Home Care segment contributed 35% of net sales in 2022 and 36% in both 2023 and 2024, and the LLM correctly reports the 35% → 36% increase without introducing errors. The years (2022, 2024) are accurate, and the lack of a specific Cascade sales breakdown is properly acknowledged. (2) The LLM correctly identifies Cascade as a major brand within the Fabric & Home Care segment and specifies its categorization under Home Care (dish-care), which is a detail consistent with the knowledge graph and adds value beyond the original answer. (3) The reasoning is sound: it infers stable positioning based on segment-level performance and correctly interprets that Cascade’s relative importance likely grew slightly as the segment’s share increased. The only minor shortcoming is that the original answer references 2023 data (segment at 36%), which the LLM omits—though this is not critical as the 2022-to-2024 trend is still accurately captured. (4) The answer is contextually excellent, directly addressing product categorization and relative contribution over time. Semantic equivalence is strong, with slightly more granular insight (sub-category placement) enhancing the response. No factual inaccuracies; deduction is minor due to partial omission of 2023 confirmation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 387,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "In 2022 Lowe’s relied on its human‑rights policy, conflict‑minerals policy and Vendor Code of Conduct (which now includes enhanced environmental standards) to monitor suppliers and required all wood sold to come from well‑managed, non‑endangered forests, while beginning a $550 million push for energy‑efficiency, LED, HVAC and renewable‑energy upgrades. In 2023 the company refreshed its wood‑sourcing policy – adding country‑specific risk levels, stronger monitoring and a new forestry‑grievance process – and kept expanding its sustainability‑focused capital spending. By 2024 the policy was made even more risk‑based with further enhanced monitoring practices and a formal grievance mechanism, and the investment strategy was accelerated, committing additional hundreds of millions to LED, HVAC, building‑management, pallet‑grinder projects and to scaling solar and wind power installations.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Lowe's supplier sustainability monitoring and wood sourcing practices from 2022 to 2024, with accurate descriptions of policy updates and investment initiatives. However, there is a discrepancy in the quantitative details: while the original answer specifies a $550 million investment in 2022 for environmental facility upgrades and a $50 million Gable Grants program in 2023, the LLM answer correctly notes the $550 million but inaccurately states that 'additional hundreds of millions' were committed in 2024 without specifying the Gable Grants or their amount. This omission and generalization reduce quantitative accuracy. (2) The $550 million figure is correctly cited, but the $50 million Gable Grants commitment in 2023 is missing entirely, and the 'hundreds of millions' phrasing in 2024 is vague and not supported in the ground truth, which does not mention additional capital beyond prior commitments. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes policy changes across years—such as the introduction of country-specific risk levels, enhanced monitoring, and the forestry grievance process in 2023, and a more risk-based approach in 2024—and links them to Lowe's broader sustainability strategy. It also correctly associates supplier monitoring with the Vendor Code of Conduct and environmental upgrades. (4) Despite the missing $50 million grant detail and overstatement of 2024 investments, the core qualitative progression of policies and practices is accurate and well-structured. The answer remains highly relevant and factually sound on all non-quantitative aspects, hence high scores in qualitative accuracy and contextual relevance. The correctness score is 8 due to the significant but not central omission in financial specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 498,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "In the 2022 filing Honeywell warned that its Safety & Productivity Solutions unit “may be adversely impacted … by changes in the competitive landscape, including new market entrants and technology that may lead to product commoditization,” and that Honeywell Building Technologies faced “changes in the competitive landscape including new market entrants and new technologies” (2022 10‑K, Risk Factors, pages 29‑33). After the 2023 realignment the same language re‑appeared under the renamed Industrial Automation (the former Safety & Productivity Solutions) and Building Automation (the former Building Technologies) segments, again stressing new entrants, new technologies and commoditization risk (2023 10‑K, Risk Factors, pages 30‑34). The 2024 filing repeats this wording for Industrial Automation and Building Automation, indicating that exposure to competitive‑landscape shifts has remained a core risk and, as the automation businesses are consolidated, the company perceives mounting market pressure and an escalating threat that its products will become commoditized, eroding share and margins (2024 10‑K, Risk Factors, pages 28‑32).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces a critical factual error in entity mapping that undermines the multi-hop reasoning. Quantitatively, the years (2022, 2023, 2024) and risk factor descriptions (new entrants, new technologies, commoditization) are accurately cited with correct semantic content and consistent with the original answer. However, the LLM incorrectly states that Safety & Productivity Solutions was renamed Industrial Automation and that Building Technologies became Building Automation after a 2023 realignment. The ground truth does not support this rebranding narrative—Honeywell’s 2023 and 2024 filings do reflect organizational changes, but the progression described in the original answer is about the *expansion* of competitive risk disclosures across distinct businesses over time, not a renaming of segments. The original answer shows that the risk was first highlighted in Safety and Productivity Solutions (2022), then in Honeywell Building Technologies (2023), and later in Industrial Automation (2024)—indicating broadening exposure. The LLM instead frames this as the same risk being repeated in renamed segments, which misrepresents the evolution and implies continuity rather than expansion. This undermines the qualitative accuracy of the reasoning: the conclusion about 'mounting market pressure' and 'escalating threat' is directionally consistent but based on flawed logic. The contextual relevance remains high because the answer addresses competitive landscape changes, commoditization risks, and time progression, but the incorrect segment mapping reduces factual reliability. Minor formatting differences (e.g., 'Building Automation' vs 'Honeywell Building Technologies') are acceptable, but the core error in attributing the risk progression to rebranding rather than cross-divisional spread significantly affects correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 509,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "In its 2022 filing Qualcomm framed the digital‑cockpit as a nascent pillar of an “automotive transformation” – a software‑defined vehicle architecture that would combine connectivity, OTA updates and ADAS/AD, but automotive revenue was only $1.5 billion that year (the automotive stream in QCT revenue includes “connectivity, digital cockpit and ADAS/AD”)【6†L1-L9】【6†L41-L48】. By the 2024 filing the same segment reporting shows automotive revenue climbing to $2.9 billion (up from $1.9 billion in 2023), reflecting that Qualcomm’s digital‑cockpit solutions have moved from an emerging opportunity to a core, high‑growth component of its QCT automotive portfolio and are now a major driver of overall segment performance【6†L41-L48】. This growth underscores a strategic shift toward a stronger, revenue‑driven position in the digital‑cockpit market between 2022 and 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Qualcomm's strategic positioning in the digital cockpit market from 2022 to 2024, aligning with the ground truth's core narrative of progression from vision to monetization to integration. It accurately notes that in 2022, Qualcomm described digital cockpit as part of a broader automotive transformation involving connectivity, OTA updates, and ADAS/AD. It also correctly identifies that by 2024, digital cockpit was embedded within the QCT automotive segment and contributing to revenue growth. However, the LLM answer omits the explicit 2023 milestone where digital cockpit products were first formally recognized as part of automotive revenue — a key multi-hop point in the original answer that bridges the transition from strategy to monetization. (2) Quantitatively, the LLM provides accurate figures: automotive revenue of $1.5B in 2022, $1.9B in 2023, and $2.9B in 2024, which match known disclosures and show correct year-over-year progression. These numbers support the conclusion of strong growth, though the original answer does not include them — their inclusion here adds value but does not contradict. (3) The reasoning is largely sound and reflects multi-hop synthesis across years and reporting changes. However, it skips the intermediate step in 2023 where revenue recognition began, instead jumping from 2022 framing to 2024 results, which weakens the full trajectory. The original answer emphasizes 2023 as the monetization inflection; the LLM answer treats it only implicitly through revenue data. (4) Despite this omission, the LLM answer remains contextually rich and highly relevant, using correct entities (Qualcomm, QCT, digital cockpit, ADAS/AD), accurate timeframes, and proper financial terminology. The omission of the explicit 2023 recognition prevents a perfect score, but the overall factual and conceptual alignment justifies a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 528,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "In the 2022 filing, Frame.io was presented as a cloud‑native collaboration platform that handled video plus still images, design files and PDFs, and was directly integrated only with Premiere Pro and After Effects (with Camera‑to‑Cloud upload for footage and still‑image cameras). By the 2024 filing, Frame.io’s media support had broadened to full‑cycle video use cases—including casting, location scouting, footage reviews and marketing‑campaign workflows—while still supporting stills, design files and PDFs; its integration footprint expanded to Photoshop, Lightroom and Workfront, and it was made available through Adobe GenStudio to enable enterprise‑scale content production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All key facts are correct: Frame.io's evolution from 2022 to 2024 is accurately described in terms of supported media types (video, still images, design files, PDFs), cross-product integrations (Premiere Pro, After Effects, then expanded to Photoshop, Lightroom, Workfront), and enterprise capabilities (inclusion in Adobe GenStudio for enterprise-scale production). The expansion into casting, location scouting, and marketing campaign workflows by 2024 is correctly noted. (2) There are no numeric values, dates, or calculations in the question or answers that are incorrect; the use of '2022 filing' and '2024 filing' aligns with the ground truth's timeline, even if 2023 is omitted—the progression is still accurately represented. (3) The multi-hop reasoning is sound: the model synthesizes information across time points and product integrations correctly, showing how Frame.io evolved functionally and organizationally within Adobe’s ecosystem. (4) The only minor shortcoming is that the LLM answer implies Frame.io was already a 'cloud-native collaboration platform' in 2022, while the ground truth notes it was first listed as a trademarked product that year—suggesting branding alignment may have preceded full functional description. However, this does not contradict the overall integration trajectory. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct and comprehensive, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 460,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "From 2022 to 2024 Mastercard’s Class A shares saw their cash dividend rise each year – $2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024 (MA 10K 2023 p. 97‑99; MA 10K 2024 p. 90‑94) – while the certificate of incorporation continued to grant Class A stock “one vote per share” and dividend rights unchanged (MA 10K 2023 p. 97‑99; MA 10K 2024 p. 90‑94). The share of voting power held by public Class A investors also edged up (≈89.3 % in 2022 → 90.6 % in 2024) (MA 10K 2023 p. 98‑101; MA 10K 2024 p. 90‑94), indicating a stable, one‑share‑one‑vote governance structure that has not been diluted even as dividend payouts have increased.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces specific dividend payout amounts ($2.04, $2.37, $2.74) which are not part of the ground truth. The original answer states only that 'dividend rights' were maintained, not that actual dividends increased. This is a significant factual error, as the question asks about rights (structural features), not payouts (executive decisions). Additionally, the claim that public Class A investors' voting power increased from 89.3% to 90.6% is not supported by the ground truth, which states voting rights remained unchanged at 'one vote per share' with no mention of ownership distribution shifts. (2) The quantitative inaccuracies are severe: the dollar amounts and percentages are fabricated or misattributed. While the years (2022–2024) and company (MA) are correct, the core numerical claims are unsupported by the ground truth. (3) The reasoning is partially sound in linking consistent voting and dividend rights to governance stability, but it fails the multi-hop requirement by conflating dividend rights with actual dividend payments and introducing ownership concentration data not present in the source. The model appears to have synthesized extraneous data not in the knowledge graph. (4) The contextual relevance is moderate because the answer addresses shareholder governance and stability, but the factual foundation is flawed. Correctness is low due to major factual and quantitative errors, despite correct entity and time period identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 415,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions segment was directly hit by retail‑market swings – in FY 2022 sales fell 1% (even though organic sales rose 5%) after the divestiture of its retail‑footwear business, a move the company flagged as a “fluctuation in retail markets” risk (2022 Risk Factors). The vulnerability deepened in FY 2023, when the segment’s net sales dropped 21% and segment profit fell 17% as weaker consumer demand hurt Warehouse‑and‑Workflow and Productivity Solutions (2023 Risk Factors). By FY 2024, after the segment was folded into Industrial Automation, sales rebounded 3% and profit rose 2%, but the recurring “fluctuations in retail markets” warning shows the business remains exposed to consumer‑demand volatility over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention specific sales or profit figures (e.g., 1% sales drop in 2022, 21% sales decline and 17% profit drop in 2023, or 3% sales and 2% profit increase in 2024), nor does it attribute the divestiture of a 'retail-footwear business' to retail market fluctuations. These specific financial metrics and the narrative around a divestiture are not supported by the original answer and appear fabricated. (2) The original answer emphasizes consistent risk disclosures in Honeywell’s filings about the adverse impact of retail market fluctuations on the Safety and Productivity Solutions segment (renamed in 2024 to Industrial Automation), but does not provide year-over-year financial performance data. The LLM invents precise percentages that cannot be verified from the ground truth, failing the quantitative accuracy test. (3) The multi-hop reasoning is partially sound in that the LLM recognizes the segment name change from Safety and Productivity Solutions to Industrial Automation by 2024 and connects ongoing exposure to retail volatility across years. However, it misrepresents the nature of the exposure—framing it as realized financial declines due to consumer demand—whereas the ground truth describes forward-looking risk disclosures, not actual reported results. (4) While the LLM captures the general theme of ongoing vulnerability to retail market fluctuations, it conflates risk disclosures with actual financial outcomes and introduces unsupported specifics. The contextual relevance is high because it addresses the core question about vulnerability over time, but correctness is low due to invented data. Thus, the correctness score is 4 (partially correct with major errors), quantitative accuracy is 3 (few correct numbers, many incorrect), qualitative accuracy is 5 (some correct reasoning but flawed synthesis), and contextual relevance is 8 (on-topic and attempts full scope).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 547,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Incyte‑LLY Olumiant agreement retained its tiered double‑digit royalty (up to 20 % of worldwide net sales) and the additional low‑teens royalty on COVID‑19 sales that exceed a set threshold, which was added in the 2020 amendment. In 2022 the collaboration still carried large capitalized milestone payments ($260 M and $210 M) and Incyte was eligible for up to $100 M each of success‑based regulatory and sales‑based milestones; by 2023 the milestone payments were still being amortized but were not material and the upside was limited to roughly $100 M of potential sales‑based milestones, and the 2024 filing no longer highlights any material milestone obligations, focusing only on the royalty structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the royalty structure: up to 20% on worldwide net sales and an additional low-teens royalty on COVID-19 sales above a threshold, consistent from 2022 to 2024. (2) Quantitatively, it accurately states that in 2022, Incyte was eligible for up to $100M in regulatory and $100M in sales-based milestones (total $200M), though it adds specific capitalized amounts ($260M and $210M) not in the original answer—these may come from actual filings but are not part of the ground truth, so they don't invalidate the response but introduce unverified detail. (3) The evolution of milestones is correctly captured: in 2023, milestone payments were being amortized (into cost of sales, per original), were no longer material, and upside was limited to ~$100M in sales-based milestones. By 2024, no material milestones remained, consistent with the shift to royalty-focused payments. (4) The reasoning across years is sound, showing a clear multi-hop synthesis of how the financial obligations evolved from milestone-driven to royalty-dominated. (5) Minor deduction in quantitative accuracy due to inclusion of unverified capitalized amounts ($260M, $210M), which aren't in the ground truth and could confuse if incorrect. Otherwise, all key facts, trends, and structures are preserved with strong semantic equivalence and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 394,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "In the 2022 filing the Baby, Feminine & Family Care segment was described as a three‑part category—baby care, feminine care and family care—with Always listed among a long list of major brands that also included Pampers and Luvs, indicating it was one of several comparable brands across the whole segment. By the 2023 and 2024 filings the segment’s product‑category description was trimmed to focus only on feminine care (adult incontinence and menstrual) and family care, and the brand table placed Always first (followed by Always Discreet, Tampax, Bounty, Charmin and Puffs), signaling a strategic shift that elevates Always as the flagship brand for the segment’s feminine‑care sub‑category and reduces its association with the baby‑care portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in entity and structural representation, despite correct dates and general thematic direction. (1) In 2022, the Baby, Feminine & Family Care segment did include baby care, feminine care, and family care, but Always was specifically listed under 'Feminine Care (Adult Incontinence, Feminine Care)'—not broadly across the entire segment as implied. The claim that Always was listed alongside Pampers and Luvs as comparable brands across the whole segment is misleading; Pampers and Luvs are baby care brands, and the original filing does not group Always with them in a way that suggests parity across categories. (2) The shift in 2023 to 'Menstrual Care' is correctly noted in spirit, but the LLM incorrectly states that baby care was removed from the segment description—while the emphasis shifted, the segment name remained unchanged and baby care was still part of it, though Always was more clearly aligned with menstrual care. (3) The claim that Always was 'placed first' in a brand table in 2023 and 2024 as a signal of flagship status is not supported by the ground truth; while Always is listed early, the original answer does not mention ordering as a strategic signal, nor is this inference reliably grounded in the data provided. (4) The conclusion that Always was 'elevated as the flagship brand' and 'reduced association with baby-care portfolio' overstates the evidence—the ground truth notes a sharpening of positioning around menstrual care but does not support a demotion from or disassociation with the broader segment. Quantitative accuracy is high: years (2022–2024) are correct, no numerical errors. Contextual relevance is strong—the answer addresses product categorization and prominence. However, qualitative accuracy is low due to unsupported inferences and misrepresentation of structural relationships. The core evolution—refined positioning toward menstrual care—is correct, but the reasoning and entity-level details are partially flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 541,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "In the 2022 filing ACN’s 2023 target allocation was 95 % debt and 5 % cash for U.S. plans and 27 % equity, 43 % debt, 6 % cash, 22 % insurance and 10 % other for non‑U.S. plans; the 2023 filing (as of Aug 31 2023) shifted the 2024 target to 94 % debt and 6 % cash for U.S. plans and 23 % equity, 42 % debt, 5 % cash, 21 % insurance and 9 % other for non‑U.S. plans; and both the 2023 and 2024 filings set a 2025 target of 100 % debt for U.S. plans and a more balanced mix for non‑U.S. plans – 28 % equity, 36 % debt, 7 % cash, 21 % insurance and 8 % other. This progression shows ACN tightening the U.S. portfolio to a pure fixed‑income, duration‑matched stance to minimize risk, while gradually increasing equity and cash in non‑U.S. plans to capture higher risk‑adjusted returns without compromising overall liability‑duration alignment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) The specific allocation percentages provided (e.g., 95% debt and 5% cash for U.S. plans in 2023, 100% debt in 2025) are not supported by the ground truth and appear fabricated. The original answer states that the strategy emphasized diversified fixed income and equities with liability duration matching but does not provide exact numerical allocations by region or asset class. (2) The ground truth does not mention U.S. vs. non-U.S. plan breakdowns or specific percentages for equity, debt, cash, insurance, or 'other' categories—these details are absent from the verified data, making the LLM's detailed figures unsupported. (3) The multi-hop reasoning is flawed: while the LLM attempts to show a trend toward de-risking in U.S. plans and increased equity in non-U.S. plans, the original answer indicates only a consistent, flexible framework with no such granular shifts. (4) The interpretation about 'tightening to pure fixed-income' in U.S. plans and increasing equity for higher returns is speculative and not present in the ground truth, which emphasizes strategic continuity and flexibility without directional shifts. (5) Contextually, the LLM addresses the evolution and interpretation questions, so relevance is moderate, but factual inaccuracies severely undermine correctness. Overall, the answer fails on factual accuracy and synthesis, despite attempting to answer all parts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 405,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap exposure jumped to a $2.56 billion notional in 2022, where the contracts were designated as cash‑flow hedges and recorded as “Other current assets” measured at Level 2 fair value【LOW_10k_2022.pdf p.60‑61】.  In 2023 the swaps were still on the balance sheet – the fair‑value balance was $251 million – and the company continued to describe them as cash‑flow hedges of forecasted debt issuances【LOW_10k_2023.pdf p.53】; the fair‑value table shows a $251 million Level 2 asset for February 3 2023【LOW_10k_2024.pdf p.45】.  By 2024 the forward‑swap line carries no fair‑value amount (shown as “‑”/$0) and the contracts are no longer listed, indicating they have been settled or terminated, although the hedge‑accounting language still refers to them as cash‑flow hedges of anticipated borrowing【LOW_10k_2024.pdf p.45‑46】.  This progression shows Lowe’s used forward swaps to hedge the interest‑rate risk of planned debt issuances, but unwound the hedge as the need for new borrowing faded, reflecting a dynamic, purpose‑driven interest‑rate risk‑management strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 exposure amount. The original answer states that no current fair value was listed for 2022, but the LLM claims a $2.56 billion notional amount and a recorded asset, which contradicts the ground truth. This number is unsupported by the provided truth and misrepresents the data. The 2023 fair value of $251 million is correct and matches the ground truth, as is its classification as a Level 2 asset in other current assets. However, the LLM incorrectly states that the swaps were still designated as cash flow hedges in 2024, while the ground truth clarifies that by 2024, Lowe's no longer held forward interest rate swaps and had shifted to fixed-to-floating swaps as fair value hedges. The LLM also fails to identify this strategic shift in hedge type and accounting treatment, instead claiming the hedge accounting language still refers to cash flow hedges, which misinterprets the evolution. (2) Quantitative accuracy is partially correct only for 2023 ($251 million). The $2.56 billion figure for 2022 is entirely fabricated in the context of fair value or notional exposure according to the ground truth, which explicitly states no current fair value was disclosed for 2022. The 2024 value is correctly interpreted as zero, but the reasoning is flawed. (3) The multi-hop reasoning is weak: the LLM fails to synthesize the shift from cash flow hedges (2022–2023) to fair value hedges (2024) and misses the replacement of forward swaps with fixed-to-floating swaps. Instead, it suggests a simple unwinding of hedges without recognizing the change in hedging strategy or instrument type. This undermines the core insight about Lowe's evolving risk management approach. (4) Contextual relevance is high because the answer addresses the timeline, hedge types, and risk management implications, but the factual and conceptual errors severely limit correctness. The qualitative accuracy is moderate due to correct mention of cash flow hedges in 2022–2023 and the cessation of swaps in 2024, but the failure to identify the new hedge instruments and accounting classification reduces its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 587,
        "total_tokens": 2128
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO reported the same $606 million of principal outstanding on its 5.0 % senior notes due April 2030 in each of the three most recent fiscal years – $606 million in FY 2022, $606 million in FY 2023, and $606 million in FY 2024【AVGO_10k_2022.pdf p. 104】【AVGO_10k_2023.pdf p. 80】【AVGO_10k_2024.pdf p. 80】. The unchanged balance shows the company has chosen to retain this fixed‑rate issue rather than refinance or retire it, reflecting a deliberate strategy of holding existing senior‑note debt while managing overall leverage through other issuances and repayments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. The ground truth states that AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023 and 2024. However, the LLM claims the amount was $606 million in all three years, including 2022, which contradicts the ground truth. This error fundamentally misrepresents the trend. (2) The numbers are inaccurate: the $1,086 million figure for 2022 is entirely missing from the LLM response, and instead, it falsely reports $606 million for 2022. This is not a formatting issue but a factual error. Calculations or comparisons based on this are invalid. (3) The multi-hop reasoning is flawed because the model fails to detect the change over time, which is central to the question. The conclusion that the company 'retained this fixed-rate issue' with an 'unchanged balance' is incorrect given the actual reduction from 2022 to 2023. The correct inference — a deliberate reduction in debt — is missed. (4) Contextual relevance is moderate because the answer addresses the right company (AVGO), the correct debt instrument (5.000% notes due April 2030), and attempts to interpret strategy. However, due to the critical numerical error, the qualitative analysis is based on false premises, severely undermining correctness. The citations to specific filings do not excuse the factual inaccuracy if they misrepresent the data in those sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 406,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "- 2022 10‑K – UPS noted that the $276 million debentures were originally issued at 8.375 % and that, on April 1 2020, the rate was reduced to 7.620 % for the remaining term to their fixed maturity of April 1 2030.  The note described the same optional early‑redemption feature – the debentures can be redeemed in whole or in part at any time at the greater of (i) principal + accrued interest or (ii) the present value of the remaining scheduled payments discounted at a benchmark Treasury yield + 5 bps (plus accrued interest) – with semi‑annual interest and no sinking‑fund requirement.\n\n- 2023 and 2024 10‑Ks – The disclosure retained the $276 million amount, the April 1 2030 maturity and the identical optional redemption terms (principal + accrued interest vs. discounted present‑value price at Treasury + 5 bps), and the semi‑annual interest schedule, but the filing no longer restated the historic 8.375 % rate, simply referring to the securities as “7.620 % debentures.”  \n\nThus, from 2022 to 2024 the interest rate remained at 7.620 % (after the 2020 reduction), the maturity and redemption mechanics stayed unchanged, and the disclosure evolved from highlighting the prior rate cut to a streamlined description that only references the current 7.620 % rate.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: the principal amount ($276 million), maturity date (April 1, 2030), interest rate reduction from 8.375% to 7.620% effective April 1, 2020, and the consistent 7.620% rate in 2022–2024. (2) Quantitative elements are precise: dollar amount, percentages, and dates match exactly. The redemption terms are accurately described—callable at any time with the redemption price as the greater of principal plus accrued interest or the present value of remaining payments discounted at Treasury yield plus 5 bps. The semi-annual interest payments and absence of sinking fund requirements are correctly noted. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across 2022, 2023, and 2024, correctly identifying the evolution in disclosure tone—shifting from explaining the 2020 rate cut in 2022 to simply referencing the current 7.620% rate in later years. (4) The answer addresses all aspects of the question: interest rates, redemption terms, maturity structure, and how disclosures evolved. Wording differs slightly from the original answer but maintains full semantic equivalence. No omissions or inaccuracies. Scores are maximized across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 356,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "In the 2022 10‑K Amgen described Olpasiran as an siRNA‑based Phase 2 candidate that lowers lipoprotein(a) and is being evaluated for atherosclerotic cardiovascular disease. By the 2023 filing the company had secured composition‑of‑matter patents on the Olpasiran compound in the United States and Europe (both with an estimated expiration in 2036), and the 2024 10‑K shows Olpasiran now advanced to Phase 3 trials while retaining its cardiovascular focus, indicating a strategic move to bring the product to market under a robust, long‑term IP shield.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Olpasiran as an siRNA in Phase 2 in 2022 targeting lipoprotein(a) for atherosclerotic cardiovascular disease, and accurately reports the U.S. and European patent expirations in 2036, which aligns with the ground truth. However, it incorrectly states that Olpasiran advanced to Phase 3 by 2024, which is not supported by the original answer—instead, the original notes only a broadening of the therapeutic indication to 'cardiovascular disease' without mentioning phase progression. This is a significant factual error affecting the developmental timeline. (2) Quantitatively, all dates (2022, 2023, 2024, 2036) are correct, and the patent expiration is accurately cited. No calculations are involved, so numerical accuracy is high. (3) The multi-hop reasoning is partially sound—information is synthesized across years and domains (clinical development, IP, therapeutic focus)—but the erroneous claim about Phase 3 advancement indicates a failure in accurately synthesizing the 2024 status. The original answer does not mention phase progression beyond Phase 2, so this is a critical deviation. (4) Contextual relevance is strong, as the answer addresses therapeutic focus, clinical development, and IP protection as required. However, due to the incorrect phase advancement claim, the qualitative and overall correctness scores are reduced despite accurate IP and earlier-phase details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 398,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "In the 2022 filing, Tampax is listed among the major brands of the Baby, Feminine & Family Care segment (alongside baby brands Luvs and Pampers) and is described as one of the two leading brands in the feminine‑care category behind Always 【PG_10k_2022.pdf p.18】; by the 2024 filing, Tampax remains in the same segment but the major‑brand table now highlights only feminine‑care and family‑care brands (Always, Always Discreet, Tampax, Charmin, Puffs) and the narrative stresses that Tampax, together with Always, leads the menstrual‑care sub‑category with over 25 % global market share 【PG_10k_2024.pdf p.17‑20】. Thus, while its segment placement stayed constant, Tampax’s positioning shifted toward a more focused, prominent role as a core feminine‑care brand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Tampax's segment placement in both 2022 and 2024 as part of 'Baby, Feminine & Family Care' and notes the shift in emphasis toward a more focused role in feminine care. The mention of Always, Charmin, and Puffs in the 2024 major-brand table is consistent with the reorganization of brand presentation. (2) Quantitatively, the claim that Tampax and Always together hold over 25% global market share in menstrual care is factually supported in the 2024 filing and correctly reported—no calculation errors or incorrect numbers. (3) The reasoning is sound: the LLM correctly synthesizes multi-hop information across 2022 and 2024 filings, noting both continuity (segment placement) and evolution (increased prominence within feminine care). It captures the strategic shift even without explicitly referencing 2023, which is acceptable since the question allows for a 2022–2024 evolution summary. (4) Minor omission: the LLM does not mention the 2023 reclassification to 'Feminine Care (Adult Incontinence, Menstrual Care)', which is part of the full evolution. However, since the 2024 categorization aligns closely with that change and the core trend of consistent strategic emphasis is captured, this is a small gap. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with full quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 400,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "MetLife’s 10‑K disclosures show that in each year – 2022, 2023 and 2024 – the company continued to apply an internally‑developed NAIC designation to any non‑agency RMBS or CMBS it bought that had not yet been evaluated by the NAIC (2022 p. 101; 2023 p. 94; 2024 p. 84). During the same period the RMBS portfolio expanded from $26.2 billion in 2022 to $34.1 billion in 2024 (2022 p. 99; 2023 p. 92; 2024 p. 82) while the NAIC’s expanded 20‑category rating system has increased coverage, indicating that NAIC designations are becoming more widely available and MetLife’s acquisition strategy is growing its non‑agency RMBS exposure, gradually reducing the need for internal designations.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but introduces significant factual and reasoning errors. (1) Quantitatively, the RMBS portfolio values cited ($26.2B in 2022, $34.1B in 2024) are not present in the ground truth and cannot be verified from the provided context; the original answer does not mention portfolio size or growth, so these figures appear to be fabricated or misattributed. No such numbers were part of the knowledge graph ground truth, making this a serious quantitative inaccuracy. (2) The claim that 'NAIC designations are becoming more widely available' and that this 'gradually reduces the need for internal designations' contradicts the original answer’s conclusion. The ground truth states that the continued use of internal designations over three years indicates ongoing reliance due to delayed NAIC evaluations, not a declining need. The LLM incorrectly infers a trend toward reduced internal designation use based on expanded NAIC coverage, which is not supported by the original reasoning. (3) While the LLM correctly identifies that MetLife applied internally developed designations in 2022, 2023, and 2024 for non-agency RMBS/CMBS not yet rated by the NAIC — which aligns with the multi-year consistency in policy — it misinterprets the implication of this trend. The original answer emphasizes sustained strategy in complex securities where NAIC lags, whereas the LLM suggests a shift toward reduced reliance on internal assessments, which is the opposite conclusion. (4) Contextually, the answer addresses the evolution and strategic implication, so relevance is high, but the flawed reasoning and unsupported numerical data reduce correctness. The synthesis fails on key logical inference despite some accurate surface-level facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 480,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "- Fiscal 2022: Accenture bought about $4.1 billion of its Class A shares (≈ $3.15 billion through the open‑market program) and entered the year with $3.13 billion of available authorization (total outstanding authority rose to $6.13 billion after a $3 billion add‑on).  \n- Fiscal 2023: The company kept the buy‑back pace near $4 billion and the remaining authorization slipped to roughly $2.9 billion.  \n- Fiscal 2024: Repurchases rose to $4.5 billion, the available authorization fell further to $2.69 billion, and the Board approved an additional $4 billion, taking total outstanding authority to $6.69 billion.  \n\nThe steady‑high level of share buybacks and the periodic increases in repurchase authority show that Accenture is maintaining a strong, ongoing capital‑return strategy focused on returning excess cash to shareholders via its open‑market share repurchase program.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key financial figures compared to the ground truth. While the original answer states that Accenture had $3.13 billion in available authorization at the start of fiscal 2022 and does not specify repurchase volume for that year beyond authorization, the LLM claims $4.1 billion in buybacks in fiscal 2022 (with $3.15 billion through the open-market program), which is not supported by the ground truth. The $3.13 billion figure is correctly cited as available authorization, but the LLM incorrectly states that total outstanding authority rose to $6.13 billion after a $3 billion add-on — this detail is absent from the original and cannot be verified, making it a fabrication or unsupported inference. (2) For fiscal 2023, the original answer mentions only that the authorization increased (but does not quantify repurchases), while the LLM asserts $4 billion in buybacks and a drop to $2.9 billion in remaining authorization — again, unsupported by the source. (3) In fiscal 2024, the original specifies that 2,000,308 shares were purchased for $605 million in Q4 only, not for the full year; the LLM incorrectly extrapolates this to $4.5 billion in annual repurchases, a significant overstatement. However, the $4 billion increase in authorization on September 25, 2024, and the resulting $6.69 billion total outstanding authority are correctly reported. (4) The qualitative reasoning about Accenture’s capital return strategy being strong and ongoing is logically sound and aligns with the trend in the original answer. The synthesis of increasing authorization and sustained repurchases supports the conclusion, even if the numerical details are inflated. (5) Contextually, the answer is highly relevant and structured well to address the evolution over time and strategic implications. However, due to multiple unsupported or incorrect quantitative claims, especially around repurchase volumes, the quantitative accuracy is low. The correctness score is reduced to 6 because while the directionality and strategic interpretation are correct, the factual foundation contains significant errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 578,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "Across the three filings Broadcom’s wording never removed industrial fiber optics – in 2022 it was listed among a “broad variety of products for the general industrial and automotive markets” alongside optocouplers, motion encoders, LEDs and Ethernet ICs. The 2023 and 2024 10‑Ks repeat the same placement (the latter adding a brief reference to industrial‑and‑medical sensors), still grouping industrial fiber optics with those same components. This steady, unchanged inclusion signals that Broadcom views industrial fiber optics as a core, ongoing pillar of its industrial‑end‑market strategy, emphasizing a persistent focus on factory‑automation, renewable‑energy and automotive connectivity.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entity accuracy and timeline (2022–2024), correctly identifying that industrial fiber optics remained part of Broadcom’s portfolio across all three years and were consistently grouped with optocouplers, motion encoders, LEDs, and Ethernet ICs. There are no numeric inaccuracies (quantitative accuracy is perfect), and the context of industrial applications like factory automation, renewable energy, and automotive is appropriately included. However, the LLM mischaracterizes the evolution as 'steady, unchanged inclusion' and claims the 2023 and 2024 filings 'repeat the same placement,' which contradicts the ground truth: in 2023, the product was placed in a structured table indicating standardized categorization, and in 2024, it was more explicitly linked to specific applications and advanced components like Ethernet PHYs and camera microcontrollers—signifying a maturing, application-focused strategy. The LLM underrepresents this evolution, missing the nuance of increasing strategic alignment and categorization refinement. While the core facts are correct, the reasoning downplays the progression toward a more targeted and integrated product strategy, resulting in a partially incomplete qualitative assessment. Contextual relevance is high as the answer directly addresses Broadcom’s strategic emphasis in the industrial market.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 390,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "In the 2022 filing UPS described SurePost as a residential‑ground service for non‑urgent, lightweight shipments that used UPS’s ground network but handed off the final‑mile delivery to the U.S. Postal Service. The same model was reiterated in the 2023 filing and, through 2024, UPS still noted that “final delivery was often provided by the United States Postal Service” (2024 U.S. Domestic Package section). However, the 2024 filing also announced a strategic shift: beginning January 1 2025 UPS will insource SurePost to gain more control over service, moving away from its reliance on USPS (2024 U.S. Domestic Package section).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: UPS SurePost served as a residential ground service for non-urgent, lightweight shipments from 2022–2024, with final delivery frequently handled by USPS. The strategic shift to insource final delivery starting January 1, 2025, is accurately reported. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and there are no numerical errors. Format and phrasing (e.g., 'insource SurePost') are semantically equivalent to 'insource final delivery for UPS SurePost'. (3) Multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024 filings, showing continuity and then change in delivery model. (4) The answer addresses all parts of the question: evolution over time, reliance on USPS, and strategic changes. Wording differs slightly but meaning is preserved. No omissions or inaccuracies. All scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 281,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s late‑stage pipeline expanded from 13 Phase 3 programs in early 2022 (the 2022 Form 10‑K notes that three programs received FDA/EC approvals, four new Phase 3 studies were launched and one COVID‑19 program was terminated) to 18 programs by early 2023 (the 2023 Form 10‑K shows five Horizon‑acquired candidates, three additional Phase 3 initiations, an FDA approval of Otezla for genital psoriasis and the failure of a KYPROLIS study) and then to 24 programs by early 2024 (the 2024 Form 10‑K reports five more Phase 3 starts and three FDA plus one Japanese approval announced for the next year). This steady rise in both the count of programs and the mix of internal launches, strategic acquisitions and regulatory clearances reflects Amgen’s R&D strategy of aggressively broadening its pipeline through organic development and external portfolio enrichment to move more assets into late‑stage testing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the progression of Amgen's Phase 3 programs: 13 in early 2022, 18 in early 2023, and 24 in early 2024, matching the ground truth. It omits the final count of 25 programs as of February 4, 2025 (noted in the 2024 filing), which slightly reduces completeness. However, all other numerical milestones and time points are accurate. (2) Quantitative accuracy is high: the increases from 13 to 18 (+5) and 18 to 24 (+6) are consistent with the ground truth, and the mention of five new initiations and regulatory approvals aligns with the data. The LLM correctly attributes growth to internal development and acquisitions, including the Horizon Therapeutics deal adding five programs. (3) Multi-hop reasoning is sound: the answer synthesizes information across multiple 10-K filings (2022, 2023, 2024), correctly linking acquisitions, new initiations, approvals, and terminations to explain pipeline growth. It accurately reflects the strategic mix of organic and inorganic growth. (4) The answer conveys the same core conclusion as the ground truth—Amgen is pursuing a robust R&D expansion strategy via diversified pipeline development—making it semantically equivalent despite slightly different phrasing. The only minor gap is the omission of the 25-program milestone, which prevents a perfect score. Contextual relevance is excellent as all content directly addresses the question’s focus on quantity, milestones, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 411,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized 127 million Class A ordinary shares in fiscal 2022 (see 2022 filing)【89】; the limit was raised to 141 million shares in fiscal 2023 (2023 filing)【81】 and the same 141 million‑share ceiling was retained in fiscal 2024 (2024 filing)【96】. The increase in 2023 expanded the pool of equity awards, signalling Accenture’s strategic move to rely more heavily on share‑based compensation to attract and retain talent, while the unchanged level in 2024 shows a continued commitment to that approach without further diluting shareholders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 127 million shares in fiscal 2022, increasing to 141 million in fiscal 2023 and maintained in 2024. The format variation (127 million vs. 127,000,000) is acceptable and semantically equivalent. (2) The answer is complete, addressing both the evolution of the share authorization over the three fiscal years and the strategic implication of this change. (3) Entity accuracy is correct: Accenture plc, Amended 2010 SIP, Class A ordinary shares, and correct fiscal years (2022, 2023, 2024) are all properly identified. (4) The reasoning is sound and reflects appropriate multi-hop synthesis across filings: the increase in 2023 indicates a strategic expansion in equity compensation, and the retention of the same limit in 2024 shows sustained commitment without further increases—this aligns with and even enriches the ground truth interpretation by adding nuance about shareholder dilution. (5) The semantic meaning is equivalent to the original answer, with slightly more detailed commentary on strategic intent, without introducing inaccuracies. All citations (e.g., 【89】, 【81】, 【96】) are consistent with document references and support the claims. No errors in logic, calculation, or fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 365,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks said its green‑coffee inventory and purchase commitments would meet demand **through fiscal 2023** in the FY 2022 filing, then **extended that outlook to cover through fiscal 2025** in the FY 2023 filing, and the FY 2024 filing repeated the same coverage through fiscal 2025. The progressively longer coverage horizon shows the company is building a larger inventory buffer and locking in longer‑term contracts, a clear sign that it is tightening its risk‑management stance to guard against coffee‑price volatility and supply‑chain disruptions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) Quantitatively, all dates and timeframes are correct: the FY2022 filing projected coverage through fiscal 2023, the FY2023 filing extended it to fiscal 2025, and the FY2024 filing maintained that same horizon. These match the original answer exactly. (2) The answer is complete, addressing both the evolution of supply coverage (from 2023 to 2025) and the implication for inventory and risk management strategy. (3) Entity accuracy is perfect: Starbucks is correctly identified, fiscal years are accurate, and the metric (green coffee supply coverage) is properly contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis across three fiscal years of disclosures. The conclusion about longer-term contracts and risk management in response to price volatility and supply-chain disruptions is a valid inference supported by the extended coverage horizon. (5) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'tightening its risk-management stance'), the meaning is consistent with the original answer's emphasis on a more forward-looking strategy with extended commitments and hedging. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 357,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "- 2022 – UPS described the UPS/IBT Full‑Time Employee Pension Plan as a non‑contributory defined‑benefit plan covering former CSPF members and other employees under collective‑bargaining agreements, but disclosed no plan amendment, remeasurement or other change for that year【UPS_10k_2022.pdf†page 90‑94】.  \n\n- 2023 – The 10‑K reported that in Q3 2023 a new five‑year national Teamsters master agreement was ratified, which included wage‑ and benefit‑rate increases for the UPS/IBT plan; the impact of those increases was reflected in the year‑end actuarial measurement of the plan (no new remeasurement beyond the historic 2021 adjustment was noted)【UPS_10k_2023.pdf†page 80‑84】.  \n\n- 2024 – The 2024 filing shows the plan unchanged, with no additional amendments, remeasurements or collective‑bargaining impacts disclosed, indicating that the only recent strategic change was the 2023 agreement and the plan otherwise remained as‑is【UPS_10k_2024.pdf†page 84‑88】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding 2022. The ground truth states that in 2022, the plan was remeasured due to the American Rescue Plan Act, resulting in a $3.3 billion pre-tax gain. However, the LLM claims no remeasurement or change occurred in 2022, directly contradicting the original answer. This is a major omission and factual error. (2) Quantitatively, the LLM fails to report the $3.3 billion pre-tax ($2.5 billion after-tax) gain from the 2022 remeasurement, which is a critical financial figure. No other numbers are provided or miscalculated, but the absence of this key data severely undermines quantitative accuracy. (3) The qualitative reasoning is partially sound: the LLM correctly identifies the 2023 Teamsters agreement and its impact on benefit rates being reflected in year-end actuarial measurements, and notes the plan's structural continuity into 2024. However, it fails to connect the 2022 remeasurement to regulatory changes (American Rescue Plan Act), missing a key strategic and financial driver. The multi-hop synthesis is incomplete—while it tracks the plan across years and links collective bargaining to pension impacts, it omits the critical regulatory-financial link in 2022. (4) Contextual relevance is strong: the answer is well-structured by year, addresses plan amendments, remeasurements, and collective bargaining, and stays focused on the UPS/IBT plan. But due to the major factual error in 2022, the overall correctness score is low despite partial accuracy in 2023 and 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 432,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 Walmart has kept “Holiday Time” in the same spot – listed among its private‑brand family (e.g., alongside Great Value, Mainstays, etc.) in the Walmart U.S. merchandise description (2022 private‑brand list 【WMT_10k_2022.pdf p.5‑9】; 2023 list 【WMT_10k_2023.pdf p.6‑10】; 2024 list 【WMT_10k_2024.pdf p.5‑9】). The brand has not been moved to a separate category but remains part of the broader private‑label suite, underscoring Walmart’s strategy of using its own labels to supply seasonal (holiday) merchandise at low‑price points and to integrate seasonal items into its overall private‑brand portfolio rather than treating them as ad‑hoc or distinct lines.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually consistent in stating that 'Holiday Time' remained listed among Walmart's private brands across fiscal years 2022–2024 and was not moved to a separate category, with citations to the 10-K filings. This aligns with the ground truth on surface-level categorization. However, the LLM answer misses a key evolution highlighted in the original answer: in fiscal 2024, Walmart restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, indicating a strategic shift in positioning holiday-themed products like 'Holiday Time' within a dedicated seasonal framework. The LLM incorrectly implies no change in strategic positioning, stating the brand 'has not been moved to a separate category' and remains part of the 'broader private-label suite' without acknowledging the structural reorganization that elevates seasonal offerings. This omission represents a failure in multi-hop reasoning—synthesizing the significance of organizational changes mentioned in the 2024 filing in the context of prior years. While entity names, years, and document references are accurate (quantitative accuracy is high), the qualitative analysis and strategic interpretation are incomplete, leading to a misleading conclusion that Walmart’s approach remained static. The answer is contextually relevant and addresses the question’s scope but fails to capture the core strategic evolution, which is central to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 408,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "ACN’s mutual‑fund equity holdings fell from $239.3 million in fiscal 2022 to $196.2 million in fiscal 2023, then rose sharply to $273.7 million in fiscal 2024. The 2023 dip followed by a sizable rebound in 2024 signals a strategic shift back toward higher equity exposure, indicating the company is increasing its allocation to mutual‑fund equity securities after a temporary reduction.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly reports the $239.3 million (approximating $239.293 million) for 2022 and $196.2 million (approximating $196.226 million) for 2023, it incorrectly states that the investment rose to $273.7 million in 2024. The ground truth shows the amount remained unchanged at $196.226 million in 2024. This major error invalidates the entire trend analysis. (2) Quantitative accuracy is low because the 2024 figure is completely wrong—there was no increase, let alone to $273.7 million. The claimed 'sharp rise' and 'rebound' are unsupported. Calculations or comparisons based on this are invalid. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the three-year trend. Instead of identifying a consistent decline and stabilization indicating a strategic reduction, it infers a rebound, leading to the opposite conclusion about strategic intent. This reflects a failure in logical synthesis across years. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses the evolution over time and attempts to interpret strategic intent, which aligns with the question's requirements. However, the conclusion is factually baseless. Scores reflect severe factual and reasoning deficiencies, particularly in numbers and trend interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 380,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks has repeatedly warned that green‑coffee prices are volatile and increasingly swayed by commodity‑index‑fund activity in the Arabica futures market, and it counters that risk with a mix of fixed‑price purchase commitments and derivative hedges – forward contracts, futures contracts and collars – to offset “C”‑price exposure【SBUX_10k_2022.pdf:12】【SBUX_10k_2023.pdf:12】【SBUX_10k_2024.pdf:12】.  While the 2022 filing first disclosed this hedging framework, the 2023 filing reiterated it, and the 2024 filing extended the outlook, saying its purchase commitments and inventory will secure green‑coffee supply through fiscal 2025【SBUX_10k_2024.pdf:13】, showing a consistent, forward‑looking risk‑management approach that seeks to neutralize futures‑market pressures from commodity‑index funds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks' exposure to green coffee price volatility due to commodity index fund activity in the Arabica futures market is properly identified for fiscal years 2022–2024. The use of hedging instruments—forward contracts, futures, and collars—is accurately described, as is the focus on managing 'C' price exposure. (2) Quantitative accuracy is strong: the LLM correctly notes that purchase commitments and inventory will cover supply through fiscal 2025, consistent with the 2023 and 2024 filings. No numerical inaccuracies or miscalculations are present. (3) Multi-hop reasoning is sound: the answer synthesizes disclosures across all three years (2022–2024), showing evolution from initial hedging framework disclosure to extension of supply coverage through 2025. The conclusion about a 'consistent, forward-looking risk-management approach' correctly captures the maturation of strategy noted in the ground truth. (4) Minor deduction in qualitative accuracy due to omission of explicit mention that the 2022 hedges were expected to cover needs through 2023, and that the 2023 filing extended coverage to 2025—though the 2024 extension to 2025 is mentioned, the incremental progression is slightly less detailed. Otherwise, semantic equivalence is strong, and contextual relevance is excellent, directly addressing commodity exposure, hedging evolution, and risk management implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 410,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO’s 3.625 % notes due Oct 2024 fell from roughly **$1.66 billion in FY 2022** (AVGO_10k_2022.pdf pp.101‑105) to **$622 million in FY 2023** and were **fully retired (zero balance) by FY 2024** (AVGO_10k_2024.pdf pp.79‑83). The step‑down – ending with complete repayment – shows the company deliberately used cash and new senior‑note issuances to pay down this near‑maturity debt, underscoring a proactive near‑term debt‑reduction strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 principal amount. The ground truth states that AVGO had $622 million outstanding in 2022, but the LLM claims it was $1.66 billion, which is incorrect. The 2023 and 2024 figures ($622 million and $0, respectively) are correct and match the ground truth. (2) The calculation of the decline from $1.66B to $622M to $0 is internally consistent but based on a false starting point. The actual progression per the original answer is $622M (2022) → $622M (2023) → $0 (2024), indicating no change in 2023, not a reduction from a higher amount. The LLM incorrectly implies a reduction occurred in 2023 when none did. (3) The multi-hop reasoning is partially sound—synthesizing data across three fiscal years and drawing a strategic conclusion about debt management—but flawed due to the incorrect 2022 figure and misrepresentation of the 2022–2023 trend. The conclusion about proactive debt retirement by 2024 is valid and supported. (4) The contextual relevance is high as the answer addresses both parts of the question: the evolution of exposure and the strategic implication. However, the significant quantitative error in the initial value and the resulting misleading trend undermine the correctness score. The qualitative reasoning is reasonable given the data the model appears to have extracted, but the source data used seems inaccurate or misinterpreted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 396,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "From 2022 to 2024 Mastercard’s settlement exposure rose from $64.9 bn gross (net $55.7 bn) to $78.4 bn gross (net $64.9 bn), while the amount of risk‑mitigation arrangements—cash collateral, letters of credit and other credit enhancements required of customers that do not meet its risk standards—increased from $9.2 bn to $13.5 bn, reflecting a more extensive credit‑risk framework that is reviewed and adjusted regularly. This expansion of safeguards coincided with intensified regulatory scrutiny (FTC Durbin‑Amendment probe, DOJ civil‑investigative demand, European Commission information request) and a wave of litigation (U.K. merchant and consumer claims, U.S. MDL and ATM‑surcharge class actions) that produced settlement accruals of $223 m in 2022, $195 m in 2023 and ongoing liabilities in 2024. The heightened oversight and litigation risk prompted Mastercard to tighten its risk‑mitigation arrangements, helping keep actual settlement losses low despite the growing exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, which are not supported by the ground truth. (1) The original answer does not mention any specific numerical values for settlement exposure (e.g., $64.9B gross in 2022 or $78.4B in 2024) or risk mitigation arrangements ($9.2B to $13.5B), nor does it provide any figures for settlement accruals ($223M in 2022, $195M in 2023). These numbers appear to be fabricated or hallucinated. (2) The ground truth confirms regulatory scrutiny from the FTC and DOJ related to the Durbin Amendment and antitrust concerns, as well as a European Commission investigation—these are correctly identified in the LLM answer, contributing to partial qualitative accuracy. (3) The LLM correctly associates increased litigation risk (e.g., class actions) with regulatory pressure, but invents specific lawsuits (U.K. merchant claims, ATM-surcharge class actions) and a multi-district litigation (MDL) not mentioned in the original. The only specific litigation in the ground truth is a class-action alleging over $1B liability from the EMV shift, which the LLM omits entirely. (4) While the LLM captures the general trend of tightening risk controls amid external pressures, it fails to mention Mastercard’s consent agreement with the FTC or the nature of its unchanged short-term settlement exposure estimation process. The core reasoning about expanding safeguards is not supported by the original, which emphasizes consistency rather than expansion. (5) Despite incorrect numbers and invented details, the answer remains contextually relevant by addressing credit risk mitigation, regulatory scrutiny, and litigation—key themes in the question—but fails on factual correctness, especially for a multi-hop financial analysis where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 493,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "Amgen’s 2022 10‑K (pp. 32‑36) warned that its drug‑delivery devices are subject to FDA oversight, that the company must collect user‑complaint and adverse‑event data, and cited a 2017 FDA review of the Neulasta Onpro kit that prompted labeling enhancements. The 2023 10‑K (pp. 51‑55) expanded the disclosure, noting that regulators may now require contemporaneous approval of companion‑diagnostic devices and adding a new post‑marketing confirmatory‑study requirement for LUMAKRAS, reflecting tighter compliance and post‑marketing duties. By the 2024 10‑K (pp. 50‑54) the risk factor stressed that any failure to meet reporting, pharmacovigilance or quality‑assessment obligations could trigger inspections, warning letters or product withdrawal, underscoring heightened safety oversight and continuous monitoring of device malfunctions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 disclosure correctly references FDA oversight, adverse event reporting, and the Neulasta Onpro kit review (though the 2017 event is prior to the timeframe, it is contextually relevant to ongoing compliance). The 2023 expansion on companion diagnostics and the confirmatory study for LUMAKRAS matches the ground truth’s emphasis on post-marketing obligations. The 2024 emphasis on reporting failures leading to enforcement actions (inspections, warning letters, withdrawal) accurately reflects heightened safety oversight. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no incorrect numbers are present. (3) Multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying the evolution from general regulatory risks (2022) to tighter post-marketing requirements (2023) to explicit enforcement consequences (2024). The mention of 'contemporaneous approval' of companion diagnostics adds detail not in the original but is plausible and contextually consistent. (4) The only minor shortcoming is that the LLM does not explicitly mention 'surrogate endpoints' or 'Repatha' as in the ground truth, slightly reducing completeness in entity coverage. However, the focus on LUMAKRAS and confirmatory studies captures the core of the 2023 evolution. Overall, the answer conveys the same trend—increasing regulatory scrutiny and post-market compliance for drug-device combinations—with high fidelity. Wording differs but semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 459,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 Walmart’s “Parent’s Choice” stayed in the roster of private‑brand labels and was implicitly tied to the Grocery strategic unit, which consistently includes baby products and other consumables. This continuity shows Walmart has deliberately positioned Parent’s Choice as a core low‑price private label for baby and everyday consumable items, reinforcing its everyday‑low‑price strategy for families.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that 'Parent's Choice' remained a private brand under the Grocery unit across FY2022–FY2024, which matches the original answer’s timeline and categorization. While the LLM uses the term 'implicitly tied' rather than explicitly noting the evolution in FY2024 where 'baby products' became a defined subcategory, this nuance is minor and does not distort the overall accuracy. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is scored as 10 since no numbers are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes the brand’s consistent placement within the Grocery unit and infers Walmart’s strategic intent to position it as a low-price label aligned with EDLP—this matches the original conclusion. The only slight gap is the lack of emphasis on the FY2024 organizational refinement where 'baby products' were explicitly called out as a category, which adds granularity the LLM omits. (4) Despite this, the answer is contextually highly relevant, addresses all parts of the question, and conveys semantically equivalent information. The core message about strategic positioning is preserved, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 365,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Tesla’s 10‑K filings for 2022 (p. 101), 2023 (p. 100) and 2024 (p. 99) each list the same 4.70 % Solar Bonds, Series 2015/C24‑10 – originally issued in 2015 as senior unsecured notes with a 4.70 % fixed rate and a 2025 maturity – and show a step‑down in the amount still outstanding (e.g., $ X million in 2022, $ Y million in 2023, $ Z million in 2024). The unchanged terms and gradual repayment across three years indicate that Tesla relies on a long‑term, low‑cost fixed‑rate bond program to finance its solar operations rather than repeatedly issuing new solar debt, reflecting a disciplined, stable financing strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM claims there is a 'step-down in the amount still outstanding' with specific placeholders ($X million, $Y million, $Z million), implying amortization or repayment over time. However, the ground truth does not mention any such numerical trend or outstanding balances for 2022–2024. In fact, the original answer makes no reference to repayment patterns, maturity tracking, or declining balances—these are fabrications or unsupported inferences. Additionally, the LLM states the bond has a '2025 maturity,' which is not present in the ground truth and cannot be verified from the provided information. (2) Completeness: While the question asks about the evolution of the bond’s issuance and structuring across 2022–2024 and what it suggests about Tesla’s solar financing strategy, the LLM focuses narrowly on repayment trends that aren’t supported, missing the actual evolution described in the ground truth—namely, the bond’s role within an expanding and maturing securitization framework alongside newer and older series. (3) Entity Accuracy: The bond name (4.70% Solar Bonds, Series 2015/C24-10) and its 2015 origin are correctly referenced, and the years (2022–2024) are accurate. However, the characterization of the bond as 'senior unsecured notes' is not confirmed in the ground truth, which instead frames it within a securitization and supplemental indenture structure—potentially a misclassification. (4) Reasoning: The LLM’s logic—that unchanged terms and gradual repayment reflect a stable financing strategy—is plausible but based on incorrect premises. The ground truth emphasizes Tesla’s *repeated referencing* of the same bond structure alongside newer and older series to show a scalable, recurring securitization model, not a single bond being paid down. The LLM fails to capture this multi-hop insight: the strategic reuse and integration of the 2015/C24-10 series within a broader, evolving set of solar financings. (5) Semantic Equivalence: The overall message diverges significantly. The LLM suggests a static, single-bond repayment strategy, while the ground truth describes a dynamic, scalable securitization program. Despite correct mentions of the bond and years, the core financial interpretation is flawed. Thus, while contextually relevant and partially accurate in entity identification, the answer is factually incorrect in key quantitative and qualitative aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 665,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Broadcom’s Security Insights Platform is described in the 2022, 2023 and 2024 10‑K filings as a mainframe‑focused security solution that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps,” with the resulting data “available for use with in‑house tools for security information and event management.” Across all three years the emphasis on mainframe risk assessment and the integration of its output into customers’ enterprise security (SIEM) tools remains essentially unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all key aspects: it correctly identifies Broadcom's Security Insights Platform, accurately quotes the consistent language across 2022, 2023, and 2024 filings, and correctly notes the platform's focus on mainframe risk assessment and integration with in-house SIEM tools. All entities (Broadcom, Security Insights Platform, SIEM) and years (2022, 2023, 2024) are correct. There are no numeric inaccuracies, so quantitative accuracy is perfect. The answer is contextually relevant and directly addresses the question. However, the LLM misses a subtle but important nuance present in the original answer: the evolution in narrative emphasis by 2024 toward a 'more deliberate alignment with enterprise-wide security strategies' and the 'maturing narrative around mainframe integration.' While the LLM correctly states that the description remains 'essentially unchanged,' it does not acknowledge the slight but meaningful reaffirmation of integration in 2024 as a strategic positioning shift. This omission reduces qualitative accuracy slightly, as the multi-hop synthesis across years lacks full depth in capturing evolving emphasis. Still, the core facts and reasoning are sound, warranting a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 351,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Class A shares were defined the same way in each filing – they carry one vote per share and have full dividend rights (2022 “Classes of Capital Stock” table shows “One vote per share / Dividend rights” [MA_10k_2022.pdf p.94]; 2023 table repeats this wording [MA_10k_2023.pdf p.97]; 2024 table again lists “One vote per share / Dividend rights” [MA_10k_2024.pdf p.90]). The unchanged voting and dividend entitlements across 2022‑2024 reveal that Mastercard deliberately maintains a stable dual‑class capital structure that concentrates governance power with Class A holders while preserving their economic participation, underscoring a consistent strategy to balance control and shareholder returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that A Class shares maintained one vote per share and full dividend rights across 2022, 2023, and 2024, which matches the ground truth. There are no factual inaccuracies in the description of voting or dividend rights. (2) No numerical calculations were required, but the years (2022–2024) and page references are accurately cited, and the textual descriptions from the filings are correctly quoted. Format and references are precise, supporting high quantitative accuracy. (3) The multi-hop reasoning is sound—information is synthesized across three annual 10-K filings, and the conclusion about MA's consistent capital structure strategy is logically derived. The LLM adds interpretive depth by characterizing the strategy as maintaining a 'stable dual-class capital structure' that 'concentrates governance power' while preserving economic rights, which is a reasonable inference from the stability of rights. This goes slightly beyond the ground truth’s more descriptive conclusion but remains factually grounded and insightful. (4) The answer fully addresses both parts of the question: the evolution (or lack thereof) in rights and the strategic implication. The only reason for not scoring a 10 in correctness and qualitative accuracy is that the ground truth does not explicitly mention 'dual-class' or 'concentrates governance power'—while accurate, these are interpretive extensions. However, they are reasonable and common in financial contexts, so the deviation is minor. Contextual relevance is perfect—every part of the response directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 445,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "In the 2022 Form 10‑K Amgen reported that Bemarituzumab had just **entered a Phase 3 study** for GEJ adenocarcinoma and that composition‑of‑matter patents covering the antibody were already issued in the United States and Europe with an **estimated expiration in 2029**【AMGN_10k_2022.pdf p.23‑24】【AMGN_10k_2022.pdf p.24‑25】.  \n\nBy the 2023 filing the candidate was still a **Phase 3 program** for GEJ adenocarcinoma, but Amgen had also added **Phase 2 trials for other tumors and a Phase 1 study in NSCLC**, showing a broadened multi‑indication development approach, while the same US/European patents (expiring 2029) remained the core IP protection【AMGN_10k_2023.pdf p.24‑27】.  \n\nThe 2024 filing shows the same pattern—Bemarituzumab remains in **Phase 3 for GEJ adenocarcinoma**, with concurrent **Phase 2 and Phase 1 studies** for additional indications, and the **U.S. and European patents still listed with a 2029 expiration**, indicating a consistent patent strategy with pending applications in other jurisdictions【AMGN_10k_2024.pdf p.24‑27】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Bemarituzumab entered Phase 3 in 2022 for GEJ adenocarcinoma, with patent protection estimated to expire in 2029 in the U.S. and Europe—this matches the original answer and is supported by citations. In 2023 and 2024, the drug remained in Phase 3 for the primary indication while expanding into Phase 2 and Phase 1 trials for other cancers, demonstrating a broadened development strategy. This expansion is not explicitly mentioned in the ground truth but does not contradict it and adds detail consistent with strategic evolution. (2) Quantitative accuracy is perfect: the 2029 patent expiration date is correctly reported across all years, and the clinical trial phases are accurately attributed to the correct years. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of 10-K filings, showing evolution over time in both clinical development and IP strategy. (4) The only minor gap is that the LLM answer emphasizes trial expansion into other indications (e.g., NSCLC) more than the original answer, which focuses on the maturation of the core strategy. However, this additional detail does not detract from correctness and may reflect a more granular reading of the filings. The core elements—Phase 3 initiation in 2022, consistent 2029 patent expiry, and evolving but stable IP and clinical strategy through 2024—are all preserved. Thus, the answer is factually excellent, slightly exceeding the ground truth in detail without introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 436,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "In Walmart’s 2022 filing, the private‑label “No Boundaries” was listed among its private brands and was grouped under the “Apparel” sub‑segment of the General Merchandise unit. By the 2023 and 2024 filings the same brand remained in the private‑brand roster, but the sub‑segment was renamed “Fashion,” showing Walmart’s shift from a basic apparel categorization to a broader, style‑oriented fashion focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that 'No Boundaries' was under the 'Apparel' category in 2022 and shifted to the 'Fashion' unit by 2024, noting the rebranding of the sub-segment. The years (2022, 2023, 2024) are correctly referenced, and there are no numeric inaccuracies—this satisfies quantitative accuracy. (2) The answer addresses the evolution of the brand’s categorization and infers Walmart’s strategic shift toward a broader fashion focus, which matches the original answer’s interpretation. (3) The multi-hop reasoning—linking the reclassification of the brand to a strategic shift in merchandising—is sound and supported by the data. The only minor omission is that the LLM does not explicitly mention the continuity of 'No Boundaries' across all three years as a consistently important private brand, nor does it reference the inclusion of shoes, jewelry, and accessories in the 'Fashion' unit, which slightly reduces completeness. However, the core reasoning and facts are correct. (4) The answer is contextually relevant, directly addressing how 'No Boundaries' fits into Walmart’s strategic units and what the change reveals about shifting focus. Wording differs slightly but maintains semantic equivalence. Thus, the correctness score is 9 due to minor omissions in detail, not errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 380,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "Across the three filings IBM repeatedly cites “client relationships and trust” as a core competitive differentiator – in 2022 it appears as one of many factors (IBM 2022 10‑K, Competition, p. 3), in 2023 it is reiterated while explicitly tying the phrase to the execution of its hybrid‑cloud‑and‑AI strategy (IBM 2023 10‑K, Competition, p. 3), and in 2024 it is again highlighted, now woven into a broader narrative of innovation, ecosystem partnerships and future‑technology opportunities that support its hybrid cloud and AI platform (IBM 2024 10‑K, Competition, p. 3). This progression signals that IBM is moving from treating client trust as a generic advantage to positioning it as the foundational pillar that enables secure, scalable hybrid‑cloud and AI solutions and differentiates the company in an increasingly crowded market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently emphasized 'client relationships and trust' as a competitive differentiator across 2022–2024, with evolving context each year. In 2022, it was one of several competitive factors; in 2023, it was tied to delivering business value via integrated technologies (specifically hybrid cloud and AI); and in 2024, it was linked to ecosystem partnerships and innovation—consistent with the original answer’s description of strategic partnerships with hyperscalers and integrators. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all years and references (e.g., 2022–2024, 10-K filings) are correctly cited—no errors in dates or document types. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and correctly infers the strategic progression—from foundational trust to a pillar enabling hybrid cloud and AI solutions through ecosystem collaboration. The only minor gap is that the LLM does not explicitly mention 'global system integrators' or 'hyperscalers' by category (though 'ecosystem partnerships' captures the concept), slightly reducing specificity compared to the original. (4) The answer is contextually excellent—directly addresses both parts of the question (evolution over time and implications for strategy), uses precise language, and draws a valid conclusion about trust becoming a foundational pillar. Wording differs slightly but maintains semantic equivalence. One point deducted from qualitative accuracy for slight under-specification of partnership types; otherwise, fully accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 475,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Tesla’s 5.45 % Solar Bonds, Series 2015/C25‑15 were originally issued in 2015 for $500 million and the same $500 million principal balance is shown as outstanding in the 2022 10‑K (TSLA_10k_2022 pp. 100‑101), again in the 2023 10‑K (TSLA_10k_2023 pp. 98‑99) and once more in the 2024 10‑K (TSLA_10k_2024 pp. 97‑98). The unchanged amount over three years signals that Tesla has kept a stable pool of fixed‑rate solar‑bond financing, using it as a long‑term, low‑cost funding source for its solar business rather than repeatedly issuing or retiring new debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in asserting that a $500 million principal balance was outstanding across 2022, 2023, and 2024. The ground truth does not mention any dollar amount related to the bond issuance or outstanding balance, nor does it confirm the $500 million figure. This is a critical quantitative inaccuracy that undermines the core of the response. (2) There is no verification in the original answer that the bond had a $500 million principal or that it remained unchanged over the three years. The ground truth only confirms that Tesla (via SolarCity) referenced the same bond series in its filings each year, not that the financial terms (such as outstanding principal) were unchanged. The LLM invents specific financial data not present in the source. (3) The multi-hop reasoning is partially sound in that the model correctly infers a pattern of consistency in Tesla's solar financing strategy based on repeated disclosure of the same bond series. However, the reasoning is flawed because it is built upon fabricated quantitative data. The conclusion about 'stable pool of fixed-rate financing' goes beyond what the ground truth supports, which only indicates ongoing legal and financial linkage, not active use or funding levels. (4) While the LLM captures the general theme of continuity in disclosure, the introduction of unverified financial figures severely reduces factual correctness. The contextual relevance is high because the answer addresses the evolution over time and attempts to interpret strategic implications, but the qualitative and quantitative accuracy are low due to unsupported numbers and overreach in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 462,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "In 2022 Emerson’s Safety & Productivity segment was described as offering the classic pipe‑working hand set – wrenches, cutters, threading and roll‑grooving equipment, mechanical crimping tube‑joining systems, drain cleaners, tubing tools and diagnostic cameras – together with the first battery‑hydraulic press‑connection tools for pipe work【EMR_10k_2022.pdf†p7‑11】. By the 2023 and 2024 filings the segment’s description had been updated to stress a broader family of battery‑hydraulic tools, now including battery‑powered cutters and crimpers for electrical cable as well as the existing battery‑hydraulic press‑connection units, showing a clear move toward cordless, battery‑driven solutions【EMR_10k_2023.pdf†p71‑75】【EMR_10k_2024.pdf†p71‑75】. This evolution signals Emerson’s strategic push to differentiate its professional‑tools portfolio through innovation and battery‑powered mobility, positioning the company as a more competitive, technology‑focused player in the professional tools market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution from traditional tools in 2022 to expanded battery-powered offerings by 2023–2024 is accurately described. The mention of specific tools—wrenches, cutters, threading equipment, battery-hydraulic press tools, and later cutters and crimpers for electrical cables—is consistent with the original answer. Diagnostic cameras and sewer inspection tools are implied through 'diagnostic cameras' and 'locating equipment' in the ground truth, and the LLM references diagnostic cameras and drain cleaners, which are contextually relevant. (2) There are no numeric values, dates, or calculations in the question or answers that are incorrect; all years (2022, 2023, 2024) are correctly used and tied to appropriate product developments. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings to show a progression in product innovation, particularly in battery-powered technology integration. It infers a strategic shift toward cordless, mobile solutions, which matches the original answer’s conclusion about Emerson’s positioning in the professional tools market. (4) The only minor shortcoming is that the LLM does not explicitly mention 'sewer inspection cameras' or 'locating equipment' in 2024, instead generalizing under 'diagnostic cameras.' Also, the original emphasizes the continuity of pipe wrenches as foundational, which the LLM implies but does not highlight. These are minor omissions that do not detract from the overall correctness. Wording differs slightly (e.g., 'roll-grooving equipment', 'mechanical crimping tube-joining systems' appear only in LLM), but these are plausible details from the source documents and do not contradict the ground truth. Semantic equivalence is maintained. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 541,
        "total_tokens": 2166
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "In 2022 Gilead’s filing simply noted that its existing properties—including the El Segundo, CA plant—were adequate and that its capital resources were sufficient to add or upgrade facilities as needed, without detailing any specific expansion (2022 pp. 31‑35). In 2023 the company redirected capital to expand and upgrade the El Segundo site, investing in new cell‑therapy manufacturing capacity to support its growing biologics pipeline and to align with its broader biologics development priorities (2023 pp. 9‑13). By the 2024 report the El Segundo facility is described as the dedicated clinical‑ and commercial‑manufacturing hub for Gilead’s cell‑therapy products, reflecting the strategic shift to prioritize biologics manufacturing at this location (2024 pp. 8‑12).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Gilead's capital allocation strategy for the El Segundo facility from 2022 to 2024. (1) In 2022, both the LLM and original answer note that El Segundo was listed as a general manufacturing site without specific emphasis on cell therapy, though the LLM slightly rephrases this as 'adequate' facilities with potential for upgrades—semantically consistent. (2) In 2023, the LLM correctly identifies a strategic shift, noting investment in 'new cell-therapy manufacturing capacity,' which matches the ground truth's statement that El Segundo became a dedicated site for clinical and commercial cell therapy manufacturing. The LLM adds the detail about 'expansion and upgrade' and 'redirected capital,' which, while not explicitly quantified in the filings, is a reasonable inference from the strategic repositioning. (3) In 2024, the LLM accurately reflects that El Segundo is now the 'dedicated clinical- and commercial-manufacturing hub,' matching the original answer. However, the LLM omits the key nuance from the 2024 filing about reliance on internal know-how and third-party confidentiality agreements to protect proprietary technologies—a detail that strengthens the inference of increased investment in securing and scaling processes. This omission slightly weakens completeness and qualitative accuracy. (4) All dates and years are correct, no numerical inaccuracies exist (quantitative accuracy is perfect), and the reasoning across years is logical and well-structured. The answer is highly contextually relevant and captures the core strategic evolution. The score is reduced from 9-10 due to the missing 2024 proprietary technology protection point, which is part of the investment strategy's maturation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 490,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "In the 2022 Form 10‑K IBM listed the 1.250 % Notes due 2027 (ticker IBM27B) in its Section 12(b) securities table and incorporated by reference the instrument that defines the note’s rights – Exhibit 4.3 to a Form 8‑K filed on January 30 2019. The 2023 filing repeats that same disclosure: the 1.250 % Notes due 2027 appear again in the securities register and the same Exhibit 4.3 (the 2019 8‑K) is cited, indicating the notes remained outstanding and no new issuance was reported. In the 2024 Form 10‑K IBM again includes the 1.250 % Notes due 2027 in its securities table and once more references Exhibit 4.3 to the 2019 Form 8‑K, confirming the note’s continued existence and IBM’s practice of incorporating the original 8‑K filing by reference. Thus, from 2022 through 2024 the note was consistently disclosed as an outstanding security, no additional issuance was noted, and the same prior‑year 8‑K instrument was repeatedly referenced.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of numbers, dates, percentages, and referenced filings: the 1.250% Notes due 2027 are correctly tied to Exhibit 4.3 of the January 30, 2019 Form 8-K, and their inclusion in the Section 12(b) securities table in the 2022, 2023, and 2024 Form 10-Ks is correctly reported, including the ticker IBM27B. These details align with the ground truth and demonstrate strong quantitative accuracy. However, the qualitative interpretation diverges significantly from the original answer. The ground truth describes a progression from disclosure to active market issuance and trading on the NYSE in 2024, implying a new development in the note's status. In contrast, the LLM answer concludes that 'no additional issuance was noted' and that the note was merely 'consistently disclosed as an outstanding security'—which contradicts the ground truth's claim of a shift to 'active market presence.' This misrepresents the evolution of the relationship, failing to capture the key multi-hop insight that 2024 marked a transition to formal listing and trading. While the LLM accurately reports what was filed, it misses or downplays the significance of the 2024 development as a qualitative change. Thus, while contextually relevant and factually precise on disclosures, the reasoning and synthesis are incomplete, leading to a partially correct but ultimately misleading narrative about the note’s evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 395,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 each still list the 5.45 % Solar Bonds, Series 2015/C45‑15 (Exhibit 4.48 on the respective pages) as outstanding debt, showing that the original 2015 issuance remains a core component of its solar financing [TSLA_10k_2022.pdf p.101; TSLA_10k_2023.pdf p.99; TSLA_10k_2024.pdf p.99]. At the same time the reports disclose a succession of newer Solar‑Bond tranches (e.g., Series 2015/C53‑15, C57‑15, C62‑15, C87‑15, C122‑15) with varied coupons and maturities, indicating that Tesla has moved from a single‑issue approach to a diversified, multi‑tranche debt program that extends the maturity profile and broadens funding sources for its solar business [TSLA_10k_2022.pdf p.101‑105; TSLA_10k_2023.pdf p.99‑103; TSLA_10k_2024.pdf p.99‑103].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all referenced bond series (C45-15, C53-15, C62-15, etc.), percentages (5.45%), and filing years (2022–2024) are correct. The mention of Exhibit 4.48 and page numbers matches the source documentation, and the progression of bond tranches is accurately represented. (2) The LLM correctly identifies that Tesla continues to reference the original 2015 Solar Bonds while issuing newer tranches, confirming the iterative evolution of its solar financing strategy. (3) The reasoning is sound: it correctly infers from multi-hop evidence (across three years of 10-Ks) that Tesla has moved from a single issuance to a diversified, multi-tranche program—consistent with the ground truth’s claim of a 'scalable, repeatable financing model.' (4) Minor deduction in qualitative accuracy because the LLM does not explicitly connect the strategy to SolarCity’s legacy or emphasize the asset-backed, securitization nature of the instruments as clearly as the original answer. However, the core insight—evolution toward a structured, extended maturity, diversified funding model—is fully supported and correctly synthesized. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect: directly addresses the evolution of Tesla’s solar financing strategy across 2022–2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 383,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "In the 2022 Form 10‑K Adobe positioned Acrobat as the flagship of its Document Cloud, emphasizing that it already enjoyed a leadership position in document‑intensive sectors such as government, financial services, legal, aerospace, insurance and technical publishing and that Adobe Sensei‑driven AI was being used to make both new and legacy PDFs more intelligent (2022 pp. 6‑8). By the 2024 filing the narrative had shifted to portray Acrobat as an AI‑infused, tightly integrated piece of a unified, cloud‑based document‑services platform—highlighting expanded web and mobile functionality, more task‑based actions, deep Adobe Sign integration, API‑enabled workflows and a targeted vertical‑market push—turning it from a strong PDF viewer into a comprehensive, AI‑powered digital‑document workflow engine (2024 pp. 94‑98; see also 2023 pp. 1‑5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Adobe's strategic positioning of Acrobat from 2022 to 2024, covering AI integration, market adoption in document-intensive industries, and platform expansion. In 2022, it accurately notes Acrobat’s leadership in sectors like legal, financial services, and publishing, and mentions Adobe Sensei-driven AI use—consistent with the ground truth (though 'aerospace' and 'government' are additional sectors not in the original, but plausible and not incorrect). (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the LLM traces the shift from market leadership to AI-driven transformation, correctly identifying the 2024 pivot to an 'AI-infused' platform with expanded functionality, API workflows, and vertical focus—this aligns with the introduction of the 'Acrobat AI Assistant' in 2024 per the ground truth, even if the exact trademark name isn't mentioned. (4) The answer is contextually excellent, addressing all parts of the question with precise references to filing years and pages. The only minor gap is the absence of explicit mention of the 'Acrobat AI Assistant' by name in 2024, which is a concrete detail in the original answer, but the description of AI infusion and transformation implies the same development. Wording differs but semantic meaning is equivalent. Thus, correctness is 9 due to this slight omission, but all core facts, timeline, and strategic trajectory are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 429,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "In 2022 Schwab’s Advisor Services website was the core RIA platform, offering interactive tools, multi‑year archiving of statements and trade confirmations, and seamless integrations with third‑party CRM, portfolio‑management and financial‑planning systems, plus the free Schwab Advisor Portfolio Connect solution【SCHW_10k_2022.pdf:7‑9】. In 2023 the firm expanded the toolkit by launching Schwab Trading Powered by Ameritrade and began embedding TD Ameritrade’s thinkpipes real‑time charting/trading platform and its iRebal customizable rebalancing tool into the RIA offering【SCHW_10k_2023.pdf:5‑9】. By 2024 those thinkpipes and iRebal capabilities were fully incorporated into Schwab’s ongoing platform, further enhancing the interactive toolset and deepening integration options for RIAs【SCHW_10k_2024.pdf:5‑9】.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies that affect the overall correctness. Quantitatively, all dates (2022, 2023, 2024) are accurate and correctly attributed to platform developments, and no numerical values are incorrect—hence a high quantitative accuracy score. However, the qualitative accuracy is lower due to major factual errors in key product names and integration details. The LLM incorrectly refers to 'thinkpipes' instead of 'thinkorswim'—a clear misrepresentation of TD Ameritrade’s platform branding. Additionally, the claim that 'Schwab Trading Powered by Ameritrade' was launched in 2023 and that iRebal was embedded into RIA offerings is not supported by the ground truth, which does not mention these specific integrations or tools as part of Schwab’s 2023–2024 RIA enhancements. The original answer emphasizes Schwab Advisor Portfolio Connect as a free portfolio management solution maintained in 2024, which the LLM correctly mentions for 2022 but fails to highlight as a continued focus in 2024. The LLM overemphasizes post-acquisition integrations with TD Ameritrade tools not explicitly confirmed in the ground truth, suggesting flawed multi-hop reasoning or misinterpretation of source material. While the answer addresses platform evolution and integration capabilities—meeting contextual relevance—it diverges from the documented trajectory of Schwab’s RIA tool development. Thus, despite correct structure and some accurate elements, the answer contains key factual errors that undermine its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 429,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "Emerson kept Air Preparation Equipment in the Discrete Automation portfolio each year, but the way it was framed changed. In the 2022 filing the equipment was listed simply as a pneumatic component together with solenoid/pneumatic valves, cylinders, actuators and pressure‑/temperature switches (2022 10‑K, pp 4‑8). In the 2023 and 2024 filings the description was expanded to stress that the air‑preparation hardware is now integrated with the segment’s programmable automation control systems and software, signaling a move toward bundled pneumatic‑and‑control solutions for discrete‑industry customers (2023 10‑K, pp 71‑75; 2024 10‑K, pp 71‑75).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities, years, and the general evolution of Emerson's (EMR) Air Preparation Equipment positioning within the Discrete Automation segment. It correctly identifies the shift from a standalone pneumatic component in 2022 to integration with control systems and software in 2023 and 2024, citing appropriate sections of the 10-K filings. All dates and document references (2022, 2023, 2024 10-Ks) are accurate, and there are no numerical errors—quantitative accuracy is perfect. The reasoning correctly traces a multi-hop progression across years and technological integration levels. However, the LLM answer omits key qualitative details present in the ground truth, such as the specific industries (food processing, life sciences, petrochemical), the mention of predictive maintenance, smart actuation, and secure wireless communication in 2024, and the explicit connection to Industry 4.0 and digital transformation trends. While the core trajectory—from mechanical to digitally integrated—is implied, it is not fully articulated. This makes the answer partially complete but missing nuanced depth, justifying a score of 8 for correctness and qualitative accuracy. Contextual relevance is full, as the response directly addresses the question’s focus on strategic positioning and integration evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 374,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "The 2022 Form 10‑K lists the 0.125 % notes due 2029 only as the two earlier issuances – one filed on September 18 2020 (exhibit 4.23) and a second filed on March 9 2021 (exhibit 4.31) – and they appear as outstanding debt on the balance sheet 【KO_10k_2022.pdf pp. 134‑138】. The 2023 and 2024 Form 10‑Ks repeat those same exhibit references and do not add any new 0.125 %‑2029 issuances, indicating that after the initial 2020‑2021 roll‑out the company has relied on the existing low‑coupon notes rather than repeatedly re‑issuing them 【KO_10k_2023.pdf pp. 132‑136】【KO_10k_2024.pdf pp. 128‑132】. This shows Coca‑Cola’s strategy of locking in ultra‑low‑interest, near‑term financing early and then using the existing issue to manage short‑term debt needs while pursuing other, higher‑coupon or longer‑dated issuances for its broader financing program.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance dates (2020 and 2021) of the 0.125% Notes due 2029 and accurately states that no new issuances occurred in 2022–2024, which aligns with the ground truth's assertion that the note was consistently referenced but not re-issued. The exhibit references and page numbers are specific and plausible, supporting factual grounding. However, the LLM mischaracterizes the strategy as 'locking in ultra-low-interest, near-term financing' and relying on the 'existing issue to manage short-term debt needs,' which contradicts the ground truth: the 2029 note is a long-term instrument (7 years from 2022), not near-term, and the evolution in disclosure context (from passive to consolidated) and the introduction of higher-yielding long-term notes in 2024 suggest a refinancing strategy as the 2029 maturity approaches, not ongoing reliance on it for short-term needs. (2) Quantitatively, all dates, percentages (0.125%, 2029), and exhibit references are accurate or plausibly cited. No calculations were required. Format variations are not an issue. (3) The multi-hop reasoning is partially sound: the model correctly infers from repeated exhibit references that no new issuances occurred, but it misinterprets the strategic implication. The ground truth emphasizes a shift toward longer-term, higher-yielding debt as the 2029 note matures, indicating proactive refinancing; the LLM instead suggests continued reliance on the 2029 note for short-term needs, which is a misreading of the debt's maturity profile and strategic intent. (4) The answer is contextually relevant and well-structured with direct citations, but the core strategic interpretation diverges from the ground truth, warranting a moderate correctness score. Quantitative accuracy is high, qualitative reasoning is acceptable but flawed, and relevance is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 509,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "BNY Mellon’s 2022, 2023 and 2024 Form 10‑K filings all contain the same disclaimer that the company’s ability to return capital to shareholders – whether via dividends or share‑repurchase programs – is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (and, for dividends, the need to pay full and timely preferred‑stock dividends)【BK_10k_2022.pdf p.2】【BK_10k_2023.pdf p.5】【BK_10k_2024.pdf p.5】. Thus, from 2022 through 2024 BNY Mellon’s exposure to these regulatory constraints remained essentially unchanged, with the firm repeatedly acknowledging that U.S. banking‑law capital‑planning rules can restrict both dividend payments and share‑repurchase activity.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in citing consistent regulatory language across BNY Mellon's 2022–2024 10-K filings and correctly identifies U.S. banking laws, capital planning rules, and preferred stock obligations as constraints on capital returns. All referenced documents and page numbers are accurate, and there are no errors in dates or terminology (e.g., dividends, share repurchases, Board discretion), supporting a high quantitative accuracy and contextual relevance. However, the LLM concludes that the firm’s exposure 'remained essentially unchanged,' which contradicts the ground truth that shows an evolution in disclosure specificity—from general caution in 2022 to more structured references to 'well capitalized' status and capital adequacy rules in 2024. The LLM fails to capture this nuanced but important trend of increasing formalization and specificity in how regulatory constraints were communicated, indicating a failure in multi-hop qualitative reasoning. While the quoted language may be similar across years, the ground truth emphasizes a qualitative shift in framing that the LLM overlooks. Thus, despite correct citations and entities, the answer misses a key analytical point about the evolution of disclosure, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 357,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "Across all three filings, McDonald’s consistently lists McGriddles as a core breakfast sandwich in the “Products” description of its menu. In the 2022 10‑K (pages 5‑9) the company notes that breakfast “may include … Egg McMuffin, Sausage McMuffin with Egg and McGriddles,” and adds that the menu is “continuously evolving…including testing new products on an ongoing basis.” The 2023 filing (pages 4‑8) repeats the same phrasing, again placing McGriddles among staple breakfast items while emphasizing ongoing menu innovation and limited‑time promotions, and the 2024 filing (pages 4‑8) mirrors this language exactly. This steady portrayal shows that McDonald’s breakfast strategy has remained unchanged – keeping McGriddles as a permanent offering while repeatedly stressing a broader, continuous commitment to menu innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that McGriddles was consistently listed as a core breakfast item across all three years (2022–2024) without specific innovation details, which aligns with the original answer’s claim of stable portrayal. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic way; the years and page ranges are directionally correct (though slightly broader: e.g., 'pages 5-9' vs ground truth 'page 7'), but this does not affect factual correctness. (3) The multi-hop reasoning is sound: the model synthesizes the consistent language across filings and connects it to the broader theme of ongoing menu innovation while McGriddles remains static—this matches the original conclusion about strategic consistency. (4) The only minor shortcoming is that the LLM states the 2023 and 2024 filings 'mirror this language exactly,' which may overstate the similarity (the ground truth notes subtle shifts in framing like 'continuous evolution' in 2023 and 'testing new products' in 2024, while McGriddles' description remains unchanged). This slight exaggeration in phrasing similarity prevents a perfect 10, but the overall reasoning and factual content are substantially correct and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 383,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "In fiscal 2022 Adobe highlighted a large suite of free online self‑service courses hosted on www.training.adobe.com, presented as part of its broader learning portfolio while Adobe Digital Learning Services focused on fee‑based classroom, virtual and on‑demand programs. By fiscal 2023 the company consolidated those free resources onto the unified learning.adobe.com portal, and the 2024 filing shows the same learning.adobe.com site still delivering the free self‑service content alongside Adobe Digital Learning Services’ extensive paid‑learning offerings. This evolution reflects a consistent emphasis on free learning within Digital Learning Services, with the delivery platform shifting from training.adobe.com to learning.adobe.com and then remaining stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, free self-service learning was hosted on www.training.adobe.com; in 2023, it moved to learning.adobe.com; and in 2024, the same platform continued to deliver free content alongside paid offerings. The fiscal years (2022, 2023, 2024) are correctly used and consistent with the original. (2) There are no numeric values requiring calculation, but the dates and platform URLs are factually accurate and match the ground truth exactly. (3) The multi-hop reasoning is sound—correctly tracing the evolution across three years, identifying the platform shift, and contextualizing free learning within Adobe Digital Learning Services. The answer correctly infers a strategic consolidation and consistent emphasis on self-service learning. (4) The only minor shortcoming is that the LLM slightly underemphasizes the 'maturing and more structured approach' and deeper integration into the broader ecosystem mentioned in the original, which adds interpretive depth about strategic evolution. However, the core factual trajectory and synthesis across years and platforms are fully correct. Wording differs slightly but maintains semantic equivalence. Thus, the answer is excellent with only a small gap in qualitative nuance, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 383,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "Emerson has kept commercial vacuums inside the **Safety & Productivity** segment throughout the 2022‑2024 period. In the 2022 filing they are listed under “Other professional tools” together with water‑jetters and wet‑dry vacuums (EMR 10‑K 2022 pp. 7‑11). The 2023 and 2024 filings repeat the same wording, still categorising commercial vacuums as a professional‑tool product line that supports the segment’s focus on infrastructure, safety and productivity (EMR 10‑K 2023 pp. 71‑75; EMR 10‑K 2024 pp. 71‑75). Consequently, there has been no re‑classification or shift in emphasis—commercial vacuums remain positioned as part of Emerson’s professional‑tools offering within Safety & Productivity.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Commercial Vacuums were in the Safety & Productivity segment throughout 2022–2024. According to the ground truth, in 2022, Commercial Vacuums were part of the Tools & Home Products segment, not Safety & Productivity—this is a critical error in entity and segment classification. The LLM incorrectly asserts continuity, stating that the 2023 and 2024 filings 'repeat the same wording,' but the ground truth shows a clear reclassification in 2023 into Safety & Productivity, along with a strategic shift in emphasis. While the LLM correctly identifies the presence of Commercial Vacuums among professional tools and references appropriate document sections, it fails to detect the multi-hop evolution across years: (1) the 2022 segment classification, (2) the 2023 repositioning, and (3) the 2024 strategic alignment with advanced industrial tools. This undermines the reasoning and qualitative accuracy. The answer is contextually relevant to the question and uses plausible formatting with citations, but the central conclusion contradicts the ground truth. Quantitative accuracy is acceptable as there are no numerical claims to evaluate, and the cited product categories (e.g., water-jetters) are accurate. However, the failure to identify a key reclassification results in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 376,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "Gilead’s 2022 10‑K listed the Hoofddorp, Netherlands plant as one of its principal manufacturing sites and noted that it “is used for commercial manufacturing and processing of our cell‑therapy products.” The 2023 filing repeats that same description, and the 2024 filing again states the Hoofddorp facility “is utilized for commercial manufacturing and processing of our cell‑therapy products.” Thus, from 2022 through 2024 the Hoofddorp site has consistently been dedicated to commercial cell‑therapy manufacturing and processing, with no change in its role.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in stating that the Hoofddorp facility was used for commercial manufacturing and processing of cell therapy products from 2022 to 2024, with accurate entity and year references. Quantitative accuracy is perfect—no numerical errors, and the dates are correct. However, the LLM misrepresents the evolution of the facility’s role. According to the ground truth, in 2022 the facility was only identified as a 'principal manufacturing site' without explicit mention of cell therapy; the specific designation for cell therapy manufacturing emerged in 2023. The LLM incorrectly claims that the 2022 10-K already described the site as being used for cell therapy, which contradicts the ground truth. This undermines the qualitative accuracy, as the reasoning fails to capture the actual progression: a strategic shift *toward* cell therapy starting in 2023, not a consistent role throughout. The answer asserts 'no change in its role,' which directly conflicts with the ground truth’s narrative of a growing emphasis and strategic evolution. While the answer is relevant and well-structured, the failure to correctly represent the multi-hop progression across years—especially the key shift in 2023—results in a partially incorrect synthesis. Thus, the correctness score is reduced due to this significant factual mischaracterization, despite correct entities and dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 386,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "Coca‑Cola’s 10‑K exhibits for 2022‑2024 all list the 1.000 % Notes due 2028 (exhibit 4.26) as an outstanding low‑coupon debt instrument, showing that the company continues to rely on this cheap financing as a core part of its capital structure【KO_10k_2022.pdf:134‑138】【KO_10k_2023.pdf:132‑136】. In 2024 the company added new, higher‑yield securities – 5.000 % Notes due 2034 (exhibit 4.39) and 5.400 % Notes due 2064 (exhibit 4.41) – indicating it is issuing fresh, longer‑dated debt at higher rates to reflect a higher‑interest‑rate environment and to extend its maturity profile, a shift toward more active management of financing costs and capital‑structure mix【KO_10k_2024.pdf:128‑132】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the persistent mention of the 1.000% Notes due 2028 in 2022–2024 filings, and the introduction in 2024 of the 5.000% Notes due 2034 and 5.400% Notes due 2064 are accurately reported. Percentages, years, and exhibit references are factually correct. (2) Quantitative accuracy is perfect: all interest rates (1.000%, 5.000%, 5.400%) and maturity years (2028, 2034, 2064) match the ground truth exactly. No calculations were required, but comparisons of rates and timing are valid. (3) The multi-hop reasoning is sound—linking the continued reliance on low-cost debt with the strategic addition of higher-cost, long-term debt in a higher-rate environment demonstrates proper synthesis across filings. The LLM correctly infers a shift in capital structure management, citing extended maturity profiles and active cost management, which is consistent with the ground truth’s interpretation of recalibration and diversification. (4) The only minor shortcoming is that the LLM slightly underemphasizes the strategic intent (e.g., funding new initiatives) mentioned in the original answer, focusing more on interest rate environment and maturity extension. However, the core reasoning and factual synthesis remain strong. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing debt financing costs and capital structure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 406,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "In the 2022 filing Emerson’s pipe‑cutters were described only as part of a conventional mechanical pipe‑working tool set (“pipe wrenches, pipe cutters …” – EMR_10k_2022 p.9). By the 2023 filing the Safety & Productivity segment began highlighting “battery hydraulic tools for press connections” together with “diagnostic systems” for pipe work (EMR_10k_2023 pp.71‑75), and the 2024 filing reinforced this trend by emphasizing diagnostic‑integrated, battery‑powered cutters (EMR_10k_2024 pp.71‑75). The shift from purely manual cutters to cordless, sensor‑enabled tools signals Emerson’s move to position itself as a technology‑focused, premium supplier in the professional plumbing‑tools market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, pipe cutters were part of a conventional mechanical tool set; by 2023, Emerson introduced battery hydraulic tools and diagnostic systems; in 2024, integration of diagnostics and battery power was emphasized. The progression across years is correctly represented. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are accurate. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the evolution in product features and linking it to a strategic shift. It accurately infers that the integration of battery power and diagnostics reflects a move toward premium, technology-enhanced tools. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'sensor-enabled tools' instead of 'diagnostic-integrated'), the meaning is consistent with the original answer. The only minor gap is that the LLM does not explicitly name 'sewer inspection cameras and locating equipment' as specific diagnostic tools (mentioned in the ground truth), which slightly reduces completeness in qualitative detail. However, 'diagnostic-integrated' and 'sensor-enabled' sufficiently capture the concept. Overall, the answer is factually correct, contextually relevant, and demonstrates strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 412,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "From 2022 through 2024 Gilead has consistently listed its Santa Monica, California site as a location used for the clinical manufacturing and processing of its cell‑therapy products (2022 p. 31‑35; 2023 p. 9‑13; 2024 p. 8‑12). This continuity shows the facility has become a dedicated hub for early‑stage cell‑therapy production, underscoring its strategic role as a core component of Gilead’s broader manufacturing network alongside other cell‑therapy sites such as El Segundo, Frederick and Hoofddorp.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of GILD's Santa Monica facility. According to the ground truth, in 2022 the facility was part of the R&D and manufacturing network but was *not* specifically highlighted for cell therapy processing. However, the LLM states that from 2022 through 2024, the facility was 'consistently listed' for clinical manufacturing and processing of cell therapy products, which contradicts the ground truth. This misrepresents the key multi-hop progression: the transition from a general R&D site in 2022 to a dedicated cell therapy hub in 2023–2024. While the LLM correctly identifies the facility’s role in 2023 and 2024 and appropriately references strategic importance and peer sites (El Segundo, Frederick, Hoofddorp), it fails to capture the *evolution*—the central point of the question. The citations to page numbers (e.g., 2022 p. 31–35) may be accurate in isolation but do not override the incorrect characterization of continuity. Quantitative accuracy is high because there are no numerical errors (dates and locations are correctly stated where applicable). Contextual relevance is strong—the answer addresses clinical manufacturing, cell therapy, and strategic role—but the reasoning is flawed due to the failure to recognize the change over time. Thus, while some facts are correct, the overall synthesis is significantly off, warranting a mid-low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 397,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "In the 2022 filing Adobe described Frame.io as a cloud‑native collaboration platform that handled video + still images, design files and PDFs and was woven into many Creative Cloud apps—Premiere Pro, After Effects, Photoshop, Lightroom and Workfront—and even highlighted as part of Adobe GenStudio. By the 2023‑2024 filings the narrative shifted: Adobe called out “more‑now” support for still‑image, design‑file and PDF assets but limited the direct integrations to only Premiere Pro and After Effects (removing Photoshop, Lightroom, Workfront and GenStudio mentions), showing a tighter video‑centric integration while expanding the range of media types Frame.io can manage.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both direction and detail. (1) It falsely claims that in 2022, Frame.io was described as a cloud-native platform with integrations into Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, and GenStudio—however, the 2022 ground truth only lists Frame.io in Adobe's trademark portfolio without functional description. This misrepresents the earliest state of integration. (2) The answer incorrectly states that by 2023–2024, Adobe *removed* mentions of Photoshop, Lightroom, Workfront, and GenStudio, implying a narrowing of integration. In reality, these integrations were *added* or emphasized in 2024, representing an expansion from the 2023 state (which only included Premiere Pro and After Effects). The LLM reverses the timeline and trajectory of integration. (3) The claim that media support expanded while application integrations narrowed is factually wrong—the ground truth shows both media types *and* application integrations (including GenStudio) expanded in 2024. (4) The LLM invents a 'narrative shift' and 'tighter video-centric integration' that is unsupported by the data. There is no evidence in the ground truth of reduced integration; rather, the trend is consistently toward broader ecosystem inclusion. While the mention of still images, design files, and PDFs aligns with 2023 data, the incorrect dating and context nullify credit. Quantitative accuracy is low due to wrong years and misattributed features. Qualitative accuracy fails on multi-hop reasoning: the model fails to correctly sequence the evolution across years and misidentifies the direction of integration changes. Contextual relevance is moderate because the answer addresses media types and integrations, but with incorrect facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 486,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "In 2022 Emerson grouped electrical distribution equipment under its **Industrial Solutions** offering, describing it as part of a set of fluid‑control, pneumatic and materials‑joining products that deliver “integrated solutions” to customers【74†L31-L35】. By 2023‑24 the company had moved this hardware into the **Discrete Automation** segment and now lists it alongside **programmable automation control systems and software**, highlighting a tighter coupling of distribution hardware with automation technology and an expanded scope that blends traditional electrical hardware with digital control solutions【71†L15-L20】【71†L21-L24】. This reflects a strategic shift from a broad industrial‑solutions role to a more integrated, automation‑focused positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Electrical Distribution Equipment was in Industrial Solutions in 2022, moved to Discrete Automation by 2023–2024, and was increasingly integrated with automation technologies. The evolution from standalone to integrated component is correctly captured. (2) No numeric values (e.g., dollar amounts, percentages) are present, so quantitative accuracy is not compromised—dates (2022, 2023–24) are correctly used and consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift across years and segments, linking the equipment’s changing context to a strategic repositioning. The mention of pairing with programmable automation control systems and software matches the original. (4) The only minor omission is that the 2024 integration specifically included electric linear motion and materials joining solutions—this detail is partially covered via 'materials-joining products' in 2022 but not explicitly tied to 2024 in the LLM answer. However, the broader point about expanded product scope and alignment with intelligent automation is conveyed. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct and contextually relevant, meriting a high score with only a slight deduction in qualitative accuracy for incomplete detail on 2024 product scope expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 402,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Capital One’s fixed‑rate unsecured senior notes grew from **$24.1 billion** at a **4.45 % weighted‑average interest rate** in 2022 to **$27.2 billion** at the same **4.45 %** rate in 2023, then fell slightly to **$26.9 billion** while the weighted‑average rate rose to **≈4.84 %** in 2024【COF_10k_2023.pdf:176】【COF_10k_2024.pdf:186】.  This shows the company is expanding its fixed‑rate debt base even as market rates climb, accepting a higher average cost to lock in longer‑dated funding and preserve interest‑rate stability rather than relying solely on low‑rate floating borrowings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies, particularly in the 2022 carrying value and interest rate. The ground truth states that in 2022, the carrying value was $19,975 million ($19.975 billion) and the weighted-average interest rate was 2.91%, but the LLM incorrectly reports $24.1 billion and 4.45% for 2022. The 4.45% rate actually corresponds to 2023, not 2022. The 2023 carrying value is close ($27.2B vs $27.168B), and the 2024 figures are accurate ($26.9B vs $26.930B; 4.84% correct). (2) Calculations: The progression of rates from 2.91% → 4.45% → 4.84% is misrepresented by stating the rate was 4.45% in both 2022 and 2023, which distorts the trend. The actual doubling of the interest rate from 2022 to 2023 is a key financial signal that is lost. (3) Multi-hop reasoning: The LLM correctly identifies the overall strategy of increasing fixed-rate debt to lock in funding amid rising rates, which aligns with the ground truth's interpretation. It synthesizes data across 2023 and 2024 filings appropriately and draws a reasonable conclusion about interest rate stability. (4) Despite strong contextual relevance and mostly sound reasoning, the severe factual errors in the 2022 data—especially assigning the wrong rate and value—undermine the quantitative accuracy. These are not formatting issues but material misstatements. The answer gets partial credit for correctly capturing the 2023–2024 trend and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 407,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s liability for product‑performance and operating‑cost guarantees fell from $1.109 billion at 12/31/2022 to $1.091 billion at 12/31/2023 and further to $0.993 billion at 12/31/2024 – a net decline of roughly $116 million over the two‑year span【RTX_10k_2024.pdf†page=100-104】【RTX_10k_2023.pdf†page=98-102】.  The gradual reduction, driven by higher settlements and lower new issuances, shows the company is managing its warranty‑related exposure, but the still‑sub‑$1 billion balance underscores that RTX remains materially exposed to long‑term product‑performance risk in its commercial‑aerospace business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its quantitative claims. According to the ground truth, RTX's liabilities for performance and operating cost guarantees were $120 million in both 2022 and 2023, and decreased slightly to $101 million in 2024. However, the LLM reports figures of $1.109 billion in 2022, $1.091 billion in 2023, and $0.993 billion in 2024—over 9 times higher than the actual values. This massive discrepancy invalidates the core of the response. (2) The calculations are internally consistent (a net decline of ~$116 million from $1.109B to $0.993B), but they are based on completely incorrect source data. The actual net decrease from 2022 to 2024 was only $19 million ($120M → $101M), not $116 million. (3) The multi-hop reasoning is partially sound in structure—the LLM attempts to track liability trends over time and interpret them in terms of risk exposure—but it fails due to incorrect data retrieval. The conclusion about ongoing exposure to long-term risks is somewhat aligned with the ground truth, but the reasoning is undermined by the wrong numbers. (4) The contextual relevance is moderate because the answer addresses the right topic (liabilities for performance and operating cost guarantees) and attempts to interpret trends in relation to commercial aerospace risk. However, the severe quantitative inaccuracy results in a low correctness score. The entity (RTX), metric (liabilities for guarantees), and time frame (2022–2024) are correctly identified, but the values are not. Thus, while the framework of the answer is appropriate, its factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 444,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑Ks Coca‑Cola’s Note 4 on investments repeatedly says that for non‑publicly traded companies it values holdings using “discounted cash flows, estimates of sales proceeds and appraisals,” applying market‑participant assumptions and stressing that “the ability to accurately predict future cash flows, especially in emerging and developing markets, may impact the determination of fair value”【KO_10k_2022.pdf pp 38‑42】【KO_10k_2023.pdf pp 76‑80】【KO_10k_2024.pdf pp 77‑81】. The reliance on the “estimates of sales proceeds” method remained unchanged, revealing a consistent yet increasingly explicit acknowledgement of the uncertainty in fair‑value assessment for emerging‑market investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the disclosures in the cited 10-Ks and correctly identifies the valuation methods used (discounted cash flows, estimates of sales proceeds, appraisals) and the associated uncertainty in predicting cash flows, especially in emerging markets. Quantitatively, there are no errors—no numerical inaccuracies in dates, years, or financial terms. However, the LLM incorrectly asserts that Coca-Cola’s 'reliance' on 'estimates of sales proceeds' 'remained unchanged' from 2022 to 2024, which directly contradicts the ground truth. The original answer shows a clear evolution: from disclosure in 2022, to explicit operational reliance in 2023 ('relies on'), to a more cautious, risk-aware use in 2024. This progression reflects a strategic shift in how the methodology is applied, particularly in response to challenges in emerging markets. The LLM fails to capture this multi-hop evolution, instead asserting consistency where there is documented intensification followed by cautious refinement. While the cited documents support the general methodology, the LLM misses the nuanced change in tone and operational emphasis over time, leading to a significant qualitative inaccuracy in reasoning and interpretation. Contextual relevance is high as the response addresses fair value assessment in emerging markets and cites appropriate sections, but the core analytical claim about 'unchanged' reliance undermines the correctness of the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 406,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "BNY Mellon’s 10‑K disclosures have been consistent but have become more detailed over the three years. In its 2022 filing (BK_10k_2022 p. 5) the company warned that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law…”. The 2023 filing (BK_10k_2023 p. 5) repeats that limitation and explicitly ties it to the firm’s regulatory capital plan and Federal Reserve supervisory expectations, while the 2024 filing (BK_10k_2024 p. 5) further emphasizes compliance with capital‑adequacy rules but again notes Board discretion. Taken together, the progression shows BNY Mellon repeatedly acknowledges regulatory caps on payouts while sharpening the language around its capital‑plan framework—signalling that the firm retains strategic flexibility to distribute capital to shareholders, but only within the bounds set by U.S. banking regulations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure across 2022–2024 regarding U.S. banking laws, Delaware law, and Board discretion, which aligns with the ground truth. It accurately cites the repetition of regulatory limitations and references correct document locations (e.g., page 5 of each 10-K), supporting quantitative and entity accuracy. However, it misses a key factual evolution highlighted in the original answer: the 2024 addition emphasizing the Parent’s dependency on dividends from subsidiaries and credit from its IHC (Intermediate Holding Company) to fund share repurchases and dividends. This omission is significant because it reflects a structural shift in how BNY Mellon manages capital flows under regulatory constraints. Instead, the LLM incorrectly suggests that the firm is 'sharpening the language around its capital-plan framework' and 'retains strategic flexibility,' which contradicts the ground truth’s conclusion of 'ongoing limitations' and 'increasing internal structural dependencies.' (2) There are no numeric values to verify, so quantitative accuracy is unaffected and scores highly. (3) The multi-hop reasoning is partially sound—linking disclosures across years—but fails in synthesis by not identifying the new 2024 emphasis on internal capital sourcing, leading to an incorrect inference about growing strategic flexibility. The model interprets increased detail as empowerment, whereas the ground truth interprets it as constraint. (4) Correctness and qualitative accuracy are penalized due to this misinterpretation of the disclosure trend’s implications, despite accurate citation of surface-level content. Contextual relevance remains high because the response stays focused on the question and uses appropriate regulatory and financial terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 494,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "In its 2022 10‑K, AMD listed the loss or modification of tax‑ and tariff‑exemptions only as one item among a broad set of political‑legal‑economic risks (2022 p. 35‑36). The 2023 filing repeats that risk but adds language about recent sanctions and export‑control revisions, and the 2024 filing further ties the risk to heightened geopolitical tensions (e.g., China‑Taiwan, Ukraine‑Russia) and ongoing trade‑policy shifts (2024 p. 38‑40). This growing emphasis and added detail show that AMD’s exposure to losing exemptions is becoming more pronounced, reflecting an increasingly complex global regulatory environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key points are correct: in 2022, AMD mentioned the risk of losing tax and tariff exemptions among other broad risks; in 2023, it added context about sanctions and export controls; in 2024, it tied the risk to geopolitical tensions (China-Taiwan, Ukraine-Russia) and trade-policy shifts. These details match the original answer's progression. (2) There are no numeric values to verify, so quantitative accuracy is not applicable beyond correct referencing of years (2022, 2023, 2024), which are accurate. Page references (e.g., 2022 p. 35–36, 2024 p. 38–40) add precision and are consistent with typical 10-K structures, though not part of the ground truth—these do not detract as they support plausibility. (3) The multi-hop reasoning is sound: the model correctly synthesizes AMD’s evolving risk disclosure across three years, identifying increasing specificity and emphasis, which supports the conclusion of growing exposure and regulatory complexity. (4) The only minor shortcoming is slightly less elaboration on the 'internal expansion' driver mentioned in the ground truth, but the focus on external geopolitical and policy factors is fully supported and sufficient for the conclusion. Wording differs but semantic meaning is equivalent. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 388,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from $883 million at year‑end 2022 to $538 million in 2023 and then ticked up to $562 million in 2024, while its long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 before declining to $45.0 billion in 2024 (combined total $48.7 billion → $49.9 billion → $45.6 billion)【COF_10k_2023.pdf, p. 176‑180】【COF_10k_2024.pdf, p. 186‑190】.  At the same time, floating‑rate unsecured senior debt collapsed from $1.6 billion in 2022 to $349 million in 2023 and was eliminated by 2024【COF_10k_2023.pdf, p. 179‑180】【COF_10k_2024.pdf, p. 186‑190】, signalling a shift toward a largely fixed‑rate debt structure and markedly lower interest‑rate exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the overall trend in Capital One's debt evolution and correctly identifies the strategic shift from floating to fixed-rate debt, which aligns with the ground truth. However, there are significant quantitative inaccuracies in the reported figures. For example, the original answer states total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM reports a combined total of $48.7B → $49.9B → $45.6B, which implies a 2022 total of $48.7B, but this contradicts the ground truth by over $5.6B. Additionally, short-term borrowings in the original are not broken out as $883M in 2022, and such a figure does not appear in the knowledge graph; instead, the total debt categories are aggregated differently. The LLM also reports long-term debt rising from $47.8B to $49.3B, whereas the original shows total debt increasing from $43.086B to $49.856B — a different composition. While the floating-rate unsecured senior debt decline from $1.6B (close to $1.709B) to $349M to $0 is mostly accurate, the fixed-rate debt trend is omitted entirely in the LLM answer, including the rise from $21.045B to $27.168B to $26.930B and the increasing interest rates (2.91% → 4.84%), which is a key part of the original answer. 2) Calculations: The LLM’s implied totals are close for 2023 and 2024 ($49.9B vs $49.856B; $45.6B vs $45.551B), so those are acceptable within rounding, but the 2022 total is off by more than $5B, which is material. Floating-rate debt values are approximately correct, though $1.6B vs $1.709B is a minor discrepancy. Fixed-rate debt and interest rate trends are missing. 3) Reasoning: The LLM correctly infers a strategic pivot toward fixed-rate debt to reduce interest rate exposure, which is sound multi-hop reasoning based on the elimination of floating-rate debt. However, it fails to incorporate the full picture by omitting the growth and cost trajectory of fixed-rate debt, weakening the completeness of the analysis. 4) Despite missing key data points and containing inaccurate base figures, the LLM answer remains contextually relevant and draws a qualitatively correct conclusion about risk mitigation in a rising rate environment. The omission of weighted-average interest rates for fixed-rate debt and incorrect short-term/long-term splits reduce quantitative accuracy, but the core narrative is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 638,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program‑share interest in International Aero Engines AG (the V2500 partnership) was 57 % in 2022, remained 57 % in 2023, and stayed at 57 % in 2024 【RTX_10k_2022.pdf p.108‑112】【RTX_10k_2023.pdf p.97‑101】【RTX_10k_2024.pdf p.99‑103】. The unchanged 57 % stake shows RTX (through Pratt & Whitney) has maintained a stable, controlling position as the primary beneficiary in the V2500 engine collaboration, underscoring its continued strategic commitment and influence over the program.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that RTX's net program share interest in IAE was 57% in 2022, 2023, and 2024. The ground truth indicates it was 61% in 2022 and decreased to 57% in both 2023 and 2024. This error fundamentally undermines the answer’s validity. (2) Quantitatively, the percentages are wrong for 2022—claiming no change over the period when there was a 4 percentage point decrease. The calculation of change (or lack thereof) is therefore inaccurate. The cited documents may contain the correct data, but the LLM misrepresents them. (3) The multi-hop reasoning fails because the model does not recognize or report the decrease from 61% to 57%, which is central to the question. As a result, the conclusion about 'stable, controlling position' and 'continued strategic commitment' contradicts the ground truth interpretation, which sees the reduction as a strategic dilution of economic exposure. The LLM draws an opposite inference based on incorrect data. (4) Contextually, the answer addresses the right entities (RTX, IAE, V2500 program) and attempts to interpret strategic implications, so relevance is moderate. However, due to major factual and quantitative errors and flawed reasoning, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 357,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K reports, Cascade is consistently listed among the major brands in the Fabric & Home Care segment and the narrative repeatedly notes that P&G’s global home‑care market share (≈25 %) is driven primarily by Cascade, Dawn, Febreze and Swiffer. Its brand status has remained that of a flagship home‑care product, while the segment’s share of total net sales rose from about 35 % in 2022 to 36 % in 2023 (and held at 36 % in 2024) and earnings share grew from 31 % to 34 %, indicating a modest but steady increase in the importance of the home‑care portfolio – and thus Cascade – within P&G’s overall business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Cascade is consistently positioned as a major brand in the Fabric & Home Care segment across 2022–2024; the segment’s net sales increased from 35% in 2022 to 36% in 2023 and remained at 36% in 2024; earnings contribution rose from 31% to 34% over the period. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—percentages for net sales and earnings are correctly reported with no calculation errors. Format variations (e.g., 'about 35%' vs. '35%') are acceptable and do not affect factual correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across three 10-K filings, identifies Cascade’s stable brand status, and infers increased strategic importance due to segment-level performance trends. (4) The only minor shortcoming is that the LLM adds a detail not present in the ground truth—P&G’s global home-care market share being ≈25% and driven by specific brands—though this does not contradict the original and is contextually plausible. However, since this claim isn’t verified in the provided ground truth, it slightly affects qualitative accuracy. Otherwise, the answer is complete, relevant, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 365,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "In 2022 BNY Mellon disclosed that its Directors’ Code of Conduct was available at a bnymellon.com URL ending in “/content/dam/bnymellon/documents/pdf/**in relations**/directors‑code‑of‑conduct.pdf” (BK 10‑K 2022, pp. 11‑13). In 2023 the same domain was kept but the path was altered to “…/**inv relations**/directors‑code‑of‑conduct.pdf” (BK 10‑K 2023, pp. 13‑14). By 2024 the firm had rebranded its web presence to the bny.com domain, referencing the code via a relative “**investor‑relations**/directors‑code‑of‑conduct.pdf” path (BK 10‑K 2024, pp. 13‑14) and explicitly integrated the Directors’ Code of Conduct into its broader corporate‑governance disclosures, stating it applies to all directors and that any amendments or waivers will be posted on the website.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 URL path with 'in relations', the 2023 update to 'inv relations', and the 2024 shift to the 'bny.com' domain with 'investor-relations' are all correctly reported, including the correct domain transitions and path changes. (2) There are no numeric values to verify, but dates (2022, 2023, 2024) and document references (10-K pages) are accurately cited, meeting quantitative accuracy standards. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and domains, showing evolution in URL structure, branding, and integration. The LLM correctly infers increased integration with corporate governance by 2024, noting explicit disclosure about amendments and waivers being posted, which supports the strategic integration claim. (4) The only minor shortcoming is that the LLM adds a detail not present in the original answer—about the code applying to all directors and posting of amendments/waivers—while factually plausible and consistent with 2024 disclosures, it slightly extends beyond the scope of the ground truth's focus on URL and branding evolution. However, this does not detract from correctness and may reflect additional context from the filing. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 394,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "Across the three filings AMD’s AIB strategy stayed anchored on two pillars. In the 2022 10‑K the company first disclosed that its agreements with add‑in‑board (AIB) manufacturers “protect their inventory of our products against price reductions” and that system integrators (SIs) “often use discrete graphics solutions as a means to differentiate their products and add value to their customers” (2022 10‑K, pp. 11‑13). The 2023 filing reiterated the same inventory‑protection clause, added that AMD “also sell[s] directly to our SI customers” and emphasized the short‑design‑cycle advantage of its discrete graphics for differentiation (2023 10‑K, pp. 13‑15). The 2024 filing again reaffirmed the inventory‑protection policy and continued to stress that discrete graphics solutions remain a key lever for SIs to add value and differentiate their offerings, showing a consistent but increasingly explicit strategic focus (2024 10‑K, pp. 11‑13).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection policies for AIB manufacturers from 2022 to 2024, and discrete graphics were consistently emphasized as a differentiator for system integrators (SIs). The LLM correctly identifies the continuity of these policies and strategic focus across all three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2023, 2024) and document references (10-K pages) are accurately cited, supporting factual precision. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings, correctly identifying consistent themes while noting subtle evolution—such as AMD selling directly to SIs and the 'short-design-cycle advantage' mentioned in 2023. This nuance adds value without contradicting the core stability emphasized in the ground truth. (4) Semantic equivalence is strong: while the LLM describes the trend as showing 'a consistent but increasingly explicit strategic focus'—a slightly more interpretive tone than the ground truth’s 'stable, long-term partnership model'—this does not constitute inaccuracy but rather a slightly different framing. The core message of strategic consistency is preserved. One minor point: the ground truth emphasizes stability, while the LLM suggests increasing explicitness, which could imply evolution; however, this is a subtle interpretive difference and does not undermine factual correctness. Hence, a score of 9 is justified, with full marks in contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 472,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "In the 2022 filing McDonald’s only listed the Egg McMuffin as one of its standard breakfast items and noted that the menu is “continuously evolving … to meet customers’ needs” (2022 10‑K, Products p. 5‑9). The 2023 filing added that the company works with suppliers to “encourage innovation and drive continuous improvement” across the supply chain, keeping core breakfast items such as the Egg McMuffin fresh and relevant (2023 10‑K, Products p. 4‑8). By 2024 the disclosure shifted to a detailed supply‑chain focus—digital data‑excellence, regular sensory evaluations and calibration training—to guarantee the Egg McMuffin’s quality and consistency, positioning it as a cornerstone of the breakfast menu that meets customer expectations for reliability (2024 10‑K, Supply Chain & Food Safety p. 4‑8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: McDonald's disclosure evolved from mentioning the Egg McMuffin as a standard breakfast item in 2022 with general menu evolution, to emphasizing supply chain collaboration in 2023, and then to a technologically driven focus on data excellence and quality consistency in 2024. The LLM correctly identifies the Egg McMuffin's role in meeting customer expectations for quality and consistency across all years. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) and document references (10-K sections) are accurately cited and contextually appropriate. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and multiple aspects (menu strategy, supply chain, innovation, digital transformation). The LLM captures the progression from general quality assurance to a more integrated, technology- and supply chain-focused approach. (4) The only minor shortcoming is that the LLM does not explicitly name the 'Global Chief Supply Chain Officer' mentioned in the 2023 disclosure in the ground truth, which slightly reduces completeness in entity identification. However, the core narrative about supply chain collaboration and continuous improvement is preserved. Overall, the answer is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 403,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "Oracle’s 4.30 % Note due 2034 appears in the exhibit index of each of the three recent 10‑K reports (2022 p. 111, 2023 p. 108, 2024 p. 108) 【ORCL_10k_2022.pdf page 111】【ORCL_10k_2023.pdf page 108】【ORCL_10k_2024.pdf page 108】. Its repeated disclosure shows that the note remains an outstanding component of Oracle’s long‑term debt, indicating that the company has deliberately kept a moderate‑coupon, decade‑plus maturity on its balance sheet to lock in low‑cost financing and maintain a diversified, staggered debt‑maturity profile across reporting periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities—Oracle, the 4.30% Note due 2034, and the reporting years 2022–2024—are correctly identified. The note’s persistent disclosure across all three 10-K filings is accurately reported, and the page references (2022 p.111, 2023 p.108, 2024 p.108) match the source documents. (2) Quantitative elements—interest rate (4.30%), maturity year (2034), and the consistent appearance across years—are factually correct with no calculation errors. Format variations (e.g., '4.30 %' vs '4.30%') are minor and acceptable. (3) The reasoning is sound: the LLM correctly infers that the continued disclosure indicates the note remains outstanding and is a strategic part of Oracle’s long-term debt structure. It accurately concludes Oracle uses this instrument to maintain low-cost financing and a staggered maturity profile. While the LLM does not explicitly mention other specific notes (e.g., 3.625% Note due 2023 or 2.950% Notes due 2024) as in the original answer, it captures the broader implication of a diversified debt portfolio. (4) The answer is contextually relevant, directly addressing Oracle’s long-term debt structure and financing priorities. The only minor shortcoming is the lack of explicit multi-hop synthesis with other debt instruments, which slightly reduces qualitative accuracy, but the core inference remains valid and well-supported. Thus, the answer is factually excellent and semantically equivalent in intent and meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 417,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One’s net Level‑3 derivative assets and liabilities grew from a year‑end balance of about **$5 million in 2022** to **$58 million in 2023** and **$69 million in 2024**【COF_10k_2022.pdf page 221】【COF_10k_2023.pdf page 208】【COF_10k_2024.pdf page 218】. In each year the fair‑value measurement was performed with a **discounted‑cash‑flow model that uses swap‑rate assumptions as the key unobservable input** (the quantitative tables list “Discounted cash flows” and “Swap rates” for net derivative assets in 2023 and 2024)【COF_10k_2023.pdf page 209】【COF_10k_2024.pdf page 219】, and the note that Level‑3 transfers are mainly SOFR‑indexed interest‑rate derivatives confirms the source of those inputs【COF_10k_2024.pdf page 218】. The steady methodology combined with the rising Level‑3 balances shows Capital One’s exposure to unobservable market inputs has increased markedly over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets/liabilities fair value was $19 million in 2022, $58 million in 2023, and remained at $58 million in 2024. However, the LLM incorrectly reports $5 million in 2022 and $69 million in 2024, both of which are materially wrong. The $58 million figure for 2023 is correct, but the trend is misrepresented due to incorrect starting and ending values. (2) The ground truth also includes important context about a $20 million net unrealized loss in 2022 and specific unobservable inputs like default rates (53–163%) in 2023, which are entirely omitted in the LLM response. While the LLM correctly identifies swap rates (3–5%) as a key unobservable input and notes the use of a discounted cash flow model, it fails to mention the default rate range, reducing completeness. (3) The multi-hop reasoning is partially sound—the LLM correctly infers increasing exposure to unobservable inputs due to rising Level-3 balances, but this conclusion is based on incorrect data (e.g., $69M in 2024 vs. actual $58M). Additionally, the LLM conflates 'Level-3 derivative balances' with 'net derivative assets/liabilities fair value,' which may not be equivalent without explicit confirmation. (4) Despite these errors, the answer is contextually relevant and correctly identifies the valuation methodology (discounted cash flow with swap rates) and its consistency across years. The reasoning about increasing exposure to unobservable inputs is directionally plausible but overstated due to incorrect quantitative support. Thus, while some qualitative elements are accurate, the severe quantitative inaccuracies limit overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 483,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "In the 2022 filing RTX disclosed that, under its 2012 IAE acquisition, it must make hourly payments to Rolls‑Royce for every V2500‑powered flight hour flown through June 2027 and that these payments are capitalized as collaboration intangible assets as they are incurred. The 2023 filing repeated the same flight‑hour‑contingent payment structure and noted that the capitalized amounts are amortized over the pattern of economic benefit. By the 2024 filing the company clarified that the collaboration assets arising from the Rolls‑Royce flight‑hour payments are amortized to cost of sales, while the hourly‑based payment arrangement remains unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of RTX's financial obligations to Rolls-Royce from 2022 through 2024. (1) All key facts are correct: the 2012 IAE acquisition established a payment structure based on V2500-powered flight hours through June 2027; payments are capitalized as collaboration intangible assets; amortization occurs to cost of sales, aligned with the pattern of economic benefit. The LLM correctly notes the consistency of the per-hour payment structure and the accounting treatment evolution. (2) Quantitative accuracy is perfect: dates (2012 acquisition, payments through June 2027), and the absence of incorrect dollar figures (though the $14.1 billion total commitment in 2024 from the ground truth is omitted, it is not misrepresented). The LLM does not include the $14.1B figure, which is a minor omission but not an error. (3) Multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024 filings, showing how accounting treatment evolved from capitalization to amortization to cost of sales. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'pattern of economic benefit' instead of explicitly stating 'amortized to cost of sales' in 2023), this is consistent with accounting terminology and clarified in 2024. The only minor gap is the lack of explicit mention of 'Other commercial aerospace commitments' in 2022 and the $14.1B total in 2024, which reduces completeness slightly but does not affect the core correctness. Overall, the answer is factually precise, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 450,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "- In the 2022 Form 10‑K (see p. 53 of the 2022 filing), Amgen reported that after a 2017 FDA review of the Neulasta Onpro kit it “implemented device and labeling enhancements to address product complaints received on this device” and that it “continuously monitor[s] complaints and adverse events and implement additional enhancements as needed.” 【AMGN_10k_2022.pdf p. 53】\n\n- The 2023 Form 10‑K (see p. 55 of the 2023 filing) reiterated the same monitoring program and added that further device‑related enhancements have been made to mitigate risk and improve the kit’s safety and usability. 【AMGN_10k_2023.pdf p. 55】\n\n- By the 2024 Form 10‑K (see pp. 54‑55 of the 2024 filing), Amgen expanded the discussion to include broader operational‑resilience measures—such as backup‑generator capacity, supply‑chain safeguards and disaster‑response planning for its Puerto Rico and California facilities—to ensure uninterrupted production and delivery of the Neulasta Onpro kit while continuing its complaint‑monitoring and device‑enhancement program. 【AMGN_10k_2024.pdf pp. 54‑55】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Amgen referenced the 2017 FDA evaluation in 2022 and implemented device and labeling enhancements in response to complaints; in 2023, it reiterated ongoing monitoring and added that further enhancements were made; by 2024, disclosures expanded to include operational resilience measures. The years, entities (Amgen, Neulasta Onpro kit), and sequence of disclosure evolution are accurate. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correctly cited. (3) The multi-hop reasoning is sound: the answer synthesizes information across three years of 10-K filings, correctly identifying the progression from device-specific responses (2022) to sustained monitoring (2023) to inclusion of broader operational risks (2024). The mention of backup generators, supply-chain safeguards, and disaster-response planning in Puerto Rico and California aligns with the ground truth’s emphasis on infrastructure instability, particularly in Puerto Rico. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the December 31, 2024 island-wide outage in Puerto Rico—a specific example included in the ground truth that illustrates the operational challenges. While the general point about backup generators and grid instability is covered, the absence of this concrete event slightly reduces completeness in qualitative accuracy. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question about the evolution of disclosures on user complaints and risk mitigation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 471,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s Item 14 simply states that the ratification of KPMG LLP as its principal accountant is set out in the proxy under “Item 3 – Ratification of KPMG LLP” and repeats that KPMG LLP’s Public Company Accounting Oversight Board (PCAOB) firm identification number is 185 (see 2022 p. 14‑15; 2023 p. 14‑16; 2024 p. 14‑16). The language and content of the disclosure are unchanged year‑to‑year, and the continual reference to the same PCAOB firm number 185 signals that BNY Mellon has retained the same audit firm, underscoring a stable and continuous audit‑governance framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BK (BNY Mellon) consistently disclosed KPMG LLP as principal accountant in 2022, 2023, and 2024 filings; the PCAOB firm number is correctly stated as 185 across all years; and the disclosure references proxy statements under Item 3. Page numbers cited (2022 p. 14–15; 2023 p. 14–16; 2024 p. 14–16) are consistent with typical 10-K structures, though minor page variations do not affect factual accuracy. (2) Quantitative accuracy is perfect: the PCAOB number 185 is correctly repeated, and no erroneous figures are introduced. (3) Multi-hop reasoning is sound—the model correctly synthesizes information across three years and infers audit governance continuity from the unchanged firm and PCAOB number. (4) The only minor shortcoming is that the LLM refers to 'BNY Mellon' instead of 'BK' without clarifying the ticker-to-name mapping upfront, though this is commonly understood. Additionally, while the conclusion about stable audit governance is valid, the LLM could have slightly expanded on the significance of the PCAOB number’s consistency, as the original answer does by linking it to 'no auditor rotation' and 'institutional trust.' However, the core reasoning and factual synthesis remain strong. Semantic equivalence is achieved with slightly more procedural framing than interpretive depth, but no factual errors exist.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 397,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s exposure to commercial‑aerospace customer‑financing guarantees has been shrinking, with the maximum‑potential payment falling from $304 million in 2022【RTX_10k_2023.pdf (p98‑102)】 to $288 million in 2023【same】 and $274 million in 2024【RTX_10k_2024.pdf (p100‑104)】. At the same time, the portion of those guarantees borne by collaboration partners has declined from $142 million in 2022【RTX_10k_2022.pdf (p109‑113)】 to $135 million in 2023【RTX_10k_2023.pdf (p98‑102)】 and $131 million in 2024【RTX_10k_2024.pdf (p100‑104)】, indicating that RTX is progressively reducing both its overall guarantee exposure and the risk transferred to partners, reflecting a tighter risk‑management stance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key figures from the ground truth: the collaboration partners' share of guarantees is accurately stated as $142M in 2022, $135M in 2023, and $131M in 2024. These values match the original answer exactly, satisfying quantitative accuracy. While the LLM introduces additional data—total exposure ($304M, $288M, $274M) not present in the ground truth—this information is contextually relevant and plausibly derived from the cited 10-Ks, enhancing rather than contradicting the response. (2) All numbers are correct and consistently formatted; minor variations like 'million' vs 'M' are acceptable. The trend (declining partner share) is correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic trend in risk management—specifically, that RTX is reducing both overall and shared exposure, indicating tighter risk control. This aligns with and extends the original answer’s conclusion about reduced contingent liabilities. (4) The only reason for not scoring a perfect 10 is that the original answer includes an important qualitative point—that RTX maintained confidence in asset values (fair market values ≥ guarantees net of reserves)—which the LLM omits. This is a minor but notable gap in completeness. Otherwise, the response is factually accurate, well-supported, and contextually appropriate, with excellent use of citations and logical interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 411,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "In the 2022 filing the segment table lists the brand as **“Pampers Always”** and groups it with baby‑care names (Luvs, Pampers) under the Baby, Feminine & Family Care segment, treating it as a sub‑brand of Pampers rather than a core feminine‑care brand. By the 2023 and 2024 filings the tables show **“Always”** as a standalone major brand in the **Feminine Care sub‑category** (Adult Incontinence, Menstrual Care), and the MD&A explicitly calls Always (and its Discreet line) a market‑leader in menstrual care alongside Tampax and a key player in adult‑incontinence, highlighting it as a primary feminine‑hygiene offering rather than a baby‑care off‑shoot.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in key aspects. (1) QUANTITATIVE ACCURACY: The original answer states that in 2022, 'Feminine Care' (including Always and Tampax) contributed 25% of net sales, and in 2023 and 2024, the renamed 'Baby, Feminine & Family Care' segment contributed 24%. The LLM answer omits all percentages and misrepresents the segment structure, falsely claiming that in 2022 Always was grouped under 'Pampers Always' in the Baby, Feminine & Family Care segment. However, in 2022, the segment was still called 'Feminine Care' and Always was not grouped under Pampers. (2) ENTITY ACCURACY: The LLM incorrectly claims that in 2022, the brand was listed as 'Pampers Always' and grouped with baby-care brands like Luvs and Pampers. This is factually wrong—Always was always part of Feminine Care, not a sub-brand of Pampers. The rebranding to 'Baby, Feminine & Family Care' occurred in 2023, not earlier. (3) REASONING: The multi-hop reasoning fails because the LLM misidentifies the timeline and categorization. It falsely implies a strategic shift from baby care to feminine care, whereas the ground truth shows Always was consistently positioned in feminine care, with only a segment name change in 2023. (4) SEMANTIC EQUIVALENCE: The LLM's narrative of repositioning Always from a baby-care sub-brand to a standalone feminine-care brand is the opposite of the truth. While it correctly notes that Always and Always Discreet were highlighted in 2023–2024, the framing is fundamentally flawed. The answer is contextually relevant to the question about brand evolution but based on incorrect data. Thus, despite addressing the right topic, the factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 475,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "In the 2022 filing AMD already flagged “difficulties in protecting our intellectual property” as a risk tied to its worldwide operations and to its reliance on third‑party wafer foundries and assembly in China, Malaysia and Taiwan, noting that 72 % of its revenue came from international sales. The 2023 filing repeated the same IP‑protection risk, but showed that international sales still represented a large share (about 65 %) and that Asian manufacturing partners remained essential, while the 2024 filing again highlighted the IP‑protection difficulty—now with international sales at 66 % and explicit reference to heightened China‑Taiwan geopolitical tensions that could further jeopardize IP safeguards. Thus, AMD’s exposure to IP‑protection challenges has persisted and become more pronounced as its overseas sales and dependence on Asian third‑party manufacturing have expanded.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that AMD consistently flagged intellectual property (IP) protection difficulties from 2022 to 2024, linking them to international operations and third-party manufacturing in Asia. The evolution of risk due to expanding international sales and geopolitical tensions is accurately captured. (2) Quantitatively, the LLM states that international sales were 72% in 2022, 65% in 2023, and 66% in 2024. The ground truth only specifies 65% for 2023 and does not give a 2022 figure—so the 72% in 2022 cannot be verified from the provided truth, but it does not contradict it outright. The 66% in 2024 is consistent with the trend. These numbers are plausible and do not appear erroneous, though the 72% figure lacks direct support in the original answer and may be an over-precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes AMD’s increasing reliance on Asian manufacturing, sustained IP risks, and the added layer of China-Taiwan geopolitical tension in 2024. It traces the progression across years and connects international sales, manufacturing dependencies, and regional risks. (4) The answer is contextually excellent—directly addressing the question’s focus on the evolution of IP exposure in relation to global operations and third-party manufacturing. The only minor issue is the unverified 72% international sales figure for 2022, which slightly affects quantitative accuracy but does not undermine the overall correctness. Hence, a score of 9 is justified—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 440,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle first issued the 2.300 % senior unsecured notes that mature in 2028 on 24 March 2021 as part of a multi‑note series that also included 1.650 % notes due 2026, 2.875 % notes due 2031, 3.650 % notes due 2041, etc. (see Exhibit 4.14 in the 2022 Form 10‑K, p. 112‑113). The 2023 and 2024 Form 10‑Ks continue to list the same 2.300 % notes due 2028 among Oracle’s outstanding debt, with no new tranches added, showing that the company has kept the original issuance on its balance sheet as a low‑coupon, medium‑term funding source (2023 10‑K, p. 108; 2024 10‑K, p. 109). This multi‑year consistency reflects Oracle’s broader strategy of building a staggered maturity profile of inexpensive, long‑dated notes to lock in favorable rates, preserve liquidity and maintain financing flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance date of the 2.300% Notes due 2028 as March 24, 2021, which aligns with the context that these notes were part of the March 2021 issuance referenced in the 2022 filing. The interest rate (2.300%), maturity year (2028), and inclusion in Exhibit 4.14 in the 2022 10-K are all factually accurate. The continued listing of the notes in the 2023 and 2024 10-Ks without new tranches is consistent with the ground truth's emphasis on consistent disclosure across years. (2) Quantitative elements—interest rate (2.300%), issuance date (March 24, 2021), maturity (2028), and exhibit number (4.14 in 2022)—are all correct. The LLM references specific page numbers (e.g., p.112–113 in 2022 10-K), which, while not contradicted, are not verifiable from the ground truth but do not detract from accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across three years (2022–2024) to infer Oracle’s ongoing reliance on this debt instrument and connects it to a broader financing strategy of maintaining a staggered maturity profile and locking in favorable rates. This aligns with the ground truth’s conclusion about a stable, deliberate long-term financing approach. The only minor discrepancy is that the ground truth mentions Exhibit 4.16 in 2022, while the LLM cites Exhibit 4.14—this is a small inconsistency in exhibit numbering, possibly due to differing document versions or typographical variation, but does not affect the core factual accuracy of the note’s existence and continuity. (4) The answer is contextually relevant, fully addressing both the evolution of the note structure and the strategic implications. The conclusion about Oracle’s strategy is semantically equivalent to the ground truth, using slightly different phrasing (e.g., 'low-coupon, medium-term funding source' vs. 'diverse maturity profile'). Overall, the answer is highly accurate with only a minor variance in exhibit reference, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 545,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "Boeing’s pension plan has consistently used private‑equity limited‑partnership vehicles that invest **both in the United States and abroad** and that target **leveraged‑buyout, venture‑capital, growth and special‑situation** strategies – language that appears unchanged in the 2022, 2023 and 2024 10‑K disclosures [BA_10k_2022.pdf pp. 108‑112; BA_10k_2023.pdf pp. 90‑94; BA_10k_2024.pdf pp. 97‑101]. While the geographic scope and strategic focus stayed the same, Boeing increased its emphasis on private equity: the target allocation rose from **4 % in 2022** to **7 % in 2023 and 2024**, and the actual share grew from **8 % (2022)** to **8 % (2023)** and **9 % (2024)** [allocation tables in the same pages].",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but significantly diverges from the ground truth in key aspects of the investment strategy evolution. (1) Correctly identifies that Boeing (BA) invests in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, and cites consistent language across 2022–2024 filings. However, it fails to report the actual evolution described in the ground truth: the expansion into global real assets (energy, farmland, infrastructure) in 2023 and the increased use of derivatives and sophisticated vehicles in 2024. Instead, it claims the strategy 'stayed the same,' which contradicts the documented strategic deepening and broadening. (2) Quantitatively, the LLM introduces allocation percentages (4% target in 2022, rising to 7% in 2023–2024; actuals from 8% to 9%) that are not present in the original answer or implied by the ground truth. While these numbers may appear in the cited 10-Ks, they were not part of the verified knowledge graph answer, and their inclusion shifts focus away from the qualitative strategic evolution to a quantitative allocation change not emphasized in the ground truth. This introduces factual misalignment, as the original answer does not mention target or actual allocation percentages. (3) The multi-hop reasoning is flawed: the question asks for evolution in geographic scope and strategic focus, but the LLM concludes no change occurred, missing the key 2023 expansion into real assets and 2024 use of derivatives. This indicates a failure to synthesize the strategic progression across years. (4) Contextually, the answer is relevant and cites appropriate documents, but it substitutes a narrative of stable strategy with increasing allocation, whereas the ground truth describes a qualitatively evolving strategy with broader integration of alternative tools. Thus, while some facts are accurate, the core evolution is misrepresented, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 531,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "- 2022 10‑K: Bemarituzumab moved from earlier‑stage testing into an **initiated Phase 3 trial** for gastro‑esophageal‑junction adenocarcinoma (while still listed in Phase 2 for other tumors and Phase 1 for NSCLC) and its composition‑of‑matter patents were shown to **expire in 2029 in both the United States and Europe**【AMGN_10k_2022.pdf p.23‑27】.  \n\n- 2023 10‑K: The candidate remains a **Phase 3 program** (no new phase change is reported) and the patent table still lists **U.S. and European expirations of 2029**【AMGN_10k_2023.pdf p.24‑28】.  \n\n- 2024 10‑K: Bemarituzumab continues to be shown as a **Phase 3 candidate** (with no further progression noted) and the **2029 expiration dates for both U.S. and Europe** are unchanged【AMGN_10k_2024.pdf p.24‑28】.  \n\nThus, from 2022 through 2024 the drug progressed to and then remained in Phase 3, while its patent protection timeline stayed fixed at an estimated 2029 expiry in both territories.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurately reported: Bemarituzumab entered a Phase 3 trial in 2022 for GEJ adenocarcinoma, remained in Phase 3 through 2024, and its composition-of-matter patents are set to expire in 2029 in both the U.S. and Europe. The answer correctly notes that no further phase progression occurred beyond initiation of Phase 3. (2) Quantitative accuracy is excellent: the 2029 patent expiration dates for both regions are consistently and correctly cited across all years, matching the ground truth. No calculations were required, but the synthesis of timelines across three annual reports is precise. (3) Multi-hop reasoning is sound—the model correctly synthesized information across three years of 10-K filings to show continuity in clinical phase and patent status, demonstrating an understanding of both development trajectory and IP positioning. (4) The answer is semantically equivalent to the original, providing even greater granularity (e.g., mentioning NSCLC and other phases for different indications) without introducing errors. It directly addresses all parts of the question: clinical progression (initiation and continuation in Phase 3) and patent expiration timelines (stable 2029 estimates in U.S. and Europe). The inclusion of specific document citations adds verifiability and strengthens contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 391,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "In 2022 the Fabric & Home Care segment contributed about 31 % of P&G’s net earnings and Dawn was listed among its core brands (Ariel, Downy, Gain, Tide, Cascade, **Dawn**, Fairy, Febreze, Mr. Clean, Swiffer). By 2024 the segment’s earnings share had risen to roughly 34 % (with a 36 % share of net sales) and Dawn remained in the same brand roster, showing that Dawn’s position stayed constant as a key brand while the segment grew to become a larger contributor to overall earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Dawn was listed as a core brand in the Fabric & Home Care segment in both 2022 and 2024; the segment’s net earnings contribution increased from 31% in 2022 to 34% in 2024; net sales share was 35% in 2022 and 36% in 2023 and 2024, which the LLM correctly notes as 36% in 2024. (2) Quantitative accuracy is perfect: percentages for earnings (31% to 34%) and sales (36% in 2024) match the original answer, and no calculations are incorrect. Minor omission: the LLM does not mention the 2022 net sales percentage (35%) or the stability of sales share across years, which slightly reduces completeness. (3) Reasoning is sound: the model correctly infers that Dawn’s consistent inclusion in brand listings and the segment’s growing earnings contribution indicate stable and ongoing strategic positioning. (4) The answer is contextually relevant, directly addressing Dawn’s positioning evolution through both brand listing and segment performance. The only reason for not scoring 10 is the omission of the 2022 sales percentage and lack of explicit mention of sales stability, which slightly weakens the completeness of the multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 346,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "Schwab’s 2022 filing disclosed that the fair‑value of client securities that could be pledged as margin collateral had risen to **$120.3 billion** (up from $84.0 bn in 2020) and that **$31.4 billion** of those securities were already pledged to third parties (up from $23.0 bn)【SCHW_10k_2022.pdf p. 106‑110】.  In the 2023‑2024 filings the firm’s borrowing facilities that rely on client securities were supported by **$63.1 billion** of pledged collateral in 2023 and **$59.8 billion** in 2024, while secured uncommitted lines of credit backed by client margin securities fell from **$950 million** at year‑end 2023 to **$500 million** at year‑end 2024【SCHW_10k_2024.pdf p. 97‑101】.  The data show a very large but now‑stabilising exposure to client‑held assets – Schwab continues to use client securities for margin lending and collateral, yet the amount pledged for short‑term borrowing has modestly declined, indicating careful management of its collateral obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. The ground truth does not include specific dollar figures such as $120.3 billion, $31.4 billion, $63.1 billion, or $59.8 billion—these numbers are fabricated or misattributed. The original answer focuses on qualitative disclosures about Schwab’s pledging practices under ASC 326, use of collateral for margin lending, and operational trends, but does not provide the detailed numerical data cited in the LLM response. Additionally, the claim that pledged collateral was $63.1B in 2023 and $59.8B in 2024 and that secured lines of credit fell from $950M to $500M is not supported by the ground truth and introduces false precision. While the LLM correctly identifies the general trend of continued pledging and use of client securities for margin and collateral purposes, it fails to mention key qualitative developments such as the practical expedient under ASC 326 in 2023 or the specific use of securities for Options Clearing Corporation activities in 2024. The reasoning is partially sound in that it infers ongoing use and some stabilization, but the conclusion about 'modestly declined' short-term borrowing is based on incorrect data. The answer is contextually relevant and addresses the evolution across years and exposure to client assets, but the inclusion of fabricated numbers severely compromises factual accuracy. Thus, while the directional interpretation aligns somewhat with the ground truth, the lack of quantitative fidelity and omission of key qualitative details limits correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 435,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "In fiscal 2023 ACN’s defined‑benefit target was 100 % debt for U.S. plans and, for non‑U.S. plans, a mix of 48 % debt, 27 % equity, 4 % cash, 11 % insurance contracts and 10 % other (see the 2022 filing’s “Plan Assets” table). By fiscal 2025 the U.S. target remained 100 % debt, while the non‑U.S. target shifted to 36 % debt, 28 % equity, 7 % cash, 21 % insurance contracts and 8 % other (see the 2024 filing’s “Plan Assets” table). The weighted‑average allocations moved in the same direction: 2022 (21 % equity, 50 % debt, 4 % cash, 15 % insurance, 10 % other), 2023 (19 % equity, 43 % debt, 6 % cash, 22 % insurance, 10 % other) and 2024 (23 % equity, 42 % debt, 5 % cash, 21 % insurance, 9 % other), indicating a gradual increase in equity, cash and insurance exposure and a reduction in debt for the non‑U.S. portion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both direction and magnitude of allocation changes. (1) The original answer states a clear, consistent increase in fixed income (55% → 58% → 61%) and decrease in equities (45% → 42% → 39%) from fiscal 2023 to 2025, based on weighted-average allocations as of August 31 in 2022, 2023, and 2024. The LLM instead claims a decrease in debt (from 50% to 42%) and increase in equity (from 21% to 23%) in the weighted averages, which is the opposite trend. (2) The LLM introduces a breakdown by U.S. and non-U.S. plans not mentioned in the original answer, citing targets like 100% debt for U.S. plans, which are not reflected in the ground truth. These specific percentages (e.g., 48% debt in non-U.S., 11% insurance contracts) and the claim of increasing insurance and cash at the expense of debt are unsupported by the provided truth. (3) The multi-hop reasoning is flawed: the LLM appears to misinterpret or misaggregate plan-level data, failing to report the correct weighted-average trend toward de-risking via higher fixed income. Instead, it suggests a risk-on shift, which is factually wrong. (4) While the LLM attempts to address the evolution over time and references the correct fiscal years (2022–2024), the core quantitative data and directional conclusion are incorrect, warranting a low correctness score. Contextual relevance is moderate because it discusses the right topic and time frame, but factual accuracy is severely lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 414,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023 and then rose slightly to $562 million in 2024, while its long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 before declining to $45.0 billion in 2024 (COF_10k_2023.pdf:176‑180; COF_10k_2024.pdf:186‑190). The three‑year trend shows the company relying less on volatile short‑term funding and more on a debt mix dominated by fixed‑rate senior notes, with the weighted‑average rate on its unsecured senior debt increasing from roughly 4.5 % (2022‑23) to 4.8 % in 2024 and the securitized‑debt rate edging up to about 3.5 %, indicating modestly higher interest‑rate exposure even as total long‑term debt has been trimmed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM incorrectly reports short-term borrowings as $883M (2022), $538M (2023), and $562M (2024), and long-term debt as $47.8B, $49.3B, and $45.0B across the same years. These values do not align with the total debt figures in the ground truth, and the LLM appears to have misinterpreted or misaggregated the components. For example, the ground truth does not support a long-term debt figure of $47.8B in 2022 — the actual total debt (short + long term) was $43.086B, so this is a major inconsistency. (2) The weighted-average interest rate on securitized debt in the ground truth increases from 1.51% (2022) to 3.01% (2023) to 3.48% (2024), but the LLM cites unsecured senior debt rates rising from ~4.5% to 4.8% and securitized debt at ~3.5% in 2024, which contradicts the source. Additionally, the LLM fails to mention the complete elimination of floating unsecured senior debt from $1,597M in 2023 to $0 in 2024 — a key strategic shift highlighted in the original answer. (3) The multi-hop reasoning is partially sound in that the LLM attempts to synthesize trends in debt structure and interest rate exposure over three years and draws a conclusion about reduced reliance on short-term funding. However, because the underlying numbers are incorrect, the conclusions are based on flawed premises. The observation about moving toward fixed-rate debt has some alignment with the ground truth (given the elimination of floating-rate debt), but this specific point is missing from the LLM response. (4) The contextual relevance is high because the answer addresses the evolution of debt and interest rate exposure over time and attempts to interpret the trend. However, due to major quantitative errors and omission of critical facts (e.g., elimination of floating-rate debt), the correctness score is low. The qualitative accuracy is moderate because the reasoning framework is logical, but based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 583,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "BA’s fleet‑support services have remained essentially flat – the 10‑K filings for 2022, 2023 and 2024 all state that fleet‑support costs “have historically been approximately 1 % of total consolidated costs of products and services”【BA_10k_2022.pdf†p40】【BA_10k_2023.pdf†p34】【BA_10k_2024.pdf†p37】. By contrast, abnormal production costs in the 787 program ballooned to $2.7 billion cumulative through 2023 and added $256 million in 2024【BA_10k_2023.pdf†p34】【BA_10k_2024.pdf†p37】, while reach‑forward losses on the 777X program surged to $2.6 billion in Q3 2024 and a further $891 million in Q4 2024【BA_10k_2024.pdf†p37】. Thus, while fleet‑support costs stayed at roughly 1 % of total costs, the company’s results were increasingly eroded by the rising abnormal and reach‑forward costs in the 787 and 777X programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that BA's fleet support services costs remained at approximately 1% of total consolidated costs in 2022, 2023, and 2024, which matches the ground truth. It accurately contrasts this stability with rising abnormal production costs and reach-forward losses in the 787 and 777X programs. (2) Quantitatively, the LLM correctly reports the $2.7 billion cumulative abnormal production costs for the 787 program through 2023 and the $2.6 billion (i.e., $2,608 million) reach-forward loss in Q3 2024 and $891 million in Q4 2024 for the 777X program. However, it states an additional $256 million in abnormal costs for the 787 in 2024, which is not mentioned in the ground truth — the ground truth only specifies the $2.7 billion cumulative through 2023 and does not break out a 2024 increment. This is a minor inaccuracy, possibly from misreading the source, but does not contradict the overall trend. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and two major programs, distinguishing between stable service costs and escalating production-related losses. It draws the correct conclusion that financial strain stems from production inefficiencies, not fleet support services. (4) The answer is contextually fully relevant, addressing both parts of the question — the trend in fleet support costs and its relation to abnormal/forward-loss costs. The minor quantitative discrepancy prevents a perfect 10, but overall accuracy, reasoning, and completeness are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 427,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie’s money‑market and time‑deposit balances were $21 million at year‑end 2022, dropped to $10 million at year‑end 2023, and stayed at $10 million at year‑end 2024. The sharp reduction after 2022 and the subsequent stabilization at a lower level indicate the company trimmed its short‑term cash cushion—likely to redeploy cash to operations, investments or debt repayment—while still maintaining a modest, steady liquidity reserve.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and trends. According to the ground truth, AbbVie's allocation was $12M in 2022, increased to $21M in 2023, and decreased to $10M in 2024. The LLM incorrectly states $21M in 2022 (should be $12M), $10M in 2023 (should be $21M), and $10M in 2024 (correct). This reverses the actual trend—ground truth shows an increase in 2023 followed by a drop in 2024, while the LLM describes a sharp drop after 2022, which is factually wrong. (2) The quantitative accuracy is severely compromised: two out of three values are incorrect, and the direction of change between years is wrong. The only correct number is the 2024 value. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the year-over-year evolution. The conclusion about 'trimming after 2022' is based on incorrect data and contradicts the actual temporary increase in 2023. While the interpretation of maintaining a modest reserve in 2024 is plausible, the overall reasoning is built on false premises. (4) Contextual relevance is moderate—the answer addresses the right topic (liquidity strategy) and attempts interpretation—but due to incorrect data, the insights are misleading. Correctness and quantitative accuracy are low due to core factual errors in numbers and trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 377,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "In fiscal 2022 Accenture repurchased roughly 12.2 million Class A shares for about $4.1 billion, leaving an aggregate of roughly $3.1 billion of authorized but unused repurchase capacity (the 2022 filing notes $3,129 million of remaining authorization). In fiscal 2023 the company again bought back about $4.5 billion of shares, with the unused authorization falling to roughly $2.5 billion (2023 filing, pp. 37‑41). In fiscal 2024 it repurchased another $4.5 billion of shares, and the remaining authorization stood at $2.694 billion after the board added $4 billion of new authority, bringing total outstanding authority to $6.694 billion (2024 filing, pp. 37‑41). This steady, sizable buy‑back activity combined with periodic increases in total authority shows that Accenture treats share repurchases as a core, ongoing component of its capital‑return strategy, consistently returning cash to shareholders while maintaining a sizable pool of authorized funds for future purchases.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its portrayal of Accenture's share repurchase activity and capital return strategy, with accurate qualitative trends and correct fiscal years. However, there are minor quantitative inaccuracies. The original answer states that in fiscal 2022, Accenture had $3,129,296 thousand (i.e., ~$3.13 billion) in remaining authorization—this matches the LLM's $3.1 billion (rounded), so that is acceptable. But the LLM claims Accenture repurchased $4.1 billion in 2022 and $4.5 billion in both 2023 and 2024, which are not present in the ground truth; the original answer does not specify annual repurchase amounts, only remaining authorizations and increases in total authority. Thus, these expenditure figures are unsupported and likely incorrect. (2) The LLM correctly notes that in fiscal 2024, the board added $4 billion to the authorization, increasing total outstanding authority to $6.694 billion—this aligns with the ground truth ($2,694 million remaining + $4,000 million added = $6,694 million). However, the original answer does not state that $4.5 billion was repurchased in 2024, so that figure is an unsupported addition. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution of remaining authorization across years and infers a consistent capital return strategy. It correctly identifies the increase in total authority in 2024 and links it to board action, showing proper cross-year synthesis. (4) Despite the unsupported repurchase amounts, the core facts about authorization levels and strategic interpretation are correct. The answer is contextually excellent and semantically aligned in intent and conclusion, warranting a high correctness score, but the inclusion of unverified financial figures reduces quantitative accuracy. Hence, correctness_score is 8, quantitative_accuracy 7, qualitative_accuracy 9, and contextual_relevance 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 520,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "AbbVie’s charter has not changed on this point – the 2022 Form 10‑K (pages 44‑48) already states that “stockholders may only remove directors for cause,” and the same language is repeated verbatim in the 2023 filing (pages 25‑29) and again in the 2024 filing (pages 25‑29)【ABBV_10k_2022.pdf†pages 44‑48】【ABBV_10k_2023.pdf†pages 25‑29】【ABBV_10k_2024.pdf†pages 25‑29】. By keeping this “for‑cause” removal restriction (along with a staggered three‑class board, inability to call special meetings, and an 80 % amendment vote), AbbVie is deliberately entrenching its board to make it harder for shareholders or hostile bidders to replace directors, signaling a long‑term defensive posture against takeovers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that AbbVie maintained the same 'removal for cause' provision across 2022, 2023, and 2024, with verbatim language cited from each year's 10-K filing, matching the original answer's claim of consistency. (2) No numerical or date inaccuracies are present—filings are correctly attributed to their respective years, and page numbers (44–48 for 2022, 25–29 for 2023 and 2024) are accurately referenced. The 80% supermajority requirement for bylaw amendments is correctly included as part of the anti-takeover framework. (3) The multi-hop reasoning is sound: the model synthesizes governance provisions across three years and correctly infers that the lack of change, combined with other structural defenses (staggered board, no special meetings), reveals a deliberate, long-term takeover defense strategy. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in governance provisions and the strategic implications of board entrenchment. Wording differs slightly but conveys identical meaning and factual content. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 337,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "PepsiCo’s 4.000 % Senior Note due 2047 is listed in the “Exhibits” section of each filing with identical wording – “Form of 4.000 % Senior Note due 2047, which is incorporated herein by reference to Exhibit 4.5 to PepsiCo’s Current Report on Form 8‑K filed on May 2 2017.” The 2022 10‑K (pages 124‑128) contains this reference, the 2023 10‑K (pages 124‑128) repeats the same line, and the 2024 10‑K (pages 125‑129) again includes the unchanged citation 【PEP_10k_2022.pdf:124‑128】【PEP_10k_2023.pdf:124‑128】【PEP_10k_2024.pdf:125‑129】.  \n\nThe fact that the note is disclosed in exactly the same way for three consecutive years shows it remains an outstanding, material component of PepsiCo’s long‑term debt, reflecting the company’s deliberate strategy of maintaining long‑dated senior‑note financing to support its capital structure and provide financial flexibility over the long run.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.000% Senior Note due 2047 is consistently referenced in the 2022, 2023, and 2024 10-K filings via Exhibit 4.5 of the May 2, 2017 8-K filing. The percentages, years, and exhibit numbers are all factually correct. (2) Quantitative accuracy is perfect: the interest rate (4.000%), maturity year (2047), filing date (May 2, 2017), and exhibit number (4.5) are all correctly reported with no discrepancies. Format variations (e.g., spacing in '4.000 %') do not affect meaning. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the consistent disclosure pattern across three years and infers the note’s role in PepsiCo’s long-term capital structure. It correctly concludes that the unchanged citation reflects stability in the debt structure. (4) The only minor shortcoming is that the LLM does not explicitly state that 'no modifications were needed to the note’s form or terms,' which is a subtle but present point in the ground truth. However, the implication of stability and ongoing relevance is clearly conveyed. The answer is contextually excellent, directly addressing both the evolution (or lack thereof) in disclosure and the strategic implication. Thus, the answer is semantically equivalent to the ground truth with only negligible omission, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 394,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle’s 4.30 % senior note due 2034—originally issued in July 2014—appears in each filing as an unchanged component of its long‑term debt: the 2022 10‑K lists the note with a $2.0 billion principal balance (p. 111), the 2023 10‑K repeats the same disclosure with the same amount (p. 108), and the 2024 10‑K again shows the note unchanged (p. 108). This consistent year‑over‑year reporting, without new issuances or retirements, signals that Oracle is deliberately preserving a stable, fixed‑rate, long‑dated debt tranche as part of a diversified, long‑term financing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: the 4.30% Note due 2034 is accurately described with a $2.0 billion principal balance in each year (2022–2024), and the citation of consistent disclosure across filings is factually sound. The note’s original issuance in July 2014, though not in the ground truth, is plausible and does not contradict it. (2) The LLM correctly identifies the multi-year pattern of unchanged disclosure, which supports the conclusion of a stable long-term debt strategy. (3) Reasoning is strong: the synthesis across three years of 10-K filings demonstrates proper multi-hop logic, and the conclusion about Oracle preserving a fixed-rate, long-dated tranche for diversification is logically derived and semantically equivalent to the ground truth’s emphasis on diversified maturity profiles and sustained capital market engagement. (4) The only minor gap is that the LLM does not explicitly mention Oracle’s broader set of debt instruments or new issuances in the same series, which the ground truth references (e.g., 'part of a broader set of debt instruments'), slightly reducing qualitative completeness. However, the core insight about strategic stability is fully preserved. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 378,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized 127 million Accenture Class A ordinary shares in fiscal 2022 【ACN_10k_2022.pdf†p.89‑93】; the ceiling was increased to 141 million shares in fiscal 2023 【ACN_10k_2023.pdf†p.81‑85】 and remained at 141 million in fiscal 2024 【ACN_10k_2024.pdf†p.96‑100】. This upward adjustment expands the equity‑award pool, indicating a long‑term strategy to rely more heavily on share‑based compensation to attract, retain and align employees with shareholder interests.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: 127 million shares in fiscal 2022, increased to 141 million in 2023, and unchanged in 2024. These numbers match the original answer exactly, with acceptable format variation (127 million = 127,000,000). (2) Quantitative accuracy is perfect—no calculation errors, and the progression (increase of 14 million shares from 2022 to 2023, stability thereafter) is correctly implied. (3) Multi-hop reasoning is sound: the model synthesized data across three fiscal years and filings (2022, 2023, 2024), correctly identifying the trend and its implications. (4) The interpretation—that the increase indicates a long-term strategy to expand share-based compensation for talent retention and alignment with shareholders—aligns with the original answer’s conclusion, using slightly different but equivalent phrasing (e.g., 'attract, retain and align employees' vs. 'support ongoing talent retention and incentive programs'). Citations are appropriately included, indicating source transparency. All aspects of the question are addressed: evolution of authorized shares and strategic implication. No factual, numerical, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 352,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "PepsiCo’s 2.750 % Senior Note due 2051 first appears in the 2022 Form 10‑K (pages 124‑128) as a stand‑alone exhibit 4.51 that incorporates the issuance terms set in the Oct 21 2021 Form 8‑K, and the same exhibit and language are repeated unchanged in the 2023 Form 10‑K (pages 126‑130). By the 2024 Form 10‑K (pages 127‑131) the note is no longer a separate exhibit but is listed within a consolidated Board‑of‑Directors resolution (exhibit 4.64) that authorizes the terms of many senior notes—including the 2.750 % due 2051—referencing the earlier 2013 resolution. This multi‑year filing pattern shows PepsiCo’s strategy of locking in long‑dated, low‑rate senior debt and maintaining consistent, transparent documentation across years to support a stable, long‑term financing framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the 2.750% Senior Note due 2051 was first introduced in 2022 in Exhibit 4.60 as part of a Board resolution, then formalized in 2023 with a dedicated 'Form of' note in Exhibit 4.51, and remained consistent in 2024 under Exhibit 4.48. However, the LLM claims the note appeared as a stand-alone Exhibit 4.51 in 2022, which contradicts the ground truth (where 4.51 appears in 2023). It further incorrectly states that in 2024 the note was folded into a consolidated Board resolution (Exhibit 4.64), reversing the actual progression: the note moved from a board resolution (2022) to a dedicated form (2023), not the other way around. (2) The dates and exhibit numbers are incorrect: the LLM references an October 21, 2021 Form 8-K and exhibit 4.51 in 2022, which is not supported by the ground truth. The ground truth does not mention any 2021 Form 8-K or exhibit 4.64 in 2024. (3) The multi-hop reasoning is flawed: the LLM misrepresents the evolution of documentation, incorrectly suggesting a move from individual disclosure back to consolidation, whereas the ground truth shows a logical progression from authorization to formalization. This undermines the conclusion about PepsiCo’s strategy, even though the general idea of stability is partially aligned. (4) The contextual relevance is moderate because the answer addresses the question’s structure and attempts to infer strategy, but the factual foundation is incorrect, leading to a misleading interpretation. Quantitative and qualitative accuracy are low due to wrong exhibits, years, and procedural sequence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 456,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "American Express’s filings show that its network has not moved in the ranking hierarchy – the 2022, 2023 and 2024 10‑K competition sections all state that the company remains the fourth‑largest general‑purpose card network worldwide behind China UnionPay, Visa and Mastercard (2022 pp. 10‑14; 2023 pp. 10‑14; 2024 pp. 32‑36). Nevertheless, the 2024 filing notes that the competitive landscape has tightened: the firm now faces heightened regulatory scrutiny (e.g., Category III supervisory status, exits from EU/Australia network‑licensing, greater focus on interchange‑fee rules) and a rapid expansion of alternative payment mechanisms such as digital wallets, payment aggregators and buy‑now‑pay‑later services, which intensify competition beyond traditional card networks (2024 pp. 32‑36).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: American Express remained the fourth-largest general-purpose card network from 2022 to 2024, behind China UnionPay, Visa, and Mastercard—this is explicitly confirmed in the cited 10-K pages across all three years. There are no numerical values (e.g., dollar amounts, percentages) in the original or LLM answer, so no calculation errors exist. (2) The LLM correctly identifies the evolving competitive landscape, including increased regulatory scrutiny by 2024, citing specific examples like Category III supervisory status, exits from EU and Australia network licensing, and interchange fee rules—details consistent with heightened regulatory pressure in the original answer. It also accurately notes the rise of alternative payment mechanisms such as digital wallets, payment aggregators, and buy-now-pay-later services, which matches the ground truth’s mention of Alipay, PayPal, and BNPL. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings to show continuity in rank but evolution in competitive dynamics, correctly inferring a shift toward regulatory constraints. (4) The only minor shortcoming is that the LLM does not explicitly mention 'closed-loop loyalty systems' or 'cobrand relationships' as part of Amex's differentiation strategy in 2022–2023, which were included in the original answer. However, it does reference 'network licensing' exits, which relates to cobrand arrangements, so the omission is partial but not critical. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with full quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 476,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "In both the 2022 and 2024 Form 10‑K filings Boeing describes upgrades and conversions as a standard part of the Global Services segment’s “full‑spectrum of products and services” (2022 Business section p. 3; 2024 Business section p. 1). The language is essentially unchanged, indicating that Boeing has not altered its strategic emphasis on these aftermarket activities. This continuity suggests the company continues to treat aircraft upgrades and conversions as a core, recurring‑revenue pillar of its services business rather than shifting its focus elsewhere.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Boeing's strategic emphasis on upgrades and conversions has not changed from 2022 to 2024. The ground truth shows a clear evolution: in 2022, upgrades and conversions were listed among several services; by 2023, 'modifications' were emphasized more prominently; and in 2024, Boeing integrated 'data analytics and digital services' as complementary, signaling a strategic shift toward technology-enabled differentiation. The LLM incorrectly asserts that the language is 'essentially unchanged' and that there has been no strategic shift, which contradicts the documented progression in Boeing’s filings. While the LLM correctly identifies that upgrades and conversions are part of the Global Services segment in both years (entity and contextually accurate), it fails to detect the nuanced but important strategic evolution—particularly the growing emphasis on digital integration and lifecycle support modernization. There are no numerical figures to verify, so quantitative accuracy is not applicable beyond correct year references (2022, 2024), which are accurate. The reasoning is flawed due to lack of multi-hop synthesis across the three-year progression, especially missing the 2023 shift and 2024 digital enhancement. Thus, while the answer is relevant to the topic, it misrepresents the strategic trajectory, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 395,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "PepsiCo’s 5.50 % Senior Note due 2035 was originally issued in 2018 (the note’s form is attached to a November 8 2018 8‑K and a November 19 2018 S‑4 registration).  In each of its subsequent annual reports the company again lists that same note among the exhibits – it appears as Exhibit 4.23/4.25 (the “Series A” version) and as Exhibit 4.27/4.29 (the S‑4 version) on the exhibit pages of the 2022 filing (pp. 124‑128), the 2023 filing (pp. 124‑128) and the 2024 filing (pp. 125‑129)【PEP_10k_2022.pdf, pp.124‑128】【PEP_10k_2023.pdf, pp.124‑128】【PEP_10k_2024.pdf, pp.125‑129】.  The fact that the note is repeatedly referenced in three consecutive 10‑K reports shows it remains outstanding and that PepsiCo consistently documents its long‑term debt, reflecting a disciplined, transparent strategy for managing and reporting its capital structure over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 5.50% Senior Note due 2035 was issued in 2018, specifically referenced in an 8-K on November 8, 2018, and also tied to an S-4 filing on November 19, 2018—this additional detail (S-4) is factually correct and adds value without contradicting the original answer. The exhibit numbers (4.23, 4.25, 4.27, 4.29) and corresponding filing years (2022–2024) are accurately reported, with correct page ranges across filings. (2) Quantitative accuracy is perfect: dates, percentages, exhibit numbers, and document types (8-K, S-4) are all factually correct and consistent with the knowledge graph. (3) Reasoning is sound: the conclusion that the repeated inclusion of the note across three 10-Ks indicates it remains outstanding is logically valid and reflects proper multi-hop synthesis across years and documents. (4) The only minor shortcoming is that the original answer emphasizes the lack of modification or retirement as evidence of a 'stable, long-duration capital structure,' while the LLM focuses on 'disciplined, transparent strategy'—a slightly different framing but semantically similar. The LLM could have more explicitly noted the absence of refinancing or changes, but the core insight about ongoing documentation and stability is present. Thus, the answer is factually excellent and contextually appropriate, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 401,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "BNY Mellon’s 10‑K filings for 2022, 2023 and 2024 all contain the same risk‑factor language that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning…”【BK_10k_2022.pdf p. 1‑5】, 【BK_10k_2023.pdf p. 3‑7】, 【BK_10k_2024.pdf p. 3‑7】. The wording is essentially unchanged over the three years, indicating that the company’s exposure to U.S. banking‑law constraints on capital planning and shareholder returns has remained a persistent, unchanged regulatory risk. This multi‑year consistency shows that BNY Mellon’s capital‑return policies continue to be bounded by banking‑law limits and that no relaxation of those constraints has occurred during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns remained consistent from 2022 to 2024, citing unchanged risk-factor language across the 10-K filings. All referenced documents and page numbers are accurate, and there are no numeric inaccuracies—this earns a 10 in quantitative accuracy. (2) The answer is complete: it addresses the evolution (or lack thereof) in regulatory constraints over the three years and interprets the implications for capital return policies. (3) Entity accuracy is strong: correct company (BNY Mellon), correct years (2022–2024), and correct legal/regulatory references (U.S. banking laws, capital planning). (4) The reasoning is sound—by noting the unchanged language, the LLM correctly infers that regulatory constraints have not relaxed, which is a valid conclusion from the consistency in disclosures. The only minor shortcoming is that the LLM omits mention of Delaware law and preferred stock obligations highlighted in 2023 and 2024 in the ground truth, and does not explicitly reference the 'well capitalized' status noted in 2024. While the core message about persistent constraints is correct, this slight lack of detail prevents a perfect 10 in qualitative accuracy. However, the omission does not distort the overall meaning, so the answer remains semantically equivalent in intent and conclusion. Contextual relevance is perfect—the response directly addresses the multi-year progression and its implications for regulatory constraints.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 443,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle’s 2.300 % senior unsecured notes due 2028 were first issued on 24 March 2021 with a 2.300 % coupon, semi‑annual interest, a March 2028 maturity and an optional‑redemption feature that allows make‑whole redemption any time before 24 March 2026 and par redemption thereafter (2022 10‑K, ORCL_10k_2022.pdf pp. 112‑116). The 2023 10‑K repeats those original terms and notes that Oracle exercised a modest early‑redemption of a portion of the issue in 2023, while the 2024 10‑K shows the remaining notes still outstanding with the same coupon and redemption schedule (2023 10‑K, ORCL_10k_2023.pdf pp. 108‑112; 2024 10‑K, ORCL_10k_2024.pdf pp. 109‑113). By locking in a low‑rate, long‑dated bond and retaining the optional‑redemption flexibility, Oracle demonstrates a disciplined approach: it secured cheap fixed‑income financing when rates were low and preserves the ability to adjust its debt cost as interest‑rate environments change.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct quantitative details: the 2.300% coupon, March 24, 2021 issuance date, semi-annual interest, and maturity in March 2028 are all factually accurate and align with the ground truth. The optional redemption terms (make-whole before March 24, 2026, par thereafter) are also correctly reported. However, the LLM introduces a claim not present in the ground truth: that Oracle 'exercised a modest early-redemption of a portion of the issue in 2023.' This detail is unsupported by the original answer and not mentioned in the knowledge graph, representing a significant factual overreach. The ground truth emphasizes Oracle's issuance strategy across years—particularly the introduction of higher-yielding 4.500% Notes due 2028 in 2023 and no new 2028-dated instruments in 2024—but the LLM fails to mention these key strategic moves. Instead, it focuses narrowly on redemption mechanics and retention of the notes, missing the broader multi-hop insight about Oracle’s fixed-income financing strategy in varying rate environments. While the conclusion about Oracle locking in low rates is partially aligned with the ground truth, the absence of comparative issuance data (e.g., the 4.500% Notes) weakens the reasoning. The answer is contextually relevant and well-structured but lacks completeness and introduces unverified claims, reducing its qualitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 389,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "Across the three filings IBM consistently lists “client relationships and trust” as a core competitive pillar, but the framing tightens over time. In the 2022 10‑K (pages 2‑6) the phrase appears in a broad list of competitive factors alongside “a broad range of capabilities,” while the 2023 and 2024 10‑Ks (pages 1‑5) not only repeat the same wording but explicitly tie it to the company’s hybrid‑cloud and AI platform as a key driver of business‑value delivery and accelerated growth. This steady, increasingly integrated emphasis signals that IBM is positioning trusted client partnerships as a strategic differentiator that underpins its push to dominate the hybrid‑cloud and AI market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that IBM consistently emphasized 'client relationships and trust' across 2022, 2023, and 2024, with evolving framing—broad in 2022 and more tightly integrated with hybrid cloud and AI in 2023 and 2024. The mention of 10-K page numbers (2-6 in 2022, 1-5 in 2023/2024) adds precision and matches expected sourcing. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes the evolution of language across years and correctly infers that the increasing integration of trust with hybrid cloud and AI indicates a strategic positioning move. The only minor gap is that the LLM does not mention the 2024 expansion of strategic partnerships (e.g., Palo Alto Networks), which is a specific detail in the ground truth that adds nuance about how trust is operationalized. (4) Despite this omission, the core message—that trust is increasingly positioned as a foundational differentiator in IBM’s hybrid cloud and AI strategy—is semantically equivalent and well-supported. The answer is fully contextually relevant, directly addressing the evolution and strategic implications. Thus, correctness is docked slightly (9/10) for the missing partnership example, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 398,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio was essentially unchanged over the three years – $630 million at year‑end 2022, $… million at year‑end 2023 and $… million at year‑end 2024 – with more than 99 % of the holdings (≈$628 million in 2022) due within one year, giving a weighted‑average yield of roughly 1.74 % (the 1‑year bucket) in 2022 (AXP_10k_2022.pdf pp.119‑122). The 2023 and 2024 filings show the same short‑duration composition and only a modest rise in the 1‑year weighted‑average yield to about 1.8 % in 2023 and 1.9 % in 2024 (AXP_10k_2023.pdf pp.133‑135; AXP_10k_2024.pdf pp.175‑177). This gradual, slight increase in yield while keeping the holdings short‑dated indicates only a limited uptick in interest‑rate exposure and reflects a continued conservative, liquidity‑focused investment strategy for its foreign‑government‑bond assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It claims American Express's foreign government bond holdings were 'essentially unchanged' at $630 million in 2022, 2023, and 2024, but the ground truth does not provide the total portfolio size for 2023 or 2024—only the yield and maturity profile. More critically, the LLM fabricates yields of 1.74% in 2022, 1.8% in 2023, and 1.9% in 2024, while the ground truth states the weighted average yield was 6.45% in 2023 and 5.85% in 2024. There is no yield provided for 2022 in the ground truth, so the 1.74% figure is unsupported. (2) The LLM incorrectly asserts that the composition remained 'short-duration' with over 99% maturing within one year in all years, but the ground truth shows a strategic shift by 2024, with a significant portion (2.03%) now maturing between 1–5 years—indicating a deliberate diversification. The LLM also misrepresents the 2022 data: while $628M of $630M did mature within one year, the remainder was split between 1–5 and 5–10 years, not entirely within one year as implied. (3) The multi-hop reasoning is flawed: the LLM fails to detect the strategic evolution from ultra-short, high-yield holdings in 2023 (6.45%) to a more diversified maturity structure in 2024 despite a yield drop to 5.85%, which the ground truth interprets as a risk management move. Instead, the LLM concludes there was only a 'limited uptick in interest-rate exposure' and a 'conservative, liquidity-focused strategy,' which contradicts the ground truth's indication of a strategic shift. (4) The contextual relevance is moderate because the answer addresses the right topic—yield profile, interest rate risk, and investment strategy—but the factual inaccuracies and incorrect synthesis severely undermine its validity. The citations to specific filings (e.g., AXP_10k_2023.pdf) appear fabricated or misapplied, as the yields cited do not match the ground truth. Overall, the answer misrepresents key data and draws opposite conclusions from the correct analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 555,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher disclosed that government‑grant assistance used to offset capital spending on diagnostics‑testing technology grew from $87 million in 2022, to $136 million in 2023, and to $198 million in 2024 【57†L...】【58†L...】【59†L...】.  This rising grant‑funded investment signals that Danaher is expanding its diagnostics‑testing capacity and treating diagnostics as an increasingly strategic pillar of its health‑care portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the dollar amounts ($87M in 2022, $136M in 2023, $198M in 2024) match the original answer exactly, with acceptable formatting (e.g., $87 million vs $87M). (2) Quantitative accuracy is perfect—each year’s grant funding is correctly reported, and the upward trend is accurately described. There are no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes the progression of funding over three years and infers the strategic importance of diagnostics testing within Danaher’s healthcare portfolio, which requires connecting investment trends with strategic intent. (4) The answer addresses all parts of the question: it details the evolution of investment via government grants from 2022–2024 and interprets the strategic implications. Wording differs slightly (e.g., 'expanding its diagnostics-testing capacity' vs 'increasingly central to Danaher’s strategic focus') but conveys the same meaning. Citations are included (though not evaluated for validity), indicating source grounding. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 338,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "Across all three Form 10‑K filings—FY 2022, FY 2023 and FY 2024—BNY Mellon’s Item 14 repeats the same language: “The information required by this Item is included in the Proxy in the following section: ‘Item 3 – Ratification of KPMG LLP,’ which is incorporated herein by reference. KPMG LLP’s Public Company Accounting Oversight Board (‘PCAOB’) firm identification number is 185.” The PCAOB number (185) and the reference to the Proxy’s “Item 3 – Ratification of KPMG LLP” are presented identically each year, indicating no change in the disclosure format or content. 【BK_10k_2022.pdf p. 14‑15】【BK_10k_2023.pdf p. 14‑15】【BK_10k_2024.pdf p. 14‑15】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements match: KPMG LLP was consistently ratified as principal accountant across FY 2022, 2023, and 2024; the PCAOB firm identification number was correctly stated as 185 in each year; and the disclosure consistently appeared under 'Item 3 – Ratification of KPMG LLP' within Item 14 of the Proxy materials. (2) Quantitative accuracy is perfect: the PCAOB number '185' is correctly reported each year with no discrepancies. (3) The multi-hop reasoning is sound—the model correctly synthesized information across three annual 10-K filings and confirmed consistency in both content and structure over time. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in disclosure practices, and correctly notes that the language and placement remained unchanged. Minor difference in company reference ('BNY Mellon' vs 'BK') does not affect accuracy as BK is a known ticker for The Bank of New York Mellon Corporation. Citations from the source documents further validate the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 315,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "From 2022 to 2024 American Express has consistently recorded revenue earned from third‑party merchant acquirers as discount or processed revenue at the moment the Card‑Member transaction occurs, recognizing the network‑rate fee from the acquirer as discount revenue (2022 10‑K, Discount Revenue, pp. 102‑106) and later reaffirming this in the Processed Revenue discussion (2023 10‑K, pp. 101‑105). The 2022 filing described the merchant‑acceptance contracts—no fixed term for small/medium merchants and 3‑to‑7‑year fixed terms for large merchants—and noted a goal of expanding merchant coverage globally; the 2023 filing added program‑specific language (e.g., OptBlue) and emphasized negotiated network‑rate fees with third‑party acquirers; and the 2024 filing explicitly linked third‑party acquirers, aggregators and processors to its strategic expansion agenda to increase coverage in priority international cities, industry verticals and digital integration (2024 10‑K, forward‑looking statements, pp. 91‑95).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: revenue recognition as discount/processed revenue tied to transaction timing and network-rate fees is consistent across 2022–2024, with proper references to OptBlue and third-party acquirer roles. The evolution in contractual relationships—from no fixed term for small/medium merchants to 3–7-year terms for large merchants—is accurately described. Strategic expansion goals in 2024, including focus on international markets, industry verticals, and digital integration via third-party acquirers and processors, are correctly reported. (2) There are no numeric inaccuracies; while no specific dollar amounts or percentages are cited, the qualitative financial reporting terms (discount revenue, processed revenue) match the original answer and SEC filings. Page references and section names (e.g., 'forward-looking statements') are plausibly cited, though not evaluated for exactness. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-Ks, correctly identifying the progression from transactional to strategic use of third-party acquirers. It connects revenue recognition, contractual terms, and strategic goals over time—core requirements of the question. (4) The only minor shortcoming is that the LLM does not explicitly name 'Global Network Services (GNS)' or frame the 2023 shift as a formal 'revenue-sharing framework' or 'royalties,' which are present in the ground truth. However, mentioning 'negotiated network-rate fees' and 'program-specific language' captures much of the same meaning. Overall, the answer is semantically equivalent with high completeness, accuracy, and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 476,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "Qualcomm’s 2025 human‑capital objectives stayed the same from FY 2022 through FY 2024 – a 15 % increase in women in leadership, a 15 % increase in under‑represented‑minority (URM) leaders and a 20 % rise in overall URM representation (see FY 2022 Human Capital goals [QCOM_10k_2022.pdf pp.15‑19] and the unchanged language in FY 2023 and FY 2024 filings [QCOM_10k_2023.pdf pp.14‑18; QCOM_10k_2024.pdf pp.14‑18]). In each year the HR & Compensation Committee tied progress on these diversity targets to executive bonuses through a non‑financial performance modifier that could adjust the payout between 0.9 × and 1.1 × the target amount (FY 2022 modifier [QCOM_10k_2022.pdf pp.15‑19]; FY 2023 modifier [QCOM_10k_2023.pdf pp.14‑18]; FY 2024 modifier [QCOM_10k_2024.pdf pp.14‑18]).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 15% increase for women and URM in leadership, 20% overall URM representation, and the 0.9 to 1.1 non-financial modifier affecting executive bonuses are all accurately reported and consistent across fiscal years 2022–2024. The citation of document pages and consistent language in filings supports this. (2) The answer correctly identifies that the structure of the executive compensation modifier remained unchanged across the three years, which matches the original answer’s claim. (3) However, the LLM omits a qualitative nuance present in the ground truth: while the compensation linkage stayed the same, Qualcomm expanded its human capital focus in FY2024 to include broader wellness and development programs and increased global engagement. This contextual evolution—though not altering the core compensation mechanism—is part of the 'evolution' asked in the question and is underemphasized. (4) Despite this minor omission, the LLM captures the central multi-hop synthesis: consistent diversity targets and their sustained linkage to executive pay over three years. The reasoning is sound, entities (Qualcomm, fiscal years, URM, leadership roles) are correct, and the answer is fully relevant. The slight deduction is for incomplete qualitative depth on the expansion of human capital initiatives in 2024, but core facts and calculations are fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 412,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "Caterpillar’s dealer network that carries its EMD‑branded reciprocating engines fell from 44 U.S. dealers and 116 overseas dealers serving 193 countries in 2022 to 41 U.S. dealers and 111 overseas dealers serving 187 countries in 2024 【CAT_10k_2022.pdf, p. 74】【CAT_10k_2024.pdf, p. 64】. The modest reduction in both the number of distributors and the countries covered suggests the company is trimming and consolidating its global distribution footprint—likely to improve efficiency and focus on higher‑margin markets—while still maintaining a broad worldwide presence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the geographic reach of Caterpillar's EMD-branded products as covering 193 countries in 2022 and 187 countries in 2024, matching the ground truth. While the original answer notes a gradual decline to 191 in 2023 and then 187 in 2024, the LLM omits the 2023 figure but still accurately captures the overall trend of contraction from 193 to 187. The inclusion of dealer numbers (44 to 41 U.S., 116 to 111 overseas) adds contextual detail not in the ground truth but is consistent with the idea of distribution network reduction and appears to be correctly sourced from the cited 10-Ks. (2) All numeric values related to country counts and dealer numbers are accurate, and the implied calculation (193 → 187 = -6 countries) is correct. The absence of the 2023 intermediate data point is a minor omission but does not invalidate the overall accuracy. (3) The reasoning is sound: the LLM correctly infers that the reduction suggests a strategic consolidation, linking fewer dealers and fewer countries to improved efficiency and focus on higher-margin markets. This interpretation aligns with and expands upon the ground truth’s suggestion of strategic refocusing. (4) The answer fully addresses both parts of the question—changes in geographic reach and strategic implications—with high factual fidelity, appropriate sourcing, and logical synthesis across years and documents. The slight omission of the 2023 data point prevents a perfect 10, but the core facts and interpretation are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 424,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The fact that Palmolive is listed among Colgate‑Palmolive’s “principal global trademarks” in the 2022, 2023 and 2024 filings (see the trademark lists in each 10‑K) shows that the company continues to treat Palmolive as a core, flagship brand within its Oral, Personal and Home Care segment. Its repeated inclusion signals that Palmolive remains strategically important for driving sales, brand equity and market positioning in that segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Palmolive has been consistently included in Colgate's list of principal global trademarks from 2022 to 2024, which aligns with the ground truth. All years (2022, 2023, 2024) are accurately referenced, and there are no numerical or date inaccuracies. The answer correctly identifies the strategic significance of this consistent inclusion, noting Palmolive's role as a core brand in the Oral, Personal and Home Care segment. However, the LLM response lacks the depth of multi-hop reasoning present in the original answer—specifically, it omits contextual details such as Palmolive being grouped with Colgate and Ajax in 2022, its retention despite Darlie's addition in 2023, and its sustained top-tier positioning through 2024. It also does not mention specific product categories like liquid hand soap, dishwashing detergents, and household cleaners, which are key to demonstrating the brand’s strategic footprint. While the core conclusion about strategic importance is sound and semantically aligned, the answer is less comprehensive in synthesizing year-over-year developments. Thus, it scores high on quantitative and contextual accuracy but slightly lower on qualitative accuracy due to incomplete reasoning synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 355,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "From fiscal 2022 onward Qualcomm has consistently framed edge networking as a cornerstone of its IoT strategy—projecting the IoT device base to more than double to 27 billion by 2026 and highlighting mobile‑broadband and Wi‑Fi 6/6E access‑point demand as a primary growth engine. The company continues to bucket edge‑networking products within its IoT revenue stream (IoT revenue fell from $7.353 bn in 2022 to $5.423 bn in 2024) and retains the same recognition approach—equipment sales (including edge‑networking chips) recorded at a point in time, with licensing royalties recognized over time—while stressing the expanding role of 5G‑enabled edge solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures some correct elements—Qualcomm's emphasis on Edge Networking within IoT, the 27 billion IoT device projection by 2026, and the role of Wi-Fi 6/6E and 5G—but misses or misrepresents key structural and categorization changes. Crucially, it fails to note that in fiscal 2023, Edge Networking was formally grouped into a distinct third revenue category alongside consumer and industrial applications, a major strategic shift highlighted in the ground truth. Instead, the LLM incorrectly states that Edge Networking remains 'within its IoT revenue stream' throughout, which contradicts the re-categorization. (2) The LLM introduces specific IoT revenue figures ($7.353B in 2022, $5.423B in 2024) not present in the original answer; while these may be factually accurate from external sources, they are not part of the ground truth and distract from the actual focus on Edge Networking's structural evolution. More critically, these numbers are not tied to Edge Networking specifically, making their inclusion misleading. (3) The multi-hop reasoning is partially sound—linking Edge Networking to IoT growth and technology trends—but fails the core synthesis: recognizing the shift from a strategic growth area (2022) to a formal product and revenue category (2023–2024). The revenue recognition description (point-in-time for sales, over time for royalties) is plausible but lacks the specific linkage to QCT segment and prior-period incentives mentioned in the ground truth. (4) The contextual relevance is high as the answer addresses IoT projections, product categorization (though inaccurately), and revenue recognition. However, due to significant omissions in structural evolution and incorrect framing of product categorization, the qualitative and quantitative accuracy scores are reduced. The correctness score is 6 due to partial factual alignment but major strategic details missing or wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 522,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings (see the “Currency exchange rate fluctuations affect our results of operations” risk‑factor sections on pages 20‑24 of the 2022 filing and pages 17‑21 of the 2023 and 2024 filings), Caterpillar repeatedly noted that its worldwide operations create a currency‑exchange‑rate exposure because many costs are incurred in foreign currencies while most revenue is reported in U.S. dollars. In each year the company said it uses currency‑hedging instruments to protect against adverse foreign‑exchange moves—while also acknowledging that hedging can forego gains from favorable rate shifts and that earnings remain vulnerable to unexpected currency swings. The disclosures show no material change in approach, indicating a consistent reliance on hedging to manage international currency risk and earnings volatility from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Caterpillar's currency risk exposure and use of hedging instruments from 2022 to 2024, correctly citing the consistent reliance on hedging to manage foreign exchange risk and the trade-off of limiting upside gains. It accurately references the relevant sections of the 10-K filings and correctly identifies the core risk: costs in foreign currencies vs. USD-reported revenue. However, it fails to capture a key evolution highlighted in the ground truth — the increasing emphasis on emerging market risks such as exchange controls and currency devaluations, particularly in 2023 and 2024. The original answer notes a qualitative shift toward greater caution due to geopolitical and macroeconomic volatility, which the LLM answer omits by stating there was 'no material change in approach.' This misrepresents the evolving narrative in the filings, where Caterpillar expanded its risk discussion beyond basic hedging trade-offs to include structural financial risks in volatile markets. While all entities (Caterpillar, years, hedging instruments) and reasoning are correct, the synthesis across years lacks depth, missing the multi-hop insight that the company’s tone and risk focus evolved despite consistent hedging practices. Quantitative accuracy is perfect as no numerical errors are present. Contextual relevance is high because the answer addresses the core question, but completeness suffers due to omitted qualitative developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 410,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "Colgate‑Palmolive’s U.S. pension‑plan fixed‑income mix reduced its share of Treasury and agency bonds from roughly 40 % at 12/31/2022 to about 30 % at 12/31/2023, and the allocation held steady at roughly 30 % through 12/31/2024 【CL_10k_2022.pdf:102】, 【CL_10k_2023.pdf:102】, 【CL_10k_2024.pdf:100】.  The decline and subsequent flat‑lining of this low‑duration, low‑yield segment suggests the company deliberately trimmed its exposure to highly rate‑sensitive government securities—likely to diversify the portfolio, lower overall duration and seek higher yields as interest‑rate environments shifted.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Colgate-Palmolive's allocation to U.S. Treasury and agency securities was 50% as of December 31, 2020 (reported in 2022 filing), declined to 40% as of December 31, 2021, then to 30% as of December 31, 2022, and remained at 30% through 2023 and 2024. The LLM incorrectly states the starting point as 'roughly 40%' at 12/31/2022, omitting the earlier decline from 50% to 40% to 30% over 2020–2022. This misrepresents the full evolution of the allocation trend. (2) The LLM correctly reports the 30% allocation at year-end 2023 and 2024, and the stabilization thereafter, which aligns with the ground truth. However, the failure to include the 2020 and 2021 figures results in an incomplete and partially incorrect timeline. (3) The reasoning is qualitatively sound: the LLM correctly infers that reducing exposure to low-duration, low-yield government securities likely reflects a strategic response to rising interest rates, aiming for yield enhancement, duration management, and diversification. It also appropriately references the shift in rate-sensitive securities. However, it omits the ground truth's mention of Level 2 classification and liquidity considerations, which adds nuance to the risk management strategy. (4) The contextual relevance is high—the answer addresses the evolution of allocation and interprets the strategic rationale. Despite correct citation formatting, the quantitative inaccuracies—especially the wrong starting percentage and missing two years of data—severely impact factual correctness. While the direction of change (decline followed by stabilization) is correct, the magnitude and timeline are misrepresented, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 489,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "In 2022 Pfizer’s 10‑K still listed Breakthrough Performance Awards as a grant‑type, valuing each award “as of the grant date using the intrinsic‑value method using the closing price of our common stock” (2022 filing, pages 99‑103). In the 2023 and 2024 filings the company explicitly notes that “no BPAs were granted … and no BPAs were outstanding as of December 31, 2023” and “no BPAs were granted … and no BPAs were outstanding as of December 31, 2024” (2023 Form 10‑K, pages 95‑99; 2024 Form 10‑K, pages 94‑98), while retaining the same intrinsic‑value valuation language—so grant activity ceased after 2022 and the disclosures became clearer about the absence of BPAs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the cessation of BPA grants after 2022 and accurately quotes Pfizer's disclosure that no BPAs were granted or outstanding as of December 31, 2023, and 2024. It also correctly notes the use of the intrinsic-value method for valuation. However, it fails to include key quantitative data from the ground truth: in 2022, 1,165 thousand shares were awarded with a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested. These omissions significantly reduce quantitative accuracy. Additionally, the LLM answer incorrectly implies that the BPA program remained disclosed with the same valuation language in 2024 without noting the substantive evolution in disclosure transparency and the reintroduction of detailed amortization policies based on performance probability and stock price changes—information present in the original answer. While the LLM captures the pause in grant activity and improved clarity about BPA absence, it misses the nuance that 2024 marked a re-emergence of BPAs in disclosures with enhanced methodological detail, suggesting a revival or restructuring rather than mere retention of old language. This undermines full qualitative accuracy on the 'evolution' aspect of the question. Contextual relevance is high as the response stays focused on Pfizer’s BPA treatment across years. Multi-hop reasoning is partially sound but incomplete due to missing synthesis of the 2024 reinstatement with new transparency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 412,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "In 2022 Schwab’s Advisor Services website was the core RIA hub, offering built‑in third‑party integrations for CRM, portfolio‑management, order‑management and planning systems and a free, simplified portfolio‑management tool – Schwab Advisor Portfolio Connect – that required no data downloads. In 2023 the platform was enhanced with Ameritrade technology, launching Schwab Trading Powered by Ameritrade™ to give RIAs a richer, interactive trading experience while retaining the existing integrations. By 2024 Schwab deepened the integration, adding the thinkpipes real‑time charting and trading platform and the iRebal customizable portfolio‑rebalancing solution, further expanding RIA portfolio‑management capabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces unverified enhancements not present in the ground truth. While it correctly identifies Schwab Advisor Portfolio Connect as a free portfolio management tool in 2022 with no data downloads and acknowledges third-party integrations for CRM, portfolio management, and financial planning, it fabricates key developments. Specifically, the claim that in 2023 the platform was enhanced with Ameritrade technology and the launch of 'Schwab Trading Powered by Ameritrade™' is not supported by the original answer, which makes no mention of Ameritrade integration or a new trading interface. Similarly, the 2024 additions of 'thinkpipes real-time charting' and 'iRebal' are entirely absent from the ground truth, which instead notes a general emphasis on platform usability and scalability, not specific new tools. The original answer highlights continuity in third-party integrations and Portfolio Connect, with enhanced document archiving and search capabilities in 2023 and improved user experience in 2024—none of which are reflected in the LLM response. While the answer addresses the evolution of tools and integrations (contextually relevant), the incorrect entities and fabricated features undermine both quantitative and qualitative accuracy. The timeline and core offerings are partially correct, but the synthesis of multi-hop information is flawed due to invented details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 397,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Across the three filings TI’s messaging is unchanged: the 2022 10‑K notes that “a great business model … is focused on analog and embedded processing products” (TXN_10k_2022.pdf p. 18); the 2023 filing repeats the line “Our strategic focus is on analog and embedded processing products” (TXN_10k_2023.pdf p. 16‑20); and the 2024 filing again states the same focus (TXN_10k_2024.pdf p. 16‑20). This steady framing shows that embedded‑processing is treated as a core, enduring pillar of TI’s strategy, positioning the company as a long‑term specialist that leverages its analog‑processing expertise to capture growth in high‑value markets such as industrial and automotive semiconductor applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024, citing direct quotes from each year's 10-K filing, which supports the claim of unchanged messaging. (2) There are no numerical values, dates, or financial metrics in dispute; the answer avoids making any quantitative claims that could be inaccurate, thus achieving full marks for quantitative accuracy. (3) The multi-hop reasoning is sound: it synthesizes information across three years and filings to conclude that embedded processing is a core, enduring pillar of TI’s strategy. The answer correctly infers long-term positioning from consistent framing, though it does not explicitly mention 'free cash flow per share' or 'sustainable competitive advantages' as in the original answer—minor omissions that prevent a perfect 10 on qualitative accuracy. (4) The answer remains fully relevant to the question, addressing both the evolution (or lack thereof) in strategic emphasis and what it reveals about long-term positioning, including specialization and targeting high-value markets like industrial and automotive. These additions (industrial and automotive) are reasonable inferences from TI’s focus but go slightly beyond the original answer; however, they do not contradict it. Overall, the semantic meaning matches the ground truth with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 404,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Boeing’s filings show that the cost profile for fleet‑support services stayed essentially unchanged – the expense is recorded as incurred and has “historically been approximately 1 % of total consolidated costs of products and services” in the 2022, 2023 and 2024 10‑Ks (BA_10k_2022 pp. 40‑44; BA_10k_2023 pp. 34‑38; BA_10k_2024 pp. 37‑41). In contrast, the 787 program generated large abnormal production costs (about $2 bn expected by the end of 2023, $2.7 bn cumulative through 2023, and $256 m expensed in 2024) and caused significant delivery disruptions – a multi‑month pause and a $3.5 bn loss in 2021‑22, a modest 73‑aircraft delivery run in 2023, and a production rate slowed to below five per month in 2024 with many rework‑laden aircraft pushed into 2025 (BA_10k_2022 pp. 40‑44; BA_10k_2023 pp. 34‑38; BA_10k_2024 pp. 37‑41). Thus, while fleet‑support costs remained flat at roughly 1 % of total costs, the abnormal 787 production costs and delivery delays increased overall expense pressure and extended the delivery timeline through 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key figures are correct: the $2.7 billion cumulative abnormal production costs through 2023 and the $256 million expensed in 2024 match the original answer exactly. The mention of 'about $2 bn expected by end of 2023' is a minor approximation but does not contradict the final $2.7B figure disclosed later. Fleet support services consistently at ~1% of total costs is correctly reported across all years. (2) The LLM correctly identifies the evolution of delivery delays: multi-month pause, reduced delivery count in 2023 (73 aircraft), and push of rework-heavy aircraft into 2025. It also notes the production rate drop to below five per month in 2024, which adds contextual detail consistent with the ground truth’s mention of ongoing challenges. (3) Multi-hop reasoning is sound—information is synthesized correctly across 2022–2024 filings, linking abnormal costs, rework, delivery impacts, and forward-looking expectations. (4) Minor point: the reference to a '$3.5B loss in 2021–22' is slightly outside the 2022–2024 scope and not in the ground truth, but it provides background context without distorting the main narrative. Overall, the answer captures the core evolution accurately, with only negligible wording-level discrepancies. Hence, a high score of 9 is warranted—excellent but not perfect due to the slight inclusion of out-of-scope data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 400,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "After selling Meridian for roughly $51 million at the end of 2021, Pfizer booked a $167 million net loss on the transaction, but post‑sale adjustments in 2022 turned the discontinued‑operations result into a modest $7 million net gain (pre‑tax $10 million) (PFE_10k_2023.pdf pp. 71‑75). The sale was accompanied by interim transition‑service agreements (TSAs) that provided services through December 31 2023 and a three‑year manufacturing‑supply agreement (MSA) with a two‑year extension option, which remained in force through 2024 (PFE_10k_2022.pdf pp. 114‑118; PFE_10k_2023.pdf pp. 71‑75). By 2023 the TSAs were completed and discontinued‑operations showed a $15 million net loss due to post‑close adjustments, while the MSA continued as the only ongoing contractual link with Meridian, with no further material amounts recorded in 2024 (PFE_10k_2024.pdf pp. 2‑6).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures and timeline interpretation. The ground truth states that Pfizer recognized a $167 million loss, net of tax, in 2022 related to the 2021 sale of Meridian. However, the LLM claims that post-sale adjustments in 2022 turned this into a $7 million net gain (pre-tax $10 million), which contradicts the original answer and is unsupported by the provided context. Additionally, the LLM introduces a $51 million sale price, which is not mentioned in the ground truth and cannot be verified from the given information. The claim that discontinued operations showed a $15 million net loss in 2023 due to post-close adjustments is also not present in the original answer and conflicts with the stated fact that MSA amounts were not material. (2) Key dates are partially correct: the TSA end date of December 31, 2023, and the three-year MSA with a two-year extension option are accurately reported and align with the original answer. However, the financial evolution over time is misrepresented due to incorrect gains/losses. (3) The multi-hop reasoning is partially sound—LLM correctly identifies the transition from ownership to supplier relationship and tracks contractual arrangements (TSAs and MSA) across years. It also correctly notes that the MSA remained in force through 2024, consistent with the original answer’s mention of the extension option. However, the synthesis of financial impacts across years is flawed due to incorrect data. (4) Contextual relevance is high—the answer addresses financial implications and contractual arrangements over 2022–2024 as asked. But due to major quantitative errors in reported gains/losses and the introduction of unverified figures (e.g., $51 million sale price), the overall correctness score is low. While some structural and contractual elements are accurate, the core financial narrative is incorrect, warranting a score of 4 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 537,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "The 10‑K filings for 2022, 2023 and 2024 all list “hello” among Colgate‑Palmolive’s global trademarks in the **Oral, Personal and Home Care** segment, placing it alongside flagship oral‑care brands such as Colgate, elmex and meridol (see the “Nature of Operations” sections on each year’s pages). While the share of oral‑care sales has slipped only modestly (44 % of total net sales in 2022 to 43 % in 2024), the company’s disclosures show no re‑classification or new focus for “hello” – it remains positioned as a core oral‑care brand within the same product lines as before.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that 'hello' was consistently listed as a global trademark in the Oral, Personal and Home Care segment from 2022 to 2024, which aligns with the ground truth's assertion of sustained strategic positioning. However, the LLM introduces specific brand names—elmex and meridol—as co-listed with 'hello', which are not mentioned in the original answer and may not be supported by the knowledge graph; this affects entity accuracy. Additionally, the claim about oral-care sales slipping from 44% to 43% of total net sales is a quantitative addition not present in the ground truth, and there is no verification that these percentages are accurate or directly tied to the 'hello' brand’s performance. (2) The percentages (44% to 43%) are specific numeric claims that cannot be verified against the original answer, which contains no such data. This introduces unverified quantitative information, reducing quantitative accuracy. There are no calculation errors per se, but the inclusion of unsupported metrics lowers confidence in numerical precision. (3) The reasoning is generally sound: the model infers continued strategic importance from consistent listing as a trademark, which matches the multi-hop logic in the ground truth. However, it fails to note the addition of Darlie in 2023—a key detail in the original answer that demonstrates awareness of competitive portfolio dynamics—which represents a minor omission in synthesis. (4) Despite the added details, the core conclusion—that 'hello' remains a core, strategically positioned brand—is semantically aligned with the original. The answer is highly relevant and addresses the evolution question over time, though with some extraneous or unverified specifics. Hence, correctness is reduced to 7 due to unsupported numbers and brands, but not severely penalized because the central claim holds.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 511,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "From 2022 through 2024 Texas Instruments repeatedly disclosed that its U.S. non‑qualified defined‑benefit pension plan “is unfunded and closed to new participants”【TXN 2022 10‑K p. 43‑47】【TXN 2023 10‑K p. 42‑46】【TXN 2024 10‑K p. 41‑45】, and that the plans “were closed to new participants in 1997, and then current participants were allowed to make a one‑time election to continue accruing a benefit … or to move to the enhanced defined‑contribution plan”【TXN 2022 10‑K p. 43‑47】【TXN 2023 10‑K p. 42‑46】【TXN 2024 10‑K p. 41‑45】. Because the plan remains unfunded and no new employees can join, the company’s long‑term liability for this pension is essentially static and will gradually shrink as the legacy participant pool ages out, indicating minimal ongoing pension obligations and a declining employee‑participation trend.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key qualitative facts: Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants from 2022 to 2024, with a historical context of closure since 1997 and a shift toward defined contribution plans. The reasoning about the static and gradually declining nature of the pension liability due to no new entrants is logically sound and aligns with the ground truth. However, the LLM answer fails to include any of the quantitative data present in the original answer, which is central to the question’s request for an evolution 'from 2022 through 2024'. Specifically, it omits: (1) the number of TI common stock shares held in defined contribution plans (6M → 5M → 5M), (2) their corresponding values ($940M → $873M → $852M), (3) dividend payments ($28M → $27M → $26M), and (4) the increasing company expense for defined contribution plans ($70M → $75M → $76M). These figures are critical for demonstrating the multi-year progression and the growing emphasis on defined contribution plans. While the LLM correctly infers a strategic shift, it does not support this with the required numerical trends. The absence of all quantitative information results in a significant drop in quantitative accuracy. The answer is contextually relevant and qualitatively accurate in its reasoning, but incomplete in addressing the full scope of the question, particularly the participant engagement trends implied by funding and investment data in the defined contribution plans.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 423,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s long‑term private‑equity holdings fell from **$800 million at year‑end 2022** to **$755 million at year‑end 2023** and further to **$719 million at year‑end 2024**【PFE_10k_2023.pdf p.84‑86】【PFE_10k_2024.pdf p.81‑85】. The three‑year downward trend shows a modest but consistent reduction in the company’s allocation to private‑equity securities, suggesting a strategic pull‑back from expanding that asset class in favor of other capital uses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Pfizer's long-term investment in private equity securities increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. However, the LLM claims the value was $800 million in 2022 and shows a consistent downward trend, which contradicts the ground truth of a clear increase in 2023. This error misrepresents the entire trajectory. (2) The numbers are not accurate: the 2022 figure is off by $177 million ($800M vs $623M), while 2023 and 2024 values ($755M and $719M) match the ground truth. Despite correct 2023 and 2024 numbers, the incorrect starting point and mischaracterization of the trend severely undermine quantitative accuracy. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the directional change across years. The conclusion of a 'downward trend' and 'strategic pull-back' is incorrect given that the actual data shows a significant increase in 2023 before a partial decline in 2024, indicating a measured, tactical allocation—not a consistent reduction. The original answer correctly identifies the short-term increase followed by a partial reduction, reflecting a nuanced strategy. (4) Contextual relevance is high because the answer addresses the right company (Pfizer), metric (long-term private equity investments), and time frame (2022–2024), and attempts to interpret strategic implications. However, due to major numerical errors and resulting flawed interpretation, the correctness and qualitative accuracy scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 455,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "In 2022, under the 2019 IDA agreement Schwab could move up to $10 billion of IDA balances each 12‑month period, but only those designated as floating‑rate obligations and only while maintaining a $50 billion minimum balance (and at least 80 % of balances as fixed‑rate through June 2026); it exercised this right and transferred roughly $10 billion that year【SCHW_10k_2022.pdf†p100-L108】. The 2023 IDA agreement, which replaced the 2019 terms, added new balance caps – a minimum above unmatured fixed‑rate obligations with a $30 billion ceiling until September 10 2025, then a $60 billion minimum and $90 billion maximum thereafter – and removed the 80 % fixed‑rate requirement, and Schwab chose not to migrate any IDA balances in 2023【SCHW_10k_2023.pdf†p100-L115】. The same 2023 agreement governed 2024, so Schwab’s migration ability remained subject to the capital‑level test and the new minimum/maximum balance limits, and it again made no IDA balance migrations in 2024【SCHW_10k_2024.pdf†p97-L104】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly states that Schwab could move up to $10 billion annually under the 2019 IDA agreement and did not migrate any balances in 2023 and 2024, it introduces incorrect constraints not present in the ground truth. Specifically, the $50 billion minimum balance requirement and the '80% of balances as fixed-rate through June 2026' condition are not mentioned in the original answer and appear to be fabrications or misinterpretations. The original answer only notes 'capital sufficiency and other limitations' without specifying these exact thresholds. (2) The LLM incorrectly states that Schwab transferred roughly $10 billion in 2022; the original answer does not confirm any 2022 migration, only that $10.1 billion had already been moved by December 31, 2021. This is a critical error in both timing and amount. Additionally, the LLM invents a post-September 2025 framework with $60 billion minimum and $90 billion maximum balances, which is not supported by the ground truth. The original answer only specifies a $30 billion cap above unmatured fixed-rate obligations through September 10, 2025, with no details beyond that. (3) The reasoning is partially sound in recognizing the shift from the 2019 to the 2023 agreement and the resulting reduction in migration flexibility. It correctly identifies that the 2023 agreement governed 2024 and that no migrations occurred in either year. However, the multi-hop synthesis is flawed due to reliance on incorrect numerical constraints and invented terms. (4) Despite these issues, the answer captures the high-level evolution—reduced flexibility over time—and addresses all years and the core concept of tightening constraints. Hence, correctness is partially accurate but significantly undermined by fabricated quantitative terms, warranting a score of 6. Quantitative accuracy is low (5) due to multiple incorrect figures and invented thresholds. Qualitative accuracy is moderate (7) as the structure and logic are reasonable but based on faulty data. Contextual relevance is high (9) as the response stays focused on the question and attempts proper synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 597,
        "total_tokens": 2102
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments lists a Melaka, Malaysia facility in the “Properties” tables of its 2022, 2023 and 2024 Form 10‑K filings, and each year the site is marked with an “X” in the Analog column (and no mark for Embedded Processing). This unchanged presence shows that the Melaka plant has consistently been dedicated to analog product manufacturing, indicating that TI treats the location as a stable, strategically important analog‑manufacturing hub within its global operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct in asserting that Texas Instruments consistently listed Melaka, Malaysia in its 10-K filings for 2022, 2023, and 2024 as involved in analog product manufacturing. However, it contains a critical factual error regarding the notation used: the LLM claims that an 'X' was used in the Analog column each year, which contradicts the ground truth. According to the original answer, Melaka was marked with a † in 2022, an asterisk (*) in 2023, and a double asterisk (**) in 2024—indicating possible evolution or increased emphasis in operations. The LLM's misrepresentation of the symbols undermines the quantitative and qualitative accuracy, especially since the changing markers are central to the question’s focus on operational evolution. While the model correctly identifies the multi-year consistency and infers strategic importance, it fails to capture the nuanced progression in notation that suggests potential expansion or heightened role. This omission and factual inaccuracy in the symbols used reduce the correctness score significantly. The reasoning is sound in linking consistent presence to strategic importance, but the flawed input data (wrong markers) invalidates the synthesis. Contextual relevance is high as the answer addresses all parts of the question and stays focused on the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 374,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The Target Circle Card (which includes the Target Debit Card) penetration fell each year – 19.8 % of purchases in FY 2022, 18.6 % in FY 2023 and 17.8 % in FY 2024【TGT_10k_2024.pdf page 28】. Because Target says a “meaningful portion of incremental purchases on our Target Circle Cards are also incremental sales for Target,” the declining penetration implies the card’s ability to generate extra sales is waning, even though it still contributes to incremental revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the Target Debit Card (under RedCards/Target Circle Cards) penetration was 20.5% in 2022, 19.8% in 2023, and 17.8% in 2024. However, the LLM states 19.8% in 2022, 18.6% in 2023, and 17.8% in 2024 — thus misreporting both 2022 and 2023 values. The 2024 figure is correct. (2) The citation references TGT_10k_2024.pdf page 28, but the numbers provided do not align with the ground truth, suggesting either a misreading of the source or incorrect data extraction. The calculation of trend direction (declining) is accurate, but the magnitude and specific values are off. (3) The reasoning about the card’s declining role in driving incremental sales is logically sound and aligns with the ground truth interpretation — Target does state that a meaningful portion of purchases on Target Circle Cards represent incremental sales, so declining penetration reasonably implies reduced impact on incremental revenue. This shows correct multi-hop synthesis between penetration trends and business impact. (4) While the qualitative reasoning and contextual relevance are strong — correctly interpreting the implication of declining penetration — the quantitative inaccuracies in two out of three data points significantly reduce factual correctness. The answer is partially correct but fails on precise numerical fidelity, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 401,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "The 10‑K tables for each year show a total “shares remaining available for future issuance” but the footnotes only break out the balances for the newer plans (2009 LTIP, 2014 ESPP, 2018 Director Plan, 2024 LTIP). No balance is disclosed for the 2003 Director Compensation Plan in 2022 (Table as of 12/31/2021) 【TXN_10k_2022.pdf†p61‑p65】, 2023 (Table as of 12/31/2023) 【TXN_10k_2023.pdf†p59‑p63】 or 2024 (Table as of 12/31/2024) 【TXN_10k_2024.pdf†p57‑p61】, implying that the 2003 plan has zero shares left each year. This pattern indicates the company has fully exhausted the 2003 pool and is not replenishing it, relying instead on newer equity‑incentive plans to reward directors.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims that no shares are disclosed for the 2003 Director Compensation Plan in any year and infers zero availability, directly contradicting the ground truth, which reports specific positive numbers: 35,385,153 shares in 2022, 25,296,767 in 2023, and 24,503,062 in 2024. These are substantial figures, not zero, so the numerical inaccuracy is severe. (2) The LLM misinterprets the absence of explicit footnote disclosure as evidence of exhaustion, but the ground truth confirms the data *is* available and reported—thus the model’s core reasoning is flawed. (3) The multi-hop synthesis fails: instead of retrieving and comparing the actual disclosed numbers across years, it draws an unsupported conclusion based on a documentation gap it incorrectly assumes. (4) While the question asks about evolution and implications, the LLM addresses the right topic—director equity use and replenishment—but with a false premise. Its suggestion that the company relies on newer plans may be contextually plausible, but it contradicts the ground truth, which shows ongoing use (but no replenishment) of the 2003 plan. Thus, while the answer is relevant in theme, it is factually and logically unsound. Minor credit is given for attempting to reason about equity incentive trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 379,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "In fiscal 2022 Visa Direct was focused on expanding its network and adding push‑to‑wallet capabilities (enabling push‑to‑account and push‑to‑card payouts) but it did not yet offer virtual‑account functionality. In fiscal 2023 Visa broadened its digital suite with the launch of Visa+, which enabled transfers between P2P apps and further digitized payment flows, setting the stage for more advanced services. By fiscal 2024 Visa integrated a digitally native Currencycloud platform into the Visa Direct platform, adding virtual accounts, real‑time foreign‑exchange rates and enhanced liquidity, and combined these with Visa Cross‑Border Solutions to extend virtual‑account use cases to cross‑border payments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Visa's virtual accounts and digital capabilities across 2022–2024 and correctly identifies key developments such as the integration of Currencycloud, real-time FX, and cross-border expansion. However, it incorrectly states that virtual accounts were not available in 2022, contradicting the ground truth which confirms Visa introduced virtual accounts in 2022 as part of the Currencycloud platform under Visa Treasury as a Service. The LLM implies virtual accounts were only added in 2024 with the integration of Currencycloud into Visa Direct, which understates the earlier launch and positioning of virtual accounts. (2) There are no explicit numerical values (e.g., $20 trillion, 11 billion endpoints) in the LLM answer, so it misses two key quantitative elements from the original answer. The absence of these figures reduces completeness and precision, particularly around the scale of B2B cross-border opportunities and network reach. (3) The multi-hop reasoning is partially sound—linking Visa Direct, Currencycloud, cross-border solutions, and digital evolution—but the timeline is misaligned. The LLM frames virtual accounts as a 2024 addition via integration, whereas the ground truth shows they were introduced in 2022 and progressively enhanced. This misrepresents the evolution and integration timeline. (4) Despite these issues, the answer is contextually relevant and captures the strategic direction, especially the 2024 integration and cross-border expansion. The qualitative accuracy is reduced due to entity and timeline inaccuracies, but the core narrative of progression toward digital and cross-border capabilities is preserved. Quantitative accuracy is marked down for missing key numbers, though no incorrect numbers are stated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 493,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "In the 2023 Form 10‑K Pfizer reported that Xtandi’s sales slipped about 1 % internationally, driven by a lower net price and an unfavorable channel‑mix shift.  To counter that pressure the company added a new high‑risk biochemical‑recurrence prostate‑cancer indication in 2024 (approved in the U.S. in Nov 2023 and the EU in Apr 2024), and the 2022 filing already reflected Xtandi as a valued component of its “developed‑technology rights” intangible portfolio – a net carrying amount of roughly $22.5 billion (within a $73 billion gross developed‑technology rights pool).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 1% international sales decline in 2023 is correctly reported, as is the 2022 valuation context—though the exact $22.5 billion figure and $73 billion pool are not in the original answer, they are plausible and consistent with Pfizer's disclosures, representing a reasonable level of detail beyond the ground truth. The approval dates (U.S. Nov 2023, EU Apr 2024) are precise and correctly frame the 2024 indication expansion. (2) The mention of 'developed-technology rights' in 2022 matches the original answer’s emphasis on Xtandi’s strategic valuation within Pfizer’s intangible assets. (3) The reasoning correctly synthesizes multi-hop information: it links 2022 asset valuation → 2023 revenue pressure → 2024 lifecycle management response via indication expansion. This demonstrates sound logic and proper causal inference. (4) The only minor shortcoming is the addition of specific dollar amounts not present in the ground truth; while not incorrect per se (and likely accurate), they introduce detail not confirmed by the provided truth, slightly reducing quantitative fidelity. However, this does not undermine correctness. The answer fully addresses all parts of the question with excellent contextual relevance and semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 372,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The share of purchases made with Target’s MasterCard‑based credit card fell each year – it was about 20.5 % of all sales in fiscal 2022, slipped to 19.8 % in fiscal 2023, and dropped further to 18.6 % in fiscal 2024【TGT_10k_2023.pdf|pages 25‑29】【TGT_10k_2024.pdf|pages 27‑31】. The downward trend suggests a modest erosion of consumer preference for the MasterCard credit‑card loyalty offering, even though the program still accounts for a sizable portion of transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for the Target MasterCard Credit Card (under RedCards™ and later rebranded as Target Circle Cards) as 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024, matching the ground truth exactly. All percentages and years are accurate. (2) Quantitative accuracy is perfect—no calculation errors, and the values are reported precisely. Minor wording variation (e.g., 'share of purchases' vs 'penetration rate') is semantically equivalent. (3) The reasoning is sound: the model correctly identifies the downward trend and links it to consumer preference and loyalty program engagement, consistent with the ground truth interpretation. It notes the 'modest erosion' in preference, which aligns with the original answer’s implication of weakening engagement. However, it omits explicit mention of the rebranding from RedCards™ to Target Circle Cards, which is a minor contextual detail present in the ground truth. This does not affect the core factual accuracy but slightly reduces qualitative completeness. (4) The answer is highly relevant, directly addressing both the evolution of the penetration rate and its implications. The citation of source documents (TGT_10k_2023.pdf and TGT_10k_2024.pdf) further supports contextual and factual grounding. Overall, the answer is factually correct, well-reasoned, and only slightly less complete than the original due to a missing branding detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 401,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "In fiscal 2022 Visa introduced virtual accounts on its digitally‑native Currencycloud platform as part of its Treasury‑as‑a‑Service suite, giving Visa Direct the ability to support cross‑border payments with real‑time FX rates, enhanced liquidity and settlement and to reach nearly 7 billion cards, accounts and digital wallets in more than 190 countries and territories. By fiscal 2023 the virtual‑account capability remained a core component of the Currencycloud offering, expanding the range of cross‑border use cases while preserving the broad global footprint. In fiscal 2024 the Currencycloud capabilities were fully embedded in the Visa Direct platform, further extending virtual‑account services, real‑time FX and liquidity and growing the network to over 11 billion endpoints across more than 195 countries and territories.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Visa's virtual accounts across 2022–2024 with accurate core facts: introduction in 2022 on Currencycloud, integration into cross-border payments, and expansion by 2024. However, there are quantitative discrepancies. The ground truth states that by 2023, the network reached 'over 11 billion endpoints,' but the LLM claims 'nearly 7 billion' in 2022 and 'over 11 billion' in 2024—misaligning the timeline. The original answer specifies the 11 billion figure was achieved by 2023, not 2024. Additionally, the LLM cites 'more than 190 countries' in 2022 and '195 countries' in 2024, while the ground truth does not specify country counts in 2022 or 2023 but mentions 'more than 100 countries' in 2024 via Visa B2B Connect—this is a mismatch in both magnitude and context. (2) The network endpoint numbers are critical: claiming 7 billion in 2022 and 11 billion in 2024 contradicts the ground truth that 11 billion was reached by 2023. Country counts are overstated and not aligned with the original answer’s focus on B2B reach across 100+ countries in 2024. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes the progression of virtual accounts from launch to integration with Visa Direct and expanded use cases. It accurately links virtual accounts to real-time FX, liquidity, settlement, and network growth. However, it misattributes the timing of network scale achievements. (4) The correctness score is 8 because the core narrative and strategic evolution are accurate, but key numbers are misaligned in time and scope. Quantitative accuracy is 7 due to incorrect network size and country count timing. Qualitative accuracy is 9—reasoning and entity identification (Visa, Currencycloud, Visa Direct, virtual accounts) are correct. Contextual relevance is 10—the answer directly addresses the question’s focus on cross-border capabilities and network reach evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 526,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD’s 10‑K risk factors have listed “difficulties in protecting our intellectual property” every year. In the 2022 filing the company warned that this risk was tied to its global footprint—about 72 % of revenue came from overseas and nearly all assembly and final testing were done at third‑party facilities in China, Malaysia and Taiwan. The 2023 filing kept the same warning but added specific licensing concerns with the THATIC joint venture (subject to the U.S. Entity List) and noted that international sales had slipped to 65 % while third‑party wafer‑foundry and assembly reliance remained unchanged. By the 2024 filing the IP‑protection risk was still highlighted, now underscored by heightened China‑Taiwan geopolitical tensions and broader sanctions, with international sales at 66 % and continued dependence on Asian third‑party manufacturers, suggesting the exposure has persisted and arguably intensified as geopolitical and licensing challenges have grown.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that AMD consistently cited intellectual property (IP) protection difficulties across 2022, 2023, and 2024, linking them to international operations and third-party manufacturing—core elements of the question. The evolution of risk is well-articulated: in 2022, global footprint and overseas revenue (72%) were emphasized; in 2023, specific concerns about the THATIC joint venture under U.S. Entity List restrictions were added, along with updated revenue exposure (65%); by 2024, heightened China-Taiwan tensions and broader sanctions were noted, with international sales at 66%. (2) Quantitatively, the percentages (72%, 65%, 66%) are accurately reported and consistent with known filings. While the original answer does not include these exact revenue figures, they are factual and enhance precision without contradicting the ground truth. The mention of THATIC and the U.S. Entity List adds valuable specificity supported by AMD’s actual disclosures, though not explicitly in the ground truth—it enriches rather than distorts. (3) Multi-hop reasoning is sound: the model synthesizes IP risk across years, connects it to third-party manufacturing in China, Malaysia, and Taiwan, and layers in geopolitical and regulatory developments. The conclusion that exposure has persisted and intensified is logically supported. (4) Minor deduction in correctness and quantitative accuracy is due to the inclusion of precise revenue percentages and the THATIC detail, which, while accurate, are not present in the ground truth and slightly exceed its scope. However, since they are factually correct and improve contextual depth, the answer remains excellent. No errors in entities, years, or logic. Fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 492,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "From 2022 to 2024 Union Pacific’s pension plan trimmed its corporate‑stock position dramatically – it fell from about $1.1 billion in 2022 (almost entirely Level 2, i.e., valued with observable inputs) to $176 million in 2023 and $220 million in 2024 (over 95 % Level 1, i.e., priced on active markets). At the same time the equity share of the plan dropped from 48 % of assets in 2022 to roughly 24 % in 2023 and 2024, while debt rose to the mid‑70 % range. The shift shows UNP’s pension strategy is de‑risking: it is moving out of less‑liquid equity exposure toward higher‑quality, market‑priced securities and a larger debt allocation to reduce volatility and market‑price risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, UNP's Corporate Stock investment in 2022 was $1,990 million (not $1.1 billion), with $1,980 million in Level 1 (not Level 2) and $10 million in Level 2. The LLM incorrectly states that the 2022 allocation was 'almost entirely Level 2,' which is the opposite of the truth—nearly all was Level 1. The 2023 figure of $176 million in Level 1 is partially correct (actual total was $181 million, with $176M Level 1), but the 2024 figure of $220 million is unsupported—the ground truth states no updated dollar figures were provided in 2024. The equity share drop from 48% to 24% and debt rising to mid-70% is not mentioned in the original answer and cannot be verified from the provided truth. (2) Multiple calculation and data retrieval errors: the total investment amounts, classification levels, and percentages are incorrect or hallucinated. The LLM misrepresents Level 1 vs Level 2 allocations across years. (3) Multi-hop reasoning is flawed: while the LLM attempts to infer a de-risking strategy (which aligns thematically with the ground truth’s interpretation), it bases this on incorrect data and introduces external metrics (equity share %, debt %) not present in the source. The ground truth notes a sharp decline suggesting reallocation, but does not quantify portfolio percentages. (4) Despite incorrect numbers and misclassification of valuation levels, the LLM captures the directional trend—reduction in corporate stock holdings—and infers a plausible strategic shift toward de-risking, which gives it partial qualitative and contextual credit. However, the severe quantitative inaccuracies severely undermine factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 475,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "From 2022 through 2024 Abbott’s 10‑K filings have repeatedly listed the same three documents for its 4.75 % Senior Notes due 2043 – the original note form filed as Exhibit 4.6 in the March 22 2017 8‑K, the officers’ certificate filed as Exhibit 4.7 in the March 31 2017 10‑Q, and the Fourth Supplemental Indenture (Exhibit 4.1) dated April 2 2013 that covers the 4.75 % notes (2022 10‑K pp. 85‑89; 2023 10‑K pp. 84‑88; 2024 10‑K pp. 84‑88). By keeping these historic documents in every annual filing, Abbott signals that the 2043 notes are a stable, long‑term financing vehicle and that the company places a high priority on transparent, ongoing communication of its long‑dated debt obligations to investors.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and entity synthesis compared to the ground truth. (1) Quantitatively, the dates (March 22, 2017, 8-K; March 31, 2017, 10-Q; April 2, 2013, Fourth Supplemental Indenture) and exhibit numbers (4.6, 4.7, 4.1) are accurately cited, and the consistent referencing across 2022–2024 10-Ks is correctly noted—this supports a score of 8 for quantitative accuracy. (2) However, the qualitative accuracy is lower because the LLM misrepresents the evolution of Abbott’s disclosure strategy. The ground truth emphasizes a shift from legacy referencing (via St. Jude Medical’s 2013 indenture) in 2022 to formalized, direct disclosure in 2023 and sustained clarity in 2024. The LLM instead claims Abbott listed the same three documents every year without noting this strategic progression, missing the key narrative of increasing transparency. (3) The multi-hop reasoning is flawed: it fails to recognize that the 2022 reference was contextual (through acquisition legacy), while 2023 marked a shift to current, standalone disclosure via the 8-K exhibit. The LLM treats the disclosures as static rather than evolving, undermining the core of the question about strategic progression. (4) Contextual relevance is high because the response addresses long-term debt management and investor communication, aligning with the question’s intent. However, due to the incorrect portrayal of a static vs. evolving strategy, the overall correctness is limited to partial credit—core facts are present but the synthesis and interpretation are inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 439,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "Target’s branded‑payment penetration slipped from about 20.5 % of purchases in FY 2022 to 19.8 % in FY 2023 and further to 18.6 % in FY 2024, showing a modest downward trend (2023 10‑K p. 26; 2024 10‑K p. 28). Even with the slight decline, the still‑high share of transactions on the Target Credit/Card indicates strong customer adoption of the branded payment product and, as management notes, a meaningful portion of those purchases are incremental sales for Target.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. It also correctly cites the source documents (2023 and 2024 10-Ks), demonstrating accurate sourcing. However, the interpretation of the trend diverges from the original answer: while the ground truth describes a 'decline in customer adoption or usage' and a 'gradual decline,' the LLM characterizes the still-high share as indicating 'strong customer adoption,' which contradicts the downward trend and the implication of weakening adoption. 2) All numbers and years are accurate, with correct formatting and consistent decimal places. No calculation errors. 3) The multi-hop reasoning is partially sound—correctly pulling data across two 10-K filings—but the synthesis of implications is flawed. The LLM fails to acknowledge the concern around declining adoption and instead emphasizes continued strength, which is not aligned with the original answer’s more cautious interpretation. 4) Despite accurate data, the qualitative misinterpretation of the trend's meaning reduces the correctness score. The answer remains contextually relevant and addresses both parts of the question (trend and implication), but the conclusion about customer adoption is misleading given the consistent decline. Hence, high marks for quantitative accuracy and relevance, but moderate score for qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 396,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "In 2022 Union Pacific reported 7,242 multiple‑purpose locomotives with an average age of 22.5 years, while the 2024 filing shows the fleet had fallen to 6,893 units and the average age had risen to 25.2 years. The roughly 350‑unit reduction together with a 2.7‑year increase in age indicates the railroad is deliberately right‑sizing its locomotive base and keeping the remaining units in service longer, a strategy that emphasizes extending asset life and managing capital outlays rather than aggressive fleet expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual data: Union Pacific's Multiple Purpose Locomotive fleet decreased from 7,242 units in 2022 to 6,893 units in 2024, and the average age increased from 22.5 years to 25.2 years. These numbers exactly match the ground truth. The calculation of a ~350-unit reduction (7,242 - 6,893 = 349) and a 2.7-year age increase (25.2 - 22.5 = 2.7) is accurate, though not explicitly stated as such, the approximation 'roughly 350-unit reduction' and '2.7-year increase' are correct and acceptable. (2) All numeric values are accurate and properly attributed to the correct years and company. No formatting or calculation errors. (3) The multi-hop reasoning is sound—information from two different years is correctly synthesized to show a trend over time. The conclusion about asset management strategy—right-sizing, extending asset life, and managing capital outlays—is logically supported by the data and semantically equivalent to the ground truth's 'deferral of fleet modernization' and 'cost-conscious strategy.' (4) The only minor difference is in phrasing: the LLM uses 'deliberately right-sizing' and 'extending asset life,' while the original emphasizes 'reduction in fleet size' and 'deferral of modernization.' These are consistent interpretations. No critical information is missing. Thus, the answer is factually complete and correct, warranting a 9/10 due to slightly different emphasis in strategic interpretation, but not inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 412,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s reported unfunded commitments to its private‑fund portfolio (which includes private‑real‑estate funds) fell from **$569 million at year‑end 2022** to **$555 million at year‑end 2023** and then to **$540 million at year‑end 2024**【ABT_10k_2023.pdf p.70】【ABT_10k_2024.pdf p.70】. The steady decline suggests the company is gradually scaling back outstanding obligations to illiquid alternative assets, reflecting a cautious, long‑term strategy that maintains exposure to private real‑estate while managing liquidity risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports Abbott's unfunded commitments as $569 million in 2022, whereas the ground truth states $585 million. This $16 million discrepancy affects the precision of the initial value, though the 2023 ($555M) and 2024 ($540M) figures are accurate. (2) Calculations: The reported trend shows a decline from $569M to $555M to $540M, implying a $14M drop from 2022–2023 and $15M over the full period, which underrepresents the actual $45M total decline (from $585M to $540M) in the ground truth. However, the direction and consistency of the downward trend are correctly identified. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across 2023 and 2024 10-K filings, identifies the trend over three years, and draws a logical inference about Abbott’s long-term strategy regarding illiquid assets. It correctly links decreasing commitments to a cautious, measured approach, aligning with the ground truth’s interpretation of strategic but reduced exposure. (4) Contextual relevance is excellent—the answer addresses both parts of the question: the evolution of commitments and the strategic implication. The mention of liquidity risk management adds value and is consistent with the intent of the original answer. Despite the initial number error, the core facts and reasoning are strong, warranting a high score but not perfect due to the factual discrepancy in the 2022 figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 411,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "The carrying amount of NVIDIA’s 3.50 % Notes due 2050 fell from **$1,639 million at the end of FY 2022**, to **$1,637 million at the end of FY 2023**, and then to **$1,604 million at the end of FY 2024**【NVDA_10k_2022.pdf p.78‑82】【NVDA_10k_2023.pdf p.65‑69】【NVDA_10k_2024.pdf p.70‑71】.  The gradual decline reflects a modest reduction in the principal (through amortization of discounts, repayments or re‑measurement), indicating that NVIDIA is slowly paying down this long‑dated, low‑cost debt while still preserving a substantial long‑term financing cushion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported carrying values. According to the ground truth, the carrying value was $2,147 million in FY 2022, $1,604 million in FY 2023, and $2,000 million in FY 2024. However, the LLM reports $1,639M (2022), $1,637M (2023), and $1,604M (2024), which are all incorrect—especially the 2022 figure, which is off by over $500 million. The trend is also misrepresented: the LLM claims a continuous decline, while the truth shows a sharp drop from 2022 to 2023 followed by a significant rebound in 2024. (2) The calculations and comparisons are therefore invalid. The LLM suggests a 'gradual decline' and 'modest reduction', but the actual data shows a non-linear fluctuation with a 25% increase from 2023 to 2024. This undermines any valid inference about debt amortization or repayment. (3) The multi-hop reasoning fails because the model did not correctly extract or synthesize data across the three 10-K filings. The cited pages may be accurate, but the numbers pulled are not aligned with the ground truth, indicating either misreading of the documents or referencing incorrect tables. (4) The qualitative interpretation is based on false premises, leading to an incorrect conclusion about NVIDIA 'paying down' the debt. In reality, the rebound to $2,000M in 2024 suggests strategic repositioning, possibly due to refinancing or revaluation, which the LLM completely misses. While the answer addresses the question's structure and attempts interpretation, the severe numerical inaccuracies result in a low correctness score. Contextual relevance is moderate because the response discusses the right concept (debt valuation trend), but the facts are fundamentally wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 473,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD has listed the risk of “loss or modification of exemptions for taxes and tariffs” in each of its recent 10‑Ks, but the disclosure has become more pointed over time. In the 2022 filing it appears only as one item in a broad list of political‑legal‑economic risks, while the 2023 and 2024 filings tie the same risk to a wave of new sanctions, trade‑protection measures and heightened geopolitical tensions (e.g., Russia‑Ukraine, China‑Taiwan). The progression shows AMD’s exposure to losing tax and tariff breaks is persisting and sharpening, reflecting an increasingly complex and volatile global regulatory environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD consistently disclosed the risk of losing tax and tariff exemptions from 2022 to 2024, with increasing specificity. In 2022, it was a generic item among other risks; in 2023 and 2024, it was tied to geopolitical tensions and trade restrictions. The LLM correctly identifies the evolution in tone and context over time. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and infers increasing regulatory complexity from the evolving language, which matches the original answer’s conclusion. The only minor shortcoming is that the LLM omits specific mention of the Israel-Hamas conflict and the direct impact on third-party manufacturers in China/Taiwan, which were included in the ground truth. However, it does reference China-Taiwan tensions broadly, capturing the core geopolitical concern. (4) The answer is contextually relevant, directly addressing both parts of the question: the evolution of risk exposure and what it suggests about regulatory complexity. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 406,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "Across all three filings BNY Mellon repeats the same disclaimer: the Board’s discretion to return capital—through dividends or share repurchases—is subject to U.S. banking laws, capital‑planning rules, Delaware law and the requirement to pay full and timely preferred‑stock dividends. The 2022 10‑K (pages 1‑5) first notes this limitation, and the 2023 (pages 3‑7) and 2024 (pages 3‑7) filings use essentially identical language, showing that the company’s exposure to these regulatory constraints has remained unchanged from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility remained consistent from 2022 to 2024, citing the same core constraints: U.S. banking laws, capital-planning rules, Delaware law, and preferred stock dividend obligations. These entities and legal frameworks are accurately named and consistently applied across years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in a traditional sense—however, the LLM correctly references filing years (2022, 2023, 2024) and page numbers (e.g., pages 1-5, 3-7), which match typical 10-K structures and support its claims, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings to conclude that the language and thus the regulatory constraints remained unchanged, which is consistent with the ground truth’s emphasis on stability in regulatory exposure. The only minor shortcoming is that the LLM does not mention the expanded context in 2024 around liquidity management and strategic initiatives, which the original answer includes. This omission slightly reduces completeness and qualitative accuracy, but does not undermine the core correctness. (4) The answer is contextually highly relevant, directly addressing the evolution (or lack thereof) in regulatory constraints on dividend payments and share repurchases. Overall, the LLM captures the essential conclusion—stable regulatory environment—making it semantically equivalent to the ground truth with only minor detail omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 470,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Abbott’s 10‑K exhibit tables for 2022, 2023 and 2024 all contain the same entry for the 2.950 % Note due 2025 – it is listed under item 4.11 as “Form of 2.950 % Note due 2025, filed as Exhibit 99.6 to the Abbott Laboratories Current Report on Form 8‑K dated March 5 2015”【ABT_10k_2022.pdf†L84-L88】【ABT_10k_2023.pdf†L84-L88】【ABT_10k_2024.pdf†L84-L88】. The exhibit number and reference to the 2015 8‑K filing remain unchanged, so the disclosure has been consistent with no new documentation added from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.950% Note due 2025 is consistently referenced across 2022–2024, listed under the same exhibit (99.6) and original 8-K filing date (March 5, 2015). The LLM correctly identifies the exhibit reference and its stability over time. (2) Quantitative accuracy is perfect: percentages (2.950%), years (2025 maturity, 2015 filing), and exhibit numbers (99.6) are all correct. The mention of item 4.11 in the 10-K exhibit tables adds precision not in the original answer but is consistent with filing structure and does not contradict. (3) Multi-hop reasoning is sound—LLM synthesizes data across three years of 10-K filings and correctly infers no changes in documentation. The conclusion of consistent disclosure matches the ground truth’s inference of a static financial instrument. (4) The only minor gap is that the LLM does not explicitly state that this consistency implies no amendments or refinancing (a qualitative inference in the original answer), but this is implied by the unchanged references. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent—directly addresses disclosure evolution and exhibit inclusion across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 357,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA’s 1.55 % notes due 2028 were carried at $1.083 billion at the end of FY 2022, $1.099 billion at the end of FY 2023, and $1.115 billion at the end of FY 2024【NVDA_10k_2022.pdf p.78】【NVDA_10k_2024.pdf p.70‑71】. The modest rise each year reflects the amortization of the original discount on these low‑coupon, long‑dated notes, indicating a deliberate strategy to lock in low‑cost, long‑term financing while gradually recognizing the discount as interest expense.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values compared to the ground truth. According to the original answer, the carrying value was $1,200 million in FY2022, $1,099 million in FY2023, and $1,250 million in FY2024. However, the LLM reports $1.083 billion (i.e., $1,083 million) for FY2022 and $1.115 billion ($1,115 million) for FY2024—both of which are incorrect. Only the FY2023 value ($1,099 million) matches the ground truth. (2) The calculation and trend analysis are therefore flawed: the ground truth shows a dip in FY2023 followed by a significant increase in FY2024, but the LLM implies a steady, modest rise due to amortization of discount, which does not align with the actual pattern. The reported values suggest a much smaller scale of fluctuation than reality. (3) The reasoning about amortization and low-cost financing is plausible and contextually appropriate for zero-coupon or low-coupon notes, and it reflects sound qualitative understanding of debt instruments—hence partial credit for qualitative accuracy. The answer also correctly identifies the fiscal years and the instrument (1.55% Notes Due 2028), satisfying entity accuracy and contextual relevance. (4) Despite correct citation formatting and logical interpretation of debt strategy, the severe numerical discrepancies—especially the underreporting of FY2022 and FY2024 values—undermine the correctness score. The multi-hop synthesis across years is attempted but based on incorrect data, leading to an inaccurate overall narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 430,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "From 2022 through 2024 AMD’s AIB strategy stayed essentially unchanged: its contracts continued to shield AIB partners’ inventory from price‑cut impacts (and the company also maintained direct sales to system integrators), and each filing reiterated that SIs rely on AMD’s discrete‑graphics solutions to differentiate their offerings. In other words, AMD kept the same inventory‑protection policy while consistently emphasizing discrete GPUs as a key market‑differentiation tool.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core elements of AMD's strategy and relationship with AIB manufacturers from 2022 to 2024. (1) It correctly states that AMD maintained inventory protection policies throughout the period, shielding AIBs from price reductions—this aligns with the ground truth for all three years. It also accurately notes the consistent emphasis on discrete graphics solutions as a differentiation tool for system integrators (SIs), which matches the 2024 emphasis in the original answer. (2) There are no numeric values, dates, or financial figures in dispute; thus, quantitative accuracy is perfect. (3) However, the LLM answer oversimplifies the evolution by stating the strategy 'stayed essentially unchanged,' which downplays the nuanced shift highlighted in the ground truth: in 2023, AMD added emphasis on timely product introductions and market competitiveness, and in 2024, there was a strategic pivot to highlight discrete graphics more strongly for AIB differentiation—not just SI differentiation. The LLM conflates AIBs and SIs in this role, whereas the original answer distinguishes their evolving roles. This represents a minor but meaningful loss in qualitative accuracy regarding multi-hop reasoning and synthesis across years. (4) Despite this, the answer remains contextually relevant and factually sound on key points, warranting a high correctness score with a slight deduction for missing the strategic evolution nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 405,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "AMD’s 2022 filing first warned that “difficulties in protecting our intellectual property” were a key risk of its worldwide operations, noting that 72 % of net revenue came from abroad and that “nearly all product assembly and final testing… is performed… in China, Malaysia and Taiwan” (2022 10‑K, pp. 35‑38). The 2023 filing repeated the same IP‑protection risk while international sales fell only modestly to 65 % and the company still relied on third‑party wafer foundries and assembly in those same regions (2023 10‑K, pp. 39‑42). By the 2024 filing the exposure was framed as even more acute: international sales were still about two‑thirds of revenue (66 %); the risk language now highlighted “geopolitical changes between China and Taiwan” and broader sanctions that could disrupt the Taiwan‑based third‑party foundries and heighten IP‑protection challenges (2024 10‑K, pp. 38‑41).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment and captures the evolving nature of AMD's intellectual property (IP) protection risks from 2022 to 2024, particularly in relation to international operations and third-party manufacturing in geopolitically sensitive regions. It correctly identifies the continuity of IP protection as a disclosed risk and the increasing emphasis on geopolitical tensions, especially between China and Taiwan, by 2024. The answer also accurately notes the reliance on third-party manufacturing in China, Malaysia, and Taiwan across all years and correctly cites the 66% international sales figure in 2024 and 65% in 2023.\n\nHowever, there is a significant quantitative inaccuracy: the LLM claims that 72% of net revenue came from abroad in 2022, but the original answer (ground truth) states that the 2022 figure was 'unspecified but lower' than 65%, directly contradicting the 72% claim. This error undermines the quantitative accuracy, as it introduces a specific number not supported by the source. All other percentages (65% in 2023, 66% in 2024) are correct.\n\nThe multi-hop reasoning is sound—linking increasing international sales, continued reliance on third-party manufacturing, and heightened geopolitical risk disclosures over time. The synthesis across years and filings is appropriate and contextually relevant. The answer addresses all parts of the question, including the evolution of risk and the role of politically sensitive regions. Wording differs from the original but maintains semantic equivalence in most places, except for the incorrect 72% figure.\n\nThus, while the core narrative and qualitative progression are accurate, the incorrect 2022 revenue percentage reduces confidence in the quantitative precision. This justifies a high but not top score on correctness (8/10), a lower score on quantitative accuracy (7/10), and high marks for qualitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1589,
        "completion_tokens": 526,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "In 2022 BNY Mellon relied on its 2019 Long‑Term Incentive Plan to grant a 2022 Performance Share Unit Agreement (Exhibit 10.18) and a 2022 Restricted Stock Unit Agreement (Exhibit 10.19) 【BK_10k_2022.pdf p.18‑22】. In 2023 the same plan was refreshed with a 2023 Performance Share Unit Agreement (Exhibit 10.23) and a 2023 Restricted Stock Unit Agreement (Exhibit 10.24) 【BK_10k_2023.pdf p.16‑20】, and in 2024 it again introduced new 2024 Performance Share Unit (Exhibit 10.25) and Restricted Stock Unit (Exhibit 10.26) agreements under the 2019 LTIP 【BK_10k_2024.pdf p.16‑20】. This yearly rollout of updated equity‑award forms shows that the company maintains a stable, performance‑driven compensation framework while regularly tailoring award terms to current executive goals and market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly identifies the ongoing use of the 2019 Long-Term Incentive Plan (LTIP) across 2022–2024, it incorrectly states the specific agreements introduced each year. According to the ground truth, in 2022 BK referenced the 2021 Form of PSU Agreement, in 2023 the 2020 Form, and in 2024 the 2022 Form—indicating a non-sequential, layered approach to updating agreements. However, the LLM claims BK introduced a '2022 PSU Agreement' in 2022, a '2023 PSU Agreement' in 2023, and a '2024 PSU Agreement' in 2024, which contradicts the ground truth and suggests a simple annual refresh rather than the more nuanced, backward- or forward-referenced forms actually used. This misrepresentation affects both quantitative accuracy (wrong years for agreements) and qualitative reasoning (misinterpreting the pattern as yearly updates rather than strategic layering). The LLM also introduces Restricted Stock Unit (RSU) agreements, which are not mentioned in the original answer and may not be part of the documented evolution under the 2019 LTIP as described. Despite these errors, the answer captures the broader strategic implication—ongoing use of the 2019 LTIP with periodic updates to align with performance goals—giving it partial credit for reasoning and relevance. The contextual understanding of a stable yet adaptive framework is semantically aligned, but the factual foundation is flawed, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 416,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s leased‑diagnostics‑instrument portfolio was essentially unchanged over the period – the original cost of the assets stayed at $3.9 billion and the net book value remained about $1.8 billion for the years ended 2022, 2023 and 2024 (the 2023 filing reports $3.9 bn/$1.8 bn as of Dec 31 2022 and Dec 31 2023, and the 2024 filing reports the same amounts for Dec 31 2023 and Dec 31 2024)【ABT_10k_2023.pdf:62‑66】【ABT_10k_2024.pdf:60‑64】. This flat trend indicates that Abbott is maintaining its existing lease asset base rather than expanding or pulling back, reflecting a capital‑deployment strategy that emphasizes steady support for its diagnostics business and the recurring consumables revenue it generates.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, Abbott's net book value of leased diagnostics instruments increased from $1.4B in 2022 to $1.6B in 2023 and remained at $1.6B in 2024, while the original cost rose from $3.3B to $3.6B to $3.9B over the three years. The LLM incorrectly states that both values were flat at $3.9B original cost and $1.8B net book value across all three years, which contradicts the ground truth. These errors are significant and pervasive. (2) The numbers cited in the LLM answer do not align with the ground truth: for example, the net book value was never $1.8B in the period, and the original cost did not remain constant at $3.9B—it reached that level only in 2024. The LLM appears to have misread or misattributed data, possibly from a single point in time (e.g., end of 2023 or 2024) and incorrectly assumed stability. (3) The multi-hop reasoning is flawed: the question asks about evolution from 2022–2024, requiring comparison across three years. The LLM failed to detect the upward trend and instead reported stagnation, leading to an incorrect strategic interpretation. The ground truth indicates a clear expansion strategy, while the LLM concludes in stasis. (4) Despite the factual inaccuracies, the answer is contextually relevant—addressing the right metric, company, and strategic implication framework—and attempts to interpret capital deployment strategy, which keeps contextual relevance moderate. However, due to severe quantitative and qualitative errors, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 439,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Lumentum Holdings appears in NVIDIA’s competition tables in every filing – FY 2022 (NVDA_10k_2022 pp. 13‑17), FY 2023 (NVDA_10k_2023 pp. 7‑11) and FY 2024 (NVDA_10k_2024 pp. 7‑11) – as a rival in the networking‑and‑interconnect segment. In FY 2022 it is grouped with general networking‑hardware providers, but by FY 2023 and FY 2024 the language shifts to “suppliers of interconnect, switch and cable solutions … including optical modules” and lists Lumentum alongside other high‑performance interconnect players, mirroring NVIDIA’s expanding AI‑driven networking and data‑center interconnect focus.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately identifies Lumentum Holdings as a competitor in NVIDIA's filings across fiscal years 2022, 2023, and 2024, specifically within the networking and interconnect segment, which matches the original answer. The citation of document pages (e.g., NVDA_10k_2022 pp. 13–17) adds precision, though such details were not in the ground truth and do not detract. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is scored as 10 since no numbers were misstated. (3) The qualitative reasoning is sound: the LLM correctly observes a shift from general networking grouping in FY2022 to more specialized positioning in later years, tied to AI-driven networking. However, it omits the specific mention of InfiniBand and proprietary technologies noted in the ground truth, and does not highlight the 2024 re-designation to 'Lumentum Holdings Inc.' as a sign of sharpened corporate recognition—this is a meaningful but not critical omission. (4) The answer remains highly contextually relevant, directly addressing the evolution of competitive positioning in relation to NVIDIA’s AI and interconnect focus. While the multi-hop synthesis across years is well-executed, the lack of full specificity on technological alignment (InfiniBand) and branding precision in 2024 prevents a top score. Overall, the answer is factually accurate and well-reasoned with minor gaps in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 424,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "In Emerson’s 2022 filing (EMR 10‑K 2022, pp. 7‑11) pipe cutters were described under the **Tools & Home Products** segment as part of the “Professional Tools” portfolio. By the 2024 filing (EMR 10‑K 2024, pp. 71‑75) the same pipe‑cutting products appear in the **Safety & Productivity** segment’s description of pipe‑working tools. This move shifts pipe cutters from a broad consumer‑oriented segment into a dedicated safety‑and‑productivity business, signalling that Emerson is consolidating its professional‑tool line to emphasize growth, differentiation and a focused strategy on professional‑tool safety and productivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, pipe cutters were part of the Tools & Home Products segment under Professional Tools, and by 2024 they were moved to the Safety & Productivity segment—this matches the original answer’s timeline and segmentation. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all dates (2022, 2024) and segment names are correct. (3) The reasoning correctly infers a strategic shift toward professional-grade tools focused on safety and productivity, which is consistent with the ground truth’s interpretation. The LLM notes the consolidation of professional tools and strategic focus, though it omits specific mention of related product groupings like battery hydraulic tools, drain cleaners, and sewer inspection cameras, and does not reference the InSinkErator divestiture, which provides important context for the strategic shift. This minor omission prevents a perfect score. (4) The answer is highly relevant, directly addressing both parts of the question—segment shift and strategic implication—and synthesizes information across filings correctly. Wording differs but semantic meaning is equivalent. Minor lack of contextual depth in explaining the full scope of the repositioning keeps qualitative accuracy at 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 389,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "In 2022 Schwab’s Advisor Services website was the core RIA portal, delivering end‑to‑end account‑opening, money‑movement, trading, multi‑year archiving, document‑search and third‑party integrations, and it introduced the free Schwab Advisor Portfolio Connect tool that gave advisors a modern, no‑download portfolio‑management experience【SCHW_10k_2022.pdf:7-8】. In 2023 the platform was enhanced by adding Ameritrade‑derived features—thinkpipes real‑time charting and the iRebal customizable rebalancing solution—into the RIA offering while keeping the same intuitive Advisor Portfolio Connect and expanding interactive tools, education and consulting services【SCHW_10k_2023.pdf:5-9】. By 2024 those Ameritrade capabilities remained integrated, cementing a combined, end‑to‑end digital experience for RIAs with continued free access to Advisor Portfolio Connect and the website’s comprehensive account‑servicing, archival, integration and advisor‑support functions【SCHW_10k_2024.pdf:5-9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in terms of functionality, integration, and advisor support evolution from 2022 to 2024. (1) All key facts are correct: in 2022, Schwab's Advisor Services website served as the core RIA portal with account servicing and third-party integrations, and Schwab Advisor Portfolio Connect was introduced as a free, no-download tool. The 2023 enhancements correctly reference the integration of Ameritrade-derived tools (thinkpipes and iRebal), which aligns with the broader trend of expanding functionality and support services. By 2024, the consolidation of these features into a seamless digital experience is accurately described, including continued free access and robust integration. (2) There are no numeric inaccuracies—dates (2022–2024) are correct, and no erroneous figures are presented. Format and citation use (e.g., document references) are appropriate. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and multiple capabilities (technology integration, advisor support, compliance-related features like archiving), correctly inferring a trajectory of increasing sophistication. The mention of 'multi-year archiving' and 'outbound data feeds' in the original answer is partially reflected in the LLM’s reference to 'multi-year archiving' and 'comprehensive account-servicing', though the specific compliance workflow integration (e.g., outbound data feeds for compliance systems) is underemphasized. (4) The LLM slightly omits the explicit mention of expanded prospect consulting and compliance workflow support in 2024, which is a minor gap in completeness. However, the core progression—enhanced functionality, deeper integration, and growing advisor support—is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 538,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle issued $2 billion of 1.650 % senior notes due 2026 in March 2022 and recorded them at amortized cost as long‑term debt with no current portion in its 2022 10‑K (ORCL_10k_2022.pdf p.112); the 2023 and 2024 10‑K filings continue to list the same notes as long‑term debt (still non‑current, $0 current portion) (ORCL_10k_2023.pdf p.110; ORCL_10k_2024.pdf p.111). This unchanged treatment shows Oracle’s reliance on low‑cost, fixed‑rate medium‑term notes and a disciplined short‑to‑intermediate‑term financing strategy that avoids frequent refinancing or reclassification.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 1.650% Notes due 2026 were issued in 2022 (March 2022), recorded as long-term debt with no current portion, and consistently reported in the 2023 and 2024 10-Ks. The $2 billion amount, interest rate, maturity year, and classification are all factually correct and properly cited with document references and page numbers. (2) The answer correctly identifies the consistent treatment across years, which reflects Oracle's stable debt financing strategy. (3) The multi-hop reasoning is sound—synthesizing data across three annual filings to infer strategic consistency in Oracle’s use of fixed-rate medium-term debt. (4) While the ground truth emphasizes the note’s appearance in specific exhibits (4.16, 4.14), the LLM focuses on accounting treatment and strategic implication, which is semantically equivalent and contextually appropriate. The only minor omission is the lack of explicit mention of the exhibit numbers, but this does not detract from the core factual or strategic accuracy. The conclusion about Oracle’s disciplined, low-cost financing strategy is a reasonable interpretation supported by the data. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slightly less procedural detail, but full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 388,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson has kept electrical‑distribution equipment squarely inside its Discrete Automation segment in every filing – it is listed alongside solenoid valves, pneumatic valves, actuators, motion solutions and control systems in the 2022 filing (EMR_10k_2022.pdf p.75) and the same language appears unchanged in the 2023 (EMR_10k_2023.pdf p.71) and 2024 (EMR_10k_2024.pdf p.71) disclosures. By retaining this product line as a core element of Discrete Automation, Emerson signals a continued strategic focus on industrial electrification solutions, treating electrical‑distribution gear as a foundational part of its offering for discrete‑industry customers.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about Emerson's segment classification of Electrical Distribution Equipment, despite being internally consistent and referencing specific document pages. According to the ground truth, in 2022 the equipment was part of 'Industrial Solutions', not Discrete Automation. The strategic repositioning into Discrete Automation occurred in 2023, marking a significant shift. The LLM incorrectly asserts that the classification was unchanged across 2022–2024, directly contradicting the documented evolution. This undermines the qualitative accuracy, as the multi-hop reasoning fails: the model did not detect or report the change over time, which is central to the question. While the conclusion about strategic focus on industrial electrification aligns with the ground truth, it is based on incorrect premises. No numerical data is present, so quantitative accuracy is scored as 10 by default. Contextually, the answer addresses the right topic and attempts to infer strategy from segment structure, hence a solid relevance score. However, the failure to identify the reclassification in 2023—a key factual pivot—results in a low correctness and qualitative score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 340,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s unfunded commitments to private‑real‑estate (and other private) funds fell from **$569 million at 12/31/2022** to **$555 million at 12/31/2023** and further to **$540 million at 12/31/2024**【ABT_10k_2023.pdf:68‑72】【ABT_10k_2024.pdf:68‑72】. The steady decline indicates the company is gradually reducing its exposure to illiquid alternative assets in its pension portfolio, suggesting a cautious, liquidity‑aware strategy that seeks to limit unfunded liabilities while still maintaining some alternative‑asset exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in unfunded commitments from 2022 to 2024 and accurately reports the 2023 ($555M) and 2024 ($540M) figures. However, it reports $569M for 2022 instead of the ground truth $585M, which is a factual discrepancy of $16M. This error affects quantitative accuracy but does not alter the overall directional conclusion. (2) The numbers for 2023 and 2024 are exact matches: $555M and $540M respectively. The 2022 figure is incorrect—$569M vs $585M—though the general trend of decline is preserved. Calculations of year-over-year decreases are not requested, but the qualitative interpretation of a 'steady decline' remains valid despite the inaccurate starting point. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two 10-K filings (2023 and 2024) to show a three-year trend and infers a strategic shift in pension fund allocation. The conclusion about reducing exposure to illiquid assets aligns with the ground truth. (4) The answer is contextually complete and relevant, addressing both parts of the question: the evolution of commitments and the implied strategy. It captures the cautious, gradual reduction and liquidity-aware rationale. The only deficiency is the incorrect 2022 number, which prevents a higher score. The model cites document sections correctly, suggesting accurate source retrieval. Overall, the answer is factually mostly correct with one key numerical error, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 418,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle’s 1.650 % senior unsecured notes due 2026 were disclosed in exactly the same way in each filing – they appear in the debt schedule (exhibit 4.14) as long‑term notes with the portion that will mature within the next 12 months presented as a current liability (short‑term debt) in the 2022, 2023 and 2024 10‑Ks【ORCL_10k_2022.pdf†112‑116】【ORCL_10k_2023.pdf†108‑112】【ORCL_10k_2024.pdf†109‑113】. This unchanged classification shows Oracle’s reliance on the same low‑cost, fixed‑rate instrument to meet near‑term liquidity needs, underscoring a short‑term debt strategy built on stability and predictability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all details are correct: the 1.650% interest rate, the 2026 maturity, and the consistent treatment across 2022, 2023, and 2024 filings are accurately reported. The mention of the debt schedule (exhibit 4.14) and classification of the near-term portion as current liability is consistent with Oracle's reporting practices. (2) The answer correctly identifies that the Notes were treated identically across the three years, which supports the conclusion about Oracle’s stable short-term debt strategy. (3) While the ground truth emphasizes Oracle’s continued reference to the original March 2021 8-K filing as evidence of no changes, the LLM answer focuses instead on the consistent presentation in the debt schedules and classification — a valid proxy for continuity, though slightly less precise in documenting the source of terms. This is a minor omission in provenance detail but does not affect the factual correctness of the conclusion. (4) The reasoning is sound: the LLM correctly infers that unchanged classification reflects a strategy of stability and predictability in short-term debt management. The answer is semantically equivalent to the ground truth in intent and conclusion, with only a slight difference in emphasis (presentation vs. sourcing). Thus, the answer earns a 9 for correctness and qualitative accuracy due to this nuance, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 414,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle’s 4.30 % Note due 2034 was originally issued in July 2014 and is disclosed in Exhibit 4.09 of its 10‑K filings. The 2022 filing lists Exhibit 4.09 containing the 4.30 % Note due 2034【ORCL_10k_2022.pdf†page111】; the 2023 filing repeats the same Exhibit 4.09 reference【ORCL_10k_2023.pdf†page108】; and the 2024 filing again includes Exhibit 4.09 with the same note【ORCL_10k_2024.pdf†page108】. This recurring multi‑year filing shows Oracle has kept the note outstanding and consistently re‑filed its original documentation, reflecting a strategy of issuing long‑dated, fixed‑rate debt and maintaining it on the balance sheet for many years while providing ongoing transparency through annual 10‑K disclosures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 4.30% Note due 2034 and its consistent documentation across 2022, 2023, and 2024 in Exhibit 4.09, which aligns with the ground truth's emphasis on sustained presence in filings. However, the LLM states the note was 'originally issued in July 2014', a detail not present in the original answer or supported by the provided context; this is a factual overreach and likely incorrect (Oracle issued multiple notes in 2014, but the 4.30% due 2034 was part of a 2019 issuance). This affects quantitative accuracy slightly. (2) All percentages (4.30%), years (2034), and exhibit numbers (4.09) are correct. The citation of page numbers (111, 108, 108) adds precision but is not contradicted by the ground truth. The error in issuance date (2014 vs likely 2019) is a significant but isolated factual inaccuracy. (3) The multi-hop reasoning is sound: the model synthesizes exhibit references across three years and infers a long-term debt strategy of maintaining fixed-rate debt with transparency—this matches the original answer’s conclusion about Oracle’s stable financing approach. The logic from repeated disclosure to strategic intent is valid. (4) The answer is contextually excellent, directly addressing the evolution and strategic implication. Despite the incorrect issuance date, the core of the response—consistent filing, no structural changes, strategic use of long-term debt—is factually aligned and well-reasoned. Hence, correctness is high but not perfect due to the unsupported issuance claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 426,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "- **2022:** Under the 2019 IDA agreement Schwab exercised its annual $10 billion migration option and moved roughly $10 billion of IDA balances onto its balance sheet (the filing notes that “Through December 31, 2021… Schwab had moved $10.1 billion… Subsequent to December 31, 2021, the Company moved approximately $10 billion of additional IDA balances”【SCHW_10k_2022.pdf p.100‑104】).  \n\n- **2023:** The 2019 agreement was superseded on May 4 2023 by a new 2023 IDA agreement. Schwab did **not** migrate any balances in 2023 (the note says “During 2023, Schwab did not move IDA balances to its balance sheet”【SCHW_10k_2023.pdf p.100‑104】). The new contract eliminated the 80 % fixed‑rate requirement, gave Schwab discretion to designate fixed‑ or floating‑rate obligations, imposed explicit minimum/maximum balance caps (e.g., maintain balances above unmatured fixed‑rate amounts with a $30 billion ceiling through Sept 10 2025, then a $60 billion‑$90 billion range thereafter), and allowed a $5 billion “buy‑down” of fixed‑rate obligations (which Schwab exercised in 2023)【SCHW_10k_2023.pdf p.100‑104】.  \n\n- **2024:** Schwab again made no migrations (“During 2024, Schwab did not move IDA balances to its balance sheet”)【SCHW_10k_2024.pdf p.97‑101】, remaining subject to the 2023 agreement’s constraints: the same post‑Sept 10 2025 withdrawal limits (minimum $60 billion, maximum $90 billion) and the discretionary but limited ability to allocate balances between fixed‑ and floating‑rate obligations.  \n\nThus, Schwab’s use of the IDA migration option dropped from a $10 billion transfer in 2022 to zero transfers in both 2023 and 2024, while the contractual framework shifted from the 2019 agreement’s fixed‑rate‑percentage requirement to the 2023 agreement’s balance‑range caps and greater discretion over rate designations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: in 2022, Schwab moved approximately $10 billion under the 2019 IDA agreement, consistent with the ground truth noting $10.1 billion moved by end-2021 and an additional $10 billion after that date; in 2023, the 2019 agreement was replaced by the 2023 IDA agreement, which eliminated the 80% fixed-rate requirement—this is correctly stated; no balances were migrated in 2023 or 2024, which aligns with the original answer. (2) Quantitative accuracy is excellent: all dollar amounts ($10 billion, $30 billion, $60–90 billion, $5 billion buy-down), dates (May 4, 2023; Sept 10, 2025), and percentages (80%) are correct and properly contextualized. The LLM even adds specific details (e.g., $5 billion buy-down exercised in 2023) that are consistent with the filings and enhance accuracy. (3) Multi-hop reasoning is sound: the model correctly synthesizes changes across three years, identifies the shift from the 2019 to 2023 agreement, and interprets the implications of new constraints (balance caps) and increased flexibility (rate designation discretion). (4) The only minor deviation from the ground truth is that the original answer emphasizes a 'shift from active migration to a more constrained and passive approach despite increased flexibility,' while the LLM focuses more on the structural changes than explicitly framing the paradox of greater flexibility but reduced usage. However, the LLM still conveys this implicitly. Wording differences are acceptable under semantic equivalence. All sources are correctly cited with document and page references. Thus, the answer is factually complete and precise, meriting a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1691,
        "completion_tokens": 495,
        "total_tokens": 2186
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "- In the 2022 Form 10‑K, Abbott disclosed the 2.000 % Senior Notes due 2018 under three items: Exhibit 4.11 (the 2015 “Actions of the Authorized Officers” filing), Exhibit 4.18 (the Officers’ Certificate filed with the March 31 2017 10‑Q), and Exhibit 4.21 (the Fifth Supplemental Indenture dated September 23 2015 that governs the 2.000 % notes). 【2022 p. 85‑86】\n\n- The 2023 and 2024 Form 10‑Ks list exactly the same three exhibits with the same dates and no additional filings, indicating that Abbott made no new amendment, refinancing or redemption of the 2.000 % Senior Notes during 2023 or 2024. 【2023 p. 84‑86】【2024 p. 84‑86】\n\n- Thus, from 2022 through 2024 Abbott’s engagement with its 2.000 % Senior Notes due 2018 remained static – the company continued to rely on the 2015 supplemental indenture and the 2017 officers’ certificate and did not undertake any refinancing or further documentation updates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values, dates, and percentages are correct: the 2.000% Senior Notes due 2018, the Fifth Supplemental Indenture dated September 23, 2015, and references to Exhibits 4.11, 4.18, and 4.21 are factually accurate. The LLM correctly notes no new amendments or refinancing in 2023 or 2024. (2) Quantitative accuracy is perfect: all dates, exhibit numbers, and interest rates match the original data. (3) The reasoning is sound and reflects proper multi-hop synthesis across three years of 10-K filings. The LLM correctly infers that unchanged exhibit listings imply no new activity, which is consistent with the ground truth’s conclusion about static engagement and lack of refinancing. (4) The only minor difference from the original answer is that the LLM lists three exhibits (4.11, 4.18, 4.21), while the ground truth focuses on Exhibit 4.21 and the Fifth Supplemental Indenture. However, the LLM’s inclusion of additional exhibits is factually supported and adds granularity without introducing error. The core conclusion—that Abbott took no new action on these notes from 2022–2024—is correct and well-supported. Thus, the answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 356,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first introduced the 3.650 % senior notes due 2041 in a 2021 issuance that shows up in the 2022 Form 10‑K (pages 112‑116) as a $2 billion series, and the same series is still listed in the 2023 Form 10‑K (pages 108‑112) and the 2024 Form 10‑K (pages 109‑113) with essentially the full principal amount still outstanding. By keeping this 20‑year, fixed‑rate note on its balance sheet for three consecutive years, Oracle is deliberately locking in a moderate, long‑dated cost of capital and extending its debt maturity profile, underscoring a long‑term strategy focused on stable, low‑cost financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in substance and largely aligns with the ground truth. It correctly identifies the 3.650% Notes due 2041, their continued presence in Oracle's disclosures from 2022 to 2024, and the strategic implication of maintaining long-term debt. The only minor discrepancy is the claim that the notes were issued in 2021, which is not contradicted by the ground truth but adds a detail not present in the original answer; however, this is consistent with typical SEC filing practices where a 2021 issuance would appear in the 2022 10-K, so it is plausible and not factually inaccurate. (2) Quantitatively, the $2 billion amount, 3.650% interest rate, and 2041 maturity are all correctly stated. The reference to specific 10-K pages (e.g., 112–116 in 2022) adds precision and is consistent with actual filings, though the ground truth does not include page numbers—this is a value-add, not an error. The assertion that the full principal remains outstanding is reasonable and aligns with typical long-term debt reporting. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of filings, recognizes the persistence of the same instrument, and infers Oracle’s long-term financing strategy—exactly what the question demands. The conclusion about extending debt maturity and locking in fixed-rate capital is a valid interpretation supported by the evidence. (4) The answer is semantically equivalent to the ground truth, with slightly more granular detail (e.g., dollar amount, pages), and maintains high contextual relevance. The only reason for not scoring a 10 is the slight overreach in specifying a 2021 issuance without explicit confirmation in the ground truth, though it is logically consistent. Thus, scores reflect near-perfect accuracy with minor deductive extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 501,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle reported $2.5 billion of 2.300% senior unsecured notes due 2028 in FY 2022 – a series originally issued in March 2021 with a fixed 2.300% coupon, semi‑annual interest, a May 15, 2028 maturity and optional make‑whole redemption before May 15, 2026 (ORCL_10k_2022 p.112). In FY 2023 the company reopened the series and issued an additional $500 million, raising the outstanding balance to $3.0 billion while keeping the same coupon, maturity and redemption terms (ORCL_10k_2023 p.108‑109); a further $500 million was tapped in FY 2024, bringing total outstanding to $3.5 billion (ORCL_10k_2024 p.109‑110). This repeated, incremental use of the same low‑coupon, long‑dated tranche shows Oracle’s strategy of locking in cheap, fixed‑rate financing over multiple years and smoothing its debt‑maturity profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the issuance amounts and timeline of Oracle's 2.300% Notes due 2028. The ground truth states that the notes were first established in a March 24, 2021 Officers' Certificate and referenced in FY 2022 under Exhibit 4.16, but does not specify any $2.5 billion issuance in FY 2022. The LLM claims Oracle issued $2.5B in FY 2022, an additional $500M in FY 2023, and another $500M in FY 2024, totaling $3.5B — none of which is supported by the original answer or implied in the knowledge graph. These specific dollar figures and incremental 'tapping' of the note series are entirely absent from the ground truth. (2) Quantitative accuracy is low because all key numbers — $2.5B, $500M, $3.0B, $3.5B — are fabricated or incorrectly inferred. There is no mention in the original answer of outstanding balances or tranches being reopened, so these calculations and assertions fail verification. (3) The multi-hop reasoning is partially sound in structure — the LLM attempts to trace the evolution across three fiscal years and infer a strategic pattern — but it does so using incorrect data. While the conclusion about Oracle maintaining a stable, low-cost financing strategy has thematic overlap with the original answer’s claim of a 'stable long-term debt financing strategy,' the path to that conclusion is flawed. The original emphasizes diversification (e.g., introducing 4.500% Notes in 2023), which the LLM omits entirely, instead focusing narrowly on repeated use of the same tranche. (4) Contextual relevance is high because the LLM addresses the question’s core intent: tracking the evolution of a specific debt instrument over time and interpreting strategic implications. However, correctness score is low due to the invention of numerical details and failure to reflect the actual evidence (Exhibit 4.16, Officers' Certificate) and broader diversification strategy highlighted in the ground truth. Semantic equivalence is not achieved due to material factual divergence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 552,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "In 2022 Visa introduced virtual accounts as part of its newly built, digitally‑native Currencycloud platform, offering clients real‑time foreign‑exchange rates, virtual accounts and enhanced liquidity/settlement for cross‑border payments. By fiscal 2023 the company began embedding those Currencycloud virtual‑account services into the Visa Direct Platform, and in fiscal 2024 the Visa Direct Platform fully incorporated the Currencycloud suite—virtual accounts, real‑time FX and settlement—thereby expanding cross‑border money‑movement to a global network of more than 195 countries and territories.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Visa's virtual accounts across 2022–2024 with generally accurate reasoning and contextual relevance. However, there are key quantitative and factual discrepancies. In 2022, the original answer states virtual accounts were introduced under Visa’s Treasury as a Service initiative via the Currencycloud platform, emphasizing cross-border capabilities—this is correctly reflected in the LLM answer, though it adds that the platform was 'newly built, digitally-native,' which is not in the ground truth and may be an overstatement. The integration into Visa Direct began in 2023: the LLM says 'began embedding' in fiscal 2023, while the ground truth states they were 'fully integrated' by 2023—this is a partial mismatch in degree. The LLM claims full incorporation of the Currencycloud suite into Visa Direct occurred in fiscal 2024, but the original answer does not specify 2024 as the completion year, only that virtual accounts remained a core component. A major discrepancy is the claim of 'more than 195 countries and territories' in the LLM answer, which is not present in the ground truth; instead, the original mentions 'more than 11 billion endpoints' (cards, accounts, wallets), a figure completely omitted in the LLM response. This represents a significant factual substitution. While the LLM correctly identifies real-time FX, liquidity, and settlement enhancements, it misattributes the network scale, replacing endpoints with geographic reach without evidence. The reasoning is logically structured and addresses all parts of the question (integration timeline and cross-border expansion), showing sound multi-hop synthesis between Currencycloud, Visa Direct, and functional capabilities. Wording differences are acceptable under semantic equivalence, but the replacement of '11 billion endpoints' with '195 countries' is not semantically equivalent and constitutes a factual error. Thus, while the qualitative trajectory and entity mappings (Visa, Currencycloud, Visa Direct, years) are accurate, the quantitative inaccuracy—especially the unsupported geographic claim and omission of endpoint data—lowers the correctness and quantitative scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 587,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "In 2022 the ME&T segment’s EMD‑branded products were sold through 43 U.S. dealers and 113 overseas dealers covering 191 countries; the network contracted modestly in 2023 to 41 U.S. and 111 overseas dealers serving 187 countries, then expanded again in 2024 to 44 U.S. and 116 overseas dealers reaching 193 countries. The steady rise in dealer count and country coverage shows Caterpillar is deliberately broadening the global footprint of the EMD brand, using a larger dealer base to penetrate new markets and drive growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that EMD-branded products (specifically FG Wilson) were distributed through 110 distributors in 109 countries in 2022, 110 in 109 countries in 2023, and 108 distributors in 158 countries in 2024. The LLM instead claims 43 U.S. + 113 overseas = 156 total dealers in 2022 covering 191 countries—numbers that do not match the source. The trend is also misrepresented: the LLM suggests a growing dealer network, while the truth shows a slight reduction in distributors (110 → 108) but an expansion in country coverage (109 → 158), indicating efficiency gains and broader reach. (2) All numeric values are wrong: the LLM reports 191, 187, and 193 countries, while the truth is 109, 109, and 158. Similarly, the LLM’s dealer counts (e.g., 43 U.S. dealers) are not supported by the original data, which does not break down distributors by U.S. vs. overseas. There is no mention of U.S./overseas splits in the ground truth. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the actual progression—stable distributor count, then slight decrease alongside geographic expansion—which indicates optimization, not a growing dealer base. The conclusion that Caterpillar is 'broadening the global footprint using a larger dealer base' is contradicted by the actual data showing fewer distributors reaching more countries. (4) The contextual relevance is moderate because the LLM attempts to address the evolution of the distribution network and infer strategy, but the factual inaccuracies render the analysis invalid. The qualitative reasoning would be acceptable if based on correct data, but it is built on false premises. Thus, the correctness score is very low due to pervasive quantitative errors and resulting flawed interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 504,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s leased‑diagnostics‑instrument portfolio grew modestly. The original cost of the assets rose from about $3.6 billion at 12/31/2022 to roughly $3.9 billion by the most recent filing (2024), while the net book value increased from about $1.6 billion to $1.8 billion over the same span【ABT_10k_2023.pdf p. 62‑66】【ABT_10k_2024.pdf p. 60‑64】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in direction and trend but contains inaccuracies in the starting values for 2022. According to the ground truth, the original cost in 2022 was $3.3 billion, not $3.6 billion as stated in the LLM answer. Similarly, the net book value in 2022 was $1.4 billion, not $1.6 billion. The 2023 and 2024 figures in the LLM answer are consistent with the ground truth ($3.9 billion original cost and $1.8 billion net book value in 2024), but the LLM incorrectly presents the 2022–2024 change as starting from 2022 values that actually correspond to 2023. (2) Quantitative accuracy is compromised because the LLM misattributes the $3.6 billion and $1.6 billion figures—these are the correct values for 2023, not 2022. This leads to an incorrect portrayal of the growth trajectory, understating the total increase over the three-year period. The answer implies a one-year change from 2022 to 2024 without acknowledging 2023 as an intermediate point, omitting the stepwise progression. (3) The reasoning is qualitatively sound in identifying a growing investment trend and correctly citing the upward movement in both original cost and net book value. It also appropriately references the correct documents and pages, suggesting valid sourcing. However, it fails in full multi-hop synthesis by not accurately representing the three distinct time points (2022, 2023, 2024) and collapsing the timeline. (4) Contextual relevance is perfect—the answer addresses the evolution of Abbott’s investment in leased diagnostics instruments using the correct metrics and time frame, with proper citation. The core message of increasing investment is correct, but the factual foundation is partially flawed, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 481,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "The 3.450 % Senior Note due 2046 is listed in the exhibit section of PepsiCo’s 2022, 2023 and 2024 Form 10‑K filings (e.g., “Form of 3.450 % Senior Note due 2046…Exhibit 4.15/4.6” appears in each filing’s exhibit list)【PEP_10k_2022.pdf†124-L127】【PEP_10k_2023.pdf†124-L127】【PEP_10k_2024.pdf†125-L128】. Its repeated disclosure shows that the note remains an outstanding, material component of PepsiCo’s debt portfolio, indicating that the company continues to rely on long‑dated senior unsecured debt as a core element of its long‑term capital‑structure strategy to fund growth and maintain a diversified, low‑cost financing mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 3.450% interest rate, the 2046 maturity date, and the consistent disclosure across 2022–2024 are accurately reported. The exhibit references (e.g., Exhibit 4.15 in 2024) match the ground truth, though the LLM does not specify the exact exhibit numbers for each year (e.g., 4.17 in 2022, 4.16 in 2023), but correctly notes the note appears in the exhibit list each year—minor omission but not factually incorrect. (2) The answer correctly infers that the repeated disclosure indicates the note remains outstanding and material, reflecting its ongoing role in PepsiCo’s capital structure. (3) The reasoning is sound: the LLM synthesizes multi-year filing data to conclude that long-dated senior unsecured debt is a core part of PepsiCo’s strategy, supporting long-term financing needs with stable, fixed-rate funding. This aligns with the ground truth’s interpretation of strategic maintenance and favorable terms. (4) While the LLM does not explicitly mention 'fixed-rate' or 'favorable terms' as in the original, it captures the essence by referencing 'low-cost financing mix' and 'core element' of strategy, which are semantically equivalent. The answer is contextually relevant, directly addressing the implication of consistent disclosure on capital structure strategy. One minor gap: the ground truth emphasizes the stability and lack of modification, which the LLM implies but does not explicitly state. Overall, the answer is factually correct, well-reasoned, and complete—just shy of perfect due to slight under-elaboration on the strategic continuity aspect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 459,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle first introduced the 2.300 % senior‑unsecured notes due 2028 in its FY 2022 filing, issuing roughly $2 billion of fixed‑rate, bullet‑maturity debt as part of a $10 billion multi‑series offering (see ORCL 10‑K 2022, pp. 112‑116). In the FY 2023 and FY 2024 filings the same series appears unchanged – the notes remain outstanding with the identical 2.300 % coupon, 2028 maturity and principal amount, and no additional issuances or amendments are disclosed (see ORCL 10‑K 2023, pp. 108‑112; ORCL 10‑K 2024, pp. 109‑113). This continuity shows Oracle’s broader financing strategy of locking in low‑cost, medium‑term funding and maintaining a diversified, stable maturity profile rather than repeatedly refinancing or restructuring its debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the introduction of the 2.300% Notes due 2028 in FY2022 and their continued presence in FY2023 and FY2024, aligning with the ground truth's timeline and structure. However, it introduces specific quantitative details not present in the original answer—namely, the $2 billion issuance amount and $10 billion multi-series offering—which are absent from the ground truth and cannot be verified from the provided knowledge graph. These figures may be accurate in reality but are not supported by the reference answer, reducing quantitative accuracy. (2) The ground truth emphasizes Oracle’s practice of referencing prior notes (like the 2.300% Notes) alongside new issuances (e.g., 4.500% Notes due 2028) in Exhibits 4.14 and 4.16 across years, highlighting a pattern of layered debt issuance. The LLM answer omits mention of these specific exhibits and newer notes like the 4.500% Notes, missing a key element of the multi-hop synthesis. (3) The reasoning about Oracle’s strategy—locking in low-cost, medium-term funding and maintaining a stable maturity profile—is semantically consistent with the ground truth’s interpretation of a consistent, layered financing approach. However, the LLM interprets the lack of amendments as strategic stability, while the ground truth emphasizes the active layering of new debt instruments, suggesting a slightly different nuance. (4) Despite missing some contextual details and introducing unsupported numbers, the LLM captures the core evolution and strategic implication, warranting a correctness score of 7. Quantitative accuracy is penalized due to unverified dollar amounts; qualitative accuracy is high for logical reasoning and entity/year alignment; contextual relevance is strong as the response directly addresses the multi-year pattern and strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 502,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa’s 10‑K filings from 2022 through 2024 all include the same “Certificate of Designations of Series B Convertible Participating Preferred Stock” as an exhibit (listed as Exhibit 4.5 in 2022 and as Exhibit 4.4 in the 2023 and 2024 filings) with no amendment, conversion or redemption disclosed【V_10k_2022.pdf page 111】【V_10k_2023.pdf page 107】【V_10k_2024.pdf page 107】. This unchanged disclosure shows that Visa keeps the Series B class on its books as a dormant but available equity instrument, reflecting a long‑term priority of preserving a flexible, multi‑class capital structure while maintaining the dominance of common equity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Visa's Series B Convertible Participating Preferred Stock treatment remained unchanged from 2022 to 2024, citing the consistent inclusion of the same Certificate of Designations without amendment, which matches the original answer's claim about referencing the June 21, 2016 document. (2) The exhibit numbers are accurately reported: Exhibit 4.5 in 2022 and Exhibit 4.4 in 2023 and 2024, showing attention to detail in document structure across years—this is a minor formatting shift but reflects correct sourcing. There are no numerical values requiring calculation, so quantitative accuracy pertains to exhibit numbers and years, all of which are correct. (3) The reasoning is sound: the LLM infers that the lack of change suggests a strategic choice to maintain capital structure flexibility and preserve a multi-class equity framework, which is a valid interpretation consistent with the ground truth’s emphasis on stability and financing flexibility. The term 'dormant but available' is not in the original but is a reasonable characterization given no conversions or redemptions were disclosed. (4) The only minor gap is that the LLM does not mention the broader context of unchanged Bylaws (2022) or the 2024 Certificate of Incorporation update, which the original answer uses to reinforce the theme of structural stability. While this adds depth to the ground truth, its omission does not invalidate the LLM’s core conclusion. Overall, the answer is factually correct, well-supported by citations, and semantically equivalent in meaning, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 456,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "In its 2022 filing Caterpillar disclosed that it relied on currency‑hedging instruments to mitigate foreign‑exchange risk but that a significant share of its variable‑rate debt and derivatives were still tied to LIBOR, so it formed a cross‑functional team to assess the impact of LIBOR’s phase‑out and to manage the associated interest‑rate and currency‑risk exposures. The 2023 report showed the company had begun issuing new floating‑rate financing on the Secured Overnight Financing Rate (SOFR) and was actively transitioning existing LIBOR‑linked contracts to SOFR while continuing its currency‑hedge program and match‑funding strategy. By the 2024 filing the LIBOR‑to‑SOFR transition was largely completed, the currency‑hedging program remained a core risk‑mitigation tool, and Caterpillar emphasized ongoing monitoring of hedge effectiveness and any residual LIBOR exposure, noting that ineffective hedges could still affect earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar's use of currency hedging instruments is consistently reported across 2022–2024, and the transition from LIBOR to SOFR is accurately described with appropriate timing and context. The formation of a cross-functional team in 2022, the shift to SOFR in 2023, and the near-completion of the transition by 2024 are all factually supported. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are used correctly. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and connects currency hedging with the broader interest rate benchmark transition, correctly distinguishing between currency and interest rate risk management while showing their interplay. (4) The only minor gap is that the LLM emphasizes 'ineffective hedges affecting earnings' in 2024, which is a detail not explicitly highlighted in the ground truth—though it is a reasonable inference from risk disclosures and does not contradict the original. The core evolution of hedging strategy and SOFR transition is accurately captured, making the answer semantically equivalent with excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 373,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "In 2022 Johnson & Johnson insulated its talc exposure by carving out LTL Management LLC, which filed a Chapter 11 petition and was funded through a $2 billion trust that the company recorded as a $2 billion reserve (2022 10‑K). After the original LTL case was dismissed in 2023, J&J re‑filed a second LTL bankruptcy (LTL 2), expanded its funding commitment to roughly a $9 billion reserve and simultaneously pursued appeals, a consensual “pre‑packaged” bankruptcy plan and aggressive tort litigation (2023 10‑K). By 2024 the strategy shifted to a broader pre‑packaged plan and a restructuring that created new Texas entities (Red River Talc, LLC, etc.) filing their own Chapter 11 cases, while the company raised its total talc reserve to about $11.6 billion and kept the $2 billion trust as the core vehicle for settling claims (2024 10‑K).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trajectory of Johnson & Johnson's legal and financial strategy around talc liabilities from 2022 to 2024 and correctly identifies key elements such as the creation of LTL Management LLC, the $2 billion trust, the Chapter 11 filings, and the use of bankruptcy appeals. However, it introduces significant factual inaccuracies, particularly in quantitative claims. The ground truth states that J&J established a $2 billion reserve/trust in 2022, which remained central, but the LLM claims the funding commitment expanded to 'roughly $9 billion' in 2023 and then to '$11.6 billion' in 2024—figures not supported by the original answer. The original makes no mention of a $9 billion or $11.6 billion reserve, nor does it state that the $2 billion trust was supplemented to that extent. These inflated numbers represent major quantitative errors. Additionally, the LLM mentions 'Red River Talc, LLC' and 'new Texas entities' filing Chapter 11 in 2024, which is not referenced in the ground truth. While the original confirms continued appellate efforts and multi-state settlements in 2024, it does not mention a pre-packaged plan or new entities. The reasoning is partially sound in tracking the sequence of bankruptcy filings and appeals, but the synthesis includes fabricated details not present in the source. The contextual relevance is high as the answer addresses the evolution of strategy and ties in financial and legal dimensions. However, due to the significant overstatement of reserves and introduction of unverified entities, the correctness and quantitative accuracy scores are reduced substantially.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 447,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "Adobe introduced the Photography Plan in 2022 as a targeted Creative Cloud bundle—Photoshop, Lightroom and Lightroom Classic—positioned as a more limited, cloud‑based alternative to the full Creative Cloud suite for photographers and photo enthusiasts. By 2023‑2024 the plan was re‑emphasized as a task‑focused, cloud‑first offering within Creative Cloud, with Firefly‑powered generative AI tools (Generative Fill/Expand/Remove, Denoise, People Masking, Lens Blur, etc.) baked into Photoshop and Lightroom and a data‑driven pricing/product‑led growth strategy to draw both professional photographers and hobbyists into the ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All key facts are correct: the Photography Plan launched in 2022 with Photoshop, Lightroom, and Lightroom Classic; it was positioned as a more limited, cloud-based option for photographers; from 2023–2024, Adobe enhanced it with generative AI features powered by Firefly (e.g., Generative Fill, People Masking, Lens Blur, Denoise); and it was strategically re-emphasized within a product-led growth framework. (2) Quantitative accuracy is perfect—dates (2022, 2023–2024), product names, and feature sets are correctly stated with no numerical errors. (3) Multi-hop reasoning is sound: the model synthesizes the evolution across years, connects AI enhancements to strategic positioning, and correctly identifies the plan’s role within the broader Creative Cloud ecosystem. (4) The only reason for not scoring a 10 is a slight compression of the 2023 strategic shift—while the LLM mentions product-led growth and AI features, it doesn’t explicitly note that 2023 was when Adobe began emphasizing Generative Credits as part of the offering, which is a minor omission. However, the inclusion of 'Firefly-powered generative AI tools' and 'data-driven pricing/product-led growth' captures the essence. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent—directly addresses the evolution, positioning, and strategic enhancements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 412,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa’s 10‑K filings from 2022, 2023 and 2024 all list the same exhibit for its Class C common stock – a “Form of specimen certificate for class C common stock of Visa Inc.” filed as an 8‑A (File No. 000‑53572) dated January 28 2009 (2022 shows it as Exhibit 4.3; 2023 and 2024 show it as Exhibit 4.2)【V_10k_2022.pdf†111-L112】【V_10k_2023.pdf†108-L109】【V_10k_2024.pdf†108-L109】. By keeping the certificate format and filing unchanged over three consecutive years, Visa signals a disciplined, continuity‑focused corporate‑governance framework and a commitment to clear, consistent communication with shareholders even as regulatory and market conditions evolve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all dates, exhibit numbers, and filing details are correct: the specimen certificate was indeed filed on January 28, 2009, under Form 8-A, File No. 000-53572, and consistently referenced across 2022–2024. The note about exhibit numbering (Exhibit 4.3 in 2022 vs. 4.2 in 2023 and 2024) is a factual detail not in the original answer but is accurate and adds value. (2) The core factual claim—that Visa has maintained the same specimen certificate without updates—is correct and well-supported. (3) Reasoning is sound: the stability in documentation is correctly linked to consistent corporate governance and investor communication practices. (4) The LLM slightly omits the contrast with other updated governance documents (e.g., the 2024 Certificate of Incorporation revision), which was a key nuance in the original answer that highlighted the specificity of the Class C certificate’s unchanged status. However, this does not undermine the overall correctness. Semantic equivalence is strong, and the answer is contextually complete and relevant. Minor deduction from 10 due to this omission in comparative analysis, but quantitative and qualitative accuracy remain excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 354,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s liability for performance and operating‑cost guarantees fell from $1.109 billion at 12/31/2022 to $1.091 billion at 12/31/2023 and further to $0.993 billion at 12/31/2024【RTX_10k_2023.pdf page 99】【RTX_10k_2024.pdf page 101】. The steady decline shows the company’s exposure to warranty‑related outflows is shrinking, indicating that product reliability and its accrual/ risk‑management practices for commercial‑aerospace contracts are improving and limiting future cash‑flow risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that RTX's collaboration partners' share of financing guarantees was $140M in 2022, $135M in 2023, and $131M in 2024. However, the LLM reports total liabilities of $1.109B, $1.091B, and $0.993B — over 7 times larger than the correct figures. These numbers appear to be misidentified liabilities, possibly conflating performance and operating cost guarantees with other warranty or product liability accruals. (2) The cited values are not equivalent under any reasonable interpretation: $1.109 billion vs $140 million is a massive discrepancy. Even if formatting were an issue, the orders of magnitude do not align. Calculations based on these numbers (e.g., 'steady decline') are numerically accurate within the LLM's incorrect framework but are built on false premises. (3) The multi-hop reasoning fails because the model did not correctly identify the relevant metric from the 10-K filings. While it references RTX_10k_2023.pdf and RTX_10k_2024.pdf, it likely extracted a different liability line item (e.g., general product warranties) rather than 'performance and operating cost guarantees' or 'collaboration partners' share of financing guarantees.' The conclusion about improving risk management parallels the ground truth, but it is unsupported by the actual data cited. (4) The contextual relevance is moderate because the answer addresses the right topic (liabilities related to performance guarantees and risk management in commercial aerospace), uses appropriate terminology, and attempts to interpret trends. However, due to the severe factual inaccuracies in the numbers and misidentification of the metric, the correctness and quantitative accuracy scores are very low. The qualitative reasoning would score higher if based on correct data, but as it stands, the synthesis is flawed at the foundational level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 522,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s lease footnotes in the 2022, 2023 and 2024 10‑Ks all state the same approach: any free‑rent or step‑rent periods are **recognised on a straight‑line basis over the lease’s original term plus any renewal options that the Company is “reasonably certain” to exercise**. The lease term is defined as the **non‑cancelable period plus those certain extensions**, and the right‑of‑use (ROU) asset and lease liability are initially measured from the **discounted future minimum lease payments over that term**. Because the definition of the lease term and the straight‑lining method were unchanged in each filing, the impact of free‑rent periods on ROU‑asset valuations remained consistent from FY 2022 through FY 2024, with no new disclosure or methodological change reported.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Costco's accounting treatment for free-rent periods across fiscal years 2022–2024, correctly stating that the company consistently applied a straight-line basis over the lease term (including reasonably certain renewal options) and used discounted minimum lease payments to measure right-of-use (ROU) assets and lease liabilities. All entities (Costco, fiscal years 2022–2024, lease terms, ROU assets) are correctly identified, and there are no numerical or date inaccuracies—consistent with the ground truth. The reasoning is sound regarding the stability of the core accounting policy. However, the LLM answer omits key qualitative developments in disclosure evolution highlighted in the original answer: specifically, the 2023 clarification on variable lease payments and the 2024 increased emphasis on impairment evaluation related to lease asset valuations in the context of facility relocations or closures. While the core accounting policy did not change, the original answer notes an evolving disclosure context reflecting growing operational complexity, which the LLM answer fails to capture. This omission limits completeness and nuance in the qualitative assessment, particularly in multi-hop synthesis across years. Despite this, the answer remains contextually relevant and quantitatively precise, accurately conveying the consistent application of lease accounting rules.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 397,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "In the 2022 filing Adobe framed AI as an “innovation” that would make PDFs more intelligent and accelerate document productivity, positioning Acrobat as the core of its Document Cloud platform and noting that Adobe Sensei‑driven AI would be embedded in Acrobat‑web and Acrobat‑Sign to expand workflow‑based actions (2022 10‑K, pp. 4‑8). By the 2024 filing the company’s forward‑looking statements again put AI at the centre of its document‑services roadmap and refer to a distinct AI‑powered product brand for its Document Cloud suite, signalling that AI has moved from a feature‑add‑on to a branded capability backed by heightened R&D investment (2024 10‑K, pp. 94‑98).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Adobe's AI strategy from 2022 to 2024 with accurate entity and year references. It correctly notes that in 2022, AI was positioned as an innovation within Acrobat and Document Cloud, with Adobe Sensei integration in Acrobat-web and Acrobat-Sign. In 2024, it accurately states that AI became a central, branded capability, reflecting increased R&D investment. However, the LLM omits the specific branded product name 'Acrobat AI Assistant' mentioned in the ground truth, which is a key detail in the formal product branding evolution. (2) There are no numeric values, dates, or financial figures in either answer that conflict; all timeframes (2022, 2024) are correct and consistently used. The citation of page numbers (pp. 4–8, 94–98) does not affect factual accuracy as they are not part of the core knowledge claim. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and connects AI’s progression from a feature to a branded product, aligning with strategic emphasis and R&D investment. The logic of AI evolving from embedded functionality to a core branded offering is preserved. (4) The answer is contextually fully relevant and semantically close to the ground truth. The omission of the exact product brand name 'Acrobat AI Assistant' prevents a top score in correctness and qualitative accuracy, but the overall trajectory and strategic shift are accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 409,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "Schwab’s pool of client securities used as collateral expanded after the 2022‑23 integration: the fair‑value of securities that could be pledged for margin loans rose from roughly $120 billion in 2022 to about $136 billion in 2023 and remained near that level in 2024, and total collateral pledged to third parties grew from the $31 billion reported in 2021 to roughly $38 billion in 2023 before a modest pull‑back in 2024.  Securities‑lending activity was essentially flat – gross securities loaned stayed around $7 billion and net securities loaned after offsetting borrowed securities hovered near $750 million each year – while the firm cut its client‑secured short‑term credit lines (secured uncommitted lines fell from $950 million in 2023 to $500 million in 2024).  The trend shows Schwab increasingly monetizing client holdings for margin and lending revenue while de‑leveraging its balance sheet by reducing external short‑term borrowing, indicating a shift toward a more self‑funded, lower‑leverage funding strategy even as client leverage stays robust.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces numerical data not present in the original answer or ground truth. (1) Quantitative Accuracy: The LLM claims specific dollar amounts such as $120 billion in 2022, $136 billion in 2023, $38 billion pledged to third parties, and $7 billion in gross securities loans, none of which appear in the original answer. The ground truth explicitly states that 'specific pledged amounts were not quantified' in 2022 and does not provide any dollar figures for collateral or securities lending activity in any year. These numbers are fabricated or hallucinated, severely undermining factual reliability. (2) Completeness: While the LLM attempts to address the evolution of client securities use and balance sheet strategy, it fails to capture the key qualitative disclosures from the original—especially the 2024 clarification that client securities are pledged for listed option contracts cleared by the Options Clearing Corporation and for securities lending collateral requirements. Instead, it invents trends in securities lending and credit lines not supported by the source. (3) Entity Accuracy: The company (Schwab) and general activities (margin lending, securities lending) are correctly identified, and the years 2022–2024 are appropriately referenced. However, the mention of a '2022–23 integration' is unsupported in the original and likely a hallucination. (4) Reasoning: The multi-hop synthesis is flawed. The original answer traces a disclosure evolution—from general permission to pledge, to more detailed processes, to explicit use in specific clearing and lending activities. The LLM instead constructs a narrative around fabricated metrics and balance sheet de-leveraging, concluding a 'self-funded, lower-leverage funding strategy'—a claim not supported by the original, which emphasizes increasing formalization and expansion of client asset use, not firm de-leveraging. (5) Semantic Equivalence: The overall message diverges significantly. The original highlights increasing regulatory and operational use of client assets; the LLM emphasizes quantitative growth and balance sheet reduction. Despite some relevant themes (use of client securities, margin, lending), the factual foundation is incorrect. Thus, the correctness score is low due to pervasive quantitative inaccuracies, even though the general topic and direction of analysis are contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 647,
        "total_tokens": 2182
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "Costco has consistently reported the 1.375 % Senior Notes due June 2027 as a non‑current liability of $1.25 billion in each filing – the note appears in the long‑term debt schedule for 2022, 2023 and 2024 (Note 4‑Debt)【COST_10k_2022.pdf】, 【COST_10k_2023.pdf】, 【COST_10k_2024.pdf】.  While the note’s carrying amount never changed, the company’s overall long‑term debt fell from $6.48 billion (net of a $73 million current portion) in 2022 to $5.38 billion (net of a $1.08 billion current portion) in 2023 and $5.79 billion (net of a $103 million current portion) in 2024, so the 1.375 % notes made up an increasingly larger share of the remaining long‑term debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Costco's 1.375% Senior Notes due June 2027 remained constant at $1.25 billion across 2022–2024 and were consistently classified as non-current (long-term) debt, which aligns with the ground truth. However, it reports incorrect total long-term debt figures: it states $6.48 billion in 2022 (matches ground truth), but then $5.38 billion in 2023 and $5.79 billion in 2024. The ground truth reports long-term debt (excluding current portion) as $6,484 million in 2022, decreasing to $5,794 million in 2024 — but does not provide the 2023 value. The LLM’s inclusion of a $5.38 billion figure for 2023 is unsupported by the ground truth and appears to be an error or hallucination. Additionally, the LLM introduces a $1.08 billion current portion in 2023, which is not mentioned in the original answer and cannot be verified. (2) The $1.25 billion note value is correct and consistently reported. However, the total long-term debt numbers are partially incorrect or unverifiable, especially the 2023 figure. The ground truth emphasizes a decline from $6,484M to $5,794M over three years due to reclassification of the 2.750% notes due 2024, but the LLM misrepresents the trajectory by inserting an intermediate low point in 2023. (3) The reasoning about the note making up an 'increasingly larger share' of long-term debt is plausible but speculative, as the ground truth does not make this claim and the LLM’s underlying data for 2023 is inaccurate. The multi-hop synthesis is partially sound — it connects the stable note value with changing total debt — but relies on flawed quantitative inputs. (4) Scores reflect: correctness docked for significant numerical inaccuracy in 2023 debt figures; quantitative accuracy penalized due to unsupported numbers; qualitative reasoning is logical but based on incorrect data; contextual relevance is high as the response directly addresses the question’s focus on classification and composition evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 536,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "Across the 2022‑2024 10‑Ks Adobe consistently notes a “large number of free online self‑service learning options on learning.adobe.com” as part of its Digital Learning Services portfolio. In the 2022 filing the free resources are presented as one element of a broader learning suite that also includes fee‑based programs and custom learning services, whereas the 2024 filing positions those free options as a core, scalable foundation that is explicitly linked to Customer Success Managers and solution‑specific skills assessments—using the free learning experience to accelerate enterprise adoption and align learning outcomes with customers’ business objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Adobe's free online self-service learning from 2022 to 2024. (1) All factual elements are correct: Adobe consistently offered free online self-service learning via learning.adobe.com as part of its Digital Learning Services; in 2022, it was one component among fee-based and custom services; by 2024, it was positioned as a core, scalable foundation tied to Customer Success Managers and skills assessments. These points align with the ground truth, which notes increasing integration with enterprise success strategies over time. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct and used appropriately. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and connects free learning to enterprise enablement strategies, noting the shift from 'one element' to 'core foundation' and linking it to Customer Success Managers and skills assessments—consistent with the ground truth’s emphasis on maturing integration. (4) The only minor limitation is that the LLM omits explicit mention of 2023, which the original answer includes as a transitional year reinforcing the importance of free learning. However, this does not detract significantly from the overall correctness, as the key comparison between 2022 and 2024 is well-supported. Wording differs but semantic meaning matches. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 440,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA reported roughly $1.25 billion of 2.00 % Notes Due 2031 in its 2022 filing, and the same $1.25 billion figure appears in the 2023 and 2024 10‑Ks (NVDA 2022 pp. 78‑82; NVDA 2023 pp. 65‑69; NVDA 2024 pp. 70‑74). The flat exposure over three years shows the company has kept this low‑cost, long‑term debt unchanged, using it as a stable financing anchor while relying on strong operating cash flow and other sources to fund its rapid AI‑driven revenue growth—evidence of a disciplined, low‑leverage debt‑management strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and increased to $1.25 billion in 2024. The LLM incorrectly states that the amount was $1.25 billion in all three years, which misrepresents the entire trend. This error invalidates the conclusion about a 'flat exposure' and undermines the analysis of debt strategy. (2) The numbers are significantly off: 2022 is overstated by $50 million ($1.25B vs $1.20B), 2023 is overstated by $193 million ($1.25B vs $1.057B), and only 2024 matches the ground truth. These are not minor rounding differences but material misstatements. (3) The multi-hop reasoning fails because the model did not detect the fluctuation pattern (decrease then increase), which is central to understanding NVIDIA's dynamic debt management. Instead, it infers a 'disciplined, low-leverage' strategy based on false stability, missing the nuance of active capital structure adjustments. (4) While the answer addresses the question's structure and discusses long-term debt strategy in the context of AI growth (hence moderate contextual relevance), the factual foundation is flawed. The incorrect data leads to an invalid conclusion, severely limiting qualitative and quantitative accuracy. A correct analysis would have noted the reduction in 2023 possibly for refinancing or optimization, followed by reinvestment in long-term debt in 2024 to support AI infrastructure—precisely the opposite of a static strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 440,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 Form 10‑K (pages 115‑119) that it was launching a multi‑year, enterprise‑wide initiative to integrate, simplify and standardize HR, IT, procurement, supply‑chain and finance processes to grow its financial shared‑service capabilities and harmonize financial systems. The same description reappears unchanged in the 2023 filing (pages 116‑120) and again in the 2024 filing (pages 117‑121), with each year emphasizing that the effort “has and will continue to align and streamline the design and operation of its financial control environment.” This steady, ongoing rollout signals that J&J is deliberately prioritizing financial‑process standardization and a tightly aligned control environment as a core strategic focus across the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative was indeed launched in 2022 and consistently reported in the 2022, 2023, and 2024 10-K filings, with identical or nearly identical language emphasizing integration, simplification, and standardization of financial processes and systems. The initiative includes finance among other functions (HR, IT, etc.), and the goal of aligning and streamlining the financial control environment is accurately cited across years. (2) Quantitative accuracy is perfect: the years (2022–2024) are correct, and no numerical values (e.g., dollar amounts, percentages) are present that could introduce error. Page numbers (115–119, 116–120, 117–121) are specific and plausible, though not part of the ground truth; they do not contradict it and reflect realistic document referencing. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the evolution of the initiative across three years, noting the consistency of messaging and interpreting it as a sign of strategic continuity. The conclusion that this reflects a deliberate, proactive focus on standardization and control environment alignment matches the ground truth’s interpretation. (4) The only minor deviation is that the original answer clarifies the initiative was *not* in response to internal control deficiencies, which the LLM omits. This is a small but contextually relevant point that slightly weakens the completeness of the qualitative reasoning. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 453,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "Costco’s description of the competitive set has changed little – the 2022 10‑K says it “also compete with other warehouse clubs, including Walmart’s Sam’s Club and BJ’s Wholesale Club” (2022 p.5‑6). In the 2023 and 2024 filings the same sentence is retained but a geographic qualifier is added, stating it competes with “Walmart’s Sam’s Club and BJ’s Wholesale Club in the U.S.” (2023 p.6; 2024 p.6). The strategic emphasis on Kirkland Signature is unchanged across all three years: each filing notes that the private‑label brand is “high quality, offered at prices that are generally lower than national brands, helps lower costs, differentiates our merchandise offerings, and generally earns higher margins,” and that Costco “expects to continue to increase the sales penetration of our private‑label items” (2022 p.8‑9; 2023 p.8‑9; 2024 p.8‑9).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its citation of filing language and page numbers, and correctly identifies that Costco consistently names BJ's Wholesale Club as a competitor across 2022–2024, with a minor geographic qualifier added in later years. It accurately quotes the consistent description of Kirkland Signature as 'high quality, offered at prices that are generally lower than national brands,' and notes the strategic goals of cost reduction, differentiation, and higher margins. However, the LLM fails to capture the nuanced evolution in tone and strategic emphasis highlighted in the ground truth. Specifically, the original answer notes a shift in 2024 toward a 'stronger tone around differentiating our merchandise offerings' in competitive metropolitan markets, suggesting a responsive strategic refinement due to pressure from BJ's. The LLM incorrectly asserts that the 'strategic emphasis... is unchanged across all three years,' which contradicts the ground truth's observation of evolving language signaling increased focus on differentiation. While the core description of Kirkland Signature remains stable, the LLM overlooks the qualitative shift in framing—particularly the growing emphasis on differentiation in dense markets and the 2023 mention of sustainability-linked brand loyalty (even if not directly tied to Kirkland). This omission represents a failure in multi-hop qualitative reasoning, as the model does not synthesize subtle shifts in strategic narrative across years. Quantitatively, there are no errors—filings, pages, and quoted text are correctly cited. Contextually, the response is highly relevant, directly addressing the question with primary source evidence. However, the lack of recognition of evolving strategic tone reduces its qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 493,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "Charles Schwab’s U.S. state‑and‑municipal securities holdings fell from **$638 million at year‑end 2022** to **$579 million at year‑end 2023**, and then **remained at $579 million at year‑end 2024** (2022 note showing $638 m; 2023 and 2024 notes showing $579 m)【SCHW_10k_2022.pdf p. 52】【SCHW_10k_2023.pdf p. 111】【SCHW_10k_2024.pdf p. 48】.  In each filing the MD&A stresses that “substantially all securities in the investment portfolios were rated investment grade” (2022 MD&A referencing 2021; 2024 MD&A referencing 2024)【SCHW_10k_2022.pdf p. 50】【SCHW_10k_2024.pdf p. 46】, revealing a fixed‑income strategy focused on high‑quality, low‑credit‑risk assets to preserve capital and maintain liquidity rather than pursuing higher‑yield, lower‑quality securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Schwab disclosed a $638 million investment in U.S. State and Municipal Securities in 2023, not 2022. The LLM incorrectly states that the amount was $638 million in 2022 and declined to $579 million in 2023 and 2024. There is no mention in the ground truth of a $579 million figure or any decline, so this data is unsupported and contradicts the original answer. (2) The quantitative inaccuracies are severe: the LLM fabricates a downward trend with specific dollar amounts ($638M → $579M) that do not appear in the ground truth. The original answer only confirms a $638M allocation in 2023 and no specific figure for 2024 beyond a reaffirmation of investment-grade focus. The citation of exact figures across three years with a consistent decline is entirely inconsistent with the ground truth. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies the emphasis on investment-grade quality across years, it misaligns the timeline and invents numerical trends not present in the source data. The synthesis fails because it builds on incorrect financial figures. (4) Despite the factual errors, the LLM captures the qualitative theme of a conservative, investment-grade-focused fixed income strategy, which addresses part of the question’s intent. This prevents a score of 0. However, the core quantitative evolution is wrong, severely undermining the answer’s reliability. The contextual relevance is moderate because the discussion of credit quality aligns with the question, but the numerical backbone is false.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 447,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s maximum‑potential liability for commercial‑aerospace customer‑financing guarantees fell from $304 million in 2022 to $288 million in 2023 and to $274 million in 2024【RTX_10k_2023.pdf†L84-L89】【RTX_10k_2024.pdf†L84-L89】.  The portion attributable to collaboration partners also declined – $140 million in 2022, $135 million in 2023 and $131 million in 2024【RTX_10k_2023.pdf†L90-L93】【RTX_10k_2024.pdf†L90-L93】 – indicating that RTX is steadily shrinking its overall exposure while modestly reducing the amount of risk it shifts to partners, a sign of a cautious risk‑transfer strategy that retains more risk in‑house as the total commitment contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collaboration partners' share of RTX's commercial aerospace customer financing guarantees as $140M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. These values show a consistent downward trend, which the model accurately characterizes. The LLM also correctly identifies the overall decline in RTX’s maximum potential liability ($304M to $288M to $274M), which, while not part of the ground truth, is factually accurate and adds context without contradicting the original answer. (2) All numeric values are correct and properly cited with document references. Calculations (year-over-year declines) are implied and accurate: $5M drop from 2022 to 2023 and $4M from 2023 to 2024 in partners’ share, consistent with a slowing but persistent reduction. (3) The multi-hop reasoning is sound: the model synthesizes data across two years of 10-K filings (2023 and 2024) and correctly infers that the declining partner share indicates reduced risk transfer. It concludes that RTX is retaining more risk in-house, which aligns with the ground truth’s interpretation of reduced reliance on third-party risk sharing. (4) The only minor shortcoming is that the LLM does not mention the ground truth point about fair market values of guaranteed assets being sufficient to cover the guarantees, which adds a layer of risk management conservatism. This omission slightly reduces completeness but does not affect the core correctness. Otherwise, the answer is factually precise, contextually relevant, and semantically equivalent in its key claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 442,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "In 2022 Adobe described Frame.io as a cloud‑native collaboration platform that handled still images, design files and PDFs and was directly integrated only with Premiere Pro and After Effects, with a “Camera‑to‑Cloud” feature for uploading footage. By 2023 the platform’s scope had broadened to support full video‑production use cases (casting, location scouting, marketing) and it was also integrated with Photoshop, Lightroom and Workfront, positioning Frame.io as a central hub for video‑centric review and approval. In the 2024 filing Adobe further embedded Frame.io in its ecosystem—making it available through Adobe GenStudio alongside Express and Firefly Services—so it now serves as a scalable, end‑to‑end content‑production workflow engine across multiple Creative Cloud apps.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments from 2022 to 2024. (1) Correct elements: In 2022, Frame.io was integrated with Premiere Pro and After Effects, supported still images, design files, and PDFs, and had Camera-to-Cloud functionality—accurately reflected. By 2023–2024, integration expanded to Photoshop, Lightroom, and Workfront, and its role broadened into casting, location scouting, and marketing—correctly captured. The evolution into an end-to-end workflow platform is also accurately conveyed. (2) Quantitative accuracy: All years (2022, 2023, 2024) are correctly used and matched to appropriate developments; no numerical errors. (3) Reasoning: The multi-hop synthesis across years and integration points is sound. However, a minor inaccuracy exists: the original answer states that Frame.io was first listed as a trademark in 2022 (indicating acquisition/branding alignment), whereas the LLM answer presents it in 2022 as already a 'cloud-native collaboration platform' with integrations—slightly advancing the integration timeline. Additionally, the mention of 'Adobe GenStudio' and integration with 'Express and Firefly Services' in 2024 is not present in the ground truth and may be speculative or incorrect, introducing a small factual overreach. (4) Despite this, the core trajectory—expanding integrations and workflow role—is correct, warranting a high score. The answer is contextually excellent, fully addressing the question’s dimensions: file types, app integrations, and workflow role over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 431,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "Lockheed Martin identified the VH‑92A Marine One transport helicopter as one of RMS’s major programs in its 2022 filing (LMT_10k_2022.pdf p.48) and again in the 2023 filing (LMT_10k_2023.pdf p.2‑6), but the 2024 10‑K noted that higher CH‑53K production was “partially offset by lower volume on the VH‑92A program” (LMT_10k_2024.pdf p.38). This shift—from a prominently highlighted program to a lower‑volume, offsetting factor—shows the VH‑92A remains strategically vital for the Marine One mission, yet its production is being managed as a steady‑state, non‑growth driver within the Rotary and Mission Systems segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that the VH-92A was listed as a major program in 2022 and 2023 (citing specific filings and page numbers), and accurately notes the 2024 shift where lower VH-92A volume was mentioned as offsetting higher CH-53K production. These details are factually correct and supported by the source documents. (2) There are no numeric values (e.g., dollar amounts, units, percentages) in either answer, so quantitative accuracy is not compromised; all dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly infers a shift in production emphasis, and interprets the strategic implication—that while the program remains vital, it is no longer a growth driver. This goes beyond repetition and offers insight consistent with the ground truth’s conclusion of 'stable, long-term commitment.' (4) The only minor gap is that the LLM does not explicitly mention the broader context from the original answer—such as the program being sustained alongside other key platforms like Black Hawk or amid increased focus on Aegis and LCS. However, this omission does not undermine the core correctness. The LLM’s characterization of the program as 'strategically vital' yet in 'steady-state' production captures the essence of the multi-year progression. Wording differs slightly but semantic equivalence is maintained. No factual errors; excellent contextual relevance and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 424,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "From the 2022 10‑K, MDLZ reported that sales‑ and media‑marketing restrictions were already in force in a number of jurisdictions, noting that over 25 European‑Union countries had adopted extended‑producer‑responsibility (EPR) rules and that emerging markets such as India and Vietnam were only beginning to contemplate similar measures. By the 2023 filing the company said many EU Member States had moved from voluntary to mandatory marketing and EPR regulations and that emerging markets were progressing toward actual implementation, expanding the geographic reach and tightening the rules. The 2024 filing confirms that the number of EU jurisdictions with mandatory marketing and packaging restrictions has grown further and that countries like India, Vietnam, Indonesia and the Philippines are actively adopting comparable restrictions, reflecting a broader scope and higher regulatory stringency across both the EU and emerging markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of regulatory stringency and geographic scope from 2022 to 2024, particularly in the EU and emerging markets. In 2022, it accurately notes that over 25 EU countries had adopted EPR policies and that India and Vietnam were contemplating similar measures—consistent with the original answer. By 2023, the shift from voluntary to mandatory regulations in the EU and progress in emerging markets is correctly captured. In 2024, the LLM correctly observes expanded mandatory restrictions in the EU and active adoption in countries like India, Vietnam, Indonesia, and the Philippines, which matches the ground truth’s emphasis on continued global spread, especially in Southeast Asia. (2) Quantitatively, the reference to 'over 25 EU countries' is consistent with the original answer. While the LLM adds Indonesia and the Philippines in 2024—specific countries not named in the ground truth—the original does state that Southeast Asia was actively considering plastic bans or taxes, so this expansion is contextually reasonable and does not contradict. (3) The multi-hop reasoning across years and regions is sound: the LLM synthesizes changes over time and across geographies, correctly inferring increasing stringency and broader reach. (4) The answer is contextually excellent, directly addressing the evolution in both geographic scope and regulatory stringency as required. The only minor deviation is the inclusion of two additional countries (Indonesia, Philippines) not explicitly named in the ground truth, but since they are part of Southeast Asia and the trend described is accurate, this does not constitute a factual error. Overall, the answer is factually correct, well-structured, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 499,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Microsoft’s 3.700 % senior notes due 2046 are listed in the Eleventh Supplemental Indenture (Exhibit 4.14) in each of the three filings and are reported as long‑term debt with no redemption, refinancing or re‑classification disclosed in the 2022, 2023 or 2024 10‑K (see MSFT_10k_2022 p.104; MSFT_10k_2023 p.104; MSFT_10k_2024 p.104). The unchanged treatment across the three years shows Microsoft’s intent to retain long‑dated, fixed‑rate notes, locking in low borrowing costs and preserving a stable, flexible long‑term capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Microsoft's 3.700% Notes due 2046 are consistently referenced in the Eleventh Supplemental Indenture (Exhibit 4.14) across the 2022, 2023, and 2024 10-K filings, with no changes disclosed. The specific page references (p.104 in each filing) support the claim and match the knowledge base. (2) Quantitative accuracy is perfect: the interest rate (3.700%), maturity year (2046), and document name (Eleventh Supplemental Indenture) are all correct. No calculations are required, but the consistency across years is accurately noted. (3) The reasoning is sound: the LLM correctly infers that the unchanged treatment reflects a strategy of maintaining long-dated, fixed-rate debt to lock in low borrowing costs and ensure capital structure stability. This matches the ground truth's interpretation about predictable debt servicing and confidence in long-term cash flows. (4) The only minor shortcoming is that the LLM does not explicitly mention the strategic implication of viewing these notes as a 'core component' of the capital structure, slightly reducing qualitative depth. However, the essence is preserved. The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 371,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "Microsoft’s 2.000 % senior notes due 2023 were first disclosed in the Eleventh Supplemental Indenture (Exhibit 4.14, dated Aug 8 2016) and appear as a 2023 maturity in the 2022 10‑K (see MSFT_10k_2022.pdf pp. 103‑107). By the 2023 10‑K the same indenture is still listed but the notes are shown as a near‑term maturity that is being retired, and the later supplemental indentures (Twelfth‑Fourteenth, Exhibits 4.15‑4.17) no longer contain that series—so the 2024 10‑K omits the 2.000 % notes, with the debt maturity profile now dominated by newer, longer‑dated issuances (e.g., 2.400 % due 2022, 2.875 % due 2024, 2.525 % due 2050) (see MSFT_10k_2023.pdf and MSFT_10k_2024.pdf pp. 103‑107).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It claims the 2.000% Notes due 2023 were omitted in the 2024 10-K, but the original answer states they were still listed in Exhibit 4.14 in 2024, indicating continued disclosure post-maturity. This is a major factual error. (2) The LLM incorrectly states that the Twelfth-Fourteenth Supplemental Indentures (Exhibits 4.15–4.17) no longer contain the series and implies the debt was retired, but the ground truth confirms the notes remained in filings through 2024. (3) The LLM references a '2.400% due 2022' note in the 2024 filing, which is chronologically impossible and factually incorrect—this maturity would have already passed and should not appear as an active note in later years. (4) The claim that the 2024 10-K omits the 2.000% notes directly contradicts the ground truth, which emphasizes their continued presence in disclosures even after maturity. (5) While the LLM correctly identifies the initial issuance under the Eleventh Supplemental Indenture (Exhibit 4.14, Aug 8, 2016) and their presence in the 2022 10-K, it fails the multi-hop synthesis by misrepresenting the evolution across all three years. The reasoning is flawed because it assumes retirement based on maturity date without acknowledging possible rollovers, delayed maturities, or disclosure requirements for recently matured debt. The contextual relevance is moderate because it addresses the right documents and structure, but the core conclusion about debt removal is incorrect. Quantitative accuracy is partially preserved for early years but fails in 2024 with incorrect instrument references. Overall, the answer misrepresents the key evolution of the debt instrument across the three filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 479,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Medtronic’s non‑employee RSU awards have not been altered in the three most recent 10‑K filings. In the 2022 filing (pages 113‑117) the agreement is shown as Exhibit *10.42 and is described as a “Form of Non‑Employee Restricted Stock Unit Award Agreement under Amended and Restated 2013 Stock Award and Incentive Plan.” The same Exhibit *10.42 and the same 2013‑plan reference appear in the 2023 filing (pages 111‑115) and again in the 2024 filing (pages 111‑115) — indicating that the underlying stock incentive plan for non‑employee RSU awards has remained the 2013 Stock Award and Incentive Plan throughout 2022‑2024. 【*10.42】",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor discrepancy in exhibit number and lacks some nuance in describing the plan's evolution. (1) Quantitatively, the years (2022–2024), plan name (Amended and Restated 2013 Stock Award and Incentive Plan), and consistency across filings are accurately reported. However, the LLM cites Exhibit *10.42 in all three years, while the ground truth specifies Exhibit 10.45 for 2022—this is a factual error, though minor given that exhibit numbers are administrative labels and do not affect the substance. (2) The answer correctly identifies that the same form agreement and underlying plan were used across all three years, confirming continuity. (3) Qualitatively, the reasoning is sound: it correctly synthesizes that the form and plan remained unchanged, which addresses the multi-hop requirement of comparing across years and linking agreements to incentive plans. However, it misses the ground truth’s insight that the plan had been amended (e.g., effective December 8, 2017) even though the reference name remained consistent—this nuance about amendments reflects a deeper understanding of plan evolution that the LLM omits. (4) Contextually, the response is fully relevant, directly addressing how the agreements evolved (or did not evolve) and which plans were referenced. Overall, the answer is factually strong with only minor omissions and one exhibit number inaccuracy, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 412,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ’s non‑U.S. pension plans held buy‑in annuity policies for ≈ 17 % of plan assets in 2022, slipped to ≈ 16 % in 2023, and rose back to ≈ 17 % in 2024 (2022 = 17 %; 2023 = 16 %; 2024 = 17 %)【MDLZ_10k_2022.pdf pp 118‑119】【MDLZ_10k_2024.pdf pp 101‑103】. The near‑steady share—only a modest dip and then a rebound—shows the company is maintaining a consistent reliance on buy‑in annuities to transfer and hedge international pension liabilities, underscoring a deliberate liability‑management strategy that balances risk mitigation with flexibility in its global plan asset mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that MDLZ's allocation to buy-in annuity policies decreased from 17% in 2022 to 16% in 2023 and was effectively discontinued by 2024 due to a shift to fair value estimation methods. However, the LLM claims the allocation rebounded to 17% in 2024, which directly contradicts the ground truth. This error fundamentally misrepresents the trend. (2) Quantitative accuracy is low: while the 2022 (17%) and 2023 (16%) figures are correct, the 2024 figure is wrong—the allocation did not rise back to 17%, but rather was discontinued. The LLM incorrectly reports a rebound that did not occur. (3) The multi-hop reasoning is flawed. The LLM fails to recognize the strategic shift in valuation methodology (to fair value estimation) in 2024, which is a key part of the company's liability management evolution. Instead, it infers continued reliance on annuities, which contradicts the actual de-risking and restructuring strategy. The cited documents (MDLZ_10k_2024.pdf pp 101-103) likely contain the discontinuation information, which the LLM either misread or ignored. (4) Contextual relevance is moderate because the answer addresses the right topic (buy-in annuities in non-U.S. pension plans) and time frame, but the incorrect trend leads to a completely opposite interpretation of MDLZ's liability management strategy. The conclusion about 'consistent reliance' and 'balancing risk mitigation with flexibility' is unsupported and misleading given the actual discontinuation of the instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 435,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft’s 2.000 % notes due 2023 were first created in the Eleventh Supplemental Indenture (dated August 8 2016) and are listed as an outstanding series in both the FY 2022 and FY 2023 10‑K filings — see the “Eleventh Supplemental Indenture … 2.000 % Notes due 2023” entry on page 104 of each report [MSFT_10k_2022.pdf:104] [MSFT_10k_2023.pdf:104]. By FY 2024 the notes had reached their scheduled maturity and no longer carry a balance, showing that Microsoft issues low‑coupon, medium‑term debt and then retires it as it matures, preserving a low‑cost, staggered‑maturity long‑term debt profile [MSFT_10k_2024.pdf:104].",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error regarding the status of Microsoft's 2.000% Notes due 2023 in the FY 2024 report. The original answer (ground truth) states that the notes were still disclosed in the 2024 10-K, indicating they remained on the books through the 2024 reporting period despite approaching maturity. However, the LLM incorrectly claims that 'by FY 2024 the notes had reached their scheduled maturity and no longer carry a balance,' which contradicts the ground truth. This misrepresents Microsoft's debt management strategy, as the persistence of the notes in disclosures suggests no early retirement or payoff, not a deliberate maturity and retirement as implied. The dates (August 8, 2016), interest rate (2.000%), and exhibit references (Exhibit 4.14, page 104) are correctly cited across years, supporting quantitative accuracy for those elements. The reasoning about a 'staggered-maturity' strategy is plausible but based on flawed evidence, weakening qualitative accuracy. The answer is contextually relevant and addresses the multi-part question about evolution and strategy, but the core conclusion is undermined by the incorrect assumption about note retirement in 2024. Thus, while some facts are correct, the key inference fails, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 363,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "In the 2022 Form 10‑K Microsoft disclosed the 4.000 % Notes due 2021 as part of **Exhibit 4.6 – the “Third Supplemental Indenture”** (which also covered 2.500 % notes due 2016 and 5.300 % notes due 2041). The 2023 and 2024 10‑Ks repeat the same reference to Exhibit 4.6, indicating that the notes have not been redeemed, re‑issued or otherwise amended and remain governed by that supplemental indenture. Thus, across all three filings the 4.000 % Notes due 2021 are treated as a standing component of Microsoft’s senior unsecured debt series under the original 2009 base indenture and its series of supplemental indentures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All numeric values—interest rate (4.000%), maturity year (2021), and reference to the Third Supplemental Indenture dated February 8, 2011 (implied via Exhibit 4.6)—are correct. The mention of co-listed notes (2.500% due 2016 and 5.300% due 2041) matches the original answer. (2) Quantitative accuracy is perfect: percentages and years are correctly reported, and no calculations were required. (3) The reasoning is sound: the LLM correctly infers that the consistent inclusion in Exhibit 4.6 across 2022–2024 indicates no amendment, redemption, or reissuance, demonstrating proper multi-hop synthesis across filings. It correctly situates the notes under the 2009 base indenture framework. (4) The only minor omission is that the original answer notes Microsoft introduced new debt instruments under subsequent supplemental indentures (e.g., 2.375% Notes due 2023 in 2023), which adds context about the broader debt structure evolution. The LLM answer does not mention these new issuances, slightly reducing completeness in addressing the 'broader debt instrument structure' aspect. However, the core focus—treatment of the 4.000% Notes due 2021—is accurately and consistently conveyed. Semantic equivalence is strong, and the answer is highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 370,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 Medtronic’s 10‑K notes to shareholders’ equity repeatedly state that the company is authorized to issue 40 000 Euro Deferred Shares with a €1.00 par value, and that at each fiscal‑year‑end – April 29 2022, April 28 2023 and April 26 2024 – no Euro Deferred Shares were issued or outstanding (MDT_10k_2022.pdf p.79; MDT_10k_2023.pdf p.79; MDT_10k_2024.pdf p.79). The unchanged disclosure and zero balance each year indicate that Medtronic does not use Euro Deferred Shares as a financing vehicle, preferring to rely on ordinary shares, share‑repurchase programs and other equity instruments, which reflects a capital‑structure strategy aimed at keeping the equity base simple and avoiding dilution from deferred‑share issuances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the authorized amount of 40,000 Euro Deferred Shares with €1.00 par value is correctly stated, and the fiscal year-end dates (April 29, 2022; April 28, 2023; April 26, 2024) align with Medtronic’s reporting cycle. The consistent zero balance for issued and outstanding shares across all three years is accurately reported. (2) The answer is complete, addressing both parts of the question: it details the evolution (or lack thereof) in disclosures from FY2022 to FY2024 and interprets the strategic implications of the zero issuance. (3) Entity accuracy is perfect: Medtronic (MDT) is correctly identified, the financial instrument (Euro Deferred Shares) is accurately named, and the cited document pages (p.79 for each 10-K) are consistent with the source data. (4) The reasoning is sound and constitutes valid multi-hop synthesis across three annual filings. The conclusion that Medtronic does not use this instrument as part of its capital structure strategy—preferring ordinary shares and share repurchases—is a logical inference supported by the unchanged disclosures over time. The LLM adds contextually appropriate insight about maintaining a simple equity base and avoiding dilution, which is semantically aligned with the ground truth’s interpretation of strategic preference or lack of market demand. Minor wording differences (e.g., 'financing vehicle' vs 'capital structure strategy') do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 438,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the same exhibit appears – Exhibit 4.6, the “Third Supplemental Indenture for 2.500 % Notes due 2016, 4.000 % Notes due 2021, and 5.300 % Notes due 2041, dated February 8 2011.” The description of the 4.000 % Notes due 2021 is identical in each filing, with no amendment or re‑classification noted. This consistency indicates that Microsoft has treated the 4.000 % Notes due 2021 as a stable, unchanged component of its debt portfolio, maintaining the same reporting treatment through each reporting year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers, dates, and percentages are correct: the 4.000% Notes due 2021, the Third Supplemental Indenture, and the date of February 8, 2011, are accurately cited. The exhibit number (4.6) is also correct. (2) The answer correctly notes that the same exhibit appears across all three years (2022–2024), with no amendments or reclassifications, which matches the ground truth assertion of no material changes. (3) The reasoning is sound: the consistency in disclosure indicates stable treatment of the debt instrument, implying it was likely matured or fully accounted for. The only minor shortcoming is that the LLM does not explicitly state that the Notes were 'matured' or that no further actions were required—this inference is implied but not directly drawn, which slightly reduces qualitative accuracy. However, the core multi-hop synthesis—linking consistent disclosure across years to static treatment of the debt—is logically sound. (4) The answer is fully contextually relevant, addressing both the evolution (or lack thereof) in disclosure and the implication of that consistency. Overall, the answer is factually correct and semantically equivalent to the ground truth, with only a slight omission in interpretive depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 368,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin’s 10‑K filings for 2022, 2023 and 2024 all state that the company has, to date, purchased “total contracts for approximately **$11.6 billion**” of defined‑benefit pension obligations (see 2022 p. 58‑62; 2023 p. 17‑21; 2024 p. 45‑49). None of the three reports disclose any additional pension‑risk‑transfer purchases for the years 2022, 2023 or 2024, indicating that the cumulative transferred amount remained unchanged. This flat pattern suggests that after completing its major risk‑transfer program (including a $4.9 billion transfer in 2021), Lockheed Martin is now concentrating on managing the remaining pension liabilities rather than pursuing further large‑scale transfers, reflecting a long‑term liability‑reduction strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer is factually incorrect in its core conclusion: it claims that the $11.6 billion figure remained unchanged from 2022 to 2024 and that no additional transfers occurred, directly contradicting the ground truth, which states that Lockheed Martin continued evaluating and reaffirmed its intent to pursue additional transfers in 2023 and 2024. While the $11.6 billion cumulative amount transferred since 2018 is correctly cited from the 2022 filing, the LLM incorrectly interprets the lack of new dollar amounts in 2023 and 2024 filings as evidence of no further activity, when the ground truth indicates ongoing strategic intent. (2) Quantitatively, the $11.6 billion and references to prior transfers (e.g., $4.9 billion in 2021) are accurate and consistently reported across filings, earning high marks for number accuracy. However, the answer fails to mention the $69 million in annual PBGC premium savings disclosed in 2022, a key indicator of liability reduction impact. (3) The multi-hop reasoning is flawed: instead of synthesizing the evolution of strategy through stated intentions (2023 evaluation, 2024 reaffirmation), the model incorrectly infers stagnation from silence on new dollar amounts. This misrepresents the trend and leads to an erroneous conclusion about strategy shifting to 'managing remaining liabilities' rather than continuing active risk transfer. (4) Contextual relevance is moderate—the answer addresses pension transfers and long-term strategy, but the incorrect inference undermines the response. The model captures the context but fails in accurate interpretation, resulting in a misleading assessment of Lockheed Martin’s liability management trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 461,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "In the 2022 Form 10‑K the 0.125 % Notes due 2029 are disclosed as Exhibit 4.23, which incorporates the note form filed in the company’s September 18 2020 8‑K 【source: Exhibit 4.23 – “Form of Note for 0.125% Notes due 2029 … filed on September 18, 2020”】. The 2023 Form 10‑K updates the reference to Exhibit 4.31, pointing to the same note form but now tied to the March 9 2021 8‑K filing 【source: Exhibit 4.31 – “Form of Note for 0.125% Notes due 2029 … filed on March 9, 2021”】, and the 2024 Form 10‑K continues to list the note (still Exhibit 4.31) with its original 0.125 % rate and 2029 maturity unchanged. This progression shows that Coca‑Cola has consistently treated the 0.125 % Notes as a stable, long‑term senior unsecured debt instrument, with no material amendment to its terms or classification across the three annual reports.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness. (1) It claims the 2022 10-K lists the note as Exhibit 4.23 incorporating the September 18, 2020 8-K, which aligns partially with the ground truth. However, the ground truth states the note appears in *both* Exhibit 4.23 and 4.31 in 2022 and 2023, not just one per year. The LLM incorrectly implies a shift from Exhibit 4.23 (2022) to 4.31 (2023), suggesting an update in documentation, when in fact both exhibits coexisted across years and referenced the same underlying Exhibit 4.4 filings. (2) The LLM incorrectly states the 2023 and 2024 references are tied to the March 9, 2021 8-K filing, while the ground truth emphasizes that *both* the September 2020 and March 2021 filings are consistently referenced across all years via the same Exhibit 4.4 linkage. There is no evidence of an 'update' in source documentation as implied. (3) While the LLM correctly identifies the consistent interest rate (0.125%) and maturity (2029), and correctly infers stable treatment of the debt instrument, its reasoning is based on flawed exhibit progression. (4) The multi-hop synthesis is partially sound—linking disclosures across years—but fails to accurately represent the consistency of source references. The conclusion about stable structuring is semantically aligned with the ground truth, but the path to that conclusion is factually flawed. Quantitative accuracy is low due to incorrect dates and exhibit mappings. Qualitative accuracy is moderate due to correct identification of the instrument and overall stability, but flawed reasoning about exhibit evolution. Contextual relevance is high as the response directly addresses the question’s focus on disclosure evolution and consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 481,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s accrued liability for performance and operating‑cost guarantees fell from **$1.109 billion at 12/31/2022** (Note 16, 2023 10‑K) to **$1.091 billion at 12/31/2023** and then to **$0.993 billion at 12/31/2024** (Note 16, 2024 10‑K). The steady decline shows a modest reduction in the amount set aside for long‑term product‑performance and operating‑cost risks, suggesting that fewer new guarantees are being issued, settlements are increasing and/or product reliability is improving, thereby lowering the company’s exposure to long‑term performance risk in its commercial‑aerospace business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states that RTX's liabilities related to performance and operating cost guarantees refer specifically to the 'collaboration partners' share of financing guarantees,' which decreased from $141M (2022) to $135M (2023) to $131M (2024). In contrast, the LLM claims RTX's total accrued liability was $1.109B in 2022, $1.091B in 2023, and $0.993B in 2024—amounts that are over seven times larger and not supported by the ground truth. These figures do not appear in the original knowledge base and represent a significant factual error. (2) The numbers provided by the LLM are not consistent with the ground truth: $1.109B vs $141M is a ~687% overstatement. Even if the LLM were referring to a broader liability category, the original answer explicitly states that 'the company's own liabilities' were not explicitly stated,' making the LLM’s precise figures suspect. There is no indication in the ground truth of a decline from over $1B to $993M. (3) The multi-hop reasoning is partially sound—the LLM attempts to interpret trends and infer implications about product reliability and risk exposure—but it does so on entirely incorrect data. The conclusion that 'fewer new guarantees are being issued, settlements are increasing and/or product reliability is improving' is speculative and not supported by the actual data, which shows only a small, steady decline in partner-related financing guarantees. (4) The contextual relevance is moderate because the LLM addresses the right topic (liabilities for performance and operating cost guarantees) and attempts to analyze trend implications for commercial aerospace risk. However, due to the severe quantitative inaccuracies and misrepresentation of the liability amounts, the overall correctness score is low. The qualitative score reflects some correct conceptual framing but flawed execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 525,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic still uses the Black‑Scholes model, but between 2022 and 2024 it tightened the inputs: volatility was raised from 23.04 % (2022) to 24.29 % (2024), the risk‑free rate climbed from 0.90 % to 4.16 %, dividend yield increased from 1.95 % to 3.18 %, and the assumed option life grew slightly from 6.0 to 6.1 years. These higher‑risk assumptions reduced the weighted‑average fair value of options granted from $22.83 in 2022 to $18.49 in 2024, signalling a more conservative view of stock‑price uncertainty and a tighter equity‑compensation risk model.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) The numbers provided—such as volatility increasing from 23.04% to 24.29%, risk-free rate rising from 0.90% to 4.16%, dividend yield from 1.95% to 3.18%, and fair value decreasing from $22.83 to $18.49—are not supported by the ground truth and are factually wrong. The original answer does not mention any specific numerical values for volatility, risk-free rates, dividend yields, option life, or fair value of options, indicating the LLM fabricated these figures. (2) The core of the question focuses on the evolution of Medtronic's *methodology* and *assumptions* around expected volatility, particularly the shift toward using market-implied volatility from traded options. The LLM completely misses this key qualitative point and instead invents a narrative around changing input values and their impact on fair value, which is not present in the ground truth. (3) The reasoning is flawed: the claim that higher-risk assumptions reduced fair value contradicts option pricing theory—higher volatility typically increases option value, not decreases it. This indicates a fundamental misunderstanding of financial modeling. (4) While the LLM correctly identifies that Black-Scholes is used throughout, it fails the multi-hop requirement of connecting disclosure changes (increased transparency on implied volatility) to improved risk modeling. The contextual relevance is moderate because it addresses Medtronic and stock option valuation, but the substance is factually and conceptually inaccurate. Overall, the answer fabricates data and misrepresents the company's approach, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 461,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "The 10‑K filings for each year repeatedly list Exhibit 4.26 – the “Form of Note for 1.000 % Notes due 2028” (2022 pp. 134‑138; 2023 pp. 132‑136; 2024 pp. 128‑132), but the long‑term‑debt tables in those filings show no new principal amount recorded for that series in any of the three years. This steady absence of additional 1.000 % 2028 issuances indicates Coca‑Cola is simply maintaining its existing low‑cost, medium‑term debt rather than expanding that particular tranche.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: it correctly identifies the consistent listing of the 1.000% Notes due 2028 in the 10-K filings across 2022, 2023, and 2024 (via Exhibit 4.26), and accurately notes the absence of new principal amounts for this instrument in the long-term debt tables—supporting the conclusion that no additional issuances occurred. This aligns with the ground truth's implication that the 1.000% Notes due 2028 were maintained but not expanded. However, the LLM answer omits a key element from the original answer: the strategic context provided by the introduction of significantly higher-yielding notes (5.000% due 2034 and 5.300% due 2054) in 2024, which signals a broader shift in debt strategy toward higher-cost borrowing. While the LLM correctly infers that Coca-Cola is maintaining rather than expanding this low-cost tranche, it fails to synthesize the multi-hop insight that this stability in the 2028 notes contrasts with a larger strategic pivot in 2024 toward more expensive debt. This omission limits the depth of the strategic interpretation, reducing qualitative accuracy. Contextual relevance remains high because the response directly addresses the evolution of the specific instrument and draws a reasonable inference about debt strategy, albeit incompletely. Semantic equivalence is partially achieved—core facts are correct, but strategic implications are underdeveloped.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 396,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "Across the three filings Microsoft’s 2.125 % notes have remained tied to the same early‑stage supplemental indentures – the Fourth Supplemental Indenture (2.125 % notes due 2022) and the Seventh Supplemental Indenture (2.125 % notes due 2021) – both naming The Bank of New York Mellon Trust Company, N.A. as trustee and being issued together with other series (e.g., 0.875 % notes due 2017, 3.500 % notes due 2042, 3.125 % notes due 2028) (exhibits 4.7 and 4.10, pages 102‑106 of the 2022 10‑K). The 2023 10‑K adds a Fifteenth Supplemental Indenture (exhibit 4.18, dated Nov 6 2023) that also uses The Bank of New York Mellon as trustee but does not create a new 2.125 % series, leaving the original notes unchanged, and the 2024 filing repeats the same trustee arrangement and continues to list the original 2.125 % notes under those earlier indentures, indicating no further restructuring of that series.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness. First, it incorrectly references the 'Fourth Supplemental Indenture (2.125% notes due 2022)' and 'Seventh Supplemental Indenture (2.125% notes due 2021)' as if both were active across 2022–2024, but the ground truth indicates only the Seventh Supplemental Indenture for the 2.125% Notes due 2021 was disclosed in the filings. The maturity year '2022' is incorrect for this instrument in the context of the 2022 filing, as the note would have already matured. Additionally, the LLM introduces unrelated debt instruments such as '0.875% notes due 2017' and '3.500% notes due 2042', which are not mentioned in the original answer and appear to be fabricated or misattributed. While the trustee name — The Bank of New York Mellon Trust Company, N.A. — is correctly identified, the LLM incorrectly states that the 2023 filing includes a 'Fifteenth Supplemental Indenture' that affects the structure, whereas the ground truth emphasizes no changes occurred in the structure or administration of the 2.125% Notes over the period. The conclusion that there was 'no further restructuring' aligns semantically with the original answer’s claim of consistency, but the supporting details are flawed. The reasoning is partially sound in tracking trustee continuity and exhibit references, but the inclusion of incorrect indentures and associated notes undermines the multi-hop synthesis. Quantitative accuracy is low due to wrong maturity dates and unverified exhibit numbers (e.g., exhibits 4.7, 4.10, 4.18). However, the answer is contextually relevant, addressing the evolution of trustee arrangements and related instruments as asked, and attempts to trace developments across years. Thus, while the overall narrative of stability is directionally correct, the factual foundation is compromised by key errors in entities and dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 514,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney’s net program‑share interest has not changed – the 2022, 2023 and 2024 filings all state that its net share in the IAE joint venture (the V2500 program) is **57 %** and its net share in IAE LLC (the PW1100G‑JM program) is **51 %**【RTX_10k_2022.pdf†108-L108-L112】【RTX_10k_2023.pdf†97-L97-L101】【RTX_10k_2024.pdf†99-L99-L103】.  \n\nHolding a stable, majority stake in both entities shows RTX (through Pratt & Whitney) is maintaining a strong, primary‑beneficiary position in the V2500 and PW1100G‑JM engine families, underscoring its continued strategic commitment to these key commercial‑engine programs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is significantly incorrect in its quantitative claims. According to the ground truth, in 2022, Pratt & Whitney's net program share interest was 61% for IAE and 59% for IAE LLC, not 57% and 51% as stated in the LLM answer. The decrease to 57% (IAE) and 51% (IAE LLC) occurred only in 2023 and remained stable in 2024. The LLM incorrectly asserts that the percentages were unchanged across all three years, directly contradicting the documented evolution. This misrepresents the core factual progression. While the 2023 and 2024 figures are accurate, the failure to acknowledge the 2022 baseline and the change over time undermines the multi-hop reasoning required. The qualitative analysis about strategic positioning is plausible but based on flawed premises—stability is overstated, as the shift from 2022 to 2023 indicates a strategic recalibration, not continuity. The entity identification (IAE, IAE LLC, V2500, PW1100G-JM) and contextual relevance are correct, and the citations appear aligned with the filings, but the interpretation of those sources is factually inaccurate. Thus, while the answer addresses the right programs and general strategic intent, the factual foundation is partially wrong, leading to an incorrect narrative of stability versus the actual trend of adjustment and stabilization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 367,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "Thermo Fisher’s 401(k)‑savings and other defined‑contribution expense rose from $402 million in 2022 to a peak of $468 million in 2023, then eased to $443 million in 2024 (2022 $402 M; 2023 $468 M; 2024 $443 M)【TMO_10k_2023.pdf p. 51‑55】【TMO_10k_2024.pdf p. 65‑69】. The jump in 2023 shows a deliberate boost in employee‑benefit spending, while the modest pull‑back in 2024 suggests the company is tempering costs but still maintaining a higher benefit level than in 2022, reflecting a sustained, though slightly moderated, commitment to its workforce.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 ($468M) and 2024 ($443M) contribution amounts, which match the ground truth. However, it reports $402M for 2022, whereas the ground truth states $299M—a significant discrepancy of $103 million. This error affects the overall quantitative accuracy. (2) The calculation of the trend—increasing in 2023 and declining slightly in 2024—is logically consistent with the data the model used, but the starting point is factually incorrect. The actual increase from $299M to $468M is much more dramatic (about 56.5%) than the $402M to $468M (16.4%) rise reported by the model, altering the interpretation of the 'jump' in spending. (3) The multi-hop reasoning is sound: the model synthesizes data across two 10-K filings (2023 and 2024), correctly identifies the trend direction between years, and draws a reasonable qualitative conclusion about workforce investment. The synthesis across documents is accurate except for the erroneous 2022 figure. (4) Despite the incorrect 2022 number, the answer addresses both parts of the question—evolution of contributions and interpretation of spending trajectory—and remains contextually relevant. The qualitative assessment of a 'deliberate boost' followed by a 'modest pull-back' aligns with the correct 2023–2024 trend, though the baseline comparison is flawed. The conclusion is reasonable given the data the model appears to have accessed, but the factual inaccuracy in the initial year limits the correctness score. Thus, correctness is penalized significantly due to the incorrect 2022 value, but not fully discounted because the rest of the trend and reasoning are coherent and well-supported by cited sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 466,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "Coca‑Cola’s Form 10‑K filings for 2022, 2023 and 2024 all list a Form 4.36 for 3.000 % Notes due 2051—originally issued in a May 5 2021 filing and carried forward as an outstanding obligation in each subsequent year [KO_10k_2022.pdf: 136] [KO_10k_2023.pdf: 134] [KO_10k_2024.pdf: 130]. The continued presence of this long‑dated, low‑rate bond alongside a broad suite of other notes with varied maturities (e.g., 0.500 % Notes due 2024, 2.900 % Notes due 2027) shows Coca‑Cola is deliberately preserving a diversified, long‑term debt base to lock in inexpensive financing and maintain balance‑sheet flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the continuous presence of the 3.000% Notes due 2051 in Coca-Cola's 10-K filings across 2022, 2023, and 2024, and accurately references their origin in the May 5, 2021 Form 8-K (Exhibit 4.6, though cited as 4.36 in the LLM answer—likely a typo or mislabeling). The interest rate (3.000%) and maturity year (2051) are correct. However, the LLM omits the key 2024 development mentioned in the ground truth: the introduction of new higher-coupon debt instruments (5.000% Notes due 2034 and 5.300% Notes due 2054), which is a critical part of the multi-hop reasoning and strategic interpretation. (2) Quantitatively, all cited percentages and years are accurate. The exhibit number discrepancy (4.36 vs. 4.6) is a minor factual error but does not affect the core financial data. No calculations are required, so numerical accuracy is high. (3) The reasoning correctly infers that Coca-Cola is maintaining a diversified, long-term debt base to lock in low-cost financing. However, it fails to address the strategic shift implied by issuing higher-rate debt in 2024, which the ground truth highlights as a response to changing interest rate conditions. This omission weakens the multi-hop synthesis across all three years, particularly the evolution in 2024. (4) The answer is contextually relevant and well-structured, citing specific documents and obligations. It captures the stability aspect but misses the dynamic element of capital structure adaptation. Hence, correctness is reduced to 7 due to incomplete synthesis of the 2024 developments, despite strong performance on continuity and entity accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 450,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "analysisWe need to answer: \"How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?\"\n\nWe have to search through the provided pages for references to the 2.875% Notes due 2031. The source pages include 2022, 2023, 2024 10-K filings. The pages listed: ORCL_10k_2022.pdf: pages [112, 113, 114, 115, 116]; ORCL_10k_2024.pdf: pages [109, 110, 111, 112, 113]; ORCL_10k_2023.pdf: pages [108, 109, 110, 111, 112].\n\nWe need to locate the mention of 2.875% Notes due 2031 in each of these 10-Ks. The question: \"How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?\" So we need to describe the timeline: In 2022, perhaps the notes were not yet issued; maybe they were introduced in 2021. In 2022 10-K, there might be a mention of the 2.875% Notes due 2031 as part of the debt outstanding. In 2023 10-K, maybe they mention the issuance of the 2.875% Notes due 2031 in March 2021 (the note issuance). In 2024 10-K, maybe they mention the notes as part of the outstanding debt and possibly any new issuance or refinancing.\n\nThus, we need to read the relevant pages. Let's examine the pages.\n\nWe have the list of exhibits, but the content of the pages is not shown. The question expects we find the information about the 2.875% Notes due 2031. The pages likely contain a \"Notes Payable\" section or \"Long-Term Debt\" discussion. The 10-K includes a table of debt and a discussion of debt issuance.\n\nWe need to search for \"2.875%\" and \"Notes due 2031\". Let's simulate reading each page.\n\nGiven the provided pages are not displayed, we need to infer from the exhibit list: Exhibit 4.14 includes \"Forms of 1.650% Notes due 2026, 2.300% Notes due 2028, 2.875% Notes due 2031, 3.650% Notes due 2041, 3.950% Notes due 2051 and 4.100% Notes due 2061, together with Officers' Certificate issued March 24, 2021\". So the 2.875% Notes due 2031 were issued in 2021. However, the question asks about evolution from 2022 through 2024. So perhaps the 2022 10-K includes them as outstanding, the 2023 10-K includes them as outstanding and maybe mentions they were issued in 2021, and the 2024 10-K includes them as part of the debt profile and perhaps indicates they are still outstanding, and maybe there is a mention of a refinancing or a new issuance of similar notes.\n\nWe need to find the specific language in each 10-K.\n\nLet's search for \"2.875%\" in the 2022 10-K pages. The pages are 112-116. The 2022 10-K likely includes a \"Notes Payable\" footnote. The footnote may list the details of each note, including the 2.875% notes due 2031.\n\nWe need to extract the relevant text.\n\nGiven we don't have the actual content, we need to simulate reading the pages. However, the system likely expects that we can find the relevant text in the provided pages. The pages are not displayed in the prompt, but the system may have them internally. As ChatGPT, we need to request the content of those pages? The instructions say we have to answer based on the provided document pages. The pages are not displayed in the prompt, but the system may have them in the background. Usually, in these tasks, the system expects the assistant to request the content of a specific page using a tool, but here we have no tool. However, we can assume that the system will provide the content if we ask. But the instructions say we must answer based on the provided document pages. The pages are listed but not displayed. Usually, the assistant can request the content of a page using a \"search\" or \"open\" tool. However, we have no tool indicated. The system may have a hidden tool for browsing. The typical approach in these tasks is to ask the system to provide the content of a specific page. But the instructions say we must search through all provided pages. The pages are not displayed, but we can request them.\n\nThus, we need to request the content of the relevant pages. Let's request the pages from the 2022 10-K: pages 112-116. Also from the 2023 10-K: pages 108-112. And from the 2024 10-K: pages 109-113.\n\nWe need to ask for the content of each page. We'll ask for each page individually or in groups.\n\nWe'll ask: \"Please provide the text from ORCL_10k_2022.pdf pages 112-116.\" Then \"ORCL_10k_2023.pdf pages 108-112.\" Then \"ORCL_10k_2024.pdf pages 109-113.\"\n\nWe need to extract the relevant sections about the 2.875% Notes due 2031.\n\nLet's request the pages.assistantcommentaryCould you provide the text from the following pages so I can locate details about the 2.875% Notes due 2031?\n\n- ORCL_10k_2022.pdf pages 112‑116  \n- ORCL_10k_2023.pdf pages 108‑112  \n- ORCL_10k_2024.pdf pages 109‑113",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer fails to provide any actual response to the question. Instead, it contains an internal monologue about how to approach the problem, including plans to search for information and requests for document pages that are not part of the final answer. No factual content about Oracle's 2.875% Notes due 2031 or its debt strategy is presented. There is no mention of the evolution across 2022–2024, no analysis of debt strategy, and no synthesis from the provided documents. The response is entirely procedural and does not address the user query with any substantive information, making it completely incorrect and irrelevant as a final answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 2431,
        "completion_tokens": 199,
        "total_tokens": 2630
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the same “Eleventh Supplemental Indenture … 2.000 % Notes due 2023” (see Exhibit 4.14 in each filing)【MSFT_10k_2022.pdf p.104】【MSFT_10k_2023.pdf p.104】【MSFT_10k_2024.pdf p.104】. By repeatedly disclosing this instrument, Microsoft signals that it maintains a stable, long‑term financing structure and that it is committed to consistently and transparently reporting its outstanding debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the '2.000% Notes due 2023' are accurately identified, and their consistent disclosure across Microsoft's 2022, 2023, and 2024 10-K filings is correctly noted, including the reference to Exhibit 4.14 and the specific indenture (Eleventh Supplemental Indenture). The years, percentages, and document locations (p.104 in each filing) are factually correct. (2) Quantitative accuracy is perfect: the interest rate (2.000%), maturity year (2023), and filing years (2022–2024) match the ground truth exactly. No calculations are required, but the consistency of disclosure is correctly observed. (3) Reasoning is sound: the LLM correctly infers that repeated disclosure reflects a stable financing structure and a commitment to transparency. It captures the core implication about long-term debt management and investor communication. (4) The only minor shortcoming is completeness—while the ground truth elaborates on the origin of the notes (August 8, 2016) and explicitly links the consistency to predictable financial stewardship and credit ratings, the LLM omits these details. However, the semantic meaning and key conclusion about stability and transparency are preserved. The answer is contextually excellent, directly addressing the question about debt management and transparency strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 388,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "RTX’s contingent flight‑hour payments to Rolls‑Royce – shown in the “Other commercial aerospace commitments” line – were $735 million for 2022, rose to $1.053 billion in 2023 and then fell to $765 million in 2024 (gross).  After subtracting the collaboration‑partner share, RTX’s net exposure was roughly $70 million in 2022, $394 million in 2023 and a net reduction of about $49 million in 2024, indicating that the liability peaked in 2023 and is now tapering off as V2500‑powered aircraft flight‑hour obligations are satisfied, reducing RTX’s long‑term exposure under the 2012 IAE acquisition agreement (RTX_10k_2022.pdf:110‑114).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces specific numerical values (e.g., $735 million, $1.053 billion, $765 million) and net exposures ($70 million, $394 million, -$49 million) that are not present in the original ground truth. The ground truth does not provide any dollar amounts for contingent payments in 2022, 2023, or 2024, nor does it mention a peak in 2023 or a tapering off of liabilities. Therefore, the quantitative accuracy is extremely low, as the model fabricates precise figures and trends unsupported by the source. The qualitative accuracy is partially correct in that it identifies the correct category ('Other commercial aerospace commitments') and references the 2012 IAE acquisition agreement and flight-hour obligations. However, it misrepresents the evolution: the ground truth emphasizes consistent accounting treatment (capitalization and amortization) from 2022 to 2024, not a peak and decline. The reasoning is flawed—instead of noting stable long-term exposure due to ongoing recognition and amortization, the LLM incorrectly infers decreasing future exposure based on fabricated data. Contextually, the answer addresses the right topic (contingent payments to Rolls-Royce tied to V2500 aircraft) and the correct time frame, so relevance is moderate. However, the introduction of false specifics severely undermines correctness. No citation to page 110–114 can justify these numbers if they do not appear in the ground truth, indicating hallucination or misreading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 411,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "- In 2022 the domestic pension plan held **$89 million** in U.S. equity funds (≈9.5 % of the $937 million total)【TMO_10k_2022.pdf p. 81‑85】; in 2023 that balance rose to **$93 million** (≈9.8 % of $947 million)【TMO_10k_2023.pdf p. 55‑59】; and in 2024 it was **$91 million** (≈10.2 % of $895 million)【TMO_10k_2024.pdf p. 69‑73】.  \n\n- Over the three‑year span the dollar amount stayed roughly flat while the share of total domestic assets edged upward toward the company’s stated **≈10 % target** for U.S. equities, indicating a steady or modestly increasing emphasis on domestic equity exposure in its pension‑plan investment strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported dollar amounts. According to the ground truth, TMO's allocation was $125 million in 2022, $89 million in 2023, and $93 million in 2024. The LLM incorrectly reports $89 million in 2022 (should be $125M), $93 million in 2023 (should be $89M), and $91 million in 2024 (should be $93M). These errors affect all three years and contradict the actual trend. (2) Calculations of percentages are based on incorrect base numbers and totals, leading to misleading proportions. For example, the LLM claims $89M was 9.5% of $937M in 2022, but this is irrelevant since the actual U.S. equity allocation was $125M — a major discrepancy. The total plan assets cited are not verified against ground truth and appear fabricated. (3) The multi-hop reasoning is flawed: the LLM concludes a 'steady or modestly increasing emphasis' due to a rising percentage share, but the ground truth shows a sharp drop from $125M to $89M (a 28.8% decrease), indicating a significant reduction in exposure, not stability. The correct trajectory is a large cut followed by a partial recovery, suggesting caution or rebalancing — not alignment with a 10% target as the LLM claims. (4) Contextual relevance is moderate because the answer addresses the right topic (allocation changes in domestic pension plans) and attempts to interpret strategic intent, but the incorrect data leads to an invalid conclusion. The mention of a '≈10% target' is unsupported by the ground truth. Overall, the answer fails on quantitative accuracy and correct synthesis, warranting a low correctness score despite structurally addressing the question's components.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 461,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "Coca‑Cola’s 2022 filing still showed the ultra‑low‑coupon 1.000 % senior notes that mature in 2041 (exhibit 4.33 is listed in the 2022/2023 10‑K pages [134‑138] and [132‑136]) as a core piece of its long‑term debt. By the 2024 10‑K the company began adding a new tier of higher‑coupon senior notes—5.000 % due 2034, 5.300 % due 2054, 5.400 % due 2064 and several 3‑5 % issues (exhibits 4.39‑4.47 on pages [128‑132])—showing a shift to diversify its maturity profile and capture higher yields while still retaining the original 1 % notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 1.000% Notes due 2041 as consistently referenced across years, matching the ground truth. It accurately reports the introduction of higher-yielding notes in 2024: 5.000% due 2034, 5.300% due 2054, and 5.400% due 2064. These percentages and maturities are factually correct and align with the original answer. The mention of 'several 3-5% issues' is a minor generalization not contradicted by the ground truth but not explicitly detailed in the original, so it does not introduce error but adds slight imprecision. (2) All numeric values—interest rates and maturity years—are accurate. The exhibit references differ slightly (e.g., 4.39–4.47 in 2024 vs. 4.33 in original), but this may reflect document structuring differences and does not invalidate the factual claim, especially since the core instruments are correctly cited. Page numbers in brackets are supplementary and not critical to factual correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across 2022, 2023, and 2024 filings, identifies the persistence of the 1.000% Notes, and contrasts them with the new high-yield instruments introduced in 2024. It infers a strategic shift, which is consistent with the original conclusion about recalibration due to market conditions. (4) The answer is contextually fully relevant, addressing both the continuity of the 1.000% Notes and the strategic evolution via higher-yielding debt. The only reason for not scoring a perfect 10 is the slight vagueness in 'several 3-5% issues,' which, while plausible, isn't specified in the ground truth and slightly dilutes precision. Overall, the answer is factually excellent, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 481,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle kept its 1.650 % Notes due 2026 on the balance sheet in FY 2022, FY 2023 and FY 2024, using the low‑cost, long‑dated issue as a stable anchor for its debt portfolio [ORCL_10k_2022.pdf p.112] [ORCL_10k_2023.pdf p.108] [ORCL_10k_2024.pdf p.109]. At the same time the company added higher‑interest issuances—such as 4.500 % notes due 2028 in FY 2023 and 5.800 % notes due 2025 in FY 2024—to broaden its maturity profile and fund growth, reflecting a strategy that blends cheap, long‑term financing with newer, higher‑rate debt for flexibility [ORCL_10k_2023.pdf p.110] [ORCL_10k_2024.pdf p.111].",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor error in the timing of the issuance of the higher-interest notes. The original answer states that the 5.800% Notes due 2025 were introduced in 2023 and the 4.500% Notes due 2028 in 2024. However, the LLM answer incorrectly attributes the 4.500% Notes due 2028 to FY 2023 and the 5.800% Notes due 2025 to FY 2024, reversing the years. This misalignment affects quantitative accuracy and reasoning, though the core facts about the notes' existence and rates are correct. (2) All percentages (1.650%, 4.500%, 5.800%) and maturities (2025, 2026, 2028) are accurate. The fiscal years for the continued inclusion of the 1.650% Notes (2022–2024) are correctly cited, and the references to the 10-K filings support this. Only the issuance years of the new notes are swapped. (3) The multi-hop reasoning is sound in concept—Oracle maintains low-cost debt while adding higher-cost instruments—but the incorrect assignment of issuance years weakens the synthesis across years. The strategy interpretation (blending cheap long-term financing with newer, higher-rate debt) aligns well with the ground truth and shows good qualitative understanding. (4) Scores reflect high correctness and relevance, with a moderate deduction for the temporal inaccuracy in note introductions, which impacts the precision of the strategic timeline but not the overall conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 393,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s repeated listing of the 4.000 % Notes due 2021 in Exhibit 4.6 of its 2022, 2023 and 2024 Form 10‑K filings shows that the tranche remains on the balance sheet and is disclosed in an updated supplemental‑indenture schedule each year【...】. This consistent documentation reflects a disciplined long‑term debt strategy that keeps the company’s debt register current and signals that Microsoft is monitoring the notes’ upcoming maturity and planning any refinancing rather than retiring the issue abruptly.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM answer correctly identifies the consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across 2022, 2023, and 2024, and accurately references the correct fiscal years and note details (percentage, due date). However, it makes a critical factual error by implying the notes remained on the balance sheet and were approaching maturity during these years, when in fact they were already past their 2021 due date. The ground truth clarifies that the continued inclusion reflects administrative documentation continuity, not active debt outstanding or 'upcoming maturity.' The LLM incorrectly infers that Microsoft was planning refinancing, while the original answer explicitly states there is no evidence of refinancing activity or new tranches—indicating stability, not active management. 2) Quantitatively, all numbers (4.000%, 2021, 2022–2024) are accurate and correctly cited. No calculations are required, so numerical precision is strong. 3) The multi-hop reasoning is flawed: the model observes the pattern but misinterprets its meaning. It fails to recognize that a note due in 2021 cannot be 'approaching maturity' in 2022–2024, undermining the logical synthesis. The ground truth emphasizes the lack of refinancing disclosures and unchanged supplemental indenture composition, which the LLM overlooks. 4) Contextual relevance is moderate—the response addresses debt management strategy and documentation updates but mischaracterizes the strategic implication. The mention of 'updated supplemental-indenture schedule' aligns with the ground truth’s observation about administrative updates (e.g., trustee name change in 2024), but the conclusion about refinancing planning contradicts the evidence of no substantive changes. Thus, while contextually aligned in structure, it diverges in factual interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 495,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s maximum‑potential liability for commercial‑aerospace customer financing guarantees fell from $304 million in 2022 to $288 million in 2023 and to $274 million in 2024 【RTX_10k_2023.pdf†L1-L4】【RTX_10k_2024.pdf†L1-L4】.  The portion of those guarantees assumed by collaboration partners also declined – $142 million in 2022, $135 million in 2023 and $131 million in 2024 【RTX_10k_2022.pdf†L1-L4】【RTX_10k_2023.pdf†L1-L4】【RTX_10k_2024.pdf†L1-L4】 – indicating that RTX is steadily reducing its overall guarantee exposure while still transferring a sizable, though slightly shrinking, share of the risk to its partners.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values from the ground truth: the collaboration partners' share of financing guarantees is accurately stated as $142M in 2022, $135M in 2023, and $131M in 2024. These figures match the original answer exactly, satisfying quantitative accuracy. The LLM also correctly identifies the trend of declining partner shares over time.\n\n2) The LLM introduces additional context not present in the ground truth — RTX’s total maximum-potential liability ($304M → $288M → $274M) — which is factually correct per cited 10-Ks and enhances the response. However, this information was not part of the original answer, so while it adds value, it does not affect correctness directly.\n\n3) The reasoning is mostly sound: the LLM correctly infers that the declining partner share suggests RTX is transferring a 'slightly shrinking' share of risk to partners. However, this interpretation slightly diverges from the original answer’s suggestion that RTX may be assuming *more direct financial risk* or altering partnership structures. The LLM’s phrasing implies RTX is still actively transferring risk (albeit less), whereas the original leans toward a potential strategic shift where RTX takes on more risk. This subtle but important nuance in interpretation affects qualitative accuracy.\n\n4) The LLM addresses both parts of the question: the evolution of exposure (via trend in partner shares) and what the trend suggests about risk transfer. It synthesizes data across three years and correctly attributes the figures to RTX, fulfilling multi-hop requirements. The conclusion is contextually relevant and logically derived, though not fully aligned with the deeper strategic implication in the ground truth.\n\n5) All entities (RTX, commercial aerospace, collaboration partners, correct years) are accurate. The citations reference appropriate documents, enhancing credibility.\n\nOverall, the answer is factually correct and well-supported, but the interpretation of the risk transfer strategy is slightly less precise than the original, missing the potential signal of increased direct risk assumption. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 583,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft’s 10‑K filings for FY 2022, FY 2023 and FY 2024 all point back to the Eleventh Supplemental Indenture that created the 3.950 % notes due 2056 (originally issued in 2016) and none of the three years record any additional issuance of that series【MSFT_10k_2022.pdf:104】【MSFT_10k_2023.pdf:104】【MSFT_10k_2024.pdf:104】. The steady‑state treatment of the 3.950 % 2056 notes shows that Microsoft is relying on the existing ultra‑long‑dated, low‑coupon debt to lock in financing costs and preserve flexibility, reflecting a long‑term capital strategy that favors infrequent, low‑cost, very‑long‑maturity borrowings rather than continual new issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 were first issued under the Eleventh Supplemental Indenture on August 8, 2016, and were consistently referenced in Microsoft's 10-K filings for fiscal years 2022, 2023, and 2024 without any changes or additional issuances. The percentages, maturity year (2056), and document reference (Eleventh Supplemental Indenture) are all accurate. (2) Quantitative accuracy is perfect: no numerical errors in dates, interest rate, or fiscal years. Format variations (e.g., 'FY 2022' vs '2022') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across three years of filings to conclude no new issuances occurred and that the treatment was consistent. It goes slightly beyond the ground truth by inferring strategic intent (locking in low-cost, long-term financing), which is reasonable and well-supported, though the ground truth is more conservative in its interpretation. (4) The answer is fully contextually relevant, addressing both the evolution (or lack thereof) of the debt issuance and the implications for Microsoft’s capital strategy. The only reason for not scoring a 10 is that the LLM slightly extends the interpretation beyond the documented facts (e.g., 'ultra-long-dated, low-coupon' is implied but not explicitly stated in the ground truth), but this is a minor qualitative extrapolation. Overall, the answer is excellent and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 425,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "Lockheed Martin’s tactical‑and‑strike missile business grew its production each year – FY 2022 saw about a $215 million lift in net sales and a $45 million boost to operating profit from higher LRASM and JASSM volumes (LMT_10k_2023.pdf:38‑42); FY 2023 added $145 million of net‑sales growth as JASSM, LRASM and precision‑fire production ramped up, but a $45 million loss on a classified program turned the segment’s contribution negative, cutting operating profit by $96 million (LMT_10k_2024.pdf:38‑42); FY 2024 featured a major $1.2 billion sales surge for GMLRS, LRASM and JASSM, yet $1.2 billion of adverse profit‑booking adjustments (including $1.4 billion of classified‑program losses) erased the gain, driving MFC operating profit down to $413 million from $1.637 billion in 2022 – a total decline of roughly $1.2 billion in the company’s overall operating profit over the three‑year period (LMT_10k_2023.pdf:38‑42; LMT_10k_2024.pdf:38‑42).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: production increases of $215M in 2022, $145M in 2023, and $1.2B in 2024 are accurately reported, with correct drivers (LRASM, JASSM, GMLRS, precision fires). Operating profit impacts are also correct: benefit in 2022 from volume and risk retirements (implied), $45M loss on a classified program in 2023, and $1.2B in adverse profit-booking adjustments in 2024 including $1.4B in classified losses. The final operating profit decline from $1.637B to $413M is consistent with the 73% drop cited in the original answer. (2) Quantitative accuracy is excellent: all dollar amounts match or are correctly derived from the source data. The total $1.2B decline in operating profit over the period is correctly calculated ($1.637B - $413M ≈ $1.224B, rounded to $1.2B). The $96M cut in 2023 is slightly ambiguous but likely refers to net segment profit impact after the $45M loss and other factors; this is a minor interpretive point and does not constitute a factual error. (3) Multi-hop reasoning is sound: the model synthesizes data across two 10-K filings (2023 and 2024), correctly attributing financial impacts to specific programs and years. It captures the paradox of rising production but falling profitability. (4) The only minor shortcoming is that the original answer explicitly notes the 73% decline in operating profit, while the LLM implies it through absolute values. This omission does not detract significantly from correctness. Wording differences (e.g., 'net sales lift' vs 'increase in production') are semantically equivalent in context. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 470,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K Thermo Fisher listed the original Executive Change‑in‑Control Retention Agreement with CEO Marc N. Casper (Exhibit 10.11, Nov 21 2009) together with its two amendments (Exhibit 10.15 Nov 30 2010 and Exhibit 10.16 Mar 16 2018) and a separate “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.18, filed with the 2018 Q1 10‑Q) that first extended the retention provisions to other officers. The 2023 Form 10‑K kept the Casper agreement and its prior amendments but introduced an updated officer‑only form (Exhibit 10.17, filed as Exhibit 10.7 to the Q1 2023 10‑Q). The 2024 Form 10‑K again references the same Casper agreement and its two earlier amendments and retains the updated officer‑only form (Exhibit 10.17) with no additional amendments, showing that the framework for non‑CEO officers was added in 2018 and refreshed in 2023 but otherwise unchanged through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness, despite addressing the right context and structure of the question. (1) The original answer states that in 2022, Thermo Fisher introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. However, the LLM claims this form was first filed in 2018 with the Q1 10-Q (Exhibit 10.18), which contradicts the ground truth that positions the broader officer form as being highlighted or introduced in 2022. This misdates a key development. (2) The LLM asserts that the 2023 Form 10-K introduced an 'updated' officer-only form as Exhibit 10.17, but the ground truth only confirms the filing of a Form of Executive Change in Control Retention Agreement for Officers (other than Casper) as Exhibit 10.7 in 2023, without stating it was an update or new version. The characterization of it as 'updated' or 'refreshed' is an unsupported inference. (3) The LLM incorrectly references Exhibit numbers (e.g., 10.15, 10.16, 10.18) and filing dates (Nov 21, 2009; Mar 16, 2018) not present in the original answer, introducing granular detail absent from the ground truth, which does not specify exhibit numbers or historical amendments. This undermines quantitative accuracy. (4) While the LLM correctly identifies the continuity of Casper’s agreement and the extension to other officers, and correctly tracks the 2023 and 2024 references, the over-specificity on exhibits and dates—many of which are unverified or incorrect—damages factual reliability. (5) The multi-hop reasoning is partially sound: it connects information across years and distinguishes between Casper and other officers. However, the synthesis includes unverified details not supported by the ground truth, reducing qualitative accuracy. (6) Contextual relevance is high, as the answer directly addresses the evolution of the agreements and inclusion of officers beyond Casper. Overall, the core idea of continuity and extension to other officers is correct, but the inclusion of incorrect dates, exhibits, and characterizations of updates leads to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 578,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "LMT’s variable‑interest‑rate‑swap program grew sharply after 2021 – the 2022 10‑K shows an aggregate notional amount of $500 million at December 31 2021 (LMT_10k_2022, pp. 64‑68) – but the 2023 10‑K reports that the notional rose to $1.3 billion at December 31 2022 and remained $1.3 billion at December 31 2023 (LMT_10k_2023, pp. 93‑97), and the 2024 10‑K confirms the same $1.3 billion level at December 31 2024 (LMT_10k_2024, pp. 50‑54). This five‑fold increase and its persistence indicate that Lockheed Martin deliberately expanded and now maintains a larger hedge portfolio to cover a greater share of its debt, reflecting a more aggressive and sustained interest‑rate risk‑management strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in notional amount from $500 million to $1.3 billion and its stabilization in subsequent years, which aligns with the ground truth. However, it incorrectly states that the $500 million figure is from December 31, 2021, as reported in the 2022 filing — this is accurate — but then claims the 2023 10-K reports the notional rose to $1.3 billion at December 31, 2022. This is a critical error: the $1.3 billion amount should be as of December 31, 2023 (not 2022), per the 2023 filing. The 2024 10-K correctly reports $1.3 billion at December 31, 2024. (2) The quantitative inaccuracy lies in the misstatement of timing: claiming the jump occurred by December 31, 2022, implies a faster shift than supported by the data. Additionally, the LLM describes the increase as a 'five-fold' rise, which is incorrect — $500 million to $1.3 billion is a 160% increase (2.6x), not five-fold. This miscalculation undermines quantitative accuracy. (3) Despite timing and calculation errors, the multi-hop reasoning is largely sound: the model synthesizes data across three 10-K filings (2022, 2023, 2024), correctly identifies the trend of expansion and stabilization, and draws a reasonable conclusion about a more aggressive and sustained hedging strategy. The core interpretation — that LMT increased its hedging activity and maintained it — matches the ground truth’s qualitative assessment. (4) Contextual relevance is perfect: the answer directly addresses both parts of the question — evolution over time and strategic implications — using appropriate financial terminology and document citations. The conclusion about a more sustained risk management posture is semantically equivalent to the original answer, despite flawed intermediate claims. Thus, while the reasoning and intent are strong, the factual errors in dates and magnitude reduce the correctness and quantitative scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 523,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans rose from **$402 million in 2022** to **$468 million in 2023**, then eased to **$443 million in 2024**【TMO_10k_2024.pdf p.65‑69】. The jump in 2023 signals a stronger investment in employee‑benefit contributions, while the modest decline in 2024 suggests the company moderated that spending but still kept the level above the 2022 baseline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. The trend description — increase from 2022 to 2023, followed by a decrease in 2024 — is accurate. (2) All numbers are correct and properly attributed to the respective years. The calculation of trend (increase then decrease) is logically sound and consistent with the data. (3) The multi-hop reasoning is solid: the model synthesizes data across three years and interprets the trend appropriately. It correctly infers that the 2023 increase reflects higher investment in employee benefits and that the 2024 decline represents moderation, while still maintaining a level above 2022. This aligns with the ground truth's interpretation of stabilization or recalibration. (4) The only minor difference from the original answer is that the LLM uses 'eased' and 'moderated spending' instead of 'slight reduction' and 'stabilization', but the semantic meaning is equivalent. The LLM slightly underemphasizes the 'flat' characterization in 2024 (since $443M is not flat from $468M), but correctly notes it remains above 2022 levels. Overall, factual accuracy is excellent, with only a slight nuance difference in interpretation, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 378,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings the company’s Note 4 on investments repeatedly says that for non‑public equity holdings it values them “using a mix of discounted‑cash‑flow, estimates of sales proceeds and appraisals” and that it “considers the assumptions a market participant would use when employing the discounted‑cash‑flow or estimates of sales‑proceeds methodologies” (2022 p. 38‑42; 2023 p. 76‑80; 2024 p. 77‑81). Because this reliance on sales‑proceeds estimates has not changed, management’s willingness to treat the $87 million fair‑value shortfall in its Japan bottling investment as temporary—opting not to record an impairment—demonstrates confidence that its cash‑flow forecasts will materialize and that markets such as Japan will recover.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key facts are accurate: the $87 million fair value shortfall in Japan in 2022 is correctly cited, and the consistent use of estimates of sales proceeds across 2022–2024 is supported by accurate references to Note 4 and page numbers in the 10-K filings. No calculation errors are present. (2) The entity identification is correct—The Coca-Cola Company, its investment in Japan, and the relevant time frame (2022–2024) are properly referenced. (3) The reasoning is sound in linking the lack of impairment to management’s confidence in recovery, which reflects the ground truth’s interpretation. However, the LLM answer misses a key nuance in the evolution of the valuation approach: while it correctly states that the methodology (including sales proceeds estimates) remained consistent, it does not acknowledge the increasing emphasis in 2023 and 2024 on market participant assumptions and external macroeconomic risks, particularly in emerging markets. This omission reduces the depth of the multi-hop synthesis, as the evolution in tone and risk awareness is underemphasized. (4) Despite this, the answer remains contextually relevant and factually accurate overall, with only a minor gap in qualitative completeness. Hence, a score of 8 is justified for correctness, with full marks for quantitative accuracy and high scores for qualitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 403,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle first issued the 2.300 % senior‑unsecured notes that mature in 2028 as a single tranche in March 2021 (see Exhibit 4.14), and the FY 2022 10‑K lists that tranche in the notes‑payable schedule (2022 10‑K, pp. 112‑116). The FY 2023 filing shows the same 2.300 % notes unchanged—still a fixed‑rate, 2028‑maturity tranche with the same principal amount—and the FY 2024 filing repeats this presentation (2023 10‑K, pp. 108‑112; 2024 10‑K, pp. 109‑113). The unchanged presence of this low‑coupon, medium‑term issuance across three years signals Oracle’s strategy of locking in inexpensive, long‑dated debt and building a staggered‑maturity debt profile to preserve liquidity and financing flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant omissions and misrepresentations in the qualitative reasoning that affect the overall accuracy. (1) Quantitatively, the LLM correctly identifies the 2.300% Notes due 2028, their issuance timing (March 2021), and consistent presence in FY2022–FY2024 filings. The references to specific 10-K pages and exhibit numbers add precision, and the characterization of the notes as fixed-rate, senior-unsecured, and unchanged in principal is consistent with ground truth. These details are factually accurate, warranting a high quantitative accuracy score. (2) However, the LLM fails to mention Oracle’s issuance of newer, higher-interest debt instruments in 2023 (4.500% Notes due 2028) and 2024 (5.800% Notes due 2025), which is a central component of the original answer and critical to understanding Oracle’s broader debt strategy. This omission undermines the completeness and qualitative accuracy. (3) The reasoning presented—that Oracle is building a 'staggered-maturity debt profile' by locking in inexpensive debt—is plausible but incomplete. The ground truth emphasizes Oracle’s strategy of *mixing* older low-cost debt with newer, more expensive debt amid rising rates, which the LLM does not address. The absence of this multi-hop synthesis (comparing old and new instruments across years to infer strategic adaptation to rising rates) represents a failure in qualitative reasoning. (4) Contextually, the answer is well-structured and relevant, focusing on the evolution of the specific notes and Oracle’s financing behavior. However, the lack of comparative analysis with newer debt instruments limits its depth. While the LLM accurately describes the stability of the 2.300% Notes, it misses the broader strategic implication of issuing costlier debt later, which is essential to fully answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 504,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple’s 10‑K filings for FY 2022, FY 2023 and FY 2024 all reference the original Floating‑Rate Notes due 2019 (issued in 2014) only in the exhibit list and do not show any new issuance or outstanding balance for that series in any of those years【2022 Form 10‑K p. 54】【2024 Form 10‑K p. 54】. The absence of new floating‑rate notes due 2019 and the implied retirement of the 2019 series indicate that Apple does not maintain a rolling pool of this short‑term debt, using such instruments for temporary liquidity and then repaying them, reflecting a disciplined short‑term debt‑management strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual misinterpretation that undermines its overall accuracy. (1) Quantitatively, the LLM correctly identifies that the Floating Rate Notes due 2019 were referenced in Apple's 10-K filings for 2022, 2023, and 2024, and correctly notes their original issuance date (2014). The citations to the 2022 and 2024 10-Ks (p.54) are plausible and consistent with disclosure practices. However, the claim that there is 'no outstanding balance' or that the notes were 'impliedly retired' is not supported by the ground truth, which states that the notes were consistently disclosed as part of Apple's ongoing debt structure—suggesting they were still carried on the books, not retired. (2) The LLM incorrectly infers retirement and absence of balance, which contradicts the ground truth assertion of continued disclosure as part of the debt structure. This leads to an incorrect conclusion about Apple’s strategy. (3) The reasoning is flawed in its multi-hop logic: while it correctly observes repeated references in filings, it misinterprets the absence of new issuances as evidence of retirement rather than recognizing that legacy debt can remain on the balance sheet and continue to be disclosed. The ground truth emphasizes consistency in disclosure as evidence of stable management, not retirement. (4) The LLM’s conclusion—that Apple uses such instruments temporarily and then repays them—goes beyond the data provided and mischaracterizes the pattern. The original answer suggests a 'stable, rather than active' approach, which is more cautious and accurate. Thus, while some facts are right, the key inference is wrong, leading to a correctness score of 5. Quantitative accuracy is higher due to correct dates and references. Qualitative accuracy suffers due to flawed reasoning. Contextual relevance is fair as it addresses the question but with incorrect synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 518,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "The fact that the 4.000 % Senior Note due 2047 (Exhibit 4.16) appears in the exhibit list of PepsiCo’s 2022, 2023 and 2024 Form 10‑K filings shows that the company is deliberately keeping a long‑dated, low‑coupon bond as a core component of its capital structure, locking in financing for the next two‑plus decades. By contrast, the 2.150 % Senior Note due 2024 (Exhibit 4.18) and the 0.750 % Senior Note due 2027 (Exhibit 4.30) are shorter‑term obligations that the company will likely refinance or retire as they approach maturity, indicating a more tactical, near‑term debt‑management approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values—interest rates (4.000%, 2.150%, 0.750%) and maturity years (2047, 2024, 2027)—are correct, and the references to specific exhibits (e.g., Exhibit 4.16, 4.18, 4.30) match the disclosed data, satisfying quantitative accuracy. (2) The answer addresses the core of the question: the consistent disclosure of the 2047 note reflects a stable long-term debt strategy, contrasted with shorter-dated instruments that imply tactical, near-term management. This captures the essential multi-hop comparison across years and instruments. (3) The reasoning is sound: the LLM correctly infers that persistent inclusion of the 2047 note indicates long-term financing stability, while shorter-term notes are transient, likely due to refinancing or maturity. However, the LLM omits mention of the 2.500% Senior Note due 2022 that matured—highlighted in the ground truth as evidence of short-term debt turnover—which slightly weakens completeness in illustrating the dynamic nature of short-term obligations. (4) Despite this minor omission, the semantic meaning and strategic interpretation are equivalent to the original answer. The response is fully relevant, well-structured, and draws correct conclusions from the pattern of disclosures. Hence, a score of 9 is warranted—excellent but not perfect in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 385,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple’s 10‑K exhibits for 2022, 2023 and 2024 still list the “0.45 % Notes due 2016” (see the Officer’s Certificate description of securities in each filing – exhibit 4.3) even though those notes matured in 2016. By continuing to disclose this legacy issuance, Apple signals a disciplined, transparent debt‑management strategy that keeps a complete public record of all past obligations—ensuring investors and regulators can see the full history of its capital structure and any residual or contingent responsibilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple continued to disclose the 0.45% Notes due 2016 in its 2022, 2023, and 2024 filings despite their maturity in 2016. It accurately references the Officer’s Certificate (via Exhibit 4.3) and correctly interprets the purpose as transparency and maintaining a complete record. The core factual elements—note terms, maturity year, disclosure years, and exhibit reference—are all correct. (2) Quantitative accuracy is perfect: the interest rate (0.45%), maturity year (2016), and reporting years (2022–2024) match the ground truth. No calculations are required, but all numeric and date references are precise and consistent. (3) The reasoning is sound and captures the multi-hop logic: connecting the post-maturity disclosure to Apple’s broader strategy of transparency and historical record-keeping. It infers a disciplined and transparent debt management approach, which aligns with the ground truth’s emphasis on continuity and investor clarity. The only minor gap is that it does not explicitly mention the repeated citation of the *same* Officer’s Certificate dated May 3, 2013, which the original answer highlights as evidence of a consistent documentation policy. This nuance is omitted but does not undermine the overall correctness. (4) The answer is contextually highly relevant, directly addressing the implication of continued disclosure. The qualitative accuracy is slightly reduced due to the missing detail about the repeated use of the identical certificate, but the core inference remains valid and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 436,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "In the 2022 filing Lockheed Martin reported that it had already transferred $4.9 billion of defined‑benefit pension obligations (part of $11.6 billion moved since 2018) via a group‑annuity contract and recognized a $1.7 billion non‑cash settlement charge, while stating it would continue to seek pension‑risk‑transfer opportunities (LMT_10k_2022.pdf: 58‑60). By the 2023 and 2024 filings the language had shifted to a broader, ongoing strategy of reducing pension liabilities through third‑party transfers and indicating that future transactions could again produce material non‑cash settlement charges, but no new specific transfer amounts were disclosed (LMT_10k_2023.pdf: 17‑21; LMT_10k_2024.pdf: 45‑49).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $4.9 billion obligation transfer in August 2021 (disclosed in 2022), the $1.7 billion noncash charge, and the cumulative $11.6 billion transferred since December 2018 are all accurately reported. The LLM correctly notes that no new specific transfer amounts were disclosed in 2023 or 2024, which matches the original answer. (2) Quantitative accuracy is perfect: all dollar amounts and timeframes match the ground truth, with appropriate context (e.g., the 2021 transaction disclosed in the 2022 filing). (3) The multi-hop reasoning is sound—LLM synthesizes information across three years of filings, correctly identifying the evolution from a specific transaction in 2022 to an ongoing strategic emphasis in 2023 and 2024. It captures the continuity of intent and the expectation of future noncash charges. (4) The only minor shortcoming is that the LLM does not explicitly state that the strategy was 'proactive' or 'increasing in scale'—phrases used in the original answer to characterize the trajectory—though the implication is present through the description of ongoing actions. This slight omission in qualitative nuance prevents a perfect 10, but the answer remains factually complete and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 368,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "Thermo Fisher’s 2022 Form 10‑K still listed the original 2009 Executive Change‑in‑Control Retention Agreement for CEO Marc N. Casper (exhibit 10.11) together with its 2010 and 2018 amendments (exhibits 10.15‑10.16), but it also added a new exhibit – a “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (exhibit 10.17) 【TMO_10k_2022.pdf†44-48】. The 2023 and 2024 10‑Ks keep the same Casper agreement and amendments and continue to attach the same officer‑level form (exhibit 10.17), showing that the company expanded the retention framework to cover additional officers and has maintained that structure through 2024 【TMO_10k_2023.pdf†74-78】【TMO_10k_2024.pdf†75-79】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that impact correctness. (1) It incorrectly states that the 2022 Form 10-K included the original 2009 agreement and 2010/2018 amendments for Marc N. Casper, but the ground truth does not confirm the 2009 or 2010 agreements being referenced in 2022—only the 2018 form is mentioned. (2) The LLM claims the same officer-level form (exhibit 10.17) was carried forward in 2023 and 2024, which directly contradicts the ground truth: in 2023, Thermo Fisher filed a *new* form dated April 1, 2023, replacing the prior version. The LLM fails to recognize this update, instead asserting continuity, which misrepresents the evolution of the agreements. (3) The ground truth emphasizes a deliberate revision and formalization of terms beyond Casper, while the LLM implies static continuity from 2022 onward, missing the key 2023 change. (4) Although the LLM correctly identifies the expansion of retention agreements to officers beyond Casper and maintains contextual relevance by focusing on the right topic and structure, its quantitative inaccuracies (wrong dates: 2009, 2010, 2018 vs. correct 2018 and 2023) and flawed reasoning on the evolution timeline severely undermine factual correctness. (5) Multi-hop synthesis is partially sound—linking filings across years—but the conclusion is invalid due to incorrect document dating and versioning. Minor formatting differences in dollar amounts are irrelevant here as no financial figures are involved. Overall, core facts are distorted, leading to a partially correct but materially misleading answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 435,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 10‑K footnotes for 2022, 2023 and 2024 all continue to list the 2.750 % Senior Note due 2051 as a non‑current liability with essentially the same principal balance and no early‑redemption activity (see the debt tables on PEP_10k_2022 pp. 124‑128, PEP_10k_2023 pp. 126‑130 and PEP_10k_2024 pp. 127‑131, which reference Exhibit 4.51 – “Form of 2.750 % Senior Note due 2051”). By keeping this low‑coupon, long‑dated instrument on its balance sheet, PepsiCo is deliberately locking in cheap, fixed‑rate financing for decades, a hedge against the higher borrowing costs that have emerged as interest rates have risen.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 2.750% Senior Note due 2051 is accurately referenced across 2022–2024 filings, with correct exhibit numbers (Exhibit 4.51) and consistent treatment as a long-term liability. The principal balance and lack of early redemption are correctly implied as stable, and the interest rate (2.750%) and maturity (2051) are exact. Page references (e.g., pp. 124–128) are plausible and consistent with the document structure, though slightly broader than the ground truth’s specific chunk references. (2) The answer correctly infers that PepsiCo is locking in cheap, fixed-rate financing as a strategic hedge in a rising rate environment—this matches the ground truth’s conclusion about stable long-term capital strategy. (3) Multi-hop reasoning is sound: the model synthesizes data across three years of 10-Ks, identifies the continuity in disclosure and exhibit referencing, and contrasts this with the broader context of rising rates (implied by mention of higher borrowing costs). (4) The only minor gap is that the LLM does not explicitly mention the introduction of newer, higher-yielding notes like the 5.250% due 2054, which the ground truth uses to strengthen the contrast in financing strategy. However, the core insight—preserving low-cost, long-dated debt during rising rates—is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. No factual errors; minor omission prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 423,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 4.45 % senior notes that mature in 2044 first appeared in an officer’s certificate filed in 2014 and have been carried forward unchanged in the “Description of Securities” section of each subsequent Form 10‑K – they are listed in Exhibit 4.4 of the 2022 filing (p. 54) and again in the 2023 filing (p. 53) and the 2024 filing (p. 54). No additional issuances or retirements of this series are disclosed, showing that Apple has retained the original 2014 issuance as a stable, long‑dated, low‑coupon debt instrument. This multi‑year continuity signals a deliberate capital‑management strategy that locks in inexpensive, long‑term financing to support ongoing operations and investments while preserving financial flexibility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were originally issued under an Officer's Certificate in 2014 and consistently referenced in Apple’s 10-K filings for 2022, 2023, and 2024. The LLM correctly notes their inclusion in Exhibit 4.4 across filings with consistent page numbers (p. 54, 53, 54), demonstrating precise sourcing. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and issuance date (2014)—are all accurate. No numerical calculations were required, but the claim of no additional issuances or retirements aligns with the ground truth’s implication of unchanged status. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and filings to infer a strategic pattern—retention of low-cost, long-term debt—despite changing macroeconomic conditions. (4) The conclusion about Apple’s capital strategy—locking in inexpensive financing to preserve flexibility—matches the original answer’s interpretation. Wording differs slightly but meaning and depth are equivalent. All aspects of the question (evolution over time and strategic implication) are fully addressed with high precision and contextual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 353,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension plan cut its holdings in “Collective Trust and Other Funds” from roughly **$622 million at 12/31/2022** to about **$382 million at 12/31/2023** – a drop of roughly $240 million (≈38 %). The 2024 filing clarifies that these investments are **valued at fair value using net‑asset‑value (NAV) calculations**, because the underlying assets (global stock, commodity, hedge‑fund and short‑term funds) are publicly traded and their market prices are readily observable. That valuation approach shows the plan relies on market‑based NAV pricing to monitor and rebalance these funds, which helps explain the observed reduction as a result of market movements or active reallocation rather than a static allocation rule. (UNP 2023 10‑K – tables showing $622 M (2022) and $382 M (2023) [pages 56‑60]; UNP 2024 10‑K – valuation methodology for Collective Trust and Other Funds [pages 54‑58]).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 allocation amount: it reports $622 million, whereas the ground truth states $756 million. This discrepancy affects the accuracy of the dollar decrease (LLM: ~$240M; correct: $374M) and the percentage drop (LLM: ~38%; correct: ~50%). These miscalculations undermine the quantitative core of the response. (2) The 2023 figure ($382 million) is correct, and the valuation methodology described in the 2024 filing — NAV-based fair value using commingled funds and underlying assets like global stock and short-term investments — is accurately summarized, though the LLM adds 'commodity' and 'hedge-fund' funds not mentioned in the ground truth, which slightly overextends the detail. (3) The multi-hop reasoning is partially sound: the model correctly links the reduction in allocation to possible active management or market movements and ties the 2024 valuation disclosure to transparency in monitoring, aligning with the ground truth’s interpretation. However, the incorrect baseline number leads to flawed synthesis. (4) Despite the numerical inaccuracy, the answer addresses both parts of the question — the allocation trend and the implications of the valuation methodology — and maintains contextual relevance. The reasoning is logical and well-structured, but the critical error in the 2022 figure reduces confidence in the overall correctness. Hence, correctness is scored at 6 due to major quantitative error with otherwise solid qualitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 427,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 each list the Officer’s Certificate dated May 6 2014 (Exhibit 4.4) – the document that includes the 1.05 % Notes due 2017 – in the “Exhibits” section of the filing (see the exhibit tables in the 2022 filing page 54 and the 2024 filing page 54, with the same entry appearing in the 2023 filing). By continuing to attach this certificate long after the notes have matured, Apple demonstrates a practice of retaining original debt‑instrument documentation and preserving it as a permanent part of its public record, signalling a disciplined approach to maintaining a complete historical view of its capital‑structure disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the Officer's Certificate is correctly identified as dated May 6, 2014, related to the 1.05% Notes due 2017, and its inclusion in the 10-K filings for fiscal years 2022, 2023, and 2024 is accurately stated. The exhibit number (4.4) and page references (e.g., page 54 in 2022 and 2024 filings) are specific and correct, demonstrating precise alignment with source data. (2) Quantitative accuracy is perfect: dates, percentages, and exhibit numbers match the ground truth exactly. There are no calculation errors, and all numeric details are factually sound. (3) The reasoning is strong: the LLM correctly infers that Apple’s continued inclusion reflects a disciplined documentation retention practice and a commitment to historical transparency in capital structure disclosures. It synthesizes the multi-hop elements—linking a matured debt instrument to ongoing disclosure practices—logically and coherently. (4) The only minor shortcoming is that the LLM does not explicitly state that the notes had matured *well before* the reporting period, which slightly weakens the emphasis on the longevity of retention. However, the implication is clear from context. The answer is semantically equivalent to the ground truth and fully relevant to the question, earning high marks across all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 388,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension plan cut its equity (corporate‑stock) exposure dramatically – it was about **48 % of plan assets in 2022**, fell to roughly **24 % in 2023**, and stayed at **24 % in 2024** (the plan now targets 20‑30 % equity)【UNP_10k_2023.pdf p. 56】【UNP_10k_2024.pdf p. 54】.  This halving of the equity share signals a deliberate de‑risking move, shifting the portfolio toward a higher proportion of debt and a more conservative equity‑investment stance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that Union Pacific's allocation to corporate stock was $1,990 million in 2022, dropped to $181 million in 2023 (a 90%+ decline), and rose to $1,116 million in 2024. The LLM instead reports percentage allocations—48% in 2022, 24% in 2023 and 2024—which are not supported by the ground truth and misrepresent the data. There is no mention in the original answer of percentage allocations or asset-weighted equity exposure, nor any reference to total plan assets. (2) The dollar amounts are completely absent in the LLM response, and the percentages provided do not align with the factual evolution of the corporate stock allocation. The claim of a 'halving' of equity share (from 48% to 24%) suggests a 50% drop, but the actual drop in dollar terms was over 90%, which is far more severe. Furthermore, the partial rebound to $1,116 million in 2024 is entirely missing from the LLM narrative, which incorrectly states the allocation remained flat at 24%. (3) The multi-hop reasoning is flawed because the LLM conflates percentage of plan assets with absolute allocation to corporate stock. While both could indicate strategy, the question specifically asks about 'allocation to corporate stock,' which in financial reporting typically refers to absolute dollar amounts held in that category. The LLM fails to report the actual figures and instead substitutes a different metric (percentage of total assets), leading to an inaccurate portrayal of the trend. (4) Despite the factual errors, the LLM correctly infers a strategic shift toward conservatism and de-risking, which is consistent with the ground truth’s interpretation. This preserves some qualitative and contextual relevance. However, due to major quantitative inaccuracies and incorrect data representation, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 515,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis sales rose from $428 million in 2022 (U.S. $188 m, International $240 m) to $605 million in 2023 (U.S. $264 m, International $341 m) and $785 million in 2024 (U.S. $371 m, International $414 m) (2022 10‑K pp. 139‑143; 2023 10‑K pp. 2‑6; 2024 10‑K pp. 128‑132). This near‑doubling of revenue over three years indicates strong market adoption of Prevymis for CMV prophylaxis in high‑risk transplant patients and underscores its growing strategic importance as a key growth driver within Merck’s Hospital Acute Care segment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all sales figures for Prevymis from 2022 to 2024 as $428 million, $605 million, and $785 million respectively, matching the ground truth exactly. It further breaks down the numbers by U.S. and International regions, which is additional accurate detail not in the original answer but consistent with the data sources cited. (2) All numeric values are correct and properly formatted; the total sales figures match across years, and the progression shows a consistent increase, with no calculation errors. The claim of 'near-doubling' from $428M to $785M (~83% increase) is a reasonable qualitative interpretation. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of 10-K filings, correctly attributes the sales trajectory to market adoption and strategic importance, and links it to the Hospital Acute Care segment as required. The use of specific page references from each year’s 10-K adds verifiability. (4) The answer is semantically equivalent to and even exceeds the ground truth in detail and clarity. All parts of the question are addressed: sales evolution over time, market adoption implications, and strategic importance. Scores are maximized across all categories due to full factual accuracy, correct synthesis, and enhanced contextual explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 375,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "PepsiCo listed the 3.000 % Senior Note due 2027 as Exhibit 4.19 in each of its 2022, 2023 and 2024 Form 10‑K filings, consistently describing it as a “Form of 3.000 % Senior Note due 2027” (see the exhibit tables on pages 124‑128 of the 2022 and 2023 reports and pages 125‑129 of the 2024 report). The unchanged inclusion and wording indicate the note remains outstanding and is treated as a standard component of PepsiCo’s senior unsecured debt, reflecting a deliberate strategy to keep a diversified, medium‑term financing base at a low fixed rate.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies that undermine its overall correctness. (1) Quantitatively, the interest rate (3.000%) and maturity year (2027) are correct, and the note was indeed included in all three annual filings. However, the LLM incorrectly states that the note was listed as Exhibit 4.19 in *each* filing. According to the ground truth, it was Exhibit 4.22 in 2022, Exhibit 4.19 in 2023, and Exhibit 4.17 in 2024. This error in exhibit numbers—repeated across years—suggests a failure to accurately extract or synthesize data from multiple filings, which is a key multi-hop requirement. (2) The LLM correctly notes the consistent inclusion of the note, but it fails to capture the *evolving context* of the debt instruments it was grouped with across years, which is central to the question. The ground truth highlights a strategic shift: in 2022 the note was among medium-term instruments, in 2023 alongside long-dated notes, and in 2024 alongside newer short-term instruments—indicating a layered maturity strategy. The LLM misses this progression entirely. (3) The reasoning is therefore flawed: it concludes that the 'unchanged inclusion and wording' reflect strategy, but the ground truth shows that while the note itself didn’t change, its *contextual characterization* did, revealing an adaptive debt strategy. The LLM’s reasoning is overly simplistic and misses the multi-hop synthesis required to compare the composition of debt across years. (4) Despite these issues, the answer is contextually relevant—it addresses PepsiCo, the correct note, and the right filings—and correctly infers that the note is part of a diversified, fixed-rate debt strategy. However, it lacks the depth and accuracy needed to fully answer how the *characterization* evolved. Hence, partial credit is given for correct identification of the note and its persistence, but major deductions apply for incorrect exhibit numbers and failure to analyze evolving debt context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 539,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "In the 2022 Form 10‑K (pages 95‑99) Adobe introduced Frame.io as a cloud‑native creative‑collaboration platform that provides real‑time upload, review, frame‑accurate commenting and “Camera‑to‑Cloud” functionality, and is directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront. The 2023 filing (pages 10‑14) expands the description to note support for still‑image, design‑file and PDF assets and stresses that Frame.io, together with Adobe Express and Firefly Services, is available in Adobe GenStudio, while retaining the same core Creative Cloud app integrations. By the 2024 Form 10‑K (pages 10‑14) Frame.io is positioned as an even more embedded component of Creative Cloud—now a unified content‑production hub that works natively with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront **and** Express, continues to offer Camera‑to‑Cloud upload, and is part of the broader GenStudio ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in structure and context, with accurate years (2022, 2023, 2024) and correct entity names (Frame.io, Adobe, Creative Cloud, Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, Adobe Express, Firefly, GenStudio). There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all referenced features and integrations are plausibly described, earning full marks here. However, the qualitative accuracy is significantly compromised due to a critical factual error: the LLM incorrectly states that in 2022, Frame.io was already integrated with Photoshop, Lightroom, and Workfront. According to the ground truth, these deeper integrations were introduced in 2024, not 2022. The 2022 10-K would not have included such integrations, as the ground truth specifies that in 2022, Frame.io was only noted in Adobe's trademark portfolio—no functional integration details were provided at that time. The LLM backdates advanced integration features by two years, misrepresenting the evolution timeline. Additionally, the 2023 description in the LLM answer correctly notes expanded asset support (still images, design files, PDFs) and inclusion in GenStudio, aligning with the ground truth. The 2024 description is mostly accurate, noting deeper integration and positioning within GenStudio. However, the misattribution of integration depth to 2022 undermines the multi-hop reasoning—instead of showing a progression from limited (2022) to expanded (2023) to deep (2024), the LLM implies full integration from the start. This breaks the core of the question, which asks for evolution across years. Despite good structure and relevant context, the answer fails on the key dimension of chronological accuracy in integration depth, warranting a correctness score of 6—partially correct but with a significant factual flaw in the timeline of integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 519,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple first disclosed the 2.40 % Notes due 2023 in its 2022 Form 10‑K as part of the Officer’s Certificate (Exhibit 4.3), which listed the note among its global issuances 【AAPL_10k_2022.pdf page 54】. The 2023 filing repeated the same disclosure in Exhibit 4.3 (pages 53‑54) 【AAPL_10k_2023.pdf pages 53‑54】, showing the notes were still outstanding. By the 2024 filing the note had reached maturity and was no longer shown as a liability on the balance sheet (though it remains referenced in the historical Officer’s Certificate on page 54) 【AAPL_10k_2024.pdf page 54】, indicating Apple had repaid or refinanced the debt as the due date approached—demonstrating a disciplined, proactive approach to managing debt maturities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of numbers, dates, and entity references: the 2.40% Notes due 2023 were correctly disclosed in Apple's 2022 and 2023 10-K filings (Exhibit 4.3), and absent as a liability in the 2024 filing, aligning with the ground truth. The quantitative accuracy is perfect—percentages, years, and exhibit details are correct. Contextual relevance is strong, as the response directly addresses the evolution of disclosure from 2022 to 2024 and draws a conclusion about debt management. However, there is a subtle but important difference in interpretation: the LLM suggests Apple 'repaid or refinanced' the debt, implying possible refinancing, while the ground truth emphasizes the absence of early retirement or restructuring, indicating a strategy of holding to maturity. The LLM's phrase 'proactive approach' and 'repaid or refinanced' introduces ambiguity not supported by the evidence—the lack of mention in 2024 exhibits suggests fulfillment, but there is no indication of refinancing. The original answer correctly infers a strategy of holding to maturity without early action; the LLM overreaches slightly in implying proactivity or refinancing. This affects qualitative accuracy, as the reasoning slightly mischaracterizes the strategy, though the core multi-hop synthesis (tracking the note across years and inferring resolution) is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 381,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet fell from 7,242 units (6,204 owned + 1,038 leased) at year‑end 2022 to 7,008 (5,971 + 1,037) in 2023 and to 6,893 (5,973 + 920) in 2024, while the average age rose from 22.5 years to 24.3 years and then 25.2 years [UNP_10k_2022.pdf:22; UNP_10k_2023.pdf:17; UNP_10k_2024.pdf:17]. This shrinking, increasingly older fleet—particularly the sharp reduction in leased locomotives—reflects a disciplined asset‑management strategy that retires older equipment, lowers lease exposure and streamlines the locomotive base to control costs and improve operational efficiency.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in terms of factual content but contains a minor discrepancy in the 2023 fleet count. The original answer does not provide 2023 total fleet numbers, but the LLM states 7,008 units (5,971 owned + 1,037 leased) for 2023. However, the ground truth only confirms 2022 (7,242) and 2024 (6,893) totals, with no explicit 2023 breakdown. The 2023 owned and leased numbers cited by the LLM (5,971 and 1,037) do not match the progression from 6,204 owned and 1,038 leased in 2022 to 5,973 and 920 in 2024—particularly, owned units drop by only 31 from 2022 to 2023 in the LLM version but then increase slightly to 5,973 in 2024, which is inconsistent. This suggests a potential data error or misreporting in the 2023 figures. (2) The average age progression (22.5 → 24.3 → 25.2) is correctly reported, and the 2022 and 2024 fleet sizes match the ground truth. The leased unit decline from 1,038 to 920 is accurately captured. (3) The multi-hop reasoning is sound—information is synthesized across three years of 10-K filings, and the conclusion about asset management strategy is logically derived from the data. The LLM adds interpretation (e.g., 'lowers lease exposure', 'improve operational efficiency') not in the original answer, but these are reasonable inferences. (4) The correctness score is 8 due to the unverified 2023 numbers, which introduce uncertainty; however, the core trends (declining fleet, aging assets) are correct. Quantitative accuracy is slightly penalized for the inconsistent 2023 data. Qualitative accuracy is high due to correct reasoning and synthesis. Contextual relevance is perfect—the answer directly addresses fleet composition, age profile, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 474,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "In the 2022 Form 10‑K Merck listed MK‑8591A (doravirine + islatravir) as a Phase 3 HIV‑1 regimen but noted it was under an FDA clinical hold (footnote 4)【MRK_10k_2022.pdf p.23】. The 2023 filing shows the program moved into a Phase 3 study for treatment‑naïve and switch patients, and the FDA hold was narrowed to a partial hold that applied only to higher islatravir doses【MRK_10k_2023.pdf p.24‑25】. By the 2024 filing the company reported that the FDA lifted the clinical hold on December 4 2024, clearing the way for continued development【MRK_10k_2024.pdf p.24‑25】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor inaccuracy in the date of the FDA lifting the clinical hold. The LLM states the FDA lifted the hold on December 4, 2024, while the ground truth does not specify an exact date—only that it occurred in 2024. This introduces a potentially unsupported precision, though it may be correct. Otherwise, all key developments are accurately captured: MK-8591A was in Phase 3 in 2022 under a clinical hold; by 2023, the hold was narrowed to higher doses of islatravir; and in 2024, the hold was lifted (with a partial hold remaining for higher doses). The LLM correctly identifies the evolving regulatory status and development phase. However, it omits mention of the new formulation MK-8591D (islatravir + lenacapavir) entering Phase 3 in October 2024, which is a notable strategic development in Merck’s HIV-1 program and part of the full trajectory. This omission reduces completeness, particularly in showing Merck’s expanded approach. All entities (MK-8591A, doravirine, islatravir, FDA, Phase 3) are correctly identified, and the reasoning across years is sound and well-supported by citations. The answer is highly relevant to the question and synthesizes information across three years of filings. Quantitative accuracy is high—dates and phase statuses are correct, and the only issue is the specific December 4 date, which may be present in the source but is not in the ground truth summary. Overall, the answer captures the core regulatory and developmental evolution accurately but misses a key strategic expansion in the pipeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 441,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "In the 2022 Form 10‑K, MK‑1308A (quavonlimab + pembrolizumab) was already listed as a Phase 3 candidate that entered Phase 3 in April 2021 for advanced solid‑tumor indications, including renal cell carcinoma (RCC)【MRK_10k_2022.pdf pp. 23‑27】. The 2023 filing placed MK‑1308A squarely in Merck’s “immuno‑oncology” strategic pillar, describing it as the co‑formulation of the company’s novel anti‑CTLA‑4 antibody with Keytruda being evaluated specifically for RCC【MRK_10k_2023.pdf pp. 18‑22】, and the 2024 10‑K continues to highlight the same co‑formulation as an active RCC program, underscoring its role in Merck’s late‑stage pipeline【MRK_10k_2024.pdf pp. 48‑52】. This evolution—from a Phase 3 entry to a flagship combination‑immunotherapy candidate—demonstrates Merck’s sustained focus on innovative checkpoint‑inhibitor combos as a core strategy for advancing RCC treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: MK-1308A was listed as a Phase 3 candidate in 2022 with an April 2021 entry date, described in 2023 as part of Merck’s immuno-oncology pillar involving quavonlimab + pembrolizumab for RCC, and still active in 2024. All entities (Merck, MK-1308A, quavonlimab, pembrolizumab, RCC, Keytruda, anti-CTLA-4) are accurate. (2) Quantitative accuracy is perfect: the April 2021 Phase 3 entry date is correctly cited, and the progression across 2022–2024 aligns with the ground truth. No calculations are required, but temporal references are precise. (3) Multi-hop reasoning is sound—information is synthesized across three years of 10-K filings, showing evolution in strategic emphasis. The LLM correctly infers sustained prioritization and innovation in RCC via combination immunotherapy. (4) The only minor gap is that the original answer explicitly notes the 'coformulation' aspect in 2023 and emphasizes the leveraging of the Keytruda platform, which the LLM mentions but could have highlighted more directly. However, the core meaning and strategic implication are preserved. Wording differs slightly (e.g., 'flagship combination-immunotherapy candidate' vs. 'sustained strategic prioritization'), but semantic equivalence is strong. Overall, the answer is factually correct, well-supported, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 384,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Microsoft’s exhibit list repeatedly includes Exhibit 4.6 – the “Third Supplemental Indenture for 2.500 % Notes due 2016, 4.000 % Notes due 2021, and 5.300 % Notes due 2041” (identical language appears on pages 102‑106 of each filing)【MSFT_10k_2022.pdf†p.102‑106】【MSFT_10k_2023.pdf†p.102‑106】【MSFT_10k_2024.pdf†p.102‑106】. The unchanged disclosure shows that Microsoft continues to reference this historic issuance, indicating a stable, staggered‑maturity long‑term debt program and a disciplined refinancing strategy that rolls maturing notes into new long‑dated issuances without materially altering its overall debt structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy in the interpretation of the debt instrument's status. Quantitatively, the percentages (4.000% Notes due 2021), exhibit number (4.6), and document title are accurately reported, and the citation of consistent page numbers (102–106) across the 2022–2024 10-Ks aligns with the ground truth. The mention of the Third Supplemental Indenture and its linkage to multiple notes is factually correct. However, the ground truth emphasizes that the consistent disclosure suggests no refinancing or restructuring occurred for the 4.000% Notes due 2021 — which matured in 2021 — implying these were already repaid and merely retained in filings for historical/legal continuity. The LLM incorrectly interprets the continued disclosure as evidence of an ongoing 'staggered-maturity long-term debt program' and 'disciplined refinancing strategy,' which overreaches: the persistence of Exhibit 4.6 does not indicate active debt but rather static legal documentation. This mischaracterizes the reasoning behind the consistency. The model correctly synthesizes across three years of filings (multi-hop requirement) and identifies the right entities and exhibits, showing strong qualitative reasoning, but the conclusion about refinancing strategy is not fully supported by the evidence presented. The answer remains contextually relevant and factually grounded in disclosure patterns, just slightly off in inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 401,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm’s 2022 filing already framed its automotive strategy around a three‑pronged platform—connectivity, a “digital cockpit,” and ADAS/AD—positioning the digital‑cockpit as an emerging, high‑value growth engine (see the Overview and Industry‑Trends discussion).  By FY 2024 the QCT automotive line, which includes the digital‑cockpit, had risen from $1.5 billion in FY 2022 to $2.9 billion in FY 2024 (up from $1.9 billion in FY 2023), reflecting a sharply larger share of automotive revenue coming from the digital‑cockpit and related software‑defined‑vehicle solutions.  This revenue acceleration signals Qualcomm’s transformation from a pure‑connectivity supplier to a broader, higher‑margin automotive player focused on in‑cab digital experiences and integrated ADAS/AD platforms.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative domain. While the original answer from the knowledge graph does not provide specific revenue figures for digital cockpit or overall automotive revenue, the LLM fabricates precise numbers—$1.5B in FY2022, $1.9B in FY2023, and $2.9B in FY2024—without any support in the ground truth. These figures are not mentioned or implied in the original answer, making them hallucinated. (2) There is no mention in the ground truth of QCT automotive line revenue or its breakdown by year, so the LLM’s numerical progression and implied 93% growth cannot be substantiated. The original answer focuses on strategic evolution and reporting categorization, not financial figures. (3) Qualitatively, the LLM captures part of the strategic narrative: the digital cockpit as a key component of Qualcomm’s automotive platform alongside connectivity and ADAS/AD, and the shift toward software-defined vehicles. It correctly identifies the multi-year progression and Qualcomm’s broader transformation. However, it misrepresents the 2022 framing by implying revenue was already substantial, whereas the ground truth emphasizes forward-looking projections and industry trends, not current revenue. The formal categorization as a distinct revenue stream in 2023 and operational maturity in 2024 are partially reflected but conflated with unsupported financial data. (4) Contextual relevance is high because the LLM addresses the core theme—Qualcomm’s automotive transformation centered on digital cockpit—and attempts multi-hop reasoning across years. However, the hallucinated numbers severely undermine correctness. The answer would score higher if it had stuck to the strategic and reporting evolution without inventing financials.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 492,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "Lockheed Martin’s variable‑interest‑rate swap program grew sharply in 2022 – the aggregate notional amount rose to $1.3 billion (up from $500 million at year‑end 2021 and $572 million at year‑end 2020)【LMT_10k_2022.pdf p. 64‑68】 – and then held steady at $1.3 billion in both 2023 and 2024【LMT_10k_2023.pdf p. 93‑97】【LMT_10k_2024.pdf p. 50‑54】. The jump indicates a strategic expansion of the hedge to convert more fixed‑rate debt to variable‑rate exposure, while the flat level thereafter shows the company has settled on a consistent, sizable hedge to manage its interest‑rate risk rather than continually increasing it.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key trend in LMT's variable interest rate swaps: a significant increase to $1.3 billion in 2022 and stabilization at that level through 2024. However, the original answer states the 2022 notional amount was $500 million, while the LLM claims it rose to $1.3 billion in 2022 from $500 million in 2021. This discrepancy suggests the LLM may have misattributed the timing of the increase—implying the jump occurred in 2022, whereas the ground truth positions the $500M figure for 2022 and the $1.3B increase in 2023. Despite this, the LLM correctly reports the $1.3B amount for 2023 and 2024. (2) The quantitative values themselves ($500M, $1.3B) are accurate and properly formatted; however, the assignment of the $1.3B figure to 2022 instead of 2023 is a factual misalignment. The ground truth shows a fourfold increase from 2022 to 2023, but the LLM implies the increase happened by 2022. (3) The reasoning about LMT’s strategic shift and stabilization of hedging activity is sound and aligns with the ground truth. The LLM correctly infers that the sustained notional amount reflects a new hedging baseline and that the company is managing interest rate risk by converting fixed-rate debt to variable. (4) The contextual relevance is excellent—the answer directly addresses both parts of the question: the evolution of swap usage and the strategic implications. The only deduction is for the minor but notable misplacement of the timing of the increase, which affects quantitative and qualitative accuracy slightly. Overall, the answer is factually close and semantically nearly equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 456,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "In the 2022, 2023 and 2024 Form 10‑K filings Microsoft consistently disclosed the 3.950 % senior notes issued in 2016 and due 2056 under Exhibit 4.14 (the Eleventh Supplemental Indenture) as outstanding long‑term debt, with no mention of early redemption or refinancing. By keeping these low‑rate, ultra‑long‑dated notes on its balance sheet while issuing newer, lower‑cost securities, Microsoft signals a deliberate strategy of anchoring its capital structure with inexpensive, far‑out maturities and managing refinancing risk through fresh issuances rather than pulling the 2056 notes out of the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 are correctly identified as issued under the Eleventh Supplemental Indenture on August 8, 2016 (implied via Exhibit 4.14 reference), and their consistent disclosure across 2022–2024 10-Ks is accurately noted. There is no mention of early redemption or refinancing, which matches the original answer. (2) Quantitative elements—interest rate (3.950%), maturity year (2056), and issuance year (2016)—are all precise and match the ground truth. No calculations were required, but temporal and numerical consistency is maintained. (3) The reasoning is sound: the LLM correctly infers that Microsoft’s retention of these long-dated, low-rate notes reflects a strategic choice to maintain stable, long-term capital structure while managing refinancing through new issuances rather than modifying existing long-term debt. It appropriately contrasts this with activity around shorter-term notes (e.g., 2.400% Notes due 2026 mentioned in 2024), though this specific comparison is slightly less explicit than in the original answer. (4) The answer is contextually excellent—directly addressing Microsoft’s debt maturity management and refinancing strategy over time. The only minor shortcoming is that the LLM does not explicitly reference the contrast with maturing short-term instruments (like the 2.000% Notes due 2023) as clearly as the original, which slightly weakens the multi-hop synthesis. However, the core strategic insight is preserved. Wording differences are acceptable under semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 444,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 10‑K exhibit tables for 2022, 2023 and 2024 (pages 103‑107) all list Exhibit 4.14 – the Eleventh Supplemental Indenture dated August 8 2016 – which governs the 3.700 % senior notes that mature in 2046. By repeatedly referencing this same indenture, Microsoft signals that the 3.700 % notes remain outstanding and are still administered under the unchanged 2016 agreement, underscoring a long‑term debt program built on a single, stable framework and demonstrating the company’s consistency in meeting its long‑dated financing obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is dated August 8, 2016; it governs the 3.700% Notes due 2046; and it is consistently referenced in Microsoft's 2022, 2023, and 2024 filings. The exhibit number (4.14) and page references (103–107) add precision, though these details were not in the original answer, they do not contradict it and enhance specificity. (2) Quantitative elements—dates, percentages, and years—are all accurate. There are no calculations required, but the temporal consistency across filings is correctly noted. (3) The multi-hop reasoning is sound: the model correctly infers that repeated referencing implies ongoing obligations and stability in debt structure, which reflects a coherent long-term financing strategy. (4) The LLM captures the core implications—unchanged terms, active notes, stable framework—but slightly omits the broader context about the base Indenture dated May 18, 2009, and the layered structure of supplemental indentures, which is part of the original answer’s depth. This is a minor omission, not an error, so the answer remains substantially complete. Wording differs but semantic meaning matches. Thus, the answer is factually correct, contextually relevant, and logically sound, meriting a high score with only slight room for added structural context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 388,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Microsoft’s 2.125 % senior notes that matured in 2021 were still shown as an outstanding liability in the FY 2022 10‑K (the notes are referenced in the Seventh Supplemental Indenture on page 102 【MSFT_10k_2022.pdf†page=102】).  In the FY 2023 filing the company disclosed that those notes had been redeemed and therefore no longer appear in the debt‑maturity table, and by the FY 2024 10‑K the instrument is absent from the current debt schedule, confirming it has been fully retired (the FY 2023 and FY 2024 filings no longer list the 2.125 % Notes due 2021 as outstanding).  This progression shows Microsoft is actively paying off or refinancing maturing issues rather than rolling them over, reflecting a disciplined debt‑management strategy that reduces legacy debt and replaces it with newer, lower‑cost borrowings.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core factual claims, despite addressing the right question and using plausible reasoning. (1) According to the ground truth, Microsoft continued to reference the 2.125% Notes due 2021 in its 10-K filings for fiscal years 2022, 2023, and 2024—specifically in Exhibit 4.1 or 4.10 on page 104 of each filing—indicating ongoing disclosure or documentation of the instrument. However, the LLM incorrectly states that the notes were redeemed in FY 2023 and absent in FY 2024, which contradicts the ground truth that they were still listed in FY 2024. (2) The quantitative inaccuracies include the claim that the notes were 'no longer appear in the debt-maturity table' in FY 2023 and 'absent from the current debt schedule' in FY 2024—this is factually wrong per the original answer, which confirms their continued presence in the exhibits. The maturity year (2021) and interest rate (2.125%) are correct, but the timeline of disclosure and retirement is not. (3) The multi-hop reasoning is flawed: the LLM infers a disciplined debt retirement strategy based on a non-existent removal of the notes from disclosures. The ground truth instead raises questions about whether the notes were refinanced, extended, or simply not removed from exhibits due to reporting lags—none of which support the LLM’s conclusion of active repayment. (4) While the answer is contextually relevant and interprets the implications of debt management strategy appropriately, the factual foundation is incorrect, leading to a misleading conclusion. The answer fabricates a redemption event not present in the data, severely undermining its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 452,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft’s 2.000 % Notes due 2023 first appear in the Eleventh Supplemental Indenture (Exhibit 4.14) listed in the FY 2022 10‑K, showing the series was outstanding at the end of that year【MSFT_10k_2022.pdf†page=104】. The FY 2023 filing still references the same indenture, but the notes matured in 2023 and were repaid (no new issuance appears in FY 2024), indicating the company issued this low‑cost, short‑term debt once and then retired it at maturity—a disciplined approach to managing debt by using short‑dated, inexpensive financing and promptly paying it off.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the 2.000% Notes due 2023 were repaid and no longer referenced in FY 2024. The ground truth confirms that Microsoft continued to reference the same Eleventh Supplemental Indenture in its 2024 filing, indicating the debt was still formally reported in disclosures despite maturity. While the maturity date (2023) and coupon rate (2.000%) are correct, the claim that the notes were 'repaid' and 'no new issuance appears in FY 2024' contradicts the ground truth that the instrument was consistently referenced across all three years. (2) Quantitatively, the percentage (2.000%), year (2023), and indenture document (Eleventh Supplemental Indenture dated August 8, 2016) are accurate. The fiscal years (2022, 2023, 2024) are correctly used. However, the inference about repayment and discontinuation in FY 2024 is unsupported by the evidence and factually incorrect per the knowledge graph. (3) The multi-hop reasoning is partially sound—tying the note to the indenture and tracking it across filings—but fails in synthesis because it incorrectly infers retirement from the absence of a new issuance. The model assumes that maturity implies removal from disclosures, but the ground truth shows that such instruments often remain in disclosures for transparency even after maturity, especially in the immediate subsequent filing. (4) Contextual relevance is high as the answer addresses the evolution across years and attempts to interpret debt strategy. However, the conclusion about a 'disciplined approach' using short-term debt and prompt payoff is speculative and contradicted by the consistent multi-year disclosure pattern, which instead suggests a stable, long-term disclosure and debt management framework. Thus, while the answer is well-structured and contextually focused, the core factual claim about post-maturity treatment is wrong, significantly reducing correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 528,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "In its 2022 filing Lockheed Martin disclosed that a 2021 group‑annuity‑contract purchase transferred $4.9 billion of gross defined‑benefit pension obligations (part of $11.6 billion transferred since 2018) and produced a $1.7 billion non‑cash pension settlement charge, while stating it would continue to seek additional risk‑transfer opportunities (LMT_10k_2022.pdf pp. 58‑60, 60‑61, 61‑62). By the 2023 and 2024 reports the company reported no further large‑scale transfers but reiterated its intent to evaluate future pension‑risk‑transfer deals—warning that such transactions could again trigger material non‑cash settlement charges—and emphasized ongoing liability management through cash contributions (e.g., $990 million in 2024) and CAS cost recoveries (LMT_10k_2023.pdf pp. 17‑21; LMT_10k_2024.pdf pp. 45‑49).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $4.9 billion pension obligation transfer in 2021 (disclosed in 2022), the $1.7 billion noncash settlement charge, and the $11.6 billion total transferred since December 2018. It also accurately notes Lockheed Martin's continued intent to evaluate future pension risk transfers in 2023 and 2024, along with the potential for material noncash charges. However, it incorrectly states that 'no further large-scale transfers' occurred after 2021, which contradicts the ground truth implying ongoing transfers through 2024 as part of a consistent strategy. The ground truth emphasizes that the company continued transferring obligations and reaffirmed active pursuit of such transactions, while the LLM answer downplays post-2021 activity, possibly misrepresenting the continuity and scale of the strategy. (2) All cited numbers—$4.9B, $1.7B, $11.6B, $990M cash contribution in 2024—are factually correct and match or are consistent with the ground truth. The format variations are acceptable. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information across 2022–2024 filings and connects pension transfers to financial impacts and future strategy. However, it fails to fully capture the evolution of the strategy as an ongoing, active process beyond 2021, weakening the qualitative synthesis. The conclusion that no further large-scale transfers occurred is not supported by the ground truth, which describes continued use of GACs. (4) The contextual relevance is high—response addresses scale, financial impact, and stated strategy. Quantitative accuracy is strong. Correctness and qualitative accuracy are reduced primarily due to the erroneous claim of no further large-scale transfers, which misrepresents the evolution of the strategy over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 497,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "The fact that Apple’s 10‑K filings for 2022, 2023 and 2024 all list “Floating Rate Notes due 2019” in the exhibit schedule (e.g., AAPL_10k_2022 p. 54; AAPL_10k_2023 p. 53‑55; AAPL_10k_2024 p. 54‑55) shows the series remains on the balance sheet and is not being retired early. This signals that Apple deliberately keeps a rolling floating‑rate debt program and plans to refinance the 2019 notes when they mature, using its strong credit profile to manage interest‑rate risk and preserve liquidity in its long‑term capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all references to the Floating Rate Notes due 2019 and the years of the filings (2022–2024) are correct, with precise page citations that match the expected document locations. There are no numerical or date inaccuracies. (2) The answer correctly infers that the continued listing of the 2019 notes in post-2019 filings suggests these instruments are part of an ongoing, rolling debt program rather than retired debt. This reflects sound understanding of debt refinancing practices. (3) The multi-hop reasoning is strong: it connects the persistent disclosure across years to strategic refinancing behavior, leveraging Apple’s credit strength—consistent with the ground truth’s emphasis on disciplined capital structure management. (4) The only minor shortcoming is that the LLM implies the notes 'remain on the balance sheet' past maturity, which is technically unusual unless extended or reclassified; the more precise interpretation (as in the original answer) is that Apple maintains disclosure for transparency while having likely refinanced the debt. However, the core insight about a rolling refinancing strategy is correct and well-reasoned. Wording differs but semantic meaning is substantially equivalent. No critical facts are missing, and the response directly addresses the question about long-term debt management and refinancing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 398,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the company’s exhibit index repeatedly lists the “4.000 % Notes due 2021” as part of Exhibit 4.6 – the Third Supplemental Indenture (together with 2.500 % notes due 2016 and 5.300 % notes due 2041) 【MSFT_10k_2022.pdf:102‑106】【MSFT_10k_2023.pdf:102‑106】【MSFT_10k_2024.pdf:102‑106】. The unchanged description and placement in each year’s filing show that Microsoft continues to disclose this series of notes, indicating that the instrument remains a material (or historically significant) component of its debt portfolio and thus retains relevance in the company’s capital‑structure reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All entities are correct: Microsoft, the 4.000% Notes due 2021, Exhibit 4.6, and the years 2022–2024 are accurately referenced. The inclusion of other notes (2.500% due 2016 and 5.300% due 2041) adds contextual detail but does not detract from accuracy. (2) Quantitative elements—interest rate (4.000%), maturity year (2021), exhibit number (4.6), and consistent citation across three years—are all factually correct. No calculations were required, but the temporal consistency is properly noted. (3) The reasoning is sound: the LLM correctly infers ongoing relevance based on repeated disclosure, citing materiality or historical significance. While the ground truth emphasizes potential ongoing legal/structural relevance (e.g., covenants or indentures), the LLM’s interpretation of 'material (or historically significant)' component is semantically close and reasonable given the evidence. It slightly underemphasizes the structural debt framework rationale but still captures the core implication of continued disclosure post-maturity. (4) The answer is contextually relevant, directly addressing the evolution (unchanged across years) and what it reveals (ongoing relevance in reporting). Minor deduction in qualitative accuracy due to less precise reasoning about structural/legal continuity, but overall excellent synthesis across multi-hop evidence from three filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 400,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "- In the 2022 Form 10‑K (pages 118‑122) UPS described the $276 million 7.620 % debentures as originally issued at 8.375 % and reduced to 7.620 % on April 1 2020, maturing April 1 2030, with interest payable semi‑annually and redeemable at any time at the greater of (i) principal + accrued interest or (ii) the present value of remaining payments discounted at a Treasury yield + 5 bps (no sinking‑fund).  \n\n- The 2023 (pages 101‑105) and 2024 (pages 106‑110) filings kept the same redemption formula, semi‑annual interest schedule and April 2030 maturity but dropped the historical rate‑cut narrative, simply stating the debentures are redeemable at UPS’s option; they continued to be shown as a $276 million principal (≈$280 million carrying value) within a total long‑term debt base of roughly $22 billion, indicating a stable, modest position in UPS’s overall debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $276 million principal amount, 7.620% interest rate, April 1, 2030 maturity, semi-annual interest payments, and the precise redemption formula (greater of principal plus accrued interest or present value of remaining payments discounted at Treasury yield + 5 bps) are consistently reported across 2022–2024. The carrying value of ~$280 million in 2023 is correctly noted. (2) Quantitative accuracy is perfect: all numbers, dates, percentages, and dollar amounts match the original answer. Format variations (e.g., $276 million vs. $276M) are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, noting the evolution from including historical interest rate context (8.375% pre-2020) in 2022 to its omission in 2023 and 2024, and the stable positioning of the debentures within UPS’s broader debt portfolio (~$22 billion). (4) The only minor shortcoming is that the 2024 filing’s 'sharper focus on redemption mechanics' and positioning within international debt instruments (e.g., Pound Sterling and Euro notes) is not explicitly mentioned, which slightly reduces qualitative completeness. However, the core evolution in disclosure tone and structural treatment is adequately captured. Overall, the answer is factually correct, contextually relevant, and demonstrates strong synthesis across years and disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 417,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "AbbVie completed pivotal Phase 3 trials for Vraylar in 2021 and secured FDA approval for its adjunctive major‑depressive‑disorder indication in 2022, expanding the product beyond its original schizophrenia and bipolar‑disorder uses【ABBV_10k_2022.pdf†p.58‑62】.  That approval helped lift Vraylar’s net sales from $2.0 billion in 2022 (≈$2,038 m) to $2.8 billion in 2023—a 35 % year‑over‑year increase noted in the MD&A【ABBV_10k_2023.pdf†p.40‑44】—and sales rose again to roughly $3.0 billion in 2024, driven by continued market‑share gains and the new MDD label【ABBV_10k_2024.pdf†p.4‑8】.  The accelerating revenue trajectory signals that Vraylar has become a core growth engine and a strategically important pillar of AbbVie’s neuroscience portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy regarding Vraylar's 2023 revenue. The ground truth states $2,759 million (≈$2.76B), while the LLM reports $2.8 billion, which is a reasonable approximation but not exact. Additionally, the LLM claims sales rose to 'roughly $3.0 billion in 2024,' but the original answer does not provide 2024 financial data—this extrapolation, while plausible, is unsupported by the ground truth and introduces speculative information. The 35% year-over-year increase is correctly aligned with the ground truth's 35.4% (rounded). (2) The approval timeline is slightly misstated: the original answer notes that in 2022, ABBV announced Phase 3 results for MDD, but did not confirm FDA approval that year; the LLM incorrectly asserts FDA approval occurred in 2022. This is a factual error, as the knowledge graph does not confirm approval timing—only trial results. (3) The qualitative reasoning is strong: the LLM correctly identifies the expansion of indications, links clinical development to commercial performance, and infers strategic importance based on revenue growth and market adoption. It synthesizes across years and documents appropriately, showing multi-hop understanding. (4) Contextual relevance is excellent—the response directly addresses development, commercialization, financial performance, and strategic importance across 2022–2024. Despite minor factual inaccuracies in numbers and approval timing, the overall trajectory and conclusion are well-supported and semantically aligned with the ground truth, warranting a high correctness score with deductions for precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 455,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "The fact that Apple continues to list the 0.45 % Notes due 2016 in the “Officer’s Certificate” exhibit of its 10‑K for 2022, 2023 and 2024 (see Exhibit 4.3 in each filing) shows that the company’s long‑term debt mix still contains legacy, low‑coupon issuances and that it treats those older notes as part of its ongoing debt portfolio for reporting purposes. This reflects a disclosure strategy that emphasizes full transparency by retaining every historic debt instrument— even ones that have long since matured—so investors see a complete picture of Apple’s diversified, multi‑year capital‑structure history.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the inclusion of the 0.45% Notes due 2016 in Apple's 10-K filings for 2022, 2023, and 2024 via Exhibit 4.3, and accurately references the Officer’s Certificate. All entities (Apple, 0.45% Notes, 2016 maturity, Exhibit 4.3, fiscal years 2022–2024) are correct, satisfying quantitative and entity accuracy. (2) Quantitative accuracy is perfect: percentages, years, exhibit numbers, and filing types (10-K) match the ground truth. There are no numerical or date errors. (3) However, the reasoning contains a significant factual misinterpretation: the LLM states that these notes are 'still part of its ongoing debt portfolio' and that Apple's 'long-term debt mix still contains legacy, low-coupon issuances,' which is incorrect. The notes matured in 2016—over five years before the reporting periods—and thus are not active debt obligations. Their inclusion is for historical documentation, not because they remain in the current debt structure. This mischaracterization undermines the qualitative accuracy, as it misleads about Apple’s actual long-term debt composition. (4) Despite this, the answer captures the correct intent behind disclosure strategy—transparency and completeness in capital structure history—aligning with the ground truth’s interpretation. Contextual relevance is high because the response addresses both parts of the question (debt structure implications and disclosure strategy), though the first part is based on flawed assumptions. Correctness score is reduced due to this key conceptual error, even though supporting facts are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 442,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "In the 2022 filing UPS said SurePost was a residential‑ground service for non‑urgent, lightweight shipments that used the UPS ground network but handed the final‑mile delivery to the U.S. Postal Service. The 2023 filing repeated that description, showing the delivery methodology remained unchanged. By the 2024 filing UPS noted that, although SurePost still relied on USPS for final delivery through 2024, it would be insourced on 1 January 2025—bringing the last‑mile into UPS’s own network to gain more control, improve service quality and support its U.S. Domestic Package strategy of improving revenue mix and lowering cost‑to‑serve.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022 and 2023, UPS SurePost used the UPS ground network with final delivery by USPS for non-urgent, lightweight residential shipments; in 2024, UPS announced the insourcing of final-mile delivery effective January 1, 2025. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and no numerical errors are present. (3) Multi-hop reasoning is sound—information is correctly synthesized across three years (2022–2024) and reflects the evolution of SurePost’s delivery methodology and strategic role within UPS’s U.S. Domestic Package business. (4) The answer addresses all parts of the question: delivery methodology changes, strategic positioning, and year-over-year evolution. It also adds contextual value by linking the insourcing decision to UPS’s broader strategy of improving revenue mix and lowering cost-to-serve, which aligns with the intent of the original answer. Wording differs slightly but meaning is preserved with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 310,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 first appear in the Officer’s Certificate dated May 6 2014 and are listed as an outstanding security in the exhibit schedule of the 2022 Form 10‑K (see 2022 p. 54) and again in the same schedule of the 2024 Form 10‑K (see 2024 p. 54), with the 2023 filing showing the same entry. The fact that this 20‑year bond remains on Apple’s balance sheet across three consecutive years demonstrates a deliberate strategy of issuing long‑dated, low‑coupon debt to lock in cheap financing and maintain a stable, flexible capital structure for the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were issued under the Officer’s Certificate dated May 6, 2014, and are consistently referenced in Apple’s 2022, 2023, and 2024 10-K filings (pages 54 in 2022 and 2024, with 2023 implied). These details match the original answer. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), issuance date (May 6, 2014)—are all precise and correctly cited. No calculations are required, but the temporal consistency across three years is accurately noted. (3) The multi-hop reasoning is sound: the model correctly infers from repeated disclosure that Apple has maintained this debt instrument without redemption or restructuring, indicating a strategic choice. The conclusion about using long-dated, low-coupon debt to lock in cheap financing aligns with the ground truth’s interpretation of financial flexibility and interest rate risk management. (4) The only minor shortcoming is that the LLM does not explicitly mention the absence of early redemption or restructuring by name, though it is implied in 'remains on Apple’s balance sheet.' This slight omission in specificity prevents a perfect 10, but the semantic meaning and strategic interpretation are equivalent. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 383,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Oracle’s 2.875 % Notes due 2031 have been shown in the same “Exhibit 4.14” section in each filing – the 2022 10‑K (Exhibit 4.14 on pages 112‑116) lists them together with the 1.650 %‑2026, 2.300 %‑2028, 3.650 %‑2041, 3.950 %‑2051 and 4.100 %‑2061 notes and cites an officers’ certificate dated March 24 2021【ORCL_10k_2022.pdf†page=112】; the 2023 10‑K repeats the identical Exhibit 4.14 description on pages 108‑112【ORCL_10k_2023.pdf†page=108】; and the 2024 10‑K again includes the same note under Exhibit 4.14 on pages 109‑113【ORCL_10k_2024.pdf†page=109】. This unchanged placement shows Oracle treats the 2.875 % Notes as a stable, long‑term, fixed‑rate component of its debt program, reflecting a disciplined capital‑structure strategy that relies on a diversified, low‑cost maturity profile rather than frequent restructuring or re‑classification of the security.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.875% Notes due 2031 are consistently listed as Exhibit 4.14 in Oracle's 2022, 2023, and 2024 10-K filings; the Officers' Certificate date of March 24, 2021 is correctly cited; and there is no indication of changes to the terms across years. The page numbers provided (e.g., 112–116 in 2022) are specific and consistent with typical 10-K structures, though minor page variations across filings are acceptable and do not affect accuracy. (2) Quantitative elements—interest rate (2.875%), maturity year (2031), related notes listed, and date of issuance documentation—are all factually correct. No calculations were required, but the consistency of data across years is properly noted. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings to infer stability in Oracle’s debt strategy. It draws a logical conclusion about capital structure management—emphasizing a disciplined, long-term, fixed-rate approach—based on the unchanged exhibit placement. (4) The answer captures the core insight of the ground truth: Oracle maintains a stable capital structure without restructuring this debt instrument. The only minor shortcoming is that the LLM does not explicitly state that 'no modifications to the terms' were indicated, though this is implied by the repetition of identical exhibit descriptions. This slight omission prevents a perfect 10 but does not undermine the overall correctness. The answer is fully contextually relevant, directly addressing both the evolution (or lack thereof) and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 457,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters master agreement added wage‑ and benefit‑rate increases that raised the accruals for the UPS/IBT Full‑Time Employee Pension Plan, which was reflected in a shift to a positive net‑periodic‑benefit cost of about $1.2 billion for 2023 (the “impacts of these increases were recognized as part of the year‑end measurement” and the net cost turned positive in the 2023 net‑periodic‑benefit‑cost table).  The 2024 filing shows that UPS still carries a very large, long‑term pension liability – a service‑cost of roughly $1.2 billion and a projected benefit obligation that changes by about $57 million for each basis‑point move in the discount rate – highlighting the magnitude and sensitivity of its pension obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct qualitative impact of the 2023 Teamsters agreement on pension benefit accruals and correctly identifies that these changes were reflected in the year-end measurement, aligning with the original answer. It also appropriately connects this to UPS's long-term pension obligations and sensitivity to discount rate changes, showing good contextual understanding and multi-hop reasoning (e.g., linking collective bargaining outcomes to financial disclosures). However, the quantitative accuracy is significantly flawed: the LLM claims a 'positive net-periodic-benefit cost of about $1.2 billion' and a service cost of '$1.2 billion' in 2024, which are not supported by the ground truth. The original answer does not provide any specific dollar amounts for net periodic benefit cost or service cost, nor does it mention a $57 million change per basis point in the discount rate. These figures appear to be hallucinated or misattributed. While the direction of impact (increased accruals leading to higher costs) is logically sound and consistent with the original, the introduction of unsupported numerical data undermines factual correctness. The entity identification (UPS, Teamsters, UPS/IBT Full-Time Employee Pension Plan) and years (2023 agreement, 2024 disclosures) are accurate. The answer addresses both parts of the question—impact on accruals and implications for long-term obligations—but the reliance on incorrect quantitative data reduces overall correctness despite strong qualitative reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 424,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple’s 10‑K filings all contain the same exhibit that describes the 1.05 % Notes due 2017. In the 2022 filing the exhibit list shows “Exhibit 4.4 – Officer’s Certificate … 1.05 % Notes due 2017”【AAPL_10k_2022.pdf:54】, the 2023 filing repeats this description in its exhibit list (pages 53‑54)【AAPL_10k_2023.pdf:53】, and the 2024 filing again lists the same Exhibit 4.4 with the identical wording【AAPL_10k_2024.pdf:54】. The unchanged disclosure across three years demonstrates Apple’s consistent, transparent treatment of the short‑term 1.05 % Notes as a continuing financing obligation under its 2014 Officer’s Certificate, reflecting a steady approach to monitoring and reporting such debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All numeric and entity details are correct: the 1.05% Notes due 2017, the 2014 Officer's Certificate, and the consistent exhibit numbering (Exhibit 4.4) across 2022, 2023, and 2024 filings are accurately reported. Page references and document citations (e.g., AAPL_10k_2022.pdf:54) are precise and support the claims. (2) Quantitative accuracy is perfect: percentages, years, and exhibit numbers match the ground truth exactly. There are no calculation errors, and the data is correctly attributed across years. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across three annual filings to identify consistency in disclosure, which supports the conclusion of unchanged treatment of the debt instrument. (4) The qualitative interpretation is strong but slightly less nuanced than the ground truth: while the LLM correctly infers a 'steady approach' and 'consistent, transparent treatment,' it stops short of explicitly stating the passive management strategy or Apple’s prioritization of capital structure stability, which are key insights in the original answer. However, the core reasoning about continuity and its implications for debt management is logically derived and semantically equivalent. (5) Contextual relevance is excellent—the response directly addresses both parts of the multi-part question: evolution (or lack thereof) of disclosure and what it reveals about Apple’s debt management. Minor deduction in qualitative accuracy due to less depth in strategic interpretation, but overall a highly accurate and well-supported answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 450,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 2.40 % Notes due 2023 are listed in the same Exhibit 4.3 (Officer’s Certificate) in each filing – the 2022 10‑K shows the note as part of the certificate dated May 3 2013 (“2.40 % Notes due 2023”)【AAPL_10k_2022.pdf p. 54】, the 2023 10‑K repeats the identical reference in its exhibit list (page 53)【AAPL_10k_2023.pdf p. 53】, and the 2024 10‑K again includes the same description in Exhibit 4.3 (page 54)【AAPL_10k_2024.pdf p. 54】. The unchanged, year‑over‑year disclosure signals that Apple maintains a stable, low‑cost fixed‑rate debt program and follows a disciplined, transparent approach to long‑term debt management, keeping the same instrument on its books until maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2.40% Notes due 2023 are consistently disclosed in Exhibit 4.3 of Apple’s 10-K filings for 2022, 2023, and 2024, with the Officer’s Certificate dated May 3, 2013, referenced each year. The page numbers cited (p.54, p.53, p.54) match the respective filings, and the percentage, maturity year, and exhibit number are all accurate. (2) Quantitative accuracy is perfect: the interest rate (2.40%), maturity (2023), and date of the certificate (May 3, 2013) are correctly reported with no calculation errors. (3) The multi-hop reasoning is sound—by identifying the consistent disclosure across three annual reports, the model correctly infers that no changes were made to the instrument, which supports the conclusion about Apple’s stable debt management strategy. (4) The LLM slightly expands the interpretation by describing the strategy as a 'low-cost fixed-rate debt program' and 'disciplined, transparent approach,' which, while not explicitly stated in the ground truth, are reasonable inferences given the context and do not contradict it. The only minor gap is that the original answer explicitly notes the implication that Apple planned to meet the 2023 maturity as structured, which the LLM implies but does not state directly. However, this does not detract significantly from the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 427,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "In 2022 Vraylar posted $2.0 billion of net revenue (up ≈ 18 % YoY) after AbbVie disclosed Phase 3 top‑line data for an adjunctive major‑depressive‑disorder (MDD) indication (ABBV 10‑K 2022, pp. 58‑62).  The FDA’s approval of Vraylar as an adjunctive MDD therapy in 2023 drove revenue to $2.76 billion—a ≈ 35 % jump—and expanded its label beyond schizophrenia and bipolar disorder, cementing its multi‑indication role in AbbVie’s neuroscience franchise (ABBV 10‑K 2023, pp. 40‑44).  The 2024 filing still lists Vraylar as a key neuroscience product, reflecting continued commercial growth and its entrenched therapeutic positioning across schizophrenia, bipolar disorder and depression (ABBV 10‑K 2024, pp. 4‑8).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM reports $2.0 billion in 2022 revenue, which matches the ground truth U.S. sales of $2,037 million (rounded appropriately). The 2023 revenue is stated as $2.76 billion, consistent with the ground truth $2,755 million (U.S.) and $2,759 million (total), with a ≈35% increase correctly reflecting the 35.2% growth. The 18% YoY growth in 2022 is not contradicted by the ground truth, though not explicitly stated in the original answer—this is a reasonable inference from available data and does not constitute an error. (2) The LLM correctly identifies the 2022 Phase 3 trial results for adjunctive MDD treatment, noting mixed outcomes (one successful, one numerically positive but non-significant), though it simplifies this as 'top-line data' without specifying statistical significance—minor omission but not inaccurate. (3) The 2023 FDA approval for adjunctive MDD is correctly cited as a driver for label expansion and revenue growth, aligning with the original answer’s emphasis on broadened therapeutic positioning. (4) In 2024, the LLM accurately reflects Vraylar’s entrenched role in AbbVie’s neuroscience portfolio, covering schizophrenia, bipolar I disorder, and MDD, matching the ground truth’s description of its expanded indications. (5) Multi-hop reasoning is sound: the model synthesizes clinical development, regulatory milestones, revenue trends, and strategic positioning across three years and multiple filings. (6) Minor formatting differences (e.g., $2.0 billion vs $2,037 million) are acceptable under semantic equivalence. The only slight shortfall is the lack of explicit mention of 'depressive episodes in bipolar I' as a distinct indication, though 'bipolar disorder and depression' captures the essence. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 513,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "Across IBM’s 2022, 2023 and 2024 Form 10‑K filings the company repeatedly lists “client relationships and trust” as a principal method of competition. In the 2022 filing the phrase is paired with “trust and security” as a core component of its flexible, secure hybrid‑cloud platform and AI solutions (2022 pp. 2‑6). By 2023 and again in 2024 the language shifts to treat client relationships and trust as a broader differentiator that, together with incumbency, deep expertise, a partner ecosystem and a strong focus on innovation, underpins IBM’s hybrid‑cloud and AI strategy (2023 pp. 1‑5; 2024 pp. 1‑5). This consistent, increasingly holistic emphasis signals that IBM is positioning trust and client engagement as a foundational strategic advantage to win in the highly competitive hybrid‑cloud and AI market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently emphasized client relationships and trust from 2022 to 2024, with evolving framing across the years. The 2022 emphasis on 'trust and security' within hybrid cloud and AI platforms is correctly noted, as is the shift in 2023–2024 toward a broader strategic differentiator involving partnerships and ecosystem. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—however, the years (2022, 2023, 2024) are correctly cited and referenced with appropriate contextual evolution, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, identifies the progression in language and strategic framing, and correctly infers that this reflects a deepening strategic positioning in hybrid cloud and AI. The mention of 'incumbency', 'partner ecosystem', and 'innovation' as co-differentiators in later years reflects accurate synthesis. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'foundational strategic advantage' vs. 'foundational element in go-to-market strategy'), the meaning matches the original answer. The only minor gap is that the LLM does not explicitly mention 'industry expertise' in 2022 or the term 'end-to-end solutions' in 2023, which slightly reduces qualitative completeness, but the core strategic trajectory is accurately captured. Overall, the answer is factually correct, contextually relevant, and demonstrates strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 458,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "In the 2022 Form 10‑K IBM only footnoted the 1.250 % Notes due 2027 in its long‑term‑debt schedule and referenced the underlying indenture (Exhibit 4.3 to Form 8‑K) without listing the issue in a securities table (IBM 2022 pp. 28‑32). The 2023 filing began to place the note in the securities‑registration schedule while still citing the same exhibit (IBM 2023 pp. 18‑22). By the 2024 filing IBM formally includes the 1.250 % Notes due 2027 in the “Securities registered pursuant to Section 12(b)” table (IBM 2024 p. 1) and again references the indenture (IBM 2024 p. 2), making its presence a clearly disclosed component of IBM’s diversified long‑term debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—IBM, 1.250% Notes due 2027, correct years (2022–2024), and exhibit references (Exhibit 4.3 to Form 8-K)—are correctly identified. The progression in disclosure practices is accurately described: from footnote mention in 2022, inclusion in securities-registration schedule in 2023, to formal listing in the Section 12(b) table in 2024. (2) Quantitative elements—interest rate (1.250%), maturity year (2027), exhibit number (4.3), and filing types (Form 10-K, Form 8-K)—are all factually correct. No calculations are required, but temporal sequence and document references are precise. (3) The multi-hop reasoning is sound: the answer synthesizes information across three annual filings to show an evolution in disclosure, correctly inferring increasing transparency and formal recognition. The mention of the trading symbol 'IBM27B' in the ground truth is slightly more specific than the LLM’s reference to inclusion in the Section 12(b) table, but the LLM captures the substance—formal registration and recognition—correctly. (4) The answer is contextually excellent, directly addressing both disclosure practices and the instrument’s role in the debt portfolio. The only minor gap is the absence of the explicit trading symbol 'IBM27B', which slightly reduces qualitative completeness, but the core meaning remains equivalent. Thus, a score of 9 is warranted—excellent accuracy with a minor omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 410,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "IBM’s Form 10‑K filings in 2022 (Item 15, pages 28‑32), 2023 (pages 17‑21) and 2024 (pages 17‑21) all state that the rights of the holders of the 6.50 % Debentures due 2028 are defined in “Exhibit 2 to Form 8‑K, filed on January 8, 1998,” and this exhibit reference and filing date are unchanged across the three years. The debenture is listed together with a broader series of IBM debt instruments—each similarly incorporated by reference to historic 8‑K filings—showing IBM’s consistent, reference‑based approach to disclosing its long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 6.50% Debentures due 2028 are consistently referenced as 'Exhibit 2 to Form 8-K, filed on January 8, 1998' across 2022, 2023, and 2024, and this exhibit reference remains unchanged—exactly matching the original answer. The years and exhibit details are factually precise. (2) Quantitative accuracy is perfect: percentages (6.50%), dates (January 8, 1998), and document types (Form 8-K, Form 10-K) are all correct. No calculations were required, but the consistency of references over time is correctly observed. (3) The reasoning is sound: the LLM correctly infers that IBM uses a consistent, reference-based disclosure approach for long-term debt, which supports regulatory compliance and investor clarity, even if not explicitly stated. However, the LLM omits some contextual evolution noted in the ground truth—specifically, the shift in focus from a broader list of debt instruments in 2022 to integration with newer debentures (e.g., 6.22% due 2027, 5.875% due 2032) in 2023 and 2024. This subtle but relevant evolution in disclosure emphasis is missing, slightly reducing completeness and qualitative accuracy. (4) Despite this omission, the answer is contextually relevant, directly addressing exhibit consistency and IBM’s disclosure approach. The core multi-hop synthesis—linking consistent exhibit references across three years of 10-Ks—is correctly executed. Minor deduction from 10 to 9 due to incomplete coverage of the broader contextual evolution in debt disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 434,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "In 2022 FedEx International Connect Plus was a contractual e‑commerce service “currently available from nearly 50 origin countries to over 130 destination countries”【FDX_10k_2022.pdf p. 12‑16】. By 2024 that footprint had grown to “nearly 60 origin countries to over 190 destination countries”【FDX_10k_2024.pdf p. 6‑10】. The steady addition of origin and destination markets shows FedEx is deliberately expanding its cross‑border, day‑definite e‑commerce network, underscoring a strategic focus on capturing more global e‑commerce volume.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the geographic reach of FedEx International Connect Plus in 2022 (nearly 50 origin, over 130 destination countries) and 2024 (nearly 60 origin, over 190 destination countries), matching the ground truth. However, it omits the 2023 data point (nearly 60 origin, over 190 destination countries), which is a key intermediate step showing when the expansion occurred. This omission reduces completeness, though the overall trajectory is still accurately conveyed. (2) All numeric values cited are factually correct and match the ground truth for the years mentioned; no calculation errors are present. The format of the numbers (e.g., 'nearly 60') is consistent with the source. (3) The reasoning is sound in linking the expansion to FedEx's strategic focus on e-commerce logistics, and the use of direct quotes with citations indicates proper sourcing. However, the failure to mention the 2023 expansion and stabilization into 2024 means the multi-hop synthesis is incomplete—specifically, the model misses the nuance that the expansion was largely completed by 2023, with 2024 reflecting maturity rather than ongoing growth. (4) Despite the omission, the answer captures the core strategic implication correctly: FedEx is aggressively expanding its e-commerce network. The answer is highly relevant and well-framed, but the missing 2023 data prevents a top score in correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 402,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "Qualcomm’s 2025 human‑capital goals were unchanged from fiscal 2022 through fiscal 2024 – it set a 15 % increase in women in leadership, a 15 % increase in under‑represented minorities in leadership, and a 20 % increase in overall URM representation in each filing【QCOM_10k_2022.pdf:15‑18】. In all three years the HR and Compensation Committee used progress on these diversity targets as a non‑financial modifier for executive bonuses, allowing the payout to be adjusted within a 0.9‑to‑1.1 × multiplier of the target bonus【QCOM_10k_2022.pdf:19】【QCOM_10k_2024.pdf:16‑18】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm maintained consistent diversity targets from fiscal 2022 to 2024—15% increase in women in leadership, 15% in underrepresented minorities (URM) in leadership, and 20% in overall URM representation—with these goals tied to a non-financial performance modifier (0.9 to 1.1×) for executive bonuses. These numbers and ranges match the original answer exactly. (2) Quantitative accuracy is perfect: percentages, multipliers, and timeframes (2022–2024, 2025 goals) are correctly reported. (3) The reasoning is sound and reflects proper multi-hop synthesis across multiple 10-K filings, correctly identifying both the stability of targets and the consistent use of the bonus modifier. (4) The only minor omission is that the LLM answer does not mention the Reboot Representation Tech Coalition or the emphasis on doubling degrees for underrepresented groups by 2025, which was noted in the original answer as part of expanding external initiatives. While this contextual detail adds depth, its absence does not undermine the core factual correctness. The answer remains semantically equivalent in terms of strategic framework and incentive alignment. Hence, a score of 9 is justified—excellent accuracy with only minor completeness gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 372,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s debt tables in the 2022, 2023 and 2024 Form 10‑K all continue to list the “Floating Rate Notes due 2019” (see Exhibit 4.4 in each filing, which describes the Floating Rate Notes due 2019 among other notes) — a short‑term variable‑rate instrument that resets with market rates【AAPL_10k_2022.pdf:54‑58】【AAPL_10k_2023.pdf:53‑57】【AAPL_10k_2024.pdf:54‑58】. By keeping this floating‑rate note on its balance sheet, Apple signals a deliberate strategy of using short‑term variable‑rate debt to hedge against interest‑rate movements while maintaining a flexible source of liquidity for working‑capital and other financing needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Apple did include the 'Floating Rate Notes due 2019' in its 10-K filings for 2022, 2023, and 2024, despite the maturity date being prior to these years, which is a documented feature of how Apple reports legacy debt instruments for transparency. The citations (Exhibit 4.4 in each filing) are correctly referenced and support the claim. (2) There are no numerical inaccuracies—dates (2019, 2022–2024), instrument type (floating rate, short-term), and reporting pattern are all factually sound. Format and references are precise. (3) The reasoning is strong: the LLM correctly infers that continued disclosure reflects a strategic approach to interest rate risk and liquidity management, linking variable-rate debt to market-rate resets and flexible financing. It accurately captures the intent behind using such instruments—hedging rate movements and maintaining liquidity—though it slightly underdevelops the point about not needing to issue new instruments, which is implied in the ground truth. (4) The answer is fully contextually relevant, directly addressing how the disclosure pattern reflects Apple’s risk and liquidity strategy. The only minor gap is a lack of explicit mention that the notes were likely fully paid but retained in disclosures for consistency or comparative purposes, which would strengthen the explanation of 'continued inclusion' post-maturity. Overall, the answer demonstrates correct multi-hop synthesis across three years of filings and accurate interpretation of financial reporting behavior.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 446,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "Qualcomm’s 2022 filing framed the digital‑cockpit as a cornerstone of its automotive push, citing analyst forecasts that > 70 % of new vehicles will have embedded cellular connectivity by 2028 and that the share of cars with Level‑2‑or‑higher autonomy would rise from 9 % in 2022 to 19 % in 2025 (Item 1, Business, pp. 6‑10). By 2023 the company had embedded that narrative in its QCT segment, reporting automotive revenue—including connectivity, digital‑cockpit and ADAS/AD—of $1.872 billion, up from $1.509 billion in 2022 (Note 8, pp. 71‑75). In the 2024 report the automotive stream grew to $2.910 billion (Note 8, pp. 80‑84), showing a clear shift from strategic positioning to a rapidly expanding revenue pillar while the same market‑size projections for connected and autonomous vehicles continue to underpin its digital‑cockpit strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall evolution of Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology from 2022 to 2024, correctly identifying the shift from market positioning to revenue generation and growth. However, there are key quantitative inaccuracies. The ground truth states that Qualcomm projected over 60% of new vehicles would have 5G connectivity by 2028 in 2022, but the LLM incorrectly cites '>70% of new vehicles will have embedded cellular connectivity by 2028'—a different metric (cellular vs 5G) and higher percentage. Additionally, the LLM introduces a statistic about Level-2-or-higher autonomy rising from 9% in 2022 to 19% in 2025, which is not present in the original answer and may be extraneous or misaligned with the focus on digital cockpit. (2) Revenue figures are mostly accurate: $1.872B in 2023 and $2.910B in 2024 align with the original answer’s implication of growing automotive revenues, though the original does not specify exact numbers but confirms commercial sales and integration into QCT. However, the original answer does not mention 2022 automotive revenue ($1.509B), so including it adds detail beyond the ground truth, potentially based on real data but not verifiable against the provided truth. (3) The multi-hop reasoning is sound—LLM connects strategic narrative in 2022, revenue reporting in 2023, and continued growth in 2024, showing progression. It correctly identifies the integration of digital cockpit into the QCT segment, though the original emphasizes structural integration in 2024 while the LLM focuses more on revenue growth. (4) Despite strong contextual relevance and logical flow, the correctness score is reduced due to incorrect or unsupported quantitative claims, particularly the 70% and autonomy stats. The core trajectory—strategic emphasis to commercialization to expansion—is preserved, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 525,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s unfunded commitments to private‑fund investments (which include private‑real‑estate funds) fell from **$569 million at year‑end 2022** to **$555 million at year‑end 2023** and then to **$540 million at year‑end 2024**【ABT_10k_2023.pdf: p.70】【ABT_10k_2024.pdf: p.70】. The gradual reduction shows the company is slowly paying down or limiting new obligations while still keeping a modest exposure, suggesting a disciplined, long‑term strategy that balances the pursuit of illiquid alternative‑asset returns with a cautious approach to liquidity risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values: $569 million in 2022, $555 million in 2023, and $540 million in 2024, matching the ground truth exactly. The year-over-year decreases of $14 million (2022–2023) and $15 million (2023–2024) are consistent with the stated trend of approximately $15 million annual decline, with only a minor rounding difference that does not affect accuracy. (2) All financial figures and years are accurately cited with correct source references (ABT 10-K filings for 2023 and 2024, p.70), confirming quantitative fidelity. (3) The reasoning is sound: the LLM correctly infers a strategic reduction in unfunded commitments, interpreting this as a cautious, disciplined approach to liquidity risk—aligning closely with the ground truth’s conclusion of 'strategic de-risking or rebalancing.' While the LLM does not explicitly mention the 2025–2034 liquidation periods noted in the original answer, it captures the essence that Abbott maintains exposure while managing risk, thus preserving semantic equivalence on the strategic implication. (4) The answer fully addresses both parts of the question—evolution of commitments and strategic interpretation—with high precision. The only minor gap is the omission of specific fund liquidation timelines, which slightly affects completeness but not core correctness. Hence, scores are high across all dimensions, with a 9 in correctness due to near-perfect alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 404,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple’s 0.45 % Notes due 2016 – issued in 2013 – were completely retired by the end of FY 2022 and therefore do not appear as an outstanding liability in the debt tables for FY 2023 or FY 2024 (see the “Long‑term debt” note in the 2022, 2023 and 2024 Form 10‑K, pages 54‑58)【AAPL_10k_2022.pdf†page54】【AAPL_10k_2023.pdf†page53】【AAPL_10k_2024.pdf†page54】. This pattern shows that Apple uses low‑interest, short‑term notes to raise cash and then retires them at maturity, preferring longer‑dated debt to fund its operations and maintain a flexible capital‑structure strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) Quantitatively, the LLM claims the 0.45% Notes due 2016 were 'completely retired by the end of FY 2022,' but the ground truth states these notes were consistently disclosed in the 2022, 2023, and 2024 10-K filings, indicating they remained part of Apple's capital structure across all three years. This directly contradicts the LLM's assertion of retirement. The dates (2016 maturity) and issuance (2013) are correct, but the status of the debt is wrong. (2) The LLM incorrectly infers that because the notes do not appear in later debt tables, they were retired—however, the ground truth confirms their continued disclosure, suggesting either a misunderstanding of 10-K footnote presentation or incorrect data extraction. (3) Qualitatively, the reasoning is flawed: the LLM concludes Apple retires short-term debt and prefers longer-dated instruments, but the 0.45% Notes due 2016 are long-term debt issued in 2013 (13-year term), and their continued reporting indicates a strategy of maintaining low-cost debt, not retiring it. The multi-hop synthesis fails—instead of recognizing consistent disclosure as evidence of stability, the model assumes absence from later tables implies retirement, which is unsupported. (4) Contextually, the answer addresses the question's structure but with incorrect facts, making it misleading. The core claim (retirement) is false, and the strategic interpretation is based on that false premise. Minor credit is given for referencing correct documents and attempting analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 435,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑Ks IBM consistently lists “client relationships and trust” as a core competitive method – first as one of many factors alongside technology, brand and performance in 2022, and then again in the same phrasing in 2023 and 2024 (IBM 2022 p. 2‑3; IBM 2023 p. 1‑2; IBM 2024 p. 1‑2). By repeatedly tying that trust to its secure, open hybrid‑cloud platform and AI‑driven solutions, IBM signals that building and leveraging trusted client partnerships is a strategic cornerstone for differentiating its hybrid‑cloud and AI offerings in a highly competitive market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that IBM consistently listed 'client relationships and trust' as a competitive differentiator across its 2022, 2023, and 2024 Form 10-K filings, and correctly references the linkage to hybrid cloud and AI. The quantitative accuracy is perfect: no numerical errors, and the years (2022–2024) are correctly cited. However, the LLM fails to capture the nuanced evolution described in the ground truth. While the original answer details a strategic shift—from trust as part of a broad portfolio (2022), to being tied with consulting and infrastructure (2023), to emphasizing strategic partnerships as enablers of trust (2024)—the LLM treats the phrasing as static ('same phrasing in 2023 and 2024'), which oversimplifies the progression. This lack of depth in capturing the evolving strategic framing reduces qualitative accuracy. The reasoning is sound in linking trust to hybrid cloud and AI, but it does not reflect the multi-hop synthesis of how the emphasis shifted over time, missing the maturation of the strategy toward ecosystem collaboration. Contextually, the answer is highly relevant and addresses the core of IBM’s strategic positioning, but the absence of year-over-year evolution limits completeness. Thus, while factually correct and relevant, it lacks the detailed progression that defines the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 378,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "FedEx’s 4.250% Note due 2030 has been backed by a dedicated Pass‑Through Trust and a revolving‑credit facility with BNP Paribas (exhibits 4.36, 4.38‑4.43) in the 2022 filing, and the company formally amended that liquidity‑provider agreement in 2023 (exhibit 4.44) — a structure that remains unchanged in the 2024 filing — showing a consistent, proactive strategy of maintaining a dedicated trust‑based credit backstop and updating its terms as needed to preserve support for the note【FDX_10k_2022.pdf p.117‑121】【FDX_10k_2023.pdf p.121‑125】【FDX_10k_2024.pdf p.121‑125】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 4.250% Note due 2030 is supported by a revolving credit facility involving BNP Paribas, with a 2023 amendment (Amendment No. 1 filed May 22, 2023), and the structure remains unchanged in 2024. The mention of the Pass-Through Trust and specific exhibits (4.36, 4.38–4.43 in 2022, 4.44 in 2023) aligns with typical SEC filing structures and supports the claim. (2) Quantitative elements—interest rate (4.250%), years (2022–2024), and amendment date (2023)—are accurate. No calculations required. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings, identifies continuity in the credit support framework, and notes the 2023 amendment as a proactive adjustment. (4) Minor difference: the LLM emphasizes the 'Pass-Through Trust' more than the original answer, which focuses on the Revolving Credit Agreement (2020-1AA) with Wilmington Trust and BNP Paribas. However, this does not contradict the ground truth and may reflect additional detail from the exhibits. The conclusion about a 'consistent, proactive strategy' matches the original's interpretation. No factual errors; slight variation in emphasis but full factual alignment. Hence, high scores across all categories with a 9 on correctness due to minor framing difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 388,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s long‑term debt portfolio continued to include the 4.45 % Notes due 2044 in each of the three most recent Form 10‑K filings – the note is listed in the “Description of Securities” exhibit for 2022, 2023 and 2024 (see Exhibit 4.4 in each filing)【2024‑exhibit 4.4】 and 【2022‑exhibit 4.4】.  The fact that this 30‑year, fixed‑rate bond remains on the balance sheet year after year shows Apple’s deliberate use of a stable, low‑cost, long‑dated debt instrument, indicating a financing strategy that locks in cheap rates and preserves liquidity over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) All entities—Apple, the 4.45% Notes due 2044, and the years 2022–2024—are accurately identified. The note's presence in each year’s 10-K filing (specifically Exhibit 4.4) is correctly cited, matching the knowledge graph. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and issuance context (implied long-term nature)—are accurate. While the LLM mentions the bond as '30-year' (suggesting a 2014 issuance), this is consistent with the ground truth and a reasonable inference. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three annual filings to observe consistency in Apple’s debt structure and infers a strategic preference for stable, low-cost long-term financing. (4) The answer captures the core implication of Apple’s financing strategy—locking in cheap rates and maintaining liquidity—though it adds slight interpretive language (e.g., 'deliberate use', 'preserves liquidity') not explicitly in the ground truth. However, these are reasonable qualitative extensions. The only minor gap is the lack of explicit mention that the notes were *first issued in 2014*, which would strengthen the historical context, but this does not detract significantly from correctness. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 381,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "In the 2022 10‑K, FedEx International Connect Plus was described as a contractual e‑commerce service “currently available from nearly 50 origin countries to over 130 destination countries” (2022 filing, p. 13). By the 2024 10‑K, the same service was “currently available from nearly 60 origin countries to over 190 destination countries” (2024 filing, p. 9). The jump in both origins and destinations signals FedEx’s deliberate push to broaden its cross‑border, day‑definite e‑commerce network, underscoring a strategic focus on capturing growing international online‑shopping demand.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the geographic reach of FedEx International Connect Plus in 2022 (nearly 50 origin countries, over 130 destination countries) and 2024 (nearly 60 origin, over 190 destination), matching the ground truth. However, it omits the 2023 data point explicitly stating the expansion occurred by 2023 and remained stable in 2024, which weakens the multi-hop synthesis. (2) All numeric values are accurate and properly attributed to the respective 10-K filings. The jump from ~50 to ~60 origins and 130 to 190 destinations is correctly interpreted as expansion, though the stabilization in 2024 is not mentioned. (3) The reasoning correctly infers FedEx’s strategic focus on global e-commerce logistics and cross-border demand, aligning with the ground truth. However, the absence of the 2023-to-2024 stabilization point means the model misses the consolidation/optimization phase, leading to an incomplete trajectory analysis. (4) Scores reflect high factual accuracy and relevance, with a moderate deduction for missing the full evolution timeline and thus partial incompleteness in multi-hop reasoning across all years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 329,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Apple’s 1.05 % Notes that matured in 2017 are still listed in the debt exhibit of each filing (2022 p. 54; 2023 p. 53; 2024 p. 54) but carry no balance – they had fully repaid at maturity and are not shown as outstanding debt on the balance‑sheet schedules. Apple’s practice of continuing to reference these retired notes each year shows it keeps a complete historical record of all issuances, underscoring a disciplined, transparent approach to monitoring and retiring maturing debt instruments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key facts are accurate: the 1.05% Notes due 2017 are correctly identified, and their maturity in 2017 is acknowledged. The answer correctly states that the notes are no longer outstanding and carry no balance, which is consistent with having matured. While the ground truth does not specify page numbers (e.g., 2022 p.54), the LLM adds these as verifiable details that do not contradict the original. (2) The LLM accurately captures the continued inclusion in disclosures across 2022–2024, matching the ground truth’s observation about Exhibit 4.4, though it refers to a 'debt exhibit' without naming the exhibit number. This is a minor omission but not factually incorrect. (3) The reasoning is sound: the LLM correctly infers that Apple maintains historical records, linking the continued reference to transparency and disciplined debt management. This interpretation is plausible and consistent with the ground truth’s suggestion of a standardized disclosure framework. However, the LLM omits the specific detail about the Officer’s Certificate dated May 6, 2014, and does not mention refinancing as a possible reason, slightly reducing completeness. (4) Despite these minor gaps, the answer addresses both parts of the question—status of the notes and implications for debt management—with high factual accuracy and strong contextual relevance. The conclusion about transparency is a reasonable qualitative extension. Thus, the answer earns a high score but not perfect due to missing a few specific details from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 444,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "From FY 2022 through FY 2024 Qualcomm’s 5G licensing continued to be a core growth engine, with 5G‑essential patents generating an expanding share of QTL royalty revenue as handset shipments and global 5G connections rose. At the same time the company deepened its financial commitment to new 5G‑enabled applications—automotive, IoT, XR, AI and edge‑computing—by scaling R&D and QSI strategic‑investment programs and by advancing the roadmap to 5G releases 16‑18 and 5G Advanced. By FY 2024 that strategic focus was tempered by heightened geopolitical exposure, highlighted by U.S./China trade tensions, the revocation of its export license to Huawei and the concentration of licensing revenue among a few Chinese licensees.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Qualcomm's strategic evolution in 5G from FY2022 to FY2024, including licensing as a growth engine, increased R&D and strategic investments in new applications (automotive, IoT, AI), and rising geopolitical risks, particularly with Huawei and U.S.-China tensions. However, it omits the specific $560 million revenue contribution from Huawei in FY2024 prior to the export license revocation, which is a key quantitative detail in the ground truth. This omission affects completeness but not overall correctness. (2) No incorrect numbers are stated; the LLM avoids making up figures and does not contradict the ground truth numerically. The absence of the $560M figure is a missing data point rather than an inaccuracy, so quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the LLM synthesizes information across fiscal years, connects licensing revenue trends with strategic investments and geopolitical developments, and correctly identifies the expansion into AI, automotive, and IoT via Qualcomm Ventures (referred to as QSI, which may be a minor misstatement but contextually acceptable). The progression of 5G-Advanced and Releases 16-18 aligns with Qualcomm’s stated roadmap. (4) The answer is contextually fully relevant, addressing all three dimensions of the question: licensing revenue, investment in new applications, and geopolitical risks. The omission of the $560M figure prevents a top score, but the core facts, trends, and strategic narrative are accurate and well-synthesized. Hence, correctness is rated 8 for minor incompleteness, not inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 448,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "In 2022 the domestic pension plan held $89 million in U.S. equity funds (≈9.5 % of the $937 million total), $91 million in international equity funds (≈9.7 %) and $739 million in fixed‑income funds (≈78.9 %)【TMO_10k_2023.pdf page 55‑56】. By 2024 the mix had shifted to $91 million in U.S. equity (≈10.2 % of $895 million), $89 million in international equity (≈9.9 %) and $692 million in fixed‑income (≈77.3 %)【TMO_10k_2024.pdf page 69‑71】. This modest increase in equity allocations and corresponding dip in fixed‑income moves the portfolio closer to the company’s stated target of roughly 10 % U.S. equity, 10 % international equity and 80 % fixed‑income, indicating a gradual tilt toward more return‑seeking equity exposure while still emphasizing liability‑hedging fixed‑income assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both dollar amounts and years. It incorrectly states that in 2022, TMO allocated $89M to U.S. equity funds, $91M to international equity, and $739M to fixed income, which are actually the 2023 figures from the ground truth. The correct 2022 allocations were $125M (U.S. equity), $126M (international equity), and $1,001M (fixed income). Similarly, for 2024, the LLM reports $91M, $89M, and $692M, but the correct figures are $93M, $93M, and $739M respectively. The total assets are also wrong: LLM says $895M in 2024, but the correct total is $947M. (2) Calculations are flawed: percentages are based on incorrect totals and allocations. For example, $89M is not 9.5% of $937M (it's ~9.5%), but this misattribution stems from assigning 2023 data to 2022. The LLM also fails to note the major asset reduction from 2022 to 2023 and the stabilization in 2024. (3) Multi-hop reasoning is unsound: the LLM incorrectly interprets the trend as a 'gradual tilt toward more return-seeking equity exposure', while the ground truth shows a sharp de-risking move in 2023 (large reduction in equities and fixed income) followed by slight equity increase in 2024. The LLM misidentifies the direction of change and misattributes the company's strategy. (4) The contextual relevance is moderate because it discusses pension asset allocation and strategy evolution, but due to severe quantitative and temporal inaccuracies, the qualitative analysis is based on false premises. The mention of a 'target allocation' is unsupported in the provided ground truth. Overall, the answer is largely incorrect due to swapped years, wrong numbers, and inverted strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 470,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "In its 2022 filing Qualcomm highlighted its edge‑networking role within the IoT segment—selling 5G‑enabled mobile‑broadband and Wi‑Fi 6/6E access‑point products and generating $7.35 billion of IoT revenue (which includes edge networking). By 2023‑24 that IoT revenue fell to $5.94 billion and $5.42 billion, but the company’s strategy shifted to next‑generation edge technologies—pursuing Wi‑Fi 7 (802.11be) and developing 5G Advanced (Release 18) to deliver higher‑speed, low‑latency connectivity—signalling a move toward more advanced, performance‑focused edge‑networking offerings even as the overall IoT contribution contracted.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that edge networking became an explicitly named key revenue contributor in 2023 and remained a core focus in 2024, with consistent strategic emphasis. However, the LLM introduces unsupported financial data—IoT revenue of $7.35B in 2022, $5.94B in 2023, and $5.42B in 2024—which does not appear in the original answer and cannot be verified from the provided truth. More critically, the original answer does not mention any decline in revenue or a contracting IoT segment, nor does it reference Wi-Fi 7 or 5G Advanced (Release 18) developments. These are fabrications or hallucinations not present in the source. (2) The quantitative figures are entirely absent from the ground truth, making them incorrect in context. There are no revenue numbers provided in the original answer for edge networking or IoT, so citing specific dollar amounts fails the quantitative accuracy test. Additionally, the claim of declining revenue contradicts the original narrative of maturing and consistent strategic focus. (3) The multi-hop reasoning is flawed. While the LLM attempts to synthesize product development and revenue trends across years, it invents a narrative of strategic shift due to declining revenues that is not supported by the original answer. The ground truth shows a steady, growing emphasis on edge networking without any indication of revenue contraction or pivot due to performance issues. (4) Despite the factual errors, the answer is contextually relevant—it addresses Qualcomm’s edge networking strategy across 2022–2024 and discusses product areas like mobile broadband and wireless access points, which aligns with the original. However, the invented numbers and erroneous causal reasoning severely undermine correctness. The qualitative accuracy is low because the entities (Qualcomm, edge networking, 5G, Wi-Fi) are correct but misaligned in logic and unsupported by evidence. Final scores reflect major factual deviations with partial relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 553,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all contain an Officer’s Certificate (Exhibit 4.3) that lists the “0.45 % Notes due 2016” among its outstanding securities (see the exhibit tables on page 54‑55 of the 2022 filing and the corresponding pages in the 2023 and 2024 filings). By repeatedly reporting this low‑coupon, short‑dated fixed‑rate note, Apple shows that it deliberately retains inexpensive, fixed‑rate debt and staggers its maturities, using the 0.45 % notes as a predictable financing source that can be refinanced or retired on schedule, thereby helping to smooth cash‑flow obligations and preserve capital‑structure stability.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly identifies the presence of the 0.45% Notes due 2016 in Apple's 10-K filings from 2022 to 2024, it incorrectly asserts that these notes are still outstanding and being actively managed as part of Apple's current debt structure. The ground truth clarifies that the 0.45% Notes due 2016 are no longer outstanding—having matured in 2016—and their inclusion in recent filings is for historical disclosure or exhibit consistency, not because they are active debt instruments. The LLM misinterprets this as evidence that Apple 'deliberately retains inexpensive, fixed-rate debt' and uses these notes as a 'predictable financing source,' which is factually wrong. This mischaracterization leads to flawed reasoning about Apple's capital structure strategy. Quantitatively, the percentage (0.45%) and maturity year (2016) are correct, and the filing years (2022–2024) are accurate, so some numeric elements are right. However, the core inference—that Apple is managing these specific notes as current debt—is invalid. The multi-hop reasoning fails because the model does not recognize that a note due in 2016 cannot be outstanding in 2024. Contextually, the answer addresses the question's theme (debt maturity management and capital structure), but the conclusions are based on a fundamental misunderstanding of the data. Thus, while the answer appears plausible and references specific exhibits, it is largely incorrect in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 419,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "Caterpillar said its dealer network for the EMD brand (sold through the worldwide machine‑dealer network) covered **193 countries in 2022**【CAT_10k_2022.pdf†L74-L78】. By the 2024 filing the same network was **serving 187 countries**, a drop of six countries【CAT_10k_2024.pdf†L64-L68】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states that Caterpillar's EMD brand distribution network covered 130 countries in 2022 and declined to 109 in 2024—a drop of 21 countries. The LLM incorrectly reports 193 countries in 2022 and 187 in 2024, a drop of only 6 countries. These numbers are factually wrong and not consistent with the ground truth. The cited documents (CAT_10k_2022.pdf and CAT_10k_2024.pdf) appear to be referenced, but the data extracted is incorrect—either due to misreading or hallucination. (2) Completeness: While the answer attempts to address the change in geographic reach over time, it fails to accurately report the data for 2023 (which remained at 130 countries), and omits the correct two-year trend. (3) Entity Accuracy: The company (Caterpillar) and brand (EMD) are correctly identified, and the time frame (2022 to 2024) is addressed. However, the metric 'number of countries covered' is incorrectly reported. (4) Reasoning: The multi-hop reasoning—comparing network size across years—is structurally attempted, but based on incorrect data, leading to flawed conclusions. The calculation of a 6-country decrease is incorrect; the actual decrease is 21 countries (16%). (5) Semantic Equivalence: The answer does not convey the same information as the ground truth—both the baseline coverage and the magnitude of change are wrong. The discrepancy is significant enough to mislead on the scale and direction of change. Thus, the correctness score is very low due to major factual and numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 440,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "Thermo Fisher’s 1.750 % 7‑year senior notes (the euro‑denominated series due 4/15/2027) were $642 million at 12/31/2022, rose to $662 million at 12/31/2023, and then fell to $621 million at 12/31/2024【TMO_10k_2023.pdf:61】【TMO_10k_2024.pdf:46】. The modest increase in 2023 reflects a deliberate use of medium‑term financing to support growth initiatives, while the subsequent reduction in 2024 shows the company beginning to repay or refinance that debt as cash flows improve—demonstrating a disciplined, flexible medium‑term debt strategy in its healthcare operations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. The ground truth states that TMO's 1.750% 7-Year Senior Notes due October 15, 2028, had an outstanding value of $700 million in each year from 2022 to 2024. However, the LLM claims the notes were euro-denominated, due on 4/15/2027, and reports fluctuating amounts ($642M, $662M, $621M), which contradicts the stable $700M value in the original. (2) Quantitative accuracy is severely lacking: all dollar amounts, maturity date, and currency are wrong. There are no correct numbers. The supposed 'modest increase' and 'subsequent reduction' are entirely fabricated. (3) The multi-hop reasoning is flawed: the LLM misidentifies the bond series (wrong maturity date and currency), fails to recognize the consistent $700M principal, and draws incorrect conclusions about debt repayment or refinancing. The synthesis across the cited documents appears spurious or hallucinated. (4) Contextual relevance is low because the answer discusses a different bond instrument altogether. While it attempts to address TMO's medium-term debt strategy, the reasoning is based on false data, rendering the interpretation invalid. The only correct element is the focus on TMO and medium-term debt, but even the strategic interpretation contradicts the stable pattern shown in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 376,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "In the 2022 filing Caterpillar noted that it used currency‑hedging instruments to protect against foreign‑exchange swings but gave no detail on benchmark‑rate risk (e.g., LIBOR). By the 2023 10‑K the company was explicitly addressing the LIBOR wind‑down—citing the FCA/IBA timelines that end most USD LIBOR tenors by June 2023—and said it had formed a cross‑functional team to evaluate and hedge its floating‑rate exposure, beginning to shift to the Secured Overnight Financing Rate (SOFR). The 2024 filing shows that Cat Financial now relies on SOFR as the primary benchmark for variable‑rate loans and derivatives while maintaining its diversified currency‑hedging program, demonstrating a proactive, structured adaptation to the global transition away from LIBOR and alignment with new market reforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Caterpillar acknowledged LIBOR phase-out timelines (FCA/IBA) ending most USD LIBOR tenors by June 30, 2023, formed a cross-functional team in 2022–2023 to assess risk, and transitioned to SOFR by 2024. The company maintained its currency hedging program throughout. (2) Quantitative accuracy is excellent: dates (June 2023), benchmark names (LIBOR, SOFR), and regulatory bodies (FCA, IBA) are correctly cited. No numerical errors. (3) Multi-hop reasoning is sound—answer synthesizes evolution across 2022–2024 filings, connects LIBOR transition to hedging practices, and infers strategic adaptation. One minor omission: the original answer notes that in 2022, Caterpillar *did* mention LIBOR-linked instruments and associated risks, while the LLM says 'gave no detail on benchmark-rate risk,' which slightly understates the 2022 disclosure. This leads to a small deduction in qualitative accuracy. (4) The answer is contextually relevant, directly addressing Caterpillar’s strategic response to financial benchmark reforms. Overall, the LLM captures the core evolution and strategic implications accurately, with only a minor inaccuracy in characterizing the 2022 disclosure depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 358,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "Thermo Fisher’s 2022 10‑K (exhibits 10.11, 10.15, 10.16 and 10.17 on pages 44‑48) disclosed the original Executive Change‑in‑Control Retention Agreement for CEO Marc N. Casper (dated 2009) together with two amendments (2010 and 2018) and, for the first time, a separate “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.17). The 2023 filing (pages 74‑78) and the 2024 filing (pages 75‑79) retain the same CEO agreement and its amendments and continue to reference the same officer form as a standard template for all non‑CEO officers, indicating that the company has moved to a standardized retention‑agreement format for officers beyond the CEO.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that in 2022, Thermo Fisher Scientific had a CEO-specific Executive Change-in-Control Retention Agreement for Marc N. Casper, with amendments from 2010 and 2018 (Exhibit 10.17), and notes the introduction of a 'Form of Executive Change-in-Control Retention Agreement for Officers (other than Marc N. Casper)' in the 2022 10-K—this aligns with the ground truth's claim of standardization beginning in 2023, though the LLM attributes it to 2022 based on the 2022 filing. This is a minor discrepancy in timing interpretation: the 2022 10-K may have disclosed the form agreement effective in 2023, but the LLM associates it with the filing year. (2) Quantitatively, all dates (2009 original, 2010 and 2018 amendments) are correct, and exhibit numbers (10.17) and usage across years are accurately cited. The LLM correctly notes that the same form is retained in 2023 and 2024 filings. (3) The multi-hop reasoning is sound—comparing the evolution across three years and synthesizing the shift from CEO-only to standardized officer agreements. The conclusion that the company moved to a standardized format is logically supported. (4) The only minor issue is the attribution of the introduction of the non-CEO form agreement to the 2022 filing rather than clarifying it took effect in 2023, which slightly affects temporal precision. However, since the 2022 10-K did disclose the form, the LLM's interpretation is defensible. Overall, the answer is factually robust, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 449,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "In the 2022 Form 10‑K Intel first announced PowerVia as a new backside‑power‑delivery technique that would debut on its planned Intel 20A node, positioning it alongside RibbonFET as a future breakthrough for signal‑integrity and performance‑per‑watt gains. The 2023 filing continued to list PowerVia as a key feature of the Intel 20A roadmap, still promising a ~15% performance‑per‑watt improvement, and the 2024 filing disclosed that Intel cancelled the 20A node but carried PowerVia forward into the Intel 18A node—making it a core element of the next‑generation advanced process. This progression shows PowerVia evolving from a planned future innovation to a central, differentiated technology that underpins Intel’s advanced‑node strategy and its drive for higher performance‑per‑watt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A alongside RibbonFET; in 2023, it was emphasized for signal integrity and performance-per-watt gains (~15% improvement, which matches known disclosures); in 2024, Intel canceled Intel 20A and moved PowerVia to Intel 18A. These developments are correctly reported. (2) Quantitative accuracy is perfect: the ~15% performance-per-watt improvement is a real figure cited by Intel and fits the timeline. No incorrect numbers or dates are present. (3) Multi-hop reasoning is sound—information is synthesized across three years of strategic evolution, showing how PowerVia persisted despite node cancellation, indicating its strategic importance. The conclusion that PowerVia became a central, differentiated technology is logically supported. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'backside power delivery' advantage in eliminating front-side routing (a key technical benefit noted in the original), nor does it reference the broader goal of process leadership by 2025 as context for the shift to 18A. However, the core progression and strategic implication are accurately captured. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually complete and well-reasoned, meriting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 399,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple’s 10‑K consistently lists the 1.05 % Notes due 2017 in Exhibit 4.4 (the Officer’s Certificate describing its global notes) in all three years – it appears in the 2022 filing (p. 54) 【AAPL_10k_2022.pdf†page 54】, in the 2023 filing (pages 53‑57) 【AAPL_10k_2023.pdf†page 53】, and again in the 2024 filing (p. 54) 【AAPL_10k_2024.pdf†page 54】 with identical wording. The unchanged, repeated inclusion shows the notes remain outstanding and Apple continues to disclose and monitor this debt each year, indicating a steady, ongoing debt‑management practice for this instrument.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Apple disclosed the 1.05% Notes due 2017 in its 2022, 2023, and 2024 10-K filings, with accurate citation of Exhibit 4.4 and consistent inclusion across years. The percentages (1.05%), maturity year (2017), and filing years (2022–2024) are all factually correct. Page references (e.g., p.54 in 2022 and 2024, pp.53–57 in 2023) align with typical disclosure locations, though exact page numbers may vary slightly by document version—this is acceptable under semantic equivalence. (2) Quantitatively, all numbers and dates are accurate: the interest rate, maturity year, and filing years match the ground truth. No calculations were required, but the repeated presence of the note is correctly observed. (3) However, the LLM's reasoning contains a significant flaw: it states the notes 'remain outstanding' and that Apple 'continues to disclose and monitor this debt each year,' implying the debt is still active. This contradicts the ground truth, which acknowledges the note matured in 2017 and suggests possible rollover or structural continuation, not that the original instrument remains outstanding. The LLM fails to recognize the anomaly of post-maturity disclosure and instead interprets it as ongoing liability, missing the nuanced implication about debt management practices like rollover or reporting continuity. (4) Despite this, the answer is contextually relevant and factually grounded in the filings’ content. It correctly synthesizes the multi-hop element—tracking the note across three years—and draws a reasonable (though oversimplified) conclusion about consistent debt management. The core facts are right, but the interpretation lacks the sophistication of the ground truth, leading to a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 483,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "In the 2022 Form 10‑K (pages 112‑116) Intel’s 2006 Equity Incentive Plan was used primarily to award restricted‑stock units (RSUs)—including standard RSUs and RSUs with retirement‑vesting for executives—and, for the first time, to grant RSUs to non‑employee directors (see Exhibit 10.1.7). The 2023 filing (pages 99‑103) shows the plan’s scope expanding to performance‑based RSUs (and performance stock units) whose vesting is tied to the achievement of defined performance metrics in addition to the existing time‑based or retirement vesting. By the 2024 filing (pages 104‑108) Intel continued to rely on RSUs for employees and directors, with most awards vesting over a three‑year service period or upon executive retirement, while performance‑based RSUs/PSUs remain contingent on meeting specified performance targets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Intel's 2006 Equity Incentive Plan from 2022 to 2024. It accurately identifies the types of equity awards (RSUs, performance-based RSUs/PSUs, retirement-vesting RSUs) and their vesting conditions across the years. The mention of RSUs being granted to non-employee directors for the first time in 2022 matches the original answer's emphasis on expanded use. In 2023, the LLM correctly notes the expansion to performance-based awards tied to performance metrics, which corresponds to the amended and restated plan introducing broader RSU types. The 2024 description accurately reflects continued use of performance-based and time/retirement-vesting RSUs. However, the LLM omits explicit mention of the May 11, 2023 amendment date and does not reference the consolidation or streamlining of documentation in 2024, which is a key nuance in the original answer. It also does not distinguish between grandfathered and non-grandfathered executives as noted in the ground truth. These omissions affect completeness and qualitative accuracy slightly but do not undermine the core factual correctness. All referenced years and award types are accurate, and there are no calculation or date errors. The reasoning is sound and contextually appropriate, synthesizing changes over time effectively. Minor lack of detail on structural documentation changes and executive categorization prevents a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 409,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 the shareholders‑equity footnote repeatedly states that Medtronic is authorized to issue 40 000 Euro Deferred Shares at €1.00 each, but “no Euro Deferred Shares were issued or outstanding” at the reporting dates of April 29 2022, April 28 2023, and April 26 2024【MDT_10k_2022.pdf†L‑11】【MDT_10k_2023.pdf†L‑11】【MDT_10k_2024.pdf†L‑11】. The unchanged disclosure and zero issuance each year indicate that the company has deliberately not used this class of shares as a financing tool, preferring other sources of capital while keeping the Euro Deferred Shares as an unused, dormant reserve.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Medtronic maintained an authorization of 40,000 Euro Deferred Shares at €1.00 par value across FY 2022–2024, with zero issuance or outstanding shares each year. The specific reporting dates (April 29, 2022; April 28, 2023; April 26, 2024) are correctly cited. (2) Quantitative accuracy is perfect: the number of authorized shares (40,000), par value (€1.00), and consistent zero issuance are all factually correct and match the original answer. Format variations (e.g., '40 000' vs '40 thousand') are acceptable and common in international formatting. (3) Multi-hop reasoning is sound: the model correctly synthesizes disclosures across three consecutive 10-K filings and draws a logical inference about financing strategy—namely, that the absence of issuance suggests non-use of this instrument, implying reliance on alternative capital tools. The mention of 'dormant reserve' aligns with the original's implication of strategic retention without utilization. (4) Contextual relevance is high: the answer directly addresses both parts of the question—evolution (or lack thereof) in disclosure and the strategic implication—without extraneous information. The citation of specific document footnotes (L-11) adds verifiability. Overall, the response demonstrates precise factual recall, correct synthesis across years, and valid strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 406,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "In 2022 Intel warned that its new disaggregated‑design strategy, which relies on novel advanced‑packaging technologies, adds significant design‑ and manufacturing‑complexity and that its R&D outlay was $17.5 billion. By 2023 the company leaned into advanced packaging—especially for AI—secured several design wins and lifted packaging revenue to $952 million, but R&D fell to $16.0 billion and the segment’s operating loss widened to $482 million as execution costs rose. In 2024 Intel’s positioning still hinges on advanced packaging, yet execution risk intensified: R&D rose again to $16.5 billion, the chiplet‑integration complexity generated $922 million of AI‑accelerator inventory charges and a $3.1 billion non‑cash impairment on the Intel 7 node, underscoring a growing financial impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Intel's strategic positioning and execution risks around Advanced Packaging from 2022 to 2024, aligning well with the ground truth in terms of narrative arc—initial strategic bet, technical progress in 2023, and financial/operational setbacks by 2024. However, several key quantitative inaccuracies undermine full correctness. (2) Specific number verification: The $17.5B and $16.0B R&D figures for 2022 and 2023 are plausible but not confirmed in the ground truth, which does not provide specific R&D numbers. The $952M packaging revenue and $482M operating loss in 2023 are not present in the ground truth and appear to be fabricated or misattributed. The $16.5B R&D in 2024 is again not in the original. The $922M AI-accelerator inventory charge is new and not mentioned in the ground truth, which only specifies a $3.1B non-cash impairment on Intel 7—this one figure is correctly cited. (3) Multi-hop reasoning is strong: the LLM synthesizes R&D trends, manufacturing complexity (chiplet integration), and financial impact across years, correctly identifying UCIe and AI as drivers, and links impairments and inventory charges to execution risk. However, it introduces unsupported financial metrics that were not in the source. (4) Correctness scored 7 because the qualitative trajectory is accurate and the $3.1B impairment is correctly used, but the inclusion of unverified revenue, loss, and inventory charge figures reduces quantitative accuracy. Qualitative accuracy is high due to sound reasoning and correct entity identification (Intel, advanced packaging, Intel 7, chiplets, AI). Contextual relevance is perfect—the answer directly addresses strategic positioning, R&D, complexity, and financial impact across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 489,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "Intel first unveiled PowerVia in its 2022 10‑K (pages 5‑9) as a novel “industry‑first” backside‑power delivery technique that would debut in the future Intel 20A node, positioning it as a differentiator for Intel’s IDM 2.0 strategy and its external‑foundry services. The 2023 10‑K (pages 12‑16) kept PowerVia on the roadmap as a cornerstone of Intel 20A, projecting up to a 15 % performance‑per‑watt gain over Intel 3 and stressing its importance to Intel Foundry Services, and the 2024 10‑K (pages 8‑12) disclosed that PowerVia has reached manufacturing readiness, with the Intel 20A (and the subsequent Intel 18A) node now slated for high‑volume production, confirming the technology’s move from concept to a producible feature.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the introduction of PowerVia in 2022 as an 'industry-first' backside power delivery solution tied to Intel 20A, its continued roadmap presence in 2023 with a projected 15% performance-per-watt improvement over Intel 3, and its manufacturing readiness disclosed in 2024. These core facts align with the ground truth. However, there is a key discrepancy: the ground truth states that in 2024, PowerVia was shifted to the Intel 18A node (not Intel 20A), indicating a refinement and delay from initial plans. The LLM answer incorrectly implies PowerVia remains on Intel 20A in 2024 and mentions Intel 18A only as a subsequent node without clarifying that PowerVia was moved to 18A. This is a significant but not fundamental error in the evolution narrative. (2) Quantitatively, all numbers are correct: the 15% performance-per-watt gain is accurately cited, and the years (2022, 2023, 2024) match. The mention of 10-K page numbers (e.g., pages 5–9, 12–16, 8–12) is extraneous but not incorrect. (3) The multi-hop reasoning is mostly sound—information is synthesized across three years of disclosures, and the progression from concept to production is correctly framed. However, the failure to note the node transition from 20A to 18A weakens the qualitative accuracy of the evolution story. (4) Contextual relevance is excellent—the answer directly addresses the question’s focus on strategic positioning and technical expectations over time. The error in node assignment prevents a higher correctness score, but the overall answer remains largely accurate and well-structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 445,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Medtronic’s FY 2022, FY 2023 and FY 2024 10‑K filings all list the same Exhibit 10.54 – the “Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan” – with no new amendment or replacement noted in any of the three years (FY 2022 p. 113; FY 2023 p. 112; FY 2024 p. 112)【MDT_10k_2022.pdf†page=113】【MDT_10k_2023.pdf†page=112】【MDT_10k_2024.pdf†page=112】. This unchanged filing suggests Medtronic is pursuing a stable, continuity‑focused equity‑compensation strategy for its U.S. workforce rather than frequently revising the RSU agreement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Medtronic did not update its U.S. employee restricted stock unit agreements from FY2022 to FY2024, citing the same exhibit (Exhibit 10.54 – Form of Restricted Stock Unit Award Agreement) across all three years. (2) The specific page references (FY2022 p.113, FY2023 p.112, FY2024 p.112) and document identifiers are correctly cited, and there are no numerical or date inaccuracies. The filing date of the original agreement (August 27, 2013) is omitted but not required for correctness since the key point is the lack of changes during the specified period. (3) The reasoning is sound: the absence of amendments over three consecutive years supports the conclusion of a stable equity compensation strategy, which the model correctly infers. (4) The answer addresses both parts of the question: whether updates occurred (no), and what this implies (strategic consistency). All entities—Medtronic, U.S. employees, RSU agreements, 2013 Plan—are correctly identified. The contextual relevance is perfect, with precise document evidence and appropriate interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 330,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan was used in the 2022 filing to issue performance‑based RSU awards to executives under two distinct grant agreements—one for “grandfathered” executives and one for “non‑grandfathered” executives (see Exhibit 10.1.5 and 10.1.6). The 2023 filing kept those same executive grant agreements unchanged and merely added a new RSU form for non‑employee directors, while the 2024 filing still referenced the same performance‑based RSU grant agreements for executives, showing that Intel’s structure for executive RSU awards under the 2006 Plan remained consistent from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in entity details and reasoning that affect overall correctness. (1) It incorrectly states that the two distinct grant agreements (for 'grandfathered' and 'non-grandfathered' executives) were present in the 2022 filing, while the ground truth indicates that the 2022 10-K only references strategic growth performance-based RSUs granted on or after February 1, 2019, without specifying the split into two agreements at that time. The distinction between grandfathered and non-grandfathered executives is explicitly mentioned in the 2023 filing, not 2022. (2) The claim that the 2023 filing 'kept those same executive grant agreements unchanged' misrepresents the evolution: the 2023 filing introduced separate agreements, which were not confirmed to exist in 2022. (3) The LLM correctly notes consistency in the use of the 2006 Equity Incentive Plan through 2024 and references to ongoing performance-based RSUs, which aligns with the ground truth. (4) The addition of a new RSU form for non-employee directors in 2023 is accurate and relevant, though not central to the question about executives. (5) The ground truth emphasizes the May 11, 2023 amendment and the September 26, 2023 S-8 filing as key developments supporting continued use of the plan—information entirely missing in the LLM answer, representing a critical omission in the evolution narrative. (6) Quantitatively, there are no numerical errors (dates like 2022–2024 are used correctly), so quantitative accuracy is high. (7) Contextually, the answer stays focused on the question and uses appropriate terminology. (8) However, the qualitative accuracy is low due to incorrect attribution of the two-agreement structure to 2022 and failure to capture the plan’s formal updates in 2023, undermining the multi-hop synthesis required. Thus, while the general trend of continued use is correct, key factual and structural details are misrepresented or omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 534,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "Intel first signaled its advanced‑packaging push in the 2022 10‑K, describing a disaggregated design approach that would stitch together components made on different process nodes via novel packaging while flagging the added cost and risk (2022 pp. 52‑56). In 2023 the plan turned into execution—Intel doubled its IFS Accelerator Ecosystem Alliance, signed multigenerational ARM and Synopsys agreements, secured five AI‑focused design wins on the 18A node and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon—showing that its packaging investments were delivering real‑world design wins (2023 pp. 35‑39). By 2024 the company emphasized continued capital spending on 2D/2.5D/3D packaging as a core differentiator and reported rising advanced‑packaging revenue, indicating that the program is maturing enough to enable chiplet‑based AI products and to compete with fabless rivals (2024 pp. 32‑36).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Intel's advanced packaging strategy from 2022 to 2024 and correctly identifies key milestones, such as the introduction of the disaggregated design approach in 2022, UCIe demonstration in silicon in 2023, and positioning of advanced packaging as a competitive differentiator in 2024. It also accurately reflects the strategic importance of packaging for AI and chiplet-based designs. However, it omits critical financial and execution challenges highlighted in the ground truth, particularly the $3.1 billion in non-cash impairment and accelerated depreciation charges in 2024 related to manufacturing assets, including those tied to the Intel 7 node. This omission significantly weakens the assessment of Intel's execution risks, which is a central theme in the original answer. While the LLM mentions rising revenue and design wins, suggesting progress, it fails to balance this with the financial setbacks that reveal ongoing scalability and execution pressures. Additionally, the LLM introduces specific details not present in the ground truth—such as 'doubled its IFS Accelerator Ecosystem Alliance,' 'multigenerational ARM and Synopsys agreements,' and 'five AI-focused design wins on the 18A node'—which, while plausible, are not supported by the provided knowledge graph and may be hallucinated or over-specified. Quantitatively, the answer lacks any dollar figures or financial metrics (e.g., $16.5B R&D investment, $3.1B charges), making it less factually precise. Despite these issues, the reasoning trajectory—acknowledging early risk, demonstrating execution progress, and asserting competitive positioning—is logically sound and contextually relevant to the question about Intel’s ability to execute its disaggregated strategy in the AI market. The answer is well-structured and semantically aligned in intent, but the absence of key quantitative data and one-sided portrayal (ignoring setbacks) reduces its factual completeness and balance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 537,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan was first expanded in 2022 when the company added a new grant template for non‑employee directors (Exhibit 10.1.7, “Form of Non‑Employee Director Restricted Stock Unit Agreement…on or after May 12 2022”) alongside its existing RSU grant forms (Exhibits 10.1.2‑10.1.6) 【INTC_10k_2022.pdf p. 112‑116】. In 2023 Intel filed the plan itself as Exhibit 10.1 (S‑8) on September 26 2023, indicating an amendment or restatement of the 2006 Equity Incentive Plan 【INTC_10k_2023.pdf p. 99‑103】. By 2024 the plan remained in effect with the same grant‑agreement templates referenced and no further amendment disclosed, showing the plan’s continued use without additional changes 【INTC_10k_2024.pdf p. 104‑108】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Intel's 2006 Equity Incentive Plan across 2022, 2023, and 2024. In 2022, it accurately notes the addition of a new grant template for non-employee directors (Exhibit 10.1.7) and references to existing RSU forms, matching the original answer's mention of multiple grant agreements including RSUs for executives, directors, and performance-based awards. (2) For 2023, the LLM correctly identifies the filing of an amended and restated version of the plan on September 26, 2023 (via S-8), which corresponds to the 'amended and restated version...effective May 11, 2023' in the ground truth. While the effective date (May 11) is not mentioned in the LLM answer, the filing date (Sept 26) is correctly cited as the disclosure date, which is consistent with SEC filing practices. This is a minor omission but does not undermine factual correctness. (3) In 2024, the LLM correctly states that the plan remained in effect with no further amendments and continued use of existing templates, which matches the ground truth's description of ongoing use of standardized RSU agreements. (4) The reasoning is sound and demonstrates multi-hop synthesis across three years of filings. The LLM correctly infers continued reliance on the plan despite its age, though this explicit phrasing is absent, the implication is clearly conveyed. All entities (Intel, 2006 Equity Incentive Plan, RSU, grant agreements) are accurate. Minor lack of detail on performance-based RSUs in 2023 prevents a perfect 10, but overall the answer is factually robust, contextually relevant, and quantitatively precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 461,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "Qualcomm kept wireless access points under its IoT revenue stream—listed as “edge networking (including mobile broadband and wireless access points)”—so the financial categorization did not change, but the segment’s sales fell from $7.353 billion in FY 2022 to $5.423 billion in FY 2024 (see the QCT revenue‑stream tables). Nonetheless, the company’s overview and industry‑trends commentary repeatedly stresses edge‑networking and wireless access points—driven by 5G, Wi‑Fi 6/6E and hybrid‑work demand—as a core strategic focus and market‑positioning priority for its connected‑intelligent‑edge vision.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention any specific revenue figures for the edge networking segment, nor does it state that sales fell from $7.353 billion in 2022 to $5.423 billion in 2024. These numbers are fabricated or misattributed, severely undermining factual correctness. The original answer explicitly states that 'exact revenue figures for wireless access points alone are not disclosed,' making the LLM's precise dollar amounts incorrect. (2) The LLM incorrectly attributes revenue declines to the edge networking segment without support from the ground truth, which makes no mention of revenue trends—positive or negative. There is no verification for the cited figures in the knowledge base, and no such numbers appear in the original answer. (3) While the LLM correctly identifies the strategic emphasis on wireless access points and their classification under edge networking (including mobile broadband), it fails in multi-hop reasoning by inventing financial data instead of acknowledging the lack of disclosed figures. The qualitative understanding of strategic focus—mentioning 5G, Wi-Fi 6/6E, and hybrid work—is consistent with the direction of the original answer and shows some correct synthesis of market positioning. (4) The contextual relevance is high because the answer addresses the core themes: financial categorization, strategic emphasis, and market positioning. However, the inclusion of false revenue numbers drastically reduces correctness and quantitative accuracy. The qualitative accuracy is moderate due to correct entity identification (Qualcomm, edge networking, wireless access points, 5G, Wi-Fi) and partial reasoning, but penalized for unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 490,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis sales rose from $428 million in 2022 to $605 million in 2023 and to $785 million in 2024 (see the Hospital Acute Care segment tables for each year)【MRK_10k_2022.pdf†L139-L143】【MRK_10k_2023.pdf†L2-L6】【MRK_10k_2024.pdf†L128-L132】. The consistent, double‑digit growth each year indicates that Prevymis is gaining traction and becoming an increasingly important product within Merck’s Hospital Acute Care portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported sales figures. According to the ground truth, Prevymis sales were $370 million in 2022 and $428 million in 2023, but the LLM incorrectly states $428 million in 2022 and $605 million in 2023. Only the 2024 figure ($785 million) is correct. This misrepresentation leads to an inaccurate growth trajectory. (2) The quantitative inaccuracies are severe: the LLM reports a 2022–2023 increase from $428M to $605M (~41% growth), whereas the actual increase was from $370M to $428M (~15.7% growth). The actual compound growth from 2022 to 2024 is ~46%, but the LLM’s numbers would imply a much higher rate. The LLM also fails to mention the compound growth rate, which is a key part of the original answer. (3) While the LLM correctly identifies the product (Prevymis), company (MRK), time frame (2022–2024), and segment (Hospital Acute Care), and draws a reasonable qualitative conclusion about market traction, it fails in multi-hop synthesis by citing incorrect base-year data. The citations reference the correct documents and line numbers, but the extracted values do not match the ground truth, suggesting data extraction or interpretation errors. (4) Despite incorrect numbers, the answer remains contextually relevant and draws a plausible inference about market positioning based on growth trends. However, the core quantitative errors undermine the factual correctness, warranting a low correctness score. The qualitative reasoning and relevance are partially sound, but accuracy is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 437,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "From 2022’s launch of the Open System Foundry and IFS accelerator ecosystem—backed by early design wins, multi‑generational ARM and Synopsys agreements, and a focus on 2‑D/2.5‑D/3‑D packaging—to 2023’s five new Intel 18A design wins, accelerated interest in AI‑focused packaging, a silicon‑demonstrated Universal Chiplet Interconnect Express (UCIe) standard and expanded ecosystem partnerships, Intel steadily deepened its advanced‑packaging position as a cornerstone of IDM 2.0. In 2024 the packaging push continued but was blunted by Intel 7 node impairments, construction‑delay penalties and a tighter “Smart Capital” spending approach, showing that while Intel can grow its packaging capabilities, execution of IDM 2.0 remains vulnerable to manufacturing delays and capital constraints.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the multi-year evolution of Intel's advanced packaging strategy and its role in IDM 2.0, aligning well with the ground truth in terms of strategic narrative and context. It accurately notes Intel’s focus on 2D/2.5D/3D packaging, the silicon demonstration of UCIe in 2023, and the continued investment in 2024 despite headwinds. However, it omits specific quantitative details present in the ground truth: the $16.5 billion R&D investment in 2024 and the $3.1 billion non-cash impairment in Q3 2024. While it references 'Intel 7 node impairments' and 'tighter Smart Capital spending,' these are qualitative descriptions without the precise figures, reducing quantitative accuracy. (2) No incorrect numbers are stated, but the absence of key dollar amounts—especially the $3.1 billion impairment and $16.5 billion R&D spend—means the answer lacks critical financial specificity required for full quantitative fidelity. Format variations are acceptable, but missing values cannot be scored as accurate. (3) The multi-hop reasoning is strong: the model synthesizes Intel’s packaging advancements across 2022–2024, connects them to IDM 2.0, and correctly infers that execution challenges (manufacturing delays, capital constraints) undermine strategic goals. It references ecosystem developments (Open System Foundry, IFS accelerator, UCIe, design wins) that reflect accurate entity identification and logical progression. (4) The answer is contextually excellent—directly addressing the question’s focus on strategic trajectory and execution challenges. The omission of exact financials prevents a top correctness score, but the qualitative and contextual accuracy is high, warranting strong scores in those areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 478,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "In IBM’s 2022 filing the company listed **“client relationships and trust”** as one of several competitive methods and explicitly tied trust to the security of its hybrid‑cloud platform. By the 2023 and 2024 filings the same phrase re‑appears, but it is now presented as a core pillar that, together with IBM’s ecosystem and innovation, fuels its **hybrid‑cloud and AI growth** and is highlighted as essential to delivering business value. This shift signals that IBM is increasingly positioning client trust as a strategic differentiator that underpins and accelerates its hybrid‑cloud and AI strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: IBM emphasized 'client relationships and trust' as a competitive differentiator in 2022, 2023, and 2024, with increasing strategic integration into its hybrid cloud and AI offerings. The evolution from being one of several competitive methods in 2022 to a core pillar by 2023–2024 is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all years (2022, 2023, 2024) are correctly referenced—scoring 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly infers the strategic progression of trust as a differentiator tied to hybrid cloud and AI. It accurately reflects the deepening strategic role of trust, though it omits the specific 2024 partnership with Palo Alto Networks, which is a minor but notable detail present in the original answer that illustrates trust-based collaboration. This omission prevents a perfect 10 on qualitative accuracy. (4) The answer is contextually excellent—directly addresses the evolution of IBM’s emphasis and what it indicates about strategy. Wording differs but meaning is semantically equivalent and factually sound. Minor deduction from 10 due to missing partnership example, but overall correctness remains very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 399,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "- In IBM’s 2022 Form 10‑K (pages 28‑32) the 0.950 % Notes due 2025 were listed among the company’s outstanding senior notes and the filing incorporated the original 8‑K exhibit dated May 22 2017 that defines the notes’ terms.  \n- The 2023 Form 10‑K (pages 18‑22) repeats the same incorporation of the May 22 2017 exhibit, indicating that no additional tranche was issued and IBM continued to rely on the existing low‑coupon series.  \n- The 2024 Form 10‑K (pages 1‑5) still references the 2017 exhibit for the 0.950 % notes while adding a new 2024 indenture for other note series, showing that IBM is preserving the low‑cost, long‑dated 0.950 % issuance as a stable component of its debt mix and using “incorporation by reference” to keep reporting efficient—an approach that underscores a broader strategy of locking in cheap, long‑term financing and maintaining a diversified, transparent debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were consistently referenced via incorporation of the May 22, 2017 Form 8-K exhibit in each year’s 10-K (2022, 2023, 2024), which matches the original answer’s claim about ongoing disclosure continuity. The LLM correctly notes that no new issuance or amendment was disclosed, indicating stability. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), and exact date of original filing (May 22, 2017)—are all factually correct and match the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across three years, correctly infers that continued incorporation by reference implies no changes to the instrument, and connects this to broader debt management strategy—specifically, preserving low-cost, long-term financing. The addition of a 2024 indenture for other notes further supports the conclusion that IBM is maintaining this series as a stable component while issuing new debt under updated terms. (4) The only minor gap is that the LLM answer does not mention the NYSE listing (trading symbol IBM25B), which is included in the ground truth and adds evidence of the note’s active market status. This omission slightly reduces completeness but does not undermine the core correctness. Overall, the reasoning is strong, the entities and dates are accurate, and the strategic interpretation is well-supported. Hence, a score of 9 is warranted—excellent but not fully comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 428,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "In the 2022 10‑K Intel first disclosed PowerVia as a planned “backside‑power delivery” technique for its upcoming Intel 20A node [INTC_10k_2022.pdf p.5‑6]. The 2023 filing then promoted PowerVia to a breakthrough feature of Intel 20A, promising up to a 15 % performance‑per‑watt improvement by eliminating front‑side power routing [INTC_10k_2023.pdf p.12‑16]. By the 2024 filing PowerVia had been shifted to the Intel 18A node as the first high‑volume commercial implementation of backside power (with Panther Lake production slated for 2025) and is slated to continue into later nodes such as Intel 14A, showing Intel’s accelerated roadmap that moves PowerVia from concept to production‑ready status and makes backside power delivery a core pillar of its advanced‑node strategy [INTC_10k_2024.pdf p.8‑12].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, promoted as a breakthrough in 2023 with a 15% performance-per-watt gain, and shifted to Intel 18A for high-volume production in 2025 as disclosed in the 2024 10-K. The mention of Panther Lake and continuation into Intel 14A adds context consistent with Intel's roadmap. (2) Quantitative accuracy is perfect: the 15% performance-per-watt improvement is correctly cited, and all dates (2022–2024 filings) and node names (Intel 20A, 18A, 14A) match or are consistent with the ground truth. The 2025 production timeline is accurately reported. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of filings, correctly tracing the evolution from concept to production. The strategic pivot from Intel 20A to 18A is accurately captured, showing understanding of Intel’s shifting priorities. (4) The only minor gap is that the original answer explicitly frames the evolution as a three-stage progression—concept (2022), integration (2023), deployment (2024)—which the LLM implies but does not explicitly articulate. However, the semantic meaning and factual content are equivalent. Wording differences do not detract from accuracy. The LLM answer even adds value with the 15% metric and Panther Lake reference, which enrich the response without introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 399,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Medtronic’s 10‑K filings for 2022, 2023 and 2024 all include the same Restricted Stock Unit (RSU) Award Agreements for U.S. employees – the 2021 Long‑Term Incentive Plan RSU grants that vest either 100 % on the third anniversary or ratably over four years – listed as exhibits 10.81‑10.82 in the 2022 filing, the same exhibits 10.81‑10.82 in the 2023 filing, and as exhibits 10.87‑10.88 in the 2024 filing【MDT_10k_2022.pdf†113】【MDT_10k_2023.pdf†113】【MDT_10k_2024.pdf†113】. This consistent documentation across three consecutive years signals a stable, unchanged U.S. equity‑compensation strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Exhibit 10.54 (Restricted Stock Unit Award Agreement) remained unchanged across 2022–2024 and consistently referenced the August 27, 2013 filing. However, the LLM claims the RSU agreements are listed as Exhibits 10.81–10.82 in 2022 and 2023, and 10.87–10.88 in 2024, which contradicts the ground truth. These exhibit numbers do not match, and the LLM incorrectly identifies the plan as the '2021 Long-Term Incentive Plan', which is not mentioned in the original answer. (2) Quantitative accuracy is low: the dates (August 27, 2013) and exhibit number (10.54) are critical facts that are entirely missing or wrong in the LLM response. The vesting schedules (100% on third anniversary or ratably over four years) are plausible details but not confirmed in the ground truth, so their inclusion introduces unverified information. (3) The multi-hop reasoning is partially sound—the LLM correctly infers stability from consistent documentation across years—but it synthesizes based on incorrect exhibits and plan names, undermining the validity. It fails to identify that the same legal document (Exhibit 10.54) was reused verbatim, which is the actual evidence of stability. (4) Contextual relevance is high because the answer addresses the core question about equity compensation strategy stability and attempts to support it with filing evidence. However, due to incorrect entities and documentation references, the qualitative and correctness scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 432,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "In 2022 Intel highlighted advanced‑packaging as a core pillar of its IDM 2.0 strategy but warned that a newly adopted disaggregated design approach—splitting processors and components across different process nodes and joining them with novel packaging—added design‑manufacturing complexity, and that constrained capital and delayed fab‑expansion projects threatened timely execution. By 2023 the company began to translate that positioning into market traction, securing multiple 18A design wins and expanding ecosystem agreements, yet it still posted operating losses and recorded asset‑impairment charges as capital limits slowed the build‑out of advanced‑packaging capacity. In 2024 those execution challenges intensified, with $755 million in penalty charges for construction delays, $3.1 billion of impairments on the Intel 7 node, and continued risk that the disaggregated‑design‑and‑packaging model could further delay product introductions and raise costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Intel's strategic positioning and execution challenges regarding advanced packaging from 2022 to 2024, including the risks of disaggregated design, capital constraints, and delays. It accurately references the $3.1 billion impairment charge on the Intel 7 node in 2024, which matches the ground truth. However, the $755 million penalty charges for construction delays in 2024 are not mentioned in the original answer and appear to be factually incorrect or unsupported by the ground truth, which only specifies the $3.1 billion impairment. This is a significant quantitative discrepancy. (2) The original answer does not mention '18A design wins' or 'ecosystem agreements' in 2023, nor does it specify 'operating losses' or 'penalty charges'—these additions, while plausible, are not present in the verified data and introduce unverified details. The core financial figure of $3.1 billion is correct, but the additional $755 million charge is not corroborated. (3) The multi-hop reasoning is strong: the LLM synthesizes Intel’s strategic intent (disaggregated design, advanced packaging), links it to execution risks (delays, capital constraints), and traces the evolution across years. It correctly identifies the connection between capital limitations and impaired asset utilization, aligning with the original’s theme. (4) The answer is contextually excellent—directly addressing all aspects of the question with a clear year-by-year evolution. The qualitative reasoning and entity accuracy (Intel, Intel 7, advanced packaging, disaggregated design) are sound. The correctness score is 8 due to accurate core facts and good synthesis, but docked for introducing unsupported financial figures and specifics not in the ground truth. Quantitative accuracy is 7 due to the incorrect $755M figure; qualitative accuracy is 9 for strong reasoning; contextual relevance is 10 as it fully addresses the question’s scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 529,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Accenture’s defined‑benefit target allocation shifted from an almost pure fixed‑income mix in FY 2022 (U.S. plans = 100 % debt; non‑U.S. plans ≈ 50 % debt and 21 % equity) to a modest equity tilt in FY 2023 (U.S. still 100 % debt; non‑U.S. equity rose to 27 % while debt fell to 48 %) and then, in FY 2024, to a slightly lower equity share but reduced debt and added cash/insurance (U.S. = 94 % debt + 6 % cash; non‑U.S. = 23 % equity, 42 % debt, 21 % insurance) [ACN_10k_2022.pdf pp.86‑90; ACN_10k_2023.pdf pp.81‑85; ACN_10k_2024.pdf pp.93‑97]. This gradual rebalancing away from a pure bond portfolio toward a more diversified, equity‑inclined mix indicates that Accenture is seeking higher risk‑adjusted returns while still managing liability‑matching risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The claim that U.S. defined benefit plans had a 100% debt allocation in FY2022 and FY2023 is incorrect — the ground truth does not specify exact percentages for fixed income and equities by region or year, nor does it support the precise breakdowns (e.g., non-U.S. plans at 50% debt and 21% equity in FY2022). These specific numbers are fabricated or misattributed. The mention of cash and insurance allocations in FY2024 (e.g., 6% cash, 21% insurance) is not reflected in the original answer, which discusses strategic flexibility but not such detailed category splits. (2) There are no verifiable calculations in the original answer to assess, but the LLM invents numerical precision that does not exist in the source material, failing quantitative accuracy. The percentages do not align with the qualitative descriptions in the ground truth. (3) The multi-hop reasoning is flawed: while the LLM attempts to show evolution across years, it misrepresents the nature of Accenture’s strategy. The original answer emphasizes qualitative shifts in strategic flexibility and risk management, not incremental percentage changes in asset classes. The conclusion about 'gradual rebalancing away from a pure bond portfolio' is unsupported, as the ground truth never describes Accenture’s strategy as 'almost pure fixed-income' or 'pure bond portfolio'. (4) Despite these issues, the LLM captures the general direction of increasing diversification and risk-adjusted return objectives, giving it partial credit for contextual relevance and qualitative intent. However, the heavy reliance on false quantitative detail severely undermines correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 467,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s 10‑K filings for 2023 and 2024 still list the 1.05 % notes due 2017 (see Exhibit 4.4 in the 2022 and 2024 filing indexes, which describes “1.05% Notes due 2017”) 【2022 10‑K p.54‑58】【2024 10‑K p.54‑58】—a practice that shows the company’s commitment to a complete, historical record of every debt issue, even those that have long since matured, as part of a disciplined and transparent disclosure regime. At the same time, the same filings disclose new, higher‑coupon, longer‑dated securities (e.g., the 4.421 % notes due 2026, 4.000 % notes due 2028, 4.150 % notes due 2030, 4.300 % notes due 2033 and 4.850 % notes due 2053 in Exhibit 4.28) 【2024 10‑K p.54‑58】, indicating that Apple’s recent debt‑issuance strategy (2022‑2024) has focused on adding higher‑yield, longer‑maturity debt to diversify its capital structure while still maintaining full disclosure of legacy issues.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's continued disclosure of the 1.05% Notes due 2017 in its 2023 and 2024 filings as a sign of transparent, historical record-keeping, which aligns with the ground truth. It also correctly contrasts this with Apple’s active issuance of new debt instruments, addressing both parts of the question. However, there are key quantitative inaccuracies: the LLM cites specific new notes (e.g., 4.421% due 2026, 4.000% due 2028, etc.) that are not mentioned in the ground truth, which instead references Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024. These discrepancies in percentages and maturities represent significant factual errors. (2) The ground truth does not include any notes due beyond 2024 in the 2022–2024 issuance strategy, whereas the LLM introduces later maturities (up to 2053), which may reflect outdated or incorrect data. This undermines the quantitative accuracy. (3) The multi-hop reasoning is sound—linking persistent disclosure of matured debt to transparency while contrasting it with current issuance strategy shows proper synthesis across time and documents. The logic and interpretation are strong and contextually appropriate. (4) Despite incorrect specific debt instruments, the overall qualitative point—that Apple maintains legacy disclosures while issuing new debt—is valid and well-supported. The answer is highly relevant and captures the intent of the question, but the use of incorrect note details reduces factual precision. Hence, correctness is reduced to 7 due to material numeric inaccuracies, though core reasoning remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 452,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "Accenture repurchased $4.11 billion of Class A shares in fiscal 2022, leaving $3.13 billion of its publicly‑announced buy‑back authority still unused (the Board’s total outstanding authority rose to $6.13 billion after a $3 billion increase)【ACN_10k_2022.pdf p.91‑95】. In fiscal 2023 the company again bought back roughly $4.0 billion of shares and the remaining available authorization fell to about $2.9 billion【ACN_10k_2023.pdf p.37‑41】. In fiscal 2024 buybacks grew to $4.5 billion, the available authorization dropped to $2.69 billion, and the Board added $4 billion of new authority, raising total outstanding authority to $6.69 billion【ACN_10k_2024.pdf p.37‑41】. This three‑year trend of sizable annual repurchases combined with periodic boosts to the authorized ceiling shows a disciplined, ongoing share‑repurchase program that is a core element of Accenture’s long‑term capital‑return strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Accenture did not repurchase $4.11 billion in fiscal 2022, nor $4.0 billion in 2023, nor $4.5 billion in 2024. The original answer only states that Accenture purchased 'over $605 million' worth of shares in fiscal 2024 — a figure vastly different from the $4.5 billion claimed by the LLM. There is no mention in the ground truth of repurchase amounts for 2022 or 2023, so asserting $4.11B and $4.0B is unsupported and incorrect. The available authorizations are partially correct: $3.13B in 2022 and $2.69B in 2024 match the ground truth, but the LLM incorrectly claims remaining authorization was $2.9B in 2023 without support. The new $4.0B authorization in September 2024 and total outstanding authority of $6.69B are accurate. (2) Calculations are flawed: the LLM implies that repurchases directly reduce available authorization, which may be conceptually correct, but applies it with fabricated input values. For example, starting from $6.13B total authority in 2022 and subtracting $4.11B repurchases would leave ~$2.02B, not $3.13B, making the internal math inconsistent. (3) Multi-hop reasoning is attempted — the model synthesizes data across three years and draws a conclusion about capital return strategy — but because the underlying data is invented, the reasoning is built on false premises. The ground truth emphasizes a 'measured' strategy with modest repurchases ($605M in 2024), while the LLM portrays 'sizable annual repurchases' of ~$4B, which contradicts the evidence. (4) Contextual relevance is high — the answer addresses share repurchase activity, authorization changes, and infers a capital return strategy — but correctness is severely undermined by quantitative errors. The conclusion about a 'disciplined, ongoing program' may seem plausible, but it is based on inflated repurchase volumes not present in the source data. Thus, while structure and intent are sound, factual accuracy fails on core metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 554,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "BMY’s 4.350 % Senior Notes due 2047 were first issued as part of the Eleventh Supplemental Indenture on Nov 22 2019 and are simply carried forward as outstanding debt in each subsequent filing – the 2022 Form 10‑K lists the notes (p. 140) 【BMY_10k_2022.pdf†page=140】, the 2023 Form 10‑K repeats the same reference (p. 135) 【BMY_10k_2023.pdf†page=135】, and the 2024 Form 10‑K again shows them unchanged (p. 136) 【BMY_10k_2024.pdf†page=136】. This continuity shows BMY’s deliberate use of long‑dated, fixed‑rate senior unsecured notes to lock in low borrowing costs and maintain a stable, diversified long‑term financing profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the issuance date (November 22, 2019), the interest rate (4.350%), and the maturity year (2047) are correct. It correctly notes that the 4.350% Senior Notes due 2047 were consistently reported in BMY's 2022, 2023, and 2024 10-K filings on the specified pages, confirming their ongoing status as outstanding debt. There are no calculation errors or incorrect numeric values. Regarding completeness and reasoning, the LLM captures the core idea that the persistence of these notes indicates a strategy of maintaining long-dated, fixed-rate debt to secure stable financing. However, it omits key contextual details present in the ground truth: specifically, the issuance of new debt instruments in 2023 and 2024 (e.g., $1.75B 2.950% Notes due 2032, $2B 3.700% Notes due 2052, and $3.75B 4.250% Senior Notes due 2049), which are critical for demonstrating BMY’s strategy of diversifying maturities and layering new debt alongside existing instruments. This omission limits the depth of multi-hop synthesis, particularly in showing how the 2047 notes fit into a broader, evolving capital structure. While the LLM draws a reasonable conclusion about stable financing, it does not fully articulate the strategic diversification and maturity staggering emphasized in the original answer. Thus, while factually sound and contextually relevant, the qualitative reasoning is slightly less comprehensive, warranting a score of 8 for qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 419,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple’s Form 10‑K filings have treated the 2.40 % Notes due 2023 the same way each year. In the 2022 filing Apple listed the notes in Exhibit 4.3 (the Officer’s Certificate) – see 2022 p. 54 – and the 2023 filing repeated that reference (see 2023 p. 53). The 2024 filing again references the same Exhibit 4.3 for the 2.40 % Notes due 2023 (see 2024 p. 54), showing that Apple’s disclosure approach remained consistent and did not materially change as the notes approached maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All key facts are accurate: Apple consistently disclosed the 2.40% Notes due 2023 in Exhibits 4.3 across 2022, 2023, and 2024 filings, with no material changes in disclosure approach. The percentages (2.40%), years (2022, 2023, 2024), and exhibit number (4.3) are correct. Page references (2022 p.54, 2023 p.53, 2024 p.54) are consistent with typical 10-K structures and do not contradict the ground truth. (2) Quantitative accuracy is perfect: no calculations required, but all numeric identifiers (interest rate, years) are correct. (3) Reasoning is sound: the model correctly infers that unchanged exhibit references over multiple years indicate a stable disclosure approach, even as the notes matured. This reflects proper multi-hop synthesis across three annual filings. (4) The only minor limitation is that the LLM does not explicitly mention the Officer’s Certificate dated May 3, 2013—a detail included in the ground truth—which slightly reduces qualitative completeness. However, referencing Exhibit 4.3 implicitly covers this, so the omission is not material. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 341,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "The Amended 2010 Share Incentive Plan allowed a maximum of **127 million** Accenture Class A ordinary shares to be used for awards in fiscal 2022 (and the same ceiling was unchanged in fiscal 2023) 【ACN_10k_2022.pdf p. 89】【ACN_10k_2023.pdf p. 81】. By fiscal 2024 the authorized ceiling had been increased to **141 million** shares 【ACN_10k_2024.pdf p. 96】. This rise in the authorized pool shows that Accenture is deliberately expanding its equity‑based compensation capacity, underscoring a long‑term strategy to use share awards to attract, retain and align employees with shareholder interests.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the timeline of share authorization. It states that the 127 million share limit was unchanged from fiscal 2022 to 2023, but in fact, the increase to 141 million occurred in fiscal 2023, not fiscal 2024 as claimed. According to the ground truth, the number rose from 127M in 2022 to 141M in 2023 and remained at that level in 2024. The LLM incorrectly reports stability between 2022 and 2023 and an increase only in 2024, reversing the actual progression. (2) The numeric values themselves (127 million and 141 million) are correct in isolation and match the ground truth, so the raw numbers are accurate, but their assignment to fiscal years is wrong, leading to incorrect interpretation. Calculations are not involved in this question, but the temporal comparison is flawed. (3) The multi-hop reasoning is partially sound—the model recognizes the need to compare across fiscal years and cites appropriate documents. However, it fails to correctly synthesize the evolution over time, misrepresenting when the increase occurred. This undermines the validity of the conclusion about strategic timing. (4) The qualitative assessment of Accenture’s long-term strategy—expanding equity compensation to attract and retain talent—is reasonable and aligns with the ground truth’s interpretation, though based on incorrect chronology. Contextually, the answer is relevant and addresses both parts of the question (evolution and strategic implication), but the factual inaccuracy in the year of increase significantly reduces overall correctness. Hence, a score of 5/10 reflects partial correctness with major factual flaws in temporal sequencing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 464,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "- In the 2022 filing Intel first announced PowerVia as a planned “industry‑first” backside‑power delivery technology slated for its future Intel 20A node, promising up to a 15% performance‑per‑watt gain over Intel 3. 【INTC_10k_2022.pdf p. 5‑6】  \n- The 2023 10‑K reiterated PowerVia as a key breakthrough of Intel 20A and then introduced it as part of the next‑generation Intel 18A node, which will be the first advanced node to ship with backside power delivery. 【INTC_10k_2023.pdf p. 12‑16】  \n- By the 2024 filing Intel had cancelled Intel 20A and positioned PowerVia firmly within Intel 18A, targeting high‑volume production in 2025, signaling that the technology has moved from a roadmap concept to a core, high‑priority element of Intel’s advanced‑process strategy. 【INTC_10k_2024.pdf p. 8‑12】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, reaffirmed in 2023, and by 2024 Intel shifted focus to Intel 18A with PowerVia as a core feature for high-volume manufacturing in 2025. The mention of a '15% performance-per-watt gain over Intel 3' is an additional detail not in the ground truth but does not contradict it and may reflect supplementary data from the cited filing. (2) Quantitative accuracy is excellent: no incorrect numbers, dates, or percentages; the 2025 high-volume production target matches the ground truth. (3) Multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024 filings to show evolution from concept to strategic priority. (4) The only minor gap is that the ground truth explicitly names Panther Lake as the vehicle for Intel 18A, while the LLM omits this detail; however, the core progression and strategic significance of PowerVia are accurately conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—the response directly addresses the evolution and strategic importance of PowerVia as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 342,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Accenture’s defined‑benefit plans held $239.3 million of mutual‑fund equity securities at August 31 2022, which fell to $196.2 million at August 31 2023, and then rose to $273.7 million at August 31 2024 (2022 $239,293 K; 2023 $196,226 K; 2024 $273,699 K)【ACN_10k_2022.pdf p.87‑91】【ACN_10k_2023.pdf p.81‑85】【ACN_10k_2024.pdf p.94‑98】. The dip in FY‑23 followed by a rebound in FY‑24 signals a brief pull‑back from equity‑fund exposure—likely due to market conditions—then a renewed strategic tilt toward higher equity‑based investments to capture upside returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, Accenture's allocation to mutual fund equity securities decreased from $239,293 million in FY2022 to $196,226 million in FY2023 and remained unchanged in FY2024. However, the LLM claims the amount rose to $273.7 million in FY2024, which directly contradicts the ground truth. Additionally, the LLM incorrectly states the values in millions (e.g., $239.3 million) when the actual figures are in billions (e.g., $239,293 million = $239.293 billion), indicating a severe unit error. (2) The cited numbers in thousands (e.g., $239,293K) are mathematically equivalent to the ground truth, but the final interpretation uses 'million' instead of 'billion', leading to a 1000x underreporting. The 2024 figure of $273,699K ($273.7 million) is entirely incorrect—ground truth shows no change from 2023, i.e., $196,226 million. (3) The multi-hop reasoning fails because the model incorrectly infers a 'rebound' and 'strategic tilt toward higher equity-based investments', while the actual trajectory shows a reduction followed by stability, indicating a strategic pullback, not re-engagement. The reasoning is based on fabricated data. (4) Due to fundamental errors in numbers, units, and trend interpretation, the correctness and quantitative accuracy scores are very low. Qualitative accuracy is also low due to flawed logic and misinterpretation. Contextual relevance is moderate because the answer addresses the right topic and cites correct documents, but with incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 429,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "Merck kept Dificid’s intangible‑asset value unchanged at $145 million throughout the three years, showing no impairment or re‑valuation (2022 p.113; 2023 p.2; 2024 p.130). The drug remained listed in the Hospital Acute‑Care franchise as fidaxomicin for C. difficile‑associated diarrhea (2022 p.113), while its worldwide sales grew from $263 million in 2022 (U.S. $241 M, intl $22 M) to $302 million in 2023 (U.S. $274 M, intl $28 M) and $340 million in 2024 (U.S. $303 M, intl $37 M), increasing its share of pharmaceutical revenue (2023 p.4; 2024 p.129).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While the 2024 revenue of $340 million (U.S. $303M, intl $37M) matches the ground truth, the LLM incorrectly reports $263M in 2022 and $302M in 203, which are not supported by the original answer. The original answer does not provide 2022 or 2023 revenue figures—only 2024—so including those numbers is an overreach and factually unsupported. Additionally, the claim that Dificid's intangible asset value remained unchanged at $145M in all three years contradicts the original answer, which only confirms the $145M valuation in 2022 and does not state values for 2023 or 2024. Thus, asserting no revaluation occurred lacks support. (2) The original answer emphasizes a strategic evolution: from a balance sheet asset in 2022, to therapeutic positioning in 2023, to revenue contribution in 2024. The LLM captures this trajectory well in qualitative terms—correctly identifying Dificid’s role in the Hospital Acute Care franchise and its indication for C. difficile—thus showing good synthesis. (3) The multi-hop reasoning is partially sound: the LLM connects asset valuation, therapeutic positioning, and revenue over time, which aligns with the question’s requirements. However, the unsupported revenue figures for 2022 and 2023 undermine the financial narrative. (4) The contextual relevance is high—the answer directly addresses asset valuation, therapeutic positioning, and revenue trends. The qualitative accuracy is decent due to correct entity identification (Dificid, fidaxomicin, Hospital Acute Care) and proper framing of strategic importance. However, the quantitative accuracy is low due to fabricated or incorrect financial data not present in the ground truth. The correctness score is 6 because the core strategic evolution is captured, but key financial claims are incorrect or unsubstantiated, significantly affecting reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 519,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "Intel’s advanced‑packaging strategy began in 2022 as a high‑risk, R&D‑intensive pillar of its IDM 2.0 plan, with the filing warning that the novel packaging stack added design‑and‑manufacturing complexity, could delay product introductions and expose the company to write‑downs and excess capacity (2022 10‑K pp. 52‑56). By 2023 Intel raised R&D spending (≈$16 bn‑$17 bn) and started to capture market traction—securing new design wins and demo‑ing its Universal Chiplet Interconnect Express—yet incurred an operating loss as packaging‑related spend surged (2023 10‑K pp. 35‑39). In 2024 R&D remained elevated at $16.5 bn, but execution problems surfaced: construction delays triggered a $755 m penalty, $3.1 bn of non‑cash impairments tied to advanced‑node and packaging assets, and $922 m of inventory‑related charges, all heightening Intel’s financial‑risk exposure (2024 10‑K pp. 32‑36).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) Correct elements include: Intel's strategic focus on Advanced Packaging as part of IDM 2.0 starting in 2022, increased R&D investment, execution challenges, and growing financial risk exposure through 2024. The mention of UCIe demonstration in 2023 and the $3.1 billion non-cash impairment in 2024 matches the original answer exactly. (2) Quantitative accuracy: The $3.1 billion impairment is correct. The R&D figures ($16–17 billion in 2023, $16.5 billion in 2024) are consistent with public filings and the trend described. However, the $755 million penalty and $922 million inventory charge, while plausible and contextually relevant, are not mentioned in the ground truth and may be over-specified details not present in the knowledge graph. These specific sub-components of financial risk were not in the original answer, introducing minor inaccuracies by adding unsupported granularity. (3) Multi-hop reasoning is strong: the LLM correctly synthesizes Intel’s evolving position across three years, linking R&D increases to execution delays and financial exposure. It captures the shift from strategic ambition to operational strain. (4) The answer is contextually excellent—directly addressing R&D investment, implementation delays, and financial risk as required. The only reason for not scoring a 10 is the inclusion of unverified specific charges ($755M, $922M) not present in the ground truth, which slightly undermines quantitative precision despite overall correctness in direction and magnitude.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 442,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "- 2022 10‑K – Merck disclosed that in December 2021 the FDA placed a **clinical hold on the doravirine + islatravir (MK‑8591A) once‑daily regimen** after lymphocyte/CD4‑cell declines were observed in study participants【MRK_10k_2022.pdf p.24‑25】.  \n\n- 2023 10‑K – The company reported that the IND for the **higher‑dose formulation remained under a partial hold**, but it had **completed enrollment in a Phase 2 study of a lower‑dose islatravir‑lenacapavir combination** and was preparing a **Phase 3 trial of MK‑8591A at a reduced dose**【MRK_10k_2023.pdf p.23‑24】.  \n\n- 2024 10‑K – Merck confirmed that **MK‑8591A (doravirine + lower‑dose islatravir) entered a Phase 3 program in 2023**, with the partial hold now limited to higher‑dose regimens, showing the program is moving forward despite earlier setbacks【MRK_10k_2024.pdf p.24‑25】.  \n\n**Interpretation:** Over three years Merck shifted MK‑8591A from a full FDA hold to a narrowed partial hold focused only on higher doses, while advancing a lower‑dose formulation into Phase 3. This trajectory signals a sustained, long‑term commitment to developing a differentiated, long‑acting once‑daily HIV‑1 therapy despite regulatory challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies the clinical hold in late 2021 (disclosed in 2022 10-K), the partial hold on higher doses in 2023, and advancement of the lower-dose MK-8591A into Phase 3 by 2024. The December 4, 2024, FDA action lifting the full hold is not explicitly mentioned, but the substance—that the hold was narrowed and the program advanced—is captured. (2) All dates and timelines are consistent: Phase 3 entry in 2023 for the lower-dose regimen (vs. original 2020 for higher dose in ground truth) is correctly contextualized as a reformulated path forward. No incorrect numbers or miscalculations present. (3) Multi-hop reasoning is sound: synthesizes regulatory status changes across three years, connects dose adjustments to clinical strategy, and infers Merck’s ongoing commitment. (4) The interpretation correctly emphasizes Merck’s strategic persistence in HIV despite setbacks, aligning with the ground truth’s conclusion. Minor omission: the exact December 4, 2024, date of FDA action is missing, but the outcome (narrowed hold, program progressing) is accurately conveyed. Wording differs slightly (e.g., 'entered Phase 3 in 2023' vs. 'remained in Phase 3' in 2024), but this reflects adaptation to the reformulated trial rather than error. Overall, factually robust, contextually appropriate, and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 388,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "Merck’s approach to MK‑1308A has stayed focused on the same anti‑CTLA‑4 (quavonlimab) + pembrolizumab co‑formulation, but the target indication has narrowed. In the 2022 filing the pipeline table listed MK‑1308A as an “advanced solid‑tumor” candidate (with multiple tumor types) while the narrative already noted it was being evaluated in RCC (2022 10‑K, pp. 23‑27). By the 2023 filing the Phase‑3 entry date was shown as April 2021 and the indication was specified as renal‑cell carcinoma (2023 10‑K, pp. 18‑22), and the 2024 filing again describes MK‑1308A as the quavonlimab‑pembrolizumab co‑formulation for RCC (2024 10‑K, pp. 48‑52). Regulatory progress has been limited to its ongoing Phase‑3 status—entered in 2021—with no new submission or approval reported through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1308A is a co-formulation of quavonlimab and pembrolizumab; it has been evaluated in renal cell carcinoma (RCC); it has remained in Phase 3 through 2024 with no regulatory approval. The evolution in clinical focus from 'advanced solid tumors' in 2022 to a more specific indication of RCC by 2023 is correctly identified, showing narrowing of indication over time. (2) Quantitative details are accurate: the Phase 3 entry date of April 2021 is correctly cited (consistent with knowledge graph context), and there are no numerical or date inaccuracies. Format variations (e.g., 'April 2021' vs. 'entered in 2021') are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly tracking changes in indication specificity, formulation clarity, and regulatory status. It infers the narrowing of focus even when early documents mention broader indications alongside RCC-specific narratives. (4) The only minor shortcoming is that the original answer emphasizes the increasing 'strategic emphasis' on MK-1308A, which the LLM answer implies but does not explicitly state. However, this is a nuance in framing rather than a factual gap. Overall, the LLM answer captures all critical dimensions—clinical focus, combination therapy, and regulatory progress—with high fidelity, making it semantically equivalent to the ground truth with excellent contextual relevance and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 430,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "Accenture repurchased roughly 12.2 million shares for about $4.1 billion in fiscal 2022, leaving $3.13 billion of authorized repurchase capacity unused (2022 10‑K, pp. 91‑95); in fiscal 2023 the buy‑back grew to roughly $4.9 billion (≈13 million shares) with the remaining authorization falling to about $2.5 billion (2023 10‑K, pp. 37‑41); and in fiscal 2024 it bought back $4.5 billion of shares (≈2 million in Q4) while $2.69 billion of authorization remained, after the board added $4 billion of new authority, raising total outstanding authority to $6.69 billion (2024 10‑K, pp. 37‑41). This steady, sizable repurchase activity—paired with periodic increases in the authorized ceiling—shows that Accenture treats share buybacks as a core, ongoing element of its capital‑return strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Accenture did not repurchase $4.1 billion in shares in fiscal 2022—this number is entirely fabricated. The original answer only states that $3.13 billion in authorization was *available*, not that it was used. Similarly, the claim of $4.9 billion in buybacks in fiscal 2023 is unsupported by the ground truth, which does not provide any data for fiscal 2023 repurchase activity. The fiscal 2024 repurchase amount is also incorrect: the LLM claims $4.5 billion, but the ground truth states only $605 million was spent on open-market repurchases. The LLM incorrectly implies large-scale repurchases occurred each year, while the ground truth shows modest activity in 2024 and no data for 2023. The only correct numbers are the $2.694 billion remaining authorization in 2024 and the $4 billion new authorization, bringing total outstanding to $6.69 billion. (2) Calculations are not verifiable due to lack of source data in the ground truth for 2022 and 2023 activity. The LLM invents share counts (e.g., 12.2 million, 13 million) with no basis in the provided truth. (3) The multi-hop reasoning is flawed: the model assumes repurchase volumes based on remaining authorization, which is not logically valid. It also fails to note that the 2023 filing contains forward-looking disclosure about 2024, a key nuance in the original answer. However, the conclusion about a sustained capital return strategy with periodic replenishment aligns semantically with the ground truth. (4) Despite incorrect numbers, the answer addresses the evolution of authorization and attempts to infer strategy, maintaining contextual relevance. However, the quantitative inaccuracies severely undermine correctness, warranting a low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 499,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "BMS’s $750 million 2.350 % senior notes due 2040 appear in every recent 10‑K debt schedule – listed in the 2022 filing (see BMY_10k_2022.pdf p. 138), again in the 2023 filing (see BMY_10k_2023.pdf p. 133) and still shown in the 2024 filing (see BMY_10k_2024.pdf p. 135). By keeping this low‑coupon, long‑dated fixed‑rate issue on its balance sheet, BMS is deliberately locking in inexpensive financing, reducing refinancing risk and preserving liquidity for its long‑term strategic investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative elements are correct: the $750 million principal amount, 2.350% interest rate, and maturity in 2040 are accurately reported. The inclusion across 2022, 2023, and 2024 filings is correctly noted, with specific page references to each 10-K, enhancing verifiability. Format variations (e.g., $750 million vs. $750,000,000) are acceptable and semantically equivalent. (2) The entity identification is accurate—Bristol-Myers Squibb (BMS/BMY) and the specific debt instrument are correctly named. The years and filings (10-K) are properly cited. (3) The reasoning is sound: the LLM correctly infers that the persistent presence of the notes reflects a strategic choice to maintain low-cost, fixed-rate long-term debt, thereby minimizing refinancing risk and stabilizing interest expenses—consistent with the ground truth’s emphasis on interest rate risk management. The LLM adds value by characterizing the coupon as 'low' and linking it to 'inexpensive financing' and 'liquidity preservation,' which is a reasonable qualitative extension supported by context. (4) The only minor gap is that the LLM does not explicitly mention 'interest rate risk management' or 'predictable long-term liabilities' in the same terms as the original, but the conceptual meaning is preserved. The answer is fully contextually relevant, directly addressing how the persistence of the notes reflects BMS's debt management strategy. No factual errors or calculation issues are present. Score reduced slightly from 10 to 9 due to slightly less explicit articulation of the strategic rationale around fixed-rate stability compared to the original, though the core insight remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 475,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "BMS’s disclosed interest‑rate commitment for the 4.350 % senior notes due 2047 has not changed – the company continues to carry a $2.5 billion fixed‑rate commitment on this series in the 2022 filing (see BMY_10k_2022 p. 138), the 2023 filing (see BMY_10k_2023 p. 133) and the 2024 filing (see BMY_10k_2024 p. 135). This steady‑state commitment shows that BMS deliberately locks in a long‑dated, fixed‑coupon debt instrument and maintains a stable long‑term capital structure rather than repeatedly refinancing or altering its senior‑note financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information correctly. (1) Quantitatively, all key facts are correct: the interest rate (4.350%), the consistency across 2022, 2023, and 2024 filings, and the $2.5 billion fixed-rate commitment are all factually accurate and align with the ground truth. The page references (p. 138, 133, 135) are plausible and consistent with typical 10-K structures. (2) The answer correctly identifies the multi-year consistency in disclosure, which supports the conclusion about stable long-term financing. (3) The reasoning is sound: maintaining a fixed-rate, long-dated note without refinancing reflects a deliberate capital structure strategy, which is a valid inference from the data. (4) The only minor shortcoming is that the LLM omits specific details about the indenture documents (e.g., Twelfth/Fourteenth Supplemental Indentures) and the Form 8-K filing from November 22, 2019, which are part of the full disclosure trail in the ground truth. While not critical to the main conclusion, these omissions slightly reduce completeness in entity-level detail. However, the semantic meaning and strategic interpretation are equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 366,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "Nike’s early 10‑K disclosures (fiscal 2022 and again in 2023) only listed FlyEase as one of a long roster of innovative technologies – e.g., “the proliferation of Nike Air, Zoom, Free, Flywire, Dri‑Fit, Flyknit, **FlyEase**, ZoomX, Air Max, React…” – without any detail on how the shoe was being made. By fiscal 2024 the company still cites FlyEase in the same technology‑portfolio paragraph, but it couples that mention with concrete manufacturing data that shows the technology is now embedded in Nike’s global supply chain: as of May 31 2024 Nike’s contract manufacturers ran **96 finished‑goods footwear factories in 11 countries**, with factories in Vietnam, Indonesia and China producing roughly **50 %**, **27 %** and **18 %** of total Nike footwear, and **four contract manufacturers each contributing >10 %** of total footwear output – evidence that FlyEase‑enabled products are being produced at scale worldwide.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the percentages for footwear production in Vietnam (50%), Indonesia (27%), and China (18%) match the original answer exactly. The mention of 96 footwear factories in 11 countries and four contract manufacturers each contributing >10% of output are consistent with typical disclosures in Nike’s 2024 10-K and do not contradict the ground truth; they add contextual detail not in the original but plausibly derived from the filing. (2) The evolution of FlyEase reporting is accurately portrayed: from being listed among other technologies in 2022–2023 without production details, to being implicitly integrated into global manufacturing operations by 2024 through association with detailed supply chain data. (3) The multi-hop reasoning is sound—linking the continued mention of FlyEase in the technology portfolio with new, concurrent disclosure of manufacturing scale demonstrates integration into global operations, which is a valid inference. (4) The only minor shortcoming is that the original answer emphasizes the *geographic distribution* as evidence of FlyEase’s integration, while the LLM extends this to include factory count and manufacturer concentration, which, while relevant and likely accurate, slightly shifts focus. However, this does not detract from factual correctness. Wording differs but semantic meaning and factual content are equivalent. No calculation errors. All entities (Nike, FlyEase, fiscal years, countries) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 429,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "Target’s loyalty‑driven payment product saw its share of purchases slip each year – RedCard penetration was **20.5 % in fiscal 2022**, fell to **19.8 % in fiscal 2023**, and dropped further to **18.6 % in fiscal 2024** (RedCard data in the 2023 10‑K pages 25‑29; re‑branded Target Circle Card data in the 2024 10‑K pages 27‑31). The steady decline, though still near‑one‑fifth of all sales, suggests the discount‑based card program remains important but is losing incremental traction, indicating that the loyalty‑driven payment strategy is becoming less effective over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rates for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it incorrectly states the 2024 penetration rate as 18.6%, whereas the ground truth reports 17.8%. This is a significant quantitative error that affects the trend interpretation. (2) The calculation of the trend — a consistent decline — is logically sound, but the magnitude of the drop from 2023 to 2024 is misrepresented (0.8 percentage points vs. the actual 2.0 percentage points), leading to an understated assessment of the decline. (3) The multi-hop reasoning is otherwise solid: the model correctly synthesizes data across two 10-K filings (2023 and 2024), identifies the rebranding to Target Circle Card as context, and draws a reasonable conclusion about the weakening effectiveness of the loyalty strategy. (4) Despite the incorrect 2024 figure, the qualitative reasoning and structure are strong, and the answer remains contextually relevant and well-supported by cited sources. The core conclusion is directionally correct (declining effectiveness), but the factual inaccuracy in a key data point reduces overall correctness. Quantitative accuracy is penalized heavily due to the wrong 2024 percentage, though other numbers are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 361,
        "total_tokens": 1625
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 7.11,
    "average_quantitative_accuracy": 7.63,
    "average_qualitative_accuracy": 7.37,
    "average_contextual_relevance": 9.04,
    "score_distribution": {
      "excellent": 388,
      "good": 132,
      "fair": 177,
      "poor": 103
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 27069.52,
    "timestamp": "2026-02-02T23:11:35.262450"
  }
}